data_1s6n_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1s6n _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -142.78 137.25 29.59 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.113 0.565 . . . . 0.0 112.093 -162.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 168.42 14.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.669 2.787 . . . . 0.0 109.953 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -83.65 -57.54 3.18 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.239 -0.913 . . . . 0.0 111.994 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -58.36 -29.65 66.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.417 1.487 . . . . 0.0 114.356 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -70.74 -40.03 72.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.33 0.513 . . . . 0.0 111.093 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -65.74 -45.32 83.08 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.962 0.801 . . . . 0.0 109.886 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.99 101.77 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 130.04 3.686 . . . . 0.0 116.756 161.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -68.4 62.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.521 2.328 . . . . 0.0 112.682 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -70.33 -17.92 63.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.382 1.873 . . . . 0.0 113.757 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -160.07 -179.15 7.52 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.444 1.497 . . . . 0.0 110.486 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.05 144.85 24.09 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.668 1.128 . . . . 0.0 114.241 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.99 95.54 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 122.969 1.366 . . . . 0.0 114.152 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 169.44 17.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 128.627 2.771 . . . . 0.0 108.299 168.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -167.27 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.585 0.754 . . . . 0.0 112.484 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? 61.99 -76.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.593 2.357 . . . . 0.0 113.647 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.49 77.06 1.59 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.802 0.81 . . . . 0.0 112.149 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -120.7 156.96 30.66 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.403 1.081 . . . . 0.0 110.144 163.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -143.11 142.39 31.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.085 1.754 . . . . 0.0 108.731 168.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.49 138.7 57.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.67 0.748 . . . . 0.0 111.398 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -43.12 3.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.077 1.351 . . . . 0.0 109.541 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.98 115.48 1.2 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.395 1.95 . . . . 0.0 109.646 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.2 p -64.12 159.58 55.46 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.648 -0.913 . . . . 0.0 111.321 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.46 137.22 68.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.139 1.893 . . . . 0.0 112.585 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 125.3 32.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.5 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.37 132.05 47.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.557 0.694 . . . . 0.0 111.454 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.2 p -78.8 -9.14 59.36 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.818 1.647 . . . . 0.0 113.944 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.16 -7.82 3.08 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 118.994 0.815 . . . . 0.0 114.061 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -94.96 4.87 53.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.069 1.748 . . . . 0.0 111.193 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.02 42.31 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.245 1.879 . . . . 0.0 114.072 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -109.47 174.76 5.72 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.034 2.134 . . . . 0.0 112.056 -171.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.42 141.01 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.936 1.294 . . . . 0.0 110.224 165.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.54 128.89 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.018 1.327 . . . . 0.0 109.918 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.55 133.09 36.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.729 2.012 . . . . 0.0 109.217 -172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HZ3' ' A' ' 79' ' ' LYS . 21.6 tt0 -121.24 132.32 54.74 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.869 0.868 . . . . 0.0 112.612 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.85 166.12 14.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.865 0.866 . . . . 0.0 110.119 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -120.95 148.74 43.67 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.885 0.874 . . . . 0.0 109.45 160.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -100.4 100.36 11.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.011 0.925 . . . . 0.0 109.702 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -80.47 13.64 2.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.453 2.301 . . . . 0.0 115.759 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.08 171.32 27.8 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.507 1.048 . . . . 0.0 113.789 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -96.52 6.42 48.78 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.715 1.606 . . . . 0.0 113.479 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.8 172.68 12.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.87 1.668 . . . . 0.0 112.308 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.65 47.76 0.89 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-O 117.046 -1.975 . . . . 0.0 117.413 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -55.11 95.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.959 0 CA-C-N 121.769 2.785 . . . . 0.0 111.458 162.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 65.4 m -152.96 168.03 27.19 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.367 1.467 . . . . 0.0 112.589 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -83.48 91.96 7.5 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.504 -1.372 . . . . 0.0 110.782 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.81 119.35 15.76 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.676 1.19 . . . . 0.0 112.105 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.83 88.87 1.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.353 2.702 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 tt -124.62 143.72 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.792 -0.567 . . . . 0.0 110.07 165.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.5 t -147.62 157.16 43.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.844 1.258 . . . . 0.0 112.055 -168.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -133.28 108.62 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.993 1.717 . . . . 0.0 110.562 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.73 170.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.794 0.837 . . . . 0.0 112.166 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.19 -12.6 18.62 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -152.93 27.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.114 -1.616 . . . . 0.0 112.602 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.47 17.66 2.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.054 2.142 . . . . 0.0 113.098 -168.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.466 HD22 ' CG2' ' A' ' 61' ' ' VAL . 13.5 p-10 -68.37 52.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.583 2.753 . . . . 0.0 111.952 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -56.94 -25.67 58.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.914 1.285 . . . . 0.0 113.2 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.58 -10.96 0.48 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.566 3.147 . . . . 0.0 116.128 166.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.3 m -153.6 95.75 2.85 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 119.869 -1.77 . . . . 0.0 111.064 166.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 118.1 4.65 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.838 3.692 . . . . 0.0 116.369 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.466 ' CG2' HD22 ' A' ' 56' ' ' ASN . 2.7 t -95.9 -26.21 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.858 1.663 . . . . 0.0 112.859 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.18 -163.52 18.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.514 2.007 . . . . 0.0 111.798 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 172.31 13.02 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.64 104.94 16.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.972 2.109 . . . . 0.0 106.857 168.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.85 -48.58 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.593 0.757 . . . . 0.0 110.453 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -59.82 -48.04 83.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -162.41 161.96 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.235 0.925 . . . . 0.0 112.033 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.16 120.73 45.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.858 0.863 . . . . 0.0 109.563 161.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.82 85.32 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.397 2.064 . . . . 0.0 110.843 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.34 123.9 11.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.048 1.739 . . . . 0.0 110.376 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.48 99.09 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.285 1.434 . . . . 0.0 108.323 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.2 t -75.71 -4.48 40.6 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.17 159.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.076 1.307 . . . . 0.0 112.842 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.62 63.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.936 1.294 . . . . 0.0 113.206 168.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.7 p -80.41 2.53 24.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.076 1.75 . . . . 0.0 114.103 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 14.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.22 16.65 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 130.969 3.708 . . . . 0.0 114.814 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.597 2.359 . . . . 0.0 114.024 -171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HZ3' ' CD ' ' A' ' 35' ' ' GLU . 10.5 tmtt? -112.38 107.83 16.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.708 2.803 . . . . 0.0 105.696 166.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.32 120.02 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.148 0.979 . . . . 0.0 113.231 -153.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.05 129.29 35.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.151 2.581 . . . . 0.0 109.748 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.55 136.92 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.826 2.45 . . . . 0.0 108.499 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -91.09 141.54 28.71 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.343 0.657 . . . . 0.0 112.347 167.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.52 159.62 30.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.339 2.256 . . . . 0.0 110.045 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.45 107.54 58.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 108.95 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.99 115.8 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 125.044 3.83 . . . . 0.0 110.711 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.4 167.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 125.115 3.877 . . . . 0.0 116.172 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -77.59 161.28 27.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.33 -87.57 1.2 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -125.7 160.38 29.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.46 1.124 . . . . 0.0 110.905 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -154.12 159.35 41.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.065 0.936 . . . . 0.0 111.651 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.55 127.96 21.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.299 1.44 . . . . 0.0 108.114 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.46 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.212 1.805 . . . . 0.0 107.011 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -106.65 135.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.56 92.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 126.156 1.782 . . . . 0.0 107.236 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.97 171.19 17.46 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.69 113.52 13.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.061 1.744 . . . . 0.0 110.436 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.07 -103.49 0.05 OUTLIER Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.078 1.799 . . . . 0.0 114.116 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -17.03 64.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.582 1.953 . . . . 0.0 115.727 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -129.43 98.6 4.91 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.545 1.066 . . . . 0.0 110.554 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -148.84 166.03 29.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.51 162.67 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 129.931 3.293 . . . . 0.0 108.502 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.69 157.1 41.62 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 172.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -139.35 151.31 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 111.684 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 160.64 14.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.232 1.413 . . . . 0.0 112.757 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -147.51 154.38 40.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.571 1.548 . . . . 0.0 112.053 158.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -139.69 114.65 9.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.842 1.657 . . . . 0.0 108.685 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -151.19 108.21 3.56 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -165.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 p 52.41 70.68 0.54 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.796 2.838 . . . . 0.0 113.784 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.83 24.63 4.22 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.571 1.557 . . . . 0.0 113.541 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -56.91 155.25 8.22 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 112.668 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 m -51.05 -25.1 4.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.324 1.449 . . . . 0.0 112.761 161.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.01 -4.47 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.332 1.853 . . . . 0.0 112.849 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.11 5.79 60.58 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.636 1.415 . . . . 0.0 116.636 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.483 1.642 . . . . 0.0 113.858 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -145.62 149.66 34.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.392 1.077 . . . . 0.0 111.018 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.11 106.14 13.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.71 2.004 . . . . 0.0 110.094 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.14 -24.15 47.5 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -163.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.74 -39.11 73.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.258 1.023 . . . . 0.0 112.918 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.55 -5.68 41.74 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -71.09 -15.58 62.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -165.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.52 84.93 0.3 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.174 1.352 . . . . 0.0 114.685 170.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -89.4 18.28 5.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.292 1.837 . . . . 0.0 113.833 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -62.16 -12.02 17.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.23 170.88 14.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.563 1.945 . . . . 0.0 108.78 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.09 161.99 40.14 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.471 -0.768 . . . . 0.0 113.396 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -72.51 91.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.269 1.509 . . . . 0.0 113.626 -172.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.67 163.1 35.92 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.281 2.232 . . . . 0.0 109.195 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.6 p -160.03 -44.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.594 1.158 . . . . 0.0 110.774 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 64.46 -70.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 128.227 2.611 . . . . 0.0 112.515 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.81 78.6 1.97 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.328 1.051 . . . . 0.0 112.228 -161.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -134.29 154.98 51.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 111.346 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -146.05 143.88 29.69 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.551 1.94 . . . . 0.0 109.617 165.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.88 129.82 42.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.851 0.86 . . . . 0.0 111.17 167.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -108.71 -51.13 2.92 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.603 1.561 . . . . 0.0 109.39 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.56 104.48 0.69 Allowed Glycine 0 C--N 1.339 0.701 0 C-N-CA 125.861 1.695 . . . . 0.0 109.137 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -64.15 157.29 70.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 117.927 0.864 . . . . 0.0 112.365 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.88 141.09 46.84 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.554 2.836 . . . . 0.0 115.621 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.95 122.91 24.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 110.019 167.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.19 123.18 18.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -72.94 -13.74 61.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.997 0.919 . . . . 0.0 112.64 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 -8.93 2.17 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 119.046 0.839 . . . . 0.0 114.14 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -89.59 11.26 20.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.737 1.615 . . . . 0.0 111.586 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 12.87 58.95 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.861 1.22 . . . . 0.0 113.836 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -131.01 163.39 27.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.835 1.317 . . . . 0.0 112.497 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 123.41 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.176 1.79 . . . . 0.0 107.765 164.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.57 124.72 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.92 146.82 45.92 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.686 1.194 . . . . 0.0 110.682 169.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 79' ' ' LYS . 26.2 tt0 -116.99 135.28 53.82 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.094 0.958 . . . . 0.0 111.073 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.7 mt -117.17 161.09 20.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.29 1.436 . . . . 0.0 109.838 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -120.34 139.54 52.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.246 1.019 . . . . 0.0 109.781 163.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.59 93.32 9.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.521 1.128 . . . . 0.0 109.827 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -72.72 32.21 0.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.88 2.472 . . . . 0.0 115.08 -165.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.42 178.57 45.3 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 122.777 1.209 . . . . 0.0 116.055 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.37 -24.96 29.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.092 2.557 . . . . 0.0 115.655 -169.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.25 173.61 15.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.091 0.956 . . . . 0.0 111.744 -153.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.85 50.88 0.31 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-O 117.131 -1.927 . . . . 0.0 116.301 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.69 87.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.026 0 CA-C-N 121.628 2.714 . . . . 0.0 112.089 160.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.76 169.54 20.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.56 1.144 . . . . 0.0 112.671 -167.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -91.26 92.98 8.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.785 1.234 . . . . 0.0 109.889 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.51 119.81 43.13 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.882 0.873 . . . . 0.0 112.87 -170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.75 88.24 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.358 2.705 . . . . 0.0 109.985 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -123.86 144.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.4 1.48 . . . . 0.0 108.567 167.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.8 t -154.59 167.85 28.73 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.2 t -142.27 125.64 16.6 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.53 2.332 . . . . 0.0 109.877 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.24 167.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.239 1.016 . . . . 0.0 113.657 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.56 22.61 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -155.32 36.05 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.036 -1.665 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.17 10.03 1.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.288 2.235 . . . . 0.0 114.723 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -68.78 46.28 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 129.575 3.15 . . . . 0.0 113.906 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.25 -2.46 4.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -166.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.65 -12.15 2.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.553 1.141 . . . . 0.0 113.672 159.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.6 m -155.0 99.82 2.35 Favored Pre-proline 0 CA--C 1.536 0.409 0 O-C-N 120.304 -1.497 . . . . 0.0 109.468 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.61 126.84 15.08 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.293 3.329 . . . . 0.0 112.619 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.49 -34.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.642 1.177 . . . . 0.0 110.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.48 -170.07 40.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.181 1.372 . . . . 0.0 111.15 161.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.468 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.3 ptp85 -134.99 171.99 13.65 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.208 1.403 . . . . 0.0 111.997 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.32 124.25 34.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.415 1.886 . . . . 0.0 107.452 168.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -95.69 -53.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 118.468 0.576 . . . . 0.0 111.088 -171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -41.3 89.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.63 150.08 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.946 0.899 . . . . 0.0 109.786 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -68.75 147.46 97.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 122.178 -0.326 . . . . 0.0 110.133 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.96 76.82 4.35 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.314 2.676 . . . . 0.0 113.54 -160.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.35 124.99 14.91 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.168 -0.957 . . . . 0.0 111.129 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.53 91.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.253 1.421 . . . . 0.0 107.228 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 t -57.67 -28.28 63.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.7 m -151.53 158.76 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.262 1.825 . . . . 0.0 111.898 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.43 -24.02 67.48 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.395 1.078 . . . . 0.0 112.858 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.68 0.66 0.74 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 129.694 3.197 . . . . 0.0 114.503 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.97 8.98 0.77 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.83 1.652 . . . . 0.0 115.072 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -61.63 18.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 130.648 3.579 . . . . 0.0 116.022 -169.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.09 174.98 11.06 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.903 2.481 . . . . 0.0 114.43 -171.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -126.5 97.72 5.14 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.131 2.572 . . . . 0.0 107.13 170.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.02 119.03 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -148.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mt -59.44 142.38 52.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.001 1.72 . . . . 0.0 112.432 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.8 148.0 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 127.571 2.348 . . . . 0.0 108.377 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -99.19 139.5 34.75 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.354 1.062 . . . . 0.0 111.724 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.3 165.78 15.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.42 2.288 . . . . 0.0 109.55 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 7.9 tt0 -95.57 116.93 66.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.642 1.177 . . . . 0.0 109.425 170.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -98.35 107.14 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.856 4.371 . . . . 0.0 112.349 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -45.76 150.89 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.046 3.164 . . . . 0.0 115.167 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -81.71 162.16 23.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.686 0.795 . . . . 0.0 112.632 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.11 -88.02 0.88 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -162.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.65 148.08 41.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.995 1.318 . . . . 0.0 110.412 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.58 106.83 5.5 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.497 1.119 . . . . 0.0 109.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -110.12 129.16 55.74 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.438 -0.789 . . . . 0.0 110.34 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.16 111.7 36.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 126.378 1.871 . . . . 0.0 107.917 -168.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.08 135.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.852 0.861 . . . . 0.0 110.118 -160.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.22 100.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.04 1.736 . . . . 0.0 108.525 -168.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.97 -175.61 19.97 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 122.242 0.912 . . . . 0.0 114.959 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -138.85 141.09 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.374 1.87 . . . . 0.0 109.789 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 16.28 -87.68 0.0 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.213 2.816 . . . . 0.0 116.255 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -70.06 -20.39 63.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -139.51 96.7 3.13 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.424 1.49 . . . . 0.0 110.382 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 159.06 43.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.48 164.07 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.852 2.461 . . . . 0.0 108.519 166.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -148.91 160.75 42.98 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.836 0.854 . . . . 0.0 109.74 166.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -136.16 167.45 21.25 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 109.93 166.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -120.86 161.47 21.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 112.426 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.33 157.65 42.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 128.927 2.891 . . . . 0.0 109.734 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -145.06 148.14 33.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.234 1.014 . . . . 0.0 109.017 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -153.05 116.83 4.76 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.821 . . . . 0.0 112.088 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.7 p 119.68 -0.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 131.146 3.778 . . . . 0.0 114.38 159.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.19 43.45 0.72 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.751 1.167 . . . . 0.0 111.687 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.3 t -88.32 -154.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.497 1.919 . . . . 0.0 112.313 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.5 p -46.95 -31.38 3.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.374 2.669 . . . . 0.0 116.577 -167.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -112.77 11.23 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 125.299 1.44 . . . . 0.0 111.767 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.55 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.46 -1.4 . . . . 0.0 113.604 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 tptp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.969 1.708 . . . . 0.0 112.499 -168.837 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 173.54 12.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.297 2.239 . . . . 0.0 110.454 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -115.07 -53.41 2.63 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -45.28 -53.03 8.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 114.179 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.73 -29.1 67.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.801 0.84 . . . . 0.0 113.057 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.21 -14.78 60.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.93 1.292 . . . . 0.0 113.518 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -17.65 129.59 0.01 OUTLIER Glycine 0 CA--C 1.533 1.213 1 C-N-CA 130.986 4.136 . . . . 0.0 117.484 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 m -62.82 68.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.882 3.273 . . . . 0.0 113.569 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.783 2.033 . . . . 0.0 114.092 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -150.02 175.45 11.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.59 2.356 . . . . 0.0 109.521 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.25 38.0 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 111.787 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -74.36 97.3 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.01 173.33 16.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.949 1.3 . . . . 0.0 111.812 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 90.3 p -151.14 -22.49 0.21 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.794 1.237 . . . . 0.0 114.321 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? 56.58 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 129.974 3.31 . . . . 0.0 115.696 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.89 74.9 1.61 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.07 1.348 . . . . 0.0 111.471 -159.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.43 160.5 16.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.122 1.369 . . . . 0.0 109.709 160.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -134.14 143.59 48.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.285 1.834 . . . . 0.0 108.106 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -68.03 140.65 56.33 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.762 -0.586 . . . . 0.0 111.075 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.62 -57.05 2.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.61 1.164 . . . . 0.0 109.028 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 107.27 0.85 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.766 1.651 . . . . 0.0 110.466 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -42.67 137.23 2.44 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 111.21 170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.89 152.15 52.28 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.299 2.0 . . . . 0.0 113.76 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.61 121.86 13.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.262 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.05 123.51 20.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.997 0.903 . . . . 0.0 110.804 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -63.38 -16.7 61.27 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.897 2.479 . . . . 0.0 114.352 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.93 -13.49 43.41 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.03 0.832 . . . . 0.0 113.174 -167.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -80.01 8.44 7.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.698 1.249 . . . . 0.0 112.063 165.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.74 84.42 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.532 -1.149 . . . . 0.0 113.949 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.0 p -125.91 146.6 49.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.143 2.177 . . . . 0.0 110.091 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 m -91.92 138.18 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.105 0.962 . . . . 0.0 111.003 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -85.81 133.45 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 155.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 126.15 16.81 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.57 2.348 . . . . 0.0 109.043 -167.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.12 134.29 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.574 1.079 . . . . 0.0 113.471 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.29 174.27 9.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.814 1.645 . . . . 0.0 111.109 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -135.67 139.44 43.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.431 1.092 . . . . 0.0 110.394 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -89.05 102.99 15.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.319 0.648 . . . . 0.0 110.039 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -80.39 -9.11 59.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 113.535 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.27 166.04 54.67 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.043 0.838 . . . . 0.0 113.394 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -118.95 11.76 12.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.862 1.665 . . . . 0.0 110.531 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -157.71 -178.6 7.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.913 2.485 . . . . 0.0 110.208 -156.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.98 58.98 2.38 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.255 1.662 . . . . 0.0 117.255 164.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -51.94 109.01 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.936 2.424 . . . . 0.0 111.072 155.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.56 155.64 19.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -164.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -81.16 91.15 6.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.543 1.537 . . . . 0.0 109.482 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.35 116.19 14.07 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.938 0.895 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.37 82.22 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 111.269 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -105.96 145.0 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 167.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -154.03 170.33 21.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.152 1.381 . . . . 0.0 113.048 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -144.31 117.16 8.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.445 2.298 . . . . 0.0 110.637 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.72 169.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.678 1.191 . . . . 0.0 112.945 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.93 -3.51 21.68 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -154.78 30.84 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.01 -1.681 . . . . 0.0 112.528 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.8 7.98 1.65 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.462 1.905 . . . . 0.0 114.286 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -69.52 46.48 0.07 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.875 3.27 . . . . 0.0 113.474 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.84 -7.42 5.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -163.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -58.31 -23.54 56.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.252 1.421 . . . . 0.0 112.96 162.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.0 m -132.71 95.64 19.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 125.652 1.581 . . . . 0.0 109.407 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 123.31 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.108 2.538 . . . . 0.0 110.916 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.17 -22.35 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.365 1.066 . . . . 0.0 111.181 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.48 -170.23 18.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.938 2.208 . . . . 0.0 111.797 165.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -138.16 172.82 12.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.918 1.287 . . . . 0.0 112.59 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 126.79 39.24 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 106.809 167.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -98.63 -41.66 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.62 -168.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -63.07 -50.29 71.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.127 0.876 . . . . 0.0 113.319 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 p -164.29 166.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.335 1.054 . . . . 0.0 111.428 -165.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.06 123.5 48.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.872 0.869 . . . . 0.0 109.164 161.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.26 95.86 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.081 1.854 . . . . 0.0 111.131 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -146.46 142.84 28.52 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.398 -0.814 . . . . 0.0 112.612 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.59 95.86 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 126.858 2.063 . . . . 0.0 106.25 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.4 p -70.24 -22.1 62.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.4 m -150.8 157.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.853 1.661 . . . . 0.0 112.065 -170.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.61 65.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.974 0.91 . . . . 0.0 113.275 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.8 p -78.56 8.11 5.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.6 1.96 . . . . 0.0 113.711 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 12.82 0.07 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.921 1.689 . . . . 0.0 115.357 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.38 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.793 3.237 . . . . 0.0 115.243 -167.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.23 163.22 28.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.19 1.796 . . . . 0.0 113.389 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -98.82 111.1 23.58 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 128.244 2.618 . . . . 0.0 106.045 159.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.72 140.3 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.319 1.048 . . . . 0.0 112.62 -157.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.84 131.64 52.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.963 2.505 . . . . 0.0 109.536 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.95 155.12 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.457 1.903 . . . . 0.0 109.522 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -109.0 132.25 54.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.578 . . . . 0.0 110.62 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.57 160.71 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.857 1.663 . . . . 0.0 110.103 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 104.58 35.46 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.167 0.987 . . . . 0.0 109.079 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.38 118.35 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.274 3.316 . . . . 0.0 109.654 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.4 160.61 49.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.215 1.943 . . . . 0.0 111.082 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -66.09 159.57 25.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.545 1.138 . . . . 0.0 112.645 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.55 -148.23 18.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.581 1.086 . . . . 0.0 110.566 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.04 146.0 55.59 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.68 -0.894 . . . . 0.0 109.048 152.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -135.37 100.56 4.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.729 0.812 . . . . 0.0 109.621 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -109.08 132.62 53.94 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.084 0.945 . . . . 0.0 111.025 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.01 99.33 8.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 127.866 2.466 . . . . 0.0 107.151 -166.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.8 t -101.08 139.44 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.461 0.704 . . . . 0.0 109.483 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.62 87.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.29 1.436 . . . . 0.0 108.369 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.83 168.52 29.14 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 118.243 2.057 . . . . 0.0 118.243 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.56 146.35 37.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.86 1.664 . . . . 0.0 109.512 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.25 -98.5 0.01 OUTLIER Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.398 1.951 . . . . 0.0 115.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -90.11 -13.55 35.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.992 1.717 . . . . 0.0 114.317 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.49 90.36 3.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.569 1.548 . . . . 0.0 109.291 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.4 155.06 45.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.8 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 129.178 2.991 . . . . 0.0 108.098 170.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.29 156.38 38.31 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.396 -0.815 . . . . 0.0 110.95 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.31 160.83 32.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.286 2.235 . . . . 0.0 109.231 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.38 144.88 40.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.839 0.456 . . . . 0.0 111.433 -168.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.67 169.94 16.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.935 1.694 . . . . 0.0 111.226 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.29 117.24 14.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.077 1.751 . . . . 0.0 108.112 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -141.03 87.32 2.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 112.793 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.9 m 54.65 63.62 2.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.749 2.02 . . . . 0.0 113.521 168.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.57 12.68 0.78 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.438 1.494 . . . . 0.0 114.101 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.5 t -75.53 158.19 32.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.734 1.214 . . . . 0.0 112.961 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 m -40.34 -33.94 0.29 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 130.326 3.45 . . . . 0.0 114.54 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.21 -7.51 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.358 1.063 . . . . 0.0 113.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.53 55.17 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 118.844 -0.975 . . . . 0.0 115.464 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 C-N-CA 125.104 1.362 . . . . 0.0 112.396 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 162.34 36.51 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.229 0.611 . . . . 0.0 111.676 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 -172.68 2.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.16 2.184 . . . . 0.0 110.773 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -106.72 -57.68 2.03 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.518 -0.738 . . . . 0.0 110.702 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -53.47 -34.41 57.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.579 2.352 . . . . 0.0 114.876 -172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.87 -22.03 66.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.364 0.984 . . . . 0.0 112.91 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -82.72 -2.49 54.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.708 0.803 . . . . 0.0 112.698 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -20.07 113.74 0.01 OUTLIER Glycine 0 CA--C 1.532 1.102 1 C-N-CA 130.818 4.056 . . . . 0.0 116.64 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -67.52 72.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.86 2.464 . . . . 0.0 113.897 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.0 p -74.27 -19.89 60.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.021 1.728 . . . . 0.0 114.172 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.66 170.53 16.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.981 2.112 . . . . 0.0 109.558 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.72 142.82 34.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.119 0.866 . . . . 0.0 112.588 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.41 103.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.65 1.18 . . . . 0.0 112.607 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 148.24 17.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.603 2.361 . . . . 0.0 109.064 -171.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -141.0 -21.9 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 45.36 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.983 3.313 . . . . 0.0 115.328 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.81 80.41 1.58 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.577 1.551 . . . . 0.0 110.571 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -124.62 155.92 38.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.366 1.066 . . . . 0.0 110.684 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -143.85 146.81 33.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.839 1.656 . . . . 0.0 108.493 166.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -69.43 140.28 54.08 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.761 -0.587 . . . . 0.0 111.27 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.58 -44.04 4.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.431 1.092 . . . . 0.0 109.812 168.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.62 117.01 1.15 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.458 1.027 . . . . 0.0 112.419 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.9 m -45.59 146.76 1.68 Allowed Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 127.934 2.494 . . . . 0.0 112.465 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.95 135.79 36.4 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.099 2.533 . . . . 0.0 113.467 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.77 111.54 13.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.025 1.73 . . . . 0.0 110.023 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.31 122.06 12.97 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.33 1.452 . . . . 0.0 111.432 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 29' ' ' HIS . 70.1 p -75.46 -11.33 60.01 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.58 -26.79 0.37 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.779 1.18 . . . . 0.0 113.866 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . 0.425 ' H ' ' C ' ' A' ' 27' ' ' THR . 51.4 m80 -70.47 -9.74 57.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.518 2.327 . . . . 0.0 112.968 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.33 14.09 12.26 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.817 1.199 . . . . 0.0 114.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 p -128.43 171.14 12.34 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.26 1.424 . . . . 0.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 m -128.82 120.21 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.904 1.682 . . . . 0.0 109.087 171.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.59 133.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.08 130.23 35.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.346 1.858 . . . . 0.0 108.645 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -109.63 128.57 55.32 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.326 0.584 . . . . 0.0 112.388 -174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.52 167.97 12.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.001 1.321 . . . . 0.0 110.501 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.41 142.45 51.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.658 1.183 . . . . 0.0 109.851 162.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -94.1 101.26 13.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -76.3 7.95 3.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.101 2.16 . . . . 0.0 115.265 -169.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.56 169.76 21.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.66 1.118 . . . . 0.0 113.859 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -103.12 -0.45 30.6 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.323 1.849 . . . . 0.0 113.666 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -136.72 173.71 11.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.246 1.818 . . . . 0.0 112.33 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 56.81 1.04 Allowed Glycine 0 CA--C 1.539 1.535 0 CA-C-O 117.823 -1.543 . . . . 0.0 116.719 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.17 99.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.29 2.66 . . . . 0.0 111.897 155.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 m -151.47 166.72 30.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.399 1.08 . . . . 0.0 112.548 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 ttmm -92.58 98.98 11.79 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.811 170.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.32 117.31 39.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.01 1.324 . . . . 0.0 111.353 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.53 85.62 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.658 2.905 . . . . 0.0 111.565 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.89 146.79 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.937 0.895 . . . . 0.0 109.966 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 t -149.65 167.35 26.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.01 1.324 . . . . 0.0 113.524 -167.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 t -142.66 107.55 4.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.284 2.233 . . . . 0.0 110.974 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 m -136.15 163.72 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.04 -7.46 16.92 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -166.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -154.04 34.75 0.43 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.385 -1.447 . . . . 0.0 111.368 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt 57.71 12.77 1.73 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.7 2.0 . . . . 0.0 114.546 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.405 HD22 ' CG2' ' A' ' 61' ' ' VAL . 3.9 p-10 -67.01 45.83 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 130.141 3.376 . . . . 0.0 114.345 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.68 -9.2 12.77 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -165.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.44 -10.36 2.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.399 1.48 . . . . 0.0 114.218 162.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.4 m -155.49 118.86 2.41 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 110.541 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.3 141.32 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.214 2.609 . . . . 0.0 111.116 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' HD22 ' A' ' 56' ' ' ASN . 3.5 t -116.58 -34.27 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.945 0.898 . . . . 0.0 110.967 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.45 -167.43 39.56 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.846 1.212 . . . . 0.0 110.753 156.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -135.33 172.04 13.58 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.916 1.286 . . . . 0.0 111.621 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.51 139.72 31.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 161.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.38 -49.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.194 0.597 . . . . 0.0 110.754 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.4 m -57.87 -43.58 86.1 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.97 161.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.996 0.816 . . . . 0.0 111.061 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.64 117.45 18.95 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 156.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.92 93.81 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.387 2.058 . . . . 0.0 111.783 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -144.82 135.07 24.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.114 1.365 . . . . 0.0 111.276 168.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.11 89.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 127.609 2.364 . . . . 0.0 107.151 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -63.38 -32.02 73.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.92 156.85 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.983 2.113 . . . . 0.0 110.914 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.04 -25.46 67.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.794 0.838 . . . . 0.0 112.436 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 4.66 5.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.057 2.143 . . . . 0.0 114.599 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 13.46 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 130.924 3.69 . . . . 0.0 115.219 -169.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.91 173.89 10.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.593 1.957 . . . . 0.0 113.667 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -117.0 108.84 16.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.615 3.166 . . . . 0.0 105.77 169.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.06 127.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.632 0.773 . . . . 0.0 112.967 -154.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mt -79.52 135.52 36.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.777 2.031 . . . . 0.0 110.911 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.96 129.35 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.089 2.155 . . . . 0.0 108.395 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -81.1 134.26 35.62 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.782 0.801 . . . . 0.0 111.667 170.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.06 161.59 18.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.973 2.109 . . . . 0.0 109.38 162.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -94.41 125.06 53.49 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.25 128.22 7.99 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 124.294 3.329 . . . . 0.0 111.036 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.7 168.68 20.79 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.299 1.333 . . . . 0.0 110.599 160.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.34 162.71 15.67 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.247 -0.908 . . . . 0.0 112.287 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.08 -83.97 1.6 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -117.97 170.01 9.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.313 1.054 . . . . 0.0 110.8 169.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.9 m -145.73 84.75 1.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.319 1.447 . . . . 0.0 108.881 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.36 128.83 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.412 1.085 . . . . 0.0 109.048 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.92 94.59 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.978 1.711 . . . . 0.0 107.749 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.46 145.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.689 0.795 . . . . 0.0 109.915 -166.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.3 94.39 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 108.132 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.73 167.67 28.74 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 119.262 2.465 . . . . 0.0 119.262 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.39 109.66 6.51 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.064 2.546 . . . . 0.0 109.274 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.43 -102.03 0.04 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.792 1.663 . . . . 0.0 114.215 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.79 -18.97 62.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 115.151 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.73 94.64 4.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.001 0.92 . . . . 0.0 108.913 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.63 43.69 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.82 167.88 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 128.754 2.822 . . . . 0.0 108.569 170.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.02 149.16 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.872 0.869 . . . . 0.0 110.805 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.27 163.39 19.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.994 2.117 . . . . 0.0 109.232 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -138.37 130.73 28.89 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.757 -0.59 . . . . 0.0 110.059 -161.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.19 165.7 28.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.352 1.061 . . . . 0.0 111.62 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -144.06 116.45 8.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.956 1.303 . . . . 0.0 109.423 -160.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -144.68 87.63 1.87 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -164.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 76.6 p 59.39 84.6 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.364 1.865 . . . . 0.0 113.81 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.36 23.84 6.46 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.759 1.647 . . . . 0.0 112.751 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.4 t -58.42 162.86 3.42 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.021 1.728 . . . . 0.0 114.013 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -56.37 -15.12 3.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.28 1.032 . . . . 0.0 113.612 163.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.45 3.38 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 126.181 1.792 . . . . 0.0 111.551 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.97 -11.5 71.93 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 119.95 -1.719 . . . . 0.0 116.124 169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--O 1.249 1.04 0 CA-C-N 118.904 1.352 . . . . 0.0 113.094 171.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -69.05 -178.96 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.056 2.142 . . . . 0.0 113.197 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.38 155.76 45.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.506 2.722 . . . . 0.0 110.827 -163.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -88.66 -61.73 1.64 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.454 -0.779 . . . . 0.0 111.757 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -60.04 -31.91 70.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.178 1.391 . . . . 0.0 113.938 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -4.97 46.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.121 0.968 . . . . 0.0 112.997 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -57.72 -31.44 66.44 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 81.15 0.57 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -68.4 -6.64 25.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.453 1.901 . . . . 0.0 114.81 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -75.12 0.97 14.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -170.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -141.76 154.08 45.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.877 1.217 . . . . 0.0 112.039 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 160.22 45.29 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.648 1.118 . . . . 0.0 112.708 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.38 95.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 122.641 1.21 . . . . 0.0 114.076 -167.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 171.28 19.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.95 1.7 . . . . 0.0 111.247 167.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -150.42 -3.22 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.097 152.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 53.98 -75.95 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.191 2.597 . . . . 0.0 113.586 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.33 74.34 5.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.18 1.792 . . . . 0.0 112.837 -163.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.67 149.2 52.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.635 0.774 . . . . 0.0 111.124 166.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -138.31 141.25 39.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.775 1.63 . . . . 0.0 109.827 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -61.7 128.69 37.46 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.057 0.943 . . . . 0.0 110.603 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.34 -26.23 6.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.063 0.945 . . . . 0.0 112.854 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.04 123.93 2.82 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.367 0.984 . . . . 0.0 111.037 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.0 p -62.54 144.2 95.86 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 125.162 1.385 . . . . 0.0 111.427 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.96 148.33 47.88 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.818 2.345 . . . . 0.0 115.142 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.38 128.15 20.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.723 1.609 . . . . 0.0 110.854 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.71 132.29 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.552 0.741 . . . . 0.0 111.048 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -78.77 -9.55 59.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.586 1.554 . . . . 0.0 113.944 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.36 -2.84 9.08 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.21 0.913 . . . . 0.0 113.891 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -103.39 5.9 37.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.94 1.696 . . . . 0.0 111.704 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.41 13.76 50.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.961 1.267 . . . . 0.0 114.083 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.9 p -129.67 168.33 16.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.272 1.429 . . . . 0.0 111.565 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.78 130.73 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.915 1.686 . . . . 0.0 108.37 164.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 m -83.28 124.77 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 160.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 154.2 49.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.645 1.178 . . . . 0.0 110.553 170.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -119.61 134.4 55.24 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.202 -0.936 . . . . 0.0 111.675 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.77 163.13 22.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.159 0.984 . . . . 0.0 111.02 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -126.55 137.11 53.31 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.796 1.239 . . . . 0.0 110.011 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.13 97.34 11.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.038 0.935 . . . . 0.0 110.373 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.9 p -77.43 43.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.519 1.928 . . . . 0.0 113.688 -166.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.56 -177.77 48.51 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.071 -1.018 . . . . 0.0 114.869 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -116.41 0.76 12.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.485 1.514 . . . . 0.0 114.295 -167.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -145.96 173.8 11.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.421 1.489 . . . . 0.0 112.546 -169.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.53 48.24 0.87 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 166.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.04 107.0 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.574 2.849 . . . . 0.0 113.03 164.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.86 165.17 18.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.348 0.659 . . . . 0.0 112.523 -164.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.35 6.57 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.365 -1.459 . . . . 0.0 111.49 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.75 114.34 5.64 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.908 1.683 . . . . 0.0 113.562 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.82 84.58 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.114 2.543 . . . . 0.0 111.213 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -125.04 144.91 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.962 1.305 . . . . 0.0 109.531 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -146.74 162.11 39.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.811 1.245 . . . . 0.0 112.883 -172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -142.0 110.88 6.23 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.749 2.02 . . . . 0.0 110.164 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.01 170.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.315 1.046 . . . . 0.0 111.95 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.17 -4.63 21.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -152.17 30.84 0.55 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.906 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.84 25.4 8.46 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.41 1.484 . . . . 0.0 112.394 -173.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.44 HD22 ' CG2' ' A' ' 61' ' ' VAL . 12.5 p-10 -91.61 50.99 1.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.122 2.569 . . . . 0.0 112.201 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -56.29 -11.11 1.06 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -9.92 11.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.909 1.283 . . . . 0.0 114.359 164.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.4 m -149.06 95.62 3.84 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.159 -1.588 . . . . 0.0 110.17 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.53 86.98 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 1 C-N-CA 125.639 4.226 . . . . 0.0 115.883 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.44 ' CG2' HD22 ' A' ' 56' ' ' ASN . 2.1 t -67.66 -33.96 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.893 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 -161.56 27.52 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.427 1.965 . . . . 0.0 112.045 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -146.96 177.69 8.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.09 1.756 . . . . 0.0 112.509 169.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.37 117.98 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.613 2.365 . . . . 0.0 107.604 171.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.7 t -90.51 -58.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 111.109 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -59.01 -44.33 91.67 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.593 0.633 . . . . 0.0 112.525 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.44 139.3 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 160.36 77.57 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 159.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.6 77.41 3.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 115.303 -156.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -145.71 127.34 15.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.495 -1.378 . . . . 0.0 114.592 154.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.31 100.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.764 1.626 . . . . 0.0 106.889 166.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 t -77.86 -6.86 55.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.74 149.52 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.504 1.047 . . . . 0.0 111.956 -170.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.95 -21.9 66.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.719 1.208 . . . . 0.0 113.061 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.12 0.32 6.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.183 2.593 . . . . 0.0 114.47 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 10.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.09 13.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 131.475 3.91 . . . . 0.0 116.06 -166.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.18 168.53 19.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.375 1.87 . . . . 0.0 114.184 -169.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.52 109.09 20.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.304 2.642 . . . . 0.0 105.946 158.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.05 125.3 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.017 0.927 . . . . 0.0 112.412 -159.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.31 133.01 43.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.189 0.996 . . . . 0.0 109.447 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.5 mt -128.58 143.33 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.131 1.772 . . . . 0.0 107.976 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -98.4 137.21 37.44 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.76 0.791 . . . . 0.0 111.571 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.83 164.31 17.7 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.01 2.124 . . . . 0.0 108.899 166.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 26.0 tt0 -100.39 107.18 46.79 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.922 1.289 . . . . 0.0 108.392 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.8 108.31 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.894 1 C-N-CA 126.581 4.854 . . . . 0.0 111.236 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -64.15 161.0 35.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.988 1.792 . . . . 0.0 110.77 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -94.56 166.69 11.91 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.8 -78.97 1.0 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.86 150.7 42.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 110.184 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -136.86 97.9 3.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.693 1.197 . . . . 0.0 109.157 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -95.43 123.53 39.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.608 1.163 . . . . 0.0 109.933 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.98 98.43 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.982 2.113 . . . . 0.0 107.153 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.22 139.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.91 -165.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.89 103.33 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.766 1.626 . . . . 0.0 108.698 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 145.68 172.36 15.99 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 172.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -132.75 143.63 49.73 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.166 1.787 . . . . 0.0 109.875 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 17.06 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 127.741 2.591 . . . . 0.0 116.354 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -74.72 -15.3 60.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.203 2.201 . . . . 0.0 116.72 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -137.88 100.38 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.134 1.374 . . . . 0.0 110.747 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -142.65 160.73 39.73 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.97 165.96 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 128.814 2.846 . . . . 0.0 108.3 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.64 167.6 25.93 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.973 -1.079 . . . . 0.0 110.613 166.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -131.73 158.97 39.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.041 1.337 . . . . 0.0 109.052 163.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -112.59 160.17 18.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.239 1.416 . . . . 0.0 110.867 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.11 155.83 36.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.131 1.773 . . . . 0.0 109.212 168.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.66 143.41 30.73 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.097 0.959 . . . . 0.0 108.753 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -134.96 158.49 44.18 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.247 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.9 p 67.96 -1.65 1.67 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.3 42.07 3.08 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.395 0.998 . . . . 0.0 112.35 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -84.83 -144.59 0.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.973 1.709 . . . . 0.0 111.934 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.3 p -46.7 -46.36 20.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.59 1.956 . . . . 0.0 115.549 -166.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.02 8.26 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 125.539 1.536 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.75 25.52 60.3 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.248 -1.533 . . . . 0.0 112.848 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 tptp . . . . . 0 C--O 1.247 0.944 0 C-N-CA 126.941 2.096 . . . . 0.0 111.881 -166.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -147.07 150.31 34.79 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.093 0.957 . . . . 0.0 110.766 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.39 173.88 11.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.859 2.464 . . . . 0.0 110.858 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -91.93 -59.61 2.07 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.408 -0.807 . . . . 0.0 112.664 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -58.17 -36.78 73.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.787 1.235 . . . . 0.0 113.632 -168.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.05 -15.56 59.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.538 1.135 . . . . 0.0 113.318 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -85.54 -11.11 54.91 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.293 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 18.37 84.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 130.139 3.733 . . . . 0.0 118.453 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -72.5 71.74 0.96 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.102 -1.234 . . . . 0.0 111.839 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p -78.36 -20.07 52.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.118 1.367 . . . . 0.0 114.551 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.25 -178.82 7.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.33 130.96 51.77 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.484 1.04 . . . . 0.0 112.663 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.82 102.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.662 1.185 . . . . 0.0 111.93 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 155.9 22.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.418 1.887 . . . . 0.0 110.008 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -160.38 -41.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.543 1.137 . . . . 0.0 111.223 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt 65.65 -65.46 0.17 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.385 2.674 . . . . 0.0 113.333 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.74 79.0 1.21 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.445 1.098 . . . . 0.0 111.434 -161.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -126.5 160.09 31.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.449 1.5 . . . . 0.0 110.09 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -142.23 147.68 36.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 108.997 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -61.82 127.89 33.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.126 0.57 . . . . 0.0 110.99 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.55 -48.4 4.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.189 0.996 . . . . 0.0 108.988 168.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.97 105.69 0.68 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.491 1.996 . . . . 0.0 109.748 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 p -57.96 156.31 20.01 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.627 0.771 . . . . 0.0 111.478 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.76 141.87 80.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.951 1.767 . . . . 0.0 113.166 -165.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 119.8 14.78 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.449 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -65.32 118.99 10.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.28 1.038 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.9 p -68.9 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 114.309 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.99 56.0 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.301 -160.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -69.53 -12.42 61.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.013 1.906 . . . . 0.0 111.296 162.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.16 -3.69 40.87 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 126.667 2.08 . . . . 0.0 113.155 -167.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -129.73 152.86 48.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.795 2.038 . . . . 0.0 111.599 -166.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 m -93.64 126.06 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 0.0 110.327 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 m -78.43 136.66 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 161.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -141.81 131.48 24.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.084 2.154 . . . . 0.0 108.138 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -118.94 131.9 56.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.825 0.739 . . . . 0.0 112.04 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.54 162.21 19.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.345 0.658 . . . . 0.0 110.703 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -115.51 129.55 56.58 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.849 1.259 . . . . 0.0 109.015 165.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.89 100.47 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.07 0.948 . . . . 0.0 109.392 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 p -78.39 -4.44 48.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.539 1.536 . . . . 0.0 114.624 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.92 169.24 12.88 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 119.311 0.96 . . . . 0.0 114.697 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -106.83 0.86 24.32 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.447 1.899 . . . . 0.0 113.244 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -138.49 -175.05 3.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.115 1.766 . . . . 0.0 111.316 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.51 45.61 1.95 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.892 -2.06 . . . . 0.0 117.523 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -54.73 102.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.984 0 CA-C-N 122.057 2.928 . . . . 0.0 111.042 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.5 m -156.92 171.17 20.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 112.624 -164.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -94.08 99.98 12.17 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.63 -1.294 . . . . 0.0 109.954 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.39 126.38 84.32 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.459 0.704 . . . . 0.0 112.603 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.37 101.63 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.711 2.941 . . . . 0.0 111.884 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.0 tt -133.47 146.55 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.144 0.978 . . . . 0.0 109.855 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -148.76 160.67 42.97 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 t -138.19 116.7 12.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.073 2.149 . . . . 0.0 110.218 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.62 164.57 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.556 1.142 . . . . 0.0 112.24 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.16 -10.18 28.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -154.79 34.34 0.4 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.085 -1.634 . . . . 0.0 112.625 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.78 11.4 1.83 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.477 1.911 . . . . 0.0 113.958 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.447 HD22 ' CG2' ' A' ' 61' ' ' VAL . 9.2 p-10 -69.83 51.32 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.032 2.933 . . . . 0.0 113.026 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -59.14 -16.38 19.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.839 1.655 . . . . 0.0 115.349 -165.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.24 -8.86 1.23 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.487 1.515 . . . . 0.0 114.876 169.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 m -155.13 104.57 2.25 Favored Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 120.203 -1.561 . . . . 0.0 111.063 166.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.42 115.69 1.06 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.164 3.909 . . . . 0.0 113.882 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.447 ' CG2' HD22 ' A' ' 56' ' ' ASN . 3.2 t -97.58 -22.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.931 1.692 . . . . 0.0 111.501 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.11 26.3 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.868 1.699 . . . . 0.0 111.041 163.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 176.78 7.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.11 106.82 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.726 2.411 . . . . 0.0 106.374 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -78.41 -45.58 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.734 0.813 . . . . 0.0 110.69 -166.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -69.78 -41.4 75.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.11 149.96 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.833 1.197 . . . . 0.0 113.54 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -61.74 119.73 50.34 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.361 1.464 . . . . 0.0 109.762 162.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.34 90.22 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.109 2.539 . . . . 0.0 113.69 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.56 126.27 12.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.501 1.921 . . . . 0.0 111.515 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.3 88.84 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.729 2.012 . . . . 0.0 108.263 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.4 t -70.6 -8.94 55.4 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.69 155.35 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.906 1.23 . . . . 0.0 112.287 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.66 -19.71 62.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.125 0.97 . . . . 0.0 112.698 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.0 p -77.54 9.79 3.08 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.086 1.754 . . . . 0.0 113.133 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.63 10.23 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.302 1.841 . . . . 0.0 115.235 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.03 22.85 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 130.27 3.428 . . . . 0.0 115.139 -165.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.2 165.73 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.797 2.039 . . . . 0.0 114.183 -170.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 109.06 21.16 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.315 2.646 . . . . 0.0 106.269 160.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.33 121.85 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 111.964 -156.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.57 128.05 40.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.056 2.542 . . . . 0.0 109.942 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.69 129.53 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.228 2.211 . . . . 0.0 108.34 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.04 138.53 33.03 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.468 -0.77 . . . . 0.0 111.022 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.94 157.59 29.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.285 2.234 . . . . 0.0 109.039 166.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -97.73 109.68 51.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.193 0.997 . . . . 0.0 109.24 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -93.03 116.64 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 125.263 3.975 . . . . 0.0 110.287 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.6 158.16 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.163 3.242 . . . . 0.0 115.552 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -75.52 161.15 29.42 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.16 -0.963 . . . . 0.0 112.502 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.65 -79.04 1.8 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.52 158.44 44.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.492 1.117 . . . . 0.0 110.446 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.5 m -158.87 156.84 30.33 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.929 -1.107 . . . . 0.0 112.264 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -145.71 136.74 24.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.484 1.113 . . . . 0.0 109.089 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 mm -120.52 114.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.301 1.841 . . . . 0.0 107.158 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.72 141.31 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.418 0.687 . . . . 0.0 109.849 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.82 101.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.171 2.188 . . . . 0.0 108.341 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.43 177.49 15.15 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.5 122.2 24.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.697 1.999 . . . . 0.0 110.632 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.26 -99.84 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.48 1.99 . . . . 0.0 114.807 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -68.46 -14.28 62.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.365 1.866 . . . . 0.0 115.758 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -136.14 98.67 3.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.44 1.096 . . . . 0.0 111.197 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.57 167.25 23.5 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.09 164.69 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.648 2.779 . . . . 0.0 108.639 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -150.99 164.57 36.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.464 0.706 . . . . 0.0 111.33 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -143.57 136.57 27.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.296 1.438 . . . . 0.0 110.439 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 162.57 23.36 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 113.071 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.74 150.63 35.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.684 1.993 . . . . 0.0 111.007 161.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -139.9 113.99 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.524 1.13 . . . . 0.0 108.156 -170.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -149.95 81.68 1.38 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.5 t 69.16 70.8 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.756 2.023 . . . . 0.0 113.876 165.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.61 21.1 2.03 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.739 2.114 . . . . 0.0 113.17 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.9 t -65.03 151.94 44.7 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.501 1.92 . . . . 0.0 113.591 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -61.59 -8.48 4.47 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 164.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.22 -4.38 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 127.019 2.128 . . . . 0.0 111.308 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.02 4.67 58.63 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.628 -1.295 . . . . 0.0 116.207 171.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 116.987 -1.482 . . . . 0.0 112.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.21 160.47 39.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.159 0.89 . . . . 0.0 112.432 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 145.32 50.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.131 2.173 . . . . 0.0 109.664 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.28 -54.43 8.4 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.17 -1.581 . . . . 0.0 112.426 -172.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -58.55 -29.8 66.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.902 1.681 . . . . 0.0 113.791 -170.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.91 -28.73 69.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.176 0.898 . . . . 0.0 112.841 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -19.42 62.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.388 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 9.46 105.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 130.584 3.945 . . . . 0.0 117.559 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -68.82 73.53 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.801 2.04 . . . . 0.0 113.602 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 p -71.93 -18.64 62.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.717 2.007 . . . . 0.0 114.676 168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -156.16 176.31 12.84 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.382 1.473 . . . . 0.0 110.511 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.48 148.54 50.5 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.443 0.544 . . . . 0.0 112.496 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.08 97.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.66 1.184 . . . . 0.0 112.544 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.76 168.81 25.62 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.876 1.671 . . . . 0.0 111.193 166.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 47' ' ' VAL . 94.1 p -144.02 -30.43 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt 59.2 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.311 2.244 . . . . 0.0 112.536 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.36 83.19 3.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.128 0.971 . . . . 0.0 112.069 -167.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.29 165.25 23.82 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.486 1.514 . . . . 0.0 111.587 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -151.05 155.11 38.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.993 2.117 . . . . 0.0 109.627 166.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.95 140.26 57.74 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.275 -0.89 . . . . 0.0 111.742 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -38.57 3.11 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.23 103.97 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.211 1.386 . . . . 0.0 110.279 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -47.74 138.09 9.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.125 2.17 . . . . 0.0 112.221 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 130.83 42.67 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.015 2.477 . . . . 0.0 112.768 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.05 119.95 28.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.167 1.387 . . . . 0.0 110.158 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.25 129.72 40.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.84 0.829 . . . . 0.0 111.032 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.3 p -78.18 -8.69 58.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 127.077 2.151 . . . . 0.0 113.586 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.63 -5.35 23.35 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.336 0.971 . . . . 0.0 113.945 -168.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -96.12 3.17 53.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.812 1.306 . . . . 0.0 112.062 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.33 4.33 56.31 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.829 1.204 . . . . 0.0 113.941 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -123.72 165.12 17.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.255 1.422 . . . . 0.0 111.941 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.15 140.66 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.025 1.33 . . . . 0.0 109.543 162.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.06 125.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.8 0.84 . . . . 0.0 109.014 161.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 120.99 18.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.531 1.932 . . . . 0.0 109.208 -167.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.73 132.6 52.52 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.189 -0.944 . . . . 0.0 112.631 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.07 162.71 20.72 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.433 1.093 . . . . 0.0 110.462 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -117.66 134.27 55.07 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.157 0.983 . . . . 0.0 109.98 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -84.8 108.03 17.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.873 0.869 . . . . 0.0 109.668 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -82.92 -4.03 57.7 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.82 172.5 14.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.504 1.047 . . . . 0.0 114.718 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -109.18 6.08 24.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.209 1.804 . . . . 0.0 113.75 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -138.71 176.14 8.95 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.0 111.143 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.75 51.43 0.75 Allowed Glycine 0 CA--C 1.538 1.526 0 CA-C-O 117.288 -1.84 . . . . 0.0 117.168 167.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -54.21 111.12 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 121.399 2.599 . . . . 0.0 110.646 162.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.83 165.95 13.77 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.175 0.99 . . . . 0.0 111.76 -168.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -89.43 104.34 16.9 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 119.839 -1.788 . . . . 0.0 113.206 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 1.2 p -58.03 117.78 22.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.577 1.151 . . . . 0.0 112.352 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.35 82.61 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.411 2.741 . . . . 0.0 109.827 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.08 142.46 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.833 0.853 . . . . 0.0 109.457 169.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.9 t -151.38 159.73 44.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.632 0.773 . . . . 0.0 113.046 -167.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -132.54 113.55 13.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.003 2.521 . . . . 0.0 108.955 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.75 170.24 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.464 1.106 . . . . 0.0 111.688 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.08 -11.44 20.52 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 m -152.03 33.2 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.106 -1.621 . . . . 0.0 112.311 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.93 10.15 2.04 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.455 1.902 . . . . 0.0 113.45 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -72.06 55.6 0.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.303 3.041 . . . . 0.0 112.589 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -63.07 -11.91 22.97 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -165.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.55 -1.28 0.77 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 114.919 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 m -153.85 119.33 2.78 Favored Pre-proline 0 N--CA 1.473 0.692 0 O-C-N 119.916 -1.74 . . . . 0.0 110.651 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.4 112.12 2.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.899 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.38 -27.15 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 0.0 110.825 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.89 -161.98 18.98 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.383 2.421 . . . . 0.0 111.853 169.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 169.58 17.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 96.58 8.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.502 1.921 . . . . 0.0 106.132 170.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.55 -49.95 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.636 1.175 . . . . 0.0 111.678 -161.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 t -88.41 -17.37 30.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -165.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -159.99 150.14 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 120.253 1.388 . . . . 0.0 111.631 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -57.48 134.49 81.95 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.673 0.789 . . . . 0.0 109.377 166.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.98 86.47 0.61 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.137 2.558 . . . . 0.0 111.658 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -152.91 112.96 3.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 112.035 -167.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -72.85 92.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 p -73.41 -14.04 61.19 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.75 158.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.13 0.972 . . . . 0.0 112.064 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.66 -23.62 65.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.18 0.992 . . . . 0.0 113.153 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 p -81.26 5.17 17.94 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.772 1.629 . . . . 0.0 113.812 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.31 22.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.648 1.579 . . . . 0.0 114.882 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.09 21.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 130.875 3.67 . . . . 0.0 114.443 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.64 157.15 20.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.983 1.713 . . . . 0.0 113.275 -164.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 105.94 17.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.429 2.291 . . . . 0.0 106.677 153.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.41 135.64 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.503 1.121 . . . . 0.0 111.985 -165.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.81 118.56 37.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.209 2.603 . . . . 0.0 108.921 -172.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.36 136.72 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.452 1.901 . . . . 0.0 108.418 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.68 137.95 31.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.017 -0.427 . . . . 0.0 111.821 163.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.48 160.36 25.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.351 1.86 . . . . 0.0 109.656 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.59 105.78 51.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.822 1.249 . . . . 0.0 108.857 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.82 121.03 2.41 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.276 2.65 . . . . 0.0 109.437 160.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.31 166.5 12.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.88 1.72 . . . . 0.0 111.993 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.88 164.3 25.94 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 -91.92 1.77 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -131.08 165.11 23.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.457 1.103 . . . . 0.0 110.764 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.0 m -156.92 163.27 39.34 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.069 -1.019 . . . . 0.0 111.784 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -133.43 129.1 36.83 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.9 2.08 . . . . 0.0 108.214 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.5 mm -110.21 109.3 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.17 1.788 . . . . 0.0 106.768 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.96 138.53 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.667 0.787 . . . . 0.0 109.167 -167.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.14 89.38 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.85 2.06 . . . . 0.0 106.725 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.02 157.44 8.75 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.314 1.686 . . . . 0.0 117.314 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -123.23 122.77 39.21 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.913 1.685 . . . . 0.0 109.395 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 32.42 -94.83 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.304 2.383 . . . . 0.0 115.385 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.53 -18.73 63.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.699 2.0 . . . . 0.0 116.161 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -130.11 101.07 5.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.74 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.12 155.92 46.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.26 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.98 2.512 . . . . 0.0 107.758 169.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.95 156.42 38.86 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.139 -0.976 . . . . 0.0 111.719 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 165.5 26.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.682 2.393 . . . . 0.0 109.019 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -133.27 155.97 48.41 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.327 -0.858 . . . . 0.0 113.101 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -141.75 151.93 43.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.494 1.518 . . . . 0.0 112.788 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -146.58 108.4 4.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.565 1.546 . . . . 0.0 108.567 -163.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -149.51 102.42 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -162.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 t 61.9 62.17 1.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.417 1.887 . . . . 0.0 113.832 163.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.32 18.01 3.49 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.515 2.007 . . . . 0.0 112.835 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.5 t -62.1 152.04 33.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.8 1.64 . . . . 0.0 112.293 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -50.59 -24.79 3.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.845 2.058 . . . . 0.0 113.291 165.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.12 -10.62 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.956 1.303 . . . . 0.0 112.138 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.76 22.7 30.2 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 121.003 -1.061 . . . . 0.0 114.396 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 125.025 1.33 . . . . 0.0 113.435 178.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -146.97 171.86 14.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 111.625 -165.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 20.9 mp0 -65.1 104.69 0.93 Allowed 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.836 4.454 . . . . 0.0 111.179 -165.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -55.65 -57.35 12.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -168.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -72.22 -20.87 61.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.295 1.038 . . . . 0.0 113.727 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.65 -3.5 50.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 113.101 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -67.0 22.27 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 129.016 2.926 . . . . 0.0 115.267 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.75 69.0 0.67 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.932 2.206 . . . . 0.0 114.293 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -41.19 -59.62 1.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.654 1.982 . . . . 0.0 113.91 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -59.15 -3.93 0.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.82 141.82 49.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.934 1.243 . . . . 0.0 111.358 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.02 171.86 55.16 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.095 0.855 . . . . 0.0 113.386 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.7 96.76 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 113.094 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 p -161.78 -177.17 5.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.606 1.562 . . . . 0.0 112.402 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 m -170.85 -29.35 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.324 1.85 . . . . 0.0 111.796 162.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt 64.67 -69.71 0.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.374 2.27 . . . . 0.0 113.349 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.16 73.36 8.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.074 0.95 . . . . 0.0 112.857 -166.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -129.69 158.5 39.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 170.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -143.52 140.94 30.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 108.906 166.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.39 147.69 49.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.382 0.673 . . . . 0.0 111.521 171.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.76 -52.82 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.397 0.679 . . . . 0.0 112.24 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.24 109.45 2.66 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.478 1.037 . . . . 0.0 111.279 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 p -52.8 142.29 34.21 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.222 1.409 . . . . 0.0 111.469 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.48 146.07 85.45 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.916 2.411 . . . . 0.0 114.049 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.52 130.03 25.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.764 1.626 . . . . 0.0 109.55 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.01 135.61 51.15 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.543 0.61 . . . . 0.0 110.57 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.6 p -68.19 -5.75 19.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.81 2.044 . . . . 0.0 113.998 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -10.66 7.28 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.62 1.105 . . . . 0.0 112.699 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -95.01 -3.63 48.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.512 1.925 . . . . 0.0 110.875 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.01 -4.14 45.21 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.57 1.557 . . . . 0.0 114.83 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -96.31 156.71 16.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.337 1.455 . . . . 0.0 110.409 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.73 122.26 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.105 0.962 . . . . 0.0 110.377 170.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.2 126.36 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.642 0.777 . . . . 0.0 109.338 162.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.59 155.73 45.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.294 1.438 . . . . 0.0 111.055 173.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -125.91 134.78 51.46 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.255 -0.903 . . . . 0.0 112.688 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.13 168.2 11.82 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.851 1.261 . . . . 0.0 109.89 165.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -126.55 143.38 51.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.557 1.143 . . . . 0.0 110.014 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -96.42 98.23 10.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.732 1.213 . . . . 0.0 109.777 -172.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -78.31 9.34 3.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.97 2.108 . . . . 0.0 115.788 -162.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.91 173.41 27.97 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.424 1.011 . . . . 0.0 113.821 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -95.64 -1.37 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.305 1.842 . . . . 0.0 114.019 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.41 173.29 11.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.715 1.606 . . . . 0.0 112.69 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.78 43.55 0.87 Allowed Glycine 0 CA--C 1.543 1.802 0 CA-C-O 116.574 -2.237 . . . . 0.0 118.688 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.84 105.54 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.939 0 CA-C-N 122.308 3.054 . . . . 0.0 112.314 161.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -163.13 162.82 25.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -166.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -82.05 94.47 7.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.942 1.297 . . . . 0.0 110.172 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.25 115.05 10.75 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.829 1.652 . . . . 0.0 113.741 -169.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.79 83.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.047 2.498 . . . . 0.0 112.147 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.31 140.27 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.112 0.965 . . . . 0.0 109.903 165.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -140.8 166.86 23.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.097 0.959 . . . . 0.0 113.408 -167.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -138.71 104.86 5.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.666 2.386 . . . . 0.0 110.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 61' ' ' VAL . 16.3 m -132.09 169.1 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.03 0.932 . . . . 0.0 112.478 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.28 0.52 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.566 1.146 . . . . 0.0 113.742 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -151.93 27.88 0.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.245 -1.535 . . . . 0.0 112.846 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.62 10.4 1.41 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.445 1.898 . . . . 0.0 113.732 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.14 52.61 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.094 2.958 . . . . 0.0 112.487 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.41 -7.35 9.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -165.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.51 -5.83 1.36 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.56 1.544 . . . . 0.0 114.591 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.0 m -154.58 114.78 2.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.108 -1.62 . . . . 0.0 110.556 168.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 111.16 2.35 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.683 2.922 . . . . 0.0 111.751 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 52' ' ' VAL . 15.5 t -75.77 -39.58 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.443 1.097 . . . . 0.0 110.517 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.75 -161.94 25.89 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.982 1.754 . . . . 0.0 113.589 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -130.96 176.74 7.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.178 0.991 . . . . 0.0 113.27 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.41 139.59 34.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.786 2.034 . . . . 0.0 108.36 166.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.09 -55.16 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.104 0.562 . . . . 0.0 111.239 -171.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -55.67 -54.21 47.01 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.06 148.81 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.75 159.26 79.81 Favored Pre-proline 0 CA--C 1.556 1.195 0 O-C-N 121.899 -0.501 . . . . 0.0 110.525 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.1 69.81 6.92 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.713 2.276 . . . . 0.0 115.391 -157.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -143.62 120.24 11.11 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.392 -1.442 . . . . 0.0 113.282 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.1 t -81.45 95.8 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 t -76.2 -3.88 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.05 143.89 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.932 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.39 -20.93 65.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.343 1.057 . . . . 0.0 112.73 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 4.68 1.72 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.545 2.738 . . . . 0.0 114.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 8.15 0.4 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.224 1.81 . . . . 0.0 115.605 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.43 19.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 130.853 3.661 . . . . 0.0 116.131 -161.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.31 173.79 8.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.375 1.87 . . . . 0.0 114.434 -169.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -105.39 101.77 11.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.092 2.957 . . . . 0.0 107.079 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.46 114.33 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -156.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.45 129.24 39.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.191 2.596 . . . . 0.0 110.562 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mt -128.0 148.52 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 129.025 2.93 . . . . 0.0 108.825 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -104.34 136.72 43.4 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 112.323 165.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -121.31 162.84 19.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.643 1.977 . . . . 0.0 110.098 163.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.93 107.33 38.03 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.078 1.351 . . . . 0.0 109.202 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -107.02 140.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.197 3.264 . . . . 0.0 110.823 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.53 162.11 1.66 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.851 3.034 . . . . 0.0 114.651 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -68.09 166.03 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.025 0.93 . . . . 0.0 113.41 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.94 -91.35 1.68 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.58 159.78 23.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.263 1.025 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -157.6 129.73 7.15 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 120.807 -1.183 . . . . 0.0 110.174 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -135.62 122.59 21.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 109.263 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.1 mm -109.86 113.68 44.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 126.251 1.82 . . . . 0.0 107.732 -173.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -109.02 140.62 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.897 0.879 . . . . 0.0 109.245 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.95 101.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.393 2.277 . . . . 0.0 107.999 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 149.3 171.53 18.03 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 117.946 1.939 . . . . 0.0 117.946 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.12 128.84 30.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.505 1.922 . . . . 0.0 110.362 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 35.55 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.89 2.186 . . . . 0.0 115.268 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -66.79 -16.39 64.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.097 2.159 . . . . 0.0 115.993 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.33 105.76 6.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.281 1.032 . . . . 0.0 111.088 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.41 162.98 34.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.03 163.94 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 130.136 3.374 . . . . 0.0 107.308 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -156.62 163.35 39.43 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.983 -1.073 . . . . 0.0 110.994 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -142.33 149.39 39.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.991 1.317 . . . . 0.0 110.044 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -102.75 160.97 14.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.864 1.266 . . . . 0.0 111.632 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.66 42.84 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.014 2.126 . . . . 0.0 110.237 166.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -145.0 142.32 29.69 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -150.0 105.08 3.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.407 1.083 . . . . 0.0 112.354 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p 128.01 -5.07 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 131.676 3.99 . . . . 0.0 114.619 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.15 33.82 0.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.643 1.116 . . . . 0.0 112.159 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -88.36 -141.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.338 1.455 . . . . 0.0 112.241 -166.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -52.59 -36.44 56.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.717 1.599 . . . . 0.0 115.136 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.13 -2.72 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 126.333 1.853 . . . . 0.0 112.515 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.68 28.8 54.24 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.518 -1.364 . . . . 0.0 112.521 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 tptp . . . . . 0 C--O 1.252 1.191 0 C-N-CA 127.174 2.19 . . . . 0.0 111.82 -169.399 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.64 152.26 45.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.61 0.641 . . . . 0.0 111.123 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.42 116.55 27.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.072 1.749 . . . . 0.0 109.498 172.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.99 -42.3 94.64 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.63 -0.669 . . . . 0.0 111.677 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -59.98 -29.47 68.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.875 1.67 . . . . 0.0 114.741 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.31 -5.11 58.53 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.111 0.868 . . . . 0.0 113.194 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -69.1 -6.31 27.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 116.808 -1.567 . . . . 0.0 114.073 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.08 73.52 0.33 Allowed Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.169 1.843 . . . . 0.0 115.477 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -77.18 64.19 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.236 1.015 . . . . 0.0 111.18 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.7 p -73.94 -27.42 61.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.614 1.966 . . . . 0.0 113.8 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -143.14 172.19 13.06 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.68 1.992 . . . . 0.0 110.462 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.43 148.8 51.03 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.109 0.385 . . . . 0.0 112.33 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 105.28 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.208 1.003 . . . . 0.0 112.041 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 162.46 39.89 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.314 2.246 . . . . 0.0 109.202 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.6 p -156.87 -43.24 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.309 1.043 . . . . 0.0 111.664 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 60.06 -69.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.366 2.666 . . . . 0.0 112.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.24 74.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.153 0.981 . . . . 0.0 112.742 -160.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -128.48 161.28 29.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.375 0.67 . . . . 0.0 111.142 161.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -145.77 149.88 35.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.442 1.897 . . . . 0.0 108.714 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.13 125.61 24.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.338 0.655 . . . . 0.0 111.042 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 -45.17 7.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.957 . . . . 0.0 109.043 167.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.65 119.34 1.74 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.126 1.822 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -57.93 155.43 23.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.424 1.49 . . . . 0.0 112.932 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.17 133.49 47.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.808 2.338 . . . . 0.0 112.026 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.59 127.59 22.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.823 1.649 . . . . 0.0 110.75 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.36 133.35 50.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.323 0.583 . . . . 0.0 112.378 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -79.12 -22.84 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.035 2.134 . . . . 0.0 114.563 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 -8.28 61.96 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 118.574 -1.126 . . . . 0.0 114.368 -160.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -72.09 -9.9 59.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.121 1.96 . . . . 0.0 111.596 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.25 62.3 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.334 1.445 . . . . 0.0 113.19 -163.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -112.33 164.0 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.96 2.104 . . . . 0.0 111.068 -170.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.77 125.62 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.209 1.004 . . . . 0.0 110.382 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 m -76.87 131.67 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 159.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.6 123.48 15.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.155 2.182 . . . . 0.0 107.378 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.83 131.35 52.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.999 0.818 . . . . 0.0 111.888 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.24 165.23 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.929 0.871 . . . . 0.0 110.134 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.109 0.963 . . . . 0.0 109.475 167.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -86.15 101.14 12.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 109.48 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -83.17 12.92 4.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -162.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.72 178.34 27.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.237 0.926 . . . . 0.0 114.623 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.3 p -109.21 2.91 21.26 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.541 1.937 . . . . 0.0 113.272 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -137.26 -176.63 4.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 0.0 110.76 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.93 29.08 2.94 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 115.745 -2.697 . . . . 0.0 118.975 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -48.69 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.124 0 CA-C-N 123.416 3.608 . . . . 0.0 112.981 162.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 m -160.43 169.69 22.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.014 1.326 . . . . 0.0 112.324 -165.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -96.78 92.76 6.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.54 1.136 . . . . 0.0 110.526 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.54 115.92 19.83 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.176 1.39 . . . . 0.0 114.627 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.84 93.25 0.87 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.526 2.15 . . . . 0.0 111.848 170.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 tt -128.12 136.08 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.22 1.008 . . . . 0.0 108.608 161.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -148.81 165.33 31.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.826 0.85 . . . . 0.0 113.126 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.1 t -140.64 115.33 9.55 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.97 2.108 . . . . 0.0 110.633 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.65 175.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.787 1.235 . . . . 0.0 112.262 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.47 -18.17 16.81 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -149.9 32.34 0.69 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.114 -1.616 . . . . 0.0 111.636 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.94 11.72 4.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.391 1.876 . . . . 0.0 113.454 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -67.19 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.204 3.401 . . . . 0.0 113.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -58.78 -12.03 3.87 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.36 -12.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.248 2.219 . . . . 0.0 115.422 167.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -155.67 107.65 2.17 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 120.352 -1.467 . . . . 0.0 109.791 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.45 110.47 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.748 3.632 . . . . 0.0 113.01 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.77 -30.38 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.401 1.08 . . . . 0.0 109.959 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.29 -173.03 22.41 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.941 2.21 . . . . 0.0 111.305 165.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -131.68 170.54 14.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.438 1.095 . . . . 0.0 112.151 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.41 133.48 33.72 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 160.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.67 -54.43 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.27 0.628 . . . . 0.0 109.967 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -63.34 -48.33 78.45 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.61 150.26 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.385 1.074 . . . . 0.0 108.909 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -82.68 156.39 67.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 118.208 0.458 . . . . 0.0 110.709 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.13 86.67 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.486 2.124 . . . . 0.0 115.731 -155.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -148.57 118.87 7.3 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.363 -1.461 . . . . 0.0 114.202 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.61 87.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.717 1.207 . . . . 0.0 107.759 167.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.8 t -72.2 -11.05 60.56 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.54 156.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.014 1.279 . . . . 0.0 112.071 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.81 -15.6 63.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 0.0 114.202 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.8 p -76.56 1.72 15.95 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.129 1.772 . . . . 0.0 113.762 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.03 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.632 1.973 . . . . 0.0 115.606 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.3 20.65 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.949 3.3 . . . . 0.0 115.901 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.18 168.17 19.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.096 2.158 . . . . 0.0 114.518 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -106.3 107.03 17.83 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.266 3.026 . . . . 0.0 105.47 160.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.27 137.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.483 1.135 . . . . 0.0 113.634 -158.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.2 128.21 47.41 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.161 2.984 . . . . 0.0 109.779 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.76 138.73 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.868 2.067 . . . . 0.0 109.149 -172.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.53 136.67 32.9 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.556 0.616 . . . . 0.0 111.803 163.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.9 159.17 26.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.104 2.162 . . . . 0.0 109.775 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -103.32 105.25 45.61 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.229 1.411 . . . . 0.0 109.565 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.01 129.87 8.14 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.604 2.869 . . . . 0.0 110.288 164.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.44 171.95 9.8 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.304 2.003 . . . . 0.0 112.165 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -82.41 166.01 19.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -173.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.23 -82.45 1.14 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.669 1.128 . . . . 0.0 111.072 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -140.6 145.69 37.01 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.582 1.153 . . . . 0.0 110.12 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.7 p -150.57 151.13 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.48 0.657 . . . . 0.0 112.525 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -137.36 139.99 41.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.928 1.291 . . . . 0.0 110.059 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.7 107.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.284 1.833 . . . . 0.0 107.044 -168.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.8 135.71 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.92 92.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.905 2.082 . . . . 0.0 107.282 -172.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.3 170.8 12.82 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.48 123.0 42.95 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.077 1.751 . . . . 0.0 109.138 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 31.82 -92.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.194 2.331 . . . . 0.0 115.472 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -73.11 -16.77 61.45 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.2 97.95 4.42 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 109.952 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.11 163.62 36.36 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.58 163.77 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 129.841 3.256 . . . . 0.0 107.573 168.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -151.48 162.81 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.131 -0.981 . . . . 0.0 111.596 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -138.62 173.57 11.45 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.43 1.892 . . . . 0.0 110.409 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -124.71 157.94 34.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.392 1.877 . . . . 0.0 111.167 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.08 154.85 33.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.583 1.553 . . . . 0.0 111.89 161.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -132.62 140.58 48.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 110.885 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -136.3 93.87 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.6 t 70.79 30.11 3.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.779 1.632 . . . . 0.0 114.477 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 8.94 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.531 1.773 . . . . 0.0 117.531 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.3 t -75.25 160.94 29.79 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.959 1.88 . . . . 0.0 112.728 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -62.89 -11.54 19.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.063 1.345 . . . . 0.0 114.569 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.6 mm -82.59 -16.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.863 1.265 . . . . 0.0 111.452 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.91 4.94 24.1 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.347 -1.252 . . . . 0.0 115.751 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-N 119.391 1.596 . . . . 0.0 114.17 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.11 145.24 30.45 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.336 0.654 . . . . 0.0 111.853 -163.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 178.05 6.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.538 2.735 . . . . 0.0 110.398 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -100.21 -54.47 2.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.999 0.904 . . . . 0.0 111.166 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -55.89 -34.94 66.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.98 2.512 . . . . 0.0 113.786 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.56 -43.5 84.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.472 0.578 . . . . 0.0 110.794 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HE2' ' CB ' ' A' ' 60' ' ' PRO . 33.0 mmtm -63.41 -45.55 90.49 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 110.393 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 36.86 104.05 0.01 OUTLIER Glycine 0 C--N 1.344 0.975 0 C-N-CA 129.67 3.51 . . . . 0.0 116.676 159.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -62.8 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.346 2.258 . . . . 0.0 112.781 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -80.98 -19.54 43.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.879 2.472 . . . . 0.0 114.31 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -160.66 175.48 12.61 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.353 1.461 . . . . 0.0 110.257 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 133.41 24.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.268 1.413 . . . . 0.0 113.681 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.3 102.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.556 1.542 . . . . 0.0 114.08 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 156.36 40.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.585 2.354 . . . . 0.0 108.783 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.96 -31.87 0.28 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 49.27 -73.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 130.507 3.523 . . . . 0.0 116.214 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.32 68.23 1.42 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 112.067 -155.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.17 156.07 24.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.932 1.293 . . . . 0.0 110.331 166.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -142.29 145.42 33.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.498 1.519 . . . . 0.0 109.139 165.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.76 137.55 58.26 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.509 0.671 . . . . 0.0 111.31 168.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 -46.12 3.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.422 1.489 . . . . 0.0 109.708 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 128.93 4.93 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.095 1.331 . . . . 0.0 111.535 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.9 p -58.11 146.26 70.14 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 112.256 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -59.54 124.75 16.13 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.126 2.551 . . . . 0.0 111.55 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.16 128.55 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.727 1.211 . . . . 0.0 110.46 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.68 129.84 41.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.612 0.72 . . . . 0.0 111.021 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -71.98 -4.59 29.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.406 2.282 . . . . 0.0 113.845 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -8.72 11.12 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 118.945 0.793 . . . . 0.0 113.174 -168.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -89.2 -0.74 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.195 1.398 . . . . 0.0 110.758 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.71 0.79 74.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.464 1.507 . . . . 0.0 113.896 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -99.91 161.82 13.37 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.883 2.073 . . . . 0.0 110.205 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.4 128.88 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.457 1.026 . . . . 0.0 110.919 169.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.62 119.04 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.273 1.029 . . . . 0.0 108.937 162.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -132.72 129.27 38.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.78 2.432 . . . . 0.0 108.429 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -119.39 132.96 55.93 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.108 0.867 . . . . 0.0 113.06 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -123.47 167.63 13.62 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.294 1.038 . . . . 0.0 111.481 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.58 136.5 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 109.49 163.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -90.86 102.97 15.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.355 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.5 p -78.61 -7.14 57.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.592 1.557 . . . . 0.0 114.017 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.03 160.36 20.8 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 122.272 0.929 . . . . 0.0 113.878 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -82.02 -10.92 59.07 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.528 2.331 . . . . 0.0 114.849 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -164.39 172.93 12.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.72 1.208 . . . . 0.0 110.748 -153.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 61.08 0.62 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.22 105.04 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.399 2.066 . . . . 0.0 109.765 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 m -154.4 162.78 40.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.212 1.405 . . . . 0.0 112.09 -166.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -87.14 97.39 10.73 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.571 . . . . 0.0 111.394 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.89 115.08 8.08 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.878 1.271 . . . . 0.0 110.825 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.86 90.31 1.05 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.933 3.089 . . . . 0.0 110.678 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 tt -115.3 142.91 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.053 0.941 . . . . 0.0 109.378 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -150.7 166.64 29.77 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.059 1.343 . . . . 0.0 112.844 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.0 t -138.18 121.4 16.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.948 2.099 . . . . 0.0 110.713 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.38 179.69 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.487 1.515 . . . . 0.0 112.263 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.63 -17.62 14.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.142 1.377 . . . . 0.0 113.725 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -157.55 43.32 0.33 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.184 -1.573 . . . . 0.0 111.731 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 8.8 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.811 2.045 . . . . 0.0 114.56 -174.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . 0.498 HD22 ' CG2' ' A' ' 61' ' ' VAL . 3.8 p-10 -70.58 46.05 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.821 3.248 . . . . 0.0 114.952 -174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -64.34 -1.77 1.86 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -10.36 5.45 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 159.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.1 m -155.96 98.37 2.23 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 120.381 -1.45 . . . . 0.0 109.8 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.401 ' CB ' ' HE2' ' A' ' 7' ' ' LYS . 80.5 Cg_exo -48.38 119.91 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.678 3.585 . . . . 0.0 113.452 170.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.498 ' CG2' HD22 ' A' ' 56' ' ' ASN . 8.0 t -99.88 -23.77 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.538 1.535 . . . . 0.0 111.813 -176.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.71 18.36 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.409 1.956 . . . . 0.0 111.29 168.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.21 175.48 9.55 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.01 149.67 25.01 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.523 1.529 . . . . 0.0 107.187 159.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -118.73 -41.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.735 0.698 . . . . 0.0 111.14 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -61.04 -45.81 93.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -162.75 165.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.136 0.88 . . . . 0.0 111.567 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.31 123.74 71.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 157.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.54 100.1 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.772 1.648 . . . . 0.0 111.422 -171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -149.07 149.87 31.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 159.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.62 88.36 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 127.524 2.33 . . . . 0.0 107.055 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -71.47 -2.86 18.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.02 158.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 112.13 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.25 -27.58 63.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.538 0.735 . . . . 0.0 112.369 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.1 p -74.87 4.86 5.75 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.249 1.82 . . . . 0.0 113.671 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.66 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.29 1.836 . . . . 0.0 115.083 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.65 27.26 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 129.169 2.987 . . . . 0.0 113.681 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.34 169.08 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.416 1.886 . . . . 0.0 113.967 -166.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -112.4 108.73 17.99 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.837 2.455 . . . . 0.0 106.092 163.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.38 123.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.775 0.798 . . . . 0.0 112.953 -157.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.82 134.99 41.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.626 1.571 . . . . 0.0 110.604 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.7 136.53 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.506 1.922 . . . . 0.0 107.949 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.87 138.13 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.775 -0.578 . . . . 0.0 111.911 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -123.06 163.13 21.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.131 2.173 . . . . 0.0 110.056 167.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -104.52 100.97 25.07 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.543 1.137 . . . . 0.0 109.236 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.44 129.13 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.802 2.335 . . . . 0.0 109.977 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.94 172.29 2.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.572 2.181 . . . . 0.0 112.504 165.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.54 166.09 11.31 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.151 0.981 . . . . 0.0 112.426 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -91.67 1.45 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -164.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -119.67 154.0 34.72 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.577 1.151 . . . . 0.0 110.331 168.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.5 t -144.95 158.42 43.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 166.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -130.19 145.76 51.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.969 0.908 . . . . 0.0 108.823 165.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -117.02 113.94 44.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.479 1.912 . . . . 0.0 106.219 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.18 135.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.24 95.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.08 1.352 . . . . 0.0 108.061 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.99 171.69 24.23 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.945 1.938 . . . . 0.0 117.945 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.4 114.21 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.644 2.378 . . . . 0.0 108.938 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.83 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 126.166 1.841 . . . . 0.0 114.848 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -68.74 -15.08 63.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -129.65 99.34 5.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.718 1.207 . . . . 0.0 109.708 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.62 159.28 44.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.99 165.64 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 129.913 3.285 . . . . 0.0 108.431 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.72 170.7 15.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.712 -0.617 . . . . 0.0 110.871 161.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -132.79 161.73 33.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.909 1.684 . . . . 0.0 108.583 162.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.8 159.59 17.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.273 1.429 . . . . 0.0 110.522 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.02 152.99 38.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.062 1.345 . . . . 0.0 111.119 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.75 115.45 8.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.936 1.294 . . . . 0.0 108.41 -170.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -152.38 109.88 3.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.8 t 66.01 37.13 5.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.321 2.248 . . . . 0.0 114.522 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.48 20.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.025 0.821 . . . . 0.0 114.538 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.9 t -64.54 154.46 36.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.985 1.314 . . . . 0.0 113.213 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.8 m -54.21 -23.24 13.84 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.432 1.893 . . . . 0.0 112.655 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.4 mm -93.35 -1.32 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.425 1.89 . . . . 0.0 111.337 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.03 10.24 62.84 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.75 -1.219 . . . . 0.0 115.727 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.086 1.355 . . . . 0.0 114.585 -178.085 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.33 168.84 23.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 -175.55 4.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.171 2.589 . . . . 0.0 110.472 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -99.49 -59.01 1.8 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.067 -1.021 . . . . 0.0 110.434 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -51.43 -33.57 31.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.613 2.765 . . . . 0.0 114.935 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -61.98 -19.79 63.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.004 0.82 . . . . 0.0 112.838 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.03 -1.4 57.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.969 1.308 . . . . 0.0 113.139 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -4.36 98.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.45 0 C-N-CA 130.524 3.916 . . . . 0.0 117.507 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.474 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -64.81 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.426 3.49 . . . . 0.0 115.92 -169.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -60.22 -27.62 67.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.1 -179.06 5.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.361 1.864 . . . . 0.0 109.923 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.58 138.63 46.89 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 121.655 -0.653 . . . . 0.0 111.71 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.95 95.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.121 0.962 . . . . 0.0 112.663 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.83 172.18 17.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.754 2.022 . . . . 0.0 110.585 170.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.6 p -142.93 -25.45 0.61 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.862 1.265 . . . . 0.0 113.934 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 23.4 ttpt 47.28 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 130.25 3.42 . . . . 0.0 114.934 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.21 72.5 1.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 111.906 -165.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -123.32 153.25 40.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.774 0.83 . . . . 0.0 110.638 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -139.73 147.46 40.92 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.782 1.633 . . . . 0.0 108.205 167.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.23 133.22 49.31 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.475 -0.765 . . . . 0.0 110.856 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -50.43 4.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.433 1.093 . . . . 0.0 109.204 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.26 120.74 1.94 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.499 1.047 . . . . 0.0 112.558 -172.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.2 m -49.59 147.35 6.1 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 127.915 2.486 . . . . 0.0 112.346 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.48 148.4 63.21 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.565 2.177 . . . . 0.0 114.12 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.0 142.64 32.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.141 1.776 . . . . 0.0 110.254 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.52 138.83 41.8 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.625 -0.672 . . . . 0.0 112.248 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.5 p -83.31 -21.87 33.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.82 -7.38 34.69 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 118.488 -1.173 . . . . 0.0 114.421 -159.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -72.08 -14.47 61.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.115 1.958 . . . . 0.0 111.166 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.93 -7.34 52.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.859 1.695 . . . . 0.0 113.012 -165.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.9 p -102.12 164.95 11.42 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 112.331 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.75 119.21 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.659 1.184 . . . . 0.0 110.592 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.19 128.34 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.765 1.226 . . . . 0.0 110.199 163.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.5 136.01 30.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.284 2.234 . . . . 0.0 109.514 -169.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HZ3' ' A' ' 79' ' ' LYS . 21.6 tt0 -116.67 131.65 56.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.56 163.0 17.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.071 1.349 . . . . 0.0 111.06 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -122.95 142.82 50.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.551 1.54 . . . . 0.0 110.128 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -95.97 97.95 10.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.992 0.917 . . . . 0.0 110.923 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.7 p -82.57 35.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.928 1.691 . . . . 0.0 113.269 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.87 175.11 33.76 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.675 -0.64 . . . . 0.0 114.293 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -121.3 3.49 10.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.042 2.137 . . . . 0.0 113.228 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 16' ' ' LYS . 11.6 p-10 -132.04 166.06 22.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.249 2.22 . . . . 0.0 110.875 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.65 51.71 0.84 Allowed Glycine 0 CA--C 1.542 1.722 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -56.15 108.55 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 121.774 2.787 . . . . 0.0 110.722 160.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.473 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -155.7 168.78 26.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.431 1.092 . . . . 0.0 111.38 -166.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 11.3 tppt? -92.9 91.69 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.377 -1.452 . . . . 0.0 109.632 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.66 114.42 11.08 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.521 1.129 . . . . 0.0 112.36 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.28 88.79 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.229 2.619 . . . . 0.0 111.466 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -112.53 145.77 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.015 0.926 . . . . 0.0 110.079 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 t -151.27 172.29 16.1 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -143.63 106.27 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.143 2.577 . . . . 0.0 109.705 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.2 151.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.26 64.16 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.72 27.37 3.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.277 1.031 . . . . 0.0 112.357 -166.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mt 63.76 3.25 1.52 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.232 1.813 . . . . 0.0 113.881 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -67.69 50.5 0.05 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.117 2.967 . . . . 0.0 114.3 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.49 -13.7 23.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.74 -6.21 0.71 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.679 1.992 . . . . 0.0 114.665 162.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m -153.54 103.67 2.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.045 -1.66 . . . . 0.0 109.042 173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 123.67 10.26 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.37 2.713 . . . . 0.0 111.046 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.33 -36.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.193 0.997 . . . . 0.0 111.702 -172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.97 -166.74 30.41 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.381 1.467 . . . . 0.0 110.58 161.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.891 0.876 . . . . 0.0 112.167 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.47 140.07 32.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.093 1.357 . . . . 0.0 107.405 163.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.62 -49.33 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.623 0.647 . . . . 0.0 109.669 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.9 m -60.01 -49.77 76.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -172.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -158.15 159.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.896 1.226 . . . . 0.0 113.031 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -59.41 114.45 9.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.392 1.077 . . . . 0.0 108.491 158.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 88.06 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.106 2.537 . . . . 0.0 111.938 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -136.18 139.59 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.744 -1.222 . . . . 0.0 111.94 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 2.6 t -74.24 88.87 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 125.557 1.543 . . . . 0.0 106.874 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -72.72 -2.81 21.73 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.95 143.35 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.146 1.378 . . . . 0.0 110.813 -172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.36 -27.07 67.6 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.883 0.849 . . . . 0.0 111.539 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 6.63 0.58 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.167 2.987 . . . . 0.0 114.192 168.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.49 17.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.888 1.675 . . . . 0.0 115.385 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.05 15.91 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 131.143 3.777 . . . . 0.0 115.562 -170.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.92 170.73 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.214 2.606 . . . . 0.0 114.3 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HZ3' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -119.9 99.74 6.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.836 3.254 . . . . 0.0 104.486 164.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.32 127.33 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.946 1.298 . . . . 0.0 112.082 -154.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.76 121.85 43.86 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.865 2.866 . . . . 0.0 108.898 -169.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.8 130.69 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.721 2.008 . . . . 0.0 109.267 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.78 133.01 36.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.539 0.736 . . . . 0.0 111.462 164.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.6 157.09 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.147 2.179 . . . . 0.0 109.854 164.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.45 111.88 48.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.558 1.143 . . . . 0.0 108.472 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.23 125.75 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.336 2.691 . . . . 0.0 109.653 171.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.67 164.78 27.78 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.245 1.297 . . . . 0.0 110.909 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -71.96 155.47 40.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.042 0.925 . . . . 0.0 112.751 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.92 -87.05 1.41 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.4 1.476 . . . . 0.0 109.87 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.95 156.36 29.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.245 1.018 . . . . 0.0 110.214 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -146.11 95.99 2.71 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.166 0.986 . . . . 0.0 108.932 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -96.42 134.76 39.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.313 1.045 . . . . 0.0 109.294 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -115.67 90.82 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 126.328 1.851 . . . . 0.0 107.343 -159.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -89.45 139.06 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.673 0.789 . . . . 0.0 109.378 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.52 91.04 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.707 2.003 . . . . 0.0 106.45 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 164.85 165.39 22.05 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.83 147.54 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.354 1.462 . . . . 0.0 109.972 167.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.64 -99.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.498 1.999 . . . . 0.0 115.092 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -85.43 -26.7 26.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.772 1.629 . . . . 0.0 113.98 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -107.8 81.85 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.284 1.434 . . . . 0.0 108.517 -173.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -138.82 148.12 43.37 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 161.29 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.593 2.757 . . . . 0.0 108.125 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.42 147.59 27.74 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.47 -0.769 . . . . 0.0 110.967 173.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.07 162.79 17.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.832 2.053 . . . . 0.0 109.434 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -132.03 129.57 40.22 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.993 0.517 . . . . 0.0 110.92 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.58 23.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.145 0.978 . . . . 0.0 111.139 171.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -141.34 123.64 15.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.848 1.659 . . . . 0.0 108.104 -161.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.21 99.61 3.07 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m 61.69 54.27 3.01 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.409 1.883 . . . . 0.0 113.189 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.13 30.2 0.53 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.239 0.923 . . . . 0.0 114.303 170.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.4 t -55.39 168.16 0.4 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.919 2.088 . . . . 0.0 115.59 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m -49.75 -20.9 0.93 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.044 1.338 . . . . 0.0 113.452 156.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -119.56 24.58 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 126.571 1.948 . . . . 0.0 111.876 171.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.4 -26.21 0.87 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 127.285 2.374 . . . . 0.0 116.586 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 tptp . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.663 2.785 . . . . 0.0 114.223 173.017 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.01 169.03 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.518 0.727 . . . . 0.0 110.955 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 171.62 13.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.124 2.169 . . . . 0.0 109.854 173.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.74 -63.99 1.16 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.128 -0.982 . . . . 0.0 111.554 -171.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -52.66 -31.29 36.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.867 2.067 . . . . 0.0 114.427 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 tp -58.09 -29.07 65.16 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.581 1.153 . . . . 0.0 113.044 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.11 -2.73 42.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 143.47 2.27 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.778 2.133 . . . . 0.0 115.683 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -70.51 74.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.748 2.019 . . . . 0.0 113.586 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.4 p -60.41 -21.24 61.99 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.197 1.399 . . . . 0.0 112.412 159.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -153.01 179.87 8.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.432 2.293 . . . . 0.0 108.305 161.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.67 157.72 51.84 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 122.074 -0.391 . . . . 0.0 112.638 166.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -77.74 103.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.831 1.252 . . . . 0.0 111.614 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.86 163.66 36.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.541 1.537 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.6 p -165.43 -48.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.857 0.863 . . . . 0.0 111.786 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt 65.2 -63.51 0.19 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.916 2.486 . . . . 0.0 113.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.69 78.59 2.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.202 1.001 . . . . 0.0 112.461 -166.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -129.86 156.73 43.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.258 1.023 . . . . 0.0 111.664 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -146.23 150.04 35.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.229 1.812 . . . . 0.0 108.948 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -70.02 149.55 47.57 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.882 0.849 . . . . 0.0 112.933 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.37 -33.97 2.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.312 1.445 . . . . 0.0 111.272 171.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 104.27 0.41 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.148 1.356 . . . . 0.0 111.239 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.3 m -46.53 140.08 5.87 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 127.042 2.137 . . . . 0.0 110.518 167.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 143.43 98.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.95 1.767 . . . . 0.0 112.805 -170.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 122.51 18.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.556 1.143 . . . . 0.0 111.223 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.27 131.26 45.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.615 0.721 . . . . 0.0 111.588 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.7 p -79.26 -10.01 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.503 1.921 . . . . 0.0 113.837 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.29 -6.65 4.08 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.203 0.906 . . . . 0.0 114.048 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -94.53 3.09 55.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.526 1.531 . . . . 0.0 111.685 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.73 5.7 41.52 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.465 1.507 . . . . 0.0 114.279 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -128.0 166.49 18.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.519 1.528 . . . . 0.0 111.784 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.95 132.06 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.516 1.526 . . . . 0.0 108.958 162.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.05 131.65 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 162.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.31 124.33 16.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.727 2.811 . . . . 0.0 108.211 -169.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.58 136.28 53.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.309 0.959 . . . . 0.0 112.922 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.48 164.92 21.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.79 139.9 52.38 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.195 163.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -90.87 101.49 14.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.729 1.212 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 p -80.5 7.63 9.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.915 1.686 . . . . 0.0 115.162 -163.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.39 -179.94 22.92 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.297 0.953 . . . . 0.0 114.34 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.1 p -113.59 6.79 17.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.168 1.787 . . . . 0.0 113.913 -165.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.52 178.8 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.872 1.669 . . . . 0.0 111.735 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.31 44.78 3.16 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-O 116.83 -2.094 . . . . 0.0 117.963 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.13 102.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.278 3.039 . . . . 0.0 111.709 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.7 m -159.57 171.27 19.94 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.99 -166.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -82.76 110.2 17.58 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.67 -1.269 . . . . 0.0 110.519 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.7 p -61.85 121.45 65.11 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.551 0.74 . . . . 0.0 110.776 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.06 97.17 0.73 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.327 2.018 . . . . 0.0 110.887 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.11 138.77 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.938 1.295 . . . . 0.0 108.926 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -153.32 169.95 21.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.912 0.885 . . . . 0.0 113.384 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 t -140.73 117.66 11.12 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.536 2.335 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.97 170.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.269 1.428 . . . . 0.0 111.473 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.4 -23.93 19.9 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -155.29 51.34 0.58 Allowed 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.587 -1.321 . . . . 0.0 111.298 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.08 11.8 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.806 2.043 . . . . 0.0 114.682 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.17 42.38 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 128.962 2.905 . . . . 0.0 114.453 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.47 -3.59 4.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.178 1.791 . . . . 0.0 115.585 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.39 -14.82 20.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.71 1.204 . . . . 0.0 113.283 159.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -152.78 104.61 2.68 Favored Pre-proline 0 N--CA 1.47 0.546 0 O-C-N 120.446 -1.409 . . . . 0.0 109.958 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 141.01 13.46 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.779 3.653 . . . . 0.0 114.285 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.33 -27.6 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.44 1.096 . . . . 0.0 111.014 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.98 -174.15 20.05 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.762 2.125 . . . . 0.0 111.0 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.8 ptp85 -136.85 175.73 9.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.352 1.061 . . . . 0.0 112.43 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.26 143.44 27.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 107.811 164.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.5 -46.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.895 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -62.5 -42.84 99.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.374 0.988 . . . . 0.0 113.621 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.66 163.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.553 0.741 . . . . 0.0 111.099 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -64.72 137.85 97.27 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.269 0.627 . . . . 0.0 109.759 166.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.88 82.47 0.98 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.047 2.498 . . . . 0.0 112.781 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -145.04 110.35 5.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.595 1.558 . . . . 0.0 112.093 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.66 87.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.974 1.709 . . . . 0.0 108.014 167.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -69.27 -19.56 63.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -170.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.51 155.07 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.682 1.193 . . . . 0.0 112.026 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -19.57 64.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.981 0.912 . . . . 0.0 112.946 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.3 p -80.81 7.88 9.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.993 1.717 . . . . 0.0 113.416 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 16.96 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.931 1.693 . . . . 0.0 115.164 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.19 23.22 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.919 3.288 . . . . 0.0 114.644 -168.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.81 171.71 12.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.634 1.974 . . . . 0.0 113.783 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.83 111.31 21.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.472 2.709 . . . . 0.0 106.198 167.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.99 122.65 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.782 0.833 . . . . 0.0 112.437 -156.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.75 135.29 35.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.907 174.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.4 mt -136.24 139.33 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.095 1.758 . . . . 0.0 108.716 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -91.88 137.27 32.5 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.371 -0.83 . . . . 0.0 111.661 164.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.03 165.68 14.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.286 2.235 . . . . 0.0 109.545 166.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 29.9 tt0 -104.88 109.25 62.88 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 109.502 174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.18 118.82 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.231 3.954 . . . . 0.0 111.138 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.96 152.81 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.999 3.133 . . . . 0.0 114.942 170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -84.34 152.53 24.04 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.436 -0.79 . . . . 0.0 110.564 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.87 -93.71 1.8 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -161.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -125.95 168.18 14.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.976 1.31 . . . . 0.0 111.315 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -154.06 155.1 34.84 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 120.945 -1.097 . . . . 0.0 112.126 171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.03 115.59 16.0 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.973 2.509 . . . . 0.0 107.953 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.52 106.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.69 2.396 . . . . 0.0 106.797 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.7 137.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.311 1.045 . . . . 0.0 109.613 -166.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.6 110.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.163 1.385 . . . . 0.0 109.113 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.07 173.21 13.33 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.2 ptm85 -126.7 123.5 37.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.976 1.71 . . . . 0.0 110.592 -171.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.51 -96.97 0.01 OUTLIER Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.932 2.206 . . . . 0.0 115.163 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -65.62 -16.88 64.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.273 1.829 . . . . 0.0 115.541 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -135.76 91.47 2.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.114 1.366 . . . . 0.0 110.461 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.54 162.06 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.07 162.82 21.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 128.631 2.773 . . . . 0.0 107.989 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.25 154.64 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.635 -0.666 . . . . 0.0 110.951 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -125.01 169.3 12.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.452 1.901 . . . . 0.0 108.185 164.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -140.0 163.18 33.38 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.389 -0.819 . . . . 0.0 112.412 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.31 158.54 43.55 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.476 1.51 . . . . 0.0 111.748 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -145.26 110.44 5.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.005 1.722 . . . . 0.0 107.089 -167.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -153.99 105.28 2.72 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t 64.78 39.81 5.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.783 2.033 . . . . 0.0 113.966 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.33 22.42 0.08 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.584 1.088 . . . . 0.0 114.178 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.6 t -65.05 155.89 33.23 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 -172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 m -53.17 -20.57 4.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.912 2.085 . . . . 0.0 113.721 161.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -101.05 2.37 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.919 1.287 . . . . 0.0 113.022 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.08 62.26 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.162 0 CA-C-N 118.985 1.393 . . . . 0.0 114.327 -179.353 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.97 153.3 32.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.21 1.004 . . . . 0.0 112.969 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.47 90.6 3.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.237 2.215 . . . . 0.0 109.09 175.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.88 -44.01 91.05 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.998 1.719 . . . . 0.0 114.149 -163.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -61.95 -26.41 68.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.493 0.717 . . . . 0.0 112.626 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -93.89 -1.53 54.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 112.361 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -62.15 -8.73 5.98 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.8 1.182 . . . . 0.0 114.169 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.71 52.01 6.14 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 119.652 1.115 . . . . 0.0 112.936 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -75.47 37.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.06 1.744 . . . . 0.0 111.557 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -78.18 -6.14 53.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.7 1.2 . . . . 0.0 114.109 -174.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -153.86 172.82 16.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.102 0.961 . . . . 0.0 111.141 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.2 143.86 45.64 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.689 0.662 . . . . 0.0 112.092 171.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.273 4.0 p -80.76 93.16 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.984 1.373 . . . . 0.0 112.58 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -148.82 164.81 33.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.701 2.0 . . . . 0.0 110.847 167.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.4 p -140.24 -15.43 0.98 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.834 1.253 . . . . 0.0 113.651 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 50.12 -64.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 129.686 3.194 . . . . 0.0 114.956 -167.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.45 83.15 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.548 1.139 . . . . 0.0 112.424 -160.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.77 162.22 29.99 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.745 1.218 . . . . 0.0 110.674 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -155.19 152.69 29.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.412 1.885 . . . . 0.0 109.84 166.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.9 132.19 51.28 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.483 -0.761 . . . . 0.0 111.693 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 -35.52 4.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.159 0.983 . . . . 0.0 110.809 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.86 103.2 0.42 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.016 1.77 . . . . 0.0 110.036 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 p -59.51 151.85 58.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.941 0.896 . . . . 0.0 112.293 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.08 141.76 77.99 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.13 1.887 . . . . 0.0 113.498 -168.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.77 135.51 33.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.292 1.437 . . . . 0.0 110.722 174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.09 141.59 54.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -13.38 59.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 114.559 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.22 -8.26 47.29 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.366 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -98.21 1.78 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.1 1.36 . . . . 0.0 112.284 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -8.79 47.93 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.98 1.276 . . . . 0.0 113.89 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -102.11 166.51 10.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.939 2.096 . . . . 0.0 111.988 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.78 123.74 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.455 1.502 . . . . 0.0 110.833 173.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -77.74 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.882 0.873 . . . . 0.0 109.781 164.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.37 121.14 9.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.35 2.26 . . . . 0.0 109.241 -164.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -108.91 133.91 52.28 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.76 -1.212 . . . . 0.0 113.029 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.18 159.54 25.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.557 0.743 . . . . 0.0 110.25 168.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -111.26 144.78 39.9 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.918 1.287 . . . . 0.0 109.49 167.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -93.36 102.8 15.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.177 1.391 . . . . 0.0 109.404 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -77.82 16.34 0.71 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.52 38.86 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 120.187 1.358 . . . . 0.0 115.587 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.53 -15.27 24.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -131.93 177.49 7.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.725 1.21 . . . . 0.0 112.61 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.32 38.42 0.73 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-O 116.307 -2.385 . . . . 0.0 118.706 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.07 107.84 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 122.715 3.258 . . . . 0.0 111.474 166.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.6 t -169.1 173.72 6.67 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.383 1.473 . . . . 0.0 110.394 -165.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -88.72 96.7 10.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 119.715 -1.866 . . . . 0.0 111.404 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.75 123.93 60.85 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.774 0.83 . . . . 0.0 112.853 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -86.12 99.37 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.641 2.894 . . . . 0.0 112.31 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -131.07 145.7 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.282 1.033 . . . . 0.0 109.255 164.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.1 t -151.18 166.49 30.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.854 1.262 . . . . 0.0 112.789 -169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.7 t -145.99 108.83 4.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.379 2.272 . . . . 0.0 110.338 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . 0.451 HG13 ' H ' ' A' ' 61' ' ' VAL . 31.5 m -142.42 171.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.839 0.855 . . . . 0.0 112.665 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.63 -6.52 20.39 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -143.9 20.03 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.422 -1.424 . . . . 0.0 112.687 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.15 20.48 10.99 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.263 1.825 . . . . 0.0 111.966 -173.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -82.15 48.31 1.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 129.896 3.278 . . . . 0.0 113.203 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -58.14 -17.19 16.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -7.66 1.2 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.376 1.87 . . . . 0.0 114.753 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -150.05 87.19 5.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 119.925 -1.734 . . . . 0.0 109.655 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.11 115.24 2.04 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 125.129 3.886 . . . . 0.0 114.279 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.451 ' H ' HG13 ' A' ' 52' ' ' VAL . 4.4 t -92.39 -36.6 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.248 1.419 . . . . 0.0 110.67 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.91 -162.99 34.91 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.624 2.059 . . . . 0.0 111.98 170.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -144.47 167.19 23.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.889 1.276 . . . . 0.0 112.261 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.78 106.77 18.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.883 1.673 . . . . 0.0 106.552 167.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.89 -54.34 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -60.64 -49.26 78.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 113.002 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.68 141.28 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 123.028 0.531 . . . . 0.0 110.536 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -75.29 134.32 73.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 122.22 0.208 . . . . 0.0 110.5 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.38 92.21 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 114.309 -153.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -140.79 128.73 21.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.234 1.413 . . . . 0.0 110.547 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.7 t -82.92 87.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.16 1.384 . . . . 0.0 108.214 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -73.26 -5.24 38.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 157.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 110.841 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.36 -19.38 60.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -74.17 5.98 3.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.421 1.889 . . . . 0.0 113.841 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 12.22 0.17 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.844 1.658 . . . . 0.0 114.815 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.27 24.5 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 130.146 3.378 . . . . 0.0 114.921 -170.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 173.07 8.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.087 . . . . 0.0 113.758 -169.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 111.48 22.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.257 2.623 . . . . 0.0 105.306 164.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.71 128.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.919 0.866 . . . . 0.0 112.439 -158.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -92.44 125.85 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.052 2.541 . . . . 0.0 109.79 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.57 136.54 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.589 2.355 . . . . 0.0 108.15 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 134.49 33.61 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.699 . . . . 0.0 110.899 159.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.72 157.34 24.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.771 1.628 . . . . 0.0 109.761 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.65 106.85 42.64 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.54 136.2 10.87 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.439 2.76 . . . . 0.0 109.829 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -61.56 161.72 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 121.467 1.445 . . . . 0.0 111.357 167.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -88.23 166.75 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.35 0.66 . . . . 0.0 112.726 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.44 -89.44 1.22 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -167.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.24 147.26 50.22 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.2 p -146.41 141.76 27.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.737 0.78 . . . . 0.0 112.088 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -130.74 121.34 25.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.385 1.874 . . . . 0.0 108.266 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.0 mm -105.9 108.51 25.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 107.278 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.6 t -113.14 139.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.289 1.036 . . . . 0.0 109.52 -164.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.0 t -136.92 97.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.709 1.604 . . . . 0.0 107.899 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.58 172.73 18.73 Favored Glycine 0 N--CA 1.467 0.71 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 114.82 15.17 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.728 2.011 . . . . 0.0 110.211 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.37 -103.5 0.04 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.202 1.858 . . . . 0.0 114.086 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.67 -18.42 62.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.138 2.175 . . . . 0.0 115.545 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -123.14 93.95 4.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.339 0.972 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.2 42.53 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.76 159.68 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 129.135 2.974 . . . . 0.0 108.139 168.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -146.05 153.95 41.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.804 0.842 . . . . 0.0 110.081 165.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -137.91 166.91 22.87 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.671 1.588 . . . . 0.0 109.493 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -124.33 157.89 33.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.886 0.874 . . . . 0.0 112.399 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.51 151.38 28.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.051 1.74 . . . . 0.0 110.738 169.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -127.29 136.86 52.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 109.312 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -140.53 91.69 2.45 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -153.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 t 76.35 17.32 2.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.223 2.209 . . . . 0.0 114.187 163.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.79 25.55 0.05 OUTLIER Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.727 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.6 t -63.53 156.41 26.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.351 1.575 . . . . 0.0 110.849 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.6 p -62.34 -16.78 56.4 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 166.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.0 mm -67.23 -10.55 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.634 1.574 . . . . 0.0 111.903 167.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.37 17.1 47.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.219 1.39 . . . . 0.0 113.993 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tptp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.367 1.467 . . . . 0.0 112.833 -161.558 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 164.57 34.28 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 -174.53 3.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.884 2.074 . . . . 0.0 111.45 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.42 -57.08 2.08 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.602 -0.686 . . . . 0.0 110.815 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -49.09 -52.47 25.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.842 2.457 . . . . 0.0 114.425 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.34 -31.42 69.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.917 0.781 . . . . 0.0 112.797 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -76.3 -12.38 60.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.064 1.345 . . . . 0.0 113.812 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -19.7 126.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 1 C-N-CA 130.773 4.035 . . . . 0.0 116.59 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.433 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 79.3 p -73.96 74.58 1.68 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 113.151 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -59.89 -45.91 91.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.882 1.673 . . . . 0.0 112.857 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -123.74 174.4 7.51 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.353 1.861 . . . . 0.0 110.712 174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.17 148.94 31.89 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.379 0.99 . . . . 0.0 113.085 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.76 105.11 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 122.621 1.2 . . . . 0.0 113.336 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.92 151.83 14.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.928 2.091 . . . . 0.0 109.281 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 p -143.94 -33.62 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.493 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 60.42 -69.27 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.596 2.759 . . . . 0.0 114.739 170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.56 72.74 1.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.492 1.517 . . . . 0.0 110.346 -161.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -115.94 160.86 19.66 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.694 1.198 . . . . 0.0 110.049 165.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -141.97 144.22 33.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.652 1.581 . . . . 0.0 108.377 164.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.72 147.63 52.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.835 0.826 . . . . 0.0 111.947 170.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -46.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.924 1.29 . . . . 0.0 110.388 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.14 110.54 0.91 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.12 1.343 . . . . 0.0 111.239 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -57.92 146.6 67.24 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.448 167.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.2 155.22 52.52 Favored 'Trans proline' 0 C--N 1.351 0.71 0 N-CA-C 115.49 1.304 . . . . 0.0 115.49 -165.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.61 39.89 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.556 1.542 . . . . 0.0 110.282 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 132.65 45.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.769 0.428 . . . . 0.0 111.134 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.7 p -77.82 -24.25 48.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 -8.23 61.45 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.68 -1.066 . . . . 0.0 113.976 -160.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -75.25 -11.67 60.12 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.656 1.728 . . . . 0.0 111.342 163.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 -13.85 62.97 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.819 2.152 . . . . 0.0 113.105 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -84.29 170.17 13.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.759 2.424 . . . . 0.0 112.036 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.24 124.41 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.581 1.153 . . . . 0.0 110.317 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.24 128.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.793 0.837 . . . . 0.0 109.357 164.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 159.27 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 167.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -132.17 135.25 46.22 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -165.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.26 168.04 16.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.819 1.247 . . . . 0.0 110.489 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -123.7 148.17 46.79 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.844 1.257 . . . . 0.0 110.267 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -97.51 108.91 21.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.7 p -87.45 0.51 55.41 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.119 1.768 . . . . 0.0 113.775 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.16 16.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.712 1.149 . . . . 0.0 113.69 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 m -118.3 11.8 13.22 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.995 1.718 . . . . 0.0 111.56 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -149.25 -175.3 4.93 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.32 2.248 . . . . 0.0 111.154 -168.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.44 56.95 2.7 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.907 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.45 95.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.548 2.832 . . . . 0.0 112.281 155.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.3 169.07 19.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.26 . . . . 0.0 112.752 -169.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 2.5 ttmm -95.78 101.38 13.06 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 110.523 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.78 115.45 18.88 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 111.321 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.3 88.45 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.932 2.422 . . . . 0.0 111.221 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 tt -106.77 144.9 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.23 1.012 . . . . 0.0 109.412 165.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t -145.85 167.87 22.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.011 1.324 . . . . 0.0 113.283 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.8 t -139.81 110.96 6.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.563 2.345 . . . . 0.0 109.811 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.3 161.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -8.57 29.67 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.4 m -155.68 36.65 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.164 -1.585 . . . . 0.0 112.321 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.96 8.41 0.98 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.324 1.85 . . . . 0.0 114.541 -175.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -67.96 40.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 131.104 3.762 . . . . 0.0 114.839 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.61 0.49 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -160.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.75 -18.67 65.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.13 -0.981 . . . . 0.0 112.966 160.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.1 m -128.33 101.48 21.77 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.102 1.761 . . . . 0.0 109.865 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -66.53 117.83 5.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.004 2.47 . . . . 0.0 110.325 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -96.83 -30.98 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.89 0.876 . . . . 0.0 111.144 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.4 -164.63 24.55 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.335 1.922 . . . . 0.0 111.537 166.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 9.4 ptp85 -139.48 169.62 17.41 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.673 1.589 . . . . 0.0 111.803 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 114.79 27.45 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.201 1.8 . . . . 0.0 106.809 170.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.9 -51.92 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.282 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -60.73 -44.31 96.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.83 159.0 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.476 0.71 . . . . 0.0 111.03 -169.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.77 127.19 67.15 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.667 0.787 . . . . 0.0 109.091 163.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.06 89.56 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 110.916 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -144.05 142.78 30.85 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.792 0.806 . . . . 0.0 112.737 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 t -76.49 86.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 127.46 2.304 . . . . 0.0 106.864 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 p -59.97 -28.68 67.87 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -167.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 161.17 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.529 1.531 . . . . 0.0 112.146 -173.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.78 -28.01 68.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.119 0.968 . . . . 0.0 112.702 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.62 5.45 4.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.384 2.274 . . . . 0.0 114.665 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 14.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.1 16.97 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.694 3.598 . . . . 0.0 115.425 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.53 169.66 17.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.279 1.832 . . . . 0.0 113.768 -172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 111.14 22.75 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.711 2.805 . . . . 0.0 105.473 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.71 126.65 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.034 0.934 . . . . 0.0 112.342 -159.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.97 130.97 36.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.286 2.234 . . . . 0.0 109.644 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -133.97 142.77 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.106 1.363 . . . . 0.0 109.889 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.81 135.1 33.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.302 1.041 . . . . 0.0 111.772 168.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.0 157.75 26.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.576 1.95 . . . . 0.0 109.844 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 35.6 tt0 -90.95 113.45 58.16 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.838 0.855 . . . . 0.0 109.041 171.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.28 122.91 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.804 3.003 . . . . 0.0 109.92 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.56 164.29 31.58 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.706 1.604 . . . . 0.0 111.846 171.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -80.98 145.0 31.41 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.29 -0.881 . . . . 0.0 111.783 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.09 -94.34 1.06 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.695 2.093 . . . . 0.0 110.268 -173.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -112.77 174.8 5.72 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 110.267 167.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 m -153.15 96.32 2.05 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.606 -1.309 . . . . 0.0 110.917 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.63 127.27 42.46 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.28 96.97 5.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.263 1.425 . . . . 0.0 107.612 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.98 140.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.695 -171.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -135.66 99.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.348 1.859 . . . . 0.0 107.834 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.08 169.14 25.01 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -137.59 123.9 20.61 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.835 2.454 . . . . 0.0 108.975 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.39 -98.54 0.01 OUTLIER Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.407 1.956 . . . . 0.0 114.92 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -71.37 -17.07 62.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.58 99.54 6.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.632 1.173 . . . . 0.0 109.58 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.39 156.28 45.82 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 164.79 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.46 2.704 . . . . 0.0 108.182 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.83 160.78 43.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.697 -0.627 . . . . 0.0 111.023 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.23 171.68 12.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.532 1.933 . . . . 0.0 109.899 170.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.1 144.16 51.11 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.221 1.008 . . . . 0.0 111.56 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.39 164.07 35.98 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.258 1.823 . . . . 0.0 110.783 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -146.17 114.46 6.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.547 1.539 . . . . 0.0 108.512 -162.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -152.54 96.3 2.12 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -163.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.7 p 56.6 82.16 0.12 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 128.609 2.763 . . . . 0.0 114.026 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.9 21.42 4.97 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.496 1.998 . . . . 0.0 112.961 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.8 t -70.77 156.95 38.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -166.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m -54.6 -19.05 5.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.852 1.661 . . . . 0.0 114.081 164.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tt -112.98 16.25 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.721 1.208 . . . . 0.0 112.735 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.4 75.81 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 116.111 1.204 . . . . 0.0 116.111 164.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.331 1.452 . . . . 0.0 113.56 179.146 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -146.61 146.95 30.6 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.171 0.51 . . . . 0.0 111.897 -168.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.62 173.02 9.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.061 2.544 . . . . 0.0 109.924 173.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -98.7 -49.39 4.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.258 -0.901 . . . . 0.0 111.336 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -61.33 -33.46 73.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.452 1.901 . . . . 0.0 114.12 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.11 -38.16 87.84 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.533 0.733 . . . . 0.0 110.963 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -69.86 -40.23 75.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.917 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 11.62 109.73 0.0 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 130.657 3.98 . . . . 0.0 117.072 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -67.49 71.34 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.925 2.09 . . . . 0.0 112.557 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -19.71 65.48 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.414 3.086 . . . . 0.0 114.78 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -158.62 -172.97 4.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 110.686 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.59 118.35 13.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.718 1.151 . . . . 0.0 112.738 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -67.41 99.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.66 1.184 . . . . 0.0 112.979 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 160.04 39.98 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.737 2.415 . . . . 0.0 109.467 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.8 p -136.8 -35.57 0.71 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.672 1.189 . . . . 0.0 112.815 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 tttm 54.86 -79.42 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.822 2.449 . . . . 0.0 114.634 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.53 84.12 1.97 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.531 0.605 . . . . 0.0 111.958 -162.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.62 163.98 26.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.782 0.833 . . . . 0.0 112.268 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -149.93 145.82 26.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.428 2.291 . . . . 0.0 108.275 160.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -65.46 140.27 58.59 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.558 -0.714 . . . . 0.0 111.449 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.34 -52.08 2.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.65 112.81 1.94 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.557 1.551 . . . . 0.0 110.37 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.1 p -52.23 141.8 30.23 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.092 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.22 145.82 84.97 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.759 2.306 . . . . 0.0 112.764 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.51 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.706 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -65.0 125.22 24.23 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.356 0.598 . . . . 0.0 110.648 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 p -70.26 -8.22 48.49 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.145 2.178 . . . . 0.0 114.0 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.85 -8.49 3.4 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.64 1.114 . . . . 0.0 113.569 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -94.62 5.62 51.3 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.447 1.899 . . . . 0.0 111.276 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.14 18.72 38.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.698 1.142 . . . . 0.0 113.97 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -130.32 161.8 30.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 111.144 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 121.71 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.657 1.583 . . . . 0.0 108.701 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.32 130.4 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 162.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.7 tt -141.9 131.89 24.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 109.704 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -115.91 130.84 57.0 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.114 0.87 . . . . 0.0 113.243 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.05 167.31 13.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.36 1.064 . . . . 0.0 111.164 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -119.21 142.84 47.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.371 1.468 . . . . 0.0 109.836 166.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -95.1 98.27 10.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.303 1.041 . . . . 0.0 110.691 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.5 p -76.06 22.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.459 2.303 . . . . 0.0 115.846 -163.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.39 176.02 37.95 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 120.905 -1.122 . . . . 0.0 114.601 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 p -99.2 -4.69 31.47 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.501 1.921 . . . . 0.0 113.64 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.23 176.77 8.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.718 1.607 . . . . 0.0 112.732 -167.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.78 48.2 2.16 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 117.244 -1.864 . . . . 0.0 116.944 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.97 99.11 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.761 2.781 . . . . 0.0 110.068 162.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 56.2 m -145.39 163.72 33.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.504 1.522 . . . . 0.0 111.725 -167.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -80.08 90.0 5.41 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.167 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.11 114.51 7.23 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.852 1.261 . . . . 0.0 112.516 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.53 99.46 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.345 2.03 . . . . 0.0 110.761 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -126.51 145.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.081 1.352 . . . . 0.0 108.446 163.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.3 t -147.02 164.11 34.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.573 1.149 . . . . 0.0 112.806 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.9 t -137.76 115.39 11.3 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.556 2.342 . . . . 0.0 109.218 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.58 169.96 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.808 1.243 . . . . 0.0 111.593 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.58 -0.03 20.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -154.31 28.87 0.45 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.198 -1.564 . . . . 0.0 112.709 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.99 6.44 0.32 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.223 2.209 . . . . 0.0 115.203 -174.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -71.36 56.74 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.912 3.285 . . . . 0.0 112.436 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -4.72 4.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -16.0 20.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.417 1.487 . . . . 0.0 114.515 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.0 m -157.11 116.11 2.0 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 120.678 -1.264 . . . . 0.0 109.16 165.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 127.82 16.02 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.229 3.286 . . . . 0.0 113.665 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.37 -26.65 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 126.054 1.742 . . . . 0.0 110.911 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.56 -164.82 29.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.484 1.992 . . . . 0.0 111.116 163.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.78 177.95 7.43 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.403 0.681 . . . . 0.0 112.62 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.49 142.49 27.37 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 163.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.0 t -106.8 -45.88 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.548 0.613 . . . . 0.0 110.108 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.2 m -61.86 -43.81 98.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.65 157.18 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.823 1.192 . . . . 0.0 112.375 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -62.09 128.6 91.08 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.29 89.02 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.367 2.045 . . . . 0.0 113.707 -172.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -155.59 114.08 3.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.227 1.811 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -76.74 93.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.836 2.054 . . . . 0.0 108.2 171.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -69.63 -7.26 37.3 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.16 154.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.874 1.216 . . . . 0.0 111.989 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.91 66.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.249 1.02 . . . . 0.0 112.322 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.16 0.05 5.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.187 2.995 . . . . 0.0 114.07 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.24 11.82 0.15 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.849 1.66 . . . . 0.0 115.429 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.35 17.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.304 3.442 . . . . 0.0 115.597 -167.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.2 176.78 8.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.893 2.077 . . . . 0.0 114.126 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.29 114.51 27.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.836 2.854 . . . . 0.0 106.171 164.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.62 132.03 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.561 0.696 . . . . 0.0 112.749 -158.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.86 137.97 33.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.263 2.225 . . . . 0.0 111.109 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.84 144.05 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.005 2.122 . . . . 0.0 108.69 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -98.91 135.75 39.89 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 112.476 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.36 166.56 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 110.442 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.37 110.67 63.32 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.073 0.949 . . . . 0.0 110.009 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.88 108.59 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.729 4.286 . . . . 0.0 111.084 172.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.34 161.56 19.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.38 165.31 16.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.92 -80.26 1.23 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -165.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.01 156.66 41.27 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.801 1.24 . . . . 0.0 111.139 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -143.02 142.17 31.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.523 1.129 . . . . 0.0 110.161 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -137.92 128.63 26.81 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.644 1.178 . . . . 0.0 108.096 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.22 98.64 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.265 1.426 . . . . 0.0 107.255 -162.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -99.92 136.49 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.939 0.896 . . . . 0.0 109.114 -167.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.6 103.98 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.67 1.588 . . . . 0.0 107.524 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.97 177.59 15.04 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.299 0.944 . . . . 0.0 114.763 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.47 154.51 45.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.195 2.198 . . . . 0.0 108.471 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -12.2 -72.74 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.68 2.562 . . . . 0.0 117.164 -173.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.11 -13.72 59.76 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.9 88.04 2.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.623 1.569 . . . . 0.0 109.971 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -143.25 157.7 44.26 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.29 161.4 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 129.382 3.073 . . . . 0.0 107.839 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.69 150.82 36.15 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.05 -1.031 . . . . 0.0 112.513 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -120.87 170.25 9.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.766 1.226 . . . . 0.0 110.832 166.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -125.8 159.74 31.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.616 1.967 . . . . 0.0 111.31 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.0 153.01 31.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.198 2.599 . . . . 0.0 110.599 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -143.58 117.3 9.27 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 108.765 -167.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -150.57 93.04 1.92 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -165.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p 65.8 58.0 0.8 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.081 1.753 . . . . 0.0 114.077 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 128.65 25.3 1.04 Allowed Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.882 1.706 . . . . 0.0 113.439 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.01 158.0 14.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.239 1.816 . . . . 0.0 113.475 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 m -55.52 -22.81 23.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.322 1.049 . . . . 0.0 112.454 163.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -91.33 -3.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 126.809 2.044 . . . . 0.0 111.523 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.54 69.87 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.635 -1.291 . . . . 0.0 115.469 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? . . . . . 0 C--O 1.249 1.029 0 C-N-CA 126.022 1.729 . . . . 0.0 113.206 178.769 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -142.78 137.25 29.59 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.113 0.565 . . . . 0.0 112.093 -162.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 168.42 14.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.669 2.787 . . . . 0.0 109.953 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -83.65 -57.54 3.18 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.239 -0.913 . . . . 0.0 111.994 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -58.36 -29.65 66.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.417 1.487 . . . . 0.0 114.356 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -70.74 -40.03 72.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.33 0.513 . . . . 0.0 111.093 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -65.74 -45.32 83.08 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.962 0.801 . . . . 0.0 109.886 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.99 101.77 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 130.04 3.686 . . . . 0.0 116.756 161.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -68.4 62.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.521 2.328 . . . . 0.0 112.682 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -70.33 -17.92 63.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.382 1.873 . . . . 0.0 113.757 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -160.07 -179.15 7.52 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.444 1.497 . . . . 0.0 110.486 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.05 144.85 24.09 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.668 1.128 . . . . 0.0 114.241 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.99 95.54 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 122.969 1.366 . . . . 0.0 114.152 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 169.44 17.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 128.627 2.771 . . . . 0.0 108.299 168.258 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -167.27 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.585 0.754 . . . . 0.0 112.484 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? 61.99 -76.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.593 2.357 . . . . 0.0 113.647 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.49 77.06 1.59 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.802 0.81 . . . . 0.0 112.149 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -120.7 156.96 30.66 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.403 1.081 . . . . 0.0 110.144 163.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -143.11 142.39 31.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.085 1.754 . . . . 0.0 108.731 168.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.49 138.7 57.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.67 0.748 . . . . 0.0 111.398 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -43.12 3.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.077 1.351 . . . . 0.0 109.541 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.98 115.48 1.2 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.395 1.95 . . . . 0.0 109.646 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.2 p -64.12 159.58 55.46 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.648 -0.913 . . . . 0.0 111.321 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.46 137.22 68.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.139 1.893 . . . . 0.0 112.585 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 125.3 32.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.5 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.37 132.05 47.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.557 0.694 . . . . 0.0 111.454 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.2 p -78.8 -9.14 59.36 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.818 1.647 . . . . 0.0 113.944 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.16 -7.82 3.08 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 118.994 0.815 . . . . 0.0 114.061 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -94.96 4.87 53.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.069 1.748 . . . . 0.0 111.193 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.02 42.31 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.245 1.879 . . . . 0.0 114.072 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -109.47 174.76 5.72 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.034 2.134 . . . . 0.0 112.056 -171.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -120.42 141.01 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.936 1.294 . . . . 0.0 110.224 165.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.54 128.89 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.018 1.327 . . . . 0.0 109.918 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.55 133.09 36.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.729 2.012 . . . . 0.0 109.217 -172.283 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HZ3' ' A' ' 79' ' ' LYS . 21.6 tt0 -121.24 132.32 54.74 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.869 0.868 . . . . 0.0 112.612 -176.165 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.85 166.12 14.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.865 0.866 . . . . 0.0 110.119 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -120.95 148.74 43.67 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.885 0.874 . . . . 0.0 109.45 160.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -100.4 100.36 11.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.011 0.925 . . . . 0.0 109.702 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -80.47 13.64 2.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.453 2.301 . . . . 0.0 115.759 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.08 171.32 27.8 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.507 1.048 . . . . 0.0 113.789 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -96.52 6.42 48.78 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.715 1.606 . . . . 0.0 113.479 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.8 172.68 12.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.87 1.668 . . . . 0.0 112.308 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.65 47.76 0.89 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-O 117.046 -1.975 . . . . 0.0 117.413 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -55.11 95.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.959 0 CA-C-N 121.769 2.785 . . . . 0.0 111.458 162.18 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 65.4 m -152.96 168.03 27.19 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.367 1.467 . . . . 0.0 112.589 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -83.48 91.96 7.5 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.504 -1.372 . . . . 0.0 110.782 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.81 119.35 15.76 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.676 1.19 . . . . 0.0 112.105 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.83 88.87 1.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.353 2.702 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 tt -124.62 143.72 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.792 -0.567 . . . . 0.0 110.07 165.603 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.5 t -147.62 157.16 43.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.844 1.258 . . . . 0.0 112.055 -168.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -133.28 108.62 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.993 1.717 . . . . 0.0 110.562 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 19.3 m -131.73 170.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.794 0.837 . . . . 0.0 112.166 -176.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.19 -12.6 18.62 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -152.93 27.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.114 -1.616 . . . . 0.0 112.602 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.47 17.66 2.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.054 2.142 . . . . 0.0 113.098 -168.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.466 HD22 ' CG2' ' A' ' 61' ' ' VAL . 13.5 p-10 -68.37 52.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.583 2.753 . . . . 0.0 111.952 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.3 t0 -56.94 -25.67 58.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.914 1.285 . . . . 0.0 113.2 -173.086 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.58 -10.96 0.48 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.566 3.147 . . . . 0.0 116.128 166.025 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.3 m -153.6 95.75 2.85 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 119.869 -1.77 . . . . 0.0 111.064 166.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_exo -54.27 118.1 4.65 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.838 3.692 . . . . 0.0 116.369 -177.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.466 ' CG2' HD22 ' A' ' 56' ' ' ASN . 2.7 t -95.9 -26.21 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.858 1.663 . . . . 0.0 112.859 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.18 -163.52 18.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.514 2.007 . . . . 0.0 111.798 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 172.31 13.02 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.64 104.94 16.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.972 2.109 . . . . 0.0 106.857 168.037 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.85 -48.58 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.593 0.757 . . . . 0.0 110.453 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -59.82 -48.04 83.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -162.41 161.96 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.235 0.925 . . . . 0.0 112.033 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.16 120.73 45.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.858 0.863 . . . . 0.0 109.563 161.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.82 85.32 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.397 2.064 . . . . 0.0 110.843 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.34 123.9 11.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.048 1.739 . . . . 0.0 110.376 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.48 99.09 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.285 1.434 . . . . 0.0 108.323 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.2 t -75.71 -4.48 40.6 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.17 159.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.076 1.307 . . . . 0.0 112.842 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.62 63.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.936 1.294 . . . . 0.0 113.206 168.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.7 p -80.41 2.53 24.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.076 1.75 . . . . 0.0 114.103 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 14.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.22 16.65 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 130.969 3.708 . . . . 0.0 114.814 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.597 2.359 . . . . 0.0 114.024 -171.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HZ3' ' CD ' ' A' ' 35' ' ' GLU . 10.5 tmtt? -112.38 107.83 16.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.708 2.803 . . . . 0.0 105.696 166.852 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.32 120.02 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.148 0.979 . . . . 0.0 113.231 -153.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.05 129.29 35.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.151 2.581 . . . . 0.0 109.748 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.55 136.92 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.826 2.45 . . . . 0.0 108.499 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -91.09 141.54 28.71 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.343 0.657 . . . . 0.0 112.347 167.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.52 159.62 30.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.339 2.256 . . . . 0.0 110.045 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.45 107.54 58.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 108.95 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -90.99 115.8 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 125.044 3.83 . . . . 0.0 110.711 167.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.4 167.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 125.115 3.877 . . . . 0.0 116.172 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -77.59 161.28 27.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.33 -87.57 1.2 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -125.7 160.38 29.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.46 1.124 . . . . 0.0 110.905 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -154.12 159.35 41.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.065 0.936 . . . . 0.0 111.651 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.55 127.96 21.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.299 1.44 . . . . 0.0 108.114 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.46 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.212 1.805 . . . . 0.0 107.011 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -106.65 135.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.56 92.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 126.156 1.782 . . . . 0.0 107.236 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.97 171.19 17.46 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.69 113.52 13.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.061 1.744 . . . . 0.0 110.436 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.07 -103.49 0.05 OUTLIER Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.078 1.799 . . . . 0.0 114.116 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -17.03 64.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.582 1.953 . . . . 0.0 115.727 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -129.43 98.6 4.91 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.545 1.066 . . . . 0.0 110.554 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -148.84 166.03 29.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.51 162.67 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 129.931 3.293 . . . . 0.0 108.502 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.69 157.1 41.62 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 172.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -139.35 151.31 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 111.684 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 160.64 14.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.232 1.413 . . . . 0.0 112.757 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -147.51 154.38 40.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.571 1.548 . . . . 0.0 112.053 158.064 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -139.69 114.65 9.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.842 1.657 . . . . 0.0 108.685 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -151.19 108.21 3.56 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -165.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 p 52.41 70.68 0.54 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.796 2.838 . . . . 0.0 113.784 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.83 24.63 4.22 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.571 1.557 . . . . 0.0 113.541 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -56.91 155.25 8.22 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 112.668 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 m -51.05 -25.1 4.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.324 1.449 . . . . 0.0 112.761 161.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.01 -4.47 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.332 1.853 . . . . 0.0 112.849 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.11 5.79 60.58 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.636 1.415 . . . . 0.0 116.636 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.483 1.642 . . . . 0.0 113.858 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -145.62 149.66 34.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.392 1.077 . . . . 0.0 111.018 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.11 106.14 13.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.71 2.004 . . . . 0.0 110.094 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.14 -24.15 47.5 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -163.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.74 -39.11 73.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.258 1.023 . . . . 0.0 112.918 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.55 -5.68 41.74 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -71.09 -15.58 62.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -165.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.52 84.93 0.3 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.174 1.352 . . . . 0.0 114.685 170.539 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -89.4 18.28 5.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.292 1.837 . . . . 0.0 113.833 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -62.16 -12.02 17.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.23 170.88 14.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.563 1.945 . . . . 0.0 108.78 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.09 161.99 40.14 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.471 -0.768 . . . . 0.0 113.396 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -72.51 91.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.269 1.509 . . . . 0.0 113.626 -172.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.67 163.1 35.92 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.281 2.232 . . . . 0.0 109.195 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.6 p -160.03 -44.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.594 1.158 . . . . 0.0 110.774 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 64.46 -70.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 128.227 2.611 . . . . 0.0 112.515 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.81 78.6 1.97 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.328 1.051 . . . . 0.0 112.228 -161.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -134.29 154.98 51.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 111.346 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -146.05 143.88 29.69 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.551 1.94 . . . . 0.0 109.617 165.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.88 129.82 42.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.851 0.86 . . . . 0.0 111.17 167.068 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -108.71 -51.13 2.92 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.603 1.561 . . . . 0.0 109.39 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.56 104.48 0.69 Allowed Glycine 0 C--N 1.339 0.701 0 C-N-CA 125.861 1.695 . . . . 0.0 109.137 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -64.15 157.29 70.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 117.927 0.864 . . . . 0.0 112.365 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.88 141.09 46.84 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.554 2.836 . . . . 0.0 115.621 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.95 122.91 24.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 110.019 167.126 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.19 123.18 18.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -72.94 -13.74 61.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.997 0.919 . . . . 0.0 112.64 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 -8.93 2.17 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 119.046 0.839 . . . . 0.0 114.14 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -89.59 11.26 20.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.737 1.615 . . . . 0.0 111.586 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 12.87 58.95 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.861 1.22 . . . . 0.0 113.836 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -131.01 163.39 27.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.835 1.317 . . . . 0.0 112.497 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 123.41 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.176 1.79 . . . . 0.0 107.765 164.071 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.57 124.72 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.92 146.82 45.92 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.686 1.194 . . . . 0.0 110.682 169.583 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.456 ' CD ' ' HZ1' ' A' ' 79' ' ' LYS . 26.2 tt0 -116.99 135.28 53.82 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.094 0.958 . . . . 0.0 111.073 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.7 mt -117.17 161.09 20.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.29 1.436 . . . . 0.0 109.838 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -120.34 139.54 52.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.246 1.019 . . . . 0.0 109.781 163.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.59 93.32 9.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.521 1.128 . . . . 0.0 109.827 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -72.72 32.21 0.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.88 2.472 . . . . 0.0 115.08 -165.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.42 178.57 45.3 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 122.777 1.209 . . . . 0.0 116.055 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.37 -24.96 29.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.092 2.557 . . . . 0.0 115.655 -169.573 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.25 173.61 15.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.091 0.956 . . . . 0.0 111.744 -153.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 118.85 50.88 0.31 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-O 117.131 -1.927 . . . . 0.0 116.301 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_exo -54.69 87.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.026 0 CA-C-N 121.628 2.714 . . . . 0.0 112.089 160.095 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.76 169.54 20.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.56 1.144 . . . . 0.0 112.671 -167.378 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -91.26 92.98 8.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.785 1.234 . . . . 0.0 109.889 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.51 119.81 43.13 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.882 0.873 . . . . 0.0 112.87 -170.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.75 88.24 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.358 2.705 . . . . 0.0 109.985 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -123.86 144.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.4 1.48 . . . . 0.0 108.567 167.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.8 t -154.59 167.85 28.73 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.2 t -142.27 125.64 16.6 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.53 2.332 . . . . 0.0 109.877 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.3 m -139.24 167.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.239 1.016 . . . . 0.0 113.657 -178.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.56 22.61 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -155.32 36.05 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.036 -1.665 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.17 10.03 1.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.288 2.235 . . . . 0.0 114.723 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -68.78 46.28 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 129.575 3.15 . . . . 0.0 113.906 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -66.25 -2.46 4.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -166.167 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.65 -12.15 2.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.553 1.141 . . . . 0.0 113.672 159.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.6 m -155.0 99.82 2.35 Favored Pre-proline 0 CA--C 1.536 0.409 0 O-C-N 120.304 -1.497 . . . . 0.0 109.468 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.61 126.84 15.08 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.293 3.329 . . . . 0.0 112.619 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.49 -34.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.642 1.177 . . . . 0.0 110.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.48 -170.07 40.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.181 1.372 . . . . 0.0 111.15 161.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.468 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.3 ptp85 -134.99 171.99 13.65 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.208 1.403 . . . . 0.0 111.997 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -90.32 124.25 34.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.415 1.886 . . . . 0.0 107.452 168.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -95.69 -53.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 118.468 0.576 . . . . 0.0 111.088 -171.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -41.3 89.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.63 150.08 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.946 0.899 . . . . 0.0 109.786 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -68.75 147.46 97.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 122.178 -0.326 . . . . 0.0 110.133 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.96 76.82 4.35 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.314 2.676 . . . . 0.0 113.54 -160.488 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.35 124.99 14.91 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.168 -0.957 . . . . 0.0 111.129 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.53 91.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.253 1.421 . . . . 0.0 107.228 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 t -57.67 -28.28 63.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.7 m -151.53 158.76 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.262 1.825 . . . . 0.0 111.898 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.43 -24.02 67.48 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.395 1.078 . . . . 0.0 112.858 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.68 0.66 0.74 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 129.694 3.197 . . . . 0.0 114.503 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.97 8.98 0.77 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.83 1.652 . . . . 0.0 115.072 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -61.63 18.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 130.648 3.579 . . . . 0.0 116.022 -169.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.09 174.98 11.06 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.903 2.481 . . . . 0.0 114.43 -171.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.456 ' HZ1' ' CD ' ' A' ' 35' ' ' GLU . 0.1 OUTLIER -126.5 97.72 5.14 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.131 2.572 . . . . 0.0 107.13 170.663 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.02 119.03 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -148.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mt -59.44 142.38 52.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.001 1.72 . . . . 0.0 112.432 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.8 148.0 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 127.571 2.348 . . . . 0.0 108.377 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -99.19 139.5 34.75 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.354 1.062 . . . . 0.0 111.724 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.3 165.78 15.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.42 2.288 . . . . 0.0 109.55 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.468 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 7.9 tt0 -95.57 116.93 66.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.642 1.177 . . . . 0.0 109.425 170.793 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -98.35 107.14 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.856 4.371 . . . . 0.0 112.349 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -45.76 150.89 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.046 3.164 . . . . 0.0 115.167 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -81.71 162.16 23.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.686 0.795 . . . . 0.0 112.632 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.11 -88.02 0.88 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -162.875 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.65 148.08 41.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.995 1.318 . . . . 0.0 110.412 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.58 106.83 5.5 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.497 1.119 . . . . 0.0 109.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -110.12 129.16 55.74 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.438 -0.789 . . . . 0.0 110.34 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.16 111.7 36.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 126.378 1.871 . . . . 0.0 107.917 -168.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.08 135.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.852 0.861 . . . . 0.0 110.118 -160.732 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.22 100.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.04 1.736 . . . . 0.0 108.525 -168.058 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.97 -175.61 19.97 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 122.242 0.912 . . . . 0.0 114.959 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -138.85 141.09 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.374 1.87 . . . . 0.0 109.789 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 16.28 -87.68 0.0 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.213 2.816 . . . . 0.0 116.255 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -70.06 -20.39 63.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -176.673 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -139.51 96.7 3.13 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.424 1.49 . . . . 0.0 110.382 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 159.06 43.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.48 164.07 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.852 2.461 . . . . 0.0 108.519 166.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -148.91 160.75 42.98 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.836 0.854 . . . . 0.0 109.74 166.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -136.16 167.45 21.25 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 109.93 166.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -120.86 161.47 21.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 112.426 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.33 157.65 42.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 128.927 2.891 . . . . 0.0 109.734 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -145.06 148.14 33.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.234 1.014 . . . . 0.0 109.017 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -153.05 116.83 4.76 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.821 . . . . 0.0 112.088 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.7 p 119.68 -0.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 131.146 3.778 . . . . 0.0 114.38 159.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.19 43.45 0.72 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.751 1.167 . . . . 0.0 111.687 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.3 t -88.32 -154.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.497 1.919 . . . . 0.0 112.313 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.5 p -46.95 -31.38 3.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.374 2.669 . . . . 0.0 116.577 -167.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -112.77 11.23 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 125.299 1.44 . . . . 0.0 111.767 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.55 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.46 -1.4 . . . . 0.0 113.604 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 tptp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.969 1.708 . . . . 0.0 112.499 -168.837 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 173.54 12.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.297 2.239 . . . . 0.0 110.454 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -115.07 -53.41 2.63 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -45.28 -53.03 8.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 114.179 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.73 -29.1 67.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.801 0.84 . . . . 0.0 113.057 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.21 -14.78 60.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.93 1.292 . . . . 0.0 113.518 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -17.65 129.59 0.01 OUTLIER Glycine 0 CA--C 1.533 1.213 1 C-N-CA 130.986 4.136 . . . . 0.0 117.484 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 m -62.82 68.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.882 3.273 . . . . 0.0 113.569 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.783 2.033 . . . . 0.0 114.092 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -150.02 175.45 11.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.59 2.356 . . . . 0.0 109.521 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.25 38.0 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 111.787 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -74.36 97.3 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.01 173.33 16.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.949 1.3 . . . . 0.0 111.812 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 90.3 p -151.14 -22.49 0.21 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.794 1.237 . . . . 0.0 114.321 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? 56.58 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 129.974 3.31 . . . . 0.0 115.696 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.89 74.9 1.61 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.07 1.348 . . . . 0.0 111.471 -159.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.43 160.5 16.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.122 1.369 . . . . 0.0 109.709 160.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -134.14 143.59 48.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.285 1.834 . . . . 0.0 108.106 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -68.03 140.65 56.33 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.762 -0.586 . . . . 0.0 111.075 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.62 -57.05 2.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.61 1.164 . . . . 0.0 109.028 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 107.27 0.85 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.766 1.651 . . . . 0.0 110.466 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -42.67 137.23 2.44 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 111.21 170.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.89 152.15 52.28 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.299 2.0 . . . . 0.0 113.76 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.61 121.86 13.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.262 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.05 123.51 20.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.997 0.903 . . . . 0.0 110.804 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -63.38 -16.7 61.27 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.897 2.479 . . . . 0.0 114.352 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.93 -13.49 43.41 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.03 0.832 . . . . 0.0 113.174 -167.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -80.01 8.44 7.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.698 1.249 . . . . 0.0 112.063 165.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.74 84.42 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.532 -1.149 . . . . 0.0 113.949 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.0 p -125.91 146.6 49.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.143 2.177 . . . . 0.0 110.091 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.0 m -91.92 138.18 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.105 0.962 . . . . 0.0 111.003 173.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -85.81 133.45 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 155.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 126.15 16.81 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.57 2.348 . . . . 0.0 109.043 -167.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.12 134.29 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.574 1.079 . . . . 0.0 113.471 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.29 174.27 9.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.814 1.645 . . . . 0.0 111.109 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -135.67 139.44 43.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.431 1.092 . . . . 0.0 110.394 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -89.05 102.99 15.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.319 0.648 . . . . 0.0 110.039 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -80.39 -9.11 59.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 113.535 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.27 166.04 54.67 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.043 0.838 . . . . 0.0 113.394 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -118.95 11.76 12.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.862 1.665 . . . . 0.0 110.531 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -157.71 -178.6 7.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.913 2.485 . . . . 0.0 110.208 -156.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.98 58.98 2.38 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.255 1.662 . . . . 0.0 117.255 164.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -51.94 109.01 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.936 2.424 . . . . 0.0 111.072 155.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.56 155.64 19.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -164.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -81.16 91.15 6.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.543 1.537 . . . . 0.0 109.482 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.35 116.19 14.07 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.938 0.895 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.37 82.22 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 111.269 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -105.96 145.0 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 167.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -154.03 170.33 21.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.152 1.381 . . . . 0.0 113.048 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -144.31 117.16 8.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.445 2.298 . . . . 0.0 110.637 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 13.9 m -140.72 169.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.678 1.191 . . . . 0.0 112.945 -178.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.93 -3.51 21.68 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -154.78 30.84 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.01 -1.681 . . . . 0.0 112.528 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.8 7.98 1.65 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.462 1.905 . . . . 0.0 114.286 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -69.52 46.48 0.07 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.875 3.27 . . . . 0.0 113.474 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.0 t0 -62.84 -7.42 5.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -163.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -58.31 -23.54 56.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.252 1.421 . . . . 0.0 112.96 162.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.0 m -132.71 95.64 19.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 125.652 1.581 . . . . 0.0 109.407 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 123.31 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.108 2.538 . . . . 0.0 110.916 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.17 -22.35 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.365 1.066 . . . . 0.0 111.181 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.48 -170.23 18.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.938 2.208 . . . . 0.0 111.797 165.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.6 ptp85 -138.16 172.82 12.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.918 1.287 . . . . 0.0 112.59 -178.941 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 126.79 39.24 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 106.809 167.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -98.63 -41.66 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.62 -168.173 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -63.07 -50.29 71.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.127 0.876 . . . . 0.0 113.319 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 p -164.29 166.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.335 1.054 . . . . 0.0 111.428 -165.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.06 123.5 48.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.872 0.869 . . . . 0.0 109.164 161.46 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.26 95.86 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.081 1.854 . . . . 0.0 111.131 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -146.46 142.84 28.52 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.398 -0.814 . . . . 0.0 112.612 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.59 95.86 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 126.858 2.063 . . . . 0.0 106.25 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.4 p -70.24 -22.1 62.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.4 m -150.8 157.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.853 1.661 . . . . 0.0 112.065 -170.178 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.61 65.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.974 0.91 . . . . 0.0 113.275 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.8 p -78.56 8.11 5.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.6 1.96 . . . . 0.0 113.711 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 12.82 0.07 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.921 1.689 . . . . 0.0 115.357 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.38 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.793 3.237 . . . . 0.0 115.243 -167.022 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.23 163.22 28.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.19 1.796 . . . . 0.0 113.389 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -98.82 111.1 23.58 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 128.244 2.618 . . . . 0.0 106.045 159.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.72 140.3 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.319 1.048 . . . . 0.0 112.62 -157.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -105.84 131.64 52.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.963 2.505 . . . . 0.0 109.536 -174.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.95 155.12 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.457 1.903 . . . . 0.0 109.522 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -109.0 132.25 54.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.578 . . . . 0.0 110.62 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.57 160.71 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.857 1.663 . . . . 0.0 110.103 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 104.58 35.46 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.167 0.987 . . . . 0.0 109.079 172.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -83.38 118.35 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.274 3.316 . . . . 0.0 109.654 171.468 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.4 160.61 49.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.215 1.943 . . . . 0.0 111.082 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -66.09 159.57 25.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.545 1.138 . . . . 0.0 112.645 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.55 -148.23 18.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.581 1.086 . . . . 0.0 110.566 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.04 146.0 55.59 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.68 -0.894 . . . . 0.0 109.048 152.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -135.37 100.56 4.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.729 0.812 . . . . 0.0 109.621 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -109.08 132.62 53.94 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.084 0.945 . . . . 0.0 111.025 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.01 99.33 8.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 127.866 2.466 . . . . 0.0 107.151 -166.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.8 t -101.08 139.44 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.461 0.704 . . . . 0.0 109.483 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.62 87.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.29 1.436 . . . . 0.0 108.369 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.83 168.52 29.14 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 118.243 2.057 . . . . 0.0 118.243 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.56 146.35 37.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.86 1.664 . . . . 0.0 109.512 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.25 -98.5 0.01 OUTLIER Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.398 1.951 . . . . 0.0 115.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -90.11 -13.55 35.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.992 1.717 . . . . 0.0 114.317 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.49 90.36 3.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.569 1.548 . . . . 0.0 109.291 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.4 155.06 45.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.8 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 129.178 2.991 . . . . 0.0 108.098 170.7 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.29 156.38 38.31 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.396 -0.815 . . . . 0.0 110.95 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.31 160.83 32.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.286 2.235 . . . . 0.0 109.231 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.38 144.88 40.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.839 0.456 . . . . 0.0 111.433 -168.013 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.67 169.94 16.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.935 1.694 . . . . 0.0 111.226 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.29 117.24 14.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.077 1.751 . . . . 0.0 108.112 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -141.03 87.32 2.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 112.793 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.9 m 54.65 63.62 2.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.749 2.02 . . . . 0.0 113.521 168.336 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.57 12.68 0.78 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.438 1.494 . . . . 0.0 114.101 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.5 t -75.53 158.19 32.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.734 1.214 . . . . 0.0 112.961 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 m -40.34 -33.94 0.29 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 130.326 3.45 . . . . 0.0 114.54 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.21 -7.51 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.358 1.063 . . . . 0.0 113.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.53 55.17 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 118.844 -0.975 . . . . 0.0 115.464 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 C-N-CA 125.104 1.362 . . . . 0.0 112.396 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 162.34 36.51 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.229 0.611 . . . . 0.0 111.676 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 -172.68 2.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.16 2.184 . . . . 0.0 110.773 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -106.72 -57.68 2.03 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.518 -0.738 . . . . 0.0 110.702 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -53.47 -34.41 57.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.579 2.352 . . . . 0.0 114.876 -172.126 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.87 -22.03 66.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.364 0.984 . . . . 0.0 112.91 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -82.72 -2.49 54.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.708 0.803 . . . . 0.0 112.698 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -20.07 113.74 0.01 OUTLIER Glycine 0 CA--C 1.532 1.102 1 C-N-CA 130.818 4.056 . . . . 0.0 116.64 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.0 p -67.52 72.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.86 2.464 . . . . 0.0 113.897 -174.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.0 p -74.27 -19.89 60.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.021 1.728 . . . . 0.0 114.172 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.66 170.53 16.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.981 2.112 . . . . 0.0 109.558 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.72 142.82 34.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.119 0.866 . . . . 0.0 112.588 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.41 103.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.65 1.18 . . . . 0.0 112.607 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 148.24 17.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.603 2.361 . . . . 0.0 109.064 -171.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -141.0 -21.9 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 45.36 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.983 3.313 . . . . 0.0 115.328 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.81 80.41 1.58 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.577 1.551 . . . . 0.0 110.571 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -124.62 155.92 38.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.366 1.066 . . . . 0.0 110.684 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -143.85 146.81 33.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.839 1.656 . . . . 0.0 108.493 166.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -69.43 140.28 54.08 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.761 -0.587 . . . . 0.0 111.27 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.58 -44.04 4.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.431 1.092 . . . . 0.0 109.812 168.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.62 117.01 1.15 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.458 1.027 . . . . 0.0 112.419 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.9 m -45.59 146.76 1.68 Allowed Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 127.934 2.494 . . . . 0.0 112.465 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.95 135.79 36.4 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.099 2.533 . . . . 0.0 113.467 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.77 111.54 13.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.025 1.73 . . . . 0.0 110.023 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.31 122.06 12.97 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.33 1.452 . . . . 0.0 111.432 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' THR . . . . . 0.425 ' C ' ' H ' ' A' ' 29' ' ' HIS . 70.1 p -75.46 -11.33 60.01 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.58 -26.79 0.37 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.779 1.18 . . . . 0.0 113.866 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.425 ' H ' ' C ' ' A' ' 27' ' ' THR . 51.4 m80 -70.47 -9.74 57.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.518 2.327 . . . . 0.0 112.968 174.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.33 14.09 12.26 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.817 1.199 . . . . 0.0 114.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 p -128.43 171.14 12.34 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.26 1.424 . . . . 0.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 m -128.82 120.21 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.904 1.682 . . . . 0.0 109.087 171.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.59 133.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.08 130.23 35.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.346 1.858 . . . . 0.0 108.645 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -109.63 128.57 55.32 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.326 0.584 . . . . 0.0 112.388 -174.394 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.52 167.97 12.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.001 1.321 . . . . 0.0 110.501 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.41 142.45 51.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.658 1.183 . . . . 0.0 109.851 162.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -94.1 101.26 13.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -76.3 7.95 3.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.101 2.16 . . . . 0.0 115.265 -169.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.56 169.76 21.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.66 1.118 . . . . 0.0 113.859 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -103.12 -0.45 30.6 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.323 1.849 . . . . 0.0 113.666 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -136.72 173.71 11.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.246 1.818 . . . . 0.0 112.33 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 56.81 1.04 Allowed Glycine 0 CA--C 1.539 1.535 0 CA-C-O 117.823 -1.543 . . . . 0.0 116.719 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.17 99.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.29 2.66 . . . . 0.0 111.897 155.152 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 m -151.47 166.72 30.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.399 1.08 . . . . 0.0 112.548 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 3.7 ttmm -92.58 98.98 11.79 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.811 170.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.32 117.31 39.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.01 1.324 . . . . 0.0 111.353 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.53 85.62 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.658 2.905 . . . . 0.0 111.565 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.89 146.79 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.937 0.895 . . . . 0.0 109.966 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 t -149.65 167.35 26.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.01 1.324 . . . . 0.0 113.524 -167.056 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 t -142.66 107.55 4.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.284 2.233 . . . . 0.0 110.974 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 20.9 m -136.15 163.72 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.566 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.04 -7.46 16.92 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -166.631 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -154.04 34.75 0.43 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.385 -1.447 . . . . 0.0 111.368 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt 57.71 12.77 1.73 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.7 2.0 . . . . 0.0 114.546 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.405 HD22 ' CG2' ' A' ' 61' ' ' VAL . 3.9 p-10 -67.01 45.83 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 130.141 3.376 . . . . 0.0 114.345 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -63.68 -9.2 12.77 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -165.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.44 -10.36 2.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.399 1.48 . . . . 0.0 114.218 162.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.4 m -155.49 118.86 2.41 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 110.541 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.3 141.32 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.214 2.609 . . . . 0.0 111.116 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' HD22 ' A' ' 56' ' ' ASN . 3.5 t -116.58 -34.27 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.945 0.898 . . . . 0.0 110.967 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.45 -167.43 39.56 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.846 1.212 . . . . 0.0 110.753 156.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -135.33 172.04 13.58 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.916 1.286 . . . . 0.0 111.621 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.51 139.72 31.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 161.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.38 -49.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.194 0.597 . . . . 0.0 110.754 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.4 m -57.87 -43.58 86.1 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.97 161.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.996 0.816 . . . . 0.0 111.061 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.64 117.45 18.95 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 156.739 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.92 93.81 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.387 2.058 . . . . 0.0 111.783 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -144.82 135.07 24.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.114 1.365 . . . . 0.0 111.276 168.162 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.11 89.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 127.609 2.364 . . . . 0.0 107.151 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -63.38 -32.02 73.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.92 156.85 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.983 2.113 . . . . 0.0 110.914 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.04 -25.46 67.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.794 0.838 . . . . 0.0 112.436 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 4.66 5.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.057 2.143 . . . . 0.0 114.599 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 13.46 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 130.924 3.69 . . . . 0.0 115.219 -169.318 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.91 173.89 10.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.593 1.957 . . . . 0.0 113.667 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -117.0 108.84 16.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.615 3.166 . . . . 0.0 105.77 169.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.06 127.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.632 0.773 . . . . 0.0 112.967 -154.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mt -79.52 135.52 36.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.777 2.031 . . . . 0.0 110.911 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.96 129.35 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.089 2.155 . . . . 0.0 108.395 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -81.1 134.26 35.62 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.782 0.801 . . . . 0.0 111.667 170.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.06 161.59 18.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.973 2.109 . . . . 0.0 109.38 162.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 22.7 tt0 -94.41 125.06 53.49 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 167.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.25 128.22 7.99 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 124.294 3.329 . . . . 0.0 111.036 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.7 168.68 20.79 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.299 1.333 . . . . 0.0 110.599 160.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.34 162.71 15.67 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.247 -0.908 . . . . 0.0 112.287 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.08 -83.97 1.6 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -117.97 170.01 9.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.313 1.054 . . . . 0.0 110.8 169.242 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.9 m -145.73 84.75 1.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.319 1.447 . . . . 0.0 108.881 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.36 128.83 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.412 1.085 . . . . 0.0 109.048 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.92 94.59 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.978 1.711 . . . . 0.0 107.749 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.46 145.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.689 0.795 . . . . 0.0 109.915 -166.116 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.3 94.39 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 108.132 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.73 167.67 28.74 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 119.262 2.465 . . . . 0.0 119.262 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.39 109.66 6.51 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.064 2.546 . . . . 0.0 109.274 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.43 -102.03 0.04 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.792 1.663 . . . . 0.0 114.215 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.79 -18.97 62.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 115.151 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.73 94.64 4.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.001 0.92 . . . . 0.0 108.913 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.63 43.69 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.82 167.88 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 128.754 2.822 . . . . 0.0 108.569 170.156 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.02 149.16 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.872 0.869 . . . . 0.0 110.805 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.27 163.39 19.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.994 2.117 . . . . 0.0 109.232 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -138.37 130.73 28.89 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.757 -0.59 . . . . 0.0 110.059 -161.349 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.19 165.7 28.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.352 1.061 . . . . 0.0 111.62 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -144.06 116.45 8.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.956 1.303 . . . . 0.0 109.423 -160.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -144.68 87.63 1.87 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -164.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 76.6 p 59.39 84.6 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.364 1.865 . . . . 0.0 113.81 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.36 23.84 6.46 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.759 1.647 . . . . 0.0 112.751 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.4 t -58.42 162.86 3.42 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.021 1.728 . . . . 0.0 114.013 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -56.37 -15.12 3.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.28 1.032 . . . . 0.0 113.612 163.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.45 3.38 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 126.181 1.792 . . . . 0.0 111.551 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.97 -11.5 71.93 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 119.95 -1.719 . . . . 0.0 116.124 169.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--O 1.249 1.04 0 CA-C-N 118.904 1.352 . . . . 0.0 113.094 171.174 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -69.05 -178.96 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.056 2.142 . . . . 0.0 113.197 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.38 155.76 45.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.506 2.722 . . . . 0.0 110.827 -163.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -88.66 -61.73 1.64 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.454 -0.779 . . . . 0.0 111.757 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -60.04 -31.91 70.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.178 1.391 . . . . 0.0 113.938 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -4.97 46.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.121 0.968 . . . . 0.0 112.997 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -57.72 -31.44 66.44 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 81.15 0.57 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -68.4 -6.64 25.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.453 1.901 . . . . 0.0 114.81 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -75.12 0.97 14.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -170.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -141.76 154.08 45.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.877 1.217 . . . . 0.0 112.039 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 160.22 45.29 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.648 1.118 . . . . 0.0 112.708 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.38 95.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 122.641 1.21 . . . . 0.0 114.076 -167.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 171.28 19.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.95 1.7 . . . . 0.0 111.247 167.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -150.42 -3.22 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.097 152.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 53.98 -75.95 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.191 2.597 . . . . 0.0 113.586 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.33 74.34 5.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.18 1.792 . . . . 0.0 112.837 -163.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.67 149.2 52.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.635 0.774 . . . . 0.0 111.124 166.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -138.31 141.25 39.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.775 1.63 . . . . 0.0 109.827 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -61.7 128.69 37.46 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.057 0.943 . . . . 0.0 110.603 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.34 -26.23 6.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.063 0.945 . . . . 0.0 112.854 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.04 123.93 2.82 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.367 0.984 . . . . 0.0 111.037 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.0 p -62.54 144.2 95.86 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 125.162 1.385 . . . . 0.0 111.427 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.96 148.33 47.88 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.818 2.345 . . . . 0.0 115.142 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.38 128.15 20.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.723 1.609 . . . . 0.0 110.854 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.71 132.29 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.552 0.741 . . . . 0.0 111.048 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -78.77 -9.55 59.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.586 1.554 . . . . 0.0 113.944 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.36 -2.84 9.08 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.21 0.913 . . . . 0.0 113.891 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -103.39 5.9 37.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.94 1.696 . . . . 0.0 111.704 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.41 13.76 50.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.961 1.267 . . . . 0.0 114.083 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.9 p -129.67 168.33 16.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.272 1.429 . . . . 0.0 111.565 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.78 130.73 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.915 1.686 . . . . 0.0 108.37 164.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 m -83.28 124.77 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 160.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 154.2 49.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.645 1.178 . . . . 0.0 110.553 170.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -119.61 134.4 55.24 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.202 -0.936 . . . . 0.0 111.675 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.77 163.13 22.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.159 0.984 . . . . 0.0 111.02 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -126.55 137.11 53.31 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.796 1.239 . . . . 0.0 110.011 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.13 97.34 11.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.038 0.935 . . . . 0.0 110.373 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.9 p -77.43 43.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.519 1.928 . . . . 0.0 113.688 -166.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.56 -177.77 48.51 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.071 -1.018 . . . . 0.0 114.869 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -116.41 0.76 12.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.485 1.514 . . . . 0.0 114.295 -167.691 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -145.96 173.8 11.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.421 1.489 . . . . 0.0 112.546 -169.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.53 48.24 0.87 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 166.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.04 107.0 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.574 2.849 . . . . 0.0 113.03 164.18 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.86 165.17 18.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.348 0.659 . . . . 0.0 112.523 -164.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.35 6.57 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.365 -1.459 . . . . 0.0 111.49 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.75 114.34 5.64 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.908 1.683 . . . . 0.0 113.562 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.82 84.58 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.114 2.543 . . . . 0.0 111.213 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -125.04 144.91 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.962 1.305 . . . . 0.0 109.531 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -146.74 162.11 39.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.811 1.245 . . . . 0.0 112.883 -172.215 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -142.0 110.88 6.23 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.749 2.02 . . . . 0.0 110.164 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 18.4 m -140.01 170.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.315 1.046 . . . . 0.0 111.95 -178.644 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.17 -4.63 21.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -152.17 30.84 0.55 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.906 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.84 25.4 8.46 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.41 1.484 . . . . 0.0 112.394 -173.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.44 HD22 ' CG2' ' A' ' 61' ' ' VAL . 12.5 p-10 -91.61 50.99 1.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.122 2.569 . . . . 0.0 112.201 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.5 m-20 -56.29 -11.11 1.06 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -9.92 11.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.909 1.283 . . . . 0.0 114.359 164.428 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.4 m -149.06 95.62 3.84 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.159 -1.588 . . . . 0.0 110.17 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.53 86.98 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 1 C-N-CA 125.639 4.226 . . . . 0.0 115.883 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.44 ' CG2' HD22 ' A' ' 56' ' ' ASN . 2.1 t -67.66 -33.96 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.893 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 -161.56 27.52 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.427 1.965 . . . . 0.0 112.045 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.409 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -146.96 177.69 8.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.09 1.756 . . . . 0.0 112.509 169.849 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.37 117.98 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.613 2.365 . . . . 0.0 107.604 171.535 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.7 t -90.51 -58.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 111.109 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -59.01 -44.33 91.67 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.593 0.633 . . . . 0.0 112.525 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.44 139.3 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 160.36 77.57 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 159.302 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.6 77.41 3.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 115.303 -156.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -145.71 127.34 15.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.495 -1.378 . . . . 0.0 114.592 154.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.31 100.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.764 1.626 . . . . 0.0 106.889 166.511 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 t -77.86 -6.86 55.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.74 149.52 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.504 1.047 . . . . 0.0 111.956 -170.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.95 -21.9 66.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.719 1.208 . . . . 0.0 113.061 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.12 0.32 6.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.183 2.593 . . . . 0.0 114.47 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 10.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.09 13.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 131.475 3.91 . . . . 0.0 116.06 -166.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.18 168.53 19.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.375 1.87 . . . . 0.0 114.184 -169.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.52 109.09 20.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.304 2.642 . . . . 0.0 105.946 158.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.05 125.3 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.017 0.927 . . . . 0.0 112.412 -159.39 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.31 133.01 43.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.189 0.996 . . . . 0.0 109.447 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.5 mt -128.58 143.33 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.131 1.772 . . . . 0.0 107.976 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -98.4 137.21 37.44 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.76 0.791 . . . . 0.0 111.571 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.83 164.31 17.7 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.01 2.124 . . . . 0.0 108.899 166.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.409 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 26.0 tt0 -100.39 107.18 46.79 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.922 1.289 . . . . 0.0 108.392 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.8 108.31 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.894 1 C-N-CA 126.581 4.854 . . . . 0.0 111.236 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -64.15 161.0 35.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.988 1.792 . . . . 0.0 110.77 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -94.56 166.69 11.91 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.8 -78.97 1.0 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.86 150.7 42.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 110.184 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -136.86 97.9 3.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.693 1.197 . . . . 0.0 109.157 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -95.43 123.53 39.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.608 1.163 . . . . 0.0 109.933 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.98 98.43 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.982 2.113 . . . . 0.0 107.153 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.22 139.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.91 -165.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.89 103.33 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.766 1.626 . . . . 0.0 108.698 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 145.68 172.36 15.99 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 172.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -132.75 143.63 49.73 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.166 1.787 . . . . 0.0 109.875 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 17.06 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 127.741 2.591 . . . . 0.0 116.354 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -74.72 -15.3 60.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.203 2.201 . . . . 0.0 116.72 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -137.88 100.38 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.134 1.374 . . . . 0.0 110.747 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -142.65 160.73 39.73 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.97 165.96 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 128.814 2.846 . . . . 0.0 108.3 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.64 167.6 25.93 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.973 -1.079 . . . . 0.0 110.613 166.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -131.73 158.97 39.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.041 1.337 . . . . 0.0 109.052 163.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -112.59 160.17 18.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.239 1.416 . . . . 0.0 110.867 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.11 155.83 36.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.131 1.773 . . . . 0.0 109.212 168.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.66 143.41 30.73 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.097 0.959 . . . . 0.0 108.753 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -134.96 158.49 44.18 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.247 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.9 p 67.96 -1.65 1.67 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.3 42.07 3.08 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.395 0.998 . . . . 0.0 112.35 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -84.83 -144.59 0.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.973 1.709 . . . . 0.0 111.934 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.3 p -46.7 -46.36 20.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.59 1.956 . . . . 0.0 115.549 -166.601 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.02 8.26 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 125.539 1.536 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.75 25.52 60.3 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.248 -1.533 . . . . 0.0 112.848 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 tptp . . . . . 0 C--O 1.247 0.944 0 C-N-CA 126.941 2.096 . . . . 0.0 111.881 -166.771 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -147.07 150.31 34.79 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.093 0.957 . . . . 0.0 110.766 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.39 173.88 11.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.859 2.464 . . . . 0.0 110.858 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -91.93 -59.61 2.07 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.408 -0.807 . . . . 0.0 112.664 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -58.17 -36.78 73.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.787 1.235 . . . . 0.0 113.632 -168.197 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.05 -15.56 59.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.538 1.135 . . . . 0.0 113.318 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -85.54 -11.11 54.91 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.293 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 18.37 84.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 130.139 3.733 . . . . 0.0 118.453 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -72.5 71.74 0.96 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.102 -1.234 . . . . 0.0 111.839 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p -78.36 -20.07 52.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.118 1.367 . . . . 0.0 114.551 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.25 -178.82 7.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.33 130.96 51.77 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.484 1.04 . . . . 0.0 112.663 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.82 102.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.662 1.185 . . . . 0.0 111.93 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 155.9 22.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.418 1.887 . . . . 0.0 110.008 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -160.38 -41.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.543 1.137 . . . . 0.0 111.223 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt 65.65 -65.46 0.17 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.385 2.674 . . . . 0.0 113.333 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.74 79.0 1.21 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.445 1.098 . . . . 0.0 111.434 -161.086 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -126.5 160.09 31.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.449 1.5 . . . . 0.0 110.09 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -142.23 147.68 36.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 108.997 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -61.82 127.89 33.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.126 0.57 . . . . 0.0 110.99 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.55 -48.4 4.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.189 0.996 . . . . 0.0 108.988 168.524 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.97 105.69 0.68 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.491 1.996 . . . . 0.0 109.748 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 p -57.96 156.31 20.01 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.627 0.771 . . . . 0.0 111.478 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.76 141.87 80.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.951 1.767 . . . . 0.0 113.166 -165.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 119.8 14.78 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.449 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -65.32 118.99 10.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.28 1.038 . . . . 0.0 110.56 179.62 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.9 p -68.9 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 114.309 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.99 56.0 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.301 -160.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -69.53 -12.42 61.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.013 1.906 . . . . 0.0 111.296 162.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.16 -3.69 40.87 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 126.667 2.08 . . . . 0.0 113.155 -167.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -129.73 152.86 48.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.795 2.038 . . . . 0.0 111.599 -166.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.2 m -93.64 126.06 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 0.0 110.327 172.435 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 m -78.43 136.66 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 161.136 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -141.81 131.48 24.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.084 2.154 . . . . 0.0 108.138 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -118.94 131.9 56.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.825 0.739 . . . . 0.0 112.04 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.54 162.21 19.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.345 0.658 . . . . 0.0 110.703 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -115.51 129.55 56.58 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.849 1.259 . . . . 0.0 109.015 165.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.89 100.47 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.07 0.948 . . . . 0.0 109.392 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 p -78.39 -4.44 48.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.539 1.536 . . . . 0.0 114.624 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.92 169.24 12.88 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 119.311 0.96 . . . . 0.0 114.697 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -106.83 0.86 24.32 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.447 1.899 . . . . 0.0 113.244 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -138.49 -175.05 3.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.115 1.766 . . . . 0.0 111.316 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.51 45.61 1.95 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.892 -2.06 . . . . 0.0 117.523 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -54.73 102.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.984 0 CA-C-N 122.057 2.928 . . . . 0.0 111.042 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.5 m -156.92 171.17 20.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 112.624 -164.067 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -94.08 99.98 12.17 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.63 -1.294 . . . . 0.0 109.954 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.39 126.38 84.32 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.459 0.704 . . . . 0.0 112.603 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.37 101.63 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.711 2.941 . . . . 0.0 111.884 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.0 tt -133.47 146.55 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.144 0.978 . . . . 0.0 109.855 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -148.76 160.67 42.97 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 t -138.19 116.7 12.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.073 2.149 . . . . 0.0 110.218 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 15.6 m -134.62 164.57 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.556 1.142 . . . . 0.0 112.24 179.14 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.16 -10.18 28.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -154.79 34.34 0.4 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.085 -1.634 . . . . 0.0 112.625 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.78 11.4 1.83 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.477 1.911 . . . . 0.0 113.958 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.447 HD22 ' CG2' ' A' ' 61' ' ' VAL . 9.2 p-10 -69.83 51.32 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.032 2.933 . . . . 0.0 113.026 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 15.9 t0 -59.14 -16.38 19.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.839 1.655 . . . . 0.0 115.349 -165.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.24 -8.86 1.23 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.487 1.515 . . . . 0.0 114.876 169.202 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 m -155.13 104.57 2.25 Favored Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 120.203 -1.561 . . . . 0.0 111.063 166.555 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.42 115.69 1.06 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.164 3.909 . . . . 0.0 113.882 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.447 ' CG2' HD22 ' A' ' 56' ' ' ASN . 3.2 t -97.58 -22.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.931 1.692 . . . . 0.0 111.501 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.11 26.3 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.868 1.699 . . . . 0.0 111.041 163.604 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 176.78 7.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.11 106.82 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.726 2.411 . . . . 0.0 106.374 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -78.41 -45.58 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.734 0.813 . . . . 0.0 110.69 -166.529 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -69.78 -41.4 75.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.11 149.96 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.833 1.197 . . . . 0.0 113.54 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -61.74 119.73 50.34 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.361 1.464 . . . . 0.0 109.762 162.569 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.34 90.22 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.109 2.539 . . . . 0.0 113.69 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.56 126.27 12.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.501 1.921 . . . . 0.0 111.515 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.3 88.84 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.729 2.012 . . . . 0.0 108.263 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.4 t -70.6 -8.94 55.4 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.69 155.35 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.906 1.23 . . . . 0.0 112.287 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.66 -19.71 62.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.125 0.97 . . . . 0.0 112.698 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.0 p -77.54 9.79 3.08 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.086 1.754 . . . . 0.0 113.133 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.63 10.23 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.302 1.841 . . . . 0.0 115.235 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.03 22.85 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 130.27 3.428 . . . . 0.0 115.139 -165.087 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.2 165.73 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.797 2.039 . . . . 0.0 114.183 -170.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 109.06 21.16 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.315 2.646 . . . . 0.0 106.269 160.993 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.33 121.85 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 111.964 -156.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.57 128.05 40.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.056 2.542 . . . . 0.0 109.942 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.69 129.53 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.228 2.211 . . . . 0.0 108.34 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.04 138.53 33.03 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.468 -0.77 . . . . 0.0 111.022 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.94 157.59 29.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.285 2.234 . . . . 0.0 109.039 166.968 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -97.73 109.68 51.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.193 0.997 . . . . 0.0 109.24 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -93.03 116.64 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 125.263 3.975 . . . . 0.0 110.287 170.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.6 158.16 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.163 3.242 . . . . 0.0 115.552 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -75.52 161.15 29.42 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.16 -0.963 . . . . 0.0 112.502 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.65 -79.04 1.8 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.52 158.44 44.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.492 1.117 . . . . 0.0 110.446 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.5 m -158.87 156.84 30.33 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.929 -1.107 . . . . 0.0 112.264 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -145.71 136.74 24.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.484 1.113 . . . . 0.0 109.089 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 mm -120.52 114.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.301 1.841 . . . . 0.0 107.158 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.72 141.31 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.418 0.687 . . . . 0.0 109.849 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.82 101.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.171 2.188 . . . . 0.0 108.341 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.43 177.49 15.15 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.5 122.2 24.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.697 1.999 . . . . 0.0 110.632 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.26 -99.84 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.48 1.99 . . . . 0.0 114.807 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -68.46 -14.28 62.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.365 1.866 . . . . 0.0 115.758 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -136.14 98.67 3.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.44 1.096 . . . . 0.0 111.197 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.57 167.25 23.5 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.09 164.69 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.648 2.779 . . . . 0.0 108.639 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -150.99 164.57 36.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.464 0.706 . . . . 0.0 111.33 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -143.57 136.57 27.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.296 1.438 . . . . 0.0 110.439 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 162.57 23.36 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 113.071 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.74 150.63 35.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.684 1.993 . . . . 0.0 111.007 161.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -139.9 113.99 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.524 1.13 . . . . 0.0 108.156 -170.1 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -149.95 81.68 1.38 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.5 t 69.16 70.8 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.756 2.023 . . . . 0.0 113.876 165.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.61 21.1 2.03 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.739 2.114 . . . . 0.0 113.17 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.9 t -65.03 151.94 44.7 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.501 1.92 . . . . 0.0 113.591 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -61.59 -8.48 4.47 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 164.148 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.22 -4.38 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 127.019 2.128 . . . . 0.0 111.308 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.02 4.67 58.63 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.628 -1.295 . . . . 0.0 116.207 171.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 116.987 -1.482 . . . . 0.0 112.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.21 160.47 39.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.159 0.89 . . . . 0.0 112.432 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 145.32 50.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.131 2.173 . . . . 0.0 109.664 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.28 -54.43 8.4 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.17 -1.581 . . . . 0.0 112.426 -172.148 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -58.55 -29.8 66.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.902 1.681 . . . . 0.0 113.791 -170.872 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.91 -28.73 69.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.176 0.898 . . . . 0.0 112.841 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -19.42 62.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.388 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 9.46 105.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 130.584 3.945 . . . . 0.0 117.559 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -68.82 73.53 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.801 2.04 . . . . 0.0 113.602 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 p -71.93 -18.64 62.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.717 2.007 . . . . 0.0 114.676 168.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -156.16 176.31 12.84 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.382 1.473 . . . . 0.0 110.511 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.48 148.54 50.5 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.443 0.544 . . . . 0.0 112.496 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.08 97.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.66 1.184 . . . . 0.0 112.544 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.76 168.81 25.62 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.876 1.671 . . . . 0.0 111.193 166.365 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' SER . . . . . 0.421 ' HB3' ' HA ' ' A' ' 47' ' ' VAL . 94.1 p -144.02 -30.43 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt 59.2 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.311 2.244 . . . . 0.0 112.536 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.36 83.19 3.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.128 0.971 . . . . 0.0 112.069 -167.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.29 165.25 23.82 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.486 1.514 . . . . 0.0 111.587 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -151.05 155.11 38.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.993 2.117 . . . . 0.0 109.627 166.512 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.95 140.26 57.74 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.275 -0.89 . . . . 0.0 111.742 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -38.57 3.11 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 176.226 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.23 103.97 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.211 1.386 . . . . 0.0 110.279 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -47.74 138.09 9.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.125 2.17 . . . . 0.0 112.221 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 130.83 42.67 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.015 2.477 . . . . 0.0 112.768 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.05 119.95 28.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.167 1.387 . . . . 0.0 110.158 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.25 129.72 40.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.84 0.829 . . . . 0.0 111.032 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.3 p -78.18 -8.69 58.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 127.077 2.151 . . . . 0.0 113.586 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.63 -5.35 23.35 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.336 0.971 . . . . 0.0 113.945 -168.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -96.12 3.17 53.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.812 1.306 . . . . 0.0 112.062 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.33 4.33 56.31 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.829 1.204 . . . . 0.0 113.941 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -123.72 165.12 17.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.255 1.422 . . . . 0.0 111.941 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -110.15 140.66 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.025 1.33 . . . . 0.0 109.543 162.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.06 125.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.8 0.84 . . . . 0.0 109.014 161.11 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 120.99 18.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.531 1.932 . . . . 0.0 109.208 -167.698 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.73 132.6 52.52 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.189 -0.944 . . . . 0.0 112.631 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.07 162.71 20.72 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.433 1.093 . . . . 0.0 110.462 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -117.66 134.27 55.07 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.157 0.983 . . . . 0.0 109.98 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -84.8 108.03 17.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.873 0.869 . . . . 0.0 109.668 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -82.92 -4.03 57.7 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.82 172.5 14.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.504 1.047 . . . . 0.0 114.718 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -109.18 6.08 24.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.209 1.804 . . . . 0.0 113.75 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -138.71 176.14 8.95 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.0 111.143 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.75 51.43 0.75 Allowed Glycine 0 CA--C 1.538 1.526 0 CA-C-O 117.288 -1.84 . . . . 0.0 117.168 167.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -54.21 111.12 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 121.399 2.599 . . . . 0.0 110.646 162.845 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.83 165.95 13.77 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.175 0.99 . . . . 0.0 111.76 -168.071 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -89.43 104.34 16.9 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 119.839 -1.788 . . . . 0.0 113.206 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.421 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 1.2 p -58.03 117.78 22.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.577 1.151 . . . . 0.0 112.352 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.35 82.61 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.411 2.741 . . . . 0.0 109.827 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.08 142.46 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.833 0.853 . . . . 0.0 109.457 169.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.9 t -151.38 159.73 44.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.632 0.773 . . . . 0.0 113.046 -167.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -132.54 113.55 13.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.003 2.521 . . . . 0.0 108.955 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 35.5 m -133.75 170.24 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.464 1.106 . . . . 0.0 111.688 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.08 -11.44 20.52 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 m -152.03 33.2 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.106 -1.621 . . . . 0.0 112.311 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.93 10.15 2.04 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.455 1.902 . . . . 0.0 113.45 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -72.06 55.6 0.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.303 3.041 . . . . 0.0 112.589 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 4.8 t0 -63.07 -11.91 22.97 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -165.652 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.55 -1.28 0.77 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 114.919 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 m -153.85 119.33 2.78 Favored Pre-proline 0 N--CA 1.473 0.692 0 O-C-N 119.916 -1.74 . . . . 0.0 110.651 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.4 112.12 2.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.899 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.38 -27.15 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 0.0 110.825 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.89 -161.98 18.98 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.383 2.421 . . . . 0.0 111.853 169.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 169.58 17.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 96.58 8.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.502 1.921 . . . . 0.0 106.132 170.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.55 -49.95 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.636 1.175 . . . . 0.0 111.678 -161.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 t -88.41 -17.37 30.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -165.52 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -159.99 150.14 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 120.253 1.388 . . . . 0.0 111.631 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -57.48 134.49 81.95 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.673 0.789 . . . . 0.0 109.377 166.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.98 86.47 0.61 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.137 2.558 . . . . 0.0 111.658 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -152.91 112.96 3.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 112.035 -167.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -72.85 92.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.253 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 p -73.41 -14.04 61.19 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.75 158.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.13 0.972 . . . . 0.0 112.064 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.66 -23.62 65.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.18 0.992 . . . . 0.0 113.153 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 p -81.26 5.17 17.94 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.772 1.629 . . . . 0.0 113.812 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.31 22.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.648 1.579 . . . . 0.0 114.882 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.09 21.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 130.875 3.67 . . . . 0.0 114.443 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.64 157.15 20.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.983 1.713 . . . . 0.0 113.275 -164.577 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 105.94 17.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.429 2.291 . . . . 0.0 106.677 153.127 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.41 135.64 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.503 1.121 . . . . 0.0 111.985 -165.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.81 118.56 37.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.209 2.603 . . . . 0.0 108.921 -172.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.36 136.72 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.452 1.901 . . . . 0.0 108.418 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.68 137.95 31.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.017 -0.427 . . . . 0.0 111.821 163.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.48 160.36 25.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.351 1.86 . . . . 0.0 109.656 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.59 105.78 51.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.822 1.249 . . . . 0.0 108.857 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -84.82 121.03 2.41 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.276 2.65 . . . . 0.0 109.437 160.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.31 166.5 12.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.88 1.72 . . . . 0.0 111.993 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.88 164.3 25.94 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 -91.92 1.77 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -131.08 165.11 23.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.457 1.103 . . . . 0.0 110.764 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.0 m -156.92 163.27 39.34 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.069 -1.019 . . . . 0.0 111.784 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -133.43 129.1 36.83 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.9 2.08 . . . . 0.0 108.214 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.5 mm -110.21 109.3 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.17 1.788 . . . . 0.0 106.768 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.96 138.53 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.667 0.787 . . . . 0.0 109.167 -167.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.14 89.38 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.85 2.06 . . . . 0.0 106.725 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 161.02 157.44 8.75 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.314 1.686 . . . . 0.0 117.314 -176.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -123.23 122.77 39.21 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.913 1.685 . . . . 0.0 109.395 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 32.42 -94.83 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.304 2.383 . . . . 0.0 115.385 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.53 -18.73 63.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.699 2.0 . . . . 0.0 116.161 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -130.11 101.07 5.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.74 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.12 155.92 46.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.646 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.26 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.98 2.512 . . . . 0.0 107.758 169.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.95 156.42 38.86 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.139 -0.976 . . . . 0.0 111.719 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 165.5 26.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.682 2.393 . . . . 0.0 109.019 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -133.27 155.97 48.41 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.327 -0.858 . . . . 0.0 113.101 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -141.75 151.93 43.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.494 1.518 . . . . 0.0 112.788 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -146.58 108.4 4.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.565 1.546 . . . . 0.0 108.567 -163.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -149.51 102.42 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -162.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 t 61.9 62.17 1.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.417 1.887 . . . . 0.0 113.832 163.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.32 18.01 3.49 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.515 2.007 . . . . 0.0 112.835 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.5 t -62.1 152.04 33.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.8 1.64 . . . . 0.0 112.293 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -50.59 -24.79 3.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.845 2.058 . . . . 0.0 113.291 165.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.12 -10.62 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.956 1.303 . . . . 0.0 112.138 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.76 22.7 30.2 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 121.003 -1.061 . . . . 0.0 114.396 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 125.025 1.33 . . . . 0.0 113.435 178.709 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -146.97 171.86 14.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 111.625 -165.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . 0.528 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 20.9 mp0 -65.1 104.69 0.93 Allowed 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.836 4.454 . . . . 0.0 111.179 -165.577 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -55.65 -57.35 12.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -168.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -72.22 -20.87 61.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.295 1.038 . . . . 0.0 113.727 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.65 -3.5 50.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 113.101 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -67.0 22.27 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 129.016 2.926 . . . . 0.0 115.267 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.75 69.0 0.67 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.932 2.206 . . . . 0.0 114.293 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -41.19 -59.62 1.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.654 1.982 . . . . 0.0 113.91 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -59.15 -3.93 0.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.82 141.82 49.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.934 1.243 . . . . 0.0 111.358 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.02 171.86 55.16 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.095 0.855 . . . . 0.0 113.386 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.7 96.76 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 113.094 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 p -161.78 -177.17 5.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.606 1.562 . . . . 0.0 112.402 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 m -170.85 -29.35 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.324 1.85 . . . . 0.0 111.796 162.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt 64.67 -69.71 0.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.374 2.27 . . . . 0.0 113.349 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.16 73.36 8.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.074 0.95 . . . . 0.0 112.857 -166.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -129.69 158.5 39.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 170.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -143.52 140.94 30.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 108.906 166.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.39 147.69 49.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.382 0.673 . . . . 0.0 111.521 171.337 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.76 -52.82 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.397 0.679 . . . . 0.0 112.24 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.24 109.45 2.66 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.478 1.037 . . . . 0.0 111.279 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 p -52.8 142.29 34.21 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.222 1.409 . . . . 0.0 111.469 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.48 146.07 85.45 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.916 2.411 . . . . 0.0 114.049 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.52 130.03 25.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.764 1.626 . . . . 0.0 109.55 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.01 135.61 51.15 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.543 0.61 . . . . 0.0 110.57 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.6 p -68.19 -5.75 19.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.81 2.044 . . . . 0.0 113.998 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -10.66 7.28 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.62 1.105 . . . . 0.0 112.699 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -95.01 -3.63 48.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.512 1.925 . . . . 0.0 110.875 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.01 -4.14 45.21 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.57 1.557 . . . . 0.0 114.83 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -96.31 156.71 16.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.337 1.455 . . . . 0.0 110.409 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.73 122.26 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.105 0.962 . . . . 0.0 110.377 170.138 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.2 126.36 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.642 0.777 . . . . 0.0 109.338 162.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.59 155.73 45.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.294 1.438 . . . . 0.0 111.055 173.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -125.91 134.78 51.46 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.255 -0.903 . . . . 0.0 112.688 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.13 168.2 11.82 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.851 1.261 . . . . 0.0 109.89 165.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -126.55 143.38 51.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.557 1.143 . . . . 0.0 110.014 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -96.42 98.23 10.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.732 1.213 . . . . 0.0 109.777 -172.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -78.31 9.34 3.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.97 2.108 . . . . 0.0 115.788 -162.43 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.91 173.41 27.97 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.424 1.011 . . . . 0.0 113.821 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -95.64 -1.37 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.305 1.842 . . . . 0.0 114.019 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.41 173.29 11.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.715 1.606 . . . . 0.0 112.69 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.78 43.55 0.87 Allowed Glycine 0 CA--C 1.543 1.802 0 CA-C-O 116.574 -2.237 . . . . 0.0 118.688 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.84 105.54 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.939 0 CA-C-N 122.308 3.054 . . . . 0.0 112.314 161.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -163.13 162.82 25.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -166.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -82.05 94.47 7.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.942 1.297 . . . . 0.0 110.172 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.25 115.05 10.75 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.829 1.652 . . . . 0.0 113.741 -169.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.79 83.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.047 2.498 . . . . 0.0 112.147 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.31 140.27 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.112 0.965 . . . . 0.0 109.903 165.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -140.8 166.86 23.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.097 0.959 . . . . 0.0 113.408 -167.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -138.71 104.86 5.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.666 2.386 . . . . 0.0 110.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.415 HG12 ' H ' ' A' ' 61' ' ' VAL . 16.3 m -132.09 169.1 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.03 0.932 . . . . 0.0 112.478 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.28 0.52 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.566 1.146 . . . . 0.0 113.742 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -151.93 27.88 0.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.245 -1.535 . . . . 0.0 112.846 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.62 10.4 1.41 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.445 1.898 . . . . 0.0 113.732 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.14 52.61 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.094 2.958 . . . . 0.0 112.487 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -64.41 -7.35 9.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -165.2 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.51 -5.83 1.36 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.56 1.544 . . . . 0.0 114.591 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.0 m -154.58 114.78 2.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.108 -1.62 . . . . 0.0 110.556 168.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 111.16 2.35 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.683 2.922 . . . . 0.0 111.751 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.415 ' H ' HG12 ' A' ' 52' ' ' VAL . 15.5 t -75.77 -39.58 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.443 1.097 . . . . 0.0 110.517 179.537 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.75 -161.94 25.89 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.982 1.754 . . . . 0.0 113.589 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -130.96 176.74 7.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.178 0.991 . . . . 0.0 113.27 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.41 139.59 34.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.786 2.034 . . . . 0.0 108.36 166.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.09 -55.16 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.104 0.562 . . . . 0.0 111.239 -171.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -55.67 -54.21 47.01 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.06 148.81 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.75 159.26 79.81 Favored Pre-proline 0 CA--C 1.556 1.195 0 O-C-N 121.899 -0.501 . . . . 0.0 110.525 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.1 69.81 6.92 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.713 2.276 . . . . 0.0 115.391 -157.331 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -143.62 120.24 11.11 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.392 -1.442 . . . . 0.0 113.282 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.1 t -81.45 95.8 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 t -76.2 -3.88 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.05 143.89 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.932 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.39 -20.93 65.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.343 1.057 . . . . 0.0 112.73 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 4.68 1.72 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.545 2.738 . . . . 0.0 114.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 8.15 0.4 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.224 1.81 . . . . 0.0 115.605 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.43 19.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 130.853 3.661 . . . . 0.0 116.131 -161.882 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.31 173.79 8.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.375 1.87 . . . . 0.0 114.434 -169.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -105.39 101.77 11.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.092 2.957 . . . . 0.0 107.079 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.46 114.33 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -156.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.45 129.24 39.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.191 2.596 . . . . 0.0 110.562 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mt -128.0 148.52 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 129.025 2.93 . . . . 0.0 108.825 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -104.34 136.72 43.4 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 112.323 165.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -121.31 162.84 19.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.643 1.977 . . . . 0.0 110.098 163.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.93 107.33 38.03 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.078 1.351 . . . . 0.0 109.202 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -107.02 140.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.197 3.264 . . . . 0.0 110.823 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.53 162.11 1.66 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.851 3.034 . . . . 0.0 114.651 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -68.09 166.03 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.025 0.93 . . . . 0.0 113.41 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.94 -91.35 1.68 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.58 159.78 23.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.263 1.025 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -157.6 129.73 7.15 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 120.807 -1.183 . . . . 0.0 110.174 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -135.62 122.59 21.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 109.263 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.1 mm -109.86 113.68 44.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 126.251 1.82 . . . . 0.0 107.732 -173.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -109.02 140.62 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.897 0.879 . . . . 0.0 109.245 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.95 101.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.393 2.277 . . . . 0.0 107.999 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 149.3 171.53 18.03 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 117.946 1.939 . . . . 0.0 117.946 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.12 128.84 30.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.505 1.922 . . . . 0.0 110.362 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 35.55 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.89 2.186 . . . . 0.0 115.268 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -66.79 -16.39 64.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.097 2.159 . . . . 0.0 115.993 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.33 105.76 6.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.281 1.032 . . . . 0.0 111.088 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.41 162.98 34.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.03 163.94 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 130.136 3.374 . . . . 0.0 107.308 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -156.62 163.35 39.43 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.983 -1.073 . . . . 0.0 110.994 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -142.33 149.39 39.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.991 1.317 . . . . 0.0 110.044 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -102.75 160.97 14.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.864 1.266 . . . . 0.0 111.632 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.66 42.84 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.014 2.126 . . . . 0.0 110.237 166.014 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -145.0 142.32 29.69 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -150.0 105.08 3.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.407 1.083 . . . . 0.0 112.354 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p 128.01 -5.07 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 131.676 3.99 . . . . 0.0 114.619 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.15 33.82 0.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.643 1.116 . . . . 0.0 112.159 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -88.36 -141.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.338 1.455 . . . . 0.0 112.241 -166.548 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -52.59 -36.44 56.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.717 1.599 . . . . 0.0 115.136 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.13 -2.72 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 126.333 1.853 . . . . 0.0 112.515 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.68 28.8 54.24 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.518 -1.364 . . . . 0.0 112.521 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 tptp . . . . . 0 C--O 1.252 1.191 0 C-N-CA 127.174 2.19 . . . . 0.0 111.82 -169.399 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.64 152.26 45.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.61 0.641 . . . . 0.0 111.123 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.42 116.55 27.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.072 1.749 . . . . 0.0 109.498 172.906 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.99 -42.3 94.64 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.63 -0.669 . . . . 0.0 111.677 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -59.98 -29.47 68.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.875 1.67 . . . . 0.0 114.741 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.31 -5.11 58.53 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.111 0.868 . . . . 0.0 113.194 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -69.1 -6.31 27.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 116.808 -1.567 . . . . 0.0 114.073 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.08 73.52 0.33 Allowed Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.169 1.843 . . . . 0.0 115.477 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -77.18 64.19 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.236 1.015 . . . . 0.0 111.18 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.7 p -73.94 -27.42 61.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.614 1.966 . . . . 0.0 113.8 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -143.14 172.19 13.06 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.68 1.992 . . . . 0.0 110.462 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.43 148.8 51.03 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.109 0.385 . . . . 0.0 112.33 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 105.28 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.208 1.003 . . . . 0.0 112.041 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 162.46 39.89 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.314 2.246 . . . . 0.0 109.202 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.6 p -156.87 -43.24 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.309 1.043 . . . . 0.0 111.664 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 60.06 -69.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.366 2.666 . . . . 0.0 112.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.24 74.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.153 0.981 . . . . 0.0 112.742 -160.999 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -128.48 161.28 29.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.375 0.67 . . . . 0.0 111.142 161.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -145.77 149.88 35.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.442 1.897 . . . . 0.0 108.714 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.13 125.61 24.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.338 0.655 . . . . 0.0 111.042 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 -45.17 7.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.957 . . . . 0.0 109.043 167.116 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.65 119.34 1.74 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.126 1.822 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -57.93 155.43 23.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.424 1.49 . . . . 0.0 112.932 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.17 133.49 47.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.808 2.338 . . . . 0.0 112.026 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.59 127.59 22.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.823 1.649 . . . . 0.0 110.75 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.36 133.35 50.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.323 0.583 . . . . 0.0 112.378 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -79.12 -22.84 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.035 2.134 . . . . 0.0 114.563 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 -8.28 61.96 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 118.574 -1.126 . . . . 0.0 114.368 -160.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -72.09 -9.9 59.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.121 1.96 . . . . 0.0 111.596 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.25 62.3 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.334 1.445 . . . . 0.0 113.19 -163.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -112.33 164.0 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.96 2.104 . . . . 0.0 111.068 -170.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.77 125.62 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.209 1.004 . . . . 0.0 110.382 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 m -76.87 131.67 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 159.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.6 123.48 15.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.155 2.182 . . . . 0.0 107.378 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.83 131.35 52.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.999 0.818 . . . . 0.0 111.888 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.24 165.23 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.929 0.871 . . . . 0.0 110.134 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.109 0.963 . . . . 0.0 109.475 167.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -86.15 101.14 12.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 109.48 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -83.17 12.92 4.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -162.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.72 178.34 27.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.237 0.926 . . . . 0.0 114.623 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.3 p -109.21 2.91 21.26 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.541 1.937 . . . . 0.0 113.272 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -137.26 -176.63 4.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 0.0 110.76 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.93 29.08 2.94 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 115.745 -2.697 . . . . 0.0 118.975 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -48.69 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.124 0 CA-C-N 123.416 3.608 . . . . 0.0 112.981 162.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 m -160.43 169.69 22.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.014 1.326 . . . . 0.0 112.324 -165.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -96.78 92.76 6.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.54 1.136 . . . . 0.0 110.526 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.54 115.92 19.83 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.176 1.39 . . . . 0.0 114.627 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.84 93.25 0.87 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.526 2.15 . . . . 0.0 111.848 170.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.7 tt -128.12 136.08 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.22 1.008 . . . . 0.0 108.608 161.393 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -148.81 165.33 31.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.826 0.85 . . . . 0.0 113.126 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.1 t -140.64 115.33 9.55 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.97 2.108 . . . . 0.0 110.633 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.3 m -137.65 175.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.787 1.235 . . . . 0.0 112.262 -179.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.47 -18.17 16.81 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -149.9 32.34 0.69 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.114 -1.616 . . . . 0.0 111.636 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.94 11.72 4.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.391 1.876 . . . . 0.0 113.454 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -67.19 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.204 3.401 . . . . 0.0 113.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.0 t0 -58.78 -12.03 3.87 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -167.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.36 -12.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.248 2.219 . . . . 0.0 115.422 167.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -155.67 107.65 2.17 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 120.352 -1.467 . . . . 0.0 109.791 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.45 110.47 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.748 3.632 . . . . 0.0 113.01 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.77 -30.38 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.401 1.08 . . . . 0.0 109.959 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.29 -173.03 22.41 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.941 2.21 . . . . 0.0 111.305 165.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -131.68 170.54 14.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.438 1.095 . . . . 0.0 112.151 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.4 mp -87.41 133.48 33.72 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 160.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.67 -54.43 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.27 0.628 . . . . 0.0 109.967 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -63.34 -48.33 78.45 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.61 150.26 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.385 1.074 . . . . 0.0 108.909 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -82.68 156.39 67.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 118.208 0.458 . . . . 0.0 110.709 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.13 86.67 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.486 2.124 . . . . 0.0 115.731 -155.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -148.57 118.87 7.3 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.363 -1.461 . . . . 0.0 114.202 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.61 87.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.717 1.207 . . . . 0.0 107.759 167.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.8 t -72.2 -11.05 60.56 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.54 156.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.014 1.279 . . . . 0.0 112.071 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.81 -15.6 63.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 0.0 114.202 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.8 p -76.56 1.72 15.95 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.129 1.772 . . . . 0.0 113.762 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.03 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.632 1.973 . . . . 0.0 115.606 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.3 20.65 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.949 3.3 . . . . 0.0 115.901 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.18 168.17 19.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.096 2.158 . . . . 0.0 114.518 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -106.3 107.03 17.83 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.266 3.026 . . . . 0.0 105.47 160.752 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.27 137.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.483 1.135 . . . . 0.0 113.634 -158.452 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.2 128.21 47.41 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.161 2.984 . . . . 0.0 109.779 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.76 138.73 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.868 2.067 . . . . 0.0 109.149 -172.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.53 136.67 32.9 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.556 0.616 . . . . 0.0 111.803 163.521 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.9 159.17 26.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.104 2.162 . . . . 0.0 109.775 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -103.32 105.25 45.61 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.229 1.411 . . . . 0.0 109.565 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.01 129.87 8.14 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.604 2.869 . . . . 0.0 110.288 164.804 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.44 171.95 9.8 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.304 2.003 . . . . 0.0 112.165 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -82.41 166.01 19.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -173.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.23 -82.45 1.14 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.669 1.128 . . . . 0.0 111.072 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -140.6 145.69 37.01 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.582 1.153 . . . . 0.0 110.12 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.7 p -150.57 151.13 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.48 0.657 . . . . 0.0 112.525 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -137.36 139.99 41.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.928 1.291 . . . . 0.0 110.059 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.7 107.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.284 1.833 . . . . 0.0 107.044 -168.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.8 135.71 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.92 92.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.905 2.082 . . . . 0.0 107.282 -172.681 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.3 170.8 12.82 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.48 123.0 42.95 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.077 1.751 . . . . 0.0 109.138 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 31.82 -92.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.194 2.331 . . . . 0.0 115.472 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -73.11 -16.77 61.45 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.2 97.95 4.42 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 109.952 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.11 163.62 36.36 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.58 163.77 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 129.841 3.256 . . . . 0.0 107.573 168.655 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -151.48 162.81 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.131 -0.981 . . . . 0.0 111.596 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -138.62 173.57 11.45 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.43 1.892 . . . . 0.0 110.409 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -124.71 157.94 34.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.392 1.877 . . . . 0.0 111.167 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.08 154.85 33.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.583 1.553 . . . . 0.0 111.89 161.453 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -132.62 140.58 48.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 110.885 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -136.3 93.87 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.6 t 70.79 30.11 3.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.779 1.632 . . . . 0.0 114.477 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 8.94 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.531 1.773 . . . . 0.0 117.531 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.3 t -75.25 160.94 29.79 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.959 1.88 . . . . 0.0 112.728 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -62.89 -11.54 19.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.063 1.345 . . . . 0.0 114.569 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.6 mm -82.59 -16.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.863 1.265 . . . . 0.0 111.452 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.91 4.94 24.1 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.347 -1.252 . . . . 0.0 115.751 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-N 119.391 1.596 . . . . 0.0 114.17 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.11 145.24 30.45 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.336 0.654 . . . . 0.0 111.853 -163.386 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 178.05 6.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.538 2.735 . . . . 0.0 110.398 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -100.21 -54.47 2.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.999 0.904 . . . . 0.0 111.166 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -55.89 -34.94 66.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.98 2.512 . . . . 0.0 113.786 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.56 -43.5 84.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.472 0.578 . . . . 0.0 110.794 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.401 ' HE2' ' CB ' ' A' ' 60' ' ' PRO . 33.0 mmtm -63.41 -45.55 90.49 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 110.393 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 36.86 104.05 0.01 OUTLIER Glycine 0 C--N 1.344 0.975 0 C-N-CA 129.67 3.51 . . . . 0.0 116.676 159.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -62.8 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.346 2.258 . . . . 0.0 112.781 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -80.98 -19.54 43.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.879 2.472 . . . . 0.0 114.31 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -160.66 175.48 12.61 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.353 1.461 . . . . 0.0 110.257 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 133.41 24.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.268 1.413 . . . . 0.0 113.681 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.3 102.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.556 1.542 . . . . 0.0 114.08 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 156.36 40.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.585 2.354 . . . . 0.0 108.783 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.96 -31.87 0.28 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 49.27 -73.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 130.507 3.523 . . . . 0.0 116.214 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.32 68.23 1.42 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 112.067 -155.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.17 156.07 24.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.932 1.293 . . . . 0.0 110.331 166.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -142.29 145.42 33.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.498 1.519 . . . . 0.0 109.139 165.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.76 137.55 58.26 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.509 0.671 . . . . 0.0 111.31 168.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 -46.12 3.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.422 1.489 . . . . 0.0 109.708 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 128.93 4.93 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.095 1.331 . . . . 0.0 111.535 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.9 p -58.11 146.26 70.14 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 112.256 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -59.54 124.75 16.13 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.126 2.551 . . . . 0.0 111.55 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.16 128.55 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.727 1.211 . . . . 0.0 110.46 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.68 129.84 41.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.612 0.72 . . . . 0.0 111.021 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -71.98 -4.59 29.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.406 2.282 . . . . 0.0 113.845 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -8.72 11.12 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 118.945 0.793 . . . . 0.0 113.174 -168.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -89.2 -0.74 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.195 1.398 . . . . 0.0 110.758 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.71 0.79 74.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.464 1.507 . . . . 0.0 113.896 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -99.91 161.82 13.37 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.883 2.073 . . . . 0.0 110.205 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.4 128.88 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.457 1.026 . . . . 0.0 110.919 169.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.62 119.04 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.273 1.029 . . . . 0.0 108.937 162.503 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -132.72 129.27 38.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.78 2.432 . . . . 0.0 108.429 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -119.39 132.96 55.93 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.108 0.867 . . . . 0.0 113.06 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -123.47 167.63 13.62 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.294 1.038 . . . . 0.0 111.481 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.58 136.5 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 109.49 163.958 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -90.86 102.97 15.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.355 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.5 p -78.61 -7.14 57.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.592 1.557 . . . . 0.0 114.017 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.03 160.36 20.8 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 122.272 0.929 . . . . 0.0 113.878 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -82.02 -10.92 59.07 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.528 2.331 . . . . 0.0 114.849 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -164.39 172.93 12.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.72 1.208 . . . . 0.0 110.748 -153.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 61.08 0.62 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.22 105.04 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.399 2.066 . . . . 0.0 109.765 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 m -154.4 162.78 40.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.212 1.405 . . . . 0.0 112.09 -166.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -87.14 97.39 10.73 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.571 . . . . 0.0 111.394 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.89 115.08 8.08 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.878 1.271 . . . . 0.0 110.825 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.86 90.31 1.05 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.933 3.089 . . . . 0.0 110.678 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 tt -115.3 142.91 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.053 0.941 . . . . 0.0 109.378 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -150.7 166.64 29.77 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.059 1.343 . . . . 0.0 112.844 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.0 t -138.18 121.4 16.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.948 2.099 . . . . 0.0 110.713 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 34.5 m -134.38 179.69 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.487 1.515 . . . . 0.0 112.263 -176.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.63 -17.62 14.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.142 1.377 . . . . 0.0 113.725 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -157.55 43.32 0.33 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.184 -1.573 . . . . 0.0 111.731 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 8.8 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.811 2.045 . . . . 0.0 114.56 -174.448 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . 0.498 HD22 ' CG2' ' A' ' 61' ' ' VAL . 3.8 p-10 -70.58 46.05 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.821 3.248 . . . . 0.0 114.952 -174.862 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -64.34 -1.77 1.86 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.291 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -10.36 5.45 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 159.409 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.1 m -155.96 98.37 2.23 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 120.381 -1.45 . . . . 0.0 109.8 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.401 ' CB ' ' HE2' ' A' ' 7' ' ' LYS . 80.5 Cg_exo -48.38 119.91 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.678 3.585 . . . . 0.0 113.452 170.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.498 ' CG2' HD22 ' A' ' 56' ' ' ASN . 8.0 t -99.88 -23.77 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.538 1.535 . . . . 0.0 111.813 -176.311 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.71 18.36 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.409 1.956 . . . . 0.0 111.29 168.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.21 175.48 9.55 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -86.01 149.67 25.01 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.523 1.529 . . . . 0.0 107.187 159.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -118.73 -41.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.735 0.698 . . . . 0.0 111.14 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -61.04 -45.81 93.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -162.75 165.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.136 0.88 . . . . 0.0 111.567 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.31 123.74 71.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 157.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.54 100.1 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.772 1.648 . . . . 0.0 111.422 -171.569 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -149.07 149.87 31.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 159.647 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.62 88.36 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 127.524 2.33 . . . . 0.0 107.055 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -71.47 -2.86 18.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.02 158.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 112.13 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.25 -27.58 63.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.538 0.735 . . . . 0.0 112.369 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.1 p -74.87 4.86 5.75 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.249 1.82 . . . . 0.0 113.671 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.66 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.29 1.836 . . . . 0.0 115.083 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.65 27.26 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 129.169 2.987 . . . . 0.0 113.681 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.34 169.08 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.416 1.886 . . . . 0.0 113.967 -166.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -112.4 108.73 17.99 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.837 2.455 . . . . 0.0 106.092 163.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.38 123.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.775 0.798 . . . . 0.0 112.953 -157.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.82 134.99 41.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.626 1.571 . . . . 0.0 110.604 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.7 136.53 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.506 1.922 . . . . 0.0 107.949 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.87 138.13 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.775 -0.578 . . . . 0.0 111.911 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -123.06 163.13 21.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.131 2.173 . . . . 0.0 110.056 167.165 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -104.52 100.97 25.07 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.543 1.137 . . . . 0.0 109.236 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.44 129.13 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.802 2.335 . . . . 0.0 109.977 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.94 172.29 2.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.572 2.181 . . . . 0.0 112.504 165.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.54 166.09 11.31 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.151 0.981 . . . . 0.0 112.426 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -91.67 1.45 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -164.074 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -119.67 154.0 34.72 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.577 1.151 . . . . 0.0 110.331 168.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.5 t -144.95 158.42 43.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 166.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -130.19 145.76 51.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.969 0.908 . . . . 0.0 108.823 165.098 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -117.02 113.94 44.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.479 1.912 . . . . 0.0 106.219 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.18 135.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.24 95.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.08 1.352 . . . . 0.0 108.061 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.99 171.69 24.23 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.945 1.938 . . . . 0.0 117.945 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.4 114.21 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.644 2.378 . . . . 0.0 108.938 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.83 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 126.166 1.841 . . . . 0.0 114.848 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -68.74 -15.08 63.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -129.65 99.34 5.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.718 1.207 . . . . 0.0 109.708 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.62 159.28 44.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.99 165.64 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 129.913 3.285 . . . . 0.0 108.431 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.72 170.7 15.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.712 -0.617 . . . . 0.0 110.871 161.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -132.79 161.73 33.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.909 1.684 . . . . 0.0 108.583 162.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.8 159.59 17.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.273 1.429 . . . . 0.0 110.522 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.02 152.99 38.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.062 1.345 . . . . 0.0 111.119 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.75 115.45 8.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.936 1.294 . . . . 0.0 108.41 -170.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -152.38 109.88 3.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.8 t 66.01 37.13 5.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.321 2.248 . . . . 0.0 114.522 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.48 20.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.025 0.821 . . . . 0.0 114.538 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 39.9 t -64.54 154.46 36.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.985 1.314 . . . . 0.0 113.213 -174.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.8 m -54.21 -23.24 13.84 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.432 1.893 . . . . 0.0 112.655 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.4 mm -93.35 -1.32 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.425 1.89 . . . . 0.0 111.337 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.03 10.24 62.84 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.75 -1.219 . . . . 0.0 115.727 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.086 1.355 . . . . 0.0 114.585 -178.085 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.33 168.84 23.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 -175.55 4.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.171 2.589 . . . . 0.0 110.472 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -99.49 -59.01 1.8 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.067 -1.021 . . . . 0.0 110.434 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -51.43 -33.57 31.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.613 2.765 . . . . 0.0 114.935 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -61.98 -19.79 63.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.004 0.82 . . . . 0.0 112.838 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.03 -1.4 57.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.969 1.308 . . . . 0.0 113.139 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -4.36 98.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.45 0 C-N-CA 130.524 3.916 . . . . 0.0 117.507 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.474 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -64.81 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.426 3.49 . . . . 0.0 115.92 -169.096 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -60.22 -27.62 67.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.1 -179.06 5.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.361 1.864 . . . . 0.0 109.923 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.58 138.63 46.89 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 121.655 -0.653 . . . . 0.0 111.71 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.95 95.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.121 0.962 . . . . 0.0 112.663 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.83 172.18 17.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.754 2.022 . . . . 0.0 110.585 170.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.6 p -142.93 -25.45 0.61 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.862 1.265 . . . . 0.0 113.934 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HZ1' ' CG ' ' A' ' 42' ' ' ASP . 23.4 ttpt 47.28 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 130.25 3.42 . . . . 0.0 114.934 -177.075 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.21 72.5 1.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 111.906 -165.011 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -123.32 153.25 40.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.774 0.83 . . . . 0.0 110.638 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -139.73 147.46 40.92 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.782 1.633 . . . . 0.0 108.205 167.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.23 133.22 49.31 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.475 -0.765 . . . . 0.0 110.856 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -50.43 4.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.433 1.093 . . . . 0.0 109.204 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.26 120.74 1.94 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.499 1.047 . . . . 0.0 112.558 -172.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.2 m -49.59 147.35 6.1 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 127.915 2.486 . . . . 0.0 112.346 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.48 148.4 63.21 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.565 2.177 . . . . 0.0 114.12 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.0 142.64 32.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.141 1.776 . . . . 0.0 110.254 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.52 138.83 41.8 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.625 -0.672 . . . . 0.0 112.248 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.5 p -83.31 -21.87 33.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.82 -7.38 34.69 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 118.488 -1.173 . . . . 0.0 114.421 -159.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -72.08 -14.47 61.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.115 1.958 . . . . 0.0 111.166 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.93 -7.34 52.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.859 1.695 . . . . 0.0 113.012 -165.037 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.9 p -102.12 164.95 11.42 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 112.331 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.75 119.21 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.659 1.184 . . . . 0.0 110.592 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.19 128.34 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.765 1.226 . . . . 0.0 110.199 163.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.5 136.01 30.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.284 2.234 . . . . 0.0 109.514 -169.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . 0.4 ' CD ' ' HZ3' ' A' ' 79' ' ' LYS . 21.6 tt0 -116.67 131.65 56.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.56 163.0 17.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.071 1.349 . . . . 0.0 111.06 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -122.95 142.82 50.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.551 1.54 . . . . 0.0 110.128 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -95.97 97.95 10.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.992 0.917 . . . . 0.0 110.923 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.7 p -82.57 35.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.928 1.691 . . . . 0.0 113.269 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.87 175.11 33.76 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.675 -0.64 . . . . 0.0 114.293 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -121.3 3.49 10.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.042 2.137 . . . . 0.0 113.228 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . 0.476 ' CG ' ' HZ1' ' A' ' 16' ' ' LYS . 11.6 p-10 -132.04 166.06 22.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.249 2.22 . . . . 0.0 110.875 179.169 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.65 51.71 0.84 Allowed Glycine 0 CA--C 1.542 1.722 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -56.15 108.55 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 121.774 2.787 . . . . 0.0 110.722 160.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.473 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -155.7 168.78 26.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.431 1.092 . . . . 0.0 111.38 -166.115 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.474 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 11.3 tppt? -92.9 91.69 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.377 -1.452 . . . . 0.0 109.632 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.66 114.42 11.08 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.521 1.129 . . . . 0.0 112.36 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.28 88.79 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.229 2.619 . . . . 0.0 111.466 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -112.53 145.77 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.015 0.926 . . . . 0.0 110.079 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 t -151.27 172.29 16.1 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -143.63 106.27 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.143 2.577 . . . . 0.0 109.705 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 14.6 m -136.2 151.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.26 64.16 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.72 27.37 3.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.277 1.031 . . . . 0.0 112.357 -166.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mt 63.76 3.25 1.52 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.232 1.813 . . . . 0.0 113.881 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -67.69 50.5 0.05 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.117 2.967 . . . . 0.0 114.3 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.7 t0 -61.49 -13.7 23.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.74 -6.21 0.71 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.679 1.992 . . . . 0.0 114.665 162.337 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m -153.54 103.67 2.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.045 -1.66 . . . . 0.0 109.042 173.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 123.67 10.26 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.37 2.713 . . . . 0.0 111.046 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.33 -36.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.193 0.997 . . . . 0.0 111.702 -172.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.97 -166.74 30.41 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.381 1.467 . . . . 0.0 110.58 161.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.1 ptp85 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.891 0.876 . . . . 0.0 112.167 178.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -83.47 140.07 32.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.093 1.357 . . . . 0.0 107.405 163.187 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.62 -49.33 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.623 0.647 . . . . 0.0 109.669 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.9 m -60.01 -49.77 76.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -172.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -158.15 159.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.896 1.226 . . . . 0.0 113.031 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -59.41 114.45 9.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.392 1.077 . . . . 0.0 108.491 158.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 88.06 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.106 2.537 . . . . 0.0 111.938 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -136.18 139.59 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.744 -1.222 . . . . 0.0 111.94 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.473 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 2.6 t -74.24 88.87 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 125.557 1.543 . . . . 0.0 106.874 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -72.72 -2.81 21.73 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.95 143.35 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.146 1.378 . . . . 0.0 110.813 -172.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.36 -27.07 67.6 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.883 0.849 . . . . 0.0 111.539 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 6.63 0.58 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.167 2.987 . . . . 0.0 114.192 168.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.49 17.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.888 1.675 . . . . 0.0 115.385 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.05 15.91 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 131.143 3.777 . . . . 0.0 115.562 -170.081 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.92 170.73 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.214 2.606 . . . . 0.0 114.3 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . 0.4 ' HZ3' ' CD ' ' A' ' 35' ' ' GLU . 0.0 OUTLIER -119.9 99.74 6.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.836 3.254 . . . . 0.0 104.486 164.357 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.32 127.33 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.946 1.298 . . . . 0.0 112.082 -154.339 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.76 121.85 43.86 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.865 2.866 . . . . 0.0 108.898 -169.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.8 130.69 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.721 2.008 . . . . 0.0 109.267 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.78 133.01 36.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.539 0.736 . . . . 0.0 111.462 164.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.6 157.09 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.147 2.179 . . . . 0.0 109.854 164.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 38.5 tt0 -89.45 111.88 48.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.558 1.143 . . . . 0.0 108.472 168.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.23 125.75 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.336 2.691 . . . . 0.0 109.653 171.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.67 164.78 27.78 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.245 1.297 . . . . 0.0 110.909 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -71.96 155.47 40.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.042 0.925 . . . . 0.0 112.751 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.92 -87.05 1.41 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.4 1.476 . . . . 0.0 109.87 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.95 156.36 29.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.245 1.018 . . . . 0.0 110.214 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -146.11 95.99 2.71 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.166 0.986 . . . . 0.0 108.932 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -96.42 134.76 39.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.313 1.045 . . . . 0.0 109.294 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -115.67 90.82 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 126.328 1.851 . . . . 0.0 107.343 -159.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -89.45 139.06 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.673 0.789 . . . . 0.0 109.378 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.52 91.04 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.707 2.003 . . . . 0.0 106.45 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . 0.415 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 164.85 165.39 22.05 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.83 147.54 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.354 1.462 . . . . 0.0 109.972 167.729 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.64 -99.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.498 1.999 . . . . 0.0 115.092 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -85.43 -26.7 26.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.772 1.629 . . . . 0.0 113.98 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -107.8 81.85 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.284 1.434 . . . . 0.0 108.517 -173.177 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . 0.415 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -138.82 148.12 43.37 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.858 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 161.29 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.593 2.757 . . . . 0.0 108.125 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.42 147.59 27.74 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.47 -0.769 . . . . 0.0 110.967 173.028 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.07 162.79 17.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.832 2.053 . . . . 0.0 109.434 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -132.03 129.57 40.22 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.993 0.517 . . . . 0.0 110.92 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.58 23.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.145 0.978 . . . . 0.0 111.139 171.0 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -141.34 123.64 15.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.848 1.659 . . . . 0.0 108.104 -161.066 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.21 99.61 3.07 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m 61.69 54.27 3.01 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.409 1.883 . . . . 0.0 113.189 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.13 30.2 0.53 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.239 0.923 . . . . 0.0 114.303 170.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.4 t -55.39 168.16 0.4 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.919 2.088 . . . . 0.0 115.59 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m -49.75 -20.9 0.93 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.044 1.338 . . . . 0.0 113.452 156.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -119.56 24.58 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 126.571 1.948 . . . . 0.0 111.876 171.171 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.4 -26.21 0.87 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 127.285 2.374 . . . . 0.0 116.586 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 tptp . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.663 2.785 . . . . 0.0 114.223 173.017 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.01 169.03 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.518 0.727 . . . . 0.0 110.955 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 171.62 13.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.124 2.169 . . . . 0.0 109.854 173.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.74 -63.99 1.16 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.128 -0.982 . . . . 0.0 111.554 -171.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -52.66 -31.29 36.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.867 2.067 . . . . 0.0 114.427 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 tp -58.09 -29.07 65.16 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.581 1.153 . . . . 0.0 113.044 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.11 -2.73 42.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 143.47 2.27 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.778 2.133 . . . . 0.0 115.683 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -70.51 74.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.748 2.019 . . . . 0.0 113.586 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.4 p -60.41 -21.24 61.99 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.197 1.399 . . . . 0.0 112.412 159.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -153.01 179.87 8.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.432 2.293 . . . . 0.0 108.305 161.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.67 157.72 51.84 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 122.074 -0.391 . . . . 0.0 112.638 166.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -77.74 103.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.831 1.252 . . . . 0.0 111.614 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.86 163.66 36.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.541 1.537 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.6 p -165.43 -48.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.857 0.863 . . . . 0.0 111.786 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt 65.2 -63.51 0.19 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.916 2.486 . . . . 0.0 113.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.69 78.59 2.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.202 1.001 . . . . 0.0 112.461 -166.839 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -129.86 156.73 43.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.258 1.023 . . . . 0.0 111.664 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -146.23 150.04 35.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.229 1.812 . . . . 0.0 108.948 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -70.02 149.55 47.57 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.882 0.849 . . . . 0.0 112.933 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.37 -33.97 2.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.312 1.445 . . . . 0.0 111.272 171.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 104.27 0.41 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.148 1.356 . . . . 0.0 111.239 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.3 m -46.53 140.08 5.87 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 127.042 2.137 . . . . 0.0 110.518 167.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 143.43 98.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.95 1.767 . . . . 0.0 112.805 -170.327 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 122.51 18.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.556 1.143 . . . . 0.0 111.223 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.27 131.26 45.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.615 0.721 . . . . 0.0 111.588 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.7 p -79.26 -10.01 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.503 1.921 . . . . 0.0 113.837 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.29 -6.65 4.08 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.203 0.906 . . . . 0.0 114.048 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -94.53 3.09 55.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.526 1.531 . . . . 0.0 111.685 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.73 5.7 41.52 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.465 1.507 . . . . 0.0 114.279 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -128.0 166.49 18.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.519 1.528 . . . . 0.0 111.784 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -114.95 132.06 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.516 1.526 . . . . 0.0 108.958 162.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.05 131.65 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 162.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.31 124.33 16.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.727 2.811 . . . . 0.0 108.211 -169.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.58 136.28 53.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.309 0.959 . . . . 0.0 112.922 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.48 164.92 21.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.79 139.9 52.38 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.195 163.414 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -90.87 101.49 14.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.729 1.212 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 p -80.5 7.63 9.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.915 1.686 . . . . 0.0 115.162 -163.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.39 -179.94 22.92 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.297 0.953 . . . . 0.0 114.34 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.1 p -113.59 6.79 17.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.168 1.787 . . . . 0.0 113.913 -165.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.52 178.8 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.872 1.669 . . . . 0.0 111.735 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.31 44.78 3.16 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-O 116.83 -2.094 . . . . 0.0 117.963 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.13 102.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.278 3.039 . . . . 0.0 111.709 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.7 m -159.57 171.27 19.94 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.99 -166.464 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -82.76 110.2 17.58 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.67 -1.269 . . . . 0.0 110.519 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.7 p -61.85 121.45 65.11 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.551 0.74 . . . . 0.0 110.776 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.06 97.17 0.73 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.327 2.018 . . . . 0.0 110.887 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.11 138.77 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.938 1.295 . . . . 0.0 108.926 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -153.32 169.95 21.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.912 0.885 . . . . 0.0 113.384 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 t -140.73 117.66 11.12 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.536 2.335 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 2.0 m -134.97 170.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.269 1.428 . . . . 0.0 111.473 -179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.4 -23.93 19.9 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -155.29 51.34 0.58 Allowed 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.587 -1.321 . . . . 0.0 111.298 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.08 11.8 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.806 2.043 . . . . 0.0 114.682 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -70.17 42.38 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 128.962 2.905 . . . . 0.0 114.453 -178.006 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.3 t0 -65.47 -3.59 4.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.178 1.791 . . . . 0.0 115.585 -166.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.39 -14.82 20.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.71 1.204 . . . . 0.0 113.283 159.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -152.78 104.61 2.68 Favored Pre-proline 0 N--CA 1.47 0.546 0 O-C-N 120.446 -1.409 . . . . 0.0 109.958 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 141.01 13.46 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.779 3.653 . . . . 0.0 114.285 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.2 t -119.33 -27.6 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.44 1.096 . . . . 0.0 111.014 179.551 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.98 -174.15 20.05 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.762 2.125 . . . . 0.0 111.0 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.45 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.8 ptp85 -136.85 175.73 9.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.352 1.061 . . . . 0.0 112.43 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.26 143.44 27.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 107.811 164.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.5 -46.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.895 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -62.5 -42.84 99.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.374 0.988 . . . . 0.0 113.621 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.66 163.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.553 0.741 . . . . 0.0 111.099 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -64.72 137.85 97.27 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.269 0.627 . . . . 0.0 109.759 166.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.88 82.47 0.98 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.047 2.498 . . . . 0.0 112.781 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -145.04 110.35 5.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.595 1.558 . . . . 0.0 112.093 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.66 87.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.974 1.709 . . . . 0.0 108.014 167.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -69.27 -19.56 63.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -170.046 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.51 155.07 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.682 1.193 . . . . 0.0 112.026 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -19.57 64.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.981 0.912 . . . . 0.0 112.946 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.3 p -80.81 7.88 9.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.993 1.717 . . . . 0.0 113.416 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 16.96 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.931 1.693 . . . . 0.0 115.164 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.19 23.22 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.919 3.288 . . . . 0.0 114.644 -168.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.81 171.71 12.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.634 1.974 . . . . 0.0 113.783 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.83 111.31 21.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.472 2.709 . . . . 0.0 106.198 167.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.99 122.65 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.782 0.833 . . . . 0.0 112.437 -156.148 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.75 135.29 35.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.907 174.038 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.4 mt -136.24 139.33 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.095 1.758 . . . . 0.0 108.716 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -91.88 137.27 32.5 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.371 -0.83 . . . . 0.0 111.661 164.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.03 165.68 14.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.286 2.235 . . . . 0.0 109.545 166.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.45 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 29.9 tt0 -104.88 109.25 62.88 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 109.502 174.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -93.18 118.82 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.231 3.954 . . . . 0.0 111.138 176.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.96 152.81 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.999 3.133 . . . . 0.0 114.942 170.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -84.34 152.53 24.04 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.436 -0.79 . . . . 0.0 110.564 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.87 -93.71 1.8 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -161.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -125.95 168.18 14.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.976 1.31 . . . . 0.0 111.315 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -154.06 155.1 34.84 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 120.945 -1.097 . . . . 0.0 112.126 171.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.03 115.59 16.0 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.973 2.509 . . . . 0.0 107.953 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.52 106.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.69 2.396 . . . . 0.0 106.797 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.7 137.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.311 1.045 . . . . 0.0 109.613 -166.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.6 110.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.163 1.385 . . . . 0.0 109.113 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 130.07 173.21 13.33 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 173.302 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.2 ptm85 -126.7 123.5 37.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.976 1.71 . . . . 0.0 110.592 -171.664 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.51 -96.97 0.01 OUTLIER Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.932 2.206 . . . . 0.0 115.163 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -65.62 -16.88 64.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.273 1.829 . . . . 0.0 115.541 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -135.76 91.47 2.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.114 1.366 . . . . 0.0 110.461 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -139.54 162.06 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 176.061 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.07 162.82 21.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 128.631 2.773 . . . . 0.0 107.989 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.25 154.64 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.635 -0.666 . . . . 0.0 110.951 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -125.01 169.3 12.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.452 1.901 . . . . 0.0 108.185 164.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -140.0 163.18 33.38 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.389 -0.819 . . . . 0.0 112.412 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.31 158.54 43.55 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.476 1.51 . . . . 0.0 111.748 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -145.26 110.44 5.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.005 1.722 . . . . 0.0 107.089 -167.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -153.99 105.28 2.72 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t 64.78 39.81 5.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.783 2.033 . . . . 0.0 113.966 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.33 22.42 0.08 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.584 1.088 . . . . 0.0 114.178 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.6 t -65.05 155.89 33.23 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 -172.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 m -53.17 -20.57 4.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.912 2.085 . . . . 0.0 113.721 161.864 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -101.05 2.37 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.919 1.287 . . . . 0.0 113.022 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.08 62.26 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.162 0 CA-C-N 118.985 1.393 . . . . 0.0 114.327 -179.353 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.97 153.3 32.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.21 1.004 . . . . 0.0 112.969 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.47 90.6 3.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.237 2.215 . . . . 0.0 109.09 175.15 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.88 -44.01 91.05 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.998 1.719 . . . . 0.0 114.149 -163.18 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -61.95 -26.41 68.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.493 0.717 . . . . 0.0 112.626 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -93.89 -1.53 54.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 112.361 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -62.15 -8.73 5.98 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.8 1.182 . . . . 0.0 114.169 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.71 52.01 6.14 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 119.652 1.115 . . . . 0.0 112.936 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -75.47 37.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.06 1.744 . . . . 0.0 111.557 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -78.18 -6.14 53.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.7 1.2 . . . . 0.0 114.109 -174.551 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -153.86 172.82 16.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.102 0.961 . . . . 0.0 111.141 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.2 143.86 45.64 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.689 0.662 . . . . 0.0 112.092 171.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.273 4.0 p -80.76 93.16 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.984 1.373 . . . . 0.0 112.58 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -148.82 164.81 33.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.701 2.0 . . . . 0.0 110.847 167.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.4 p -140.24 -15.43 0.98 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.834 1.253 . . . . 0.0 113.651 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 50.12 -64.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 129.686 3.194 . . . . 0.0 114.956 -167.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.45 83.15 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.548 1.139 . . . . 0.0 112.424 -160.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.77 162.22 29.99 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.745 1.218 . . . . 0.0 110.674 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -155.19 152.69 29.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.412 1.885 . . . . 0.0 109.84 166.409 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.9 132.19 51.28 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.483 -0.761 . . . . 0.0 111.693 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 -35.52 4.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.159 0.983 . . . . 0.0 110.809 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.86 103.2 0.42 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.016 1.77 . . . . 0.0 110.036 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 p -59.51 151.85 58.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.941 0.896 . . . . 0.0 112.293 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.08 141.76 77.99 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.13 1.887 . . . . 0.0 113.498 -168.256 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.77 135.51 33.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.292 1.437 . . . . 0.0 110.722 174.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.09 141.59 54.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -13.38 59.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 114.559 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.22 -8.26 47.29 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.366 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -98.21 1.78 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.1 1.36 . . . . 0.0 112.284 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -8.79 47.93 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.98 1.276 . . . . 0.0 113.89 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -102.11 166.51 10.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.939 2.096 . . . . 0.0 111.988 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.78 123.74 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.455 1.502 . . . . 0.0 110.833 173.182 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -77.74 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.882 0.873 . . . . 0.0 109.781 164.449 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.37 121.14 9.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.35 2.26 . . . . 0.0 109.241 -164.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -108.91 133.91 52.28 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.76 -1.212 . . . . 0.0 113.029 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.18 159.54 25.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.557 0.743 . . . . 0.0 110.25 168.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -111.26 144.78 39.9 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.918 1.287 . . . . 0.0 109.49 167.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -93.36 102.8 15.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.177 1.391 . . . . 0.0 109.404 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -77.82 16.34 0.71 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.698 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.52 38.86 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 120.187 1.358 . . . . 0.0 115.587 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.53 -15.27 24.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -131.93 177.49 7.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.725 1.21 . . . . 0.0 112.61 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.32 38.42 0.73 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-O 116.307 -2.385 . . . . 0.0 118.706 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.07 107.84 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 122.715 3.258 . . . . 0.0 111.474 166.394 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 4.6 t -169.1 173.72 6.67 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.383 1.473 . . . . 0.0 110.394 -165.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -88.72 96.7 10.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 119.715 -1.866 . . . . 0.0 111.404 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.75 123.93 60.85 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.774 0.83 . . . . 0.0 112.853 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -86.12 99.37 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.641 2.894 . . . . 0.0 112.31 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -131.07 145.7 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.282 1.033 . . . . 0.0 109.255 164.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.1 t -151.18 166.49 30.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.854 1.262 . . . . 0.0 112.789 -169.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.7 t -145.99 108.83 4.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.379 2.272 . . . . 0.0 110.338 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . 0.451 HG13 ' H ' ' A' ' 61' ' ' VAL . 31.5 m -142.42 171.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.839 0.855 . . . . 0.0 112.665 -176.923 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.63 -6.52 20.39 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -143.9 20.03 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.422 -1.424 . . . . 0.0 112.687 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.15 20.48 10.99 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.263 1.825 . . . . 0.0 111.966 -173.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -82.15 48.31 1.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 129.896 3.278 . . . . 0.0 113.203 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 29.9 m-20 -58.14 -17.19 16.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -7.66 1.2 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.376 1.87 . . . . 0.0 114.753 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -150.05 87.19 5.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 119.925 -1.734 . . . . 0.0 109.655 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.11 115.24 2.04 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 125.129 3.886 . . . . 0.0 114.279 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.451 ' H ' HG13 ' A' ' 52' ' ' VAL . 4.4 t -92.39 -36.6 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.248 1.419 . . . . 0.0 110.67 -178.067 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.91 -162.99 34.91 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.624 2.059 . . . . 0.0 111.98 170.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -144.47 167.19 23.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.889 1.276 . . . . 0.0 112.261 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.78 106.77 18.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.883 1.673 . . . . 0.0 106.552 167.157 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.89 -54.34 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -60.64 -49.26 78.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 113.002 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.68 141.28 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 123.028 0.531 . . . . 0.0 110.536 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -75.29 134.32 73.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 122.22 0.208 . . . . 0.0 110.5 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.38 92.21 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 114.309 -153.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -140.79 128.73 21.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.234 1.413 . . . . 0.0 110.547 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 20.7 t -82.92 87.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.16 1.384 . . . . 0.0 108.214 178.535 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -73.26 -5.24 38.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 157.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 110.841 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.36 -19.38 60.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -74.17 5.98 3.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.421 1.889 . . . . 0.0 113.841 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 12.22 0.17 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.844 1.658 . . . . 0.0 114.815 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.27 24.5 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 130.146 3.378 . . . . 0.0 114.921 -170.583 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 173.07 8.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.087 . . . . 0.0 113.758 -169.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 111.48 22.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.257 2.623 . . . . 0.0 105.306 164.656 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.71 128.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.919 0.866 . . . . 0.0 112.439 -158.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -92.44 125.85 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.052 2.541 . . . . 0.0 109.79 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.57 136.54 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.589 2.355 . . . . 0.0 108.15 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 134.49 33.61 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.699 . . . . 0.0 110.899 159.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.72 157.34 24.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.771 1.628 . . . . 0.0 109.761 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.65 106.85 42.64 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.54 136.2 10.87 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.439 2.76 . . . . 0.0 109.829 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -61.56 161.72 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 121.467 1.445 . . . . 0.0 111.357 167.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -88.23 166.75 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.35 0.66 . . . . 0.0 112.726 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.44 -89.44 1.22 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -167.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.24 147.26 50.22 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.2 p -146.41 141.76 27.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.737 0.78 . . . . 0.0 112.088 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -130.74 121.34 25.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.385 1.874 . . . . 0.0 108.266 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.0 mm -105.9 108.51 25.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 107.278 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.6 t -113.14 139.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.289 1.036 . . . . 0.0 109.52 -164.411 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.0 t -136.92 97.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.709 1.604 . . . . 0.0 107.899 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.58 172.73 18.73 Favored Glycine 0 N--CA 1.467 0.71 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 114.82 15.17 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.728 2.011 . . . . 0.0 110.211 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.37 -103.5 0.04 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.202 1.858 . . . . 0.0 114.086 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.67 -18.42 62.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.138 2.175 . . . . 0.0 115.545 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -123.14 93.95 4.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.339 0.972 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.2 42.53 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.76 159.68 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 129.135 2.974 . . . . 0.0 108.139 168.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -146.05 153.95 41.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.804 0.842 . . . . 0.0 110.081 165.711 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -137.91 166.91 22.87 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.671 1.588 . . . . 0.0 109.493 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -124.33 157.89 33.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.886 0.874 . . . . 0.0 112.399 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.51 151.38 28.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.051 1.74 . . . . 0.0 110.738 169.336 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -127.29 136.86 52.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 109.312 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -140.53 91.69 2.45 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -153.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 t 76.35 17.32 2.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.223 2.209 . . . . 0.0 114.187 163.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.79 25.55 0.05 OUTLIER Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.727 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.6 t -63.53 156.41 26.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.351 1.575 . . . . 0.0 110.849 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.6 p -62.34 -16.78 56.4 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 166.671 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.0 mm -67.23 -10.55 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.634 1.574 . . . . 0.0 111.903 167.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.37 17.1 47.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.219 1.39 . . . . 0.0 113.993 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tptp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.367 1.467 . . . . 0.0 112.833 -161.558 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 164.57 34.28 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 -174.53 3.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.884 2.074 . . . . 0.0 111.45 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.42 -57.08 2.08 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.602 -0.686 . . . . 0.0 110.815 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -49.09 -52.47 25.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.842 2.457 . . . . 0.0 114.425 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.34 -31.42 69.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.917 0.781 . . . . 0.0 112.797 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -76.3 -12.38 60.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.064 1.345 . . . . 0.0 113.812 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -19.7 126.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 1 C-N-CA 130.773 4.035 . . . . 0.0 116.59 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.433 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 79.3 p -73.96 74.58 1.68 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 113.151 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -59.89 -45.91 91.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.882 1.673 . . . . 0.0 112.857 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -123.74 174.4 7.51 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.353 1.861 . . . . 0.0 110.712 174.389 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.17 148.94 31.89 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.379 0.99 . . . . 0.0 113.085 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.76 105.11 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 122.621 1.2 . . . . 0.0 113.336 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.92 151.83 14.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.928 2.091 . . . . 0.0 109.281 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 p -143.94 -33.62 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.493 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 60.42 -69.27 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.596 2.759 . . . . 0.0 114.739 170.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.56 72.74 1.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.492 1.517 . . . . 0.0 110.346 -161.05 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -115.94 160.86 19.66 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.694 1.198 . . . . 0.0 110.049 165.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -141.97 144.22 33.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.652 1.581 . . . . 0.0 108.377 164.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.72 147.63 52.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.835 0.826 . . . . 0.0 111.947 170.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -46.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.924 1.29 . . . . 0.0 110.388 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.14 110.54 0.91 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.12 1.343 . . . . 0.0 111.239 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -57.92 146.6 67.24 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.448 167.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.2 155.22 52.52 Favored 'Trans proline' 0 C--N 1.351 0.71 0 N-CA-C 115.49 1.304 . . . . 0.0 115.49 -165.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.61 39.89 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.556 1.542 . . . . 0.0 110.282 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 132.65 45.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.769 0.428 . . . . 0.0 111.134 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.7 p -77.82 -24.25 48.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 -8.23 61.45 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.68 -1.066 . . . . 0.0 113.976 -160.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -75.25 -11.67 60.12 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.656 1.728 . . . . 0.0 111.342 163.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 -13.85 62.97 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.819 2.152 . . . . 0.0 113.105 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -84.29 170.17 13.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.759 2.424 . . . . 0.0 112.036 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.24 124.41 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.581 1.153 . . . . 0.0 110.317 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.24 128.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.793 0.837 . . . . 0.0 109.357 164.07 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 159.27 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 167.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -132.17 135.25 46.22 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -165.404 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.26 168.04 16.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.819 1.247 . . . . 0.0 110.489 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -123.7 148.17 46.79 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.844 1.257 . . . . 0.0 110.267 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -97.51 108.91 21.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.7 p -87.45 0.51 55.41 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.119 1.768 . . . . 0.0 113.775 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.16 16.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.712 1.149 . . . . 0.0 113.69 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 m -118.3 11.8 13.22 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.995 1.718 . . . . 0.0 111.56 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -149.25 -175.3 4.93 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.32 2.248 . . . . 0.0 111.154 -168.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.44 56.95 2.7 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.907 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.45 95.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.548 2.832 . . . . 0.0 112.281 155.586 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.3 169.07 19.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.26 . . . . 0.0 112.752 -169.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . 0.433 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 2.5 ttmm -95.78 101.38 13.06 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 110.523 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.78 115.45 18.88 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 111.321 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.3 88.45 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.932 2.422 . . . . 0.0 111.221 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 tt -106.77 144.9 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.23 1.012 . . . . 0.0 109.412 165.39 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t -145.85 167.87 22.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.011 1.324 . . . . 0.0 113.283 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.8 t -139.81 110.96 6.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.563 2.345 . . . . 0.0 109.811 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 28.4 m -137.3 161.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -8.57 29.67 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.4 m -155.68 36.65 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.164 -1.585 . . . . 0.0 112.321 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.96 8.41 0.98 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.324 1.85 . . . . 0.0 114.541 -175.309 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -67.96 40.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 131.104 3.762 . . . . 0.0 114.839 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.8 t0 -63.61 0.49 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -160.306 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.75 -18.67 65.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.13 -0.981 . . . . 0.0 112.966 160.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.1 m -128.33 101.48 21.77 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.102 1.761 . . . . 0.0 109.865 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -66.53 117.83 5.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.004 2.47 . . . . 0.0 110.325 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -96.83 -30.98 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.89 0.876 . . . . 0.0 111.144 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.4 -164.63 24.55 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.335 1.922 . . . . 0.0 111.537 166.298 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . 0.426 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 9.4 ptp85 -139.48 169.62 17.41 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.673 1.589 . . . . 0.0 111.803 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 114.79 27.45 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.201 1.8 . . . . 0.0 106.809 170.421 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.9 -51.92 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.282 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -60.73 -44.31 96.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.83 159.0 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.476 0.71 . . . . 0.0 111.03 -169.153 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.77 127.19 67.15 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.667 0.787 . . . . 0.0 109.091 163.789 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.06 89.56 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 110.916 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -144.05 142.78 30.85 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.792 0.806 . . . . 0.0 112.737 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 t -76.49 86.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 127.46 2.304 . . . . 0.0 106.864 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 p -59.97 -28.68 67.87 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -167.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 161.17 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.529 1.531 . . . . 0.0 112.146 -173.438 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.78 -28.01 68.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.119 0.968 . . . . 0.0 112.702 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.62 5.45 4.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.384 2.274 . . . . 0.0 114.665 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 14.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.1 16.97 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.694 3.598 . . . . 0.0 115.425 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.53 169.66 17.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.279 1.832 . . . . 0.0 113.768 -172.299 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 111.14 22.75 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.711 2.805 . . . . 0.0 105.473 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.71 126.65 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.034 0.934 . . . . 0.0 112.342 -159.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.97 130.97 36.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.286 2.234 . . . . 0.0 109.644 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -133.97 142.77 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.106 1.363 . . . . 0.0 109.889 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.81 135.1 33.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.302 1.041 . . . . 0.0 111.772 168.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.0 157.75 26.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.576 1.95 . . . . 0.0 109.844 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.426 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 35.6 tt0 -90.95 113.45 58.16 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.838 0.855 . . . . 0.0 109.041 171.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.28 122.91 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.804 3.003 . . . . 0.0 109.92 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.56 164.29 31.58 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.706 1.604 . . . . 0.0 111.846 171.17 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -80.98 145.0 31.41 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.29 -0.881 . . . . 0.0 111.783 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.09 -94.34 1.06 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.695 2.093 . . . . 0.0 110.268 -173.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -112.77 174.8 5.72 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 110.267 167.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 m -153.15 96.32 2.05 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.606 -1.309 . . . . 0.0 110.917 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.63 127.27 42.46 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.28 96.97 5.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.263 1.425 . . . . 0.0 107.612 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.98 140.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.695 -171.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -135.66 99.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.348 1.859 . . . . 0.0 107.834 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.08 169.14 25.01 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -137.59 123.9 20.61 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.835 2.454 . . . . 0.0 108.975 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.39 -98.54 0.01 OUTLIER Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.407 1.956 . . . . 0.0 114.92 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -71.37 -17.07 62.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.58 99.54 6.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.632 1.173 . . . . 0.0 109.58 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.39 156.28 45.82 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 164.79 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.46 2.704 . . . . 0.0 108.182 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.83 160.78 43.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.697 -0.627 . . . . 0.0 111.023 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.23 171.68 12.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.532 1.933 . . . . 0.0 109.899 170.398 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.1 144.16 51.11 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.221 1.008 . . . . 0.0 111.56 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.39 164.07 35.98 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.258 1.823 . . . . 0.0 110.783 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -146.17 114.46 6.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.547 1.539 . . . . 0.0 108.512 -162.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -152.54 96.3 2.12 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -163.018 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.7 p 56.6 82.16 0.12 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 128.609 2.763 . . . . 0.0 114.026 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.9 21.42 4.97 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.496 1.998 . . . . 0.0 112.961 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.8 t -70.77 156.95 38.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -166.95 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m -54.6 -19.05 5.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.852 1.661 . . . . 0.0 114.081 164.563 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tt -112.98 16.25 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.721 1.208 . . . . 0.0 112.735 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.4 75.81 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 116.111 1.204 . . . . 0.0 116.111 164.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.331 1.452 . . . . 0.0 113.56 179.146 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -146.61 146.95 30.6 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.171 0.51 . . . . 0.0 111.897 -168.007 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.62 173.02 9.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.061 2.544 . . . . 0.0 109.924 173.175 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -98.7 -49.39 4.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.258 -0.901 . . . . 0.0 111.336 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -61.33 -33.46 73.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.452 1.901 . . . . 0.0 114.12 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.11 -38.16 87.84 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.533 0.733 . . . . 0.0 110.963 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.0 mmtm -69.86 -40.23 75.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.917 -179.727 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 11.62 109.73 0.0 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 130.657 3.98 . . . . 0.0 117.072 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 80.9 p -67.49 71.34 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.925 2.09 . . . . 0.0 112.557 177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -19.71 65.48 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.414 3.086 . . . . 0.0 114.78 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -158.62 -172.97 4.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 110.686 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.59 118.35 13.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.718 1.151 . . . . 0.0 112.738 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -67.41 99.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.66 1.184 . . . . 0.0 112.979 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 160.04 39.98 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.737 2.415 . . . . 0.0 109.467 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.8 p -136.8 -35.57 0.71 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.672 1.189 . . . . 0.0 112.815 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 tttm 54.86 -79.42 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.822 2.449 . . . . 0.0 114.634 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.53 84.12 1.97 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.531 0.605 . . . . 0.0 111.958 -162.558 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.62 163.98 26.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.782 0.833 . . . . 0.0 112.268 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -149.93 145.82 26.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.428 2.291 . . . . 0.0 108.275 160.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -65.46 140.27 58.59 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.558 -0.714 . . . . 0.0 111.449 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.34 -52.08 2.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.65 112.81 1.94 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.557 1.551 . . . . 0.0 110.37 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.1 p -52.23 141.8 30.23 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.092 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.22 145.82 84.97 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.759 2.306 . . . . 0.0 112.764 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.51 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.706 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -65.0 125.22 24.23 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.356 0.598 . . . . 0.0 110.648 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 p -70.26 -8.22 48.49 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.145 2.178 . . . . 0.0 114.0 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.85 -8.49 3.4 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.64 1.114 . . . . 0.0 113.569 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -94.62 5.62 51.3 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.447 1.899 . . . . 0.0 111.276 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.14 18.72 38.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.698 1.142 . . . . 0.0 113.97 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -130.32 161.8 30.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 111.144 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 121.71 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.657 1.583 . . . . 0.0 108.701 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.32 130.4 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 162.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.7 tt -141.9 131.89 24.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 109.704 -169.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -115.91 130.84 57.0 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.114 0.87 . . . . 0.0 113.243 -177.508 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.05 167.31 13.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.36 1.064 . . . . 0.0 111.164 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -119.21 142.84 47.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.371 1.468 . . . . 0.0 109.836 166.349 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -95.1 98.27 10.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.303 1.041 . . . . 0.0 110.691 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.5 p -76.06 22.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.459 2.303 . . . . 0.0 115.846 -163.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.39 176.02 37.95 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 120.905 -1.122 . . . . 0.0 114.601 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 p -99.2 -4.69 31.47 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.501 1.921 . . . . 0.0 113.64 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.23 176.77 8.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.718 1.607 . . . . 0.0 112.732 -167.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.78 48.2 2.16 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 117.244 -1.864 . . . . 0.0 116.944 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.97 99.11 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.761 2.781 . . . . 0.0 110.068 162.598 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 56.2 m -145.39 163.72 33.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.504 1.522 . . . . 0.0 111.725 -167.173 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 4.3 tmtm? -80.08 90.0 5.41 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.167 172.331 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.11 114.51 7.23 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.852 1.261 . . . . 0.0 112.516 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.53 99.46 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.345 2.03 . . . . 0.0 110.761 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -126.51 145.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.081 1.352 . . . . 0.0 108.446 163.573 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.3 t -147.02 164.11 34.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.573 1.149 . . . . 0.0 112.806 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.9 t -137.76 115.39 11.3 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.556 2.342 . . . . 0.0 109.218 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 11.1 m -130.58 169.96 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.808 1.243 . . . . 0.0 111.593 176.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.58 -0.03 20.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -154.31 28.87 0.45 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.198 -1.564 . . . . 0.0 112.709 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.99 6.44 0.32 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.223 2.209 . . . . 0.0 115.203 -174.006 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -71.36 56.74 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.912 3.285 . . . . 0.0 112.436 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -64.82 -4.72 4.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -165.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -16.0 20.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.417 1.487 . . . . 0.0 114.515 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.0 m -157.11 116.11 2.0 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 120.678 -1.264 . . . . 0.0 109.16 165.789 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -48.23 127.82 16.02 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.229 3.286 . . . . 0.0 113.665 176.979 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.37 -26.65 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 126.054 1.742 . . . . 0.0 110.911 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.56 -164.82 29.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.484 1.992 . . . . 0.0 111.116 163.034 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -135.78 177.95 7.43 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.403 0.681 . . . . 0.0 112.62 173.598 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.49 142.49 27.37 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 163.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.0 t -106.8 -45.88 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.548 0.613 . . . . 0.0 110.108 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.2 m -61.86 -43.81 98.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.65 157.18 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.823 1.192 . . . . 0.0 112.375 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -62.09 128.6 91.08 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.29 89.02 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.367 2.045 . . . . 0.0 113.707 -172.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -155.59 114.08 3.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.227 1.811 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -76.74 93.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.836 2.054 . . . . 0.0 108.2 171.822 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -69.63 -7.26 37.3 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.16 154.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.874 1.216 . . . . 0.0 111.989 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.91 66.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.249 1.02 . . . . 0.0 112.322 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.16 0.05 5.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.187 2.995 . . . . 0.0 114.07 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.24 11.82 0.15 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.849 1.66 . . . . 0.0 115.429 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.35 17.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.304 3.442 . . . . 0.0 115.597 -167.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.2 176.78 8.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.893 2.077 . . . . 0.0 114.126 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.29 114.51 27.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.836 2.854 . . . . 0.0 106.171 164.209 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.62 132.03 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.561 0.696 . . . . 0.0 112.749 -158.497 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.86 137.97 33.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.263 2.225 . . . . 0.0 111.109 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.84 144.05 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.005 2.122 . . . . 0.0 108.69 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -98.91 135.75 39.89 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 112.476 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.36 166.56 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 110.442 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -102.37 110.67 63.32 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.073 0.949 . . . . 0.0 110.009 171.128 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -84.88 108.59 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.729 4.286 . . . . 0.0 111.084 172.571 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -60.34 161.56 19.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 172.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.38 165.31 16.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.92 -80.26 1.23 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -165.067 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.01 156.66 41.27 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.801 1.24 . . . . 0.0 111.139 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -143.02 142.17 31.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.523 1.129 . . . . 0.0 110.161 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -137.92 128.63 26.81 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.644 1.178 . . . . 0.0 108.096 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.22 98.64 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.265 1.426 . . . . 0.0 107.255 -162.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -99.92 136.49 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.939 0.896 . . . . 0.0 109.114 -167.153 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.6 103.98 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.67 1.588 . . . . 0.0 107.524 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.97 177.59 15.04 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.299 0.944 . . . . 0.0 114.763 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.47 154.51 45.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.195 2.198 . . . . 0.0 108.471 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -12.2 -72.74 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.68 2.562 . . . . 0.0 117.164 -173.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.11 -13.72 59.76 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.9 88.04 2.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.623 1.569 . . . . 0.0 109.971 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -143.25 157.7 44.26 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.29 161.4 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 129.382 3.073 . . . . 0.0 107.839 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.69 150.82 36.15 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.05 -1.031 . . . . 0.0 112.513 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -120.87 170.25 9.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.766 1.226 . . . . 0.0 110.832 166.333 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -125.8 159.74 31.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.616 1.967 . . . . 0.0 111.31 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.0 153.01 31.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.198 2.599 . . . . 0.0 110.599 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -143.58 117.3 9.27 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 108.765 -167.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -150.57 93.04 1.92 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -165.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p 65.8 58.0 0.8 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.081 1.753 . . . . 0.0 114.077 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 128.65 25.3 1.04 Allowed Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.882 1.706 . . . . 0.0 113.439 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.1 t -61.01 158.0 14.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.239 1.816 . . . . 0.0 113.475 -177.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 m -55.52 -22.81 23.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.322 1.049 . . . . 0.0 112.454 163.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -91.33 -3.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 126.809 2.044 . . . . 0.0 111.523 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.54 69.87 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.635 -1.291 . . . . 0.0 115.469 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.6 ptmm? . . . . . 0 C--O 1.249 1.029 0 C-N-CA 126.022 1.729 . . . . 0.0 113.206 178.769 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -142.78 137.25 29.59 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.113 0.565 . . . . 0.0 112.093 -162.222 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 168.42 14.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.669 2.787 . . . . 0.0 109.953 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -83.65 -57.54 3.18 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.239 -0.913 . . . . 0.0 111.994 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -58.36 -29.65 66.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.417 1.487 . . . . 0.0 114.356 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -70.74 -40.03 72.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.33 0.513 . . . . 0.0 111.093 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -65.74 -45.32 83.08 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.962 0.801 . . . . 0.0 109.886 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.99 101.77 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 130.04 3.686 . . . . 0.0 116.756 161.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -68.4 62.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.521 2.328 . . . . 0.0 112.682 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -70.33 -17.92 63.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.382 1.873 . . . . 0.0 113.757 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -160.07 -179.15 7.52 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.444 1.497 . . . . 0.0 110.486 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.05 144.85 24.09 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.668 1.128 . . . . 0.0 114.241 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.99 95.54 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 122.969 1.366 . . . . 0.0 114.152 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 169.44 17.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 128.627 2.771 . . . . 0.0 108.299 168.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -167.27 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.585 0.754 . . . . 0.0 112.484 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? 61.99 -76.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.593 2.357 . . . . 0.0 113.647 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.49 77.06 1.59 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.802 0.81 . . . . 0.0 112.149 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -120.7 156.96 30.66 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.403 1.081 . . . . 0.0 110.144 163.735 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -143.11 142.39 31.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.085 1.754 . . . . 0.0 108.731 168.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.49 138.7 57.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.67 0.748 . . . . 0.0 111.398 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -43.12 3.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.077 1.351 . . . . 0.0 109.541 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.98 115.48 1.2 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.395 1.95 . . . . 0.0 109.646 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.2 p -64.12 159.58 55.46 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.648 -0.913 . . . . 0.0 111.321 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.46 137.22 68.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.139 1.893 . . . . 0.0 112.585 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 125.3 32.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.5 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.37 132.05 47.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.557 0.694 . . . . 0.0 111.454 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.2 p -78.8 -9.14 59.36 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.818 1.647 . . . . 0.0 113.944 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.16 -7.82 3.08 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 118.994 0.815 . . . . 0.0 114.061 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -94.96 4.87 53.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.069 1.748 . . . . 0.0 111.193 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.02 42.31 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.245 1.879 . . . . 0.0 114.072 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -109.47 174.76 5.72 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.034 2.134 . . . . 0.0 112.056 -171.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -120.42 141.01 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.936 1.294 . . . . 0.0 110.224 165.364 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.54 128.89 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.018 1.327 . . . . 0.0 109.918 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.55 133.09 36.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.729 2.012 . . . . 0.0 109.217 -172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -121.24 132.32 54.74 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.869 0.868 . . . . 0.0 112.612 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.85 166.12 14.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.865 0.866 . . . . 0.0 110.119 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -120.95 148.74 43.67 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.885 0.874 . . . . 0.0 109.45 160.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -100.4 100.36 11.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.011 0.925 . . . . 0.0 109.702 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -80.47 13.64 2.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.453 2.301 . . . . 0.0 115.759 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.08 171.32 27.8 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.507 1.048 . . . . 0.0 113.789 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -96.52 6.42 48.78 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.715 1.606 . . . . 0.0 113.479 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.8 172.68 12.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.87 1.668 . . . . 0.0 112.308 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.65 47.76 0.89 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-O 117.046 -1.975 . . . . 0.0 117.413 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -55.11 95.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.959 0 CA-C-N 121.769 2.785 . . . . 0.0 111.458 162.18 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 65.4 m -152.96 168.03 27.19 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.367 1.467 . . . . 0.0 112.589 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -83.48 91.96 7.5 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.504 -1.372 . . . . 0.0 110.782 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.81 119.35 15.76 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.676 1.19 . . . . 0.0 112.105 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.83 88.87 1.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.353 2.702 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 tt -124.62 143.72 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.792 -0.567 . . . . 0.0 110.07 165.603 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.5 t -147.62 157.16 43.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.844 1.258 . . . . 0.0 112.055 -168.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -133.28 108.62 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.993 1.717 . . . . 0.0 110.562 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 57' ' ' ASP . 19.3 m -131.73 170.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.794 0.837 . . . . 0.0 112.166 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.19 -12.6 18.62 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -152.93 27.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.114 -1.616 . . . . 0.0 112.602 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.47 17.66 2.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.054 2.142 . . . . 0.0 113.098 -168.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.489 HD21 ' CG2' ' A' ' 61' ' ' VAL . 13.5 p-10 -68.37 52.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.583 2.753 . . . . 0.0 111.952 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HA ' HG11 ' A' ' 52' ' ' VAL . 12.3 t0 -56.94 -25.67 58.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.914 1.285 . . . . 0.0 113.2 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.58 -10.96 0.48 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.566 3.147 . . . . 0.0 116.128 166.025 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.3 m -153.6 95.75 2.85 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 119.869 -1.77 . . . . 0.0 111.064 166.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HA ' HG12 ' A' ' 52' ' ' VAL . 85.7 Cg_exo -54.27 118.1 4.65 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.838 3.692 . . . . 0.0 116.369 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.7 t -95.9 -26.21 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.858 1.663 . . . . 0.0 112.859 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.18 -163.52 18.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.514 2.007 . . . . 0.0 111.798 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 172.31 13.02 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.64 104.94 16.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.972 2.109 . . . . 0.0 106.857 168.037 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.85 -48.58 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.593 0.757 . . . . 0.0 110.453 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -59.82 -48.04 83.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -162.41 161.96 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.235 0.925 . . . . 0.0 112.033 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.16 120.73 45.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.858 0.863 . . . . 0.0 109.563 161.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.82 85.32 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.397 2.064 . . . . 0.0 110.843 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.34 123.9 11.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.048 1.739 . . . . 0.0 110.376 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.48 99.09 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.285 1.434 . . . . 0.0 108.323 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.2 t -75.71 -4.48 40.6 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.17 159.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.076 1.307 . . . . 0.0 112.842 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.62 63.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.936 1.294 . . . . 0.0 113.206 168.902 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.7 p -80.41 2.53 24.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.076 1.75 . . . . 0.0 114.103 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 14.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.22 16.65 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 130.969 3.708 . . . . 0.0 114.814 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.597 2.359 . . . . 0.0 114.024 -171.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.38 107.83 16.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.708 2.803 . . . . 0.0 105.696 166.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.32 120.02 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.148 0.979 . . . . 0.0 113.231 -153.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.05 129.29 35.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.151 2.581 . . . . 0.0 109.748 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.55 136.92 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.826 2.45 . . . . 0.0 108.499 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -91.09 141.54 28.71 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.343 0.657 . . . . 0.0 112.347 167.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.52 159.62 30.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.339 2.256 . . . . 0.0 110.045 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.45 107.54 58.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 108.95 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.55 ' HG3' HG13 ' A' ' 32' ' ' VAL . 97.7 Cg_endo -90.99 115.8 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 125.044 3.83 . . . . 0.0 110.711 167.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.4 167.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 125.115 3.877 . . . . 0.0 116.172 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -77.59 161.28 27.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.33 -87.57 1.2 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -125.7 160.38 29.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.46 1.124 . . . . 0.0 110.905 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -154.12 159.35 41.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.065 0.936 . . . . 0.0 111.651 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.55 127.96 21.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.299 1.44 . . . . 0.0 108.114 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.46 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.212 1.805 . . . . 0.0 107.011 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -106.65 135.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.56 92.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 126.156 1.782 . . . . 0.0 107.236 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.97 171.19 17.46 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.69 113.52 13.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.061 1.744 . . . . 0.0 110.436 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.07 -103.49 0.05 OUTLIER Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.078 1.799 . . . . 0.0 114.116 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -17.03 64.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.582 1.953 . . . . 0.0 115.727 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -129.43 98.6 4.91 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.545 1.066 . . . . 0.0 110.554 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -148.84 166.03 29.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.51 162.67 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 129.931 3.293 . . . . 0.0 108.502 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.69 157.1 41.62 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 172.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -139.35 151.31 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 111.684 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 160.64 14.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.232 1.413 . . . . 0.0 112.757 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -147.51 154.38 40.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.571 1.548 . . . . 0.0 112.053 158.064 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -139.69 114.65 9.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.842 1.657 . . . . 0.0 108.685 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -151.19 108.21 3.56 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -165.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 p 52.41 70.68 0.54 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.796 2.838 . . . . 0.0 113.784 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.83 24.63 4.22 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.571 1.557 . . . . 0.0 113.541 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -56.91 155.25 8.22 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 112.668 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 m -51.05 -25.1 4.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.324 1.449 . . . . 0.0 112.761 161.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.01 -4.47 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.332 1.853 . . . . 0.0 112.849 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.11 5.79 60.58 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.636 1.415 . . . . 0.0 116.636 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.483 1.642 . . . . 0.0 113.858 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -145.62 149.66 34.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.392 1.077 . . . . 0.0 111.018 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.11 106.14 13.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.71 2.004 . . . . 0.0 110.094 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.14 -24.15 47.5 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -163.077 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.74 -39.11 73.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.258 1.023 . . . . 0.0 112.918 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.55 -5.68 41.74 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -71.09 -15.58 62.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -165.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.52 84.93 0.3 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.174 1.352 . . . . 0.0 114.685 170.539 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -89.4 18.28 5.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.292 1.837 . . . . 0.0 113.833 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -62.16 -12.02 17.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.23 170.88 14.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.563 1.945 . . . . 0.0 108.78 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.09 161.99 40.14 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.471 -0.768 . . . . 0.0 113.396 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -72.51 91.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.269 1.509 . . . . 0.0 113.626 -172.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.67 163.1 35.92 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.281 2.232 . . . . 0.0 109.195 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.6 p -160.03 -44.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.594 1.158 . . . . 0.0 110.774 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 64.46 -70.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 128.227 2.611 . . . . 0.0 112.515 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.81 78.6 1.97 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.328 1.051 . . . . 0.0 112.228 -161.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -134.29 154.98 51.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 111.346 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -146.05 143.88 29.69 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.551 1.94 . . . . 0.0 109.617 165.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.88 129.82 42.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.851 0.86 . . . . 0.0 111.17 167.068 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -108.71 -51.13 2.92 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.603 1.561 . . . . 0.0 109.39 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.56 104.48 0.69 Allowed Glycine 0 C--N 1.339 0.701 0 C-N-CA 125.861 1.695 . . . . 0.0 109.137 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -64.15 157.29 70.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 117.927 0.864 . . . . 0.0 112.365 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.88 141.09 46.84 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.554 2.836 . . . . 0.0 115.621 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.95 122.91 24.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 110.019 167.126 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.19 123.18 18.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -72.94 -13.74 61.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.997 0.919 . . . . 0.0 112.64 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 -8.93 2.17 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 119.046 0.839 . . . . 0.0 114.14 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -89.59 11.26 20.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.737 1.615 . . . . 0.0 111.586 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 12.87 58.95 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.861 1.22 . . . . 0.0 113.836 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -131.01 163.39 27.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.835 1.317 . . . . 0.0 112.497 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 123.41 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.176 1.79 . . . . 0.0 107.765 164.071 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.57 124.72 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.92 146.82 45.92 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.686 1.194 . . . . 0.0 110.682 169.583 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.99 135.28 53.82 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.094 0.958 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.7 mt -117.17 161.09 20.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.29 1.436 . . . . 0.0 109.838 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -120.34 139.54 52.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.246 1.019 . . . . 0.0 109.781 163.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.59 93.32 9.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.521 1.128 . . . . 0.0 109.827 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -72.72 32.21 0.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.88 2.472 . . . . 0.0 115.08 -165.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.42 178.57 45.3 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 122.777 1.209 . . . . 0.0 116.055 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.37 -24.96 29.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.092 2.557 . . . . 0.0 115.655 -169.573 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.25 173.61 15.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.091 0.956 . . . . 0.0 111.744 -153.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' ' HD3' ' A' ' 44' ' ' PRO . . . 118.85 50.88 0.31 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-O 117.131 -1.927 . . . . 0.0 116.301 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 43' ' ' GLY . 36.2 Cg_exo -54.69 87.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.026 0 CA-C-N 121.628 2.714 . . . . 0.0 112.089 160.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.76 169.54 20.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.56 1.144 . . . . 0.0 112.671 -167.378 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -91.26 92.98 8.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.785 1.234 . . . . 0.0 109.889 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.51 119.81 43.13 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.882 0.873 . . . . 0.0 112.87 -170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.75 88.24 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.358 2.705 . . . . 0.0 109.985 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -123.86 144.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.4 1.48 . . . . 0.0 108.567 167.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.8 t -154.59 167.85 28.73 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.2 t -142.27 125.64 16.6 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.53 2.332 . . . . 0.0 109.877 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.3 m -139.24 167.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.239 1.016 . . . . 0.0 113.657 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.56 22.61 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -155.32 36.05 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.036 -1.665 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.17 10.03 1.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.288 2.235 . . . . 0.0 114.723 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -68.78 46.28 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 129.575 3.15 . . . . 0.0 113.906 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.6 t70 -66.25 -2.46 4.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -166.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.65 -12.15 2.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.553 1.141 . . . . 0.0 113.672 159.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.6 m -155.0 99.82 2.35 Favored Pre-proline 0 CA--C 1.536 0.409 0 O-C-N 120.304 -1.497 . . . . 0.0 109.468 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.61 126.84 15.08 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.293 3.329 . . . . 0.0 112.619 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.49 -34.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.642 1.177 . . . . 0.0 110.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.48 -170.07 40.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.181 1.372 . . . . 0.0 111.15 161.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.5 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.3 ptp85 -134.99 171.99 13.65 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.208 1.403 . . . . 0.0 111.997 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -90.32 124.25 34.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.415 1.886 . . . . 0.0 107.452 168.391 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -95.69 -53.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 118.468 0.576 . . . . 0.0 111.088 -171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -41.3 89.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.63 150.08 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.946 0.899 . . . . 0.0 109.786 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -68.75 147.46 97.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 122.178 -0.326 . . . . 0.0 110.133 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.96 76.82 4.35 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.314 2.676 . . . . 0.0 113.54 -160.488 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.35 124.99 14.91 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.168 -0.957 . . . . 0.0 111.129 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.53 91.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.253 1.421 . . . . 0.0 107.228 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 t -57.67 -28.28 63.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.7 m -151.53 158.76 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.262 1.825 . . . . 0.0 111.898 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.43 -24.02 67.48 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.395 1.078 . . . . 0.0 112.858 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.68 0.66 0.74 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 129.694 3.197 . . . . 0.0 114.503 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.97 8.98 0.77 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.83 1.652 . . . . 0.0 115.072 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -61.63 18.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 130.648 3.579 . . . . 0.0 116.022 -169.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.09 174.98 11.06 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.903 2.481 . . . . 0.0 114.43 -171.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.5 97.72 5.14 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.131 2.572 . . . . 0.0 107.13 170.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.02 119.03 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -148.604 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mt -59.44 142.38 52.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.001 1.72 . . . . 0.0 112.432 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.8 148.0 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 127.571 2.348 . . . . 0.0 108.377 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -99.19 139.5 34.75 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.354 1.062 . . . . 0.0 111.724 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.3 165.78 15.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.42 2.288 . . . . 0.0 109.55 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.5 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 7.9 tt0 -95.57 116.93 66.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.642 1.177 . . . . 0.0 109.425 170.793 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -98.35 107.14 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.856 4.371 . . . . 0.0 112.349 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -45.76 150.89 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.046 3.164 . . . . 0.0 115.167 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -81.71 162.16 23.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.686 0.795 . . . . 0.0 112.632 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.11 -88.02 0.88 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -162.875 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.65 148.08 41.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.995 1.318 . . . . 0.0 110.412 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.58 106.83 5.5 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.497 1.119 . . . . 0.0 109.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -110.12 129.16 55.74 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.438 -0.789 . . . . 0.0 110.34 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.16 111.7 36.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 126.378 1.871 . . . . 0.0 107.917 -168.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.08 135.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.852 0.861 . . . . 0.0 110.118 -160.732 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.22 100.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.04 1.736 . . . . 0.0 108.525 -168.058 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.97 -175.61 19.97 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 122.242 0.912 . . . . 0.0 114.959 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -138.85 141.09 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.374 1.87 . . . . 0.0 109.789 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 16.28 -87.68 0.0 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.213 2.816 . . . . 0.0 116.255 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -70.06 -20.39 63.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -139.51 96.7 3.13 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.424 1.49 . . . . 0.0 110.382 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 159.06 43.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.48 164.07 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.852 2.461 . . . . 0.0 108.519 166.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -148.91 160.75 42.98 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.836 0.854 . . . . 0.0 109.74 166.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -136.16 167.45 21.25 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 109.93 166.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -120.86 161.47 21.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 112.426 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.33 157.65 42.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 128.927 2.891 . . . . 0.0 109.734 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -145.06 148.14 33.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.234 1.014 . . . . 0.0 109.017 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -153.05 116.83 4.76 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.821 . . . . 0.0 112.088 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.7 p 119.68 -0.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 131.146 3.778 . . . . 0.0 114.38 159.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.19 43.45 0.72 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.751 1.167 . . . . 0.0 111.687 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.3 t -88.32 -154.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.497 1.919 . . . . 0.0 112.313 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.5 p -46.95 -31.38 3.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.374 2.669 . . . . 0.0 116.577 -167.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -112.77 11.23 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 125.299 1.44 . . . . 0.0 111.767 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.55 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.46 -1.4 . . . . 0.0 113.604 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 tptp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.969 1.708 . . . . 0.0 112.499 -168.837 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 173.54 12.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.297 2.239 . . . . 0.0 110.454 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -115.07 -53.41 2.63 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -45.28 -53.03 8.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 114.179 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.73 -29.1 67.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.801 0.84 . . . . 0.0 113.057 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.21 -14.78 60.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.93 1.292 . . . . 0.0 113.518 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -17.65 129.59 0.01 OUTLIER Glycine 0 CA--C 1.533 1.213 1 C-N-CA 130.986 4.136 . . . . 0.0 117.484 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 m -62.82 68.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.882 3.273 . . . . 0.0 113.569 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.783 2.033 . . . . 0.0 114.092 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -150.02 175.45 11.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.59 2.356 . . . . 0.0 109.521 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.25 38.0 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 111.787 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -74.36 97.3 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.01 173.33 16.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.949 1.3 . . . . 0.0 111.812 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 90.3 p -151.14 -22.49 0.21 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.794 1.237 . . . . 0.0 114.321 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? 56.58 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 129.974 3.31 . . . . 0.0 115.696 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.89 74.9 1.61 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.07 1.348 . . . . 0.0 111.471 -159.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.43 160.5 16.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.122 1.369 . . . . 0.0 109.709 160.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -134.14 143.59 48.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.285 1.834 . . . . 0.0 108.106 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -68.03 140.65 56.33 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.762 -0.586 . . . . 0.0 111.075 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.62 -57.05 2.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.61 1.164 . . . . 0.0 109.028 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 107.27 0.85 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.766 1.651 . . . . 0.0 110.466 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -42.67 137.23 2.44 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 111.21 170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.89 152.15 52.28 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.299 2.0 . . . . 0.0 113.76 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.61 121.86 13.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.262 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.05 123.51 20.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.997 0.903 . . . . 0.0 110.804 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -63.38 -16.7 61.27 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.897 2.479 . . . . 0.0 114.352 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.93 -13.49 43.41 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.03 0.832 . . . . 0.0 113.174 -167.891 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -80.01 8.44 7.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.698 1.249 . . . . 0.0 112.063 165.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.74 84.42 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.532 -1.149 . . . . 0.0 113.949 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.0 p -125.91 146.6 49.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.143 2.177 . . . . 0.0 110.091 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.69 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.0 m -91.92 138.18 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.105 0.962 . . . . 0.0 111.003 173.129 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.424 ' HB ' HD21 ' A' ' 81' ' ' LEU . 2.5 m -85.81 133.45 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 155.879 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 126.15 16.81 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.57 2.348 . . . . 0.0 109.043 -167.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.12 134.29 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.574 1.079 . . . . 0.0 113.471 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.29 174.27 9.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.814 1.645 . . . . 0.0 111.109 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -135.67 139.44 43.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.431 1.092 . . . . 0.0 110.394 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -89.05 102.99 15.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.319 0.648 . . . . 0.0 110.039 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -80.39 -9.11 59.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 113.535 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.27 166.04 54.67 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.043 0.838 . . . . 0.0 113.394 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -118.95 11.76 12.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.862 1.665 . . . . 0.0 110.531 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -157.71 -178.6 7.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.913 2.485 . . . . 0.0 110.208 -156.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.98 58.98 2.38 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.255 1.662 . . . . 0.0 117.255 164.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -51.94 109.01 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.936 2.424 . . . . 0.0 111.072 155.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.56 155.64 19.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -164.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -81.16 91.15 6.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.543 1.537 . . . . 0.0 109.482 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.35 116.19 14.07 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.938 0.895 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.37 82.22 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 111.269 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -105.96 145.0 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 167.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -154.03 170.33 21.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.152 1.381 . . . . 0.0 113.048 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -144.31 117.16 8.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.445 2.298 . . . . 0.0 110.637 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 57' ' ' ASP . 13.9 m -140.72 169.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.678 1.191 . . . . 0.0 112.945 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.93 -3.51 21.68 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -154.78 30.84 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.01 -1.681 . . . . 0.0 112.528 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.8 7.98 1.65 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.462 1.905 . . . . 0.0 114.286 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -69.52 46.48 0.07 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.875 3.27 . . . . 0.0 113.474 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.0 t0 -62.84 -7.42 5.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -163.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -58.31 -23.54 56.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.252 1.421 . . . . 0.0 112.96 162.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.0 m -132.71 95.64 19.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 125.652 1.581 . . . . 0.0 109.407 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 123.31 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.108 2.538 . . . . 0.0 110.916 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.17 -22.35 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.365 1.066 . . . . 0.0 111.181 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.48 -170.23 18.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.938 2.208 . . . . 0.0 111.797 165.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.418 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.6 ptp85 -138.16 172.82 12.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.918 1.287 . . . . 0.0 112.59 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 126.79 39.24 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 106.809 167.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -98.63 -41.66 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.62 -168.173 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -63.07 -50.29 71.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.127 0.876 . . . . 0.0 113.319 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 p -164.29 166.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.335 1.054 . . . . 0.0 111.428 -165.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.06 123.5 48.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.872 0.869 . . . . 0.0 109.164 161.46 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.26 95.86 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.081 1.854 . . . . 0.0 111.131 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -146.46 142.84 28.52 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.398 -0.814 . . . . 0.0 112.612 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.59 95.86 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 126.858 2.063 . . . . 0.0 106.25 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.4 p -70.24 -22.1 62.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.4 m -150.8 157.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.853 1.661 . . . . 0.0 112.065 -170.178 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.61 65.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.974 0.91 . . . . 0.0 113.275 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.8 p -78.56 8.11 5.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.6 1.96 . . . . 0.0 113.711 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 12.82 0.07 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.921 1.689 . . . . 0.0 115.357 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.38 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.793 3.237 . . . . 0.0 115.243 -167.022 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.23 163.22 28.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.19 1.796 . . . . 0.0 113.389 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -98.82 111.1 23.58 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 128.244 2.618 . . . . 0.0 106.045 159.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.72 140.3 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.319 1.048 . . . . 0.0 112.62 -157.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 33' ' ' VAL . 2.8 tm? -105.84 131.64 52.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.963 2.505 . . . . 0.0 109.536 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.95 155.12 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.457 1.903 . . . . 0.0 109.522 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -109.0 132.25 54.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.578 . . . . 0.0 110.62 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.57 160.71 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.857 1.663 . . . . 0.0 110.103 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 32.0 tt0 -101.62 104.58 35.46 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.167 0.987 . . . . 0.0 109.079 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.69 ' HG3' HG13 ' A' ' 32' ' ' VAL . 73.8 Cg_endo -83.38 118.35 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.274 3.316 . . . . 0.0 109.654 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.4 160.61 49.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.215 1.943 . . . . 0.0 111.082 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -66.09 159.57 25.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.545 1.138 . . . . 0.0 112.645 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.55 -148.23 18.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.581 1.086 . . . . 0.0 110.566 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.04 146.0 55.59 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.68 -0.894 . . . . 0.0 109.048 152.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -135.37 100.56 4.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.729 0.812 . . . . 0.0 109.621 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -109.08 132.62 53.94 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.084 0.945 . . . . 0.0 111.025 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.01 99.33 8.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 127.866 2.466 . . . . 0.0 107.151 -166.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.8 t -101.08 139.44 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.461 0.704 . . . . 0.0 109.483 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.62 87.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.29 1.436 . . . . 0.0 108.369 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.83 168.52 29.14 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 118.243 2.057 . . . . 0.0 118.243 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.56 146.35 37.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.86 1.664 . . . . 0.0 109.512 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.25 -98.5 0.01 OUTLIER Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.398 1.951 . . . . 0.0 115.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -90.11 -13.55 35.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.992 1.717 . . . . 0.0 114.317 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.49 90.36 3.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.569 1.548 . . . . 0.0 109.291 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.4 155.06 45.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.8 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 129.178 2.991 . . . . 0.0 108.098 170.7 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.29 156.38 38.31 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.396 -0.815 . . . . 0.0 110.95 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.31 160.83 32.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.286 2.235 . . . . 0.0 109.231 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.38 144.88 40.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.839 0.456 . . . . 0.0 111.433 -168.013 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.67 169.94 16.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.935 1.694 . . . . 0.0 111.226 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.29 117.24 14.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.077 1.751 . . . . 0.0 108.112 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -141.03 87.32 2.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 112.793 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.9 m 54.65 63.62 2.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.749 2.02 . . . . 0.0 113.521 168.336 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.57 12.68 0.78 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.438 1.494 . . . . 0.0 114.101 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.5 t -75.53 158.19 32.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.734 1.214 . . . . 0.0 112.961 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 m -40.34 -33.94 0.29 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 130.326 3.45 . . . . 0.0 114.54 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.21 -7.51 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.358 1.063 . . . . 0.0 113.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.53 55.17 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 118.844 -0.975 . . . . 0.0 115.464 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 C-N-CA 125.104 1.362 . . . . 0.0 112.396 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 162.34 36.51 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.229 0.611 . . . . 0.0 111.676 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 -172.68 2.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.16 2.184 . . . . 0.0 110.773 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -106.72 -57.68 2.03 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.518 -0.738 . . . . 0.0 110.702 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -53.47 -34.41 57.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.579 2.352 . . . . 0.0 114.876 -172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.87 -22.03 66.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.364 0.984 . . . . 0.0 112.91 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -82.72 -2.49 54.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.708 0.803 . . . . 0.0 112.698 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -20.07 113.74 0.01 OUTLIER Glycine 0 CA--C 1.532 1.102 1 C-N-CA 130.818 4.056 . . . . 0.0 116.64 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.401 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 82.0 p -67.52 72.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.86 2.464 . . . . 0.0 113.897 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.0 p -74.27 -19.89 60.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.021 1.728 . . . . 0.0 114.172 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.66 170.53 16.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.981 2.112 . . . . 0.0 109.558 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.72 142.82 34.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.119 0.866 . . . . 0.0 112.588 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.41 103.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.65 1.18 . . . . 0.0 112.607 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 148.24 17.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.603 2.361 . . . . 0.0 109.064 -171.852 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -141.0 -21.9 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 45.36 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.983 3.313 . . . . 0.0 115.328 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.81 80.41 1.58 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.577 1.551 . . . . 0.0 110.571 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -124.62 155.92 38.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.366 1.066 . . . . 0.0 110.684 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -143.85 146.81 33.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.839 1.656 . . . . 0.0 108.493 166.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -69.43 140.28 54.08 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.761 -0.587 . . . . 0.0 111.27 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.58 -44.04 4.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.431 1.092 . . . . 0.0 109.812 168.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.62 117.01 1.15 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.458 1.027 . . . . 0.0 112.419 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.9 m -45.59 146.76 1.68 Allowed Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 127.934 2.494 . . . . 0.0 112.465 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.95 135.79 36.4 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.099 2.533 . . . . 0.0 113.467 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.77 111.54 13.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.025 1.73 . . . . 0.0 110.023 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.31 122.06 12.97 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.33 1.452 . . . . 0.0 111.432 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.1 p -75.46 -11.33 60.01 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.58 -26.79 0.37 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.779 1.18 . . . . 0.0 113.866 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.47 -9.74 57.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.518 2.327 . . . . 0.0 112.968 174.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.33 14.09 12.26 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.817 1.199 . . . . 0.0 114.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 p -128.43 171.14 12.34 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.26 1.424 . . . . 0.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 m -128.82 120.21 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.904 1.682 . . . . 0.0 109.087 171.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.59 133.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.08 130.23 35.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.346 1.858 . . . . 0.0 108.645 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -109.63 128.57 55.32 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.326 0.584 . . . . 0.0 112.388 -174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.52 167.97 12.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.001 1.321 . . . . 0.0 110.501 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.41 142.45 51.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.658 1.183 . . . . 0.0 109.851 162.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -94.1 101.26 13.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -76.3 7.95 3.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.101 2.16 . . . . 0.0 115.265 -169.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.56 169.76 21.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.66 1.118 . . . . 0.0 113.859 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -103.12 -0.45 30.6 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.323 1.849 . . . . 0.0 113.666 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -136.72 173.71 11.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.246 1.818 . . . . 0.0 112.33 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 56.81 1.04 Allowed Glycine 0 CA--C 1.539 1.535 0 CA-C-O 117.823 -1.543 . . . . 0.0 116.719 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.17 99.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.29 2.66 . . . . 0.0 111.897 155.152 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 m -151.47 166.72 30.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.399 1.08 . . . . 0.0 112.548 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 3.7 ttmm -92.58 98.98 11.79 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.811 170.067 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.32 117.31 39.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.01 1.324 . . . . 0.0 111.353 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.53 85.62 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.658 2.905 . . . . 0.0 111.565 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.89 146.79 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.937 0.895 . . . . 0.0 109.966 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 t -149.65 167.35 26.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.01 1.324 . . . . 0.0 113.524 -167.056 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 t -142.66 107.55 4.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.284 2.233 . . . . 0.0 110.974 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 57' ' ' ASP . 20.9 m -136.15 163.72 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.04 -7.46 16.92 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -166.631 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -154.04 34.75 0.43 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.385 -1.447 . . . . 0.0 111.368 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt 57.71 12.77 1.73 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.7 2.0 . . . . 0.0 114.546 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.9 p-10 -67.01 45.83 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 130.141 3.376 . . . . 0.0 114.345 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.1 t70 -63.68 -9.2 12.77 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -165.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.44 -10.36 2.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.399 1.48 . . . . 0.0 114.218 162.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.4 m -155.49 118.86 2.41 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 110.541 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.3 141.32 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.214 2.609 . . . . 0.0 111.116 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.5 t -116.58 -34.27 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.945 0.898 . . . . 0.0 110.967 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.45 -167.43 39.56 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.846 1.212 . . . . 0.0 110.753 156.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.9 ptp85 -135.33 172.04 13.58 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.916 1.286 . . . . 0.0 111.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.51 139.72 31.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 161.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.38 -49.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.194 0.597 . . . . 0.0 110.754 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.4 m -57.87 -43.58 86.1 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.97 161.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.996 0.816 . . . . 0.0 111.061 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.64 117.45 18.95 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 156.739 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.92 93.81 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.387 2.058 . . . . 0.0 111.783 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -144.82 135.07 24.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.114 1.365 . . . . 0.0 111.276 168.162 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.11 89.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 127.609 2.364 . . . . 0.0 107.151 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -63.38 -32.02 73.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.92 156.85 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.983 2.113 . . . . 0.0 110.914 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.04 -25.46 67.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.794 0.838 . . . . 0.0 112.436 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 4.66 5.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.057 2.143 . . . . 0.0 114.599 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 13.46 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 130.924 3.69 . . . . 0.0 115.219 -169.318 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.91 173.89 10.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.593 1.957 . . . . 0.0 113.667 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -117.0 108.84 16.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.615 3.166 . . . . 0.0 105.77 169.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.06 127.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.632 0.773 . . . . 0.0 112.967 -154.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mt -79.52 135.52 36.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.777 2.031 . . . . 0.0 110.911 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.96 129.35 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.089 2.155 . . . . 0.0 108.395 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -81.1 134.26 35.62 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.782 0.801 . . . . 0.0 111.667 170.193 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.06 161.59 18.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.973 2.109 . . . . 0.0 109.38 162.551 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 22.7 tt0 -94.41 125.06 53.49 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 167.407 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.25 128.22 7.99 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 124.294 3.329 . . . . 0.0 111.036 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.7 168.68 20.79 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.299 1.333 . . . . 0.0 110.599 160.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.34 162.71 15.67 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.247 -0.908 . . . . 0.0 112.287 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.08 -83.97 1.6 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -117.97 170.01 9.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.313 1.054 . . . . 0.0 110.8 169.242 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.9 m -145.73 84.75 1.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.319 1.447 . . . . 0.0 108.881 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.36 128.83 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.412 1.085 . . . . 0.0 109.048 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.92 94.59 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.978 1.711 . . . . 0.0 107.749 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.46 145.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.689 0.795 . . . . 0.0 109.915 -166.116 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.3 94.39 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 108.132 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.73 167.67 28.74 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 119.262 2.465 . . . . 0.0 119.262 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.39 109.66 6.51 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.064 2.546 . . . . 0.0 109.274 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.43 -102.03 0.04 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.792 1.663 . . . . 0.0 114.215 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.79 -18.97 62.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 115.151 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.73 94.64 4.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.001 0.92 . . . . 0.0 108.913 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.63 43.69 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.82 167.88 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 128.754 2.822 . . . . 0.0 108.569 170.156 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.02 149.16 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.872 0.869 . . . . 0.0 110.805 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.27 163.39 19.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.994 2.117 . . . . 0.0 109.232 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -138.37 130.73 28.89 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.757 -0.59 . . . . 0.0 110.059 -161.349 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.19 165.7 28.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.352 1.061 . . . . 0.0 111.62 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -144.06 116.45 8.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.956 1.303 . . . . 0.0 109.423 -160.758 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -144.68 87.63 1.87 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -164.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 76.6 p 59.39 84.6 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.364 1.865 . . . . 0.0 113.81 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.36 23.84 6.46 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.759 1.647 . . . . 0.0 112.751 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.4 t -58.42 162.86 3.42 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.021 1.728 . . . . 0.0 114.013 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -56.37 -15.12 3.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.28 1.032 . . . . 0.0 113.612 163.895 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.45 3.38 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 126.181 1.792 . . . . 0.0 111.551 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.97 -11.5 71.93 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 119.95 -1.719 . . . . 0.0 116.124 169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--O 1.249 1.04 0 CA-C-N 118.904 1.352 . . . . 0.0 113.094 171.174 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -69.05 -178.96 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.056 2.142 . . . . 0.0 113.197 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.38 155.76 45.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.506 2.722 . . . . 0.0 110.827 -163.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -88.66 -61.73 1.64 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.454 -0.779 . . . . 0.0 111.757 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -60.04 -31.91 70.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.178 1.391 . . . . 0.0 113.938 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -4.97 46.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.121 0.968 . . . . 0.0 112.997 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -57.72 -31.44 66.44 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 81.15 0.57 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -68.4 -6.64 25.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.453 1.901 . . . . 0.0 114.81 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -75.12 0.97 14.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -170.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -141.76 154.08 45.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.877 1.217 . . . . 0.0 112.039 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 160.22 45.29 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.648 1.118 . . . . 0.0 112.708 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.38 95.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 122.641 1.21 . . . . 0.0 114.076 -167.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 171.28 19.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.95 1.7 . . . . 0.0 111.247 167.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -150.42 -3.22 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.097 152.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 53.98 -75.95 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.191 2.597 . . . . 0.0 113.586 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.33 74.34 5.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.18 1.792 . . . . 0.0 112.837 -163.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.67 149.2 52.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.635 0.774 . . . . 0.0 111.124 166.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -138.31 141.25 39.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.775 1.63 . . . . 0.0 109.827 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -61.7 128.69 37.46 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.057 0.943 . . . . 0.0 110.603 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.34 -26.23 6.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.063 0.945 . . . . 0.0 112.854 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.04 123.93 2.82 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.367 0.984 . . . . 0.0 111.037 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.0 p -62.54 144.2 95.86 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 125.162 1.385 . . . . 0.0 111.427 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.96 148.33 47.88 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.818 2.345 . . . . 0.0 115.142 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.38 128.15 20.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.723 1.609 . . . . 0.0 110.854 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.71 132.29 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.552 0.741 . . . . 0.0 111.048 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -78.77 -9.55 59.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.586 1.554 . . . . 0.0 113.944 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.36 -2.84 9.08 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.21 0.913 . . . . 0.0 113.891 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -103.39 5.9 37.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.94 1.696 . . . . 0.0 111.704 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.41 13.76 50.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.961 1.267 . . . . 0.0 114.083 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.9 p -129.67 168.33 16.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.272 1.429 . . . . 0.0 111.565 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.78 130.73 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.915 1.686 . . . . 0.0 108.37 164.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 m -83.28 124.77 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 160.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 154.2 49.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.645 1.178 . . . . 0.0 110.553 170.489 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -119.61 134.4 55.24 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.202 -0.936 . . . . 0.0 111.675 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.77 163.13 22.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.159 0.984 . . . . 0.0 111.02 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -126.55 137.11 53.31 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.796 1.239 . . . . 0.0 110.011 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.13 97.34 11.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.038 0.935 . . . . 0.0 110.373 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.9 p -77.43 43.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.519 1.928 . . . . 0.0 113.688 -166.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.56 -177.77 48.51 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.071 -1.018 . . . . 0.0 114.869 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -116.41 0.76 12.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.485 1.514 . . . . 0.0 114.295 -167.691 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -145.96 173.8 11.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.421 1.489 . . . . 0.0 112.546 -169.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.53 48.24 0.87 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 166.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.04 107.0 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.574 2.849 . . . . 0.0 113.03 164.18 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.86 165.17 18.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.348 0.659 . . . . 0.0 112.523 -164.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.35 6.57 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.365 -1.459 . . . . 0.0 111.49 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.75 114.34 5.64 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.908 1.683 . . . . 0.0 113.562 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.82 84.58 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.114 2.543 . . . . 0.0 111.213 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -125.04 144.91 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.962 1.305 . . . . 0.0 109.531 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -146.74 162.11 39.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.811 1.245 . . . . 0.0 112.883 -172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -142.0 110.88 6.23 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.749 2.02 . . . . 0.0 110.164 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 57' ' ' ASP . 18.4 m -140.01 170.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.315 1.046 . . . . 0.0 111.95 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.17 -4.63 21.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -152.17 30.84 0.55 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.906 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.84 25.4 8.46 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.41 1.484 . . . . 0.0 112.394 -173.133 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.437 HD21 ' CG2' ' A' ' 61' ' ' VAL . 12.5 p-10 -91.61 50.99 1.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.122 2.569 . . . . 0.0 112.201 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.5 m-20 -56.29 -11.11 1.06 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.483 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -9.92 11.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.909 1.283 . . . . 0.0 114.359 164.428 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.4 m -149.06 95.62 3.84 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.159 -1.588 . . . . 0.0 110.17 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.53 86.98 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 1 C-N-CA 125.639 4.226 . . . . 0.0 115.883 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.1 t -67.66 -33.96 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.893 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 -161.56 27.52 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.427 1.965 . . . . 0.0 112.045 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -146.96 177.69 8.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.09 1.756 . . . . 0.0 112.509 169.849 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.37 117.98 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.613 2.365 . . . . 0.0 107.604 171.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.7 t -90.51 -58.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 111.109 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -59.01 -44.33 91.67 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.593 0.633 . . . . 0.0 112.525 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.44 139.3 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 160.36 77.57 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 159.302 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.6 77.41 3.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 115.303 -156.384 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -145.71 127.34 15.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.495 -1.378 . . . . 0.0 114.592 154.763 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.31 100.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.764 1.626 . . . . 0.0 106.889 166.511 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 t -77.86 -6.86 55.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.74 149.52 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.504 1.047 . . . . 0.0 111.956 -170.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.95 -21.9 66.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.719 1.208 . . . . 0.0 113.061 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.12 0.32 6.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.183 2.593 . . . . 0.0 114.47 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 10.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.09 13.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 131.475 3.91 . . . . 0.0 116.06 -166.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.18 168.53 19.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.375 1.87 . . . . 0.0 114.184 -169.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.52 109.09 20.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.304 2.642 . . . . 0.0 105.946 158.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.05 125.3 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.017 0.927 . . . . 0.0 112.412 -159.39 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.31 133.01 43.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.189 0.996 . . . . 0.0 109.447 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.5 mt -128.58 143.33 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.131 1.772 . . . . 0.0 107.976 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -98.4 137.21 37.44 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.76 0.791 . . . . 0.0 111.571 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.83 164.31 17.7 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.01 2.124 . . . . 0.0 108.899 166.92 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.53 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 26.0 tt0 -100.39 107.18 46.79 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.922 1.289 . . . . 0.0 108.392 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.8 108.31 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.894 1 C-N-CA 126.581 4.854 . . . . 0.0 111.236 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -64.15 161.0 35.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.988 1.792 . . . . 0.0 110.77 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -94.56 166.69 11.91 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.8 -78.97 1.0 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.86 150.7 42.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 110.184 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -136.86 97.9 3.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.693 1.197 . . . . 0.0 109.157 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -95.43 123.53 39.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.608 1.163 . . . . 0.0 109.933 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.98 98.43 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.982 2.113 . . . . 0.0 107.153 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.22 139.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.91 -165.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.89 103.33 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.766 1.626 . . . . 0.0 108.698 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 145.68 172.36 15.99 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 172.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -132.75 143.63 49.73 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.166 1.787 . . . . 0.0 109.875 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 17.06 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 127.741 2.591 . . . . 0.0 116.354 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -74.72 -15.3 60.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.203 2.201 . . . . 0.0 116.72 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -137.88 100.38 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.134 1.374 . . . . 0.0 110.747 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -142.65 160.73 39.73 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.97 165.96 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 128.814 2.846 . . . . 0.0 108.3 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.64 167.6 25.93 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.973 -1.079 . . . . 0.0 110.613 166.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -131.73 158.97 39.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.041 1.337 . . . . 0.0 109.052 163.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -112.59 160.17 18.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.239 1.416 . . . . 0.0 110.867 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.11 155.83 36.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.131 1.773 . . . . 0.0 109.212 168.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.66 143.41 30.73 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.097 0.959 . . . . 0.0 108.753 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -134.96 158.49 44.18 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.247 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.9 p 67.96 -1.65 1.67 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.3 42.07 3.08 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.395 0.998 . . . . 0.0 112.35 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -84.83 -144.59 0.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.973 1.709 . . . . 0.0 111.934 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.3 p -46.7 -46.36 20.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.59 1.956 . . . . 0.0 115.549 -166.601 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.02 8.26 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 125.539 1.536 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.75 25.52 60.3 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.248 -1.533 . . . . 0.0 112.848 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 tptp . . . . . 0 C--O 1.247 0.944 0 C-N-CA 126.941 2.096 . . . . 0.0 111.881 -166.771 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -147.07 150.31 34.79 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.093 0.957 . . . . 0.0 110.766 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.39 173.88 11.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.859 2.464 . . . . 0.0 110.858 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -91.93 -59.61 2.07 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.408 -0.807 . . . . 0.0 112.664 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -58.17 -36.78 73.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.787 1.235 . . . . 0.0 113.632 -168.197 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.05 -15.56 59.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.538 1.135 . . . . 0.0 113.318 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -85.54 -11.11 54.91 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.293 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 18.37 84.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 130.139 3.733 . . . . 0.0 118.453 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -72.5 71.74 0.96 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.102 -1.234 . . . . 0.0 111.839 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p -78.36 -20.07 52.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.118 1.367 . . . . 0.0 114.551 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.25 -178.82 7.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.33 130.96 51.77 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.484 1.04 . . . . 0.0 112.663 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.82 102.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.662 1.185 . . . . 0.0 111.93 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 155.9 22.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.418 1.887 . . . . 0.0 110.008 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -160.38 -41.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.543 1.137 . . . . 0.0 111.223 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt 65.65 -65.46 0.17 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.385 2.674 . . . . 0.0 113.333 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.74 79.0 1.21 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.445 1.098 . . . . 0.0 111.434 -161.086 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -126.5 160.09 31.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.449 1.5 . . . . 0.0 110.09 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -142.23 147.68 36.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 108.997 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -61.82 127.89 33.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.126 0.57 . . . . 0.0 110.99 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.55 -48.4 4.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.189 0.996 . . . . 0.0 108.988 168.524 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.97 105.69 0.68 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.491 1.996 . . . . 0.0 109.748 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 p -57.96 156.31 20.01 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.627 0.771 . . . . 0.0 111.478 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.76 141.87 80.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.951 1.767 . . . . 0.0 113.166 -165.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 119.8 14.78 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.449 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 32' ' ' VAL . 9.5 t0 -65.32 118.99 10.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.28 1.038 . . . . 0.0 110.56 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.9 p -68.9 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 114.309 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.99 56.0 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.301 -160.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -69.53 -12.42 61.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.013 1.906 . . . . 0.0 111.296 162.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.16 -3.69 40.87 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 126.667 2.08 . . . . 0.0 113.155 -167.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -129.73 152.86 48.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.795 2.038 . . . . 0.0 111.599 -166.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 86' ' ' PRO . 1.2 m -93.64 126.06 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 0.0 110.327 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 m -78.43 136.66 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 161.136 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -141.81 131.48 24.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.084 2.154 . . . . 0.0 108.138 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -118.94 131.9 56.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.825 0.739 . . . . 0.0 112.04 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.54 162.21 19.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.345 0.658 . . . . 0.0 110.703 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -115.51 129.55 56.58 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.849 1.259 . . . . 0.0 109.015 165.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.89 100.47 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.07 0.948 . . . . 0.0 109.392 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 p -78.39 -4.44 48.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.539 1.536 . . . . 0.0 114.624 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.92 169.24 12.88 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 119.311 0.96 . . . . 0.0 114.697 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -106.83 0.86 24.32 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.447 1.899 . . . . 0.0 113.244 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -138.49 -175.05 3.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.115 1.766 . . . . 0.0 111.316 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.51 45.61 1.95 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.892 -2.06 . . . . 0.0 117.523 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -54.73 102.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.984 0 CA-C-N 122.057 2.928 . . . . 0.0 111.042 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.5 m -156.92 171.17 20.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 112.624 -164.067 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -94.08 99.98 12.17 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.63 -1.294 . . . . 0.0 109.954 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.39 126.38 84.32 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.459 0.704 . . . . 0.0 112.603 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.37 101.63 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.711 2.941 . . . . 0.0 111.884 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.0 tt -133.47 146.55 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.144 0.978 . . . . 0.0 109.855 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -148.76 160.67 42.97 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 t -138.19 116.7 12.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.073 2.149 . . . . 0.0 110.218 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 57' ' ' ASP . 15.6 m -134.62 164.57 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.556 1.142 . . . . 0.0 112.24 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.16 -10.18 28.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -154.79 34.34 0.4 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.085 -1.634 . . . . 0.0 112.625 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.78 11.4 1.83 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.477 1.911 . . . . 0.0 113.958 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.469 HD21 ' CG2' ' A' ' 61' ' ' VAL . 9.2 p-10 -69.83 51.32 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.032 2.933 . . . . 0.0 113.026 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.9 t0 -59.14 -16.38 19.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.839 1.655 . . . . 0.0 115.349 -165.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.24 -8.86 1.23 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.487 1.515 . . . . 0.0 114.876 169.202 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 m -155.13 104.57 2.25 Favored Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 120.203 -1.561 . . . . 0.0 111.063 166.555 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.42 115.69 1.06 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.164 3.909 . . . . 0.0 113.882 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.2 t -97.58 -22.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.931 1.692 . . . . 0.0 111.501 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.11 26.3 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.868 1.699 . . . . 0.0 111.041 163.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 176.78 7.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.11 106.82 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.726 2.411 . . . . 0.0 106.374 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -78.41 -45.58 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.734 0.813 . . . . 0.0 110.69 -166.529 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -69.78 -41.4 75.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.11 149.96 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.833 1.197 . . . . 0.0 113.54 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -61.74 119.73 50.34 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.361 1.464 . . . . 0.0 109.762 162.569 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.34 90.22 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.109 2.539 . . . . 0.0 113.69 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.56 126.27 12.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.501 1.921 . . . . 0.0 111.515 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.3 88.84 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.729 2.012 . . . . 0.0 108.263 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.4 t -70.6 -8.94 55.4 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.69 155.35 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.906 1.23 . . . . 0.0 112.287 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.66 -19.71 62.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.125 0.97 . . . . 0.0 112.698 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.0 p -77.54 9.79 3.08 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.086 1.754 . . . . 0.0 113.133 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.63 10.23 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.302 1.841 . . . . 0.0 115.235 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.03 22.85 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 130.27 3.428 . . . . 0.0 115.139 -165.087 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.2 165.73 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.797 2.039 . . . . 0.0 114.183 -170.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 109.06 21.16 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.315 2.646 . . . . 0.0 106.269 160.993 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.33 121.85 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 111.964 -156.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.57 128.05 40.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.056 2.542 . . . . 0.0 109.942 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.69 129.53 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.228 2.211 . . . . 0.0 108.34 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.04 138.53 33.03 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.468 -0.77 . . . . 0.0 111.022 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.94 157.59 29.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.285 2.234 . . . . 0.0 109.039 166.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -97.73 109.68 51.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.193 0.997 . . . . 0.0 109.24 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.634 ' HG3' HG13 ' A' ' 32' ' ' VAL . 54.9 Cg_endo -93.03 116.64 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 125.263 3.975 . . . . 0.0 110.287 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.6 158.16 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.163 3.242 . . . . 0.0 115.552 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -75.52 161.15 29.42 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.16 -0.963 . . . . 0.0 112.502 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.65 -79.04 1.8 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.52 158.44 44.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.492 1.117 . . . . 0.0 110.446 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.5 m -158.87 156.84 30.33 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.929 -1.107 . . . . 0.0 112.264 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -145.71 136.74 24.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.484 1.113 . . . . 0.0 109.089 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 mm -120.52 114.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.301 1.841 . . . . 0.0 107.158 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.72 141.31 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.418 0.687 . . . . 0.0 109.849 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.82 101.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.171 2.188 . . . . 0.0 108.341 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.43 177.49 15.15 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.5 122.2 24.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.697 1.999 . . . . 0.0 110.632 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.26 -99.84 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.48 1.99 . . . . 0.0 114.807 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -68.46 -14.28 62.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.365 1.866 . . . . 0.0 115.758 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -136.14 98.67 3.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.44 1.096 . . . . 0.0 111.197 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.57 167.25 23.5 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.09 164.69 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.648 2.779 . . . . 0.0 108.639 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -150.99 164.57 36.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.464 0.706 . . . . 0.0 111.33 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -143.57 136.57 27.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.296 1.438 . . . . 0.0 110.439 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 162.57 23.36 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 113.071 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.74 150.63 35.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.684 1.993 . . . . 0.0 111.007 161.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -139.9 113.99 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.524 1.13 . . . . 0.0 108.156 -170.1 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -149.95 81.68 1.38 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.5 t 69.16 70.8 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.756 2.023 . . . . 0.0 113.876 165.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.61 21.1 2.03 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.739 2.114 . . . . 0.0 113.17 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.9 t -65.03 151.94 44.7 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.501 1.92 . . . . 0.0 113.591 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -61.59 -8.48 4.47 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 164.148 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.22 -4.38 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 127.019 2.128 . . . . 0.0 111.308 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.02 4.67 58.63 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.628 -1.295 . . . . 0.0 116.207 171.73 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 116.987 -1.482 . . . . 0.0 112.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.21 160.47 39.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.159 0.89 . . . . 0.0 112.432 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 145.32 50.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.131 2.173 . . . . 0.0 109.664 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.28 -54.43 8.4 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.17 -1.581 . . . . 0.0 112.426 -172.148 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -58.55 -29.8 66.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.902 1.681 . . . . 0.0 113.791 -170.872 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.91 -28.73 69.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.176 0.898 . . . . 0.0 112.841 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -19.42 62.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.388 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 9.46 105.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 130.584 3.945 . . . . 0.0 117.559 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -68.82 73.53 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.801 2.04 . . . . 0.0 113.602 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 p -71.93 -18.64 62.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.717 2.007 . . . . 0.0 114.676 168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -156.16 176.31 12.84 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.382 1.473 . . . . 0.0 110.511 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.48 148.54 50.5 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.443 0.544 . . . . 0.0 112.496 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.08 97.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.66 1.184 . . . . 0.0 112.544 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.76 168.81 25.62 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.876 1.671 . . . . 0.0 111.193 166.365 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 47' ' ' VAL . 94.1 p -144.02 -30.43 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt 59.2 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.311 2.244 . . . . 0.0 112.536 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.36 83.19 3.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.128 0.971 . . . . 0.0 112.069 -167.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.29 165.25 23.82 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.486 1.514 . . . . 0.0 111.587 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -151.05 155.11 38.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.993 2.117 . . . . 0.0 109.627 166.512 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.95 140.26 57.74 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.275 -0.89 . . . . 0.0 111.742 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -38.57 3.11 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.23 103.97 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.211 1.386 . . . . 0.0 110.279 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -47.74 138.09 9.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.125 2.17 . . . . 0.0 112.221 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 130.83 42.67 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.015 2.477 . . . . 0.0 112.768 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.05 119.95 28.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.167 1.387 . . . . 0.0 110.158 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.25 129.72 40.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.84 0.829 . . . . 0.0 111.032 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.3 p -78.18 -8.69 58.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 127.077 2.151 . . . . 0.0 113.586 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.63 -5.35 23.35 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.336 0.971 . . . . 0.0 113.945 -168.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -96.12 3.17 53.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.812 1.306 . . . . 0.0 112.062 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.33 4.33 56.31 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.829 1.204 . . . . 0.0 113.941 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -123.72 165.12 17.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.255 1.422 . . . . 0.0 111.941 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -110.15 140.66 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.025 1.33 . . . . 0.0 109.543 162.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.06 125.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.8 0.84 . . . . 0.0 109.014 161.11 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 120.99 18.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.531 1.932 . . . . 0.0 109.208 -167.698 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.73 132.6 52.52 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.189 -0.944 . . . . 0.0 112.631 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.07 162.71 20.72 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.433 1.093 . . . . 0.0 110.462 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -117.66 134.27 55.07 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.157 0.983 . . . . 0.0 109.98 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -84.8 108.03 17.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.873 0.869 . . . . 0.0 109.668 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -82.92 -4.03 57.7 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.82 172.5 14.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.504 1.047 . . . . 0.0 114.718 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -109.18 6.08 24.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.209 1.804 . . . . 0.0 113.75 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -138.71 176.14 8.95 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.0 111.143 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.75 51.43 0.75 Allowed Glycine 0 CA--C 1.538 1.526 0 CA-C-O 117.288 -1.84 . . . . 0.0 117.168 167.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -54.21 111.12 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 121.399 2.599 . . . . 0.0 110.646 162.845 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.83 165.95 13.77 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.175 0.99 . . . . 0.0 111.76 -168.071 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -89.43 104.34 16.9 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 119.839 -1.788 . . . . 0.0 113.206 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 1.2 p -58.03 117.78 22.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.577 1.151 . . . . 0.0 112.352 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.35 82.61 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.411 2.741 . . . . 0.0 109.827 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.08 142.46 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.833 0.853 . . . . 0.0 109.457 169.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.9 t -151.38 159.73 44.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.632 0.773 . . . . 0.0 113.046 -167.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -132.54 113.55 13.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.003 2.521 . . . . 0.0 108.955 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 57' ' ' ASP . 35.5 m -133.75 170.24 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.464 1.106 . . . . 0.0 111.688 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.08 -11.44 20.52 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 m -152.03 33.2 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.106 -1.621 . . . . 0.0 112.311 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.93 10.15 2.04 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.455 1.902 . . . . 0.0 113.45 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -72.06 55.6 0.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.303 3.041 . . . . 0.0 112.589 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HA ' HG11 ' A' ' 52' ' ' VAL . 4.8 t0 -63.07 -11.91 22.97 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -165.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.55 -1.28 0.77 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 114.919 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 m -153.85 119.33 2.78 Favored Pre-proline 0 N--CA 1.473 0.692 0 O-C-N 119.916 -1.74 . . . . 0.0 110.651 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.4 112.12 2.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.899 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.38 -27.15 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 0.0 110.825 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.89 -161.98 18.98 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.383 2.421 . . . . 0.0 111.853 169.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 169.58 17.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 96.58 8.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.502 1.921 . . . . 0.0 106.132 170.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.55 -49.95 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.636 1.175 . . . . 0.0 111.678 -161.665 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 t -88.41 -17.37 30.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -165.52 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -159.99 150.14 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 120.253 1.388 . . . . 0.0 111.631 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -57.48 134.49 81.95 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.673 0.789 . . . . 0.0 109.377 166.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.98 86.47 0.61 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.137 2.558 . . . . 0.0 111.658 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -152.91 112.96 3.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 112.035 -167.837 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -72.85 92.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.253 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 p -73.41 -14.04 61.19 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.75 158.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.13 0.972 . . . . 0.0 112.064 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.66 -23.62 65.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.18 0.992 . . . . 0.0 113.153 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 p -81.26 5.17 17.94 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.772 1.629 . . . . 0.0 113.812 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.31 22.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.648 1.579 . . . . 0.0 114.882 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.09 21.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 130.875 3.67 . . . . 0.0 114.443 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.64 157.15 20.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.983 1.713 . . . . 0.0 113.275 -164.577 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 105.94 17.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.429 2.291 . . . . 0.0 106.677 153.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.41 135.64 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.503 1.121 . . . . 0.0 111.985 -165.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.81 118.56 37.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.209 2.603 . . . . 0.0 108.921 -172.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.36 136.72 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.452 1.901 . . . . 0.0 108.418 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.68 137.95 31.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.017 -0.427 . . . . 0.0 111.821 163.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.48 160.36 25.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.351 1.86 . . . . 0.0 109.656 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.59 105.78 51.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.822 1.249 . . . . 0.0 108.857 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HG3' HG13 ' A' ' 32' ' ' VAL . 55.6 Cg_endo -84.82 121.03 2.41 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.276 2.65 . . . . 0.0 109.437 160.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.31 166.5 12.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.88 1.72 . . . . 0.0 111.993 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.88 164.3 25.94 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 -91.92 1.77 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -131.08 165.11 23.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.457 1.103 . . . . 0.0 110.764 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.0 m -156.92 163.27 39.34 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.069 -1.019 . . . . 0.0 111.784 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -133.43 129.1 36.83 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.9 2.08 . . . . 0.0 108.214 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.5 mm -110.21 109.3 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.17 1.788 . . . . 0.0 106.768 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.96 138.53 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.667 0.787 . . . . 0.0 109.167 -167.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.14 89.38 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.85 2.06 . . . . 0.0 106.725 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 161.02 157.44 8.75 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.314 1.686 . . . . 0.0 117.314 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -123.23 122.77 39.21 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.913 1.685 . . . . 0.0 109.395 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 32.42 -94.83 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.304 2.383 . . . . 0.0 115.385 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.53 -18.73 63.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.699 2.0 . . . . 0.0 116.161 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -130.11 101.07 5.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.74 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -141.12 155.92 46.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.26 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.98 2.512 . . . . 0.0 107.758 169.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.95 156.42 38.86 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.139 -0.976 . . . . 0.0 111.719 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 165.5 26.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.682 2.393 . . . . 0.0 109.019 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -133.27 155.97 48.41 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.327 -0.858 . . . . 0.0 113.101 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -141.75 151.93 43.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.494 1.518 . . . . 0.0 112.788 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -146.58 108.4 4.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.565 1.546 . . . . 0.0 108.567 -163.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -149.51 102.42 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -162.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 t 61.9 62.17 1.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.417 1.887 . . . . 0.0 113.832 163.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.32 18.01 3.49 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.515 2.007 . . . . 0.0 112.835 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.5 t -62.1 152.04 33.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.8 1.64 . . . . 0.0 112.293 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -50.59 -24.79 3.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.845 2.058 . . . . 0.0 113.291 165.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.12 -10.62 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.956 1.303 . . . . 0.0 112.138 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.76 22.7 30.2 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 121.003 -1.061 . . . . 0.0 114.396 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 125.025 1.33 . . . . 0.0 113.435 178.709 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -146.97 171.86 14.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 111.625 -165.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 20.9 mp0 -65.1 104.69 0.93 Allowed 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.836 4.454 . . . . 0.0 111.179 -165.577 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -55.65 -57.35 12.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -168.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -72.22 -20.87 61.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.295 1.038 . . . . 0.0 113.727 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.65 -3.5 50.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 113.101 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -67.0 22.27 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 129.016 2.926 . . . . 0.0 115.267 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.75 69.0 0.67 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.932 2.206 . . . . 0.0 114.293 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -41.19 -59.62 1.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.654 1.982 . . . . 0.0 113.91 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -59.15 -3.93 0.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.82 141.82 49.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.934 1.243 . . . . 0.0 111.358 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.02 171.86 55.16 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.095 0.855 . . . . 0.0 113.386 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.7 96.76 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 113.094 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 p -161.78 -177.17 5.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.606 1.562 . . . . 0.0 112.402 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 m -170.85 -29.35 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.324 1.85 . . . . 0.0 111.796 162.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt 64.67 -69.71 0.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.374 2.27 . . . . 0.0 113.349 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.16 73.36 8.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.074 0.95 . . . . 0.0 112.857 -166.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -129.69 158.5 39.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 170.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -143.52 140.94 30.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 108.906 166.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.39 147.69 49.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.382 0.673 . . . . 0.0 111.521 171.337 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.76 -52.82 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.397 0.679 . . . . 0.0 112.24 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.24 109.45 2.66 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.478 1.037 . . . . 0.0 111.279 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 p -52.8 142.29 34.21 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.222 1.409 . . . . 0.0 111.469 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.48 146.07 85.45 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.916 2.411 . . . . 0.0 114.049 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.52 130.03 25.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.764 1.626 . . . . 0.0 109.55 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.01 135.61 51.15 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.543 0.61 . . . . 0.0 110.57 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.6 p -68.19 -5.75 19.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.81 2.044 . . . . 0.0 113.998 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -10.66 7.28 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.62 1.105 . . . . 0.0 112.699 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -95.01 -3.63 48.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.512 1.925 . . . . 0.0 110.875 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.01 -4.14 45.21 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.57 1.557 . . . . 0.0 114.83 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -96.31 156.71 16.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.337 1.455 . . . . 0.0 110.409 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.73 122.26 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.105 0.962 . . . . 0.0 110.377 170.138 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.2 126.36 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.642 0.777 . . . . 0.0 109.338 162.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.59 155.73 45.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.294 1.438 . . . . 0.0 111.055 173.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -125.91 134.78 51.46 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.255 -0.903 . . . . 0.0 112.688 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.13 168.2 11.82 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.851 1.261 . . . . 0.0 109.89 165.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -126.55 143.38 51.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.557 1.143 . . . . 0.0 110.014 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -96.42 98.23 10.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.732 1.213 . . . . 0.0 109.777 -172.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -78.31 9.34 3.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.97 2.108 . . . . 0.0 115.788 -162.43 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.91 173.41 27.97 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.424 1.011 . . . . 0.0 113.821 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -95.64 -1.37 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.305 1.842 . . . . 0.0 114.019 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.41 173.29 11.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.715 1.606 . . . . 0.0 112.69 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.78 43.55 0.87 Allowed Glycine 0 CA--C 1.543 1.802 0 CA-C-O 116.574 -2.237 . . . . 0.0 118.688 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.84 105.54 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.939 0 CA-C-N 122.308 3.054 . . . . 0.0 112.314 161.905 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -163.13 162.82 25.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -166.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -82.05 94.47 7.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.942 1.297 . . . . 0.0 110.172 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.25 115.05 10.75 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.829 1.652 . . . . 0.0 113.741 -169.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.79 83.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.047 2.498 . . . . 0.0 112.147 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.31 140.27 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.112 0.965 . . . . 0.0 109.903 165.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -140.8 166.86 23.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.097 0.959 . . . . 0.0 113.408 -167.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -138.71 104.86 5.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.666 2.386 . . . . 0.0 110.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 57' ' ' ASP . 16.3 m -132.09 169.1 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.03 0.932 . . . . 0.0 112.478 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.28 0.52 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.566 1.146 . . . . 0.0 113.742 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -151.93 27.88 0.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.245 -1.535 . . . . 0.0 112.846 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.62 10.4 1.41 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.445 1.898 . . . . 0.0 113.732 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.14 52.61 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.094 2.958 . . . . 0.0 112.487 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HA ' HG11 ' A' ' 52' ' ' VAL . 10.3 t0 -64.41 -7.35 9.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -165.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.51 -5.83 1.36 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.56 1.544 . . . . 0.0 114.591 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.0 m -154.58 114.78 2.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.108 -1.62 . . . . 0.0 110.556 168.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 111.16 2.35 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.683 2.922 . . . . 0.0 111.751 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -75.77 -39.58 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.443 1.097 . . . . 0.0 110.517 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.75 -161.94 25.89 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.982 1.754 . . . . 0.0 113.589 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -130.96 176.74 7.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.178 0.991 . . . . 0.0 113.27 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.41 139.59 34.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.786 2.034 . . . . 0.0 108.36 166.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.09 -55.16 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.104 0.562 . . . . 0.0 111.239 -171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -55.67 -54.21 47.01 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.06 148.81 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.75 159.26 79.81 Favored Pre-proline 0 CA--C 1.556 1.195 0 O-C-N 121.899 -0.501 . . . . 0.0 110.525 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.1 69.81 6.92 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.713 2.276 . . . . 0.0 115.391 -157.331 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -143.62 120.24 11.11 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.392 -1.442 . . . . 0.0 113.282 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.1 t -81.45 95.8 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 t -76.2 -3.88 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.05 143.89 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.932 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.39 -20.93 65.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.343 1.057 . . . . 0.0 112.73 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 4.68 1.72 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.545 2.738 . . . . 0.0 114.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 8.15 0.4 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.224 1.81 . . . . 0.0 115.605 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.43 19.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 130.853 3.661 . . . . 0.0 116.131 -161.882 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.31 173.79 8.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.375 1.87 . . . . 0.0 114.434 -169.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -105.39 101.77 11.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.092 2.957 . . . . 0.0 107.079 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.46 114.33 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -156.877 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.45 129.24 39.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.191 2.596 . . . . 0.0 110.562 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mt -128.0 148.52 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 129.025 2.93 . . . . 0.0 108.825 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -104.34 136.72 43.4 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 112.323 165.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -121.31 162.84 19.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.643 1.977 . . . . 0.0 110.098 163.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.93 107.33 38.03 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.078 1.351 . . . . 0.0 109.202 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -107.02 140.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.197 3.264 . . . . 0.0 110.823 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.53 162.11 1.66 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.851 3.034 . . . . 0.0 114.651 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -68.09 166.03 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.025 0.93 . . . . 0.0 113.41 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.94 -91.35 1.68 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.58 159.78 23.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.263 1.025 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -157.6 129.73 7.15 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 120.807 -1.183 . . . . 0.0 110.174 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -135.62 122.59 21.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 109.263 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.1 mm -109.86 113.68 44.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 126.251 1.82 . . . . 0.0 107.732 -173.018 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -109.02 140.62 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.897 0.879 . . . . 0.0 109.245 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.95 101.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.393 2.277 . . . . 0.0 107.999 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 149.3 171.53 18.03 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 117.946 1.939 . . . . 0.0 117.946 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.12 128.84 30.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.505 1.922 . . . . 0.0 110.362 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 35.55 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.89 2.186 . . . . 0.0 115.268 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -66.79 -16.39 64.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.097 2.159 . . . . 0.0 115.993 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.33 105.76 6.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.281 1.032 . . . . 0.0 111.088 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.41 162.98 34.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.03 163.94 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 130.136 3.374 . . . . 0.0 107.308 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -156.62 163.35 39.43 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.983 -1.073 . . . . 0.0 110.994 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -142.33 149.39 39.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.991 1.317 . . . . 0.0 110.044 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -102.75 160.97 14.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.864 1.266 . . . . 0.0 111.632 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.66 42.84 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.014 2.126 . . . . 0.0 110.237 166.014 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -145.0 142.32 29.69 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -150.0 105.08 3.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.407 1.083 . . . . 0.0 112.354 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p 128.01 -5.07 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 131.676 3.99 . . . . 0.0 114.619 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.15 33.82 0.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.643 1.116 . . . . 0.0 112.159 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -88.36 -141.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.338 1.455 . . . . 0.0 112.241 -166.548 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -52.59 -36.44 56.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.717 1.599 . . . . 0.0 115.136 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.13 -2.72 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 126.333 1.853 . . . . 0.0 112.515 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.68 28.8 54.24 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.518 -1.364 . . . . 0.0 112.521 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 tptp . . . . . 0 C--O 1.252 1.191 0 C-N-CA 127.174 2.19 . . . . 0.0 111.82 -169.399 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.64 152.26 45.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.61 0.641 . . . . 0.0 111.123 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.42 116.55 27.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.072 1.749 . . . . 0.0 109.498 172.906 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.99 -42.3 94.64 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.63 -0.669 . . . . 0.0 111.677 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -59.98 -29.47 68.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.875 1.67 . . . . 0.0 114.741 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.31 -5.11 58.53 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.111 0.868 . . . . 0.0 113.194 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -69.1 -6.31 27.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 116.808 -1.567 . . . . 0.0 114.073 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.08 73.52 0.33 Allowed Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.169 1.843 . . . . 0.0 115.477 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -77.18 64.19 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.236 1.015 . . . . 0.0 111.18 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.7 p -73.94 -27.42 61.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.614 1.966 . . . . 0.0 113.8 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -143.14 172.19 13.06 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.68 1.992 . . . . 0.0 110.462 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.43 148.8 51.03 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.109 0.385 . . . . 0.0 112.33 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 105.28 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.208 1.003 . . . . 0.0 112.041 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 162.46 39.89 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.314 2.246 . . . . 0.0 109.202 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.6 p -156.87 -43.24 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.309 1.043 . . . . 0.0 111.664 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 60.06 -69.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.366 2.666 . . . . 0.0 112.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.24 74.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.153 0.981 . . . . 0.0 112.742 -160.999 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -128.48 161.28 29.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.375 0.67 . . . . 0.0 111.142 161.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -145.77 149.88 35.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.442 1.897 . . . . 0.0 108.714 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.13 125.61 24.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.338 0.655 . . . . 0.0 111.042 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 -45.17 7.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.957 . . . . 0.0 109.043 167.116 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.65 119.34 1.74 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.126 1.822 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -57.93 155.43 23.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.424 1.49 . . . . 0.0 112.932 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.17 133.49 47.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.808 2.338 . . . . 0.0 112.026 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.59 127.59 22.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.823 1.649 . . . . 0.0 110.75 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.36 133.35 50.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.323 0.583 . . . . 0.0 112.378 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -79.12 -22.84 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.035 2.134 . . . . 0.0 114.563 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 -8.28 61.96 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 118.574 -1.126 . . . . 0.0 114.368 -160.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -72.09 -9.9 59.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.121 1.96 . . . . 0.0 111.596 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.25 62.3 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.334 1.445 . . . . 0.0 113.19 -163.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -112.33 164.0 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.96 2.104 . . . . 0.0 111.068 -170.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.77 125.62 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.209 1.004 . . . . 0.0 110.382 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 m -76.87 131.67 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 159.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.6 123.48 15.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.155 2.182 . . . . 0.0 107.378 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.83 131.35 52.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.999 0.818 . . . . 0.0 111.888 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.24 165.23 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.929 0.871 . . . . 0.0 110.134 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.109 0.963 . . . . 0.0 109.475 167.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -86.15 101.14 12.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 109.48 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -83.17 12.92 4.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -162.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.72 178.34 27.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.237 0.926 . . . . 0.0 114.623 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.3 p -109.21 2.91 21.26 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.541 1.937 . . . . 0.0 113.272 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -137.26 -176.63 4.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 0.0 110.76 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.93 29.08 2.94 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 115.745 -2.697 . . . . 0.0 118.975 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -48.69 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.124 0 CA-C-N 123.416 3.608 . . . . 0.0 112.981 162.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 m -160.43 169.69 22.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.014 1.326 . . . . 0.0 112.324 -165.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -96.78 92.76 6.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.54 1.136 . . . . 0.0 110.526 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.54 115.92 19.83 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.176 1.39 . . . . 0.0 114.627 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.84 93.25 0.87 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.526 2.15 . . . . 0.0 111.848 170.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 64' ' ' LEU . 19.7 tt -128.12 136.08 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.22 1.008 . . . . 0.0 108.608 161.393 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -148.81 165.33 31.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.826 0.85 . . . . 0.0 113.126 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.1 t -140.64 115.33 9.55 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.97 2.108 . . . . 0.0 110.633 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 31.3 m -137.65 175.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.787 1.235 . . . . 0.0 112.262 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.47 -18.17 16.81 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -149.9 32.34 0.69 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.114 -1.616 . . . . 0.0 111.636 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.94 11.72 4.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.391 1.876 . . . . 0.0 113.454 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -67.19 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.204 3.401 . . . . 0.0 113.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.0 t0 -58.78 -12.03 3.87 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -167.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.36 -12.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.248 2.219 . . . . 0.0 115.422 167.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -155.67 107.65 2.17 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 120.352 -1.467 . . . . 0.0 109.791 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.45 110.47 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.748 3.632 . . . . 0.0 113.01 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.77 -30.38 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.401 1.08 . . . . 0.0 109.959 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.29 -173.03 22.41 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.941 2.21 . . . . 0.0 111.305 165.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -131.68 170.54 14.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.438 1.095 . . . . 0.0 112.151 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 49' ' ' ILE . 4.4 mp -87.41 133.48 33.72 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 160.968 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.67 -54.43 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.27 0.628 . . . . 0.0 109.967 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -63.34 -48.33 78.45 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.61 150.26 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.385 1.074 . . . . 0.0 108.909 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -82.68 156.39 67.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 118.208 0.458 . . . . 0.0 110.709 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.13 86.67 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.486 2.124 . . . . 0.0 115.731 -155.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -148.57 118.87 7.3 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.363 -1.461 . . . . 0.0 114.202 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.61 87.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.717 1.207 . . . . 0.0 107.759 167.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.8 t -72.2 -11.05 60.56 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.54 156.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.014 1.279 . . . . 0.0 112.071 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.81 -15.6 63.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 0.0 114.202 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.8 p -76.56 1.72 15.95 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.129 1.772 . . . . 0.0 113.762 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.03 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.632 1.973 . . . . 0.0 115.606 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.3 20.65 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.949 3.3 . . . . 0.0 115.901 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.18 168.17 19.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.096 2.158 . . . . 0.0 114.518 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -106.3 107.03 17.83 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.266 3.026 . . . . 0.0 105.47 160.752 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.27 137.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.483 1.135 . . . . 0.0 113.634 -158.452 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.2 128.21 47.41 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.161 2.984 . . . . 0.0 109.779 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.76 138.73 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.868 2.067 . . . . 0.0 109.149 -172.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.53 136.67 32.9 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.556 0.616 . . . . 0.0 111.803 163.521 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.9 159.17 26.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.104 2.162 . . . . 0.0 109.775 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -103.32 105.25 45.61 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.229 1.411 . . . . 0.0 109.565 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.01 129.87 8.14 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.604 2.869 . . . . 0.0 110.288 164.804 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.44 171.95 9.8 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.304 2.003 . . . . 0.0 112.165 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -82.41 166.01 19.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -173.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.23 -82.45 1.14 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.669 1.128 . . . . 0.0 111.072 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -140.6 145.69 37.01 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.582 1.153 . . . . 0.0 110.12 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.7 p -150.57 151.13 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.48 0.657 . . . . 0.0 112.525 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -137.36 139.99 41.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.928 1.291 . . . . 0.0 110.059 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.7 107.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.284 1.833 . . . . 0.0 107.044 -168.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.8 135.71 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.92 92.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.905 2.082 . . . . 0.0 107.282 -172.681 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.3 170.8 12.82 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.48 123.0 42.95 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.077 1.751 . . . . 0.0 109.138 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 31.82 -92.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.194 2.331 . . . . 0.0 115.472 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -73.11 -16.77 61.45 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.2 97.95 4.42 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 109.952 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.11 163.62 36.36 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.58 163.77 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 129.841 3.256 . . . . 0.0 107.573 168.655 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -151.48 162.81 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.131 -0.981 . . . . 0.0 111.596 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -138.62 173.57 11.45 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.43 1.892 . . . . 0.0 110.409 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -124.71 157.94 34.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.392 1.877 . . . . 0.0 111.167 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.08 154.85 33.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.583 1.553 . . . . 0.0 111.89 161.453 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -132.62 140.58 48.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 110.885 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -136.3 93.87 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.6 t 70.79 30.11 3.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.779 1.632 . . . . 0.0 114.477 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 8.94 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.531 1.773 . . . . 0.0 117.531 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.3 t -75.25 160.94 29.79 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.959 1.88 . . . . 0.0 112.728 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -62.89 -11.54 19.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.063 1.345 . . . . 0.0 114.569 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.6 mm -82.59 -16.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.863 1.265 . . . . 0.0 111.452 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.91 4.94 24.1 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.347 -1.252 . . . . 0.0 115.751 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-N 119.391 1.596 . . . . 0.0 114.17 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.11 145.24 30.45 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.336 0.654 . . . . 0.0 111.853 -163.386 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 178.05 6.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.538 2.735 . . . . 0.0 110.398 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -100.21 -54.47 2.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.999 0.904 . . . . 0.0 111.166 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -55.89 -34.94 66.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.98 2.512 . . . . 0.0 113.786 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.56 -43.5 84.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.472 0.578 . . . . 0.0 110.794 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 60' ' ' PRO . 33.0 mmtm -63.41 -45.55 90.49 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 110.393 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 36.86 104.05 0.01 OUTLIER Glycine 0 C--N 1.344 0.975 0 C-N-CA 129.67 3.51 . . . . 0.0 116.676 159.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -62.8 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.346 2.258 . . . . 0.0 112.781 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -80.98 -19.54 43.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.879 2.472 . . . . 0.0 114.31 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -160.66 175.48 12.61 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.353 1.461 . . . . 0.0 110.257 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 133.41 24.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.268 1.413 . . . . 0.0 113.681 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.3 102.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.556 1.542 . . . . 0.0 114.08 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 156.36 40.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.585 2.354 . . . . 0.0 108.783 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.96 -31.87 0.28 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 49.27 -73.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 130.507 3.523 . . . . 0.0 116.214 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.32 68.23 1.42 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 112.067 -155.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.17 156.07 24.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.932 1.293 . . . . 0.0 110.331 166.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -142.29 145.42 33.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.498 1.519 . . . . 0.0 109.139 165.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.76 137.55 58.26 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.509 0.671 . . . . 0.0 111.31 168.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 -46.12 3.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.422 1.489 . . . . 0.0 109.708 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 128.93 4.93 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.095 1.331 . . . . 0.0 111.535 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.9 p -58.11 146.26 70.14 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 112.256 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -59.54 124.75 16.13 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.126 2.551 . . . . 0.0 111.55 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.16 128.55 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.727 1.211 . . . . 0.0 110.46 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.68 129.84 41.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.612 0.72 . . . . 0.0 111.021 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -71.98 -4.59 29.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.406 2.282 . . . . 0.0 113.845 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -8.72 11.12 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 118.945 0.793 . . . . 0.0 113.174 -168.807 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -89.2 -0.74 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.195 1.398 . . . . 0.0 110.758 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.71 0.79 74.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.464 1.507 . . . . 0.0 113.896 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -99.91 161.82 13.37 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.883 2.073 . . . . 0.0 110.205 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.4 128.88 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.457 1.026 . . . . 0.0 110.919 169.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.62 119.04 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.273 1.029 . . . . 0.0 108.937 162.503 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -132.72 129.27 38.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.78 2.432 . . . . 0.0 108.429 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -119.39 132.96 55.93 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.108 0.867 . . . . 0.0 113.06 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -123.47 167.63 13.62 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.294 1.038 . . . . 0.0 111.481 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.58 136.5 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 109.49 163.958 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -90.86 102.97 15.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.355 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.5 p -78.61 -7.14 57.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.592 1.557 . . . . 0.0 114.017 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.03 160.36 20.8 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 122.272 0.929 . . . . 0.0 113.878 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -82.02 -10.92 59.07 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.528 2.331 . . . . 0.0 114.849 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -164.39 172.93 12.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.72 1.208 . . . . 0.0 110.748 -153.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 61.08 0.62 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.22 105.04 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.399 2.066 . . . . 0.0 109.765 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 m -154.4 162.78 40.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.212 1.405 . . . . 0.0 112.09 -166.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -87.14 97.39 10.73 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.571 . . . . 0.0 111.394 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.89 115.08 8.08 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.878 1.271 . . . . 0.0 110.825 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.86 90.31 1.05 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.933 3.089 . . . . 0.0 110.678 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 tt -115.3 142.91 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.053 0.941 . . . . 0.0 109.378 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -150.7 166.64 29.77 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.059 1.343 . . . . 0.0 112.844 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.0 t -138.18 121.4 16.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.948 2.099 . . . . 0.0 110.713 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 57' ' ' ASP . 34.5 m -134.38 179.69 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.487 1.515 . . . . 0.0 112.263 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.63 -17.62 14.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.142 1.377 . . . . 0.0 113.725 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -157.55 43.32 0.33 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.184 -1.573 . . . . 0.0 111.731 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 8.8 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.811 2.045 . . . . 0.0 114.56 -174.448 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.514 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.8 p-10 -70.58 46.05 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.821 3.248 . . . . 0.0 114.952 -174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HA ' HG11 ' A' ' 52' ' ' VAL . 8.9 t0 -64.34 -1.77 1.86 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.291 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -10.36 5.45 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 159.409 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.1 m -155.96 98.37 2.23 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 120.381 -1.45 . . . . 0.0 109.8 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.418 ' CB ' ' HE2' ' A' ' 7' ' ' LYS . 80.5 Cg_exo -48.38 119.91 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.678 3.585 . . . . 0.0 113.452 170.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.514 ' CG2' HD21 ' A' ' 56' ' ' ASN . 8.0 t -99.88 -23.77 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.538 1.535 . . . . 0.0 111.813 -176.311 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.71 18.36 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.409 1.956 . . . . 0.0 111.29 168.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.21 175.48 9.55 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.499 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -86.01 149.67 25.01 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.523 1.529 . . . . 0.0 107.187 159.759 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -118.73 -41.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.735 0.698 . . . . 0.0 111.14 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -61.04 -45.81 93.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -162.75 165.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.136 0.88 . . . . 0.0 111.567 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.31 123.74 71.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 157.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.54 100.1 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.772 1.648 . . . . 0.0 111.422 -171.569 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -149.07 149.87 31.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 159.647 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.62 88.36 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 127.524 2.33 . . . . 0.0 107.055 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -71.47 -2.86 18.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.02 158.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 112.13 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.25 -27.58 63.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.538 0.735 . . . . 0.0 112.369 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.1 p -74.87 4.86 5.75 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.249 1.82 . . . . 0.0 113.671 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.66 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.29 1.836 . . . . 0.0 115.083 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.65 27.26 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 129.169 2.987 . . . . 0.0 113.681 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.34 169.08 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.416 1.886 . . . . 0.0 113.967 -166.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -112.4 108.73 17.99 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.837 2.455 . . . . 0.0 106.092 163.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.38 123.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.775 0.798 . . . . 0.0 112.953 -157.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.82 134.99 41.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.626 1.571 . . . . 0.0 110.604 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.7 136.53 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.506 1.922 . . . . 0.0 107.949 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.87 138.13 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.775 -0.578 . . . . 0.0 111.911 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -123.06 163.13 21.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.131 2.173 . . . . 0.0 110.056 167.165 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -104.52 100.97 25.07 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.543 1.137 . . . . 0.0 109.236 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.44 129.13 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.802 2.335 . . . . 0.0 109.977 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.94 172.29 2.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.572 2.181 . . . . 0.0 112.504 165.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.54 166.09 11.31 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.151 0.981 . . . . 0.0 112.426 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -91.67 1.45 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -164.074 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -119.67 154.0 34.72 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.577 1.151 . . . . 0.0 110.331 168.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.5 t -144.95 158.42 43.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 166.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -130.19 145.76 51.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.969 0.908 . . . . 0.0 108.823 165.098 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -117.02 113.94 44.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.479 1.912 . . . . 0.0 106.219 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.18 135.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.24 95.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.08 1.352 . . . . 0.0 108.061 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.99 171.69 24.23 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.945 1.938 . . . . 0.0 117.945 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.4 114.21 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.644 2.378 . . . . 0.0 108.938 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.83 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 126.166 1.841 . . . . 0.0 114.848 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -68.74 -15.08 63.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -129.65 99.34 5.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.718 1.207 . . . . 0.0 109.708 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.62 159.28 44.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.99 165.64 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 129.913 3.285 . . . . 0.0 108.431 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.72 170.7 15.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.712 -0.617 . . . . 0.0 110.871 161.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -132.79 161.73 33.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.909 1.684 . . . . 0.0 108.583 162.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.8 159.59 17.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.273 1.429 . . . . 0.0 110.522 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.02 152.99 38.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.062 1.345 . . . . 0.0 111.119 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.75 115.45 8.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.936 1.294 . . . . 0.0 108.41 -170.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -152.38 109.88 3.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.8 t 66.01 37.13 5.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.321 2.248 . . . . 0.0 114.522 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.48 20.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.025 0.821 . . . . 0.0 114.538 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 39.9 t -64.54 154.46 36.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.985 1.314 . . . . 0.0 113.213 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.8 m -54.21 -23.24 13.84 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.432 1.893 . . . . 0.0 112.655 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.4 mm -93.35 -1.32 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.425 1.89 . . . . 0.0 111.337 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.03 10.24 62.84 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.75 -1.219 . . . . 0.0 115.727 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.0 ptmm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.086 1.355 . . . . 0.0 114.585 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.33 168.84 23.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 -175.55 4.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.171 2.589 . . . . 0.0 110.472 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -99.49 -59.01 1.8 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.067 -1.021 . . . . 0.0 110.434 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -51.43 -33.57 31.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.613 2.765 . . . . 0.0 114.935 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -61.98 -19.79 63.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.004 0.82 . . . . 0.0 112.838 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.03 -1.4 57.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.969 1.308 . . . . 0.0 113.139 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -4.36 98.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.45 0 C-N-CA 130.524 3.916 . . . . 0.0 117.507 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -64.81 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.426 3.49 . . . . 0.0 115.92 -169.096 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -60.22 -27.62 67.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.1 -179.06 5.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.361 1.864 . . . . 0.0 109.923 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.58 138.63 46.89 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 121.655 -0.653 . . . . 0.0 111.71 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.95 95.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.121 0.962 . . . . 0.0 112.663 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.83 172.18 17.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.754 2.022 . . . . 0.0 110.585 170.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.6 p -142.93 -25.45 0.61 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.862 1.265 . . . . 0.0 113.934 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt 47.28 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 130.25 3.42 . . . . 0.0 114.934 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.21 72.5 1.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 111.906 -165.011 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -123.32 153.25 40.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.774 0.83 . . . . 0.0 110.638 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -139.73 147.46 40.92 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.782 1.633 . . . . 0.0 108.205 167.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.23 133.22 49.31 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.475 -0.765 . . . . 0.0 110.856 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -50.43 4.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.433 1.093 . . . . 0.0 109.204 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.26 120.74 1.94 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.499 1.047 . . . . 0.0 112.558 -172.846 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.2 m -49.59 147.35 6.1 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 127.915 2.486 . . . . 0.0 112.346 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.48 148.4 63.21 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.565 2.177 . . . . 0.0 114.12 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.0 142.64 32.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.141 1.776 . . . . 0.0 110.254 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.52 138.83 41.8 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.625 -0.672 . . . . 0.0 112.248 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.5 p -83.31 -21.87 33.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.82 -7.38 34.69 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 118.488 -1.173 . . . . 0.0 114.421 -159.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -72.08 -14.47 61.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.115 1.958 . . . . 0.0 111.166 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.93 -7.34 52.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.859 1.695 . . . . 0.0 113.012 -165.037 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.9 p -102.12 164.95 11.42 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 112.331 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.75 119.21 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.659 1.184 . . . . 0.0 110.592 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.19 128.34 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.765 1.226 . . . . 0.0 110.199 163.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.5 136.01 30.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.284 2.234 . . . . 0.0 109.514 -169.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -116.67 131.65 56.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.56 163.0 17.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.071 1.349 . . . . 0.0 111.06 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -122.95 142.82 50.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.551 1.54 . . . . 0.0 110.128 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -95.97 97.95 10.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.992 0.917 . . . . 0.0 110.923 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.7 p -82.57 35.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.928 1.691 . . . . 0.0 113.269 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.87 175.11 33.76 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.675 -0.64 . . . . 0.0 114.293 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -121.3 3.49 10.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.042 2.137 . . . . 0.0 113.228 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -132.04 166.06 22.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.249 2.22 . . . . 0.0 110.875 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.65 51.71 0.84 Allowed Glycine 0 CA--C 1.542 1.722 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -56.15 108.55 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 121.774 2.787 . . . . 0.0 110.722 160.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.476 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -155.7 168.78 26.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.431 1.092 . . . . 0.0 111.38 -166.115 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 11.3 tppt? -92.9 91.69 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.377 -1.452 . . . . 0.0 109.632 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.66 114.42 11.08 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.521 1.129 . . . . 0.0 112.36 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.28 88.79 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.229 2.619 . . . . 0.0 111.466 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -112.53 145.77 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.015 0.926 . . . . 0.0 110.079 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 t -151.27 172.29 16.1 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -143.63 106.27 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.143 2.577 . . . . 0.0 109.705 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.6 m -136.2 151.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.26 64.16 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.72 27.37 3.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.277 1.031 . . . . 0.0 112.357 -166.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mt 63.76 3.25 1.52 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.232 1.813 . . . . 0.0 113.881 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -67.69 50.5 0.05 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.117 2.967 . . . . 0.0 114.3 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.494 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.7 t0 -61.49 -13.7 23.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.74 -6.21 0.71 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.679 1.992 . . . . 0.0 114.665 162.337 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m -153.54 103.67 2.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.045 -1.66 . . . . 0.0 109.042 173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 123.67 10.26 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.37 2.713 . . . . 0.0 111.046 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.33 -36.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.193 0.997 . . . . 0.0 111.702 -172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.97 -166.74 30.41 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.381 1.467 . . . . 0.0 110.58 161.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.1 ptp85 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.891 0.876 . . . . 0.0 112.167 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -83.47 140.07 32.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.093 1.357 . . . . 0.0 107.405 163.187 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.62 -49.33 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.623 0.647 . . . . 0.0 109.669 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.9 m -60.01 -49.77 76.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -172.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -158.15 159.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.896 1.226 . . . . 0.0 113.031 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -59.41 114.45 9.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.392 1.077 . . . . 0.0 108.491 158.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 88.06 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.106 2.537 . . . . 0.0 111.938 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -136.18 139.59 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.744 -1.222 . . . . 0.0 111.94 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 2.6 t -74.24 88.87 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 125.557 1.543 . . . . 0.0 106.874 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -72.72 -2.81 21.73 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.95 143.35 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.146 1.378 . . . . 0.0 110.813 -172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.36 -27.07 67.6 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.883 0.849 . . . . 0.0 111.539 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 6.63 0.58 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.167 2.987 . . . . 0.0 114.192 168.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.49 17.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.888 1.675 . . . . 0.0 115.385 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.05 15.91 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 131.143 3.777 . . . . 0.0 115.562 -170.081 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.92 170.73 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.214 2.606 . . . . 0.0 114.3 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 99.74 6.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.836 3.254 . . . . 0.0 104.486 164.357 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.32 127.33 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.946 1.298 . . . . 0.0 112.082 -154.339 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.76 121.85 43.86 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.865 2.866 . . . . 0.0 108.898 -169.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.8 130.69 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.721 2.008 . . . . 0.0 109.267 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.78 133.01 36.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.539 0.736 . . . . 0.0 111.462 164.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.6 157.09 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.147 2.179 . . . . 0.0 109.854 164.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 38.5 tt0 -89.45 111.88 48.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.558 1.143 . . . . 0.0 108.472 168.08 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.23 125.75 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.336 2.691 . . . . 0.0 109.653 171.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.67 164.78 27.78 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.245 1.297 . . . . 0.0 110.909 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -71.96 155.47 40.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.042 0.925 . . . . 0.0 112.751 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.92 -87.05 1.41 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.4 1.476 . . . . 0.0 109.87 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.95 156.36 29.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.245 1.018 . . . . 0.0 110.214 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -146.11 95.99 2.71 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.166 0.986 . . . . 0.0 108.932 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -96.42 134.76 39.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.313 1.045 . . . . 0.0 109.294 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -115.67 90.82 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 126.328 1.851 . . . . 0.0 107.343 -159.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -89.45 139.06 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.673 0.789 . . . . 0.0 109.378 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.52 91.04 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.707 2.003 . . . . 0.0 106.45 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 164.85 165.39 22.05 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.83 147.54 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.354 1.462 . . . . 0.0 109.972 167.729 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.64 -99.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.498 1.999 . . . . 0.0 115.092 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -85.43 -26.7 26.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.772 1.629 . . . . 0.0 113.98 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -107.8 81.85 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.284 1.434 . . . . 0.0 108.517 -173.177 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.501 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -138.82 148.12 43.37 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.858 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 161.29 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.593 2.757 . . . . 0.0 108.125 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.42 147.59 27.74 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.47 -0.769 . . . . 0.0 110.967 173.028 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.07 162.79 17.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.832 2.053 . . . . 0.0 109.434 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -132.03 129.57 40.22 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.993 0.517 . . . . 0.0 110.92 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.58 23.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.145 0.978 . . . . 0.0 111.139 171.0 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -141.34 123.64 15.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.848 1.659 . . . . 0.0 108.104 -161.066 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.21 99.61 3.07 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m 61.69 54.27 3.01 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.409 1.883 . . . . 0.0 113.189 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.13 30.2 0.53 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.239 0.923 . . . . 0.0 114.303 170.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.4 t -55.39 168.16 0.4 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.919 2.088 . . . . 0.0 115.59 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m -49.75 -20.9 0.93 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.044 1.338 . . . . 0.0 113.452 156.625 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -119.56 24.58 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 126.571 1.948 . . . . 0.0 111.876 171.171 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.4 -26.21 0.87 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 127.285 2.374 . . . . 0.0 116.586 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 tptp . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.663 2.785 . . . . 0.0 114.223 173.017 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.01 169.03 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.518 0.727 . . . . 0.0 110.955 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 171.62 13.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.124 2.169 . . . . 0.0 109.854 173.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.74 -63.99 1.16 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.128 -0.982 . . . . 0.0 111.554 -171.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -52.66 -31.29 36.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.867 2.067 . . . . 0.0 114.427 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 tp -58.09 -29.07 65.16 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.581 1.153 . . . . 0.0 113.044 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.11 -2.73 42.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 143.47 2.27 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.778 2.133 . . . . 0.0 115.683 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -70.51 74.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.748 2.019 . . . . 0.0 113.586 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.4 p -60.41 -21.24 61.99 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.197 1.399 . . . . 0.0 112.412 159.105 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -153.01 179.87 8.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.432 2.293 . . . . 0.0 108.305 161.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.67 157.72 51.84 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 122.074 -0.391 . . . . 0.0 112.638 166.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -77.74 103.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.831 1.252 . . . . 0.0 111.614 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.86 163.66 36.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.541 1.537 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.6 p -165.43 -48.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.857 0.863 . . . . 0.0 111.786 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt 65.2 -63.51 0.19 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.916 2.486 . . . . 0.0 113.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.69 78.59 2.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.202 1.001 . . . . 0.0 112.461 -166.839 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -129.86 156.73 43.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.258 1.023 . . . . 0.0 111.664 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -146.23 150.04 35.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.229 1.812 . . . . 0.0 108.948 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -70.02 149.55 47.57 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.882 0.849 . . . . 0.0 112.933 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.37 -33.97 2.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.312 1.445 . . . . 0.0 111.272 171.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 104.27 0.41 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.148 1.356 . . . . 0.0 111.239 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.3 m -46.53 140.08 5.87 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 127.042 2.137 . . . . 0.0 110.518 167.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 143.43 98.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.95 1.767 . . . . 0.0 112.805 -170.327 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 122.51 18.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.556 1.143 . . . . 0.0 111.223 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.27 131.26 45.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.615 0.721 . . . . 0.0 111.588 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.7 p -79.26 -10.01 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.503 1.921 . . . . 0.0 113.837 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.29 -6.65 4.08 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.203 0.906 . . . . 0.0 114.048 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -94.53 3.09 55.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.526 1.531 . . . . 0.0 111.685 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.73 5.7 41.52 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.465 1.507 . . . . 0.0 114.279 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -128.0 166.49 18.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.519 1.528 . . . . 0.0 111.784 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG13 ' HG3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -114.95 132.06 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.516 1.526 . . . . 0.0 108.958 162.937 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.05 131.65 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 162.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.31 124.33 16.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.727 2.811 . . . . 0.0 108.211 -169.161 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.58 136.28 53.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.309 0.959 . . . . 0.0 112.922 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.48 164.92 21.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.79 139.9 52.38 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.195 163.414 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -90.87 101.49 14.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.729 1.212 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 p -80.5 7.63 9.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.915 1.686 . . . . 0.0 115.162 -163.726 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.39 -179.94 22.92 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.297 0.953 . . . . 0.0 114.34 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.1 p -113.59 6.79 17.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.168 1.787 . . . . 0.0 113.913 -165.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.52 178.8 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.872 1.669 . . . . 0.0 111.735 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.31 44.78 3.16 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-O 116.83 -2.094 . . . . 0.0 117.963 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.13 102.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.278 3.039 . . . . 0.0 111.709 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.7 m -159.57 171.27 19.94 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.99 -166.464 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -82.76 110.2 17.58 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.67 -1.269 . . . . 0.0 110.519 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.7 p -61.85 121.45 65.11 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.551 0.74 . . . . 0.0 110.776 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.06 97.17 0.73 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.327 2.018 . . . . 0.0 110.887 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.11 138.77 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.938 1.295 . . . . 0.0 108.926 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -153.32 169.95 21.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.912 0.885 . . . . 0.0 113.384 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 t -140.73 117.66 11.12 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.536 2.335 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 57' ' ' ASP . 2.0 m -134.97 170.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.269 1.428 . . . . 0.0 111.473 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.4 -23.93 19.9 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -155.29 51.34 0.58 Allowed 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.587 -1.321 . . . . 0.0 111.298 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.08 11.8 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.806 2.043 . . . . 0.0 114.682 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASN . . . . . 0.434 HD21 HG23 ' A' ' 61' ' ' VAL . 3.3 p-10 -70.17 42.38 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 128.962 2.905 . . . . 0.0 114.453 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.3 t0 -65.47 -3.59 4.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.178 1.791 . . . . 0.0 115.585 -166.987 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.39 -14.82 20.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.71 1.204 . . . . 0.0 113.283 159.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -152.78 104.61 2.68 Favored Pre-proline 0 N--CA 1.47 0.546 0 O-C-N 120.446 -1.409 . . . . 0.0 109.958 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 141.01 13.46 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.779 3.653 . . . . 0.0 114.285 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.434 HG23 HD21 ' A' ' 56' ' ' ASN . 14.2 t -119.33 -27.6 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.44 1.096 . . . . 0.0 111.014 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.98 -174.15 20.05 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.762 2.125 . . . . 0.0 111.0 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.462 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.8 ptp85 -136.85 175.73 9.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.352 1.061 . . . . 0.0 112.43 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.26 143.44 27.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 107.811 164.974 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.5 -46.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.895 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -62.5 -42.84 99.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.374 0.988 . . . . 0.0 113.621 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.66 163.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.553 0.741 . . . . 0.0 111.099 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -64.72 137.85 97.27 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.269 0.627 . . . . 0.0 109.759 166.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.88 82.47 0.98 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.047 2.498 . . . . 0.0 112.781 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -145.04 110.35 5.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.595 1.558 . . . . 0.0 112.093 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.66 87.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.974 1.709 . . . . 0.0 108.014 167.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -69.27 -19.56 63.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -170.046 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.51 155.07 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.682 1.193 . . . . 0.0 112.026 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -19.57 64.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.981 0.912 . . . . 0.0 112.946 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.3 p -80.81 7.88 9.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.993 1.717 . . . . 0.0 113.416 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 16.96 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.931 1.693 . . . . 0.0 115.164 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.19 23.22 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.919 3.288 . . . . 0.0 114.644 -168.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.81 171.71 12.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.634 1.974 . . . . 0.0 113.783 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.83 111.31 21.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.472 2.709 . . . . 0.0 106.198 167.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.99 122.65 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.782 0.833 . . . . 0.0 112.437 -156.148 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.75 135.29 35.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.907 174.038 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.4 mt -136.24 139.33 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.095 1.758 . . . . 0.0 108.716 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -91.88 137.27 32.5 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.371 -0.83 . . . . 0.0 111.661 164.905 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.03 165.68 14.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.286 2.235 . . . . 0.0 109.545 166.347 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 29.9 tt0 -104.88 109.25 62.88 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 109.502 174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.675 ' HG3' HG13 ' A' ' 32' ' ' VAL . 60.3 Cg_endo -93.18 118.82 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.231 3.954 . . . . 0.0 111.138 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.96 152.81 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.999 3.133 . . . . 0.0 114.942 170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -84.34 152.53 24.04 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.436 -0.79 . . . . 0.0 110.564 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.87 -93.71 1.8 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -161.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -125.95 168.18 14.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.976 1.31 . . . . 0.0 111.315 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -154.06 155.1 34.84 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 120.945 -1.097 . . . . 0.0 112.126 171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.03 115.59 16.0 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.973 2.509 . . . . 0.0 107.953 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.52 106.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.69 2.396 . . . . 0.0 106.797 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.7 137.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.311 1.045 . . . . 0.0 109.613 -166.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.6 110.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.163 1.385 . . . . 0.0 109.113 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 130.07 173.21 13.33 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 173.302 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.2 ptm85 -126.7 123.5 37.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.976 1.71 . . . . 0.0 110.592 -171.664 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.51 -96.97 0.01 OUTLIER Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.932 2.206 . . . . 0.0 115.163 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -65.62 -16.88 64.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.273 1.829 . . . . 0.0 115.541 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -135.76 91.47 2.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.114 1.366 . . . . 0.0 110.461 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -139.54 162.06 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 176.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.07 162.82 21.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 128.631 2.773 . . . . 0.0 107.989 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.25 154.64 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.635 -0.666 . . . . 0.0 110.951 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -125.01 169.3 12.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.452 1.901 . . . . 0.0 108.185 164.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -140.0 163.18 33.38 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.389 -0.819 . . . . 0.0 112.412 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.31 158.54 43.55 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.476 1.51 . . . . 0.0 111.748 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -145.26 110.44 5.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.005 1.722 . . . . 0.0 107.089 -167.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -153.99 105.28 2.72 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t 64.78 39.81 5.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.783 2.033 . . . . 0.0 113.966 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.33 22.42 0.08 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.584 1.088 . . . . 0.0 114.178 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.6 t -65.05 155.89 33.23 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 -172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 m -53.17 -20.57 4.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.912 2.085 . . . . 0.0 113.721 161.864 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -101.05 2.37 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.919 1.287 . . . . 0.0 113.022 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.08 62.26 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.162 0 CA-C-N 118.985 1.393 . . . . 0.0 114.327 -179.353 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.97 153.3 32.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.21 1.004 . . . . 0.0 112.969 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.47 90.6 3.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.237 2.215 . . . . 0.0 109.09 175.15 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.88 -44.01 91.05 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.998 1.719 . . . . 0.0 114.149 -163.18 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -61.95 -26.41 68.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.493 0.717 . . . . 0.0 112.626 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -93.89 -1.53 54.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 112.361 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -62.15 -8.73 5.98 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.8 1.182 . . . . 0.0 114.169 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.71 52.01 6.14 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 119.652 1.115 . . . . 0.0 112.936 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -75.47 37.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.06 1.744 . . . . 0.0 111.557 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -78.18 -6.14 53.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.7 1.2 . . . . 0.0 114.109 -174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -153.86 172.82 16.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.102 0.961 . . . . 0.0 111.141 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.2 143.86 45.64 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.689 0.662 . . . . 0.0 112.092 171.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.273 4.0 p -80.76 93.16 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.984 1.373 . . . . 0.0 112.58 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -148.82 164.81 33.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.701 2.0 . . . . 0.0 110.847 167.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.4 p -140.24 -15.43 0.98 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.834 1.253 . . . . 0.0 113.651 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 50.12 -64.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 129.686 3.194 . . . . 0.0 114.956 -167.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.45 83.15 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.548 1.139 . . . . 0.0 112.424 -160.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.77 162.22 29.99 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.745 1.218 . . . . 0.0 110.674 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -155.19 152.69 29.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.412 1.885 . . . . 0.0 109.84 166.409 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.9 132.19 51.28 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.483 -0.761 . . . . 0.0 111.693 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 -35.52 4.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.159 0.983 . . . . 0.0 110.809 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.86 103.2 0.42 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.016 1.77 . . . . 0.0 110.036 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 p -59.51 151.85 58.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.941 0.896 . . . . 0.0 112.293 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.08 141.76 77.99 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.13 1.887 . . . . 0.0 113.498 -168.256 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.77 135.51 33.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.292 1.437 . . . . 0.0 110.722 174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.09 141.59 54.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -13.38 59.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 114.559 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.22 -8.26 47.29 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.366 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -98.21 1.78 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.1 1.36 . . . . 0.0 112.284 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -8.79 47.93 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.98 1.276 . . . . 0.0 113.89 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -102.11 166.51 10.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.939 2.096 . . . . 0.0 111.988 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.78 123.74 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.455 1.502 . . . . 0.0 110.833 173.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -77.74 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.882 0.873 . . . . 0.0 109.781 164.449 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.37 121.14 9.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.35 2.26 . . . . 0.0 109.241 -164.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -108.91 133.91 52.28 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.76 -1.212 . . . . 0.0 113.029 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.18 159.54 25.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.557 0.743 . . . . 0.0 110.25 168.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -111.26 144.78 39.9 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.918 1.287 . . . . 0.0 109.49 167.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -93.36 102.8 15.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.177 1.391 . . . . 0.0 109.404 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -77.82 16.34 0.71 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.698 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.52 38.86 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 120.187 1.358 . . . . 0.0 115.587 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.53 -15.27 24.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -131.93 177.49 7.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.725 1.21 . . . . 0.0 112.61 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.32 38.42 0.73 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-O 116.307 -2.385 . . . . 0.0 118.706 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.07 107.84 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 122.715 3.258 . . . . 0.0 111.474 166.394 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 4.6 t -169.1 173.72 6.67 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.383 1.473 . . . . 0.0 110.394 -165.948 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -88.72 96.7 10.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 119.715 -1.866 . . . . 0.0 111.404 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.75 123.93 60.85 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.774 0.83 . . . . 0.0 112.853 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -86.12 99.37 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.641 2.894 . . . . 0.0 112.31 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -131.07 145.7 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.282 1.033 . . . . 0.0 109.255 164.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' SER . . . . . 0.408 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 41.1 t -151.18 166.49 30.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.854 1.262 . . . . 0.0 112.789 -169.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.7 t -145.99 108.83 4.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.379 2.272 . . . . 0.0 110.338 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.42 171.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.839 0.855 . . . . 0.0 112.665 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.63 -6.52 20.39 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -143.9 20.03 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.422 -1.424 . . . . 0.0 112.687 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.15 20.48 10.99 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.263 1.825 . . . . 0.0 111.966 -173.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -82.15 48.31 1.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 129.896 3.278 . . . . 0.0 113.203 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' OD1' ' OG ' ' A' ' 50' ' ' SER . 29.9 m-20 -58.14 -17.19 16.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -7.66 1.2 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.376 1.87 . . . . 0.0 114.753 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -150.05 87.19 5.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 119.925 -1.734 . . . . 0.0 109.655 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.11 115.24 2.04 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 125.129 3.886 . . . . 0.0 114.279 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.39 -36.6 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.248 1.419 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.91 -162.99 34.91 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.624 2.059 . . . . 0.0 111.98 170.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -144.47 167.19 23.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.889 1.276 . . . . 0.0 112.261 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.78 106.77 18.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.883 1.673 . . . . 0.0 106.552 167.157 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.89 -54.34 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -60.64 -49.26 78.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 113.002 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.68 141.28 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 123.028 0.531 . . . . 0.0 110.536 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -75.29 134.32 73.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 122.22 0.208 . . . . 0.0 110.5 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.38 92.21 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 114.309 -153.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -140.79 128.73 21.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.234 1.413 . . . . 0.0 110.547 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -82.92 87.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.16 1.384 . . . . 0.0 108.214 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -73.26 -5.24 38.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 157.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 110.841 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.36 -19.38 60.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -74.17 5.98 3.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.421 1.889 . . . . 0.0 113.841 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 12.22 0.17 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.844 1.658 . . . . 0.0 114.815 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.27 24.5 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 130.146 3.378 . . . . 0.0 114.921 -170.583 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 173.07 8.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.087 . . . . 0.0 113.758 -169.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 111.48 22.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.257 2.623 . . . . 0.0 105.306 164.656 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.71 128.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.919 0.866 . . . . 0.0 112.439 -158.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -92.44 125.85 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.052 2.541 . . . . 0.0 109.79 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.57 136.54 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.589 2.355 . . . . 0.0 108.15 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 134.49 33.61 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.699 . . . . 0.0 110.899 159.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.72 157.34 24.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.771 1.628 . . . . 0.0 109.761 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.65 106.85 42.64 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.54 136.2 10.87 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.439 2.76 . . . . 0.0 109.829 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -61.56 161.72 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 121.467 1.445 . . . . 0.0 111.357 167.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -88.23 166.75 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.35 0.66 . . . . 0.0 112.726 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.44 -89.44 1.22 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -167.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.24 147.26 50.22 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.2 p -146.41 141.76 27.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.737 0.78 . . . . 0.0 112.088 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -130.74 121.34 25.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.385 1.874 . . . . 0.0 108.266 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.0 mm -105.9 108.51 25.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 107.278 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.6 t -113.14 139.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.289 1.036 . . . . 0.0 109.52 -164.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.0 t -136.92 97.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.709 1.604 . . . . 0.0 107.899 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.58 172.73 18.73 Favored Glycine 0 N--CA 1.467 0.71 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 114.82 15.17 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.728 2.011 . . . . 0.0 110.211 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.37 -103.5 0.04 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.202 1.858 . . . . 0.0 114.086 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.67 -18.42 62.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.138 2.175 . . . . 0.0 115.545 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -123.14 93.95 4.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.339 0.972 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.2 42.53 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.76 159.68 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 129.135 2.974 . . . . 0.0 108.139 168.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -146.05 153.95 41.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.804 0.842 . . . . 0.0 110.081 165.711 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -137.91 166.91 22.87 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.671 1.588 . . . . 0.0 109.493 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -124.33 157.89 33.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.886 0.874 . . . . 0.0 112.399 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.51 151.38 28.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.051 1.74 . . . . 0.0 110.738 169.336 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -127.29 136.86 52.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 109.312 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -140.53 91.69 2.45 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -153.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 t 76.35 17.32 2.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.223 2.209 . . . . 0.0 114.187 163.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.79 25.55 0.05 OUTLIER Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.727 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.6 t -63.53 156.41 26.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.351 1.575 . . . . 0.0 110.849 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.6 p -62.34 -16.78 56.4 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 166.671 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.0 mm -67.23 -10.55 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.634 1.574 . . . . 0.0 111.903 167.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.37 17.1 47.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.219 1.39 . . . . 0.0 113.993 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tptp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.367 1.467 . . . . 0.0 112.833 -161.558 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 164.57 34.28 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 -174.53 3.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.884 2.074 . . . . 0.0 111.45 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.42 -57.08 2.08 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.602 -0.686 . . . . 0.0 110.815 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -49.09 -52.47 25.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.842 2.457 . . . . 0.0 114.425 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.34 -31.42 69.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.917 0.781 . . . . 0.0 112.797 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -76.3 -12.38 60.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.064 1.345 . . . . 0.0 113.812 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -19.7 126.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 1 C-N-CA 130.773 4.035 . . . . 0.0 116.59 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.476 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 79.3 p -73.96 74.58 1.68 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 113.151 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -59.89 -45.91 91.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.882 1.673 . . . . 0.0 112.857 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -123.74 174.4 7.51 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.353 1.861 . . . . 0.0 110.712 174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.17 148.94 31.89 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.379 0.99 . . . . 0.0 113.085 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.76 105.11 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 122.621 1.2 . . . . 0.0 113.336 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.92 151.83 14.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.928 2.091 . . . . 0.0 109.281 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 p -143.94 -33.62 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.493 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 60.42 -69.27 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.596 2.759 . . . . 0.0 114.739 170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.56 72.74 1.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.492 1.517 . . . . 0.0 110.346 -161.05 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -115.94 160.86 19.66 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.694 1.198 . . . . 0.0 110.049 165.734 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -141.97 144.22 33.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.652 1.581 . . . . 0.0 108.377 164.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.72 147.63 52.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.835 0.826 . . . . 0.0 111.947 170.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -46.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.924 1.29 . . . . 0.0 110.388 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.14 110.54 0.91 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.12 1.343 . . . . 0.0 111.239 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -57.92 146.6 67.24 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.448 167.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.2 155.22 52.52 Favored 'Trans proline' 0 C--N 1.351 0.71 0 N-CA-C 115.49 1.304 . . . . 0.0 115.49 -165.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.61 39.89 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.556 1.542 . . . . 0.0 110.282 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 132.65 45.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.769 0.428 . . . . 0.0 111.134 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.7 p -77.82 -24.25 48.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 -8.23 61.45 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.68 -1.066 . . . . 0.0 113.976 -160.128 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -75.25 -11.67 60.12 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.656 1.728 . . . . 0.0 111.342 163.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 -13.85 62.97 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.819 2.152 . . . . 0.0 113.105 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -84.29 170.17 13.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.759 2.424 . . . . 0.0 112.036 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.24 124.41 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.581 1.153 . . . . 0.0 110.317 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.24 128.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.793 0.837 . . . . 0.0 109.357 164.07 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 159.27 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 167.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -132.17 135.25 46.22 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -165.404 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.26 168.04 16.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.819 1.247 . . . . 0.0 110.489 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -123.7 148.17 46.79 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.844 1.257 . . . . 0.0 110.267 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -97.51 108.91 21.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.7 p -87.45 0.51 55.41 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.119 1.768 . . . . 0.0 113.775 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.16 16.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.712 1.149 . . . . 0.0 113.69 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 m -118.3 11.8 13.22 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.995 1.718 . . . . 0.0 111.56 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -149.25 -175.3 4.93 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.32 2.248 . . . . 0.0 111.154 -168.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.44 56.95 2.7 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.907 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.45 95.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.548 2.832 . . . . 0.0 112.281 155.586 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.3 169.07 19.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.26 . . . . 0.0 112.752 -169.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 2.5 ttmm -95.78 101.38 13.06 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 110.523 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.78 115.45 18.88 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 111.321 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.3 88.45 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.932 2.422 . . . . 0.0 111.221 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 tt -106.77 144.9 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.23 1.012 . . . . 0.0 109.412 165.39 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t -145.85 167.87 22.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.011 1.324 . . . . 0.0 113.283 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.8 t -139.81 110.96 6.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.563 2.345 . . . . 0.0 109.811 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 57' ' ' ASP . 28.4 m -137.3 161.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -8.57 29.67 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.4 m -155.68 36.65 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.164 -1.585 . . . . 0.0 112.321 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.96 8.41 0.98 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.324 1.85 . . . . 0.0 114.541 -175.309 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -67.96 40.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 131.104 3.762 . . . . 0.0 114.839 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.8 t0 -63.61 0.49 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -160.306 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.75 -18.67 65.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.13 -0.981 . . . . 0.0 112.966 160.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.1 m -128.33 101.48 21.77 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.102 1.761 . . . . 0.0 109.865 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -66.53 117.83 5.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.004 2.47 . . . . 0.0 110.325 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -96.83 -30.98 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.89 0.876 . . . . 0.0 111.144 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.4 -164.63 24.55 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.335 1.922 . . . . 0.0 111.537 166.298 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 9.4 ptp85 -139.48 169.62 17.41 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.673 1.589 . . . . 0.0 111.803 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 114.79 27.45 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.201 1.8 . . . . 0.0 106.809 170.421 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.9 -51.92 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.282 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -60.73 -44.31 96.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.83 159.0 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.476 0.71 . . . . 0.0 111.03 -169.153 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.77 127.19 67.15 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.667 0.787 . . . . 0.0 109.091 163.789 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.06 89.56 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 110.916 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -144.05 142.78 30.85 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.792 0.806 . . . . 0.0 112.737 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 t -76.49 86.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 127.46 2.304 . . . . 0.0 106.864 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 p -59.97 -28.68 67.87 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -167.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 161.17 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.529 1.531 . . . . 0.0 112.146 -173.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.78 -28.01 68.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.119 0.968 . . . . 0.0 112.702 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.62 5.45 4.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.384 2.274 . . . . 0.0 114.665 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 14.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.1 16.97 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.694 3.598 . . . . 0.0 115.425 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.53 169.66 17.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.279 1.832 . . . . 0.0 113.768 -172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 111.14 22.75 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.711 2.805 . . . . 0.0 105.473 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.71 126.65 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.034 0.934 . . . . 0.0 112.342 -159.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.97 130.97 36.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.286 2.234 . . . . 0.0 109.644 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -133.97 142.77 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.106 1.363 . . . . 0.0 109.889 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.81 135.1 33.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.302 1.041 . . . . 0.0 111.772 168.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.0 157.75 26.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.576 1.95 . . . . 0.0 109.844 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 35.6 tt0 -90.95 113.45 58.16 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.838 0.855 . . . . 0.0 109.041 171.216 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.28 122.91 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.804 3.003 . . . . 0.0 109.92 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.56 164.29 31.58 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.706 1.604 . . . . 0.0 111.846 171.17 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -80.98 145.0 31.41 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.29 -0.881 . . . . 0.0 111.783 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.09 -94.34 1.06 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.695 2.093 . . . . 0.0 110.268 -173.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -112.77 174.8 5.72 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 110.267 167.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 m -153.15 96.32 2.05 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.606 -1.309 . . . . 0.0 110.917 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.63 127.27 42.46 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.28 96.97 5.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.263 1.425 . . . . 0.0 107.612 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.98 140.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.695 -171.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -135.66 99.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.348 1.859 . . . . 0.0 107.834 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.08 169.14 25.01 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -137.59 123.9 20.61 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.835 2.454 . . . . 0.0 108.975 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.39 -98.54 0.01 OUTLIER Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.407 1.956 . . . . 0.0 114.92 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -71.37 -17.07 62.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.58 99.54 6.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.632 1.173 . . . . 0.0 109.58 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.39 156.28 45.82 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 164.79 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.46 2.704 . . . . 0.0 108.182 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.83 160.78 43.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.697 -0.627 . . . . 0.0 111.023 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.23 171.68 12.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.532 1.933 . . . . 0.0 109.899 170.398 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.1 144.16 51.11 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.221 1.008 . . . . 0.0 111.56 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.39 164.07 35.98 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.258 1.823 . . . . 0.0 110.783 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -146.17 114.46 6.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.547 1.539 . . . . 0.0 108.512 -162.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -152.54 96.3 2.12 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -163.018 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.7 p 56.6 82.16 0.12 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 128.609 2.763 . . . . 0.0 114.026 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.9 21.42 4.97 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.496 1.998 . . . . 0.0 112.961 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.8 t -70.77 156.95 38.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -166.95 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m -54.6 -19.05 5.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.852 1.661 . . . . 0.0 114.081 164.563 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tt -112.98 16.25 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.721 1.208 . . . . 0.0 112.735 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.4 75.81 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 116.111 1.204 . . . . 0.0 116.111 164.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.331 1.452 . . . . 0.0 113.56 179.146 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -146.61 146.95 30.6 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.171 0.51 . . . . 0.0 111.897 -168.007 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.62 173.02 9.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.061 2.544 . . . . 0.0 109.924 173.175 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -98.7 -49.39 4.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.258 -0.901 . . . . 0.0 111.336 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -61.33 -33.46 73.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.452 1.901 . . . . 0.0 114.12 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.11 -38.16 87.84 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.533 0.733 . . . . 0.0 110.963 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' PRO . 32.0 mmtm -69.86 -40.23 75.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.917 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 11.62 109.73 0.0 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 130.657 3.98 . . . . 0.0 117.072 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.412 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 80.9 p -67.49 71.34 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.925 2.09 . . . . 0.0 112.557 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -19.71 65.48 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.414 3.086 . . . . 0.0 114.78 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -158.62 -172.97 4.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 110.686 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.59 118.35 13.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.718 1.151 . . . . 0.0 112.738 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -67.41 99.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.66 1.184 . . . . 0.0 112.979 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 160.04 39.98 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.737 2.415 . . . . 0.0 109.467 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.8 p -136.8 -35.57 0.71 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.672 1.189 . . . . 0.0 112.815 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 tttm 54.86 -79.42 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.822 2.449 . . . . 0.0 114.634 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.53 84.12 1.97 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.531 0.605 . . . . 0.0 111.958 -162.558 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.62 163.98 26.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.782 0.833 . . . . 0.0 112.268 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -149.93 145.82 26.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.428 2.291 . . . . 0.0 108.275 160.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -65.46 140.27 58.59 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.558 -0.714 . . . . 0.0 111.449 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.34 -52.08 2.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.65 112.81 1.94 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.557 1.551 . . . . 0.0 110.37 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.1 p -52.23 141.8 30.23 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.092 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.22 145.82 84.97 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.759 2.306 . . . . 0.0 112.764 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.51 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.706 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -65.0 125.22 24.23 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.356 0.598 . . . . 0.0 110.648 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 p -70.26 -8.22 48.49 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.145 2.178 . . . . 0.0 114.0 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.85 -8.49 3.4 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.64 1.114 . . . . 0.0 113.569 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -94.62 5.62 51.3 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.447 1.899 . . . . 0.0 111.276 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.14 18.72 38.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.698 1.142 . . . . 0.0 113.97 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -130.32 161.8 30.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 111.144 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 121.71 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.657 1.583 . . . . 0.0 108.701 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.32 130.4 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 162.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 35' ' ' GLU . 4.7 tt -141.9 131.89 24.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 109.704 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' N ' HD23 ' A' ' 34' ' ' LEU . 19.0 tt0 -115.91 130.84 57.0 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.114 0.87 . . . . 0.0 113.243 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.05 167.31 13.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.36 1.064 . . . . 0.0 111.164 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -119.21 142.84 47.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.371 1.468 . . . . 0.0 109.836 166.349 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -95.1 98.27 10.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.303 1.041 . . . . 0.0 110.691 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.5 p -76.06 22.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.459 2.303 . . . . 0.0 115.846 -163.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.39 176.02 37.95 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 120.905 -1.122 . . . . 0.0 114.601 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 p -99.2 -4.69 31.47 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.501 1.921 . . . . 0.0 113.64 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.23 176.77 8.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.718 1.607 . . . . 0.0 112.732 -167.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.78 48.2 2.16 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 117.244 -1.864 . . . . 0.0 116.944 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.97 99.11 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.761 2.781 . . . . 0.0 110.068 162.598 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.437 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 56.2 m -145.39 163.72 33.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.504 1.522 . . . . 0.0 111.725 -167.173 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 9' ' ' THR . 4.3 tmtm? -80.08 90.0 5.41 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.167 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.11 114.51 7.23 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.852 1.261 . . . . 0.0 112.516 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.53 99.46 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.345 2.03 . . . . 0.0 110.761 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -126.51 145.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.081 1.352 . . . . 0.0 108.446 163.573 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.3 t -147.02 164.11 34.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.573 1.149 . . . . 0.0 112.806 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.9 t -137.76 115.39 11.3 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.556 2.342 . . . . 0.0 109.218 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 11.1 m -130.58 169.96 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.808 1.243 . . . . 0.0 111.593 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.58 -0.03 20.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -154.31 28.87 0.45 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.198 -1.564 . . . . 0.0 112.709 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.99 6.44 0.32 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.223 2.209 . . . . 0.0 115.203 -174.006 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -71.36 56.74 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.912 3.285 . . . . 0.0 112.436 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.8 t70 -64.82 -4.72 4.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -165.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -16.0 20.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.417 1.487 . . . . 0.0 114.515 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.0 m -157.11 116.11 2.0 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 120.678 -1.264 . . . . 0.0 109.16 165.789 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 85.0 Cg_exo -48.23 127.82 16.02 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.229 3.286 . . . . 0.0 113.665 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.37 -26.65 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 126.054 1.742 . . . . 0.0 110.911 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.56 -164.82 29.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.484 1.992 . . . . 0.0 111.116 163.034 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ARG . . . . . 0.402 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -135.78 177.95 7.43 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.403 0.681 . . . . 0.0 112.62 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.49 142.49 27.37 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 163.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.0 t -106.8 -45.88 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.548 0.613 . . . . 0.0 110.108 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.2 m -61.86 -43.81 98.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.65 157.18 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.823 1.192 . . . . 0.0 112.375 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -62.09 128.6 91.08 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.29 89.02 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.367 2.045 . . . . 0.0 113.707 -172.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -155.59 114.08 3.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.227 1.811 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -76.74 93.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.836 2.054 . . . . 0.0 108.2 171.822 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -69.63 -7.26 37.3 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.16 154.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.874 1.216 . . . . 0.0 111.989 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.91 66.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.249 1.02 . . . . 0.0 112.322 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.16 0.05 5.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.187 2.995 . . . . 0.0 114.07 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.24 11.82 0.15 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.849 1.66 . . . . 0.0 115.429 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.35 17.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.304 3.442 . . . . 0.0 115.597 -167.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.2 176.78 8.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.893 2.077 . . . . 0.0 114.126 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.29 114.51 27.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.836 2.854 . . . . 0.0 106.171 164.209 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.62 132.03 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.561 0.696 . . . . 0.0 112.749 -158.497 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.86 137.97 33.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.263 2.225 . . . . 0.0 111.109 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.84 144.05 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.005 2.122 . . . . 0.0 108.69 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -98.91 135.75 39.89 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 112.476 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.36 166.56 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 110.442 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 5.3 tt0 -102.37 110.67 63.32 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.073 0.949 . . . . 0.0 110.009 171.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 92.0 Cg_endo -84.88 108.59 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.729 4.286 . . . . 0.0 111.084 172.571 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 58.2 Cg_endo -60.34 161.56 19.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.38 165.31 16.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.92 -80.26 1.23 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -165.067 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.01 156.66 41.27 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.801 1.24 . . . . 0.0 111.139 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -143.02 142.17 31.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.523 1.129 . . . . 0.0 110.161 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -137.92 128.63 26.81 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.644 1.178 . . . . 0.0 108.096 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.22 98.64 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.265 1.426 . . . . 0.0 107.255 -162.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -99.92 136.49 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.939 0.896 . . . . 0.0 109.114 -167.153 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.6 103.98 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.67 1.588 . . . . 0.0 107.524 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.97 177.59 15.04 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.299 0.944 . . . . 0.0 114.763 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.47 154.51 45.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.195 2.198 . . . . 0.0 108.471 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -12.2 -72.74 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.68 2.562 . . . . 0.0 117.164 -173.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.11 -13.72 59.76 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.9 88.04 2.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.623 1.569 . . . . 0.0 109.971 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -143.25 157.7 44.26 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.29 161.4 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 129.382 3.073 . . . . 0.0 107.839 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.69 150.82 36.15 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.05 -1.031 . . . . 0.0 112.513 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -120.87 170.25 9.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.766 1.226 . . . . 0.0 110.832 166.333 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -125.8 159.74 31.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.616 1.967 . . . . 0.0 111.31 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.0 153.01 31.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.198 2.599 . . . . 0.0 110.599 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -143.58 117.3 9.27 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 108.765 -167.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -150.57 93.04 1.92 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -165.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p 65.8 58.0 0.8 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.081 1.753 . . . . 0.0 114.077 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 128.65 25.3 1.04 Allowed Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.882 1.706 . . . . 0.0 113.439 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 30.1 t -61.01 158.0 14.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.239 1.816 . . . . 0.0 113.475 -177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 m -55.52 -22.81 23.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.322 1.049 . . . . 0.0 112.454 163.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -91.33 -3.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 126.809 2.044 . . . . 0.0 111.523 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.54 69.87 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.635 -1.291 . . . . 0.0 115.469 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.6 ptmm? . . . . . 0 C--O 1.249 1.029 0 C-N-CA 126.022 1.729 . . . . 0.0 113.206 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -142.78 137.25 29.59 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.113 0.565 . . . . 0.0 112.093 -162.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 168.42 14.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.669 2.787 . . . . 0.0 109.953 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -83.65 -57.54 3.18 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.239 -0.913 . . . . 0.0 111.994 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -58.36 -29.65 66.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.417 1.487 . . . . 0.0 114.356 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -70.74 -40.03 72.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.33 0.513 . . . . 0.0 111.093 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -65.74 -45.32 83.08 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.962 0.801 . . . . 0.0 109.886 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.99 101.77 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 130.04 3.686 . . . . 0.0 116.756 161.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -68.4 62.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.521 2.328 . . . . 0.0 112.682 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -70.33 -17.92 63.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.382 1.873 . . . . 0.0 113.757 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -160.07 -179.15 7.52 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.444 1.497 . . . . 0.0 110.486 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.05 144.85 24.09 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.668 1.128 . . . . 0.0 114.241 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.99 95.54 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 122.969 1.366 . . . . 0.0 114.152 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 169.44 17.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 128.627 2.771 . . . . 0.0 108.299 168.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -167.27 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.585 0.754 . . . . 0.0 112.484 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? 61.99 -76.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.593 2.357 . . . . 0.0 113.647 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.49 77.06 1.59 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.802 0.81 . . . . 0.0 112.149 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -120.7 156.96 30.66 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.403 1.081 . . . . 0.0 110.144 163.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -143.11 142.39 31.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.085 1.754 . . . . 0.0 108.731 168.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.49 138.7 57.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.67 0.748 . . . . 0.0 111.398 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -43.12 3.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.077 1.351 . . . . 0.0 109.541 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.98 115.48 1.2 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.395 1.95 . . . . 0.0 109.646 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.2 p -64.12 159.58 55.46 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.648 -0.913 . . . . 0.0 111.321 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.46 137.22 68.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.139 1.893 . . . . 0.0 112.585 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 125.3 32.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.5 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.37 132.05 47.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.557 0.694 . . . . 0.0 111.454 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.2 p -78.8 -9.14 59.36 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.818 1.647 . . . . 0.0 113.944 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.16 -7.82 3.08 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 118.994 0.815 . . . . 0.0 114.061 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -94.96 4.87 53.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.069 1.748 . . . . 0.0 111.193 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.02 42.31 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.245 1.879 . . . . 0.0 114.072 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -109.47 174.76 5.72 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.034 2.134 . . . . 0.0 112.056 -171.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -120.42 141.01 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.936 1.294 . . . . 0.0 110.224 165.364 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.54 128.89 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.018 1.327 . . . . 0.0 109.918 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.55 133.09 36.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.729 2.012 . . . . 0.0 109.217 -172.283 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -121.24 132.32 54.74 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.869 0.868 . . . . 0.0 112.612 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.85 166.12 14.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.865 0.866 . . . . 0.0 110.119 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -120.95 148.74 43.67 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.885 0.874 . . . . 0.0 109.45 160.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -100.4 100.36 11.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.011 0.925 . . . . 0.0 109.702 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -80.47 13.64 2.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.453 2.301 . . . . 0.0 115.759 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.08 171.32 27.8 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.507 1.048 . . . . 0.0 113.789 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -96.52 6.42 48.78 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.715 1.606 . . . . 0.0 113.479 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.8 172.68 12.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.87 1.668 . . . . 0.0 112.308 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.65 47.76 0.89 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-O 117.046 -1.975 . . . . 0.0 117.413 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -55.11 95.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.959 0 CA-C-N 121.769 2.785 . . . . 0.0 111.458 162.18 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 65.4 m -152.96 168.03 27.19 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.367 1.467 . . . . 0.0 112.589 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -83.48 91.96 7.5 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.504 -1.372 . . . . 0.0 110.782 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.81 119.35 15.76 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.676 1.19 . . . . 0.0 112.105 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.83 88.87 1.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.353 2.702 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 tt -124.62 143.72 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.792 -0.567 . . . . 0.0 110.07 165.603 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.5 t -147.62 157.16 43.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.844 1.258 . . . . 0.0 112.055 -168.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -133.28 108.62 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.993 1.717 . . . . 0.0 110.562 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 57' ' ' ASP . 19.3 m -131.73 170.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.794 0.837 . . . . 0.0 112.166 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.19 -12.6 18.62 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -152.93 27.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.114 -1.616 . . . . 0.0 112.602 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.47 17.66 2.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.054 2.142 . . . . 0.0 113.098 -168.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.489 HD21 ' CG2' ' A' ' 61' ' ' VAL . 13.5 p-10 -68.37 52.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.583 2.753 . . . . 0.0 111.952 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HA ' HG11 ' A' ' 52' ' ' VAL . 12.3 t0 -56.94 -25.67 58.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.914 1.285 . . . . 0.0 113.2 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.58 -10.96 0.48 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.566 3.147 . . . . 0.0 116.128 166.025 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.3 m -153.6 95.75 2.85 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 119.869 -1.77 . . . . 0.0 111.064 166.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HA ' HG12 ' A' ' 52' ' ' VAL . 85.7 Cg_exo -54.27 118.1 4.65 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.838 3.692 . . . . 0.0 116.369 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.7 t -95.9 -26.21 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.858 1.663 . . . . 0.0 112.859 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.18 -163.52 18.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.514 2.007 . . . . 0.0 111.798 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 172.31 13.02 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.64 104.94 16.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.972 2.109 . . . . 0.0 106.857 168.037 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.85 -48.58 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.593 0.757 . . . . 0.0 110.453 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -59.82 -48.04 83.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -162.41 161.96 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.235 0.925 . . . . 0.0 112.033 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.16 120.73 45.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.858 0.863 . . . . 0.0 109.563 161.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.82 85.32 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.397 2.064 . . . . 0.0 110.843 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.34 123.9 11.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.048 1.739 . . . . 0.0 110.376 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.48 99.09 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.285 1.434 . . . . 0.0 108.323 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.2 t -75.71 -4.48 40.6 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.17 159.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.076 1.307 . . . . 0.0 112.842 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.62 63.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.936 1.294 . . . . 0.0 113.206 168.902 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.7 p -80.41 2.53 24.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.076 1.75 . . . . 0.0 114.103 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 14.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.22 16.65 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 130.969 3.708 . . . . 0.0 114.814 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.597 2.359 . . . . 0.0 114.024 -171.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.38 107.83 16.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.708 2.803 . . . . 0.0 105.696 166.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.32 120.02 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.148 0.979 . . . . 0.0 113.231 -153.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.05 129.29 35.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.151 2.581 . . . . 0.0 109.748 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.55 136.92 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.826 2.45 . . . . 0.0 108.499 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -91.09 141.54 28.71 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.343 0.657 . . . . 0.0 112.347 167.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.52 159.62 30.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.339 2.256 . . . . 0.0 110.045 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.45 107.54 58.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 108.95 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.55 ' HG3' HG13 ' A' ' 32' ' ' VAL . 97.7 Cg_endo -90.99 115.8 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 125.044 3.83 . . . . 0.0 110.711 167.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.4 167.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 125.115 3.877 . . . . 0.0 116.172 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -77.59 161.28 27.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.33 -87.57 1.2 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -125.7 160.38 29.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.46 1.124 . . . . 0.0 110.905 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -154.12 159.35 41.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.065 0.936 . . . . 0.0 111.651 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.55 127.96 21.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.299 1.44 . . . . 0.0 108.114 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.46 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.212 1.805 . . . . 0.0 107.011 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -106.65 135.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.56 92.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 126.156 1.782 . . . . 0.0 107.236 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.97 171.19 17.46 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.69 113.52 13.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.061 1.744 . . . . 0.0 110.436 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.07 -103.49 0.05 OUTLIER Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.078 1.799 . . . . 0.0 114.116 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -17.03 64.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.582 1.953 . . . . 0.0 115.727 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -129.43 98.6 4.91 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.545 1.066 . . . . 0.0 110.554 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -148.84 166.03 29.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.51 162.67 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 129.931 3.293 . . . . 0.0 108.502 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.69 157.1 41.62 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 172.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -139.35 151.31 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 111.684 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 160.64 14.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.232 1.413 . . . . 0.0 112.757 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -147.51 154.38 40.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.571 1.548 . . . . 0.0 112.053 158.064 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -139.69 114.65 9.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.842 1.657 . . . . 0.0 108.685 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -151.19 108.21 3.56 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -165.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 p 52.41 70.68 0.54 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.796 2.838 . . . . 0.0 113.784 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.83 24.63 4.22 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.571 1.557 . . . . 0.0 113.541 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -56.91 155.25 8.22 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 112.668 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 m -51.05 -25.1 4.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.324 1.449 . . . . 0.0 112.761 161.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.01 -4.47 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.332 1.853 . . . . 0.0 112.849 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.11 5.79 60.58 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.636 1.415 . . . . 0.0 116.636 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.483 1.642 . . . . 0.0 113.858 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -145.62 149.66 34.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.392 1.077 . . . . 0.0 111.018 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.11 106.14 13.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.71 2.004 . . . . 0.0 110.094 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.14 -24.15 47.5 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -163.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.74 -39.11 73.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.258 1.023 . . . . 0.0 112.918 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.55 -5.68 41.74 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -71.09 -15.58 62.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -165.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.52 84.93 0.3 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.174 1.352 . . . . 0.0 114.685 170.539 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -89.4 18.28 5.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.292 1.837 . . . . 0.0 113.833 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -62.16 -12.02 17.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.23 170.88 14.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.563 1.945 . . . . 0.0 108.78 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.09 161.99 40.14 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.471 -0.768 . . . . 0.0 113.396 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -72.51 91.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.269 1.509 . . . . 0.0 113.626 -172.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.67 163.1 35.92 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.281 2.232 . . . . 0.0 109.195 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.6 p -160.03 -44.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.594 1.158 . . . . 0.0 110.774 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 64.46 -70.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 128.227 2.611 . . . . 0.0 112.515 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.81 78.6 1.97 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.328 1.051 . . . . 0.0 112.228 -161.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -134.29 154.98 51.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 111.346 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -146.05 143.88 29.69 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.551 1.94 . . . . 0.0 109.617 165.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.88 129.82 42.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.851 0.86 . . . . 0.0 111.17 167.068 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -108.71 -51.13 2.92 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.603 1.561 . . . . 0.0 109.39 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.56 104.48 0.69 Allowed Glycine 0 C--N 1.339 0.701 0 C-N-CA 125.861 1.695 . . . . 0.0 109.137 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -64.15 157.29 70.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 117.927 0.864 . . . . 0.0 112.365 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.88 141.09 46.84 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.554 2.836 . . . . 0.0 115.621 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.95 122.91 24.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 110.019 167.126 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.19 123.18 18.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -72.94 -13.74 61.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.997 0.919 . . . . 0.0 112.64 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 -8.93 2.17 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 119.046 0.839 . . . . 0.0 114.14 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -89.59 11.26 20.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.737 1.615 . . . . 0.0 111.586 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 12.87 58.95 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.861 1.22 . . . . 0.0 113.836 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -131.01 163.39 27.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.835 1.317 . . . . 0.0 112.497 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 123.41 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.176 1.79 . . . . 0.0 107.765 164.071 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.57 124.72 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.92 146.82 45.92 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.686 1.194 . . . . 0.0 110.682 169.583 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.99 135.28 53.82 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.094 0.958 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.7 mt -117.17 161.09 20.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.29 1.436 . . . . 0.0 109.838 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -120.34 139.54 52.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.246 1.019 . . . . 0.0 109.781 163.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.59 93.32 9.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.521 1.128 . . . . 0.0 109.827 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -72.72 32.21 0.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.88 2.472 . . . . 0.0 115.08 -165.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.42 178.57 45.3 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 122.777 1.209 . . . . 0.0 116.055 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.37 -24.96 29.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.092 2.557 . . . . 0.0 115.655 -169.573 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.25 173.61 15.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.091 0.956 . . . . 0.0 111.744 -153.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' ' HD3' ' A' ' 44' ' ' PRO . . . 118.85 50.88 0.31 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-O 117.131 -1.927 . . . . 0.0 116.301 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 43' ' ' GLY . 36.2 Cg_exo -54.69 87.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.026 0 CA-C-N 121.628 2.714 . . . . 0.0 112.089 160.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.76 169.54 20.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.56 1.144 . . . . 0.0 112.671 -167.378 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -91.26 92.98 8.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.785 1.234 . . . . 0.0 109.889 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.51 119.81 43.13 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.882 0.873 . . . . 0.0 112.87 -170.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.75 88.24 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.358 2.705 . . . . 0.0 109.985 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -123.86 144.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.4 1.48 . . . . 0.0 108.567 167.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.8 t -154.59 167.85 28.73 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.2 t -142.27 125.64 16.6 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.53 2.332 . . . . 0.0 109.877 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.3 m -139.24 167.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.239 1.016 . . . . 0.0 113.657 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.56 22.61 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -155.32 36.05 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.036 -1.665 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.17 10.03 1.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.288 2.235 . . . . 0.0 114.723 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -68.78 46.28 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 129.575 3.15 . . . . 0.0 113.906 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.6 t70 -66.25 -2.46 4.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -166.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.65 -12.15 2.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.553 1.141 . . . . 0.0 113.672 159.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.6 m -155.0 99.82 2.35 Favored Pre-proline 0 CA--C 1.536 0.409 0 O-C-N 120.304 -1.497 . . . . 0.0 109.468 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.61 126.84 15.08 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.293 3.329 . . . . 0.0 112.619 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.49 -34.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.642 1.177 . . . . 0.0 110.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.48 -170.07 40.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.181 1.372 . . . . 0.0 111.15 161.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.5 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.3 ptp85 -134.99 171.99 13.65 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.208 1.403 . . . . 0.0 111.997 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.412 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -90.32 124.25 34.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.415 1.886 . . . . 0.0 107.452 168.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -95.69 -53.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 118.468 0.576 . . . . 0.0 111.088 -171.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -41.3 89.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.63 150.08 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.946 0.899 . . . . 0.0 109.786 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -68.75 147.46 97.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 122.178 -0.326 . . . . 0.0 110.133 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.96 76.82 4.35 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.314 2.676 . . . . 0.0 113.54 -160.488 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.35 124.99 14.91 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.168 -0.957 . . . . 0.0 111.129 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.53 91.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.253 1.421 . . . . 0.0 107.228 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 t -57.67 -28.28 63.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.7 m -151.53 158.76 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.262 1.825 . . . . 0.0 111.898 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.43 -24.02 67.48 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.395 1.078 . . . . 0.0 112.858 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.68 0.66 0.74 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 129.694 3.197 . . . . 0.0 114.503 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.97 8.98 0.77 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.83 1.652 . . . . 0.0 115.072 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -61.63 18.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 130.648 3.579 . . . . 0.0 116.022 -169.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.09 174.98 11.06 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.903 2.481 . . . . 0.0 114.43 -171.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.5 97.72 5.14 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.131 2.572 . . . . 0.0 107.13 170.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.02 119.03 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -148.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mt -59.44 142.38 52.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.001 1.72 . . . . 0.0 112.432 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.8 148.0 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 127.571 2.348 . . . . 0.0 108.377 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -99.19 139.5 34.75 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.354 1.062 . . . . 0.0 111.724 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.3 165.78 15.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.42 2.288 . . . . 0.0 109.55 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.5 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 7.9 tt0 -95.57 116.93 66.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.642 1.177 . . . . 0.0 109.425 170.793 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -98.35 107.14 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.856 4.371 . . . . 0.0 112.349 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -45.76 150.89 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.046 3.164 . . . . 0.0 115.167 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -81.71 162.16 23.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.686 0.795 . . . . 0.0 112.632 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.11 -88.02 0.88 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -162.875 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.65 148.08 41.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.995 1.318 . . . . 0.0 110.412 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.58 106.83 5.5 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.497 1.119 . . . . 0.0 109.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -110.12 129.16 55.74 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.438 -0.789 . . . . 0.0 110.34 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.16 111.7 36.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 126.378 1.871 . . . . 0.0 107.917 -168.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.08 135.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.852 0.861 . . . . 0.0 110.118 -160.732 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.22 100.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.04 1.736 . . . . 0.0 108.525 -168.058 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.97 -175.61 19.97 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 122.242 0.912 . . . . 0.0 114.959 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -138.85 141.09 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.374 1.87 . . . . 0.0 109.789 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 16.28 -87.68 0.0 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.213 2.816 . . . . 0.0 116.255 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -70.06 -20.39 63.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -176.673 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -139.51 96.7 3.13 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.424 1.49 . . . . 0.0 110.382 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 159.06 43.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.48 164.07 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.852 2.461 . . . . 0.0 108.519 166.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -148.91 160.75 42.98 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.836 0.854 . . . . 0.0 109.74 166.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -136.16 167.45 21.25 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 109.93 166.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -120.86 161.47 21.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 112.426 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.33 157.65 42.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 128.927 2.891 . . . . 0.0 109.734 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -145.06 148.14 33.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.234 1.014 . . . . 0.0 109.017 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -153.05 116.83 4.76 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.821 . . . . 0.0 112.088 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.7 p 119.68 -0.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 131.146 3.778 . . . . 0.0 114.38 159.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.19 43.45 0.72 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.751 1.167 . . . . 0.0 111.687 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.3 t -88.32 -154.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.497 1.919 . . . . 0.0 112.313 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.5 p -46.95 -31.38 3.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.374 2.669 . . . . 0.0 116.577 -167.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -112.77 11.23 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 125.299 1.44 . . . . 0.0 111.767 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.55 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.46 -1.4 . . . . 0.0 113.604 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 tptp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.969 1.708 . . . . 0.0 112.499 -168.837 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 173.54 12.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.297 2.239 . . . . 0.0 110.454 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -115.07 -53.41 2.63 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -45.28 -53.03 8.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 114.179 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.73 -29.1 67.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.801 0.84 . . . . 0.0 113.057 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.21 -14.78 60.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.93 1.292 . . . . 0.0 113.518 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -17.65 129.59 0.01 OUTLIER Glycine 0 CA--C 1.533 1.213 1 C-N-CA 130.986 4.136 . . . . 0.0 117.484 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 m -62.82 68.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.882 3.273 . . . . 0.0 113.569 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.783 2.033 . . . . 0.0 114.092 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -150.02 175.45 11.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.59 2.356 . . . . 0.0 109.521 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.25 38.0 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 111.787 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -74.36 97.3 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.01 173.33 16.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.949 1.3 . . . . 0.0 111.812 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 90.3 p -151.14 -22.49 0.21 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.794 1.237 . . . . 0.0 114.321 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? 56.58 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 129.974 3.31 . . . . 0.0 115.696 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.89 74.9 1.61 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.07 1.348 . . . . 0.0 111.471 -159.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.43 160.5 16.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.122 1.369 . . . . 0.0 109.709 160.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -134.14 143.59 48.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.285 1.834 . . . . 0.0 108.106 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -68.03 140.65 56.33 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.762 -0.586 . . . . 0.0 111.075 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.62 -57.05 2.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.61 1.164 . . . . 0.0 109.028 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 107.27 0.85 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.766 1.651 . . . . 0.0 110.466 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -42.67 137.23 2.44 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 111.21 170.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.89 152.15 52.28 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.299 2.0 . . . . 0.0 113.76 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.61 121.86 13.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.262 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.05 123.51 20.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.997 0.903 . . . . 0.0 110.804 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -63.38 -16.7 61.27 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.897 2.479 . . . . 0.0 114.352 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.93 -13.49 43.41 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.03 0.832 . . . . 0.0 113.174 -167.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -80.01 8.44 7.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.698 1.249 . . . . 0.0 112.063 165.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.74 84.42 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.532 -1.149 . . . . 0.0 113.949 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.0 p -125.91 146.6 49.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.143 2.177 . . . . 0.0 110.091 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.69 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.0 m -91.92 138.18 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.105 0.962 . . . . 0.0 111.003 173.129 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.424 ' HB ' HD21 ' A' ' 81' ' ' LEU . 2.5 m -85.81 133.45 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 155.879 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 126.15 16.81 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.57 2.348 . . . . 0.0 109.043 -167.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.12 134.29 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.574 1.079 . . . . 0.0 113.471 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.29 174.27 9.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.814 1.645 . . . . 0.0 111.109 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -135.67 139.44 43.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.431 1.092 . . . . 0.0 110.394 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -89.05 102.99 15.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.319 0.648 . . . . 0.0 110.039 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -80.39 -9.11 59.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 113.535 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.27 166.04 54.67 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.043 0.838 . . . . 0.0 113.394 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -118.95 11.76 12.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.862 1.665 . . . . 0.0 110.531 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -157.71 -178.6 7.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.913 2.485 . . . . 0.0 110.208 -156.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.98 58.98 2.38 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.255 1.662 . . . . 0.0 117.255 164.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -51.94 109.01 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.936 2.424 . . . . 0.0 111.072 155.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.56 155.64 19.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -164.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -81.16 91.15 6.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.543 1.537 . . . . 0.0 109.482 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.35 116.19 14.07 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.938 0.895 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.37 82.22 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 111.269 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -105.96 145.0 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 167.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -154.03 170.33 21.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.152 1.381 . . . . 0.0 113.048 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -144.31 117.16 8.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.445 2.298 . . . . 0.0 110.637 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 57' ' ' ASP . 13.9 m -140.72 169.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.678 1.191 . . . . 0.0 112.945 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.93 -3.51 21.68 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -154.78 30.84 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.01 -1.681 . . . . 0.0 112.528 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.8 7.98 1.65 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.462 1.905 . . . . 0.0 114.286 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -69.52 46.48 0.07 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.875 3.27 . . . . 0.0 113.474 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.0 t0 -62.84 -7.42 5.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -163.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -58.31 -23.54 56.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.252 1.421 . . . . 0.0 112.96 162.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.0 m -132.71 95.64 19.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 125.652 1.581 . . . . 0.0 109.407 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 123.31 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.108 2.538 . . . . 0.0 110.916 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.17 -22.35 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.365 1.066 . . . . 0.0 111.181 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.48 -170.23 18.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.938 2.208 . . . . 0.0 111.797 165.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.418 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.6 ptp85 -138.16 172.82 12.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.918 1.287 . . . . 0.0 112.59 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 126.79 39.24 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 106.809 167.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -98.63 -41.66 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.62 -168.173 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -63.07 -50.29 71.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.127 0.876 . . . . 0.0 113.319 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 p -164.29 166.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.335 1.054 . . . . 0.0 111.428 -165.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.06 123.5 48.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.872 0.869 . . . . 0.0 109.164 161.46 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.26 95.86 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.081 1.854 . . . . 0.0 111.131 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -146.46 142.84 28.52 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.398 -0.814 . . . . 0.0 112.612 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.59 95.86 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 126.858 2.063 . . . . 0.0 106.25 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.4 p -70.24 -22.1 62.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.4 m -150.8 157.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.853 1.661 . . . . 0.0 112.065 -170.178 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.61 65.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.974 0.91 . . . . 0.0 113.275 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.8 p -78.56 8.11 5.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.6 1.96 . . . . 0.0 113.711 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 12.82 0.07 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.921 1.689 . . . . 0.0 115.357 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.38 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.793 3.237 . . . . 0.0 115.243 -167.022 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.23 163.22 28.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.19 1.796 . . . . 0.0 113.389 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -98.82 111.1 23.58 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 128.244 2.618 . . . . 0.0 106.045 159.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.72 140.3 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.319 1.048 . . . . 0.0 112.62 -157.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 33' ' ' VAL . 2.8 tm? -105.84 131.64 52.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.963 2.505 . . . . 0.0 109.536 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.95 155.12 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.457 1.903 . . . . 0.0 109.522 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -109.0 132.25 54.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.578 . . . . 0.0 110.62 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.57 160.71 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.857 1.663 . . . . 0.0 110.103 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 32.0 tt0 -101.62 104.58 35.46 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.167 0.987 . . . . 0.0 109.079 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.69 ' HG3' HG13 ' A' ' 32' ' ' VAL . 73.8 Cg_endo -83.38 118.35 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.274 3.316 . . . . 0.0 109.654 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.4 160.61 49.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.215 1.943 . . . . 0.0 111.082 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -66.09 159.57 25.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.545 1.138 . . . . 0.0 112.645 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.55 -148.23 18.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.581 1.086 . . . . 0.0 110.566 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.04 146.0 55.59 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.68 -0.894 . . . . 0.0 109.048 152.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -135.37 100.56 4.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.729 0.812 . . . . 0.0 109.621 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -109.08 132.62 53.94 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.084 0.945 . . . . 0.0 111.025 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.01 99.33 8.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 127.866 2.466 . . . . 0.0 107.151 -166.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.8 t -101.08 139.44 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.461 0.704 . . . . 0.0 109.483 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.62 87.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.29 1.436 . . . . 0.0 108.369 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.83 168.52 29.14 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 118.243 2.057 . . . . 0.0 118.243 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.56 146.35 37.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.86 1.664 . . . . 0.0 109.512 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.25 -98.5 0.01 OUTLIER Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.398 1.951 . . . . 0.0 115.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -90.11 -13.55 35.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.992 1.717 . . . . 0.0 114.317 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.49 90.36 3.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.569 1.548 . . . . 0.0 109.291 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.4 155.06 45.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.8 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 129.178 2.991 . . . . 0.0 108.098 170.7 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.29 156.38 38.31 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.396 -0.815 . . . . 0.0 110.95 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.31 160.83 32.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.286 2.235 . . . . 0.0 109.231 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.38 144.88 40.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.839 0.456 . . . . 0.0 111.433 -168.013 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.67 169.94 16.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.935 1.694 . . . . 0.0 111.226 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.29 117.24 14.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.077 1.751 . . . . 0.0 108.112 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -141.03 87.32 2.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 112.793 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.9 m 54.65 63.62 2.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.749 2.02 . . . . 0.0 113.521 168.336 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.57 12.68 0.78 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.438 1.494 . . . . 0.0 114.101 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.5 t -75.53 158.19 32.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.734 1.214 . . . . 0.0 112.961 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 m -40.34 -33.94 0.29 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 130.326 3.45 . . . . 0.0 114.54 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.21 -7.51 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.358 1.063 . . . . 0.0 113.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.53 55.17 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 118.844 -0.975 . . . . 0.0 115.464 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 C-N-CA 125.104 1.362 . . . . 0.0 112.396 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 162.34 36.51 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.229 0.611 . . . . 0.0 111.676 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 -172.68 2.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.16 2.184 . . . . 0.0 110.773 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -106.72 -57.68 2.03 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.518 -0.738 . . . . 0.0 110.702 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -53.47 -34.41 57.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.579 2.352 . . . . 0.0 114.876 -172.126 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.87 -22.03 66.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.364 0.984 . . . . 0.0 112.91 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -82.72 -2.49 54.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.708 0.803 . . . . 0.0 112.698 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -20.07 113.74 0.01 OUTLIER Glycine 0 CA--C 1.532 1.102 1 C-N-CA 130.818 4.056 . . . . 0.0 116.64 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.401 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 82.0 p -67.52 72.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.86 2.464 . . . . 0.0 113.897 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.0 p -74.27 -19.89 60.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.021 1.728 . . . . 0.0 114.172 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.66 170.53 16.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.981 2.112 . . . . 0.0 109.558 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.72 142.82 34.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.119 0.866 . . . . 0.0 112.588 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.41 103.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.65 1.18 . . . . 0.0 112.607 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 148.24 17.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.603 2.361 . . . . 0.0 109.064 -171.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -141.0 -21.9 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 45.36 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.983 3.313 . . . . 0.0 115.328 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.81 80.41 1.58 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.577 1.551 . . . . 0.0 110.571 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -124.62 155.92 38.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.366 1.066 . . . . 0.0 110.684 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -143.85 146.81 33.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.839 1.656 . . . . 0.0 108.493 166.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -69.43 140.28 54.08 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.761 -0.587 . . . . 0.0 111.27 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.58 -44.04 4.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.431 1.092 . . . . 0.0 109.812 168.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.62 117.01 1.15 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.458 1.027 . . . . 0.0 112.419 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.9 m -45.59 146.76 1.68 Allowed Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 127.934 2.494 . . . . 0.0 112.465 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.95 135.79 36.4 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.099 2.533 . . . . 0.0 113.467 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.77 111.54 13.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.025 1.73 . . . . 0.0 110.023 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.31 122.06 12.97 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.33 1.452 . . . . 0.0 111.432 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.1 p -75.46 -11.33 60.01 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.58 -26.79 0.37 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.779 1.18 . . . . 0.0 113.866 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.47 -9.74 57.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.518 2.327 . . . . 0.0 112.968 174.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.33 14.09 12.26 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.817 1.199 . . . . 0.0 114.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 p -128.43 171.14 12.34 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.26 1.424 . . . . 0.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 m -128.82 120.21 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.904 1.682 . . . . 0.0 109.087 171.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.59 133.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.08 130.23 35.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.346 1.858 . . . . 0.0 108.645 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -109.63 128.57 55.32 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.326 0.584 . . . . 0.0 112.388 -174.394 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.52 167.97 12.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.001 1.321 . . . . 0.0 110.501 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.41 142.45 51.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.658 1.183 . . . . 0.0 109.851 162.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -94.1 101.26 13.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -76.3 7.95 3.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.101 2.16 . . . . 0.0 115.265 -169.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.56 169.76 21.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.66 1.118 . . . . 0.0 113.859 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -103.12 -0.45 30.6 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.323 1.849 . . . . 0.0 113.666 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -136.72 173.71 11.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.246 1.818 . . . . 0.0 112.33 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 56.81 1.04 Allowed Glycine 0 CA--C 1.539 1.535 0 CA-C-O 117.823 -1.543 . . . . 0.0 116.719 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.17 99.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.29 2.66 . . . . 0.0 111.897 155.152 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 m -151.47 166.72 30.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.399 1.08 . . . . 0.0 112.548 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 3.7 ttmm -92.58 98.98 11.79 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.811 170.067 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.32 117.31 39.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.01 1.324 . . . . 0.0 111.353 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.53 85.62 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.658 2.905 . . . . 0.0 111.565 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.89 146.79 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.937 0.895 . . . . 0.0 109.966 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 t -149.65 167.35 26.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.01 1.324 . . . . 0.0 113.524 -167.056 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 t -142.66 107.55 4.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.284 2.233 . . . . 0.0 110.974 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 57' ' ' ASP . 20.9 m -136.15 163.72 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.04 -7.46 16.92 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -166.631 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -154.04 34.75 0.43 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.385 -1.447 . . . . 0.0 111.368 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt 57.71 12.77 1.73 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.7 2.0 . . . . 0.0 114.546 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.9 p-10 -67.01 45.83 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 130.141 3.376 . . . . 0.0 114.345 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.1 t70 -63.68 -9.2 12.77 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -165.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.44 -10.36 2.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.399 1.48 . . . . 0.0 114.218 162.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.4 m -155.49 118.86 2.41 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 110.541 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.3 141.32 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.214 2.609 . . . . 0.0 111.116 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.5 t -116.58 -34.27 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.945 0.898 . . . . 0.0 110.967 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.45 -167.43 39.56 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.846 1.212 . . . . 0.0 110.753 156.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.9 ptp85 -135.33 172.04 13.58 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.916 1.286 . . . . 0.0 111.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.51 139.72 31.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 161.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.38 -49.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.194 0.597 . . . . 0.0 110.754 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.4 m -57.87 -43.58 86.1 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.97 161.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.996 0.816 . . . . 0.0 111.061 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.64 117.45 18.95 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 156.739 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.92 93.81 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.387 2.058 . . . . 0.0 111.783 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -144.82 135.07 24.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.114 1.365 . . . . 0.0 111.276 168.162 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.11 89.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 127.609 2.364 . . . . 0.0 107.151 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -63.38 -32.02 73.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.92 156.85 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.983 2.113 . . . . 0.0 110.914 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.04 -25.46 67.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.794 0.838 . . . . 0.0 112.436 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 4.66 5.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.057 2.143 . . . . 0.0 114.599 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 13.46 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 130.924 3.69 . . . . 0.0 115.219 -169.318 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.91 173.89 10.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.593 1.957 . . . . 0.0 113.667 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -117.0 108.84 16.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.615 3.166 . . . . 0.0 105.77 169.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.06 127.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.632 0.773 . . . . 0.0 112.967 -154.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mt -79.52 135.52 36.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.777 2.031 . . . . 0.0 110.911 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.96 129.35 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.089 2.155 . . . . 0.0 108.395 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -81.1 134.26 35.62 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.782 0.801 . . . . 0.0 111.667 170.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.06 161.59 18.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.973 2.109 . . . . 0.0 109.38 162.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 22.7 tt0 -94.41 125.06 53.49 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 167.407 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.25 128.22 7.99 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 124.294 3.329 . . . . 0.0 111.036 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.7 168.68 20.79 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.299 1.333 . . . . 0.0 110.599 160.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.34 162.71 15.67 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.247 -0.908 . . . . 0.0 112.287 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.08 -83.97 1.6 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -117.97 170.01 9.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.313 1.054 . . . . 0.0 110.8 169.242 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.9 m -145.73 84.75 1.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.319 1.447 . . . . 0.0 108.881 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.36 128.83 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.412 1.085 . . . . 0.0 109.048 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.92 94.59 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.978 1.711 . . . . 0.0 107.749 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.46 145.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.689 0.795 . . . . 0.0 109.915 -166.116 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.3 94.39 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 108.132 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.73 167.67 28.74 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 119.262 2.465 . . . . 0.0 119.262 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.39 109.66 6.51 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.064 2.546 . . . . 0.0 109.274 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.43 -102.03 0.04 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.792 1.663 . . . . 0.0 114.215 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.79 -18.97 62.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 115.151 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.73 94.64 4.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.001 0.92 . . . . 0.0 108.913 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.63 43.69 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.82 167.88 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 128.754 2.822 . . . . 0.0 108.569 170.156 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.02 149.16 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.872 0.869 . . . . 0.0 110.805 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.27 163.39 19.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.994 2.117 . . . . 0.0 109.232 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -138.37 130.73 28.89 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.757 -0.59 . . . . 0.0 110.059 -161.349 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.19 165.7 28.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.352 1.061 . . . . 0.0 111.62 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -144.06 116.45 8.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.956 1.303 . . . . 0.0 109.423 -160.758 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -144.68 87.63 1.87 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -164.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 76.6 p 59.39 84.6 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.364 1.865 . . . . 0.0 113.81 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.36 23.84 6.46 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.759 1.647 . . . . 0.0 112.751 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.4 t -58.42 162.86 3.42 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.021 1.728 . . . . 0.0 114.013 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -56.37 -15.12 3.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.28 1.032 . . . . 0.0 113.612 163.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.45 3.38 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 126.181 1.792 . . . . 0.0 111.551 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.97 -11.5 71.93 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 119.95 -1.719 . . . . 0.0 116.124 169.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--O 1.249 1.04 0 CA-C-N 118.904 1.352 . . . . 0.0 113.094 171.174 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -69.05 -178.96 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.056 2.142 . . . . 0.0 113.197 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.38 155.76 45.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.506 2.722 . . . . 0.0 110.827 -163.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -88.66 -61.73 1.64 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.454 -0.779 . . . . 0.0 111.757 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -60.04 -31.91 70.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.178 1.391 . . . . 0.0 113.938 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -4.97 46.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.121 0.968 . . . . 0.0 112.997 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -57.72 -31.44 66.44 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 81.15 0.57 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -68.4 -6.64 25.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.453 1.901 . . . . 0.0 114.81 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -75.12 0.97 14.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -170.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -141.76 154.08 45.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.877 1.217 . . . . 0.0 112.039 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 160.22 45.29 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.648 1.118 . . . . 0.0 112.708 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.38 95.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 122.641 1.21 . . . . 0.0 114.076 -167.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 171.28 19.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.95 1.7 . . . . 0.0 111.247 167.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -150.42 -3.22 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.097 152.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 53.98 -75.95 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.191 2.597 . . . . 0.0 113.586 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.33 74.34 5.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.18 1.792 . . . . 0.0 112.837 -163.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.67 149.2 52.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.635 0.774 . . . . 0.0 111.124 166.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -138.31 141.25 39.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.775 1.63 . . . . 0.0 109.827 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -61.7 128.69 37.46 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.057 0.943 . . . . 0.0 110.603 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.34 -26.23 6.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.063 0.945 . . . . 0.0 112.854 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.04 123.93 2.82 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.367 0.984 . . . . 0.0 111.037 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.0 p -62.54 144.2 95.86 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 125.162 1.385 . . . . 0.0 111.427 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.96 148.33 47.88 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.818 2.345 . . . . 0.0 115.142 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.38 128.15 20.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.723 1.609 . . . . 0.0 110.854 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.71 132.29 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.552 0.741 . . . . 0.0 111.048 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -78.77 -9.55 59.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.586 1.554 . . . . 0.0 113.944 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.36 -2.84 9.08 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.21 0.913 . . . . 0.0 113.891 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -103.39 5.9 37.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.94 1.696 . . . . 0.0 111.704 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.41 13.76 50.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.961 1.267 . . . . 0.0 114.083 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.9 p -129.67 168.33 16.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.272 1.429 . . . . 0.0 111.565 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.78 130.73 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.915 1.686 . . . . 0.0 108.37 164.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 m -83.28 124.77 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 160.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 154.2 49.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.645 1.178 . . . . 0.0 110.553 170.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -119.61 134.4 55.24 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.202 -0.936 . . . . 0.0 111.675 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.77 163.13 22.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.159 0.984 . . . . 0.0 111.02 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -126.55 137.11 53.31 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.796 1.239 . . . . 0.0 110.011 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.13 97.34 11.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.038 0.935 . . . . 0.0 110.373 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.9 p -77.43 43.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.519 1.928 . . . . 0.0 113.688 -166.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.56 -177.77 48.51 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.071 -1.018 . . . . 0.0 114.869 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -116.41 0.76 12.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.485 1.514 . . . . 0.0 114.295 -167.691 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -145.96 173.8 11.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.421 1.489 . . . . 0.0 112.546 -169.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.53 48.24 0.87 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 166.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.04 107.0 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.574 2.849 . . . . 0.0 113.03 164.18 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.86 165.17 18.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.348 0.659 . . . . 0.0 112.523 -164.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.35 6.57 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.365 -1.459 . . . . 0.0 111.49 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.75 114.34 5.64 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.908 1.683 . . . . 0.0 113.562 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.82 84.58 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.114 2.543 . . . . 0.0 111.213 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -125.04 144.91 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.962 1.305 . . . . 0.0 109.531 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -146.74 162.11 39.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.811 1.245 . . . . 0.0 112.883 -172.215 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -142.0 110.88 6.23 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.749 2.02 . . . . 0.0 110.164 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 57' ' ' ASP . 18.4 m -140.01 170.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.315 1.046 . . . . 0.0 111.95 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.17 -4.63 21.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -152.17 30.84 0.55 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.906 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.84 25.4 8.46 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.41 1.484 . . . . 0.0 112.394 -173.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.437 HD21 ' CG2' ' A' ' 61' ' ' VAL . 12.5 p-10 -91.61 50.99 1.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.122 2.569 . . . . 0.0 112.201 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.5 m-20 -56.29 -11.11 1.06 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.483 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -9.92 11.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.909 1.283 . . . . 0.0 114.359 164.428 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.4 m -149.06 95.62 3.84 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.159 -1.588 . . . . 0.0 110.17 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.53 86.98 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 1 C-N-CA 125.639 4.226 . . . . 0.0 115.883 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.1 t -67.66 -33.96 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.893 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 -161.56 27.52 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.427 1.965 . . . . 0.0 112.045 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -146.96 177.69 8.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.09 1.756 . . . . 0.0 112.509 169.849 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.37 117.98 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.613 2.365 . . . . 0.0 107.604 171.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.7 t -90.51 -58.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 111.109 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -59.01 -44.33 91.67 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.593 0.633 . . . . 0.0 112.525 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.44 139.3 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 160.36 77.57 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 159.302 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.6 77.41 3.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 115.303 -156.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -145.71 127.34 15.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.495 -1.378 . . . . 0.0 114.592 154.763 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.31 100.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.764 1.626 . . . . 0.0 106.889 166.511 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 t -77.86 -6.86 55.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.74 149.52 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.504 1.047 . . . . 0.0 111.956 -170.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.95 -21.9 66.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.719 1.208 . . . . 0.0 113.061 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.12 0.32 6.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.183 2.593 . . . . 0.0 114.47 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 10.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.09 13.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 131.475 3.91 . . . . 0.0 116.06 -166.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.18 168.53 19.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.375 1.87 . . . . 0.0 114.184 -169.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.52 109.09 20.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.304 2.642 . . . . 0.0 105.946 158.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.05 125.3 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.017 0.927 . . . . 0.0 112.412 -159.39 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.31 133.01 43.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.189 0.996 . . . . 0.0 109.447 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.5 mt -128.58 143.33 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.131 1.772 . . . . 0.0 107.976 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -98.4 137.21 37.44 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.76 0.791 . . . . 0.0 111.571 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.83 164.31 17.7 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.01 2.124 . . . . 0.0 108.899 166.92 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 26.0 tt0 -100.39 107.18 46.79 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.922 1.289 . . . . 0.0 108.392 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.8 108.31 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.894 1 C-N-CA 126.581 4.854 . . . . 0.0 111.236 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -64.15 161.0 35.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.988 1.792 . . . . 0.0 110.77 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -94.56 166.69 11.91 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.8 -78.97 1.0 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.86 150.7 42.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 110.184 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -136.86 97.9 3.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.693 1.197 . . . . 0.0 109.157 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -95.43 123.53 39.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.608 1.163 . . . . 0.0 109.933 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.98 98.43 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.982 2.113 . . . . 0.0 107.153 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.22 139.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.91 -165.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.89 103.33 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.766 1.626 . . . . 0.0 108.698 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 145.68 172.36 15.99 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 172.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -132.75 143.63 49.73 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.166 1.787 . . . . 0.0 109.875 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 17.06 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 127.741 2.591 . . . . 0.0 116.354 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -74.72 -15.3 60.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.203 2.201 . . . . 0.0 116.72 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -137.88 100.38 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.134 1.374 . . . . 0.0 110.747 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -142.65 160.73 39.73 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.97 165.96 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 128.814 2.846 . . . . 0.0 108.3 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.64 167.6 25.93 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.973 -1.079 . . . . 0.0 110.613 166.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -131.73 158.97 39.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.041 1.337 . . . . 0.0 109.052 163.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -112.59 160.17 18.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.239 1.416 . . . . 0.0 110.867 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.11 155.83 36.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.131 1.773 . . . . 0.0 109.212 168.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.66 143.41 30.73 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.097 0.959 . . . . 0.0 108.753 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -134.96 158.49 44.18 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.247 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.9 p 67.96 -1.65 1.67 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.3 42.07 3.08 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.395 0.998 . . . . 0.0 112.35 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -84.83 -144.59 0.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.973 1.709 . . . . 0.0 111.934 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.3 p -46.7 -46.36 20.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.59 1.956 . . . . 0.0 115.549 -166.601 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.02 8.26 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 125.539 1.536 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.75 25.52 60.3 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.248 -1.533 . . . . 0.0 112.848 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 tptp . . . . . 0 C--O 1.247 0.944 0 C-N-CA 126.941 2.096 . . . . 0.0 111.881 -166.771 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -147.07 150.31 34.79 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.093 0.957 . . . . 0.0 110.766 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.39 173.88 11.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.859 2.464 . . . . 0.0 110.858 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -91.93 -59.61 2.07 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.408 -0.807 . . . . 0.0 112.664 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -58.17 -36.78 73.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.787 1.235 . . . . 0.0 113.632 -168.197 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.05 -15.56 59.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.538 1.135 . . . . 0.0 113.318 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -85.54 -11.11 54.91 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.293 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 18.37 84.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 130.139 3.733 . . . . 0.0 118.453 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -72.5 71.74 0.96 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.102 -1.234 . . . . 0.0 111.839 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p -78.36 -20.07 52.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.118 1.367 . . . . 0.0 114.551 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.25 -178.82 7.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.33 130.96 51.77 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.484 1.04 . . . . 0.0 112.663 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.82 102.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.662 1.185 . . . . 0.0 111.93 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 155.9 22.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.418 1.887 . . . . 0.0 110.008 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -160.38 -41.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.543 1.137 . . . . 0.0 111.223 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt 65.65 -65.46 0.17 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.385 2.674 . . . . 0.0 113.333 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.74 79.0 1.21 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.445 1.098 . . . . 0.0 111.434 -161.086 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -126.5 160.09 31.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.449 1.5 . . . . 0.0 110.09 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -142.23 147.68 36.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 108.997 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -61.82 127.89 33.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.126 0.57 . . . . 0.0 110.99 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.55 -48.4 4.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.189 0.996 . . . . 0.0 108.988 168.524 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.97 105.69 0.68 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.491 1.996 . . . . 0.0 109.748 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 p -57.96 156.31 20.01 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.627 0.771 . . . . 0.0 111.478 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.76 141.87 80.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.951 1.767 . . . . 0.0 113.166 -165.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 119.8 14.78 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.449 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 32' ' ' VAL . 9.5 t0 -65.32 118.99 10.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.28 1.038 . . . . 0.0 110.56 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.9 p -68.9 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 114.309 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.99 56.0 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.301 -160.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -69.53 -12.42 61.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.013 1.906 . . . . 0.0 111.296 162.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.16 -3.69 40.87 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 126.667 2.08 . . . . 0.0 113.155 -167.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -129.73 152.86 48.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.795 2.038 . . . . 0.0 111.599 -166.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 86' ' ' PRO . 1.2 m -93.64 126.06 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 0.0 110.327 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 m -78.43 136.66 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 161.136 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -141.81 131.48 24.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.084 2.154 . . . . 0.0 108.138 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -118.94 131.9 56.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.825 0.739 . . . . 0.0 112.04 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.54 162.21 19.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.345 0.658 . . . . 0.0 110.703 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -115.51 129.55 56.58 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.849 1.259 . . . . 0.0 109.015 165.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.89 100.47 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.07 0.948 . . . . 0.0 109.392 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 p -78.39 -4.44 48.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.539 1.536 . . . . 0.0 114.624 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.92 169.24 12.88 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 119.311 0.96 . . . . 0.0 114.697 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -106.83 0.86 24.32 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.447 1.899 . . . . 0.0 113.244 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -138.49 -175.05 3.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.115 1.766 . . . . 0.0 111.316 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.51 45.61 1.95 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.892 -2.06 . . . . 0.0 117.523 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -54.73 102.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.984 0 CA-C-N 122.057 2.928 . . . . 0.0 111.042 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.5 m -156.92 171.17 20.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 112.624 -164.067 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -94.08 99.98 12.17 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.63 -1.294 . . . . 0.0 109.954 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.39 126.38 84.32 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.459 0.704 . . . . 0.0 112.603 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.37 101.63 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.711 2.941 . . . . 0.0 111.884 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.0 tt -133.47 146.55 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.144 0.978 . . . . 0.0 109.855 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -148.76 160.67 42.97 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 t -138.19 116.7 12.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.073 2.149 . . . . 0.0 110.218 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 57' ' ' ASP . 15.6 m -134.62 164.57 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.556 1.142 . . . . 0.0 112.24 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.16 -10.18 28.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -154.79 34.34 0.4 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.085 -1.634 . . . . 0.0 112.625 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.78 11.4 1.83 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.477 1.911 . . . . 0.0 113.958 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.469 HD21 ' CG2' ' A' ' 61' ' ' VAL . 9.2 p-10 -69.83 51.32 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.032 2.933 . . . . 0.0 113.026 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.9 t0 -59.14 -16.38 19.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.839 1.655 . . . . 0.0 115.349 -165.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.24 -8.86 1.23 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.487 1.515 . . . . 0.0 114.876 169.202 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 m -155.13 104.57 2.25 Favored Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 120.203 -1.561 . . . . 0.0 111.063 166.555 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.42 115.69 1.06 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.164 3.909 . . . . 0.0 113.882 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.2 t -97.58 -22.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.931 1.692 . . . . 0.0 111.501 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.11 26.3 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.868 1.699 . . . . 0.0 111.041 163.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 176.78 7.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.11 106.82 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.726 2.411 . . . . 0.0 106.374 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -78.41 -45.58 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.734 0.813 . . . . 0.0 110.69 -166.529 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -69.78 -41.4 75.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.11 149.96 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.833 1.197 . . . . 0.0 113.54 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -61.74 119.73 50.34 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.361 1.464 . . . . 0.0 109.762 162.569 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.34 90.22 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.109 2.539 . . . . 0.0 113.69 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.56 126.27 12.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.501 1.921 . . . . 0.0 111.515 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.3 88.84 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.729 2.012 . . . . 0.0 108.263 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.4 t -70.6 -8.94 55.4 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.69 155.35 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.906 1.23 . . . . 0.0 112.287 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.66 -19.71 62.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.125 0.97 . . . . 0.0 112.698 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.0 p -77.54 9.79 3.08 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.086 1.754 . . . . 0.0 113.133 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.63 10.23 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.302 1.841 . . . . 0.0 115.235 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.03 22.85 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 130.27 3.428 . . . . 0.0 115.139 -165.087 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.2 165.73 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.797 2.039 . . . . 0.0 114.183 -170.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 109.06 21.16 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.315 2.646 . . . . 0.0 106.269 160.993 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.33 121.85 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 111.964 -156.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.57 128.05 40.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.056 2.542 . . . . 0.0 109.942 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.69 129.53 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.228 2.211 . . . . 0.0 108.34 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.04 138.53 33.03 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.468 -0.77 . . . . 0.0 111.022 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.94 157.59 29.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.285 2.234 . . . . 0.0 109.039 166.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -97.73 109.68 51.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.193 0.997 . . . . 0.0 109.24 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.634 ' HG3' HG13 ' A' ' 32' ' ' VAL . 54.9 Cg_endo -93.03 116.64 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 125.263 3.975 . . . . 0.0 110.287 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.6 158.16 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.163 3.242 . . . . 0.0 115.552 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -75.52 161.15 29.42 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.16 -0.963 . . . . 0.0 112.502 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.65 -79.04 1.8 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.52 158.44 44.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.492 1.117 . . . . 0.0 110.446 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.5 m -158.87 156.84 30.33 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.929 -1.107 . . . . 0.0 112.264 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -145.71 136.74 24.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.484 1.113 . . . . 0.0 109.089 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 mm -120.52 114.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.301 1.841 . . . . 0.0 107.158 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.72 141.31 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.418 0.687 . . . . 0.0 109.849 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.82 101.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.171 2.188 . . . . 0.0 108.341 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.43 177.49 15.15 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.5 122.2 24.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.697 1.999 . . . . 0.0 110.632 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.26 -99.84 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.48 1.99 . . . . 0.0 114.807 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -68.46 -14.28 62.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.365 1.866 . . . . 0.0 115.758 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -136.14 98.67 3.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.44 1.096 . . . . 0.0 111.197 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.57 167.25 23.5 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.09 164.69 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.648 2.779 . . . . 0.0 108.639 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -150.99 164.57 36.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.464 0.706 . . . . 0.0 111.33 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -143.57 136.57 27.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.296 1.438 . . . . 0.0 110.439 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 162.57 23.36 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 113.071 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.74 150.63 35.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.684 1.993 . . . . 0.0 111.007 161.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -139.9 113.99 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.524 1.13 . . . . 0.0 108.156 -170.1 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -149.95 81.68 1.38 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.5 t 69.16 70.8 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.756 2.023 . . . . 0.0 113.876 165.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.61 21.1 2.03 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.739 2.114 . . . . 0.0 113.17 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.9 t -65.03 151.94 44.7 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.501 1.92 . . . . 0.0 113.591 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -61.59 -8.48 4.47 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 164.148 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.22 -4.38 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 127.019 2.128 . . . . 0.0 111.308 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.02 4.67 58.63 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.628 -1.295 . . . . 0.0 116.207 171.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 116.987 -1.482 . . . . 0.0 112.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.21 160.47 39.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.159 0.89 . . . . 0.0 112.432 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 145.32 50.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.131 2.173 . . . . 0.0 109.664 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.28 -54.43 8.4 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.17 -1.581 . . . . 0.0 112.426 -172.148 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -58.55 -29.8 66.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.902 1.681 . . . . 0.0 113.791 -170.872 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.91 -28.73 69.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.176 0.898 . . . . 0.0 112.841 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -19.42 62.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.388 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 9.46 105.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 130.584 3.945 . . . . 0.0 117.559 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -68.82 73.53 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.801 2.04 . . . . 0.0 113.602 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 p -71.93 -18.64 62.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.717 2.007 . . . . 0.0 114.676 168.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -156.16 176.31 12.84 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.382 1.473 . . . . 0.0 110.511 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.48 148.54 50.5 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.443 0.544 . . . . 0.0 112.496 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.08 97.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.66 1.184 . . . . 0.0 112.544 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.76 168.81 25.62 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.876 1.671 . . . . 0.0 111.193 166.365 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 47' ' ' VAL . 94.1 p -144.02 -30.43 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt 59.2 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.311 2.244 . . . . 0.0 112.536 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.36 83.19 3.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.128 0.971 . . . . 0.0 112.069 -167.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.29 165.25 23.82 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.486 1.514 . . . . 0.0 111.587 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -151.05 155.11 38.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.993 2.117 . . . . 0.0 109.627 166.512 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.95 140.26 57.74 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.275 -0.89 . . . . 0.0 111.742 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -38.57 3.11 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 176.226 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.23 103.97 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.211 1.386 . . . . 0.0 110.279 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -47.74 138.09 9.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.125 2.17 . . . . 0.0 112.221 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 130.83 42.67 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.015 2.477 . . . . 0.0 112.768 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.05 119.95 28.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.167 1.387 . . . . 0.0 110.158 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.25 129.72 40.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.84 0.829 . . . . 0.0 111.032 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.3 p -78.18 -8.69 58.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 127.077 2.151 . . . . 0.0 113.586 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.63 -5.35 23.35 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.336 0.971 . . . . 0.0 113.945 -168.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -96.12 3.17 53.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.812 1.306 . . . . 0.0 112.062 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.33 4.33 56.31 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.829 1.204 . . . . 0.0 113.941 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -123.72 165.12 17.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.255 1.422 . . . . 0.0 111.941 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -110.15 140.66 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.025 1.33 . . . . 0.0 109.543 162.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.06 125.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.8 0.84 . . . . 0.0 109.014 161.11 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 120.99 18.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.531 1.932 . . . . 0.0 109.208 -167.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.73 132.6 52.52 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.189 -0.944 . . . . 0.0 112.631 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.07 162.71 20.72 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.433 1.093 . . . . 0.0 110.462 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -117.66 134.27 55.07 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.157 0.983 . . . . 0.0 109.98 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -84.8 108.03 17.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.873 0.869 . . . . 0.0 109.668 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -82.92 -4.03 57.7 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.82 172.5 14.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.504 1.047 . . . . 0.0 114.718 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -109.18 6.08 24.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.209 1.804 . . . . 0.0 113.75 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -138.71 176.14 8.95 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.0 111.143 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.75 51.43 0.75 Allowed Glycine 0 CA--C 1.538 1.526 0 CA-C-O 117.288 -1.84 . . . . 0.0 117.168 167.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -54.21 111.12 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 121.399 2.599 . . . . 0.0 110.646 162.845 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.83 165.95 13.77 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.175 0.99 . . . . 0.0 111.76 -168.071 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -89.43 104.34 16.9 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 119.839 -1.788 . . . . 0.0 113.206 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 1.2 p -58.03 117.78 22.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.577 1.151 . . . . 0.0 112.352 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.35 82.61 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.411 2.741 . . . . 0.0 109.827 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.08 142.46 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.833 0.853 . . . . 0.0 109.457 169.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.9 t -151.38 159.73 44.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.632 0.773 . . . . 0.0 113.046 -167.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -132.54 113.55 13.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.003 2.521 . . . . 0.0 108.955 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 57' ' ' ASP . 35.5 m -133.75 170.24 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.464 1.106 . . . . 0.0 111.688 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.08 -11.44 20.52 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 m -152.03 33.2 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.106 -1.621 . . . . 0.0 112.311 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.93 10.15 2.04 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.455 1.902 . . . . 0.0 113.45 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -72.06 55.6 0.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.303 3.041 . . . . 0.0 112.589 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HA ' HG11 ' A' ' 52' ' ' VAL . 4.8 t0 -63.07 -11.91 22.97 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -165.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.55 -1.28 0.77 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 114.919 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 m -153.85 119.33 2.78 Favored Pre-proline 0 N--CA 1.473 0.692 0 O-C-N 119.916 -1.74 . . . . 0.0 110.651 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.4 112.12 2.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.899 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.38 -27.15 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 0.0 110.825 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.89 -161.98 18.98 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.383 2.421 . . . . 0.0 111.853 169.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 169.58 17.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 96.58 8.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.502 1.921 . . . . 0.0 106.132 170.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.55 -49.95 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.636 1.175 . . . . 0.0 111.678 -161.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 t -88.41 -17.37 30.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -165.52 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -159.99 150.14 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 120.253 1.388 . . . . 0.0 111.631 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -57.48 134.49 81.95 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.673 0.789 . . . . 0.0 109.377 166.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.98 86.47 0.61 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.137 2.558 . . . . 0.0 111.658 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -152.91 112.96 3.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 112.035 -167.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -72.85 92.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.253 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 p -73.41 -14.04 61.19 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.75 158.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.13 0.972 . . . . 0.0 112.064 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.66 -23.62 65.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.18 0.992 . . . . 0.0 113.153 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 p -81.26 5.17 17.94 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.772 1.629 . . . . 0.0 113.812 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.31 22.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.648 1.579 . . . . 0.0 114.882 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.09 21.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 130.875 3.67 . . . . 0.0 114.443 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.64 157.15 20.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.983 1.713 . . . . 0.0 113.275 -164.577 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 105.94 17.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.429 2.291 . . . . 0.0 106.677 153.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.41 135.64 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.503 1.121 . . . . 0.0 111.985 -165.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.81 118.56 37.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.209 2.603 . . . . 0.0 108.921 -172.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.36 136.72 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.452 1.901 . . . . 0.0 108.418 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.68 137.95 31.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.017 -0.427 . . . . 0.0 111.821 163.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.48 160.36 25.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.351 1.86 . . . . 0.0 109.656 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.59 105.78 51.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.822 1.249 . . . . 0.0 108.857 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HG3' HG13 ' A' ' 32' ' ' VAL . 55.6 Cg_endo -84.82 121.03 2.41 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.276 2.65 . . . . 0.0 109.437 160.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.31 166.5 12.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.88 1.72 . . . . 0.0 111.993 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.88 164.3 25.94 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 -91.92 1.77 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -131.08 165.11 23.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.457 1.103 . . . . 0.0 110.764 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.0 m -156.92 163.27 39.34 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.069 -1.019 . . . . 0.0 111.784 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -133.43 129.1 36.83 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.9 2.08 . . . . 0.0 108.214 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.5 mm -110.21 109.3 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.17 1.788 . . . . 0.0 106.768 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.96 138.53 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.667 0.787 . . . . 0.0 109.167 -167.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.14 89.38 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.85 2.06 . . . . 0.0 106.725 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 161.02 157.44 8.75 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.314 1.686 . . . . 0.0 117.314 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -123.23 122.77 39.21 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.913 1.685 . . . . 0.0 109.395 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 32.42 -94.83 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.304 2.383 . . . . 0.0 115.385 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.53 -18.73 63.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.699 2.0 . . . . 0.0 116.161 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -130.11 101.07 5.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.74 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -141.12 155.92 46.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.26 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.98 2.512 . . . . 0.0 107.758 169.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.95 156.42 38.86 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.139 -0.976 . . . . 0.0 111.719 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 165.5 26.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.682 2.393 . . . . 0.0 109.019 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -133.27 155.97 48.41 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.327 -0.858 . . . . 0.0 113.101 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -141.75 151.93 43.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.494 1.518 . . . . 0.0 112.788 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -146.58 108.4 4.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.565 1.546 . . . . 0.0 108.567 -163.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -149.51 102.42 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -162.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 t 61.9 62.17 1.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.417 1.887 . . . . 0.0 113.832 163.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.32 18.01 3.49 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.515 2.007 . . . . 0.0 112.835 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.5 t -62.1 152.04 33.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.8 1.64 . . . . 0.0 112.293 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -50.59 -24.79 3.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.845 2.058 . . . . 0.0 113.291 165.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.12 -10.62 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.956 1.303 . . . . 0.0 112.138 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.76 22.7 30.2 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 121.003 -1.061 . . . . 0.0 114.396 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 125.025 1.33 . . . . 0.0 113.435 178.709 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -146.97 171.86 14.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 111.625 -165.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' H ' ' CD ' ' A' ' 3' ' ' GLU . 20.9 mp0 -65.1 104.69 0.93 Allowed 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.836 4.454 . . . . 0.0 111.179 -165.577 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -55.65 -57.35 12.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -168.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -72.22 -20.87 61.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.295 1.038 . . . . 0.0 113.727 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.65 -3.5 50.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 113.101 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -67.0 22.27 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 129.016 2.926 . . . . 0.0 115.267 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.75 69.0 0.67 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.932 2.206 . . . . 0.0 114.293 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -41.19 -59.62 1.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.654 1.982 . . . . 0.0 113.91 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -59.15 -3.93 0.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.82 141.82 49.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.934 1.243 . . . . 0.0 111.358 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.02 171.86 55.16 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.095 0.855 . . . . 0.0 113.386 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.7 96.76 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 113.094 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 p -161.78 -177.17 5.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.606 1.562 . . . . 0.0 112.402 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 m -170.85 -29.35 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.324 1.85 . . . . 0.0 111.796 162.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt 64.67 -69.71 0.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.374 2.27 . . . . 0.0 113.349 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.16 73.36 8.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.074 0.95 . . . . 0.0 112.857 -166.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -129.69 158.5 39.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 170.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -143.52 140.94 30.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 108.906 166.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.39 147.69 49.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.382 0.673 . . . . 0.0 111.521 171.337 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.76 -52.82 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.397 0.679 . . . . 0.0 112.24 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.24 109.45 2.66 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.478 1.037 . . . . 0.0 111.279 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 p -52.8 142.29 34.21 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.222 1.409 . . . . 0.0 111.469 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.48 146.07 85.45 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.916 2.411 . . . . 0.0 114.049 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.52 130.03 25.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.764 1.626 . . . . 0.0 109.55 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.01 135.61 51.15 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.543 0.61 . . . . 0.0 110.57 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.6 p -68.19 -5.75 19.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.81 2.044 . . . . 0.0 113.998 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -10.66 7.28 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.62 1.105 . . . . 0.0 112.699 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -95.01 -3.63 48.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.512 1.925 . . . . 0.0 110.875 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.01 -4.14 45.21 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.57 1.557 . . . . 0.0 114.83 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -96.31 156.71 16.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.337 1.455 . . . . 0.0 110.409 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.73 122.26 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.105 0.962 . . . . 0.0 110.377 170.138 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.2 126.36 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.642 0.777 . . . . 0.0 109.338 162.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.59 155.73 45.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.294 1.438 . . . . 0.0 111.055 173.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -125.91 134.78 51.46 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.255 -0.903 . . . . 0.0 112.688 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.13 168.2 11.82 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.851 1.261 . . . . 0.0 109.89 165.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -126.55 143.38 51.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.557 1.143 . . . . 0.0 110.014 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -96.42 98.23 10.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.732 1.213 . . . . 0.0 109.777 -172.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -78.31 9.34 3.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.97 2.108 . . . . 0.0 115.788 -162.43 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.91 173.41 27.97 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.424 1.011 . . . . 0.0 113.821 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -95.64 -1.37 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.305 1.842 . . . . 0.0 114.019 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.41 173.29 11.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.715 1.606 . . . . 0.0 112.69 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.78 43.55 0.87 Allowed Glycine 0 CA--C 1.543 1.802 0 CA-C-O 116.574 -2.237 . . . . 0.0 118.688 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.84 105.54 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.939 0 CA-C-N 122.308 3.054 . . . . 0.0 112.314 161.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -163.13 162.82 25.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -166.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -82.05 94.47 7.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.942 1.297 . . . . 0.0 110.172 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.25 115.05 10.75 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.829 1.652 . . . . 0.0 113.741 -169.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.79 83.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.047 2.498 . . . . 0.0 112.147 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.31 140.27 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.112 0.965 . . . . 0.0 109.903 165.12 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -140.8 166.86 23.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.097 0.959 . . . . 0.0 113.408 -167.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -138.71 104.86 5.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.666 2.386 . . . . 0.0 110.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 57' ' ' ASP . 16.3 m -132.09 169.1 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.03 0.932 . . . . 0.0 112.478 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.28 0.52 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.566 1.146 . . . . 0.0 113.742 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -151.93 27.88 0.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.245 -1.535 . . . . 0.0 112.846 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.62 10.4 1.41 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.445 1.898 . . . . 0.0 113.732 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.14 52.61 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.094 2.958 . . . . 0.0 112.487 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HA ' HG11 ' A' ' 52' ' ' VAL . 10.3 t0 -64.41 -7.35 9.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -165.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.51 -5.83 1.36 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.56 1.544 . . . . 0.0 114.591 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.0 m -154.58 114.78 2.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.108 -1.62 . . . . 0.0 110.556 168.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 111.16 2.35 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.683 2.922 . . . . 0.0 111.751 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -75.77 -39.58 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.443 1.097 . . . . 0.0 110.517 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.75 -161.94 25.89 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.982 1.754 . . . . 0.0 113.589 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -130.96 176.74 7.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.178 0.991 . . . . 0.0 113.27 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.41 139.59 34.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.786 2.034 . . . . 0.0 108.36 166.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.09 -55.16 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.104 0.562 . . . . 0.0 111.239 -171.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -55.67 -54.21 47.01 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.06 148.81 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.75 159.26 79.81 Favored Pre-proline 0 CA--C 1.556 1.195 0 O-C-N 121.899 -0.501 . . . . 0.0 110.525 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.1 69.81 6.92 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.713 2.276 . . . . 0.0 115.391 -157.331 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -143.62 120.24 11.11 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.392 -1.442 . . . . 0.0 113.282 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.1 t -81.45 95.8 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 t -76.2 -3.88 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.05 143.89 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.932 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.39 -20.93 65.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.343 1.057 . . . . 0.0 112.73 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 4.68 1.72 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.545 2.738 . . . . 0.0 114.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 8.15 0.4 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.224 1.81 . . . . 0.0 115.605 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.43 19.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 130.853 3.661 . . . . 0.0 116.131 -161.882 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.31 173.79 8.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.375 1.87 . . . . 0.0 114.434 -169.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -105.39 101.77 11.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.092 2.957 . . . . 0.0 107.079 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.46 114.33 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -156.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.45 129.24 39.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.191 2.596 . . . . 0.0 110.562 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mt -128.0 148.52 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 129.025 2.93 . . . . 0.0 108.825 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -104.34 136.72 43.4 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 112.323 165.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -121.31 162.84 19.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.643 1.977 . . . . 0.0 110.098 163.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.93 107.33 38.03 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.078 1.351 . . . . 0.0 109.202 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -107.02 140.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.197 3.264 . . . . 0.0 110.823 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.53 162.11 1.66 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.851 3.034 . . . . 0.0 114.651 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -68.09 166.03 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.025 0.93 . . . . 0.0 113.41 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.94 -91.35 1.68 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.58 159.78 23.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.263 1.025 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -157.6 129.73 7.15 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 120.807 -1.183 . . . . 0.0 110.174 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -135.62 122.59 21.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 109.263 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.1 mm -109.86 113.68 44.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 126.251 1.82 . . . . 0.0 107.732 -173.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -109.02 140.62 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.897 0.879 . . . . 0.0 109.245 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.95 101.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.393 2.277 . . . . 0.0 107.999 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 149.3 171.53 18.03 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 117.946 1.939 . . . . 0.0 117.946 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.12 128.84 30.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.505 1.922 . . . . 0.0 110.362 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 35.55 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.89 2.186 . . . . 0.0 115.268 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -66.79 -16.39 64.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.097 2.159 . . . . 0.0 115.993 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.33 105.76 6.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.281 1.032 . . . . 0.0 111.088 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.41 162.98 34.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.03 163.94 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 130.136 3.374 . . . . 0.0 107.308 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -156.62 163.35 39.43 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.983 -1.073 . . . . 0.0 110.994 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -142.33 149.39 39.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.991 1.317 . . . . 0.0 110.044 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -102.75 160.97 14.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.864 1.266 . . . . 0.0 111.632 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.66 42.84 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.014 2.126 . . . . 0.0 110.237 166.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -145.0 142.32 29.69 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -150.0 105.08 3.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.407 1.083 . . . . 0.0 112.354 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p 128.01 -5.07 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 131.676 3.99 . . . . 0.0 114.619 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.15 33.82 0.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.643 1.116 . . . . 0.0 112.159 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -88.36 -141.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.338 1.455 . . . . 0.0 112.241 -166.548 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -52.59 -36.44 56.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.717 1.599 . . . . 0.0 115.136 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.13 -2.72 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 126.333 1.853 . . . . 0.0 112.515 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.68 28.8 54.24 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.518 -1.364 . . . . 0.0 112.521 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 tptp . . . . . 0 C--O 1.252 1.191 0 C-N-CA 127.174 2.19 . . . . 0.0 111.82 -169.399 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.64 152.26 45.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.61 0.641 . . . . 0.0 111.123 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.42 116.55 27.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.072 1.749 . . . . 0.0 109.498 172.906 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.99 -42.3 94.64 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.63 -0.669 . . . . 0.0 111.677 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -59.98 -29.47 68.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.875 1.67 . . . . 0.0 114.741 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.31 -5.11 58.53 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.111 0.868 . . . . 0.0 113.194 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -69.1 -6.31 27.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 116.808 -1.567 . . . . 0.0 114.073 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.08 73.52 0.33 Allowed Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.169 1.843 . . . . 0.0 115.477 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -77.18 64.19 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.236 1.015 . . . . 0.0 111.18 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.7 p -73.94 -27.42 61.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.614 1.966 . . . . 0.0 113.8 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -143.14 172.19 13.06 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.68 1.992 . . . . 0.0 110.462 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.43 148.8 51.03 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.109 0.385 . . . . 0.0 112.33 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 105.28 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.208 1.003 . . . . 0.0 112.041 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 162.46 39.89 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.314 2.246 . . . . 0.0 109.202 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.6 p -156.87 -43.24 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.309 1.043 . . . . 0.0 111.664 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 60.06 -69.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.366 2.666 . . . . 0.0 112.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.24 74.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.153 0.981 . . . . 0.0 112.742 -160.999 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -128.48 161.28 29.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.375 0.67 . . . . 0.0 111.142 161.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -145.77 149.88 35.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.442 1.897 . . . . 0.0 108.714 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.13 125.61 24.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.338 0.655 . . . . 0.0 111.042 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 -45.17 7.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.957 . . . . 0.0 109.043 167.116 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.65 119.34 1.74 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.126 1.822 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -57.93 155.43 23.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.424 1.49 . . . . 0.0 112.932 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.17 133.49 47.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.808 2.338 . . . . 0.0 112.026 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.59 127.59 22.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.823 1.649 . . . . 0.0 110.75 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.36 133.35 50.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.323 0.583 . . . . 0.0 112.378 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -79.12 -22.84 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.035 2.134 . . . . 0.0 114.563 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 -8.28 61.96 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 118.574 -1.126 . . . . 0.0 114.368 -160.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -72.09 -9.9 59.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.121 1.96 . . . . 0.0 111.596 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.25 62.3 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.334 1.445 . . . . 0.0 113.19 -163.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -112.33 164.0 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.96 2.104 . . . . 0.0 111.068 -170.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.77 125.62 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.209 1.004 . . . . 0.0 110.382 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 m -76.87 131.67 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 159.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.6 123.48 15.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.155 2.182 . . . . 0.0 107.378 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.83 131.35 52.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.999 0.818 . . . . 0.0 111.888 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.24 165.23 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.929 0.871 . . . . 0.0 110.134 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.109 0.963 . . . . 0.0 109.475 167.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -86.15 101.14 12.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 109.48 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -83.17 12.92 4.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -162.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.72 178.34 27.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.237 0.926 . . . . 0.0 114.623 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.3 p -109.21 2.91 21.26 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.541 1.937 . . . . 0.0 113.272 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -137.26 -176.63 4.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 0.0 110.76 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.93 29.08 2.94 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 115.745 -2.697 . . . . 0.0 118.975 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -48.69 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.124 0 CA-C-N 123.416 3.608 . . . . 0.0 112.981 162.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 m -160.43 169.69 22.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.014 1.326 . . . . 0.0 112.324 -165.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -96.78 92.76 6.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.54 1.136 . . . . 0.0 110.526 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.54 115.92 19.83 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.176 1.39 . . . . 0.0 114.627 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.84 93.25 0.87 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.526 2.15 . . . . 0.0 111.848 170.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 64' ' ' LEU . 19.7 tt -128.12 136.08 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.22 1.008 . . . . 0.0 108.608 161.393 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -148.81 165.33 31.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.826 0.85 . . . . 0.0 113.126 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.1 t -140.64 115.33 9.55 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.97 2.108 . . . . 0.0 110.633 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 31.3 m -137.65 175.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.787 1.235 . . . . 0.0 112.262 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.47 -18.17 16.81 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -149.9 32.34 0.69 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.114 -1.616 . . . . 0.0 111.636 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.94 11.72 4.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.391 1.876 . . . . 0.0 113.454 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -67.19 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.204 3.401 . . . . 0.0 113.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.0 t0 -58.78 -12.03 3.87 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -167.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.36 -12.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.248 2.219 . . . . 0.0 115.422 167.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -155.67 107.65 2.17 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 120.352 -1.467 . . . . 0.0 109.791 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.45 110.47 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.748 3.632 . . . . 0.0 113.01 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.77 -30.38 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.401 1.08 . . . . 0.0 109.959 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.29 -173.03 22.41 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.941 2.21 . . . . 0.0 111.305 165.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -131.68 170.54 14.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.438 1.095 . . . . 0.0 112.151 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 49' ' ' ILE . 4.4 mp -87.41 133.48 33.72 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 160.968 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.67 -54.43 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.27 0.628 . . . . 0.0 109.967 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -63.34 -48.33 78.45 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.61 150.26 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.385 1.074 . . . . 0.0 108.909 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -82.68 156.39 67.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 118.208 0.458 . . . . 0.0 110.709 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.13 86.67 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.486 2.124 . . . . 0.0 115.731 -155.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -148.57 118.87 7.3 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.363 -1.461 . . . . 0.0 114.202 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.61 87.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.717 1.207 . . . . 0.0 107.759 167.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.8 t -72.2 -11.05 60.56 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.54 156.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.014 1.279 . . . . 0.0 112.071 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.81 -15.6 63.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 0.0 114.202 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.8 p -76.56 1.72 15.95 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.129 1.772 . . . . 0.0 113.762 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.03 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.632 1.973 . . . . 0.0 115.606 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.3 20.65 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.949 3.3 . . . . 0.0 115.901 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.18 168.17 19.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.096 2.158 . . . . 0.0 114.518 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -106.3 107.03 17.83 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.266 3.026 . . . . 0.0 105.47 160.752 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.27 137.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.483 1.135 . . . . 0.0 113.634 -158.452 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.2 128.21 47.41 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.161 2.984 . . . . 0.0 109.779 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.76 138.73 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.868 2.067 . . . . 0.0 109.149 -172.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.53 136.67 32.9 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.556 0.616 . . . . 0.0 111.803 163.521 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.9 159.17 26.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.104 2.162 . . . . 0.0 109.775 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -103.32 105.25 45.61 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.229 1.411 . . . . 0.0 109.565 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.01 129.87 8.14 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.604 2.869 . . . . 0.0 110.288 164.804 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.44 171.95 9.8 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.304 2.003 . . . . 0.0 112.165 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -82.41 166.01 19.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -173.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.23 -82.45 1.14 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.669 1.128 . . . . 0.0 111.072 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -140.6 145.69 37.01 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.582 1.153 . . . . 0.0 110.12 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.7 p -150.57 151.13 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.48 0.657 . . . . 0.0 112.525 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -137.36 139.99 41.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.928 1.291 . . . . 0.0 110.059 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.7 107.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.284 1.833 . . . . 0.0 107.044 -168.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.8 135.71 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.92 92.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.905 2.082 . . . . 0.0 107.282 -172.681 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.3 170.8 12.82 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.48 123.0 42.95 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.077 1.751 . . . . 0.0 109.138 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 31.82 -92.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.194 2.331 . . . . 0.0 115.472 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -73.11 -16.77 61.45 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.2 97.95 4.42 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 109.952 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.11 163.62 36.36 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.58 163.77 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 129.841 3.256 . . . . 0.0 107.573 168.655 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -151.48 162.81 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.131 -0.981 . . . . 0.0 111.596 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -138.62 173.57 11.45 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.43 1.892 . . . . 0.0 110.409 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -124.71 157.94 34.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.392 1.877 . . . . 0.0 111.167 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.08 154.85 33.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.583 1.553 . . . . 0.0 111.89 161.453 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -132.62 140.58 48.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 110.885 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -136.3 93.87 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.6 t 70.79 30.11 3.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.779 1.632 . . . . 0.0 114.477 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 8.94 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.531 1.773 . . . . 0.0 117.531 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.3 t -75.25 160.94 29.79 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.959 1.88 . . . . 0.0 112.728 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -62.89 -11.54 19.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.063 1.345 . . . . 0.0 114.569 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.6 mm -82.59 -16.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.863 1.265 . . . . 0.0 111.452 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.91 4.94 24.1 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.347 -1.252 . . . . 0.0 115.751 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-N 119.391 1.596 . . . . 0.0 114.17 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.11 145.24 30.45 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.336 0.654 . . . . 0.0 111.853 -163.386 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 178.05 6.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.538 2.735 . . . . 0.0 110.398 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -100.21 -54.47 2.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.999 0.904 . . . . 0.0 111.166 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -55.89 -34.94 66.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.98 2.512 . . . . 0.0 113.786 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.56 -43.5 84.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.472 0.578 . . . . 0.0 110.794 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 60' ' ' PRO . 33.0 mmtm -63.41 -45.55 90.49 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 110.393 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 36.86 104.05 0.01 OUTLIER Glycine 0 C--N 1.344 0.975 0 C-N-CA 129.67 3.51 . . . . 0.0 116.676 159.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -62.8 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.346 2.258 . . . . 0.0 112.781 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -80.98 -19.54 43.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.879 2.472 . . . . 0.0 114.31 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -160.66 175.48 12.61 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.353 1.461 . . . . 0.0 110.257 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 133.41 24.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.268 1.413 . . . . 0.0 113.681 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.3 102.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.556 1.542 . . . . 0.0 114.08 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 156.36 40.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.585 2.354 . . . . 0.0 108.783 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.96 -31.87 0.28 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 49.27 -73.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 130.507 3.523 . . . . 0.0 116.214 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.32 68.23 1.42 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 112.067 -155.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.17 156.07 24.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.932 1.293 . . . . 0.0 110.331 166.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -142.29 145.42 33.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.498 1.519 . . . . 0.0 109.139 165.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.76 137.55 58.26 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.509 0.671 . . . . 0.0 111.31 168.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 -46.12 3.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.422 1.489 . . . . 0.0 109.708 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 128.93 4.93 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.095 1.331 . . . . 0.0 111.535 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.9 p -58.11 146.26 70.14 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 112.256 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -59.54 124.75 16.13 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.126 2.551 . . . . 0.0 111.55 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.16 128.55 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.727 1.211 . . . . 0.0 110.46 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.68 129.84 41.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.612 0.72 . . . . 0.0 111.021 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -71.98 -4.59 29.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.406 2.282 . . . . 0.0 113.845 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -8.72 11.12 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 118.945 0.793 . . . . 0.0 113.174 -168.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -89.2 -0.74 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.195 1.398 . . . . 0.0 110.758 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.71 0.79 74.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.464 1.507 . . . . 0.0 113.896 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -99.91 161.82 13.37 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.883 2.073 . . . . 0.0 110.205 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.4 128.88 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.457 1.026 . . . . 0.0 110.919 169.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.62 119.04 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.273 1.029 . . . . 0.0 108.937 162.503 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -132.72 129.27 38.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.78 2.432 . . . . 0.0 108.429 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -119.39 132.96 55.93 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.108 0.867 . . . . 0.0 113.06 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -123.47 167.63 13.62 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.294 1.038 . . . . 0.0 111.481 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.58 136.5 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 109.49 163.958 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -90.86 102.97 15.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.355 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.5 p -78.61 -7.14 57.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.592 1.557 . . . . 0.0 114.017 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.03 160.36 20.8 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 122.272 0.929 . . . . 0.0 113.878 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -82.02 -10.92 59.07 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.528 2.331 . . . . 0.0 114.849 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -164.39 172.93 12.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.72 1.208 . . . . 0.0 110.748 -153.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 61.08 0.62 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.22 105.04 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.399 2.066 . . . . 0.0 109.765 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 m -154.4 162.78 40.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.212 1.405 . . . . 0.0 112.09 -166.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -87.14 97.39 10.73 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.571 . . . . 0.0 111.394 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.89 115.08 8.08 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.878 1.271 . . . . 0.0 110.825 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.86 90.31 1.05 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.933 3.089 . . . . 0.0 110.678 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 tt -115.3 142.91 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.053 0.941 . . . . 0.0 109.378 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -150.7 166.64 29.77 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.059 1.343 . . . . 0.0 112.844 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.0 t -138.18 121.4 16.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.948 2.099 . . . . 0.0 110.713 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 57' ' ' ASP . 34.5 m -134.38 179.69 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.487 1.515 . . . . 0.0 112.263 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.63 -17.62 14.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.142 1.377 . . . . 0.0 113.725 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -157.55 43.32 0.33 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.184 -1.573 . . . . 0.0 111.731 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 8.8 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.811 2.045 . . . . 0.0 114.56 -174.448 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.514 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.8 p-10 -70.58 46.05 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.821 3.248 . . . . 0.0 114.952 -174.862 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HA ' HG11 ' A' ' 52' ' ' VAL . 8.9 t0 -64.34 -1.77 1.86 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.291 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -10.36 5.45 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 159.409 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.1 m -155.96 98.37 2.23 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 120.381 -1.45 . . . . 0.0 109.8 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' CB ' ' HE2' ' A' ' 7' ' ' LYS . 80.5 Cg_exo -48.38 119.91 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.678 3.585 . . . . 0.0 113.452 170.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.514 ' CG2' HD21 ' A' ' 56' ' ' ASN . 8.0 t -99.88 -23.77 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.538 1.535 . . . . 0.0 111.813 -176.311 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.71 18.36 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.409 1.956 . . . . 0.0 111.29 168.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.21 175.48 9.55 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.499 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.4 OUTLIER -86.01 149.67 25.01 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.523 1.529 . . . . 0.0 107.187 159.759 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -118.73 -41.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.735 0.698 . . . . 0.0 111.14 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -61.04 -45.81 93.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -162.75 165.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.136 0.88 . . . . 0.0 111.567 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.31 123.74 71.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 157.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.54 100.1 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.772 1.648 . . . . 0.0 111.422 -171.569 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -149.07 149.87 31.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 159.647 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.62 88.36 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 127.524 2.33 . . . . 0.0 107.055 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -71.47 -2.86 18.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.02 158.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 112.13 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.25 -27.58 63.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.538 0.735 . . . . 0.0 112.369 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.1 p -74.87 4.86 5.75 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.249 1.82 . . . . 0.0 113.671 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.66 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.29 1.836 . . . . 0.0 115.083 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.65 27.26 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 129.169 2.987 . . . . 0.0 113.681 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.34 169.08 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.416 1.886 . . . . 0.0 113.967 -166.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -112.4 108.73 17.99 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.837 2.455 . . . . 0.0 106.092 163.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.38 123.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.775 0.798 . . . . 0.0 112.953 -157.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.82 134.99 41.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.626 1.571 . . . . 0.0 110.604 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.7 136.53 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.506 1.922 . . . . 0.0 107.949 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.87 138.13 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.775 -0.578 . . . . 0.0 111.911 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -123.06 163.13 21.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.131 2.173 . . . . 0.0 110.056 167.165 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -104.52 100.97 25.07 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.543 1.137 . . . . 0.0 109.236 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.44 129.13 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.802 2.335 . . . . 0.0 109.977 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.94 172.29 2.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.572 2.181 . . . . 0.0 112.504 165.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.54 166.09 11.31 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.151 0.981 . . . . 0.0 112.426 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -91.67 1.45 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -164.074 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -119.67 154.0 34.72 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.577 1.151 . . . . 0.0 110.331 168.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.5 t -144.95 158.42 43.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 166.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -130.19 145.76 51.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.969 0.908 . . . . 0.0 108.823 165.098 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -117.02 113.94 44.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.479 1.912 . . . . 0.0 106.219 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.18 135.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.24 95.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.08 1.352 . . . . 0.0 108.061 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.99 171.69 24.23 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.945 1.938 . . . . 0.0 117.945 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.4 114.21 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.644 2.378 . . . . 0.0 108.938 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.83 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 126.166 1.841 . . . . 0.0 114.848 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -68.74 -15.08 63.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -129.65 99.34 5.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.718 1.207 . . . . 0.0 109.708 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.62 159.28 44.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.99 165.64 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 129.913 3.285 . . . . 0.0 108.431 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.72 170.7 15.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.712 -0.617 . . . . 0.0 110.871 161.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -132.79 161.73 33.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.909 1.684 . . . . 0.0 108.583 162.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.8 159.59 17.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.273 1.429 . . . . 0.0 110.522 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.02 152.99 38.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.062 1.345 . . . . 0.0 111.119 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.75 115.45 8.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.936 1.294 . . . . 0.0 108.41 -170.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -152.38 109.88 3.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.8 t 66.01 37.13 5.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.321 2.248 . . . . 0.0 114.522 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.48 20.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.025 0.821 . . . . 0.0 114.538 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 39.9 t -64.54 154.46 36.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.985 1.314 . . . . 0.0 113.213 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.8 m -54.21 -23.24 13.84 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.432 1.893 . . . . 0.0 112.655 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.4 mm -93.35 -1.32 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.425 1.89 . . . . 0.0 111.337 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.03 10.24 62.84 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.75 -1.219 . . . . 0.0 115.727 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.0 ptmm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.086 1.355 . . . . 0.0 114.585 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.33 168.84 23.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 -175.55 4.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.171 2.589 . . . . 0.0 110.472 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -99.49 -59.01 1.8 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.067 -1.021 . . . . 0.0 110.434 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -51.43 -33.57 31.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.613 2.765 . . . . 0.0 114.935 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -61.98 -19.79 63.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.004 0.82 . . . . 0.0 112.838 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.03 -1.4 57.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.969 1.308 . . . . 0.0 113.139 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -4.36 98.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.45 0 C-N-CA 130.524 3.916 . . . . 0.0 117.507 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -64.81 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.426 3.49 . . . . 0.0 115.92 -169.096 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -60.22 -27.62 67.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.1 -179.06 5.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.361 1.864 . . . . 0.0 109.923 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.58 138.63 46.89 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 121.655 -0.653 . . . . 0.0 111.71 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.95 95.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.121 0.962 . . . . 0.0 112.663 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.83 172.18 17.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.754 2.022 . . . . 0.0 110.585 170.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.6 p -142.93 -25.45 0.61 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.862 1.265 . . . . 0.0 113.934 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt 47.28 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 130.25 3.42 . . . . 0.0 114.934 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.21 72.5 1.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 111.906 -165.011 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -123.32 153.25 40.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.774 0.83 . . . . 0.0 110.638 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -139.73 147.46 40.92 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.782 1.633 . . . . 0.0 108.205 167.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.23 133.22 49.31 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.475 -0.765 . . . . 0.0 110.856 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -50.43 4.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.433 1.093 . . . . 0.0 109.204 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.26 120.74 1.94 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.499 1.047 . . . . 0.0 112.558 -172.846 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.2 m -49.59 147.35 6.1 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 127.915 2.486 . . . . 0.0 112.346 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.48 148.4 63.21 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.565 2.177 . . . . 0.0 114.12 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.0 142.64 32.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.141 1.776 . . . . 0.0 110.254 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.52 138.83 41.8 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.625 -0.672 . . . . 0.0 112.248 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.5 p -83.31 -21.87 33.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.82 -7.38 34.69 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 118.488 -1.173 . . . . 0.0 114.421 -159.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -72.08 -14.47 61.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.115 1.958 . . . . 0.0 111.166 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.93 -7.34 52.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.859 1.695 . . . . 0.0 113.012 -165.037 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.9 p -102.12 164.95 11.42 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 112.331 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.75 119.21 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.659 1.184 . . . . 0.0 110.592 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.19 128.34 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.765 1.226 . . . . 0.0 110.199 163.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.5 136.01 30.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.284 2.234 . . . . 0.0 109.514 -169.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -116.67 131.65 56.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.56 163.0 17.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.071 1.349 . . . . 0.0 111.06 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -122.95 142.82 50.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.551 1.54 . . . . 0.0 110.128 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -95.97 97.95 10.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.992 0.917 . . . . 0.0 110.923 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.7 p -82.57 35.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.928 1.691 . . . . 0.0 113.269 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.87 175.11 33.76 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.675 -0.64 . . . . 0.0 114.293 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -121.3 3.49 10.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.042 2.137 . . . . 0.0 113.228 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -132.04 166.06 22.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.249 2.22 . . . . 0.0 110.875 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.65 51.71 0.84 Allowed Glycine 0 CA--C 1.542 1.722 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -56.15 108.55 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 121.774 2.787 . . . . 0.0 110.722 160.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.476 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -155.7 168.78 26.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.431 1.092 . . . . 0.0 111.38 -166.115 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 11.3 tppt? -92.9 91.69 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.377 -1.452 . . . . 0.0 109.632 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.66 114.42 11.08 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.521 1.129 . . . . 0.0 112.36 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.28 88.79 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.229 2.619 . . . . 0.0 111.466 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -112.53 145.77 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.015 0.926 . . . . 0.0 110.079 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 t -151.27 172.29 16.1 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -143.63 106.27 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.143 2.577 . . . . 0.0 109.705 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.6 m -136.2 151.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.26 64.16 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.72 27.37 3.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.277 1.031 . . . . 0.0 112.357 -166.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mt 63.76 3.25 1.52 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.232 1.813 . . . . 0.0 113.881 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -67.69 50.5 0.05 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.117 2.967 . . . . 0.0 114.3 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.7 t0 -61.49 -13.7 23.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.74 -6.21 0.71 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.679 1.992 . . . . 0.0 114.665 162.337 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m -153.54 103.67 2.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.045 -1.66 . . . . 0.0 109.042 173.99 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 123.67 10.26 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.37 2.713 . . . . 0.0 111.046 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.33 -36.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.193 0.997 . . . . 0.0 111.702 -172.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.97 -166.74 30.41 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.381 1.467 . . . . 0.0 110.58 161.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.1 ptp85 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.891 0.876 . . . . 0.0 112.167 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.486 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.7 OUTLIER -83.47 140.07 32.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.093 1.357 . . . . 0.0 107.405 163.187 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.62 -49.33 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.623 0.647 . . . . 0.0 109.669 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.9 m -60.01 -49.77 76.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -172.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -158.15 159.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.896 1.226 . . . . 0.0 113.031 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -59.41 114.45 9.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.392 1.077 . . . . 0.0 108.491 158.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 88.06 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.106 2.537 . . . . 0.0 111.938 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -136.18 139.59 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.744 -1.222 . . . . 0.0 111.94 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 2.6 t -74.24 88.87 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 125.557 1.543 . . . . 0.0 106.874 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -72.72 -2.81 21.73 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.95 143.35 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.146 1.378 . . . . 0.0 110.813 -172.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.36 -27.07 67.6 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.883 0.849 . . . . 0.0 111.539 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 6.63 0.58 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.167 2.987 . . . . 0.0 114.192 168.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.49 17.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.888 1.675 . . . . 0.0 115.385 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.05 15.91 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 131.143 3.777 . . . . 0.0 115.562 -170.081 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.92 170.73 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.214 2.606 . . . . 0.0 114.3 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 99.74 6.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.836 3.254 . . . . 0.0 104.486 164.357 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.32 127.33 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.946 1.298 . . . . 0.0 112.082 -154.339 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.76 121.85 43.86 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.865 2.866 . . . . 0.0 108.898 -169.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.8 130.69 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.721 2.008 . . . . 0.0 109.267 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.78 133.01 36.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.539 0.736 . . . . 0.0 111.462 164.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.6 157.09 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.147 2.179 . . . . 0.0 109.854 164.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 38.5 tt0 -89.45 111.88 48.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.558 1.143 . . . . 0.0 108.472 168.08 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.23 125.75 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.336 2.691 . . . . 0.0 109.653 171.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.67 164.78 27.78 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.245 1.297 . . . . 0.0 110.909 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -71.96 155.47 40.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.042 0.925 . . . . 0.0 112.751 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.92 -87.05 1.41 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.4 1.476 . . . . 0.0 109.87 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.95 156.36 29.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.245 1.018 . . . . 0.0 110.214 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -146.11 95.99 2.71 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.166 0.986 . . . . 0.0 108.932 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -96.42 134.76 39.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.313 1.045 . . . . 0.0 109.294 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -115.67 90.82 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 126.328 1.851 . . . . 0.0 107.343 -159.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -89.45 139.06 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.673 0.789 . . . . 0.0 109.378 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.52 91.04 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.707 2.003 . . . . 0.0 106.45 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 164.85 165.39 22.05 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.83 147.54 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.354 1.462 . . . . 0.0 109.972 167.729 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.64 -99.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.498 1.999 . . . . 0.0 115.092 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -85.43 -26.7 26.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.772 1.629 . . . . 0.0 113.98 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -107.8 81.85 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.284 1.434 . . . . 0.0 108.517 -173.177 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.501 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -138.82 148.12 43.37 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.858 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 161.29 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.593 2.757 . . . . 0.0 108.125 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.42 147.59 27.74 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.47 -0.769 . . . . 0.0 110.967 173.028 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.07 162.79 17.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.832 2.053 . . . . 0.0 109.434 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -132.03 129.57 40.22 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.993 0.517 . . . . 0.0 110.92 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.58 23.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.145 0.978 . . . . 0.0 111.139 171.0 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -141.34 123.64 15.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.848 1.659 . . . . 0.0 108.104 -161.066 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.21 99.61 3.07 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m 61.69 54.27 3.01 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.409 1.883 . . . . 0.0 113.189 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.13 30.2 0.53 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.239 0.923 . . . . 0.0 114.303 170.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.4 t -55.39 168.16 0.4 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.919 2.088 . . . . 0.0 115.59 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m -49.75 -20.9 0.93 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.044 1.338 . . . . 0.0 113.452 156.625 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -119.56 24.58 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 126.571 1.948 . . . . 0.0 111.876 171.171 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.4 -26.21 0.87 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 127.285 2.374 . . . . 0.0 116.586 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 tptp . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.663 2.785 . . . . 0.0 114.223 173.017 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.01 169.03 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.518 0.727 . . . . 0.0 110.955 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 171.62 13.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.124 2.169 . . . . 0.0 109.854 173.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.74 -63.99 1.16 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.128 -0.982 . . . . 0.0 111.554 -171.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -52.66 -31.29 36.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.867 2.067 . . . . 0.0 114.427 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 tp -58.09 -29.07 65.16 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.581 1.153 . . . . 0.0 113.044 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.11 -2.73 42.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 143.47 2.27 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.778 2.133 . . . . 0.0 115.683 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -70.51 74.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.748 2.019 . . . . 0.0 113.586 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.4 p -60.41 -21.24 61.99 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.197 1.399 . . . . 0.0 112.412 159.105 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -153.01 179.87 8.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.432 2.293 . . . . 0.0 108.305 161.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.67 157.72 51.84 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 122.074 -0.391 . . . . 0.0 112.638 166.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -77.74 103.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.831 1.252 . . . . 0.0 111.614 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.86 163.66 36.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.541 1.537 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.6 p -165.43 -48.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.857 0.863 . . . . 0.0 111.786 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt 65.2 -63.51 0.19 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.916 2.486 . . . . 0.0 113.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.69 78.59 2.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.202 1.001 . . . . 0.0 112.461 -166.839 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -129.86 156.73 43.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.258 1.023 . . . . 0.0 111.664 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -146.23 150.04 35.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.229 1.812 . . . . 0.0 108.948 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -70.02 149.55 47.57 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.882 0.849 . . . . 0.0 112.933 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.37 -33.97 2.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.312 1.445 . . . . 0.0 111.272 171.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 104.27 0.41 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.148 1.356 . . . . 0.0 111.239 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.3 m -46.53 140.08 5.87 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 127.042 2.137 . . . . 0.0 110.518 167.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 143.43 98.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.95 1.767 . . . . 0.0 112.805 -170.327 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 122.51 18.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.556 1.143 . . . . 0.0 111.223 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.27 131.26 45.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.615 0.721 . . . . 0.0 111.588 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.7 p -79.26 -10.01 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.503 1.921 . . . . 0.0 113.837 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.29 -6.65 4.08 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.203 0.906 . . . . 0.0 114.048 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -94.53 3.09 55.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.526 1.531 . . . . 0.0 111.685 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.73 5.7 41.52 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.465 1.507 . . . . 0.0 114.279 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -128.0 166.49 18.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.519 1.528 . . . . 0.0 111.784 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG13 ' HG3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -114.95 132.06 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.516 1.526 . . . . 0.0 108.958 162.937 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.05 131.65 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 162.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.31 124.33 16.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.727 2.811 . . . . 0.0 108.211 -169.161 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.58 136.28 53.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.309 0.959 . . . . 0.0 112.922 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.48 164.92 21.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.79 139.9 52.38 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.195 163.414 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -90.87 101.49 14.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.729 1.212 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 p -80.5 7.63 9.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.915 1.686 . . . . 0.0 115.162 -163.726 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.39 -179.94 22.92 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.297 0.953 . . . . 0.0 114.34 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.1 p -113.59 6.79 17.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.168 1.787 . . . . 0.0 113.913 -165.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.52 178.8 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.872 1.669 . . . . 0.0 111.735 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.31 44.78 3.16 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-O 116.83 -2.094 . . . . 0.0 117.963 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.13 102.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.278 3.039 . . . . 0.0 111.709 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.7 m -159.57 171.27 19.94 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.99 -166.464 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -82.76 110.2 17.58 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.67 -1.269 . . . . 0.0 110.519 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.7 p -61.85 121.45 65.11 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.551 0.74 . . . . 0.0 110.776 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.06 97.17 0.73 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.327 2.018 . . . . 0.0 110.887 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.11 138.77 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.938 1.295 . . . . 0.0 108.926 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -153.32 169.95 21.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.912 0.885 . . . . 0.0 113.384 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 t -140.73 117.66 11.12 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.536 2.335 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 57' ' ' ASP . 2.0 m -134.97 170.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.269 1.428 . . . . 0.0 111.473 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.4 -23.93 19.9 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -155.29 51.34 0.58 Allowed 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.587 -1.321 . . . . 0.0 111.298 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.08 11.8 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.806 2.043 . . . . 0.0 114.682 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASN . . . . . 0.434 HD21 HG23 ' A' ' 61' ' ' VAL . 3.3 p-10 -70.17 42.38 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 128.962 2.905 . . . . 0.0 114.453 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.3 t0 -65.47 -3.59 4.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.178 1.791 . . . . 0.0 115.585 -166.987 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.39 -14.82 20.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.71 1.204 . . . . 0.0 113.283 159.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -152.78 104.61 2.68 Favored Pre-proline 0 N--CA 1.47 0.546 0 O-C-N 120.446 -1.409 . . . . 0.0 109.958 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 141.01 13.46 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.779 3.653 . . . . 0.0 114.285 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.434 HG23 HD21 ' A' ' 56' ' ' ASN . 14.2 t -119.33 -27.6 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.44 1.096 . . . . 0.0 111.014 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.98 -174.15 20.05 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.762 2.125 . . . . 0.0 111.0 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.462 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.8 ptp85 -136.85 175.73 9.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.352 1.061 . . . . 0.0 112.43 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.26 143.44 27.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 107.811 164.974 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.5 -46.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.895 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -62.5 -42.84 99.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.374 0.988 . . . . 0.0 113.621 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.66 163.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.553 0.741 . . . . 0.0 111.099 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -64.72 137.85 97.27 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.269 0.627 . . . . 0.0 109.759 166.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.88 82.47 0.98 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.047 2.498 . . . . 0.0 112.781 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -145.04 110.35 5.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.595 1.558 . . . . 0.0 112.093 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.66 87.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.974 1.709 . . . . 0.0 108.014 167.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -69.27 -19.56 63.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -170.046 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.51 155.07 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.682 1.193 . . . . 0.0 112.026 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -19.57 64.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.981 0.912 . . . . 0.0 112.946 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.3 p -80.81 7.88 9.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.993 1.717 . . . . 0.0 113.416 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 16.96 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.931 1.693 . . . . 0.0 115.164 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.19 23.22 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.919 3.288 . . . . 0.0 114.644 -168.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.81 171.71 12.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.634 1.974 . . . . 0.0 113.783 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.83 111.31 21.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.472 2.709 . . . . 0.0 106.198 167.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.99 122.65 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.782 0.833 . . . . 0.0 112.437 -156.148 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.75 135.29 35.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.907 174.038 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.4 mt -136.24 139.33 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.095 1.758 . . . . 0.0 108.716 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -91.88 137.27 32.5 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.371 -0.83 . . . . 0.0 111.661 164.905 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.03 165.68 14.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.286 2.235 . . . . 0.0 109.545 166.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 29.9 tt0 -104.88 109.25 62.88 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 109.502 174.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.675 ' HG3' HG13 ' A' ' 32' ' ' VAL . 60.3 Cg_endo -93.18 118.82 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.231 3.954 . . . . 0.0 111.138 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.96 152.81 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.999 3.133 . . . . 0.0 114.942 170.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -84.34 152.53 24.04 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.436 -0.79 . . . . 0.0 110.564 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.87 -93.71 1.8 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -161.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -125.95 168.18 14.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.976 1.31 . . . . 0.0 111.315 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -154.06 155.1 34.84 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 120.945 -1.097 . . . . 0.0 112.126 171.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.03 115.59 16.0 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.973 2.509 . . . . 0.0 107.953 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.52 106.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.69 2.396 . . . . 0.0 106.797 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.7 137.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.311 1.045 . . . . 0.0 109.613 -166.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.6 110.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.163 1.385 . . . . 0.0 109.113 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 130.07 173.21 13.33 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 173.302 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.2 ptm85 -126.7 123.5 37.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.976 1.71 . . . . 0.0 110.592 -171.664 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.51 -96.97 0.01 OUTLIER Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.932 2.206 . . . . 0.0 115.163 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -65.62 -16.88 64.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.273 1.829 . . . . 0.0 115.541 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -135.76 91.47 2.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.114 1.366 . . . . 0.0 110.461 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -139.54 162.06 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 176.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.07 162.82 21.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 128.631 2.773 . . . . 0.0 107.989 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.25 154.64 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.635 -0.666 . . . . 0.0 110.951 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -125.01 169.3 12.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.452 1.901 . . . . 0.0 108.185 164.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -140.0 163.18 33.38 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.389 -0.819 . . . . 0.0 112.412 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.31 158.54 43.55 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.476 1.51 . . . . 0.0 111.748 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -145.26 110.44 5.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.005 1.722 . . . . 0.0 107.089 -167.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -153.99 105.28 2.72 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t 64.78 39.81 5.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.783 2.033 . . . . 0.0 113.966 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.33 22.42 0.08 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.584 1.088 . . . . 0.0 114.178 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.6 t -65.05 155.89 33.23 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 -172.848 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 m -53.17 -20.57 4.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.912 2.085 . . . . 0.0 113.721 161.864 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -101.05 2.37 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.919 1.287 . . . . 0.0 113.022 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.08 62.26 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.162 0 CA-C-N 118.985 1.393 . . . . 0.0 114.327 -179.353 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.97 153.3 32.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.21 1.004 . . . . 0.0 112.969 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.47 90.6 3.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.237 2.215 . . . . 0.0 109.09 175.15 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.88 -44.01 91.05 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.998 1.719 . . . . 0.0 114.149 -163.18 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -61.95 -26.41 68.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.493 0.717 . . . . 0.0 112.626 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -93.89 -1.53 54.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 112.361 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -62.15 -8.73 5.98 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.8 1.182 . . . . 0.0 114.169 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.71 52.01 6.14 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 119.652 1.115 . . . . 0.0 112.936 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -75.47 37.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.06 1.744 . . . . 0.0 111.557 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -78.18 -6.14 53.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.7 1.2 . . . . 0.0 114.109 -174.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -153.86 172.82 16.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.102 0.961 . . . . 0.0 111.141 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.2 143.86 45.64 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.689 0.662 . . . . 0.0 112.092 171.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.273 4.0 p -80.76 93.16 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.984 1.373 . . . . 0.0 112.58 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -148.82 164.81 33.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.701 2.0 . . . . 0.0 110.847 167.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.4 p -140.24 -15.43 0.98 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.834 1.253 . . . . 0.0 113.651 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 50.12 -64.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 129.686 3.194 . . . . 0.0 114.956 -167.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.45 83.15 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.548 1.139 . . . . 0.0 112.424 -160.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.77 162.22 29.99 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.745 1.218 . . . . 0.0 110.674 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -155.19 152.69 29.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.412 1.885 . . . . 0.0 109.84 166.409 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.9 132.19 51.28 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.483 -0.761 . . . . 0.0 111.693 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 -35.52 4.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.159 0.983 . . . . 0.0 110.809 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.86 103.2 0.42 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.016 1.77 . . . . 0.0 110.036 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 p -59.51 151.85 58.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.941 0.896 . . . . 0.0 112.293 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.08 141.76 77.99 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.13 1.887 . . . . 0.0 113.498 -168.256 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.77 135.51 33.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.292 1.437 . . . . 0.0 110.722 174.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.09 141.59 54.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -13.38 59.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 114.559 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.22 -8.26 47.29 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.366 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -98.21 1.78 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.1 1.36 . . . . 0.0 112.284 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -8.79 47.93 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.98 1.276 . . . . 0.0 113.89 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -102.11 166.51 10.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.939 2.096 . . . . 0.0 111.988 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.78 123.74 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.455 1.502 . . . . 0.0 110.833 173.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -77.74 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.882 0.873 . . . . 0.0 109.781 164.449 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.37 121.14 9.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.35 2.26 . . . . 0.0 109.241 -164.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -108.91 133.91 52.28 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.76 -1.212 . . . . 0.0 113.029 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.18 159.54 25.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.557 0.743 . . . . 0.0 110.25 168.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -111.26 144.78 39.9 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.918 1.287 . . . . 0.0 109.49 167.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -93.36 102.8 15.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.177 1.391 . . . . 0.0 109.404 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -77.82 16.34 0.71 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.698 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.52 38.86 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 120.187 1.358 . . . . 0.0 115.587 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.53 -15.27 24.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -131.93 177.49 7.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.725 1.21 . . . . 0.0 112.61 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.32 38.42 0.73 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-O 116.307 -2.385 . . . . 0.0 118.706 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.07 107.84 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 122.715 3.258 . . . . 0.0 111.474 166.394 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 4.6 t -169.1 173.72 6.67 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.383 1.473 . . . . 0.0 110.394 -165.948 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -88.72 96.7 10.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 119.715 -1.866 . . . . 0.0 111.404 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.75 123.93 60.85 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.774 0.83 . . . . 0.0 112.853 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -86.12 99.37 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.641 2.894 . . . . 0.0 112.31 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -131.07 145.7 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.282 1.033 . . . . 0.0 109.255 164.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' SER . . . . . 0.408 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 41.1 t -151.18 166.49 30.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.854 1.262 . . . . 0.0 112.789 -169.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.7 t -145.99 108.83 4.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.379 2.272 . . . . 0.0 110.338 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.42 171.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.839 0.855 . . . . 0.0 112.665 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.63 -6.52 20.39 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -143.9 20.03 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.422 -1.424 . . . . 0.0 112.687 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.15 20.48 10.99 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.263 1.825 . . . . 0.0 111.966 -173.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -82.15 48.31 1.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 129.896 3.278 . . . . 0.0 113.203 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' OD1' ' OG ' ' A' ' 50' ' ' SER . 29.9 m-20 -58.14 -17.19 16.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -7.66 1.2 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.376 1.87 . . . . 0.0 114.753 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -150.05 87.19 5.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 119.925 -1.734 . . . . 0.0 109.655 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.11 115.24 2.04 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 125.129 3.886 . . . . 0.0 114.279 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.39 -36.6 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.248 1.419 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.91 -162.99 34.91 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.624 2.059 . . . . 0.0 111.98 170.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -144.47 167.19 23.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.889 1.276 . . . . 0.0 112.261 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.514 HD22 ' H ' ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.78 106.77 18.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.883 1.673 . . . . 0.0 106.552 167.157 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.89 -54.34 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -60.64 -49.26 78.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 113.002 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.68 141.28 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 123.028 0.531 . . . . 0.0 110.536 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -75.29 134.32 73.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 122.22 0.208 . . . . 0.0 110.5 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.38 92.21 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 114.309 -153.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -140.79 128.73 21.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.234 1.413 . . . . 0.0 110.547 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -82.92 87.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.16 1.384 . . . . 0.0 108.214 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -73.26 -5.24 38.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 157.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 110.841 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.36 -19.38 60.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -74.17 5.98 3.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.421 1.889 . . . . 0.0 113.841 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 12.22 0.17 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.844 1.658 . . . . 0.0 114.815 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.27 24.5 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 130.146 3.378 . . . . 0.0 114.921 -170.583 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 173.07 8.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.087 . . . . 0.0 113.758 -169.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 111.48 22.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.257 2.623 . . . . 0.0 105.306 164.656 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.71 128.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.919 0.866 . . . . 0.0 112.439 -158.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -92.44 125.85 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.052 2.541 . . . . 0.0 109.79 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.57 136.54 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.589 2.355 . . . . 0.0 108.15 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 134.49 33.61 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.699 . . . . 0.0 110.899 159.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.72 157.34 24.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.771 1.628 . . . . 0.0 109.761 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.65 106.85 42.64 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.54 136.2 10.87 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.439 2.76 . . . . 0.0 109.829 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -61.56 161.72 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 121.467 1.445 . . . . 0.0 111.357 167.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -88.23 166.75 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.35 0.66 . . . . 0.0 112.726 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.44 -89.44 1.22 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -167.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.24 147.26 50.22 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.2 p -146.41 141.76 27.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.737 0.78 . . . . 0.0 112.088 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -130.74 121.34 25.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.385 1.874 . . . . 0.0 108.266 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.0 mm -105.9 108.51 25.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 107.278 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.6 t -113.14 139.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.289 1.036 . . . . 0.0 109.52 -164.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.0 t -136.92 97.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.709 1.604 . . . . 0.0 107.899 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.58 172.73 18.73 Favored Glycine 0 N--CA 1.467 0.71 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 114.82 15.17 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.728 2.011 . . . . 0.0 110.211 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.37 -103.5 0.04 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.202 1.858 . . . . 0.0 114.086 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.67 -18.42 62.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.138 2.175 . . . . 0.0 115.545 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -123.14 93.95 4.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.339 0.972 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.2 42.53 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.76 159.68 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 129.135 2.974 . . . . 0.0 108.139 168.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -146.05 153.95 41.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.804 0.842 . . . . 0.0 110.081 165.711 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -137.91 166.91 22.87 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.671 1.588 . . . . 0.0 109.493 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -124.33 157.89 33.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.886 0.874 . . . . 0.0 112.399 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.51 151.38 28.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.051 1.74 . . . . 0.0 110.738 169.336 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -127.29 136.86 52.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 109.312 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -140.53 91.69 2.45 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -153.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 t 76.35 17.32 2.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.223 2.209 . . . . 0.0 114.187 163.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.79 25.55 0.05 OUTLIER Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.727 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.6 t -63.53 156.41 26.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.351 1.575 . . . . 0.0 110.849 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.6 p -62.34 -16.78 56.4 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 166.671 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.0 mm -67.23 -10.55 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.634 1.574 . . . . 0.0 111.903 167.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.37 17.1 47.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.219 1.39 . . . . 0.0 113.993 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tptp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.367 1.467 . . . . 0.0 112.833 -161.558 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 164.57 34.28 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 -174.53 3.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.884 2.074 . . . . 0.0 111.45 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.42 -57.08 2.08 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.602 -0.686 . . . . 0.0 110.815 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -49.09 -52.47 25.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.842 2.457 . . . . 0.0 114.425 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.34 -31.42 69.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.917 0.781 . . . . 0.0 112.797 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -76.3 -12.38 60.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.064 1.345 . . . . 0.0 113.812 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -19.7 126.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 1 C-N-CA 130.773 4.035 . . . . 0.0 116.59 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.476 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 79.3 p -73.96 74.58 1.68 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 113.151 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -59.89 -45.91 91.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.882 1.673 . . . . 0.0 112.857 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -123.74 174.4 7.51 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.353 1.861 . . . . 0.0 110.712 174.389 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.17 148.94 31.89 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.379 0.99 . . . . 0.0 113.085 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.76 105.11 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 122.621 1.2 . . . . 0.0 113.336 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.92 151.83 14.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.928 2.091 . . . . 0.0 109.281 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 p -143.94 -33.62 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.493 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 60.42 -69.27 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.596 2.759 . . . . 0.0 114.739 170.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.56 72.74 1.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.492 1.517 . . . . 0.0 110.346 -161.05 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -115.94 160.86 19.66 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.694 1.198 . . . . 0.0 110.049 165.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -141.97 144.22 33.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.652 1.581 . . . . 0.0 108.377 164.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.72 147.63 52.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.835 0.826 . . . . 0.0 111.947 170.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -46.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.924 1.29 . . . . 0.0 110.388 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.14 110.54 0.91 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.12 1.343 . . . . 0.0 111.239 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -57.92 146.6 67.24 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.448 167.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.2 155.22 52.52 Favored 'Trans proline' 0 C--N 1.351 0.71 0 N-CA-C 115.49 1.304 . . . . 0.0 115.49 -165.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.61 39.89 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.556 1.542 . . . . 0.0 110.282 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 132.65 45.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.769 0.428 . . . . 0.0 111.134 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.7 p -77.82 -24.25 48.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 -8.23 61.45 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.68 -1.066 . . . . 0.0 113.976 -160.128 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -75.25 -11.67 60.12 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.656 1.728 . . . . 0.0 111.342 163.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 -13.85 62.97 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.819 2.152 . . . . 0.0 113.105 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -84.29 170.17 13.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.759 2.424 . . . . 0.0 112.036 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.24 124.41 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.581 1.153 . . . . 0.0 110.317 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.24 128.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.793 0.837 . . . . 0.0 109.357 164.07 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 159.27 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 167.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -132.17 135.25 46.22 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -165.404 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.26 168.04 16.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.819 1.247 . . . . 0.0 110.489 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -123.7 148.17 46.79 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.844 1.257 . . . . 0.0 110.267 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -97.51 108.91 21.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.7 p -87.45 0.51 55.41 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.119 1.768 . . . . 0.0 113.775 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.16 16.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.712 1.149 . . . . 0.0 113.69 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 m -118.3 11.8 13.22 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.995 1.718 . . . . 0.0 111.56 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -149.25 -175.3 4.93 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.32 2.248 . . . . 0.0 111.154 -168.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.44 56.95 2.7 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.907 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.45 95.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.548 2.832 . . . . 0.0 112.281 155.586 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.3 169.07 19.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.26 . . . . 0.0 112.752 -169.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 2.5 ttmm -95.78 101.38 13.06 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 110.523 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.78 115.45 18.88 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 111.321 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.3 88.45 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.932 2.422 . . . . 0.0 111.221 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 tt -106.77 144.9 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.23 1.012 . . . . 0.0 109.412 165.39 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t -145.85 167.87 22.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.011 1.324 . . . . 0.0 113.283 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.8 t -139.81 110.96 6.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.563 2.345 . . . . 0.0 109.811 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 57' ' ' ASP . 28.4 m -137.3 161.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -8.57 29.67 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.4 m -155.68 36.65 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.164 -1.585 . . . . 0.0 112.321 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.96 8.41 0.98 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.324 1.85 . . . . 0.0 114.541 -175.309 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -67.96 40.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 131.104 3.762 . . . . 0.0 114.839 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.8 t0 -63.61 0.49 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -160.306 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.75 -18.67 65.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.13 -0.981 . . . . 0.0 112.966 160.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.1 m -128.33 101.48 21.77 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.102 1.761 . . . . 0.0 109.865 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -66.53 117.83 5.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.004 2.47 . . . . 0.0 110.325 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -96.83 -30.98 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.89 0.876 . . . . 0.0 111.144 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.4 -164.63 24.55 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.335 1.922 . . . . 0.0 111.537 166.298 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 9.4 ptp85 -139.48 169.62 17.41 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.673 1.589 . . . . 0.0 111.803 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 114.79 27.45 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.201 1.8 . . . . 0.0 106.809 170.421 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.9 -51.92 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.282 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -60.73 -44.31 96.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.83 159.0 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.476 0.71 . . . . 0.0 111.03 -169.153 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.77 127.19 67.15 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.667 0.787 . . . . 0.0 109.091 163.789 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.06 89.56 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 110.916 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -144.05 142.78 30.85 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.792 0.806 . . . . 0.0 112.737 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 t -76.49 86.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 127.46 2.304 . . . . 0.0 106.864 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 p -59.97 -28.68 67.87 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -167.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 161.17 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.529 1.531 . . . . 0.0 112.146 -173.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.78 -28.01 68.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.119 0.968 . . . . 0.0 112.702 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.62 5.45 4.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.384 2.274 . . . . 0.0 114.665 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 14.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.1 16.97 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.694 3.598 . . . . 0.0 115.425 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.53 169.66 17.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.279 1.832 . . . . 0.0 113.768 -172.299 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 111.14 22.75 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.711 2.805 . . . . 0.0 105.473 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.71 126.65 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.034 0.934 . . . . 0.0 112.342 -159.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.97 130.97 36.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.286 2.234 . . . . 0.0 109.644 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -133.97 142.77 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.106 1.363 . . . . 0.0 109.889 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.81 135.1 33.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.302 1.041 . . . . 0.0 111.772 168.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.0 157.75 26.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.576 1.95 . . . . 0.0 109.844 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 35.6 tt0 -90.95 113.45 58.16 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.838 0.855 . . . . 0.0 109.041 171.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.28 122.91 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.804 3.003 . . . . 0.0 109.92 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.56 164.29 31.58 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.706 1.604 . . . . 0.0 111.846 171.17 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -80.98 145.0 31.41 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.29 -0.881 . . . . 0.0 111.783 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.09 -94.34 1.06 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.695 2.093 . . . . 0.0 110.268 -173.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -112.77 174.8 5.72 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 110.267 167.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 m -153.15 96.32 2.05 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.606 -1.309 . . . . 0.0 110.917 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.63 127.27 42.46 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.28 96.97 5.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.263 1.425 . . . . 0.0 107.612 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.98 140.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.695 -171.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -135.66 99.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.348 1.859 . . . . 0.0 107.834 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.08 169.14 25.01 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -137.59 123.9 20.61 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.835 2.454 . . . . 0.0 108.975 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.39 -98.54 0.01 OUTLIER Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.407 1.956 . . . . 0.0 114.92 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -71.37 -17.07 62.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.58 99.54 6.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.632 1.173 . . . . 0.0 109.58 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.39 156.28 45.82 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 164.79 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.46 2.704 . . . . 0.0 108.182 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.83 160.78 43.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.697 -0.627 . . . . 0.0 111.023 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.23 171.68 12.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.532 1.933 . . . . 0.0 109.899 170.398 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.1 144.16 51.11 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.221 1.008 . . . . 0.0 111.56 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.39 164.07 35.98 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.258 1.823 . . . . 0.0 110.783 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -146.17 114.46 6.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.547 1.539 . . . . 0.0 108.512 -162.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -152.54 96.3 2.12 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -163.018 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.7 p 56.6 82.16 0.12 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 128.609 2.763 . . . . 0.0 114.026 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.9 21.42 4.97 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.496 1.998 . . . . 0.0 112.961 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.8 t -70.77 156.95 38.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -166.95 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m -54.6 -19.05 5.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.852 1.661 . . . . 0.0 114.081 164.563 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tt -112.98 16.25 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.721 1.208 . . . . 0.0 112.735 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.4 75.81 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 116.111 1.204 . . . . 0.0 116.111 164.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.331 1.452 . . . . 0.0 113.56 179.146 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -146.61 146.95 30.6 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.171 0.51 . . . . 0.0 111.897 -168.007 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.62 173.02 9.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.061 2.544 . . . . 0.0 109.924 173.175 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -98.7 -49.39 4.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.258 -0.901 . . . . 0.0 111.336 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -61.33 -33.46 73.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.452 1.901 . . . . 0.0 114.12 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.11 -38.16 87.84 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.533 0.733 . . . . 0.0 110.963 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' PRO . 32.0 mmtm -69.86 -40.23 75.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.917 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 11.62 109.73 0.0 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 130.657 3.98 . . . . 0.0 117.072 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.412 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 80.9 p -67.49 71.34 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.925 2.09 . . . . 0.0 112.557 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -19.71 65.48 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.414 3.086 . . . . 0.0 114.78 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -158.62 -172.97 4.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 110.686 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.59 118.35 13.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.718 1.151 . . . . 0.0 112.738 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -67.41 99.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.66 1.184 . . . . 0.0 112.979 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 160.04 39.98 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.737 2.415 . . . . 0.0 109.467 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.8 p -136.8 -35.57 0.71 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.672 1.189 . . . . 0.0 112.815 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 tttm 54.86 -79.42 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.822 2.449 . . . . 0.0 114.634 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.53 84.12 1.97 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.531 0.605 . . . . 0.0 111.958 -162.558 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.62 163.98 26.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.782 0.833 . . . . 0.0 112.268 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -149.93 145.82 26.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.428 2.291 . . . . 0.0 108.275 160.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -65.46 140.27 58.59 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.558 -0.714 . . . . 0.0 111.449 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.34 -52.08 2.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.65 112.81 1.94 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.557 1.551 . . . . 0.0 110.37 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.1 p -52.23 141.8 30.23 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.092 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.22 145.82 84.97 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.759 2.306 . . . . 0.0 112.764 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.51 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.706 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -65.0 125.22 24.23 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.356 0.598 . . . . 0.0 110.648 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 p -70.26 -8.22 48.49 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.145 2.178 . . . . 0.0 114.0 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.85 -8.49 3.4 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.64 1.114 . . . . 0.0 113.569 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -94.62 5.62 51.3 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.447 1.899 . . . . 0.0 111.276 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.14 18.72 38.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.698 1.142 . . . . 0.0 113.97 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -130.32 161.8 30.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 111.144 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 121.71 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.657 1.583 . . . . 0.0 108.701 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.32 130.4 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 162.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 35' ' ' GLU . 4.7 tt -141.9 131.89 24.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 109.704 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' N ' HD23 ' A' ' 34' ' ' LEU . 19.0 tt0 -115.91 130.84 57.0 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.114 0.87 . . . . 0.0 113.243 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.05 167.31 13.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.36 1.064 . . . . 0.0 111.164 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -119.21 142.84 47.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.371 1.468 . . . . 0.0 109.836 166.349 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -95.1 98.27 10.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.303 1.041 . . . . 0.0 110.691 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.5 p -76.06 22.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.459 2.303 . . . . 0.0 115.846 -163.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.39 176.02 37.95 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 120.905 -1.122 . . . . 0.0 114.601 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 p -99.2 -4.69 31.47 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.501 1.921 . . . . 0.0 113.64 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.23 176.77 8.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.718 1.607 . . . . 0.0 112.732 -167.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.78 48.2 2.16 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 117.244 -1.864 . . . . 0.0 116.944 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.97 99.11 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.761 2.781 . . . . 0.0 110.068 162.598 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.437 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 56.2 m -145.39 163.72 33.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.504 1.522 . . . . 0.0 111.725 -167.173 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 9' ' ' THR . 4.3 tmtm? -80.08 90.0 5.41 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.167 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.11 114.51 7.23 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.852 1.261 . . . . 0.0 112.516 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.53 99.46 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.345 2.03 . . . . 0.0 110.761 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -126.51 145.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.081 1.352 . . . . 0.0 108.446 163.573 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.3 t -147.02 164.11 34.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.573 1.149 . . . . 0.0 112.806 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.9 t -137.76 115.39 11.3 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.556 2.342 . . . . 0.0 109.218 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 11.1 m -130.58 169.96 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.808 1.243 . . . . 0.0 111.593 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.58 -0.03 20.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -154.31 28.87 0.45 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.198 -1.564 . . . . 0.0 112.709 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.99 6.44 0.32 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.223 2.209 . . . . 0.0 115.203 -174.006 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -71.36 56.74 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.912 3.285 . . . . 0.0 112.436 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.8 t70 -64.82 -4.72 4.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -165.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -16.0 20.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.417 1.487 . . . . 0.0 114.515 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.0 m -157.11 116.11 2.0 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 120.678 -1.264 . . . . 0.0 109.16 165.789 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 85.0 Cg_exo -48.23 127.82 16.02 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.229 3.286 . . . . 0.0 113.665 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.37 -26.65 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 126.054 1.742 . . . . 0.0 110.911 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.56 -164.82 29.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.484 1.992 . . . . 0.0 111.116 163.034 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ARG . . . . . 0.402 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -135.78 177.95 7.43 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.403 0.681 . . . . 0.0 112.62 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.49 142.49 27.37 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 163.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.0 t -106.8 -45.88 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.548 0.613 . . . . 0.0 110.108 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.2 m -61.86 -43.81 98.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.65 157.18 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.823 1.192 . . . . 0.0 112.375 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -62.09 128.6 91.08 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.29 89.02 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.367 2.045 . . . . 0.0 113.707 -172.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -155.59 114.08 3.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.227 1.811 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -76.74 93.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.836 2.054 . . . . 0.0 108.2 171.822 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -69.63 -7.26 37.3 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.16 154.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.874 1.216 . . . . 0.0 111.989 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.91 66.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.249 1.02 . . . . 0.0 112.322 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.16 0.05 5.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.187 2.995 . . . . 0.0 114.07 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.24 11.82 0.15 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.849 1.66 . . . . 0.0 115.429 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.35 17.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.304 3.442 . . . . 0.0 115.597 -167.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.2 176.78 8.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.893 2.077 . . . . 0.0 114.126 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.29 114.51 27.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.836 2.854 . . . . 0.0 106.171 164.209 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.62 132.03 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.561 0.696 . . . . 0.0 112.749 -158.497 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.86 137.97 33.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.263 2.225 . . . . 0.0 111.109 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.84 144.05 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.005 2.122 . . . . 0.0 108.69 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -98.91 135.75 39.89 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 112.476 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.36 166.56 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 110.442 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 5.3 tt0 -102.37 110.67 63.32 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.073 0.949 . . . . 0.0 110.009 171.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 92.0 Cg_endo -84.88 108.59 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.729 4.286 . . . . 0.0 111.084 172.571 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 58.2 Cg_endo -60.34 161.56 19.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.38 165.31 16.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.92 -80.26 1.23 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -165.067 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.01 156.66 41.27 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.801 1.24 . . . . 0.0 111.139 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -143.02 142.17 31.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.523 1.129 . . . . 0.0 110.161 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -137.92 128.63 26.81 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.644 1.178 . . . . 0.0 108.096 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.22 98.64 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.265 1.426 . . . . 0.0 107.255 -162.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -99.92 136.49 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.939 0.896 . . . . 0.0 109.114 -167.153 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.6 103.98 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.67 1.588 . . . . 0.0 107.524 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.97 177.59 15.04 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.299 0.944 . . . . 0.0 114.763 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.47 154.51 45.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.195 2.198 . . . . 0.0 108.471 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -12.2 -72.74 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.68 2.562 . . . . 0.0 117.164 -173.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.11 -13.72 59.76 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.9 88.04 2.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.623 1.569 . . . . 0.0 109.971 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -143.25 157.7 44.26 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.29 161.4 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 129.382 3.073 . . . . 0.0 107.839 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.69 150.82 36.15 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.05 -1.031 . . . . 0.0 112.513 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -120.87 170.25 9.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.766 1.226 . . . . 0.0 110.832 166.333 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -125.8 159.74 31.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.616 1.967 . . . . 0.0 111.31 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.0 153.01 31.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.198 2.599 . . . . 0.0 110.599 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -143.58 117.3 9.27 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 108.765 -167.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -150.57 93.04 1.92 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -165.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p 65.8 58.0 0.8 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.081 1.753 . . . . 0.0 114.077 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 128.65 25.3 1.04 Allowed Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.882 1.706 . . . . 0.0 113.439 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 30.1 t -61.01 158.0 14.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.239 1.816 . . . . 0.0 113.475 -177.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 m -55.52 -22.81 23.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.322 1.049 . . . . 0.0 112.454 163.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -91.33 -3.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 126.809 2.044 . . . . 0.0 111.523 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.54 69.87 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.635 -1.291 . . . . 0.0 115.469 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.6 ptmm? . . . . . 0 C--O 1.249 1.029 0 C-N-CA 126.022 1.729 . . . . 0.0 113.206 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -142.78 137.25 29.59 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.113 0.565 . . . . 0.0 112.093 -162.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 168.42 14.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.669 2.787 . . . . 0.0 109.953 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -83.65 -57.54 3.18 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.239 -0.913 . . . . 0.0 111.994 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -58.36 -29.65 66.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.417 1.487 . . . . 0.0 114.356 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -70.74 -40.03 72.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.33 0.513 . . . . 0.0 111.093 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -65.74 -45.32 83.08 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.962 0.801 . . . . 0.0 109.886 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.99 101.77 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 130.04 3.686 . . . . 0.0 116.756 161.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -68.4 62.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.521 2.328 . . . . 0.0 112.682 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -70.33 -17.92 63.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.382 1.873 . . . . 0.0 113.757 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -160.07 -179.15 7.52 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.444 1.497 . . . . 0.0 110.486 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.05 144.85 24.09 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.668 1.128 . . . . 0.0 114.241 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.99 95.54 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 122.969 1.366 . . . . 0.0 114.152 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 169.44 17.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 128.627 2.771 . . . . 0.0 108.299 168.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -167.27 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.585 0.754 . . . . 0.0 112.484 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? 61.99 -76.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.593 2.357 . . . . 0.0 113.647 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.49 77.06 1.59 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.802 0.81 . . . . 0.0 112.149 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -120.7 156.96 30.66 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.403 1.081 . . . . 0.0 110.144 163.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -143.11 142.39 31.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.085 1.754 . . . . 0.0 108.731 168.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.49 138.7 57.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.67 0.748 . . . . 0.0 111.398 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -43.12 3.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.077 1.351 . . . . 0.0 109.541 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.98 115.48 1.2 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.395 1.95 . . . . 0.0 109.646 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.2 p -64.12 159.58 55.46 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.648 -0.913 . . . . 0.0 111.321 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.46 137.22 68.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.139 1.893 . . . . 0.0 112.585 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 125.3 32.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.5 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.37 132.05 47.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.557 0.694 . . . . 0.0 111.454 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.2 p -78.8 -9.14 59.36 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.818 1.647 . . . . 0.0 113.944 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.16 -7.82 3.08 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 118.994 0.815 . . . . 0.0 114.061 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -94.96 4.87 53.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.069 1.748 . . . . 0.0 111.193 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.02 42.31 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.245 1.879 . . . . 0.0 114.072 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -109.47 174.76 5.72 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.034 2.134 . . . . 0.0 112.056 -171.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -120.42 141.01 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.936 1.294 . . . . 0.0 110.224 165.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.54 128.89 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.018 1.327 . . . . 0.0 109.918 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.55 133.09 36.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.729 2.012 . . . . 0.0 109.217 -172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -121.24 132.32 54.74 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.869 0.868 . . . . 0.0 112.612 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.85 166.12 14.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.865 0.866 . . . . 0.0 110.119 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -120.95 148.74 43.67 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.885 0.874 . . . . 0.0 109.45 160.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -100.4 100.36 11.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.011 0.925 . . . . 0.0 109.702 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -80.47 13.64 2.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.453 2.301 . . . . 0.0 115.759 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.08 171.32 27.8 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.507 1.048 . . . . 0.0 113.789 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -96.52 6.42 48.78 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.715 1.606 . . . . 0.0 113.479 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.8 172.68 12.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.87 1.668 . . . . 0.0 112.308 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.65 47.76 0.89 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-O 117.046 -1.975 . . . . 0.0 117.413 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -55.11 95.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.959 0 CA-C-N 121.769 2.785 . . . . 0.0 111.458 162.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 65.4 m -152.96 168.03 27.19 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.367 1.467 . . . . 0.0 112.589 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -83.48 91.96 7.5 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.504 -1.372 . . . . 0.0 110.782 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.81 119.35 15.76 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.676 1.19 . . . . 0.0 112.105 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.83 88.87 1.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.353 2.702 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 tt -124.62 143.72 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.792 -0.567 . . . . 0.0 110.07 165.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.5 t -147.62 157.16 43.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.844 1.258 . . . . 0.0 112.055 -168.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -133.28 108.62 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.993 1.717 . . . . 0.0 110.562 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 57' ' ' ASP . 19.3 m -131.73 170.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.794 0.837 . . . . 0.0 112.166 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.19 -12.6 18.62 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -152.93 27.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.114 -1.616 . . . . 0.0 112.602 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.47 17.66 2.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.054 2.142 . . . . 0.0 113.098 -168.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.489 HD21 ' CG2' ' A' ' 61' ' ' VAL . 13.5 p-10 -68.37 52.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.583 2.753 . . . . 0.0 111.952 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HA ' HG11 ' A' ' 52' ' ' VAL . 12.3 t0 -56.94 -25.67 58.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.914 1.285 . . . . 0.0 113.2 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.58 -10.96 0.48 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.566 3.147 . . . . 0.0 116.128 166.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.3 m -153.6 95.75 2.85 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 119.869 -1.77 . . . . 0.0 111.064 166.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HA ' HG12 ' A' ' 52' ' ' VAL . 85.7 Cg_exo -54.27 118.1 4.65 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.838 3.692 . . . . 0.0 116.369 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.7 t -95.9 -26.21 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.858 1.663 . . . . 0.0 112.859 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.18 -163.52 18.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.514 2.007 . . . . 0.0 111.798 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 172.31 13.02 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.64 104.94 16.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.972 2.109 . . . . 0.0 106.857 168.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.85 -48.58 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.593 0.757 . . . . 0.0 110.453 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -59.82 -48.04 83.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -162.41 161.96 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.235 0.925 . . . . 0.0 112.033 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.16 120.73 45.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.858 0.863 . . . . 0.0 109.563 161.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.82 85.32 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.397 2.064 . . . . 0.0 110.843 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.34 123.9 11.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.048 1.739 . . . . 0.0 110.376 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.48 99.09 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.285 1.434 . . . . 0.0 108.323 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.2 t -75.71 -4.48 40.6 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.17 159.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.076 1.307 . . . . 0.0 112.842 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.62 63.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.936 1.294 . . . . 0.0 113.206 168.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.7 p -80.41 2.53 24.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.076 1.75 . . . . 0.0 114.103 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 14.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.22 16.65 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 130.969 3.708 . . . . 0.0 114.814 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.597 2.359 . . . . 0.0 114.024 -171.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.38 107.83 16.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.708 2.803 . . . . 0.0 105.696 166.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.32 120.02 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.148 0.979 . . . . 0.0 113.231 -153.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.05 129.29 35.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.151 2.581 . . . . 0.0 109.748 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.55 136.92 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.826 2.45 . . . . 0.0 108.499 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -91.09 141.54 28.71 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.343 0.657 . . . . 0.0 112.347 167.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.52 159.62 30.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.339 2.256 . . . . 0.0 110.045 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.45 107.54 58.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 108.95 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.55 ' HG3' HG13 ' A' ' 32' ' ' VAL . 97.7 Cg_endo -90.99 115.8 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 125.044 3.83 . . . . 0.0 110.711 167.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.4 167.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 125.115 3.877 . . . . 0.0 116.172 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -77.59 161.28 27.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.33 -87.57 1.2 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -125.7 160.38 29.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.46 1.124 . . . . 0.0 110.905 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -154.12 159.35 41.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.065 0.936 . . . . 0.0 111.651 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.55 127.96 21.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.299 1.44 . . . . 0.0 108.114 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.46 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.212 1.805 . . . . 0.0 107.011 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -106.65 135.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.56 92.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 126.156 1.782 . . . . 0.0 107.236 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.97 171.19 17.46 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.69 113.52 13.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.061 1.744 . . . . 0.0 110.436 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.07 -103.49 0.05 OUTLIER Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.078 1.799 . . . . 0.0 114.116 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -17.03 64.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.582 1.953 . . . . 0.0 115.727 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -129.43 98.6 4.91 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.545 1.066 . . . . 0.0 110.554 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -148.84 166.03 29.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.51 162.67 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 129.931 3.293 . . . . 0.0 108.502 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.69 157.1 41.62 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 172.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -139.35 151.31 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 111.684 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 160.64 14.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.232 1.413 . . . . 0.0 112.757 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -147.51 154.38 40.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.571 1.548 . . . . 0.0 112.053 158.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -139.69 114.65 9.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.842 1.657 . . . . 0.0 108.685 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -151.19 108.21 3.56 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -165.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 p 52.41 70.68 0.54 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.796 2.838 . . . . 0.0 113.784 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.83 24.63 4.22 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.571 1.557 . . . . 0.0 113.541 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -56.91 155.25 8.22 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 112.668 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 m -51.05 -25.1 4.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.324 1.449 . . . . 0.0 112.761 161.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.01 -4.47 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.332 1.853 . . . . 0.0 112.849 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.11 5.79 60.58 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.636 1.415 . . . . 0.0 116.636 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.483 1.642 . . . . 0.0 113.858 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -145.62 149.66 34.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.392 1.077 . . . . 0.0 111.018 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.11 106.14 13.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.71 2.004 . . . . 0.0 110.094 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.14 -24.15 47.5 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -163.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.74 -39.11 73.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.258 1.023 . . . . 0.0 112.918 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.55 -5.68 41.74 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -71.09 -15.58 62.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -165.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.52 84.93 0.3 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.174 1.352 . . . . 0.0 114.685 170.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -89.4 18.28 5.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.292 1.837 . . . . 0.0 113.833 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -62.16 -12.02 17.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.23 170.88 14.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.563 1.945 . . . . 0.0 108.78 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.09 161.99 40.14 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.471 -0.768 . . . . 0.0 113.396 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -72.51 91.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.269 1.509 . . . . 0.0 113.626 -172.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.67 163.1 35.92 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.281 2.232 . . . . 0.0 109.195 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.6 p -160.03 -44.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.594 1.158 . . . . 0.0 110.774 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 64.46 -70.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 128.227 2.611 . . . . 0.0 112.515 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.81 78.6 1.97 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.328 1.051 . . . . 0.0 112.228 -161.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -134.29 154.98 51.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 111.346 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -146.05 143.88 29.69 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.551 1.94 . . . . 0.0 109.617 165.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.88 129.82 42.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.851 0.86 . . . . 0.0 111.17 167.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -108.71 -51.13 2.92 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.603 1.561 . . . . 0.0 109.39 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.56 104.48 0.69 Allowed Glycine 0 C--N 1.339 0.701 0 C-N-CA 125.861 1.695 . . . . 0.0 109.137 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -64.15 157.29 70.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 117.927 0.864 . . . . 0.0 112.365 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.88 141.09 46.84 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.554 2.836 . . . . 0.0 115.621 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.95 122.91 24.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 110.019 167.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.19 123.18 18.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -72.94 -13.74 61.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.997 0.919 . . . . 0.0 112.64 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 -8.93 2.17 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 119.046 0.839 . . . . 0.0 114.14 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -89.59 11.26 20.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.737 1.615 . . . . 0.0 111.586 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 12.87 58.95 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.861 1.22 . . . . 0.0 113.836 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -131.01 163.39 27.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.835 1.317 . . . . 0.0 112.497 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 123.41 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.176 1.79 . . . . 0.0 107.765 164.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.57 124.72 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.92 146.82 45.92 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.686 1.194 . . . . 0.0 110.682 169.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.99 135.28 53.82 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.094 0.958 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.7 mt -117.17 161.09 20.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.29 1.436 . . . . 0.0 109.838 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -120.34 139.54 52.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.246 1.019 . . . . 0.0 109.781 163.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.59 93.32 9.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.521 1.128 . . . . 0.0 109.827 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -72.72 32.21 0.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.88 2.472 . . . . 0.0 115.08 -165.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.42 178.57 45.3 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 122.777 1.209 . . . . 0.0 116.055 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.37 -24.96 29.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.092 2.557 . . . . 0.0 115.655 -169.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.25 173.61 15.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.091 0.956 . . . . 0.0 111.744 -153.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' ' HD3' ' A' ' 44' ' ' PRO . . . 118.85 50.88 0.31 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-O 117.131 -1.927 . . . . 0.0 116.301 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 43' ' ' GLY . 36.2 Cg_exo -54.69 87.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.026 0 CA-C-N 121.628 2.714 . . . . 0.0 112.089 160.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.76 169.54 20.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.56 1.144 . . . . 0.0 112.671 -167.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -91.26 92.98 8.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.785 1.234 . . . . 0.0 109.889 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.51 119.81 43.13 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.882 0.873 . . . . 0.0 112.87 -170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.75 88.24 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.358 2.705 . . . . 0.0 109.985 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -123.86 144.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.4 1.48 . . . . 0.0 108.567 167.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.8 t -154.59 167.85 28.73 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.2 t -142.27 125.64 16.6 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.53 2.332 . . . . 0.0 109.877 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.3 m -139.24 167.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.239 1.016 . . . . 0.0 113.657 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.56 22.61 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -155.32 36.05 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.036 -1.665 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.17 10.03 1.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.288 2.235 . . . . 0.0 114.723 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -68.78 46.28 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 129.575 3.15 . . . . 0.0 113.906 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.6 t70 -66.25 -2.46 4.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -166.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.65 -12.15 2.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.553 1.141 . . . . 0.0 113.672 159.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.6 m -155.0 99.82 2.35 Favored Pre-proline 0 CA--C 1.536 0.409 0 O-C-N 120.304 -1.497 . . . . 0.0 109.468 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.61 126.84 15.08 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.293 3.329 . . . . 0.0 112.619 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.49 -34.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.642 1.177 . . . . 0.0 110.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.48 -170.07 40.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.181 1.372 . . . . 0.0 111.15 161.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.5 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.3 ptp85 -134.99 171.99 13.65 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.208 1.403 . . . . 0.0 111.997 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -90.32 124.25 34.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.415 1.886 . . . . 0.0 107.452 168.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -95.69 -53.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 118.468 0.576 . . . . 0.0 111.088 -171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -41.3 89.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.63 150.08 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.946 0.899 . . . . 0.0 109.786 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -68.75 147.46 97.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 122.178 -0.326 . . . . 0.0 110.133 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.96 76.82 4.35 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.314 2.676 . . . . 0.0 113.54 -160.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.35 124.99 14.91 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.168 -0.957 . . . . 0.0 111.129 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.53 91.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.253 1.421 . . . . 0.0 107.228 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 t -57.67 -28.28 63.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.7 m -151.53 158.76 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.262 1.825 . . . . 0.0 111.898 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.43 -24.02 67.48 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.395 1.078 . . . . 0.0 112.858 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.68 0.66 0.74 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 129.694 3.197 . . . . 0.0 114.503 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.97 8.98 0.77 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.83 1.652 . . . . 0.0 115.072 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -61.63 18.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 130.648 3.579 . . . . 0.0 116.022 -169.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.09 174.98 11.06 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.903 2.481 . . . . 0.0 114.43 -171.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.5 97.72 5.14 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.131 2.572 . . . . 0.0 107.13 170.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.02 119.03 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -148.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mt -59.44 142.38 52.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.001 1.72 . . . . 0.0 112.432 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.8 148.0 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 127.571 2.348 . . . . 0.0 108.377 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -99.19 139.5 34.75 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.354 1.062 . . . . 0.0 111.724 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.3 165.78 15.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.42 2.288 . . . . 0.0 109.55 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.5 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 7.9 tt0 -95.57 116.93 66.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.642 1.177 . . . . 0.0 109.425 170.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -98.35 107.14 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.856 4.371 . . . . 0.0 112.349 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -45.76 150.89 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.046 3.164 . . . . 0.0 115.167 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -81.71 162.16 23.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.686 0.795 . . . . 0.0 112.632 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.11 -88.02 0.88 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -162.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.65 148.08 41.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.995 1.318 . . . . 0.0 110.412 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.58 106.83 5.5 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.497 1.119 . . . . 0.0 109.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -110.12 129.16 55.74 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.438 -0.789 . . . . 0.0 110.34 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.16 111.7 36.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 126.378 1.871 . . . . 0.0 107.917 -168.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.08 135.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.852 0.861 . . . . 0.0 110.118 -160.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.22 100.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.04 1.736 . . . . 0.0 108.525 -168.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.97 -175.61 19.97 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 122.242 0.912 . . . . 0.0 114.959 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -138.85 141.09 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.374 1.87 . . . . 0.0 109.789 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 16.28 -87.68 0.0 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.213 2.816 . . . . 0.0 116.255 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -70.06 -20.39 63.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -139.51 96.7 3.13 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.424 1.49 . . . . 0.0 110.382 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 159.06 43.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.48 164.07 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.852 2.461 . . . . 0.0 108.519 166.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -148.91 160.75 42.98 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.836 0.854 . . . . 0.0 109.74 166.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -136.16 167.45 21.25 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 109.93 166.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -120.86 161.47 21.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 112.426 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.33 157.65 42.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 128.927 2.891 . . . . 0.0 109.734 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -145.06 148.14 33.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.234 1.014 . . . . 0.0 109.017 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -153.05 116.83 4.76 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.821 . . . . 0.0 112.088 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.7 p 119.68 -0.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 131.146 3.778 . . . . 0.0 114.38 159.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.19 43.45 0.72 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.751 1.167 . . . . 0.0 111.687 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.3 t -88.32 -154.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.497 1.919 . . . . 0.0 112.313 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.5 p -46.95 -31.38 3.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.374 2.669 . . . . 0.0 116.577 -167.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -112.77 11.23 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 125.299 1.44 . . . . 0.0 111.767 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.55 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.46 -1.4 . . . . 0.0 113.604 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 tptp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.969 1.708 . . . . 0.0 112.499 -168.837 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 173.54 12.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.297 2.239 . . . . 0.0 110.454 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -115.07 -53.41 2.63 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -45.28 -53.03 8.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 114.179 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.73 -29.1 67.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.801 0.84 . . . . 0.0 113.057 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.21 -14.78 60.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.93 1.292 . . . . 0.0 113.518 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -17.65 129.59 0.01 OUTLIER Glycine 0 CA--C 1.533 1.213 1 C-N-CA 130.986 4.136 . . . . 0.0 117.484 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 m -62.82 68.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.882 3.273 . . . . 0.0 113.569 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.783 2.033 . . . . 0.0 114.092 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -150.02 175.45 11.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.59 2.356 . . . . 0.0 109.521 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.25 38.0 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 111.787 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -74.36 97.3 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.01 173.33 16.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.949 1.3 . . . . 0.0 111.812 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 90.3 p -151.14 -22.49 0.21 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.794 1.237 . . . . 0.0 114.321 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? 56.58 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 129.974 3.31 . . . . 0.0 115.696 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.89 74.9 1.61 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.07 1.348 . . . . 0.0 111.471 -159.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.43 160.5 16.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.122 1.369 . . . . 0.0 109.709 160.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -134.14 143.59 48.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.285 1.834 . . . . 0.0 108.106 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -68.03 140.65 56.33 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.762 -0.586 . . . . 0.0 111.075 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.62 -57.05 2.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.61 1.164 . . . . 0.0 109.028 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 107.27 0.85 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.766 1.651 . . . . 0.0 110.466 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -42.67 137.23 2.44 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 111.21 170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.89 152.15 52.28 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.299 2.0 . . . . 0.0 113.76 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.61 121.86 13.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.262 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.05 123.51 20.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.997 0.903 . . . . 0.0 110.804 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -63.38 -16.7 61.27 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.897 2.479 . . . . 0.0 114.352 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.93 -13.49 43.41 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.03 0.832 . . . . 0.0 113.174 -167.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -80.01 8.44 7.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.698 1.249 . . . . 0.0 112.063 165.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.74 84.42 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.532 -1.149 . . . . 0.0 113.949 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.0 p -125.91 146.6 49.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.143 2.177 . . . . 0.0 110.091 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.69 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.0 m -91.92 138.18 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.105 0.962 . . . . 0.0 111.003 173.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.424 ' HB ' HD21 ' A' ' 81' ' ' LEU . 2.5 m -85.81 133.45 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 155.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 126.15 16.81 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.57 2.348 . . . . 0.0 109.043 -167.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.12 134.29 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.574 1.079 . . . . 0.0 113.471 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.29 174.27 9.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.814 1.645 . . . . 0.0 111.109 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -135.67 139.44 43.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.431 1.092 . . . . 0.0 110.394 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -89.05 102.99 15.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.319 0.648 . . . . 0.0 110.039 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -80.39 -9.11 59.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 113.535 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.27 166.04 54.67 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.043 0.838 . . . . 0.0 113.394 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -118.95 11.76 12.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.862 1.665 . . . . 0.0 110.531 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -157.71 -178.6 7.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.913 2.485 . . . . 0.0 110.208 -156.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.98 58.98 2.38 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.255 1.662 . . . . 0.0 117.255 164.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -51.94 109.01 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.936 2.424 . . . . 0.0 111.072 155.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.56 155.64 19.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -164.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -81.16 91.15 6.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.543 1.537 . . . . 0.0 109.482 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.35 116.19 14.07 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.938 0.895 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.37 82.22 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 111.269 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -105.96 145.0 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 167.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -154.03 170.33 21.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.152 1.381 . . . . 0.0 113.048 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -144.31 117.16 8.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.445 2.298 . . . . 0.0 110.637 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 57' ' ' ASP . 13.9 m -140.72 169.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.678 1.191 . . . . 0.0 112.945 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.93 -3.51 21.68 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -154.78 30.84 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.01 -1.681 . . . . 0.0 112.528 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.8 7.98 1.65 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.462 1.905 . . . . 0.0 114.286 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -69.52 46.48 0.07 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.875 3.27 . . . . 0.0 113.474 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.512 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.0 t0 -62.84 -7.42 5.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -163.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -58.31 -23.54 56.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.252 1.421 . . . . 0.0 112.96 162.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.0 m -132.71 95.64 19.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 125.652 1.581 . . . . 0.0 109.407 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 123.31 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.108 2.538 . . . . 0.0 110.916 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.17 -22.35 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.365 1.066 . . . . 0.0 111.181 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.48 -170.23 18.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.938 2.208 . . . . 0.0 111.797 165.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.418 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.6 ptp85 -138.16 172.82 12.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.918 1.287 . . . . 0.0 112.59 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 126.79 39.24 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 106.809 167.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -98.63 -41.66 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.62 -168.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -63.07 -50.29 71.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.127 0.876 . . . . 0.0 113.319 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 p -164.29 166.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.335 1.054 . . . . 0.0 111.428 -165.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.06 123.5 48.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.872 0.869 . . . . 0.0 109.164 161.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.26 95.86 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.081 1.854 . . . . 0.0 111.131 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -146.46 142.84 28.52 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.398 -0.814 . . . . 0.0 112.612 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.59 95.86 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 126.858 2.063 . . . . 0.0 106.25 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.4 p -70.24 -22.1 62.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.4 m -150.8 157.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.853 1.661 . . . . 0.0 112.065 -170.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.61 65.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.974 0.91 . . . . 0.0 113.275 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.8 p -78.56 8.11 5.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.6 1.96 . . . . 0.0 113.711 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 12.82 0.07 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.921 1.689 . . . . 0.0 115.357 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.38 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.793 3.237 . . . . 0.0 115.243 -167.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.23 163.22 28.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.19 1.796 . . . . 0.0 113.389 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -98.82 111.1 23.58 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 128.244 2.618 . . . . 0.0 106.045 159.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.72 140.3 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.319 1.048 . . . . 0.0 112.62 -157.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 33' ' ' VAL . 2.8 tm? -105.84 131.64 52.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.963 2.505 . . . . 0.0 109.536 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.95 155.12 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.457 1.903 . . . . 0.0 109.522 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -109.0 132.25 54.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.578 . . . . 0.0 110.62 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.57 160.71 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.857 1.663 . . . . 0.0 110.103 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 32.0 tt0 -101.62 104.58 35.46 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.167 0.987 . . . . 0.0 109.079 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.69 ' HG3' HG13 ' A' ' 32' ' ' VAL . 73.8 Cg_endo -83.38 118.35 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.274 3.316 . . . . 0.0 109.654 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.4 160.61 49.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.215 1.943 . . . . 0.0 111.082 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -66.09 159.57 25.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.545 1.138 . . . . 0.0 112.645 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.55 -148.23 18.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.581 1.086 . . . . 0.0 110.566 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.04 146.0 55.59 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.68 -0.894 . . . . 0.0 109.048 152.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -135.37 100.56 4.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.729 0.812 . . . . 0.0 109.621 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -109.08 132.62 53.94 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.084 0.945 . . . . 0.0 111.025 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.01 99.33 8.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 127.866 2.466 . . . . 0.0 107.151 -166.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.8 t -101.08 139.44 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.461 0.704 . . . . 0.0 109.483 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.62 87.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.29 1.436 . . . . 0.0 108.369 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.83 168.52 29.14 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 118.243 2.057 . . . . 0.0 118.243 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.56 146.35 37.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.86 1.664 . . . . 0.0 109.512 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.25 -98.5 0.01 OUTLIER Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.398 1.951 . . . . 0.0 115.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -90.11 -13.55 35.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.992 1.717 . . . . 0.0 114.317 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.49 90.36 3.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.569 1.548 . . . . 0.0 109.291 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.4 155.06 45.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.8 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 129.178 2.991 . . . . 0.0 108.098 170.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.29 156.38 38.31 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.396 -0.815 . . . . 0.0 110.95 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.31 160.83 32.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.286 2.235 . . . . 0.0 109.231 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.38 144.88 40.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.839 0.456 . . . . 0.0 111.433 -168.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.67 169.94 16.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.935 1.694 . . . . 0.0 111.226 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.29 117.24 14.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.077 1.751 . . . . 0.0 108.112 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -141.03 87.32 2.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 112.793 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.9 m 54.65 63.62 2.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.749 2.02 . . . . 0.0 113.521 168.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.57 12.68 0.78 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.438 1.494 . . . . 0.0 114.101 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.5 t -75.53 158.19 32.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.734 1.214 . . . . 0.0 112.961 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 m -40.34 -33.94 0.29 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 130.326 3.45 . . . . 0.0 114.54 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.21 -7.51 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.358 1.063 . . . . 0.0 113.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.53 55.17 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 118.844 -0.975 . . . . 0.0 115.464 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 C-N-CA 125.104 1.362 . . . . 0.0 112.396 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 162.34 36.51 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.229 0.611 . . . . 0.0 111.676 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 -172.68 2.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.16 2.184 . . . . 0.0 110.773 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -106.72 -57.68 2.03 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.518 -0.738 . . . . 0.0 110.702 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -53.47 -34.41 57.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.579 2.352 . . . . 0.0 114.876 -172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.87 -22.03 66.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.364 0.984 . . . . 0.0 112.91 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -82.72 -2.49 54.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.708 0.803 . . . . 0.0 112.698 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -20.07 113.74 0.01 OUTLIER Glycine 0 CA--C 1.532 1.102 1 C-N-CA 130.818 4.056 . . . . 0.0 116.64 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.401 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 82.0 p -67.52 72.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.86 2.464 . . . . 0.0 113.897 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.0 p -74.27 -19.89 60.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.021 1.728 . . . . 0.0 114.172 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.66 170.53 16.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.981 2.112 . . . . 0.0 109.558 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.72 142.82 34.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.119 0.866 . . . . 0.0 112.588 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.41 103.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.65 1.18 . . . . 0.0 112.607 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 148.24 17.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.603 2.361 . . . . 0.0 109.064 -171.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -141.0 -21.9 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 45.36 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.983 3.313 . . . . 0.0 115.328 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.81 80.41 1.58 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.577 1.551 . . . . 0.0 110.571 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -124.62 155.92 38.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.366 1.066 . . . . 0.0 110.684 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -143.85 146.81 33.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.839 1.656 . . . . 0.0 108.493 166.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -69.43 140.28 54.08 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.761 -0.587 . . . . 0.0 111.27 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.58 -44.04 4.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.431 1.092 . . . . 0.0 109.812 168.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.62 117.01 1.15 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.458 1.027 . . . . 0.0 112.419 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.9 m -45.59 146.76 1.68 Allowed Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 127.934 2.494 . . . . 0.0 112.465 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.95 135.79 36.4 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.099 2.533 . . . . 0.0 113.467 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.77 111.54 13.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.025 1.73 . . . . 0.0 110.023 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.31 122.06 12.97 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.33 1.452 . . . . 0.0 111.432 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.1 p -75.46 -11.33 60.01 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.58 -26.79 0.37 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.779 1.18 . . . . 0.0 113.866 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.47 -9.74 57.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.518 2.327 . . . . 0.0 112.968 174.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.33 14.09 12.26 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.817 1.199 . . . . 0.0 114.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 p -128.43 171.14 12.34 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.26 1.424 . . . . 0.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 m -128.82 120.21 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.904 1.682 . . . . 0.0 109.087 171.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.59 133.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.08 130.23 35.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.346 1.858 . . . . 0.0 108.645 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -109.63 128.57 55.32 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.326 0.584 . . . . 0.0 112.388 -174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.52 167.97 12.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.001 1.321 . . . . 0.0 110.501 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.41 142.45 51.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.658 1.183 . . . . 0.0 109.851 162.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -94.1 101.26 13.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -76.3 7.95 3.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.101 2.16 . . . . 0.0 115.265 -169.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.56 169.76 21.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.66 1.118 . . . . 0.0 113.859 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -103.12 -0.45 30.6 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.323 1.849 . . . . 0.0 113.666 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -136.72 173.71 11.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.246 1.818 . . . . 0.0 112.33 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 56.81 1.04 Allowed Glycine 0 CA--C 1.539 1.535 0 CA-C-O 117.823 -1.543 . . . . 0.0 116.719 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.17 99.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.29 2.66 . . . . 0.0 111.897 155.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 m -151.47 166.72 30.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.399 1.08 . . . . 0.0 112.548 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 3.7 ttmm -92.58 98.98 11.79 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.811 170.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.32 117.31 39.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.01 1.324 . . . . 0.0 111.353 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.53 85.62 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.658 2.905 . . . . 0.0 111.565 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.89 146.79 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.937 0.895 . . . . 0.0 109.966 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 t -149.65 167.35 26.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.01 1.324 . . . . 0.0 113.524 -167.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 t -142.66 107.55 4.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.284 2.233 . . . . 0.0 110.974 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 57' ' ' ASP . 20.9 m -136.15 163.72 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.04 -7.46 16.92 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -166.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -154.04 34.75 0.43 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.385 -1.447 . . . . 0.0 111.368 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt 57.71 12.77 1.73 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.7 2.0 . . . . 0.0 114.546 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.9 p-10 -67.01 45.83 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 130.141 3.376 . . . . 0.0 114.345 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.1 t70 -63.68 -9.2 12.77 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -165.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.44 -10.36 2.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.399 1.48 . . . . 0.0 114.218 162.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.4 m -155.49 118.86 2.41 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 110.541 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.3 141.32 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.214 2.609 . . . . 0.0 111.116 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.5 t -116.58 -34.27 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.945 0.898 . . . . 0.0 110.967 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.45 -167.43 39.56 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.846 1.212 . . . . 0.0 110.753 156.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.9 ptp85 -135.33 172.04 13.58 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.916 1.286 . . . . 0.0 111.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.51 139.72 31.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 161.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.38 -49.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.194 0.597 . . . . 0.0 110.754 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.4 m -57.87 -43.58 86.1 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.97 161.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.996 0.816 . . . . 0.0 111.061 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.64 117.45 18.95 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 156.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.92 93.81 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.387 2.058 . . . . 0.0 111.783 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -144.82 135.07 24.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.114 1.365 . . . . 0.0 111.276 168.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.11 89.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 127.609 2.364 . . . . 0.0 107.151 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -63.38 -32.02 73.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.92 156.85 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.983 2.113 . . . . 0.0 110.914 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.04 -25.46 67.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.794 0.838 . . . . 0.0 112.436 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 4.66 5.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.057 2.143 . . . . 0.0 114.599 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 13.46 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 130.924 3.69 . . . . 0.0 115.219 -169.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.91 173.89 10.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.593 1.957 . . . . 0.0 113.667 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -117.0 108.84 16.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.615 3.166 . . . . 0.0 105.77 169.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.06 127.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.632 0.773 . . . . 0.0 112.967 -154.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mt -79.52 135.52 36.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.777 2.031 . . . . 0.0 110.911 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.96 129.35 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.089 2.155 . . . . 0.0 108.395 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -81.1 134.26 35.62 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.782 0.801 . . . . 0.0 111.667 170.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.06 161.59 18.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.973 2.109 . . . . 0.0 109.38 162.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 22.7 tt0 -94.41 125.06 53.49 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 167.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.25 128.22 7.99 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 124.294 3.329 . . . . 0.0 111.036 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.7 168.68 20.79 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.299 1.333 . . . . 0.0 110.599 160.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.34 162.71 15.67 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.247 -0.908 . . . . 0.0 112.287 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.08 -83.97 1.6 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -117.97 170.01 9.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.313 1.054 . . . . 0.0 110.8 169.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.9 m -145.73 84.75 1.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.319 1.447 . . . . 0.0 108.881 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.36 128.83 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.412 1.085 . . . . 0.0 109.048 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.92 94.59 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.978 1.711 . . . . 0.0 107.749 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.46 145.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.689 0.795 . . . . 0.0 109.915 -166.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.3 94.39 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 108.132 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.73 167.67 28.74 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 119.262 2.465 . . . . 0.0 119.262 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.39 109.66 6.51 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.064 2.546 . . . . 0.0 109.274 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.43 -102.03 0.04 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.792 1.663 . . . . 0.0 114.215 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.79 -18.97 62.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 115.151 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.73 94.64 4.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.001 0.92 . . . . 0.0 108.913 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.63 43.69 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.82 167.88 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 128.754 2.822 . . . . 0.0 108.569 170.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.02 149.16 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.872 0.869 . . . . 0.0 110.805 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.27 163.39 19.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.994 2.117 . . . . 0.0 109.232 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -138.37 130.73 28.89 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.757 -0.59 . . . . 0.0 110.059 -161.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.19 165.7 28.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.352 1.061 . . . . 0.0 111.62 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -144.06 116.45 8.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.956 1.303 . . . . 0.0 109.423 -160.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -144.68 87.63 1.87 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -164.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 76.6 p 59.39 84.6 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.364 1.865 . . . . 0.0 113.81 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.36 23.84 6.46 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.759 1.647 . . . . 0.0 112.751 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.4 t -58.42 162.86 3.42 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.021 1.728 . . . . 0.0 114.013 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -56.37 -15.12 3.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.28 1.032 . . . . 0.0 113.612 163.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.45 3.38 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 126.181 1.792 . . . . 0.0 111.551 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.97 -11.5 71.93 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 119.95 -1.719 . . . . 0.0 116.124 169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--O 1.249 1.04 0 CA-C-N 118.904 1.352 . . . . 0.0 113.094 171.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -69.05 -178.96 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.056 2.142 . . . . 0.0 113.197 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.38 155.76 45.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.506 2.722 . . . . 0.0 110.827 -163.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -88.66 -61.73 1.64 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.454 -0.779 . . . . 0.0 111.757 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -60.04 -31.91 70.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.178 1.391 . . . . 0.0 113.938 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -4.97 46.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.121 0.968 . . . . 0.0 112.997 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -57.72 -31.44 66.44 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 81.15 0.57 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -68.4 -6.64 25.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.453 1.901 . . . . 0.0 114.81 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -75.12 0.97 14.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -170.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -141.76 154.08 45.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.877 1.217 . . . . 0.0 112.039 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 160.22 45.29 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.648 1.118 . . . . 0.0 112.708 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.38 95.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 122.641 1.21 . . . . 0.0 114.076 -167.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 171.28 19.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.95 1.7 . . . . 0.0 111.247 167.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -150.42 -3.22 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.097 152.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 53.98 -75.95 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.191 2.597 . . . . 0.0 113.586 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.33 74.34 5.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.18 1.792 . . . . 0.0 112.837 -163.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.67 149.2 52.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.635 0.774 . . . . 0.0 111.124 166.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -138.31 141.25 39.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.775 1.63 . . . . 0.0 109.827 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -61.7 128.69 37.46 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.057 0.943 . . . . 0.0 110.603 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.34 -26.23 6.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.063 0.945 . . . . 0.0 112.854 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.04 123.93 2.82 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.367 0.984 . . . . 0.0 111.037 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.0 p -62.54 144.2 95.86 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 125.162 1.385 . . . . 0.0 111.427 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.96 148.33 47.88 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.818 2.345 . . . . 0.0 115.142 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.38 128.15 20.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.723 1.609 . . . . 0.0 110.854 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.71 132.29 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.552 0.741 . . . . 0.0 111.048 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -78.77 -9.55 59.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.586 1.554 . . . . 0.0 113.944 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.36 -2.84 9.08 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.21 0.913 . . . . 0.0 113.891 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -103.39 5.9 37.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.94 1.696 . . . . 0.0 111.704 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.41 13.76 50.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.961 1.267 . . . . 0.0 114.083 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.9 p -129.67 168.33 16.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.272 1.429 . . . . 0.0 111.565 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.78 130.73 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.915 1.686 . . . . 0.0 108.37 164.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 m -83.28 124.77 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 160.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 154.2 49.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.645 1.178 . . . . 0.0 110.553 170.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -119.61 134.4 55.24 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.202 -0.936 . . . . 0.0 111.675 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.77 163.13 22.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.159 0.984 . . . . 0.0 111.02 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -126.55 137.11 53.31 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.796 1.239 . . . . 0.0 110.011 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.13 97.34 11.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.038 0.935 . . . . 0.0 110.373 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.9 p -77.43 43.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.519 1.928 . . . . 0.0 113.688 -166.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.56 -177.77 48.51 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.071 -1.018 . . . . 0.0 114.869 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -116.41 0.76 12.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.485 1.514 . . . . 0.0 114.295 -167.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -145.96 173.8 11.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.421 1.489 . . . . 0.0 112.546 -169.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.53 48.24 0.87 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 166.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.04 107.0 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.574 2.849 . . . . 0.0 113.03 164.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.86 165.17 18.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.348 0.659 . . . . 0.0 112.523 -164.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.35 6.57 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.365 -1.459 . . . . 0.0 111.49 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.75 114.34 5.64 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.908 1.683 . . . . 0.0 113.562 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.82 84.58 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.114 2.543 . . . . 0.0 111.213 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -125.04 144.91 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.962 1.305 . . . . 0.0 109.531 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -146.74 162.11 39.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.811 1.245 . . . . 0.0 112.883 -172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -142.0 110.88 6.23 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.749 2.02 . . . . 0.0 110.164 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 57' ' ' ASP . 18.4 m -140.01 170.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.315 1.046 . . . . 0.0 111.95 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.17 -4.63 21.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -152.17 30.84 0.55 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.906 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.84 25.4 8.46 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.41 1.484 . . . . 0.0 112.394 -173.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.437 HD21 ' CG2' ' A' ' 61' ' ' VAL . 12.5 p-10 -91.61 50.99 1.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.122 2.569 . . . . 0.0 112.201 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.5 m-20 -56.29 -11.11 1.06 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -9.92 11.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.909 1.283 . . . . 0.0 114.359 164.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.4 m -149.06 95.62 3.84 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.159 -1.588 . . . . 0.0 110.17 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.53 86.98 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 1 C-N-CA 125.639 4.226 . . . . 0.0 115.883 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.1 t -67.66 -33.96 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.893 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 -161.56 27.52 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.427 1.965 . . . . 0.0 112.045 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -146.96 177.69 8.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.09 1.756 . . . . 0.0 112.509 169.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.37 117.98 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.613 2.365 . . . . 0.0 107.604 171.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.7 t -90.51 -58.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 111.109 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -59.01 -44.33 91.67 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.593 0.633 . . . . 0.0 112.525 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.44 139.3 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 160.36 77.57 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 159.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.6 77.41 3.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 115.303 -156.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -145.71 127.34 15.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.495 -1.378 . . . . 0.0 114.592 154.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.31 100.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.764 1.626 . . . . 0.0 106.889 166.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 t -77.86 -6.86 55.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.74 149.52 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.504 1.047 . . . . 0.0 111.956 -170.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.95 -21.9 66.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.719 1.208 . . . . 0.0 113.061 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.12 0.32 6.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.183 2.593 . . . . 0.0 114.47 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 10.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.09 13.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 131.475 3.91 . . . . 0.0 116.06 -166.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.18 168.53 19.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.375 1.87 . . . . 0.0 114.184 -169.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.52 109.09 20.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.304 2.642 . . . . 0.0 105.946 158.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.05 125.3 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.017 0.927 . . . . 0.0 112.412 -159.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.31 133.01 43.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.189 0.996 . . . . 0.0 109.447 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.5 mt -128.58 143.33 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.131 1.772 . . . . 0.0 107.976 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -98.4 137.21 37.44 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.76 0.791 . . . . 0.0 111.571 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.83 164.31 17.7 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.01 2.124 . . . . 0.0 108.899 166.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.53 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 26.0 tt0 -100.39 107.18 46.79 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.922 1.289 . . . . 0.0 108.392 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.8 108.31 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.894 1 C-N-CA 126.581 4.854 . . . . 0.0 111.236 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -64.15 161.0 35.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.988 1.792 . . . . 0.0 110.77 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -94.56 166.69 11.91 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.8 -78.97 1.0 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.86 150.7 42.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 110.184 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -136.86 97.9 3.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.693 1.197 . . . . 0.0 109.157 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -95.43 123.53 39.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.608 1.163 . . . . 0.0 109.933 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.98 98.43 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.982 2.113 . . . . 0.0 107.153 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.22 139.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.91 -165.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.89 103.33 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.766 1.626 . . . . 0.0 108.698 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 145.68 172.36 15.99 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 172.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -132.75 143.63 49.73 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.166 1.787 . . . . 0.0 109.875 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 17.06 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 127.741 2.591 . . . . 0.0 116.354 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -74.72 -15.3 60.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.203 2.201 . . . . 0.0 116.72 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -137.88 100.38 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.134 1.374 . . . . 0.0 110.747 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -142.65 160.73 39.73 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.97 165.96 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 128.814 2.846 . . . . 0.0 108.3 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.64 167.6 25.93 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.973 -1.079 . . . . 0.0 110.613 166.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -131.73 158.97 39.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.041 1.337 . . . . 0.0 109.052 163.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -112.59 160.17 18.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.239 1.416 . . . . 0.0 110.867 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.11 155.83 36.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.131 1.773 . . . . 0.0 109.212 168.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.66 143.41 30.73 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.097 0.959 . . . . 0.0 108.753 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -134.96 158.49 44.18 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.247 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.9 p 67.96 -1.65 1.67 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.3 42.07 3.08 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.395 0.998 . . . . 0.0 112.35 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -84.83 -144.59 0.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.973 1.709 . . . . 0.0 111.934 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.3 p -46.7 -46.36 20.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.59 1.956 . . . . 0.0 115.549 -166.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.02 8.26 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 125.539 1.536 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.75 25.52 60.3 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.248 -1.533 . . . . 0.0 112.848 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 tptp . . . . . 0 C--O 1.247 0.944 0 C-N-CA 126.941 2.096 . . . . 0.0 111.881 -166.771 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -147.07 150.31 34.79 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.093 0.957 . . . . 0.0 110.766 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.39 173.88 11.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.859 2.464 . . . . 0.0 110.858 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -91.93 -59.61 2.07 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.408 -0.807 . . . . 0.0 112.664 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -58.17 -36.78 73.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.787 1.235 . . . . 0.0 113.632 -168.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.05 -15.56 59.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.538 1.135 . . . . 0.0 113.318 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -85.54 -11.11 54.91 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.293 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 18.37 84.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 130.139 3.733 . . . . 0.0 118.453 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -72.5 71.74 0.96 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.102 -1.234 . . . . 0.0 111.839 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p -78.36 -20.07 52.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.118 1.367 . . . . 0.0 114.551 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.25 -178.82 7.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.33 130.96 51.77 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.484 1.04 . . . . 0.0 112.663 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.82 102.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.662 1.185 . . . . 0.0 111.93 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 155.9 22.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.418 1.887 . . . . 0.0 110.008 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -160.38 -41.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.543 1.137 . . . . 0.0 111.223 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt 65.65 -65.46 0.17 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.385 2.674 . . . . 0.0 113.333 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.74 79.0 1.21 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.445 1.098 . . . . 0.0 111.434 -161.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -126.5 160.09 31.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.449 1.5 . . . . 0.0 110.09 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -142.23 147.68 36.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 108.997 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -61.82 127.89 33.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.126 0.57 . . . . 0.0 110.99 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.55 -48.4 4.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.189 0.996 . . . . 0.0 108.988 168.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.97 105.69 0.68 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.491 1.996 . . . . 0.0 109.748 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 p -57.96 156.31 20.01 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.627 0.771 . . . . 0.0 111.478 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.76 141.87 80.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.951 1.767 . . . . 0.0 113.166 -165.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 119.8 14.78 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.449 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 32' ' ' VAL . 9.5 t0 -65.32 118.99 10.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.28 1.038 . . . . 0.0 110.56 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.9 p -68.9 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 114.309 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.99 56.0 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.301 -160.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -69.53 -12.42 61.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.013 1.906 . . . . 0.0 111.296 162.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.16 -3.69 40.87 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 126.667 2.08 . . . . 0.0 113.155 -167.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -129.73 152.86 48.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.795 2.038 . . . . 0.0 111.599 -166.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 86' ' ' PRO . 1.2 m -93.64 126.06 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 0.0 110.327 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 m -78.43 136.66 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 161.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -141.81 131.48 24.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.084 2.154 . . . . 0.0 108.138 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -118.94 131.9 56.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.825 0.739 . . . . 0.0 112.04 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.54 162.21 19.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.345 0.658 . . . . 0.0 110.703 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -115.51 129.55 56.58 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.849 1.259 . . . . 0.0 109.015 165.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.89 100.47 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.07 0.948 . . . . 0.0 109.392 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 p -78.39 -4.44 48.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.539 1.536 . . . . 0.0 114.624 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.92 169.24 12.88 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 119.311 0.96 . . . . 0.0 114.697 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -106.83 0.86 24.32 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.447 1.899 . . . . 0.0 113.244 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -138.49 -175.05 3.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.115 1.766 . . . . 0.0 111.316 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.51 45.61 1.95 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.892 -2.06 . . . . 0.0 117.523 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -54.73 102.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.984 0 CA-C-N 122.057 2.928 . . . . 0.0 111.042 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.5 m -156.92 171.17 20.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 112.624 -164.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -94.08 99.98 12.17 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.63 -1.294 . . . . 0.0 109.954 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.39 126.38 84.32 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.459 0.704 . . . . 0.0 112.603 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.37 101.63 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.711 2.941 . . . . 0.0 111.884 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.0 tt -133.47 146.55 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.144 0.978 . . . . 0.0 109.855 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -148.76 160.67 42.97 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 t -138.19 116.7 12.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.073 2.149 . . . . 0.0 110.218 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 57' ' ' ASP . 15.6 m -134.62 164.57 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.556 1.142 . . . . 0.0 112.24 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.16 -10.18 28.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -154.79 34.34 0.4 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.085 -1.634 . . . . 0.0 112.625 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.78 11.4 1.83 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.477 1.911 . . . . 0.0 113.958 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.469 HD21 ' CG2' ' A' ' 61' ' ' VAL . 9.2 p-10 -69.83 51.32 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.032 2.933 . . . . 0.0 113.026 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.9 t0 -59.14 -16.38 19.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.839 1.655 . . . . 0.0 115.349 -165.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.24 -8.86 1.23 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.487 1.515 . . . . 0.0 114.876 169.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 m -155.13 104.57 2.25 Favored Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 120.203 -1.561 . . . . 0.0 111.063 166.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.42 115.69 1.06 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.164 3.909 . . . . 0.0 113.882 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.2 t -97.58 -22.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.931 1.692 . . . . 0.0 111.501 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.11 26.3 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.868 1.699 . . . . 0.0 111.041 163.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 176.78 7.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.11 106.82 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.726 2.411 . . . . 0.0 106.374 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -78.41 -45.58 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.734 0.813 . . . . 0.0 110.69 -166.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -69.78 -41.4 75.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.11 149.96 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.833 1.197 . . . . 0.0 113.54 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -61.74 119.73 50.34 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.361 1.464 . . . . 0.0 109.762 162.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.34 90.22 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.109 2.539 . . . . 0.0 113.69 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.56 126.27 12.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.501 1.921 . . . . 0.0 111.515 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.3 88.84 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.729 2.012 . . . . 0.0 108.263 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.4 t -70.6 -8.94 55.4 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.69 155.35 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.906 1.23 . . . . 0.0 112.287 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.66 -19.71 62.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.125 0.97 . . . . 0.0 112.698 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.0 p -77.54 9.79 3.08 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.086 1.754 . . . . 0.0 113.133 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.63 10.23 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.302 1.841 . . . . 0.0 115.235 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.03 22.85 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 130.27 3.428 . . . . 0.0 115.139 -165.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.2 165.73 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.797 2.039 . . . . 0.0 114.183 -170.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 109.06 21.16 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.315 2.646 . . . . 0.0 106.269 160.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.33 121.85 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 111.964 -156.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.57 128.05 40.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.056 2.542 . . . . 0.0 109.942 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.69 129.53 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.228 2.211 . . . . 0.0 108.34 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.04 138.53 33.03 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.468 -0.77 . . . . 0.0 111.022 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.94 157.59 29.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.285 2.234 . . . . 0.0 109.039 166.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -97.73 109.68 51.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.193 0.997 . . . . 0.0 109.24 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.634 ' HG3' HG13 ' A' ' 32' ' ' VAL . 54.9 Cg_endo -93.03 116.64 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 125.263 3.975 . . . . 0.0 110.287 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.6 158.16 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.163 3.242 . . . . 0.0 115.552 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -75.52 161.15 29.42 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.16 -0.963 . . . . 0.0 112.502 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.65 -79.04 1.8 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.52 158.44 44.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.492 1.117 . . . . 0.0 110.446 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.5 m -158.87 156.84 30.33 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.929 -1.107 . . . . 0.0 112.264 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -145.71 136.74 24.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.484 1.113 . . . . 0.0 109.089 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 mm -120.52 114.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.301 1.841 . . . . 0.0 107.158 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.72 141.31 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.418 0.687 . . . . 0.0 109.849 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.82 101.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.171 2.188 . . . . 0.0 108.341 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.43 177.49 15.15 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.5 122.2 24.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.697 1.999 . . . . 0.0 110.632 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.26 -99.84 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.48 1.99 . . . . 0.0 114.807 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -68.46 -14.28 62.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.365 1.866 . . . . 0.0 115.758 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -136.14 98.67 3.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.44 1.096 . . . . 0.0 111.197 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.57 167.25 23.5 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.09 164.69 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.648 2.779 . . . . 0.0 108.639 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -150.99 164.57 36.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.464 0.706 . . . . 0.0 111.33 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -143.57 136.57 27.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.296 1.438 . . . . 0.0 110.439 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 162.57 23.36 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 113.071 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.74 150.63 35.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.684 1.993 . . . . 0.0 111.007 161.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -139.9 113.99 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.524 1.13 . . . . 0.0 108.156 -170.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -149.95 81.68 1.38 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.5 t 69.16 70.8 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.756 2.023 . . . . 0.0 113.876 165.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.61 21.1 2.03 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.739 2.114 . . . . 0.0 113.17 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.9 t -65.03 151.94 44.7 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.501 1.92 . . . . 0.0 113.591 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -61.59 -8.48 4.47 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 164.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.22 -4.38 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 127.019 2.128 . . . . 0.0 111.308 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.02 4.67 58.63 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.628 -1.295 . . . . 0.0 116.207 171.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 116.987 -1.482 . . . . 0.0 112.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.21 160.47 39.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.159 0.89 . . . . 0.0 112.432 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 145.32 50.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.131 2.173 . . . . 0.0 109.664 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.28 -54.43 8.4 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.17 -1.581 . . . . 0.0 112.426 -172.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -58.55 -29.8 66.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.902 1.681 . . . . 0.0 113.791 -170.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.91 -28.73 69.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.176 0.898 . . . . 0.0 112.841 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -19.42 62.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.388 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 9.46 105.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 130.584 3.945 . . . . 0.0 117.559 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -68.82 73.53 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.801 2.04 . . . . 0.0 113.602 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 p -71.93 -18.64 62.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.717 2.007 . . . . 0.0 114.676 168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -156.16 176.31 12.84 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.382 1.473 . . . . 0.0 110.511 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.48 148.54 50.5 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.443 0.544 . . . . 0.0 112.496 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.08 97.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.66 1.184 . . . . 0.0 112.544 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.76 168.81 25.62 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.876 1.671 . . . . 0.0 111.193 166.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 47' ' ' VAL . 94.1 p -144.02 -30.43 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt 59.2 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.311 2.244 . . . . 0.0 112.536 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.36 83.19 3.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.128 0.971 . . . . 0.0 112.069 -167.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.29 165.25 23.82 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.486 1.514 . . . . 0.0 111.587 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -151.05 155.11 38.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.993 2.117 . . . . 0.0 109.627 166.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.95 140.26 57.74 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.275 -0.89 . . . . 0.0 111.742 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -38.57 3.11 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.23 103.97 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.211 1.386 . . . . 0.0 110.279 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -47.74 138.09 9.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.125 2.17 . . . . 0.0 112.221 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 130.83 42.67 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.015 2.477 . . . . 0.0 112.768 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.05 119.95 28.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.167 1.387 . . . . 0.0 110.158 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.25 129.72 40.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.84 0.829 . . . . 0.0 111.032 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.3 p -78.18 -8.69 58.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 127.077 2.151 . . . . 0.0 113.586 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.63 -5.35 23.35 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.336 0.971 . . . . 0.0 113.945 -168.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -96.12 3.17 53.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.812 1.306 . . . . 0.0 112.062 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.33 4.33 56.31 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.829 1.204 . . . . 0.0 113.941 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -123.72 165.12 17.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.255 1.422 . . . . 0.0 111.941 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -110.15 140.66 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.025 1.33 . . . . 0.0 109.543 162.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.06 125.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.8 0.84 . . . . 0.0 109.014 161.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 120.99 18.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.531 1.932 . . . . 0.0 109.208 -167.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.73 132.6 52.52 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.189 -0.944 . . . . 0.0 112.631 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.07 162.71 20.72 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.433 1.093 . . . . 0.0 110.462 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -117.66 134.27 55.07 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.157 0.983 . . . . 0.0 109.98 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -84.8 108.03 17.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.873 0.869 . . . . 0.0 109.668 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -82.92 -4.03 57.7 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.82 172.5 14.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.504 1.047 . . . . 0.0 114.718 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -109.18 6.08 24.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.209 1.804 . . . . 0.0 113.75 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -138.71 176.14 8.95 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.0 111.143 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.75 51.43 0.75 Allowed Glycine 0 CA--C 1.538 1.526 0 CA-C-O 117.288 -1.84 . . . . 0.0 117.168 167.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -54.21 111.12 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 121.399 2.599 . . . . 0.0 110.646 162.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.83 165.95 13.77 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.175 0.99 . . . . 0.0 111.76 -168.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -89.43 104.34 16.9 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 119.839 -1.788 . . . . 0.0 113.206 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 1.2 p -58.03 117.78 22.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.577 1.151 . . . . 0.0 112.352 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.35 82.61 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.411 2.741 . . . . 0.0 109.827 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.08 142.46 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.833 0.853 . . . . 0.0 109.457 169.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.9 t -151.38 159.73 44.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.632 0.773 . . . . 0.0 113.046 -167.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -132.54 113.55 13.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.003 2.521 . . . . 0.0 108.955 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 57' ' ' ASP . 35.5 m -133.75 170.24 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.464 1.106 . . . . 0.0 111.688 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.08 -11.44 20.52 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 m -152.03 33.2 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.106 -1.621 . . . . 0.0 112.311 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.93 10.15 2.04 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.455 1.902 . . . . 0.0 113.45 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -72.06 55.6 0.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.303 3.041 . . . . 0.0 112.589 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HA ' HG11 ' A' ' 52' ' ' VAL . 4.8 t0 -63.07 -11.91 22.97 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -165.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.55 -1.28 0.77 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 114.919 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 m -153.85 119.33 2.78 Favored Pre-proline 0 N--CA 1.473 0.692 0 O-C-N 119.916 -1.74 . . . . 0.0 110.651 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.4 112.12 2.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.899 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.38 -27.15 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 0.0 110.825 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.89 -161.98 18.98 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.383 2.421 . . . . 0.0 111.853 169.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 169.58 17.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 96.58 8.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.502 1.921 . . . . 0.0 106.132 170.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.55 -49.95 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.636 1.175 . . . . 0.0 111.678 -161.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 t -88.41 -17.37 30.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -165.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -159.99 150.14 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 120.253 1.388 . . . . 0.0 111.631 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -57.48 134.49 81.95 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.673 0.789 . . . . 0.0 109.377 166.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.98 86.47 0.61 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.137 2.558 . . . . 0.0 111.658 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -152.91 112.96 3.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 112.035 -167.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -72.85 92.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 p -73.41 -14.04 61.19 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.75 158.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.13 0.972 . . . . 0.0 112.064 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.66 -23.62 65.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.18 0.992 . . . . 0.0 113.153 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 p -81.26 5.17 17.94 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.772 1.629 . . . . 0.0 113.812 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.31 22.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.648 1.579 . . . . 0.0 114.882 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.09 21.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 130.875 3.67 . . . . 0.0 114.443 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.64 157.15 20.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.983 1.713 . . . . 0.0 113.275 -164.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 105.94 17.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.429 2.291 . . . . 0.0 106.677 153.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.41 135.64 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.503 1.121 . . . . 0.0 111.985 -165.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.81 118.56 37.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.209 2.603 . . . . 0.0 108.921 -172.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.36 136.72 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.452 1.901 . . . . 0.0 108.418 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.68 137.95 31.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.017 -0.427 . . . . 0.0 111.821 163.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.48 160.36 25.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.351 1.86 . . . . 0.0 109.656 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.59 105.78 51.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.822 1.249 . . . . 0.0 108.857 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HG3' HG13 ' A' ' 32' ' ' VAL . 55.6 Cg_endo -84.82 121.03 2.41 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.276 2.65 . . . . 0.0 109.437 160.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.31 166.5 12.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.88 1.72 . . . . 0.0 111.993 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.88 164.3 25.94 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 -91.92 1.77 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -131.08 165.11 23.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.457 1.103 . . . . 0.0 110.764 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.0 m -156.92 163.27 39.34 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.069 -1.019 . . . . 0.0 111.784 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -133.43 129.1 36.83 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.9 2.08 . . . . 0.0 108.214 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.5 mm -110.21 109.3 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.17 1.788 . . . . 0.0 106.768 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.96 138.53 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.667 0.787 . . . . 0.0 109.167 -167.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.14 89.38 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.85 2.06 . . . . 0.0 106.725 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 161.02 157.44 8.75 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.314 1.686 . . . . 0.0 117.314 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -123.23 122.77 39.21 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.913 1.685 . . . . 0.0 109.395 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 32.42 -94.83 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.304 2.383 . . . . 0.0 115.385 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.53 -18.73 63.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.699 2.0 . . . . 0.0 116.161 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -130.11 101.07 5.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.74 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -141.12 155.92 46.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.26 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.98 2.512 . . . . 0.0 107.758 169.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.95 156.42 38.86 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.139 -0.976 . . . . 0.0 111.719 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 165.5 26.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.682 2.393 . . . . 0.0 109.019 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -133.27 155.97 48.41 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.327 -0.858 . . . . 0.0 113.101 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -141.75 151.93 43.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.494 1.518 . . . . 0.0 112.788 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -146.58 108.4 4.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.565 1.546 . . . . 0.0 108.567 -163.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -149.51 102.42 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -162.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 t 61.9 62.17 1.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.417 1.887 . . . . 0.0 113.832 163.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.32 18.01 3.49 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.515 2.007 . . . . 0.0 112.835 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.5 t -62.1 152.04 33.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.8 1.64 . . . . 0.0 112.293 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -50.59 -24.79 3.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.845 2.058 . . . . 0.0 113.291 165.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.12 -10.62 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.956 1.303 . . . . 0.0 112.138 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.76 22.7 30.2 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 121.003 -1.061 . . . . 0.0 114.396 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 125.025 1.33 . . . . 0.0 113.435 178.709 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -146.97 171.86 14.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 111.625 -165.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 20.9 mp0 -65.1 104.69 0.93 Allowed 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.836 4.454 . . . . 0.0 111.179 -165.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -55.65 -57.35 12.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -168.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -72.22 -20.87 61.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.295 1.038 . . . . 0.0 113.727 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.65 -3.5 50.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 113.101 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -67.0 22.27 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 129.016 2.926 . . . . 0.0 115.267 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.75 69.0 0.67 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.932 2.206 . . . . 0.0 114.293 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -41.19 -59.62 1.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.654 1.982 . . . . 0.0 113.91 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -59.15 -3.93 0.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.82 141.82 49.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.934 1.243 . . . . 0.0 111.358 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.02 171.86 55.16 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.095 0.855 . . . . 0.0 113.386 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.7 96.76 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 113.094 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 p -161.78 -177.17 5.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.606 1.562 . . . . 0.0 112.402 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 m -170.85 -29.35 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.324 1.85 . . . . 0.0 111.796 162.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt 64.67 -69.71 0.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.374 2.27 . . . . 0.0 113.349 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.16 73.36 8.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.074 0.95 . . . . 0.0 112.857 -166.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -129.69 158.5 39.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 170.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -143.52 140.94 30.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 108.906 166.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.39 147.69 49.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.382 0.673 . . . . 0.0 111.521 171.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.76 -52.82 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.397 0.679 . . . . 0.0 112.24 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.24 109.45 2.66 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.478 1.037 . . . . 0.0 111.279 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 p -52.8 142.29 34.21 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.222 1.409 . . . . 0.0 111.469 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.48 146.07 85.45 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.916 2.411 . . . . 0.0 114.049 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.52 130.03 25.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.764 1.626 . . . . 0.0 109.55 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.01 135.61 51.15 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.543 0.61 . . . . 0.0 110.57 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.6 p -68.19 -5.75 19.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.81 2.044 . . . . 0.0 113.998 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -10.66 7.28 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.62 1.105 . . . . 0.0 112.699 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -95.01 -3.63 48.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.512 1.925 . . . . 0.0 110.875 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.01 -4.14 45.21 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.57 1.557 . . . . 0.0 114.83 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -96.31 156.71 16.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.337 1.455 . . . . 0.0 110.409 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.73 122.26 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.105 0.962 . . . . 0.0 110.377 170.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.2 126.36 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.642 0.777 . . . . 0.0 109.338 162.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.59 155.73 45.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.294 1.438 . . . . 0.0 111.055 173.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -125.91 134.78 51.46 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.255 -0.903 . . . . 0.0 112.688 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.13 168.2 11.82 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.851 1.261 . . . . 0.0 109.89 165.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -126.55 143.38 51.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.557 1.143 . . . . 0.0 110.014 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -96.42 98.23 10.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.732 1.213 . . . . 0.0 109.777 -172.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -78.31 9.34 3.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.97 2.108 . . . . 0.0 115.788 -162.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.91 173.41 27.97 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.424 1.011 . . . . 0.0 113.821 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -95.64 -1.37 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.305 1.842 . . . . 0.0 114.019 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.41 173.29 11.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.715 1.606 . . . . 0.0 112.69 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.78 43.55 0.87 Allowed Glycine 0 CA--C 1.543 1.802 0 CA-C-O 116.574 -2.237 . . . . 0.0 118.688 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.84 105.54 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.939 0 CA-C-N 122.308 3.054 . . . . 0.0 112.314 161.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -163.13 162.82 25.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -166.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -82.05 94.47 7.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.942 1.297 . . . . 0.0 110.172 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.25 115.05 10.75 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.829 1.652 . . . . 0.0 113.741 -169.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.79 83.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.047 2.498 . . . . 0.0 112.147 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.31 140.27 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.112 0.965 . . . . 0.0 109.903 165.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -140.8 166.86 23.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.097 0.959 . . . . 0.0 113.408 -167.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -138.71 104.86 5.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.666 2.386 . . . . 0.0 110.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 57' ' ' ASP . 16.3 m -132.09 169.1 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.03 0.932 . . . . 0.0 112.478 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.28 0.52 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.566 1.146 . . . . 0.0 113.742 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -151.93 27.88 0.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.245 -1.535 . . . . 0.0 112.846 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.62 10.4 1.41 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.445 1.898 . . . . 0.0 113.732 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.14 52.61 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.094 2.958 . . . . 0.0 112.487 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HA ' HG11 ' A' ' 52' ' ' VAL . 10.3 t0 -64.41 -7.35 9.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -165.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.51 -5.83 1.36 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.56 1.544 . . . . 0.0 114.591 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.0 m -154.58 114.78 2.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.108 -1.62 . . . . 0.0 110.556 168.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 111.16 2.35 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.683 2.922 . . . . 0.0 111.751 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -75.77 -39.58 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.443 1.097 . . . . 0.0 110.517 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.75 -161.94 25.89 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.982 1.754 . . . . 0.0 113.589 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -130.96 176.74 7.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.178 0.991 . . . . 0.0 113.27 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.41 139.59 34.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.786 2.034 . . . . 0.0 108.36 166.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.09 -55.16 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.104 0.562 . . . . 0.0 111.239 -171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -55.67 -54.21 47.01 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.06 148.81 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.75 159.26 79.81 Favored Pre-proline 0 CA--C 1.556 1.195 0 O-C-N 121.899 -0.501 . . . . 0.0 110.525 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.1 69.81 6.92 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.713 2.276 . . . . 0.0 115.391 -157.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -143.62 120.24 11.11 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.392 -1.442 . . . . 0.0 113.282 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.1 t -81.45 95.8 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 t -76.2 -3.88 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.05 143.89 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.932 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.39 -20.93 65.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.343 1.057 . . . . 0.0 112.73 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 4.68 1.72 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.545 2.738 . . . . 0.0 114.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 8.15 0.4 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.224 1.81 . . . . 0.0 115.605 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.43 19.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 130.853 3.661 . . . . 0.0 116.131 -161.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.31 173.79 8.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.375 1.87 . . . . 0.0 114.434 -169.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -105.39 101.77 11.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.092 2.957 . . . . 0.0 107.079 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.46 114.33 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -156.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.45 129.24 39.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.191 2.596 . . . . 0.0 110.562 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mt -128.0 148.52 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 129.025 2.93 . . . . 0.0 108.825 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -104.34 136.72 43.4 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 112.323 165.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -121.31 162.84 19.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.643 1.977 . . . . 0.0 110.098 163.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.93 107.33 38.03 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.078 1.351 . . . . 0.0 109.202 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -107.02 140.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.197 3.264 . . . . 0.0 110.823 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.53 162.11 1.66 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.851 3.034 . . . . 0.0 114.651 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -68.09 166.03 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.025 0.93 . . . . 0.0 113.41 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.94 -91.35 1.68 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.58 159.78 23.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.263 1.025 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -157.6 129.73 7.15 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 120.807 -1.183 . . . . 0.0 110.174 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -135.62 122.59 21.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 109.263 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.1 mm -109.86 113.68 44.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 126.251 1.82 . . . . 0.0 107.732 -173.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -109.02 140.62 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.897 0.879 . . . . 0.0 109.245 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.95 101.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.393 2.277 . . . . 0.0 107.999 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 149.3 171.53 18.03 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 117.946 1.939 . . . . 0.0 117.946 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.12 128.84 30.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.505 1.922 . . . . 0.0 110.362 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 35.55 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.89 2.186 . . . . 0.0 115.268 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -66.79 -16.39 64.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.097 2.159 . . . . 0.0 115.993 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.33 105.76 6.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.281 1.032 . . . . 0.0 111.088 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.41 162.98 34.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.03 163.94 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 130.136 3.374 . . . . 0.0 107.308 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -156.62 163.35 39.43 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.983 -1.073 . . . . 0.0 110.994 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -142.33 149.39 39.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.991 1.317 . . . . 0.0 110.044 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -102.75 160.97 14.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.864 1.266 . . . . 0.0 111.632 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.66 42.84 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.014 2.126 . . . . 0.0 110.237 166.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -145.0 142.32 29.69 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -150.0 105.08 3.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.407 1.083 . . . . 0.0 112.354 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p 128.01 -5.07 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 131.676 3.99 . . . . 0.0 114.619 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.15 33.82 0.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.643 1.116 . . . . 0.0 112.159 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -88.36 -141.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.338 1.455 . . . . 0.0 112.241 -166.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -52.59 -36.44 56.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.717 1.599 . . . . 0.0 115.136 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.13 -2.72 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 126.333 1.853 . . . . 0.0 112.515 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.68 28.8 54.24 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.518 -1.364 . . . . 0.0 112.521 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 tptp . . . . . 0 C--O 1.252 1.191 0 C-N-CA 127.174 2.19 . . . . 0.0 111.82 -169.399 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.64 152.26 45.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.61 0.641 . . . . 0.0 111.123 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.42 116.55 27.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.072 1.749 . . . . 0.0 109.498 172.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.99 -42.3 94.64 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.63 -0.669 . . . . 0.0 111.677 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -59.98 -29.47 68.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.875 1.67 . . . . 0.0 114.741 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.31 -5.11 58.53 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.111 0.868 . . . . 0.0 113.194 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -69.1 -6.31 27.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 116.808 -1.567 . . . . 0.0 114.073 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.08 73.52 0.33 Allowed Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.169 1.843 . . . . 0.0 115.477 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -77.18 64.19 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.236 1.015 . . . . 0.0 111.18 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.7 p -73.94 -27.42 61.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.614 1.966 . . . . 0.0 113.8 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -143.14 172.19 13.06 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.68 1.992 . . . . 0.0 110.462 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.43 148.8 51.03 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.109 0.385 . . . . 0.0 112.33 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 105.28 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.208 1.003 . . . . 0.0 112.041 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 162.46 39.89 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.314 2.246 . . . . 0.0 109.202 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.6 p -156.87 -43.24 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.309 1.043 . . . . 0.0 111.664 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 60.06 -69.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.366 2.666 . . . . 0.0 112.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.24 74.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.153 0.981 . . . . 0.0 112.742 -160.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -128.48 161.28 29.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.375 0.67 . . . . 0.0 111.142 161.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -145.77 149.88 35.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.442 1.897 . . . . 0.0 108.714 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.13 125.61 24.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.338 0.655 . . . . 0.0 111.042 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 -45.17 7.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.957 . . . . 0.0 109.043 167.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.65 119.34 1.74 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.126 1.822 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -57.93 155.43 23.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.424 1.49 . . . . 0.0 112.932 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.17 133.49 47.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.808 2.338 . . . . 0.0 112.026 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.59 127.59 22.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.823 1.649 . . . . 0.0 110.75 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.36 133.35 50.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.323 0.583 . . . . 0.0 112.378 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -79.12 -22.84 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.035 2.134 . . . . 0.0 114.563 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 -8.28 61.96 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 118.574 -1.126 . . . . 0.0 114.368 -160.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -72.09 -9.9 59.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.121 1.96 . . . . 0.0 111.596 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.25 62.3 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.334 1.445 . . . . 0.0 113.19 -163.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -112.33 164.0 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.96 2.104 . . . . 0.0 111.068 -170.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.77 125.62 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.209 1.004 . . . . 0.0 110.382 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 m -76.87 131.67 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 159.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.6 123.48 15.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.155 2.182 . . . . 0.0 107.378 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.83 131.35 52.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.999 0.818 . . . . 0.0 111.888 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.24 165.23 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.929 0.871 . . . . 0.0 110.134 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.109 0.963 . . . . 0.0 109.475 167.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -86.15 101.14 12.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 109.48 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -83.17 12.92 4.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -162.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.72 178.34 27.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.237 0.926 . . . . 0.0 114.623 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.3 p -109.21 2.91 21.26 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.541 1.937 . . . . 0.0 113.272 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -137.26 -176.63 4.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 0.0 110.76 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.93 29.08 2.94 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 115.745 -2.697 . . . . 0.0 118.975 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -48.69 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.124 0 CA-C-N 123.416 3.608 . . . . 0.0 112.981 162.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 m -160.43 169.69 22.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.014 1.326 . . . . 0.0 112.324 -165.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -96.78 92.76 6.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.54 1.136 . . . . 0.0 110.526 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.54 115.92 19.83 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.176 1.39 . . . . 0.0 114.627 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.84 93.25 0.87 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.526 2.15 . . . . 0.0 111.848 170.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 64' ' ' LEU . 19.7 tt -128.12 136.08 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.22 1.008 . . . . 0.0 108.608 161.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -148.81 165.33 31.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.826 0.85 . . . . 0.0 113.126 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.1 t -140.64 115.33 9.55 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.97 2.108 . . . . 0.0 110.633 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 31.3 m -137.65 175.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.787 1.235 . . . . 0.0 112.262 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.47 -18.17 16.81 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -149.9 32.34 0.69 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.114 -1.616 . . . . 0.0 111.636 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.94 11.72 4.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.391 1.876 . . . . 0.0 113.454 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -67.19 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.204 3.401 . . . . 0.0 113.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.0 t0 -58.78 -12.03 3.87 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -167.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.36 -12.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.248 2.219 . . . . 0.0 115.422 167.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -155.67 107.65 2.17 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 120.352 -1.467 . . . . 0.0 109.791 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.45 110.47 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.748 3.632 . . . . 0.0 113.01 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.77 -30.38 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.401 1.08 . . . . 0.0 109.959 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.29 -173.03 22.41 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.941 2.21 . . . . 0.0 111.305 165.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -131.68 170.54 14.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.438 1.095 . . . . 0.0 112.151 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 49' ' ' ILE . 4.4 mp -87.41 133.48 33.72 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 160.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.67 -54.43 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.27 0.628 . . . . 0.0 109.967 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -63.34 -48.33 78.45 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.61 150.26 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.385 1.074 . . . . 0.0 108.909 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -82.68 156.39 67.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 118.208 0.458 . . . . 0.0 110.709 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.13 86.67 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.486 2.124 . . . . 0.0 115.731 -155.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -148.57 118.87 7.3 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.363 -1.461 . . . . 0.0 114.202 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.61 87.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.717 1.207 . . . . 0.0 107.759 167.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.8 t -72.2 -11.05 60.56 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.54 156.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.014 1.279 . . . . 0.0 112.071 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.81 -15.6 63.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 0.0 114.202 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.8 p -76.56 1.72 15.95 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.129 1.772 . . . . 0.0 113.762 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.03 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.632 1.973 . . . . 0.0 115.606 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.3 20.65 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.949 3.3 . . . . 0.0 115.901 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.18 168.17 19.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.096 2.158 . . . . 0.0 114.518 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -106.3 107.03 17.83 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.266 3.026 . . . . 0.0 105.47 160.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.27 137.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.483 1.135 . . . . 0.0 113.634 -158.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.2 128.21 47.41 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.161 2.984 . . . . 0.0 109.779 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.76 138.73 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.868 2.067 . . . . 0.0 109.149 -172.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.53 136.67 32.9 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.556 0.616 . . . . 0.0 111.803 163.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.9 159.17 26.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.104 2.162 . . . . 0.0 109.775 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -103.32 105.25 45.61 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.229 1.411 . . . . 0.0 109.565 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.01 129.87 8.14 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.604 2.869 . . . . 0.0 110.288 164.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.44 171.95 9.8 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.304 2.003 . . . . 0.0 112.165 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -82.41 166.01 19.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -173.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.23 -82.45 1.14 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.669 1.128 . . . . 0.0 111.072 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -140.6 145.69 37.01 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.582 1.153 . . . . 0.0 110.12 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.7 p -150.57 151.13 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.48 0.657 . . . . 0.0 112.525 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -137.36 139.99 41.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.928 1.291 . . . . 0.0 110.059 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.7 107.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.284 1.833 . . . . 0.0 107.044 -168.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.8 135.71 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.92 92.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.905 2.082 . . . . 0.0 107.282 -172.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.3 170.8 12.82 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.48 123.0 42.95 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.077 1.751 . . . . 0.0 109.138 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 31.82 -92.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.194 2.331 . . . . 0.0 115.472 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -73.11 -16.77 61.45 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.2 97.95 4.42 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 109.952 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.11 163.62 36.36 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.58 163.77 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 129.841 3.256 . . . . 0.0 107.573 168.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -151.48 162.81 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.131 -0.981 . . . . 0.0 111.596 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -138.62 173.57 11.45 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.43 1.892 . . . . 0.0 110.409 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -124.71 157.94 34.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.392 1.877 . . . . 0.0 111.167 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.08 154.85 33.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.583 1.553 . . . . 0.0 111.89 161.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -132.62 140.58 48.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 110.885 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -136.3 93.87 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.6 t 70.79 30.11 3.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.779 1.632 . . . . 0.0 114.477 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 8.94 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.531 1.773 . . . . 0.0 117.531 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.3 t -75.25 160.94 29.79 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.959 1.88 . . . . 0.0 112.728 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -62.89 -11.54 19.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.063 1.345 . . . . 0.0 114.569 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.6 mm -82.59 -16.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.863 1.265 . . . . 0.0 111.452 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.91 4.94 24.1 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.347 -1.252 . . . . 0.0 115.751 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-N 119.391 1.596 . . . . 0.0 114.17 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.11 145.24 30.45 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.336 0.654 . . . . 0.0 111.853 -163.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 178.05 6.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.538 2.735 . . . . 0.0 110.398 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -100.21 -54.47 2.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.999 0.904 . . . . 0.0 111.166 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -55.89 -34.94 66.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.98 2.512 . . . . 0.0 113.786 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.56 -43.5 84.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.472 0.578 . . . . 0.0 110.794 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 60' ' ' PRO . 33.0 mmtm -63.41 -45.55 90.49 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 110.393 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 36.86 104.05 0.01 OUTLIER Glycine 0 C--N 1.344 0.975 0 C-N-CA 129.67 3.51 . . . . 0.0 116.676 159.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -62.8 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.346 2.258 . . . . 0.0 112.781 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -80.98 -19.54 43.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.879 2.472 . . . . 0.0 114.31 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -160.66 175.48 12.61 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.353 1.461 . . . . 0.0 110.257 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 133.41 24.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.268 1.413 . . . . 0.0 113.681 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.3 102.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.556 1.542 . . . . 0.0 114.08 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 156.36 40.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.585 2.354 . . . . 0.0 108.783 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.96 -31.87 0.28 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 49.27 -73.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 130.507 3.523 . . . . 0.0 116.214 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.32 68.23 1.42 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 112.067 -155.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.17 156.07 24.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.932 1.293 . . . . 0.0 110.331 166.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -142.29 145.42 33.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.498 1.519 . . . . 0.0 109.139 165.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.76 137.55 58.26 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.509 0.671 . . . . 0.0 111.31 168.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 -46.12 3.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.422 1.489 . . . . 0.0 109.708 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 128.93 4.93 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.095 1.331 . . . . 0.0 111.535 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.9 p -58.11 146.26 70.14 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 112.256 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -59.54 124.75 16.13 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.126 2.551 . . . . 0.0 111.55 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.16 128.55 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.727 1.211 . . . . 0.0 110.46 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.68 129.84 41.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.612 0.72 . . . . 0.0 111.021 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -71.98 -4.59 29.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.406 2.282 . . . . 0.0 113.845 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -8.72 11.12 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 118.945 0.793 . . . . 0.0 113.174 -168.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -89.2 -0.74 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.195 1.398 . . . . 0.0 110.758 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.71 0.79 74.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.464 1.507 . . . . 0.0 113.896 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -99.91 161.82 13.37 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.883 2.073 . . . . 0.0 110.205 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.4 128.88 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.457 1.026 . . . . 0.0 110.919 169.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.62 119.04 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.273 1.029 . . . . 0.0 108.937 162.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -132.72 129.27 38.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.78 2.432 . . . . 0.0 108.429 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -119.39 132.96 55.93 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.108 0.867 . . . . 0.0 113.06 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -123.47 167.63 13.62 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.294 1.038 . . . . 0.0 111.481 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.58 136.5 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 109.49 163.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -90.86 102.97 15.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.355 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.5 p -78.61 -7.14 57.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.592 1.557 . . . . 0.0 114.017 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.03 160.36 20.8 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 122.272 0.929 . . . . 0.0 113.878 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -82.02 -10.92 59.07 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.528 2.331 . . . . 0.0 114.849 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -164.39 172.93 12.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.72 1.208 . . . . 0.0 110.748 -153.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 61.08 0.62 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.22 105.04 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.399 2.066 . . . . 0.0 109.765 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 m -154.4 162.78 40.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.212 1.405 . . . . 0.0 112.09 -166.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -87.14 97.39 10.73 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.571 . . . . 0.0 111.394 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.89 115.08 8.08 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.878 1.271 . . . . 0.0 110.825 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.86 90.31 1.05 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.933 3.089 . . . . 0.0 110.678 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 tt -115.3 142.91 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.053 0.941 . . . . 0.0 109.378 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -150.7 166.64 29.77 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.059 1.343 . . . . 0.0 112.844 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.0 t -138.18 121.4 16.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.948 2.099 . . . . 0.0 110.713 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 57' ' ' ASP . 34.5 m -134.38 179.69 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.487 1.515 . . . . 0.0 112.263 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.63 -17.62 14.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.142 1.377 . . . . 0.0 113.725 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -157.55 43.32 0.33 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.184 -1.573 . . . . 0.0 111.731 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 8.8 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.811 2.045 . . . . 0.0 114.56 -174.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.514 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.8 p-10 -70.58 46.05 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.821 3.248 . . . . 0.0 114.952 -174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HA ' HG11 ' A' ' 52' ' ' VAL . 8.9 t0 -64.34 -1.77 1.86 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -10.36 5.45 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 159.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.1 m -155.96 98.37 2.23 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 120.381 -1.45 . . . . 0.0 109.8 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.418 ' CB ' ' HE2' ' A' ' 7' ' ' LYS . 80.5 Cg_exo -48.38 119.91 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.678 3.585 . . . . 0.0 113.452 170.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.514 ' CG2' HD21 ' A' ' 56' ' ' ASN . 8.0 t -99.88 -23.77 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.538 1.535 . . . . 0.0 111.813 -176.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.71 18.36 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.409 1.956 . . . . 0.0 111.29 168.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.21 175.48 9.55 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.499 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -86.01 149.67 25.01 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.523 1.529 . . . . 0.0 107.187 159.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -118.73 -41.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.735 0.698 . . . . 0.0 111.14 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -61.04 -45.81 93.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -162.75 165.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.136 0.88 . . . . 0.0 111.567 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.31 123.74 71.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 157.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.54 100.1 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.772 1.648 . . . . 0.0 111.422 -171.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -149.07 149.87 31.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 159.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.62 88.36 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 127.524 2.33 . . . . 0.0 107.055 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -71.47 -2.86 18.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.02 158.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 112.13 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.25 -27.58 63.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.538 0.735 . . . . 0.0 112.369 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.1 p -74.87 4.86 5.75 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.249 1.82 . . . . 0.0 113.671 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.66 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.29 1.836 . . . . 0.0 115.083 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.65 27.26 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 129.169 2.987 . . . . 0.0 113.681 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.34 169.08 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.416 1.886 . . . . 0.0 113.967 -166.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -112.4 108.73 17.99 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.837 2.455 . . . . 0.0 106.092 163.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.38 123.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.775 0.798 . . . . 0.0 112.953 -157.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.82 134.99 41.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.626 1.571 . . . . 0.0 110.604 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.7 136.53 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.506 1.922 . . . . 0.0 107.949 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.87 138.13 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.775 -0.578 . . . . 0.0 111.911 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -123.06 163.13 21.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.131 2.173 . . . . 0.0 110.056 167.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -104.52 100.97 25.07 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.543 1.137 . . . . 0.0 109.236 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.44 129.13 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.802 2.335 . . . . 0.0 109.977 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.94 172.29 2.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.572 2.181 . . . . 0.0 112.504 165.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.54 166.09 11.31 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.151 0.981 . . . . 0.0 112.426 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -91.67 1.45 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -164.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -119.67 154.0 34.72 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.577 1.151 . . . . 0.0 110.331 168.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.5 t -144.95 158.42 43.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 166.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -130.19 145.76 51.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.969 0.908 . . . . 0.0 108.823 165.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -117.02 113.94 44.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.479 1.912 . . . . 0.0 106.219 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.18 135.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.24 95.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.08 1.352 . . . . 0.0 108.061 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.99 171.69 24.23 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.945 1.938 . . . . 0.0 117.945 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.4 114.21 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.644 2.378 . . . . 0.0 108.938 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.83 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 126.166 1.841 . . . . 0.0 114.848 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -68.74 -15.08 63.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -129.65 99.34 5.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.718 1.207 . . . . 0.0 109.708 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.62 159.28 44.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.99 165.64 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 129.913 3.285 . . . . 0.0 108.431 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.72 170.7 15.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.712 -0.617 . . . . 0.0 110.871 161.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -132.79 161.73 33.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.909 1.684 . . . . 0.0 108.583 162.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.8 159.59 17.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.273 1.429 . . . . 0.0 110.522 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.02 152.99 38.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.062 1.345 . . . . 0.0 111.119 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.75 115.45 8.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.936 1.294 . . . . 0.0 108.41 -170.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -152.38 109.88 3.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.8 t 66.01 37.13 5.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.321 2.248 . . . . 0.0 114.522 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.48 20.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.025 0.821 . . . . 0.0 114.538 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 39.9 t -64.54 154.46 36.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.985 1.314 . . . . 0.0 113.213 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.8 m -54.21 -23.24 13.84 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.432 1.893 . . . . 0.0 112.655 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.4 mm -93.35 -1.32 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.425 1.89 . . . . 0.0 111.337 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.03 10.24 62.84 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.75 -1.219 . . . . 0.0 115.727 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.0 ptmm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.086 1.355 . . . . 0.0 114.585 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.33 168.84 23.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 -175.55 4.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.171 2.589 . . . . 0.0 110.472 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -99.49 -59.01 1.8 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.067 -1.021 . . . . 0.0 110.434 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -51.43 -33.57 31.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.613 2.765 . . . . 0.0 114.935 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -61.98 -19.79 63.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.004 0.82 . . . . 0.0 112.838 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.03 -1.4 57.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.969 1.308 . . . . 0.0 113.139 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -4.36 98.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.45 0 C-N-CA 130.524 3.916 . . . . 0.0 117.507 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -64.81 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.426 3.49 . . . . 0.0 115.92 -169.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -60.22 -27.62 67.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.1 -179.06 5.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.361 1.864 . . . . 0.0 109.923 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.58 138.63 46.89 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 121.655 -0.653 . . . . 0.0 111.71 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.95 95.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.121 0.962 . . . . 0.0 112.663 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.83 172.18 17.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.754 2.022 . . . . 0.0 110.585 170.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.6 p -142.93 -25.45 0.61 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.862 1.265 . . . . 0.0 113.934 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt 47.28 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 130.25 3.42 . . . . 0.0 114.934 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.21 72.5 1.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 111.906 -165.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -123.32 153.25 40.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.774 0.83 . . . . 0.0 110.638 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -139.73 147.46 40.92 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.782 1.633 . . . . 0.0 108.205 167.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.23 133.22 49.31 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.475 -0.765 . . . . 0.0 110.856 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -50.43 4.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.433 1.093 . . . . 0.0 109.204 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.26 120.74 1.94 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.499 1.047 . . . . 0.0 112.558 -172.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.2 m -49.59 147.35 6.1 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 127.915 2.486 . . . . 0.0 112.346 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.48 148.4 63.21 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.565 2.177 . . . . 0.0 114.12 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.0 142.64 32.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.141 1.776 . . . . 0.0 110.254 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.52 138.83 41.8 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.625 -0.672 . . . . 0.0 112.248 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.5 p -83.31 -21.87 33.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.82 -7.38 34.69 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 118.488 -1.173 . . . . 0.0 114.421 -159.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -72.08 -14.47 61.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.115 1.958 . . . . 0.0 111.166 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.93 -7.34 52.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.859 1.695 . . . . 0.0 113.012 -165.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.9 p -102.12 164.95 11.42 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 112.331 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.75 119.21 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.659 1.184 . . . . 0.0 110.592 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.19 128.34 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.765 1.226 . . . . 0.0 110.199 163.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.5 136.01 30.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.284 2.234 . . . . 0.0 109.514 -169.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -116.67 131.65 56.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.56 163.0 17.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.071 1.349 . . . . 0.0 111.06 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -122.95 142.82 50.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.551 1.54 . . . . 0.0 110.128 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -95.97 97.95 10.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.992 0.917 . . . . 0.0 110.923 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.7 p -82.57 35.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.928 1.691 . . . . 0.0 113.269 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.87 175.11 33.76 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.675 -0.64 . . . . 0.0 114.293 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -121.3 3.49 10.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.042 2.137 . . . . 0.0 113.228 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -132.04 166.06 22.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.249 2.22 . . . . 0.0 110.875 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.65 51.71 0.84 Allowed Glycine 0 CA--C 1.542 1.722 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -56.15 108.55 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 121.774 2.787 . . . . 0.0 110.722 160.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.476 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -155.7 168.78 26.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.431 1.092 . . . . 0.0 111.38 -166.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 11.3 tppt? -92.9 91.69 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.377 -1.452 . . . . 0.0 109.632 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.66 114.42 11.08 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.521 1.129 . . . . 0.0 112.36 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.28 88.79 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.229 2.619 . . . . 0.0 111.466 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -112.53 145.77 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.015 0.926 . . . . 0.0 110.079 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 t -151.27 172.29 16.1 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -143.63 106.27 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.143 2.577 . . . . 0.0 109.705 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.6 m -136.2 151.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.26 64.16 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.72 27.37 3.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.277 1.031 . . . . 0.0 112.357 -166.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mt 63.76 3.25 1.52 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.232 1.813 . . . . 0.0 113.881 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -67.69 50.5 0.05 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.117 2.967 . . . . 0.0 114.3 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.494 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.7 t0 -61.49 -13.7 23.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.74 -6.21 0.71 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.679 1.992 . . . . 0.0 114.665 162.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m -153.54 103.67 2.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.045 -1.66 . . . . 0.0 109.042 173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 123.67 10.26 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.37 2.713 . . . . 0.0 111.046 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.33 -36.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.193 0.997 . . . . 0.0 111.702 -172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.97 -166.74 30.41 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.381 1.467 . . . . 0.0 110.58 161.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.1 ptp85 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.891 0.876 . . . . 0.0 112.167 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.486 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -83.47 140.07 32.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.093 1.357 . . . . 0.0 107.405 163.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.62 -49.33 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.623 0.647 . . . . 0.0 109.669 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.9 m -60.01 -49.77 76.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -172.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -158.15 159.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.896 1.226 . . . . 0.0 113.031 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -59.41 114.45 9.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.392 1.077 . . . . 0.0 108.491 158.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 88.06 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.106 2.537 . . . . 0.0 111.938 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -136.18 139.59 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.744 -1.222 . . . . 0.0 111.94 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 2.6 t -74.24 88.87 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 125.557 1.543 . . . . 0.0 106.874 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -72.72 -2.81 21.73 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.95 143.35 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.146 1.378 . . . . 0.0 110.813 -172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.36 -27.07 67.6 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.883 0.849 . . . . 0.0 111.539 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 6.63 0.58 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.167 2.987 . . . . 0.0 114.192 168.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.49 17.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.888 1.675 . . . . 0.0 115.385 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.05 15.91 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 131.143 3.777 . . . . 0.0 115.562 -170.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.92 170.73 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.214 2.606 . . . . 0.0 114.3 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 99.74 6.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.836 3.254 . . . . 0.0 104.486 164.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.32 127.33 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.946 1.298 . . . . 0.0 112.082 -154.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.76 121.85 43.86 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.865 2.866 . . . . 0.0 108.898 -169.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.8 130.69 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.721 2.008 . . . . 0.0 109.267 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.78 133.01 36.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.539 0.736 . . . . 0.0 111.462 164.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.6 157.09 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.147 2.179 . . . . 0.0 109.854 164.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 38.5 tt0 -89.45 111.88 48.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.558 1.143 . . . . 0.0 108.472 168.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.23 125.75 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.336 2.691 . . . . 0.0 109.653 171.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.67 164.78 27.78 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.245 1.297 . . . . 0.0 110.909 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -71.96 155.47 40.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.042 0.925 . . . . 0.0 112.751 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.92 -87.05 1.41 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.4 1.476 . . . . 0.0 109.87 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.95 156.36 29.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.245 1.018 . . . . 0.0 110.214 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -146.11 95.99 2.71 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.166 0.986 . . . . 0.0 108.932 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -96.42 134.76 39.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.313 1.045 . . . . 0.0 109.294 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -115.67 90.82 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 126.328 1.851 . . . . 0.0 107.343 -159.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -89.45 139.06 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.673 0.789 . . . . 0.0 109.378 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.52 91.04 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.707 2.003 . . . . 0.0 106.45 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 164.85 165.39 22.05 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.83 147.54 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.354 1.462 . . . . 0.0 109.972 167.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.64 -99.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.498 1.999 . . . . 0.0 115.092 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -85.43 -26.7 26.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.772 1.629 . . . . 0.0 113.98 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -107.8 81.85 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.284 1.434 . . . . 0.0 108.517 -173.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.501 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -138.82 148.12 43.37 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 161.29 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.593 2.757 . . . . 0.0 108.125 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.42 147.59 27.74 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.47 -0.769 . . . . 0.0 110.967 173.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.07 162.79 17.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.832 2.053 . . . . 0.0 109.434 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -132.03 129.57 40.22 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.993 0.517 . . . . 0.0 110.92 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.58 23.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.145 0.978 . . . . 0.0 111.139 171.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -141.34 123.64 15.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.848 1.659 . . . . 0.0 108.104 -161.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.21 99.61 3.07 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m 61.69 54.27 3.01 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.409 1.883 . . . . 0.0 113.189 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.13 30.2 0.53 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.239 0.923 . . . . 0.0 114.303 170.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.4 t -55.39 168.16 0.4 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.919 2.088 . . . . 0.0 115.59 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m -49.75 -20.9 0.93 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.044 1.338 . . . . 0.0 113.452 156.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -119.56 24.58 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 126.571 1.948 . . . . 0.0 111.876 171.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.4 -26.21 0.87 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 127.285 2.374 . . . . 0.0 116.586 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 tptp . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.663 2.785 . . . . 0.0 114.223 173.017 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.01 169.03 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.518 0.727 . . . . 0.0 110.955 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 171.62 13.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.124 2.169 . . . . 0.0 109.854 173.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.74 -63.99 1.16 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.128 -0.982 . . . . 0.0 111.554 -171.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -52.66 -31.29 36.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.867 2.067 . . . . 0.0 114.427 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 tp -58.09 -29.07 65.16 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.581 1.153 . . . . 0.0 113.044 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.11 -2.73 42.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 143.47 2.27 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.778 2.133 . . . . 0.0 115.683 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -70.51 74.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.748 2.019 . . . . 0.0 113.586 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.4 p -60.41 -21.24 61.99 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.197 1.399 . . . . 0.0 112.412 159.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -153.01 179.87 8.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.432 2.293 . . . . 0.0 108.305 161.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.67 157.72 51.84 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 122.074 -0.391 . . . . 0.0 112.638 166.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -77.74 103.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.831 1.252 . . . . 0.0 111.614 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.86 163.66 36.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.541 1.537 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.6 p -165.43 -48.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.857 0.863 . . . . 0.0 111.786 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt 65.2 -63.51 0.19 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.916 2.486 . . . . 0.0 113.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.69 78.59 2.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.202 1.001 . . . . 0.0 112.461 -166.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -129.86 156.73 43.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.258 1.023 . . . . 0.0 111.664 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -146.23 150.04 35.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.229 1.812 . . . . 0.0 108.948 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -70.02 149.55 47.57 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.882 0.849 . . . . 0.0 112.933 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.37 -33.97 2.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.312 1.445 . . . . 0.0 111.272 171.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 104.27 0.41 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.148 1.356 . . . . 0.0 111.239 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.3 m -46.53 140.08 5.87 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 127.042 2.137 . . . . 0.0 110.518 167.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 143.43 98.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.95 1.767 . . . . 0.0 112.805 -170.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 122.51 18.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.556 1.143 . . . . 0.0 111.223 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.27 131.26 45.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.615 0.721 . . . . 0.0 111.588 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.7 p -79.26 -10.01 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.503 1.921 . . . . 0.0 113.837 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.29 -6.65 4.08 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.203 0.906 . . . . 0.0 114.048 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -94.53 3.09 55.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.526 1.531 . . . . 0.0 111.685 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.73 5.7 41.52 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.465 1.507 . . . . 0.0 114.279 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -128.0 166.49 18.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.519 1.528 . . . . 0.0 111.784 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . 0.675 HG13 ' HG3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -114.95 132.06 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.516 1.526 . . . . 0.0 108.958 162.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.05 131.65 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 162.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.31 124.33 16.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.727 2.811 . . . . 0.0 108.211 -169.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.58 136.28 53.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.309 0.959 . . . . 0.0 112.922 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.48 164.92 21.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.79 139.9 52.38 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.195 163.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -90.87 101.49 14.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.729 1.212 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 p -80.5 7.63 9.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.915 1.686 . . . . 0.0 115.162 -163.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.39 -179.94 22.92 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.297 0.953 . . . . 0.0 114.34 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.1 p -113.59 6.79 17.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.168 1.787 . . . . 0.0 113.913 -165.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.52 178.8 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.872 1.669 . . . . 0.0 111.735 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.31 44.78 3.16 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-O 116.83 -2.094 . . . . 0.0 117.963 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.13 102.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.278 3.039 . . . . 0.0 111.709 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.7 m -159.57 171.27 19.94 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.99 -166.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -82.76 110.2 17.58 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.67 -1.269 . . . . 0.0 110.519 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.7 p -61.85 121.45 65.11 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.551 0.74 . . . . 0.0 110.776 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.06 97.17 0.73 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.327 2.018 . . . . 0.0 110.887 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.11 138.77 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.938 1.295 . . . . 0.0 108.926 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -153.32 169.95 21.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.912 0.885 . . . . 0.0 113.384 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 t -140.73 117.66 11.12 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.536 2.335 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 57' ' ' ASP . 2.0 m -134.97 170.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.269 1.428 . . . . 0.0 111.473 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.4 -23.93 19.9 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -155.29 51.34 0.58 Allowed 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.587 -1.321 . . . . 0.0 111.298 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.08 11.8 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.806 2.043 . . . . 0.0 114.682 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . 0.434 HD21 HG23 ' A' ' 61' ' ' VAL . 3.3 p-10 -70.17 42.38 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 128.962 2.905 . . . . 0.0 114.453 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.3 t0 -65.47 -3.59 4.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.178 1.791 . . . . 0.0 115.585 -166.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.39 -14.82 20.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.71 1.204 . . . . 0.0 113.283 159.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -152.78 104.61 2.68 Favored Pre-proline 0 N--CA 1.47 0.546 0 O-C-N 120.446 -1.409 . . . . 0.0 109.958 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 141.01 13.46 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.779 3.653 . . . . 0.0 114.285 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.434 HG23 HD21 ' A' ' 56' ' ' ASN . 14.2 t -119.33 -27.6 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.44 1.096 . . . . 0.0 111.014 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.98 -174.15 20.05 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.762 2.125 . . . . 0.0 111.0 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.462 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.8 ptp85 -136.85 175.73 9.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.352 1.061 . . . . 0.0 112.43 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.26 143.44 27.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 107.811 164.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.5 -46.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.895 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -62.5 -42.84 99.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.374 0.988 . . . . 0.0 113.621 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.66 163.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.553 0.741 . . . . 0.0 111.099 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -64.72 137.85 97.27 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.269 0.627 . . . . 0.0 109.759 166.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.88 82.47 0.98 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.047 2.498 . . . . 0.0 112.781 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -145.04 110.35 5.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.595 1.558 . . . . 0.0 112.093 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.66 87.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.974 1.709 . . . . 0.0 108.014 167.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -69.27 -19.56 63.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -170.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.51 155.07 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.682 1.193 . . . . 0.0 112.026 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -19.57 64.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.981 0.912 . . . . 0.0 112.946 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.3 p -80.81 7.88 9.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.993 1.717 . . . . 0.0 113.416 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 16.96 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.931 1.693 . . . . 0.0 115.164 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.19 23.22 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.919 3.288 . . . . 0.0 114.644 -168.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.81 171.71 12.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.634 1.974 . . . . 0.0 113.783 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.83 111.31 21.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.472 2.709 . . . . 0.0 106.198 167.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.99 122.65 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.782 0.833 . . . . 0.0 112.437 -156.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.75 135.29 35.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.907 174.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.4 mt -136.24 139.33 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.095 1.758 . . . . 0.0 108.716 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -91.88 137.27 32.5 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.371 -0.83 . . . . 0.0 111.661 164.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.03 165.68 14.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.286 2.235 . . . . 0.0 109.545 166.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 29.9 tt0 -104.88 109.25 62.88 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 109.502 174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.675 ' HG3' HG13 ' A' ' 32' ' ' VAL . 60.3 Cg_endo -93.18 118.82 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.231 3.954 . . . . 0.0 111.138 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.96 152.81 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.999 3.133 . . . . 0.0 114.942 170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -84.34 152.53 24.04 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.436 -0.79 . . . . 0.0 110.564 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.87 -93.71 1.8 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -161.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -125.95 168.18 14.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.976 1.31 . . . . 0.0 111.315 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -154.06 155.1 34.84 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 120.945 -1.097 . . . . 0.0 112.126 171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.03 115.59 16.0 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.973 2.509 . . . . 0.0 107.953 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.52 106.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.69 2.396 . . . . 0.0 106.797 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.7 137.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.311 1.045 . . . . 0.0 109.613 -166.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.6 110.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.163 1.385 . . . . 0.0 109.113 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 130.07 173.21 13.33 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 173.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.2 ptm85 -126.7 123.5 37.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.976 1.71 . . . . 0.0 110.592 -171.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.51 -96.97 0.01 OUTLIER Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.932 2.206 . . . . 0.0 115.163 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -65.62 -16.88 64.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.273 1.829 . . . . 0.0 115.541 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -135.76 91.47 2.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.114 1.366 . . . . 0.0 110.461 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -139.54 162.06 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 176.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.07 162.82 21.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 128.631 2.773 . . . . 0.0 107.989 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.25 154.64 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.635 -0.666 . . . . 0.0 110.951 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -125.01 169.3 12.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.452 1.901 . . . . 0.0 108.185 164.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -140.0 163.18 33.38 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.389 -0.819 . . . . 0.0 112.412 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.31 158.54 43.55 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.476 1.51 . . . . 0.0 111.748 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -145.26 110.44 5.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.005 1.722 . . . . 0.0 107.089 -167.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -153.99 105.28 2.72 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t 64.78 39.81 5.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.783 2.033 . . . . 0.0 113.966 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.33 22.42 0.08 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.584 1.088 . . . . 0.0 114.178 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.6 t -65.05 155.89 33.23 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 -172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 m -53.17 -20.57 4.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.912 2.085 . . . . 0.0 113.721 161.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -101.05 2.37 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.919 1.287 . . . . 0.0 113.022 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.08 62.26 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.162 0 CA-C-N 118.985 1.393 . . . . 0.0 114.327 -179.353 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.97 153.3 32.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.21 1.004 . . . . 0.0 112.969 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.47 90.6 3.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.237 2.215 . . . . 0.0 109.09 175.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.88 -44.01 91.05 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.998 1.719 . . . . 0.0 114.149 -163.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -61.95 -26.41 68.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.493 0.717 . . . . 0.0 112.626 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -93.89 -1.53 54.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 112.361 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -62.15 -8.73 5.98 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.8 1.182 . . . . 0.0 114.169 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.71 52.01 6.14 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 119.652 1.115 . . . . 0.0 112.936 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -75.47 37.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.06 1.744 . . . . 0.0 111.557 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -78.18 -6.14 53.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.7 1.2 . . . . 0.0 114.109 -174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -153.86 172.82 16.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.102 0.961 . . . . 0.0 111.141 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.2 143.86 45.64 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.689 0.662 . . . . 0.0 112.092 171.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.273 4.0 p -80.76 93.16 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.984 1.373 . . . . 0.0 112.58 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -148.82 164.81 33.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.701 2.0 . . . . 0.0 110.847 167.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.4 p -140.24 -15.43 0.98 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.834 1.253 . . . . 0.0 113.651 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 50.12 -64.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 129.686 3.194 . . . . 0.0 114.956 -167.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.45 83.15 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.548 1.139 . . . . 0.0 112.424 -160.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.77 162.22 29.99 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.745 1.218 . . . . 0.0 110.674 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -155.19 152.69 29.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.412 1.885 . . . . 0.0 109.84 166.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.9 132.19 51.28 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.483 -0.761 . . . . 0.0 111.693 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 -35.52 4.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.159 0.983 . . . . 0.0 110.809 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.86 103.2 0.42 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.016 1.77 . . . . 0.0 110.036 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 p -59.51 151.85 58.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.941 0.896 . . . . 0.0 112.293 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.08 141.76 77.99 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.13 1.887 . . . . 0.0 113.498 -168.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.77 135.51 33.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.292 1.437 . . . . 0.0 110.722 174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.09 141.59 54.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -13.38 59.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 114.559 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.22 -8.26 47.29 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.366 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -98.21 1.78 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.1 1.36 . . . . 0.0 112.284 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -8.79 47.93 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.98 1.276 . . . . 0.0 113.89 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -102.11 166.51 10.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.939 2.096 . . . . 0.0 111.988 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.78 123.74 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.455 1.502 . . . . 0.0 110.833 173.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -77.74 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.882 0.873 . . . . 0.0 109.781 164.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.37 121.14 9.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.35 2.26 . . . . 0.0 109.241 -164.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -108.91 133.91 52.28 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.76 -1.212 . . . . 0.0 113.029 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.18 159.54 25.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.557 0.743 . . . . 0.0 110.25 168.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -111.26 144.78 39.9 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.918 1.287 . . . . 0.0 109.49 167.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -93.36 102.8 15.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.177 1.391 . . . . 0.0 109.404 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -77.82 16.34 0.71 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.52 38.86 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 120.187 1.358 . . . . 0.0 115.587 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.53 -15.27 24.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -131.93 177.49 7.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.725 1.21 . . . . 0.0 112.61 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.32 38.42 0.73 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-O 116.307 -2.385 . . . . 0.0 118.706 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.07 107.84 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 122.715 3.258 . . . . 0.0 111.474 166.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 4.6 t -169.1 173.72 6.67 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.383 1.473 . . . . 0.0 110.394 -165.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -88.72 96.7 10.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 119.715 -1.866 . . . . 0.0 111.404 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.75 123.93 60.85 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.774 0.83 . . . . 0.0 112.853 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -86.12 99.37 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.641 2.894 . . . . 0.0 112.31 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -131.07 145.7 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.282 1.033 . . . . 0.0 109.255 164.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . 0.408 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 41.1 t -151.18 166.49 30.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.854 1.262 . . . . 0.0 112.789 -169.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.7 t -145.99 108.83 4.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.379 2.272 . . . . 0.0 110.338 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.42 171.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.839 0.855 . . . . 0.0 112.665 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.63 -6.52 20.39 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -143.9 20.03 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.422 -1.424 . . . . 0.0 112.687 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.15 20.48 10.99 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.263 1.825 . . . . 0.0 111.966 -173.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -82.15 48.31 1.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 129.896 3.278 . . . . 0.0 113.203 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.408 ' OD1' ' OG ' ' A' ' 50' ' ' SER . 29.9 m-20 -58.14 -17.19 16.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -7.66 1.2 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.376 1.87 . . . . 0.0 114.753 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -150.05 87.19 5.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 119.925 -1.734 . . . . 0.0 109.655 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.11 115.24 2.04 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 125.129 3.886 . . . . 0.0 114.279 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.39 -36.6 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.248 1.419 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.91 -162.99 34.91 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.624 2.059 . . . . 0.0 111.98 170.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -144.47 167.19 23.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.889 1.276 . . . . 0.0 112.261 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.514 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.78 106.77 18.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.883 1.673 . . . . 0.0 106.552 167.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.89 -54.34 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -60.64 -49.26 78.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 113.002 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.68 141.28 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 123.028 0.531 . . . . 0.0 110.536 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -75.29 134.32 73.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 122.22 0.208 . . . . 0.0 110.5 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.38 92.21 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 114.309 -153.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -140.79 128.73 21.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.234 1.413 . . . . 0.0 110.547 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -82.92 87.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.16 1.384 . . . . 0.0 108.214 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -73.26 -5.24 38.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 157.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 110.841 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.36 -19.38 60.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -74.17 5.98 3.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.421 1.889 . . . . 0.0 113.841 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 12.22 0.17 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.844 1.658 . . . . 0.0 114.815 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.27 24.5 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 130.146 3.378 . . . . 0.0 114.921 -170.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 173.07 8.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.087 . . . . 0.0 113.758 -169.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 111.48 22.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.257 2.623 . . . . 0.0 105.306 164.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.71 128.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.919 0.866 . . . . 0.0 112.439 -158.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -92.44 125.85 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.052 2.541 . . . . 0.0 109.79 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.57 136.54 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.589 2.355 . . . . 0.0 108.15 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 134.49 33.61 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.699 . . . . 0.0 110.899 159.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.72 157.34 24.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.771 1.628 . . . . 0.0 109.761 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.65 106.85 42.64 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.54 136.2 10.87 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.439 2.76 . . . . 0.0 109.829 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -61.56 161.72 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 121.467 1.445 . . . . 0.0 111.357 167.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -88.23 166.75 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.35 0.66 . . . . 0.0 112.726 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.44 -89.44 1.22 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -167.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.24 147.26 50.22 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.2 p -146.41 141.76 27.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.737 0.78 . . . . 0.0 112.088 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -130.74 121.34 25.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.385 1.874 . . . . 0.0 108.266 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.0 mm -105.9 108.51 25.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 107.278 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.6 t -113.14 139.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.289 1.036 . . . . 0.0 109.52 -164.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.0 t -136.92 97.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.709 1.604 . . . . 0.0 107.899 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.58 172.73 18.73 Favored Glycine 0 N--CA 1.467 0.71 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 114.82 15.17 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.728 2.011 . . . . 0.0 110.211 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.37 -103.5 0.04 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.202 1.858 . . . . 0.0 114.086 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.67 -18.42 62.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.138 2.175 . . . . 0.0 115.545 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -123.14 93.95 4.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.339 0.972 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.2 42.53 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.76 159.68 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 129.135 2.974 . . . . 0.0 108.139 168.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -146.05 153.95 41.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.804 0.842 . . . . 0.0 110.081 165.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -137.91 166.91 22.87 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.671 1.588 . . . . 0.0 109.493 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -124.33 157.89 33.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.886 0.874 . . . . 0.0 112.399 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.51 151.38 28.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.051 1.74 . . . . 0.0 110.738 169.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -127.29 136.86 52.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 109.312 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -140.53 91.69 2.45 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -153.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 t 76.35 17.32 2.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.223 2.209 . . . . 0.0 114.187 163.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.79 25.55 0.05 OUTLIER Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.727 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.6 t -63.53 156.41 26.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.351 1.575 . . . . 0.0 110.849 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.6 p -62.34 -16.78 56.4 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 166.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.0 mm -67.23 -10.55 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.634 1.574 . . . . 0.0 111.903 167.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.37 17.1 47.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.219 1.39 . . . . 0.0 113.993 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tptp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.367 1.467 . . . . 0.0 112.833 -161.558 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 164.57 34.28 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 -174.53 3.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.884 2.074 . . . . 0.0 111.45 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.42 -57.08 2.08 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.602 -0.686 . . . . 0.0 110.815 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -49.09 -52.47 25.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.842 2.457 . . . . 0.0 114.425 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.34 -31.42 69.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.917 0.781 . . . . 0.0 112.797 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -76.3 -12.38 60.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.064 1.345 . . . . 0.0 113.812 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -19.7 126.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 1 C-N-CA 130.773 4.035 . . . . 0.0 116.59 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.476 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 79.3 p -73.96 74.58 1.68 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 113.151 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -59.89 -45.91 91.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.882 1.673 . . . . 0.0 112.857 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -123.74 174.4 7.51 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.353 1.861 . . . . 0.0 110.712 174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.17 148.94 31.89 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.379 0.99 . . . . 0.0 113.085 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.76 105.11 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 122.621 1.2 . . . . 0.0 113.336 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.92 151.83 14.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.928 2.091 . . . . 0.0 109.281 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 p -143.94 -33.62 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.493 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 60.42 -69.27 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.596 2.759 . . . . 0.0 114.739 170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.56 72.74 1.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.492 1.517 . . . . 0.0 110.346 -161.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -115.94 160.86 19.66 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.694 1.198 . . . . 0.0 110.049 165.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -141.97 144.22 33.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.652 1.581 . . . . 0.0 108.377 164.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.72 147.63 52.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.835 0.826 . . . . 0.0 111.947 170.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -46.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.924 1.29 . . . . 0.0 110.388 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.14 110.54 0.91 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.12 1.343 . . . . 0.0 111.239 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -57.92 146.6 67.24 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.448 167.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.2 155.22 52.52 Favored 'Trans proline' 0 C--N 1.351 0.71 0 N-CA-C 115.49 1.304 . . . . 0.0 115.49 -165.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.61 39.89 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.556 1.542 . . . . 0.0 110.282 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 132.65 45.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.769 0.428 . . . . 0.0 111.134 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.7 p -77.82 -24.25 48.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 -8.23 61.45 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.68 -1.066 . . . . 0.0 113.976 -160.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -75.25 -11.67 60.12 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.656 1.728 . . . . 0.0 111.342 163.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 -13.85 62.97 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.819 2.152 . . . . 0.0 113.105 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -84.29 170.17 13.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.759 2.424 . . . . 0.0 112.036 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.24 124.41 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.581 1.153 . . . . 0.0 110.317 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.24 128.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.793 0.837 . . . . 0.0 109.357 164.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 159.27 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 167.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -132.17 135.25 46.22 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -165.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.26 168.04 16.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.819 1.247 . . . . 0.0 110.489 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -123.7 148.17 46.79 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.844 1.257 . . . . 0.0 110.267 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -97.51 108.91 21.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.7 p -87.45 0.51 55.41 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.119 1.768 . . . . 0.0 113.775 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.16 16.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.712 1.149 . . . . 0.0 113.69 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 m -118.3 11.8 13.22 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.995 1.718 . . . . 0.0 111.56 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -149.25 -175.3 4.93 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.32 2.248 . . . . 0.0 111.154 -168.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.44 56.95 2.7 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.907 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.45 95.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.548 2.832 . . . . 0.0 112.281 155.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.3 169.07 19.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.26 . . . . 0.0 112.752 -169.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 2.5 ttmm -95.78 101.38 13.06 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 110.523 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.78 115.45 18.88 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 111.321 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.3 88.45 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.932 2.422 . . . . 0.0 111.221 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 tt -106.77 144.9 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.23 1.012 . . . . 0.0 109.412 165.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t -145.85 167.87 22.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.011 1.324 . . . . 0.0 113.283 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.8 t -139.81 110.96 6.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.563 2.345 . . . . 0.0 109.811 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 57' ' ' ASP . 28.4 m -137.3 161.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -8.57 29.67 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.4 m -155.68 36.65 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.164 -1.585 . . . . 0.0 112.321 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.96 8.41 0.98 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.324 1.85 . . . . 0.0 114.541 -175.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -67.96 40.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 131.104 3.762 . . . . 0.0 114.839 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.429 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.8 t0 -63.61 0.49 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -160.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.75 -18.67 65.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.13 -0.981 . . . . 0.0 112.966 160.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.1 m -128.33 101.48 21.77 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.102 1.761 . . . . 0.0 109.865 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -66.53 117.83 5.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.004 2.47 . . . . 0.0 110.325 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -96.83 -30.98 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.89 0.876 . . . . 0.0 111.144 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.4 -164.63 24.55 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.335 1.922 . . . . 0.0 111.537 166.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.458 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 9.4 ptp85 -139.48 169.62 17.41 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.673 1.589 . . . . 0.0 111.803 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 114.79 27.45 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.201 1.8 . . . . 0.0 106.809 170.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.9 -51.92 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.282 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -60.73 -44.31 96.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.83 159.0 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.476 0.71 . . . . 0.0 111.03 -169.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.77 127.19 67.15 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.667 0.787 . . . . 0.0 109.091 163.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.06 89.56 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 110.916 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -144.05 142.78 30.85 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.792 0.806 . . . . 0.0 112.737 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 t -76.49 86.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 127.46 2.304 . . . . 0.0 106.864 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 p -59.97 -28.68 67.87 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -167.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 161.17 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.529 1.531 . . . . 0.0 112.146 -173.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.78 -28.01 68.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.119 0.968 . . . . 0.0 112.702 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.62 5.45 4.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.384 2.274 . . . . 0.0 114.665 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 14.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.1 16.97 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.694 3.598 . . . . 0.0 115.425 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.53 169.66 17.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.279 1.832 . . . . 0.0 113.768 -172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 111.14 22.75 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.711 2.805 . . . . 0.0 105.473 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.71 126.65 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.034 0.934 . . . . 0.0 112.342 -159.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.97 130.97 36.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.286 2.234 . . . . 0.0 109.644 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -133.97 142.77 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.106 1.363 . . . . 0.0 109.889 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.81 135.1 33.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.302 1.041 . . . . 0.0 111.772 168.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.0 157.75 26.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.576 1.95 . . . . 0.0 109.844 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 35.6 tt0 -90.95 113.45 58.16 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.838 0.855 . . . . 0.0 109.041 171.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.28 122.91 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.804 3.003 . . . . 0.0 109.92 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.56 164.29 31.58 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.706 1.604 . . . . 0.0 111.846 171.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -80.98 145.0 31.41 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.29 -0.881 . . . . 0.0 111.783 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.09 -94.34 1.06 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.695 2.093 . . . . 0.0 110.268 -173.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -112.77 174.8 5.72 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 110.267 167.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 m -153.15 96.32 2.05 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.606 -1.309 . . . . 0.0 110.917 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.63 127.27 42.46 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.28 96.97 5.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.263 1.425 . . . . 0.0 107.612 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.98 140.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.695 -171.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -135.66 99.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.348 1.859 . . . . 0.0 107.834 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.08 169.14 25.01 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -137.59 123.9 20.61 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.835 2.454 . . . . 0.0 108.975 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.39 -98.54 0.01 OUTLIER Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.407 1.956 . . . . 0.0 114.92 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -71.37 -17.07 62.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.58 99.54 6.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.632 1.173 . . . . 0.0 109.58 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.39 156.28 45.82 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 164.79 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.46 2.704 . . . . 0.0 108.182 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.83 160.78 43.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.697 -0.627 . . . . 0.0 111.023 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.23 171.68 12.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.532 1.933 . . . . 0.0 109.899 170.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.1 144.16 51.11 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.221 1.008 . . . . 0.0 111.56 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.39 164.07 35.98 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.258 1.823 . . . . 0.0 110.783 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -146.17 114.46 6.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.547 1.539 . . . . 0.0 108.512 -162.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -152.54 96.3 2.12 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -163.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.7 p 56.6 82.16 0.12 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 128.609 2.763 . . . . 0.0 114.026 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.9 21.42 4.97 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.496 1.998 . . . . 0.0 112.961 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.8 t -70.77 156.95 38.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -166.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m -54.6 -19.05 5.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.852 1.661 . . . . 0.0 114.081 164.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tt -112.98 16.25 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.721 1.208 . . . . 0.0 112.735 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.4 75.81 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 116.111 1.204 . . . . 0.0 116.111 164.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.331 1.452 . . . . 0.0 113.56 179.146 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -146.61 146.95 30.6 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.171 0.51 . . . . 0.0 111.897 -168.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.62 173.02 9.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.061 2.544 . . . . 0.0 109.924 173.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -98.7 -49.39 4.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.258 -0.901 . . . . 0.0 111.336 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -61.33 -33.46 73.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.452 1.901 . . . . 0.0 114.12 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.11 -38.16 87.84 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.533 0.733 . . . . 0.0 110.963 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' PRO . 32.0 mmtm -69.86 -40.23 75.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.917 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 11.62 109.73 0.0 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 130.657 3.98 . . . . 0.0 117.072 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.412 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 80.9 p -67.49 71.34 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.925 2.09 . . . . 0.0 112.557 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -19.71 65.48 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.414 3.086 . . . . 0.0 114.78 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -158.62 -172.97 4.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 110.686 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.59 118.35 13.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.718 1.151 . . . . 0.0 112.738 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -67.41 99.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.66 1.184 . . . . 0.0 112.979 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 160.04 39.98 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.737 2.415 . . . . 0.0 109.467 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.8 p -136.8 -35.57 0.71 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.672 1.189 . . . . 0.0 112.815 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 tttm 54.86 -79.42 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.822 2.449 . . . . 0.0 114.634 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.53 84.12 1.97 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.531 0.605 . . . . 0.0 111.958 -162.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.62 163.98 26.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.782 0.833 . . . . 0.0 112.268 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -149.93 145.82 26.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.428 2.291 . . . . 0.0 108.275 160.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -65.46 140.27 58.59 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.558 -0.714 . . . . 0.0 111.449 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.34 -52.08 2.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.65 112.81 1.94 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.557 1.551 . . . . 0.0 110.37 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.1 p -52.23 141.8 30.23 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.092 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.22 145.82 84.97 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.759 2.306 . . . . 0.0 112.764 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.51 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.706 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -65.0 125.22 24.23 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.356 0.598 . . . . 0.0 110.648 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 p -70.26 -8.22 48.49 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.145 2.178 . . . . 0.0 114.0 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.85 -8.49 3.4 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.64 1.114 . . . . 0.0 113.569 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -94.62 5.62 51.3 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.447 1.899 . . . . 0.0 111.276 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.14 18.72 38.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.698 1.142 . . . . 0.0 113.97 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -130.32 161.8 30.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 111.144 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 121.71 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.657 1.583 . . . . 0.0 108.701 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.32 130.4 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 162.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 35' ' ' GLU . 4.7 tt -141.9 131.89 24.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 109.704 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLU . . . . . 0.416 ' N ' HD23 ' A' ' 34' ' ' LEU . 19.0 tt0 -115.91 130.84 57.0 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.114 0.87 . . . . 0.0 113.243 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.05 167.31 13.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.36 1.064 . . . . 0.0 111.164 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -119.21 142.84 47.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.371 1.468 . . . . 0.0 109.836 166.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -95.1 98.27 10.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.303 1.041 . . . . 0.0 110.691 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.5 p -76.06 22.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.459 2.303 . . . . 0.0 115.846 -163.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.39 176.02 37.95 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 120.905 -1.122 . . . . 0.0 114.601 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 p -99.2 -4.69 31.47 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.501 1.921 . . . . 0.0 113.64 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.23 176.77 8.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.718 1.607 . . . . 0.0 112.732 -167.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.78 48.2 2.16 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 117.244 -1.864 . . . . 0.0 116.944 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.97 99.11 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.761 2.781 . . . . 0.0 110.068 162.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.437 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 56.2 m -145.39 163.72 33.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.504 1.522 . . . . 0.0 111.725 -167.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 9' ' ' THR . 4.3 tmtm? -80.08 90.0 5.41 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.167 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.11 114.51 7.23 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.852 1.261 . . . . 0.0 112.516 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.53 99.46 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.345 2.03 . . . . 0.0 110.761 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -126.51 145.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.081 1.352 . . . . 0.0 108.446 163.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.3 t -147.02 164.11 34.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.573 1.149 . . . . 0.0 112.806 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.9 t -137.76 115.39 11.3 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.556 2.342 . . . . 0.0 109.218 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 11.1 m -130.58 169.96 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.808 1.243 . . . . 0.0 111.593 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.58 -0.03 20.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -154.31 28.87 0.45 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.198 -1.564 . . . . 0.0 112.709 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.99 6.44 0.32 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.223 2.209 . . . . 0.0 115.203 -174.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -71.36 56.74 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.912 3.285 . . . . 0.0 112.436 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.8 t70 -64.82 -4.72 4.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -165.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -16.0 20.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.417 1.487 . . . . 0.0 114.515 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.0 m -157.11 116.11 2.0 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 120.678 -1.264 . . . . 0.0 109.16 165.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 85.0 Cg_exo -48.23 127.82 16.02 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.229 3.286 . . . . 0.0 113.665 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.37 -26.65 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 126.054 1.742 . . . . 0.0 110.911 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.56 -164.82 29.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.484 1.992 . . . . 0.0 111.116 163.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ARG . . . . . 0.402 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -135.78 177.95 7.43 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.403 0.681 . . . . 0.0 112.62 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.49 142.49 27.37 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 163.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.0 t -106.8 -45.88 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.548 0.613 . . . . 0.0 110.108 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.2 m -61.86 -43.81 98.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.65 157.18 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.823 1.192 . . . . 0.0 112.375 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -62.09 128.6 91.08 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.29 89.02 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.367 2.045 . . . . 0.0 113.707 -172.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -155.59 114.08 3.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.227 1.811 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -76.74 93.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.836 2.054 . . . . 0.0 108.2 171.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -69.63 -7.26 37.3 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.16 154.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.874 1.216 . . . . 0.0 111.989 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.91 66.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.249 1.02 . . . . 0.0 112.322 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.16 0.05 5.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.187 2.995 . . . . 0.0 114.07 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.24 11.82 0.15 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.849 1.66 . . . . 0.0 115.429 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.35 17.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.304 3.442 . . . . 0.0 115.597 -167.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.2 176.78 8.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.893 2.077 . . . . 0.0 114.126 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.29 114.51 27.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.836 2.854 . . . . 0.0 106.171 164.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.62 132.03 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.561 0.696 . . . . 0.0 112.749 -158.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.86 137.97 33.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.263 2.225 . . . . 0.0 111.109 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.84 144.05 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.005 2.122 . . . . 0.0 108.69 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -98.91 135.75 39.89 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 112.476 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.36 166.56 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 110.442 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 5.3 tt0 -102.37 110.67 63.32 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.073 0.949 . . . . 0.0 110.009 171.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 92.0 Cg_endo -84.88 108.59 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.729 4.286 . . . . 0.0 111.084 172.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 58.2 Cg_endo -60.34 161.56 19.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.38 165.31 16.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.92 -80.26 1.23 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -165.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.01 156.66 41.27 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.801 1.24 . . . . 0.0 111.139 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -143.02 142.17 31.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.523 1.129 . . . . 0.0 110.161 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -137.92 128.63 26.81 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.644 1.178 . . . . 0.0 108.096 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.22 98.64 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.265 1.426 . . . . 0.0 107.255 -162.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -99.92 136.49 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.939 0.896 . . . . 0.0 109.114 -167.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.6 103.98 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.67 1.588 . . . . 0.0 107.524 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.97 177.59 15.04 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.299 0.944 . . . . 0.0 114.763 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.47 154.51 45.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.195 2.198 . . . . 0.0 108.471 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -12.2 -72.74 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.68 2.562 . . . . 0.0 117.164 -173.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.11 -13.72 59.76 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.9 88.04 2.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.623 1.569 . . . . 0.0 109.971 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -143.25 157.7 44.26 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.29 161.4 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 129.382 3.073 . . . . 0.0 107.839 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.69 150.82 36.15 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.05 -1.031 . . . . 0.0 112.513 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -120.87 170.25 9.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.766 1.226 . . . . 0.0 110.832 166.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -125.8 159.74 31.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.616 1.967 . . . . 0.0 111.31 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.0 153.01 31.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.198 2.599 . . . . 0.0 110.599 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -143.58 117.3 9.27 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 108.765 -167.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -150.57 93.04 1.92 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -165.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p 65.8 58.0 0.8 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.081 1.753 . . . . 0.0 114.077 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 128.65 25.3 1.04 Allowed Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.882 1.706 . . . . 0.0 113.439 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 30.1 t -61.01 158.0 14.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.239 1.816 . . . . 0.0 113.475 -177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 m -55.52 -22.81 23.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.322 1.049 . . . . 0.0 112.454 163.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -91.33 -3.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 126.809 2.044 . . . . 0.0 111.523 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.54 69.87 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.635 -1.291 . . . . 0.0 115.469 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.6 ptmm? . . . . . 0 C--O 1.249 1.029 0 C-N-CA 126.022 1.729 . . . . 0.0 113.206 178.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 2.8 mt . . . . . 0 N--CA 1.48 1.046 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 7.6 t -142.78 137.25 29.59 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 123.113 0.565 . . . . 0.0 112.093 -162.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.89 168.42 14.5 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 128.669 2.787 . . . . 0.0 109.953 176.11 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 36.6 t80 -83.65 -57.54 3.18 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 121.239 -0.913 . . . . 0.0 111.994 178.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.2 pm0 -58.36 -29.65 66.14 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.417 1.487 . . . . 0.0 114.356 -166.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 11.1 tp -70.74 -40.03 72.98 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 118.33 0.513 . . . . 0.0 111.093 175.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 31.0 mmtm -65.74 -45.32 83.08 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 118.962 0.801 . . . . 0.0 109.886 168.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 39.99 101.77 0.01 OUTLIER Glycine 0 CA--C 1.53 0.993 0 C-N-CA 130.04 3.686 . . . . 0.0 116.756 161.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 67.8 p -68.4 62.11 0.09 Allowed 'General case' 0 N--CA 1.473 0.697 0 C-N-CA 127.521 2.328 . . . . 0.0 112.682 175.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -70.33 -17.92 63.07 Favored 'General case' 0 N--CA 1.471 0.58 0 C-N-CA 126.382 1.873 . . . . 0.0 113.757 175.302 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 19.0 t80 -160.07 -179.15 7.52 Favored 'General case' 0 CA--C 1.549 0.936 0 C-N-CA 125.444 1.497 . . . . 0.0 110.486 178.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -82.05 144.85 24.09 Favored Glycine 0 CA--C 1.539 1.553 0 C-N-CA 124.668 1.128 . . . . 0.0 114.241 176.334 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.7 p -75.99 95.54 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 122.969 1.366 . . . . 0.0 114.152 -173.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.82 169.44 17.62 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 128.627 2.771 . . . . 0.0 108.299 168.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 63.4 p -167.27 -44.91 0.02 OUTLIER 'General case' 0 N--CA 1.475 0.778 0 C-N-CA 123.585 0.754 . . . . 0.0 112.484 174.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? 61.99 -76.09 0.03 OUTLIER 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.593 2.357 . . . . 0.0 113.647 177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -102.49 77.06 1.59 Allowed 'General case' 0 CA--C 1.535 0.399 0 CA-C-O 121.802 0.81 . . . . 0.0 112.149 -163.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -120.7 156.96 30.66 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 124.403 1.081 . . . . 0.0 110.144 163.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.6 tttm -143.11 142.39 31.49 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 126.085 1.754 . . . . 0.0 108.731 168.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -60.49 138.7 57.98 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-O 121.67 0.748 . . . . 0.0 111.398 168.604 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -114.16 -43.12 3.26 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.077 1.351 . . . . 0.0 109.541 170.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -137.98 115.48 1.2 Allowed Glycine 0 CA--C 1.525 0.658 0 C-N-CA 126.395 1.95 . . . . 0.0 109.646 176.172 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.2 p -64.12 159.58 55.46 Favored Pre-proline 0 CA--C 1.544 0.733 0 O-C-N 121.648 -0.913 . . . . 0.0 111.321 174.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -61.46 137.22 68.35 Favored 'Trans proline' 0 C--N 1.352 0.762 0 C-N-CA 122.139 1.893 . . . . 0.0 112.585 -172.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -131.19 125.3 32.61 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.386 1.475 . . . . 0.0 110.5 175.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.4 t70 -66.37 132.05 47.46 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 121.557 0.694 . . . . 0.0 111.454 -175.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 80.2 p -78.8 -9.14 59.36 Favored 'General case' 0 N--CA 1.465 0.292 0 C-N-CA 125.818 1.647 . . . . 0.0 113.944 -173.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.16 -7.82 3.08 Favored Glycine 0 CA--C 1.536 1.397 0 CA-C-N 118.994 0.815 . . . . 0.0 114.061 -167.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 55.4 m80 -94.96 4.87 53.31 Favored 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 126.069 1.748 . . . . 0.0 111.193 175.591 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 106.61 -11.02 42.31 Favored Glycine 0 CA--C 1.532 1.094 0 C-N-CA 126.245 1.879 . . . . 0.0 114.072 178.174 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -109.47 174.76 5.72 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.034 2.134 . . . . 0.0 112.056 -171.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.55 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -120.42 141.01 42.65 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.857 0 C-N-CA 124.936 1.294 . . . . 0.0 110.224 165.364 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 3.6 m -96.54 128.89 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.564 0 C-N-CA 125.018 1.327 . . . . 0.0 109.918 168.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 6.4 tt -136.55 133.09 36.04 Favored 'General case' 0 N--CA 1.467 0.376 0 C-N-CA 126.729 2.012 . . . . 0.0 109.217 -172.283 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -121.24 132.32 54.74 Favored 'General case' 0 C--O 1.235 0.338 0 C-N-CA 123.869 0.868 . . . . 0.0 112.612 -176.165 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.2 mt -121.85 166.12 14.87 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 123.865 0.866 . . . . 0.0 110.119 172.078 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.7 pt20 -120.95 148.74 43.67 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.885 0.874 . . . . 0.0 109.45 160.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 11.0 t80 -100.4 100.36 11.12 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 124.011 0.925 . . . . 0.0 109.702 -175.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 1.2 p -80.47 13.64 2.38 Favored 'General case' 0 N--CA 1.473 0.721 0 C-N-CA 127.453 2.301 . . . . 0.0 115.759 -163.613 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.08 171.32 27.8 Favored Glycine 0 CA--C 1.529 0.936 0 CA-C-N 119.507 1.048 . . . . 0.0 113.789 -179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 67.3 p -96.52 6.42 48.78 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 125.715 1.606 . . . . 0.0 113.479 -176.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -141.8 172.68 12.35 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.87 1.668 . . . . 0.0 112.308 -169.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.65 47.76 0.89 Allowed Glycine 0 CA--C 1.541 1.682 0 CA-C-O 117.046 -1.975 . . . . 0.0 117.413 170.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_exo -55.11 95.79 0.05 OUTLIER 'Trans proline' 0 CA--C 1.543 0.959 0 CA-C-N 121.769 2.785 . . . . 0.0 111.458 162.18 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 65.4 m -152.96 168.03 27.19 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 125.367 1.467 . . . . 0.0 112.589 -171.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.8 tmtm? -83.48 91.96 7.5 Favored 'General case' 0 CA--C 1.538 0.517 0 O-C-N 120.504 -1.372 . . . . 0.0 110.782 178.726 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.6 p -52.81 119.35 15.76 Favored Pre-proline 0 N--CA 1.475 0.817 0 C-N-CA 124.676 1.19 . . . . 0.0 112.105 -177.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -81.83 88.87 1.28 Allowed 'Trans proline' 0 N--CA 1.454 -0.817 0 C-N-CA 123.353 2.702 . . . . 0.0 111.394 -179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.7 tt -124.62 143.72 37.08 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.333 0 O-C-N 121.792 -0.567 . . . . 0.0 110.07 165.603 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 35.5 t -147.62 157.16 43.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.844 1.258 . . . . 0.0 112.055 -168.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 14.2 t -133.28 108.62 8.86 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 125.993 1.717 . . . . 0.0 110.562 179.881 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 57' ' ' ASP . 19.3 m -131.73 170.69 19.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.841 0 C-N-CA 123.794 0.837 . . . . 0.0 112.166 -176.451 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -101.19 -12.6 18.62 Favored 'General case' 0 CA--C 1.542 0.644 0 N-CA-C 114.54 1.311 . . . . 0.0 114.54 -169.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.1 m -152.93 27.99 0.53 Allowed 'General case' 0 N--CA 1.475 0.793 0 O-C-N 120.114 -1.616 . . . . 0.0 112.602 -175.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.47 17.66 2.31 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 127.054 2.142 . . . . 0.0 113.098 -168.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.489 HD21 ' CG2' ' A' ' 61' ' ' VAL . 13.5 p-10 -68.37 52.15 0.07 Allowed 'General case' 0 CA--C 1.543 0.684 0 C-N-CA 128.583 2.753 . . . . 0.0 111.952 167.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.678 ' HA ' HG11 ' A' ' 52' ' ' VAL . 12.3 t0 -56.94 -25.67 58.07 Favored 'General case' 0 CA--C 1.543 0.679 0 C-N-CA 124.914 1.285 . . . . 0.0 113.2 -173.086 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.2 pp -54.58 -10.96 0.48 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 129.566 3.147 . . . . 0.0 116.128 166.025 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.3 m -153.6 95.75 2.85 Favored Pre-proline 0 N--CA 1.477 0.921 0 O-C-N 119.869 -1.77 . . . . 0.0 111.064 166.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.654 ' HA ' HG12 ' A' ' 52' ' ' VAL . 85.7 Cg_exo -54.27 118.1 4.65 Favored 'Trans proline' 0 C--N 1.351 0.693 0 C-N-CA 124.838 3.692 . . . . 0.0 116.369 -177.615 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.489 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.7 t -95.9 -26.21 4.25 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.122 0 C-N-CA 125.858 1.663 . . . . 0.0 112.859 -177.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.18 -163.52 18.03 Favored Glycine 0 CA--C 1.531 1.065 0 C-N-CA 126.514 2.007 . . . . 0.0 111.798 175.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.22 172.31 13.02 Favored 'General case' 0 N--CA 1.471 0.593 0 N-CA-C 113.855 1.057 . . . . 0.0 113.855 176.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -94.64 104.94 16.88 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 126.972 2.109 . . . . 0.0 106.857 168.037 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 88.0 t -70.85 -48.58 56.04 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 C-N-CA 123.593 0.757 . . . . 0.0 110.453 -171.002 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -59.82 -48.04 83.31 Favored 'General case' 0 N--CA 1.472 0.628 0 N-CA-C 113.685 0.995 . . . . 0.0 113.685 -172.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -162.41 161.96 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.716 0 CA-C-N 119.235 0.925 . . . . 0.0 112.033 -173.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.4 t-20 -58.16 120.73 45.8 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 123.858 0.863 . . . . 0.0 109.563 161.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -74.82 85.32 1.51 Allowed 'Trans proline' 0 CA--C 1.54 0.784 0 C-N-CA 122.397 2.064 . . . . 0.0 110.843 -171.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -147.34 123.9 11.08 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.048 1.739 . . . . 0.0 110.376 178.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 53.8 t -86.48 99.09 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.247 0 C-N-CA 125.285 1.434 . . . . 0.0 108.323 177.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 24.2 t -75.71 -4.48 40.6 Favored 'General case' 0 CA--C 1.539 0.557 0 N-CA-C 115.524 1.676 . . . . 0.0 115.524 -174.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.17 159.18 2.91 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.742 0 CA-C-N 120.076 1.307 . . . . 0.0 112.842 -172.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.31 -18.62 63.84 Favored 'General case' 0 CA--C 1.543 0.71 0 C-N-CA 124.936 1.294 . . . . 0.0 113.206 168.902 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 67.7 p -80.41 2.53 24.67 Favored 'General case' 0 N--CA 1.472 0.669 0 C-N-CA 126.076 1.75 . . . . 0.0 114.103 -179.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.35 14.31 0.04 OUTLIER 'General case' 0 CA--C 1.546 0.825 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 179.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.22 16.65 0.01 OUTLIER 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 130.969 3.708 . . . . 0.0 114.814 -173.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.54 173.1 11.44 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 127.597 2.359 . . . . 0.0 114.024 -171.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.38 107.83 16.77 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 128.708 2.803 . . . . 0.0 105.696 166.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -138.32 120.02 17.55 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.609 0 C-N-CA 124.148 0.979 . . . . 0.0 113.231 -153.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.8 tm? -89.05 129.29 35.7 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 128.151 2.581 . . . . 0.0 109.748 176.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 80.2 mt -130.55 136.92 57.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 C-N-CA 127.826 2.45 . . . . 0.0 108.499 -175.553 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 23.5 mt-10 -91.09 141.54 28.71 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.343 0.657 . . . . 0.0 112.347 167.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 8.2 mp -124.52 159.62 30.16 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 127.339 2.256 . . . . 0.0 110.045 168.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.1 tt0 -104.45 107.54 58.07 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.297 1.039 . . . . 0.0 108.95 172.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.55 ' HG3' HG13 ' A' ' 32' ' ' VAL . 97.7 Cg_endo -90.99 115.8 0.46 Allowed 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 125.044 3.83 . . . . 0.0 110.711 167.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_exo -47.4 167.66 0.08 OUTLIER 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 125.115 3.877 . . . . 0.0 116.172 167.841 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 71.6 m-85 -77.59 161.28 27.96 Favored 'General case' 0 CA--C 1.535 0.394 0 N-CA-C 113.712 1.005 . . . . 0.0 113.712 -177.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.33 -87.57 1.2 Allowed Glycine 0 CA--C 1.523 0.577 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 -171.023 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 51.8 m-20 -125.7 160.38 29.87 Favored 'General case' 0 C--O 1.234 0.272 0 CA-C-O 122.46 1.124 . . . . 0.0 110.905 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 25.4 m -154.12 159.35 41.43 Favored 'General case' 0 CA--C 1.518 -0.252 0 CA-C-O 122.065 0.936 . . . . 0.0 111.651 166.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 99.1 m-85 -140.55 127.96 21.28 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 125.299 1.44 . . . . 0.0 108.114 -179.171 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -112.46 108.93 26.77 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 126.212 1.805 . . . . 0.0 107.011 -169.801 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 25.6 t -106.65 135.56 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.367 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -171.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 47.9 t -129.56 92.17 1.73 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.225 0 C-N-CA 126.156 1.782 . . . . 0.0 107.236 -174.695 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.97 171.19 17.46 Favored Glycine 0 C--N 1.335 0.512 0 N-CA-C 116.643 1.417 . . . . 0.0 116.643 179.144 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.69 113.52 13.09 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 126.061 1.744 . . . . 0.0 110.436 -171.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 44.07 -103.49 0.05 OUTLIER Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.078 1.799 . . . . 0.0 114.116 179.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -66.01 -17.03 64.41 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 126.582 1.953 . . . . 0.0 115.727 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.5 pt20 -129.43 98.6 4.91 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 119.545 1.066 . . . . 0.0 110.554 -177.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -148.84 166.03 29.73 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 116.896 2.184 . . . . 0.0 116.896 -179.022 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.51 162.67 32.41 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.802 0 C-N-CA 129.931 3.293 . . . . 0.0 108.502 167.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.69 157.1 41.62 Favored 'General case' 0 CA--C 1.536 0.442 0 O-C-N 121.236 -0.915 . . . . 0.0 112.102 172.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 42.7 t-80 -139.35 151.31 46.26 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.323 1.049 . . . . 0.0 111.684 173.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -92.47 160.64 14.97 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.232 1.413 . . . . 0.0 112.757 178.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -147.51 154.38 40.68 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.571 1.548 . . . . 0.0 112.053 158.064 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 75.2 m-70 -139.69 114.65 9.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.842 1.657 . . . . 0.0 108.685 -171.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.5 ptmt -151.19 108.21 3.56 Favored 'General case' 0 N--CA 1.473 0.725 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -165.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.9 p 52.41 70.68 0.54 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 128.796 2.838 . . . . 0.0 113.784 174.414 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 114.83 24.63 4.22 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 125.571 1.557 . . . . 0.0 113.541 175.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.9 t -56.91 155.25 8.22 Favored 'General case' 0 C--O 1.232 0.166 0 C-N-CA 125.341 1.456 . . . . 0.0 112.668 177.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.6 m -51.05 -25.1 4.44 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.324 1.449 . . . . 0.0 112.761 161.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -93.01 -4.47 10.78 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.866 0 C-N-CA 126.332 1.853 . . . . 0.0 112.849 177.454 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 95.11 5.79 60.58 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.636 1.415 . . . . 0.0 116.636 171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 1.5 ptmm? . . . . . 0 C--O 1.249 1.045 0 CA-C-N 119.483 1.642 . . . . 0.0 113.858 176.506 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 95.5 mt . . . . . 0 N--CA 1.481 1.122 0 N-CA-C 108.692 -0.855 . . . . 0.0 108.692 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 46.3 t -145.62 149.66 34.93 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.392 1.077 . . . . 0.0 111.018 175.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -115.11 106.14 13.75 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 126.71 2.004 . . . . 0.0 110.094 176.221 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 70.1 m-85 -78.14 -24.15 47.5 Favored 'General case' 0 CA--C 1.538 0.512 0 N-CA-C 115.152 1.538 . . . . 0.0 115.152 -163.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 2.2 pm0 -70.74 -39.11 73.51 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 124.258 1.023 . . . . 0.0 112.918 -177.487 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 88.0 mt -73.55 -5.68 41.74 Favored 'General case' 0 CA--C 1.541 0.624 0 N-CA-C 113.869 1.063 . . . . 0.0 113.869 -179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 30.9 mmtm -71.09 -15.58 62.53 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 115.16 1.541 . . . . 0.0 115.16 -165.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 74.52 84.93 0.3 Allowed Glycine 0 CA--C 1.536 1.344 0 CA-C-N 120.174 1.352 . . . . 0.0 114.685 170.539 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 35.9 p -89.4 18.28 5.4 Favored 'General case' 0 N--CA 1.478 0.942 0 C-N-CA 126.292 1.837 . . . . 0.0 113.833 177.179 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.5 t -62.16 -12.02 17.54 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.827 1.788 . . . . 0.0 115.827 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 18.8 m-85 -132.23 170.88 14.4 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.563 1.945 . . . . 0.0 108.78 169.625 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -83.09 161.99 40.14 Favored Glycine 0 CA--C 1.538 1.505 0 O-C-N 121.471 -0.768 . . . . 0.0 113.396 174.251 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.284 8.6 p -72.51 91.32 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-O 123.269 1.509 . . . . 0.0 113.626 -172.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -145.67 163.1 35.92 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 127.281 2.232 . . . . 0.0 109.195 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 66.6 p -160.03 -44.57 0.05 OUTLIER 'General case' 0 N--CA 1.47 0.541 0 C-N-CA 124.594 1.158 . . . . 0.0 110.774 173.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 32.2 ttpt 64.46 -70.62 0.08 Allowed 'General case' 0 N--CA 1.466 0.327 0 C-N-CA 128.227 2.611 . . . . 0.0 112.515 177.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -100.81 78.6 1.97 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.328 1.051 . . . . 0.0 112.228 -161.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 46.5 m-85 -134.29 154.98 51.0 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 124.125 0.97 . . . . 0.0 111.346 169.668 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -146.05 143.88 29.69 Favored 'General case' 0 N--CA 1.473 0.681 0 C-N-CA 126.551 1.94 . . . . 0.0 109.617 165.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 17.2 m-85 -61.88 129.82 42.77 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 123.851 0.86 . . . . 0.0 111.17 167.068 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -108.71 -51.13 2.92 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.603 1.561 . . . . 0.0 109.39 177.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.56 104.48 0.69 Allowed Glycine 0 C--N 1.339 0.701 0 C-N-CA 125.861 1.695 . . . . 0.0 109.137 177.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 17.9 p -64.15 157.29 70.91 Favored Pre-proline 0 CA--C 1.543 0.698 0 CA-C-N 117.927 0.864 . . . . 0.0 112.365 -175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -51.88 141.09 46.84 Favored 'Trans proline' 0 C--N 1.352 0.721 0 C-N-CA 123.554 2.836 . . . . 0.0 115.621 -170.173 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -132.95 122.91 24.98 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.413 1.485 . . . . 0.0 110.019 167.126 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 4.2 t70 -64.19 123.18 18.42 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 123.888 0.875 . . . . 0.0 110.504 177.947 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 74.6 p -72.94 -13.74 61.31 Favored 'General case' 0 N--CA 1.467 0.41 0 C-N-CA 123.997 0.919 . . . . 0.0 112.64 178.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.88 -8.93 2.17 Favored Glycine 0 CA--C 1.537 1.443 0 CA-C-N 119.046 0.839 . . . . 0.0 114.14 -166.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.6 m80 -89.59 11.26 20.16 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.737 1.615 . . . . 0.0 111.586 178.203 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 91.64 12.87 58.95 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 124.861 1.22 . . . . 0.0 113.836 -175.004 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.4 p -131.01 163.39 27.69 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-N 118.835 1.317 . . . . 0.0 112.497 -177.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -115.82 123.41 71.13 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 126.176 1.79 . . . . 0.0 107.765 164.071 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.57 124.72 37.38 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.444 0 N-CA-C 108.981 -0.748 . . . . 0.0 108.981 162.089 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -136.92 146.82 45.92 Favored 'General case' 0 N--CA 1.468 0.45 0 C-N-CA 124.686 1.194 . . . . 0.0 110.682 169.583 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -116.99 135.28 53.82 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 124.094 0.958 . . . . 0.0 111.073 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 7.7 mt -117.17 161.09 20.02 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.29 1.436 . . . . 0.0 109.838 172.013 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -120.34 139.54 52.61 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.246 1.019 . . . . 0.0 109.781 163.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 23.3 t80 -90.59 93.32 9.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.521 1.128 . . . . 0.0 109.827 -177.081 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.5 p -72.72 32.21 0.06 Allowed 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 127.88 2.472 . . . . 0.0 115.08 -165.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -173.42 178.57 45.3 Favored Glycine 0 CA--C 1.527 0.789 0 CA-C-O 122.777 1.209 . . . . 0.0 116.055 -172.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -84.37 -24.96 29.47 Favored 'General case' 0 N--CA 1.467 0.407 0 C-N-CA 128.092 2.557 . . . . 0.0 115.655 -169.573 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -153.25 173.61 15.34 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.091 0.956 . . . . 0.0 111.744 -153.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . 0.447 ' H ' ' HD3' ' A' ' 44' ' ' PRO . . . 118.85 50.88 0.31 Allowed Glycine 0 CA--C 1.541 1.691 0 CA-C-O 117.131 -1.927 . . . . 0.0 116.301 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . 0.447 ' HD3' ' H ' ' A' ' 43' ' ' GLY . 36.2 Cg_exo -54.69 87.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.026 0 CA-C-N 121.628 2.714 . . . . 0.0 112.089 160.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 79.3 m -149.76 169.54 20.83 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.56 1.144 . . . . 0.0 112.671 -167.378 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -91.26 92.98 8.87 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 124.785 1.234 . . . . 0.0 109.889 179.806 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -59.51 119.81 43.13 Favored Pre-proline 0 N--CA 1.475 0.79 0 C-N-CA 123.882 0.873 . . . . 0.0 112.87 -170.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -76.75 88.24 1.4 Allowed 'Trans proline' 0 N--CA 1.452 -0.917 0 C-N-CA 123.358 2.705 . . . . 0.0 109.985 169.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.2 tt -123.86 144.1 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.407 0 C-N-CA 125.4 1.48 . . . . 0.0 108.567 167.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 43.8 t -154.59 167.85 28.73 Favored 'General case' 0 CA--C 1.542 0.636 0 N-CA-C 113.576 0.954 . . . . 0.0 113.576 -166.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.2 t -142.27 125.64 16.6 Favored 'General case' 0 C--O 1.237 0.416 0 C-N-CA 127.53 2.332 . . . . 0.0 109.877 177.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.447 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.3 m -139.24 167.71 19.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 124.239 1.016 . . . . 0.0 113.657 -178.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -98.19 -11.56 22.61 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -172.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.7 m -155.32 36.05 0.38 Allowed 'General case' 0 N--CA 1.475 0.792 0 O-C-N 120.036 -1.665 . . . . 0.0 112.128 -179.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.17 10.03 1.14 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 127.288 2.235 . . . . 0.0 114.723 -174.795 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 7.7 p-10 -68.78 46.28 0.05 Allowed 'General case' 0 CA--C 1.549 0.937 0 C-N-CA 129.575 3.15 . . . . 0.0 113.906 178.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.447 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.6 t70 -66.25 -2.46 4.37 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 -166.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.65 -12.15 2.66 Favored 'General case' 0 CA--C 1.546 0.796 0 C-N-CA 124.553 1.141 . . . . 0.0 113.672 159.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 84.6 m -155.0 99.82 2.35 Favored Pre-proline 0 CA--C 1.536 0.409 0 O-C-N 120.304 -1.497 . . . . 0.0 109.468 179.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 71.7 Cg_exo -48.61 126.84 15.08 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 124.293 3.329 . . . . 0.0 112.619 172.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 47.9 t -107.49 -34.02 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 C-N-CA 124.642 1.177 . . . . 0.0 110.387 -179.892 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.48 -170.07 40.58 Favored Glycine 0 CA--C 1.533 1.182 0 C-N-CA 125.181 1.372 . . . . 0.0 111.15 161.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.5 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.3 ptp85 -134.99 171.99 13.65 Favored 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 125.208 1.403 . . . . 0.0 111.997 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.412 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -90.32 124.25 34.75 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 126.415 1.886 . . . . 0.0 107.452 168.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 53.8 t -95.69 -53.84 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 118.468 0.576 . . . . 0.0 111.088 -171.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 21.5 m -59.58 -41.3 89.94 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 113.374 0.879 . . . . 0.0 113.374 -174.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.1 p -154.63 150.08 12.04 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 123.946 0.899 . . . . 0.0 109.786 179.174 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 55.9 m-80 -68.75 147.46 97.93 Favored Pre-proline 0 CA--C 1.551 0.984 0 O-C-N 122.178 -0.326 . . . . 0.0 110.133 170.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 96.5 Cg_endo -78.96 76.82 4.35 Favored 'Trans proline' 0 CA--C 1.542 0.878 0 C-N-CA 123.314 2.676 . . . . 0.0 113.54 -160.488 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -143.35 124.99 14.91 Favored 'General case' 0 CA--C 1.54 0.572 0 O-C-N 121.168 -0.957 . . . . 0.0 111.129 175.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 22.1 t -86.53 91.39 3.37 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.364 0 C-N-CA 125.253 1.421 . . . . 0.0 107.228 177.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.1 t -57.67 -28.28 63.63 Favored 'General case' 0 N--CA 1.467 0.397 0 N-CA-C 114.984 1.475 . . . . 0.0 114.984 -171.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 4.7 m -151.53 158.76 4.45 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 126.262 1.825 . . . . 0.0 111.898 -163.002 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -64.43 -24.02 67.48 Favored 'General case' 0 CA--C 1.543 0.68 0 C-N-CA 124.395 1.078 . . . . 0.0 112.858 170.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -63.68 0.66 0.74 Allowed 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 129.694 3.197 . . . . 0.0 114.503 179.824 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -70.97 8.98 0.77 Allowed 'General case' 0 CA--C 1.546 0.799 0 C-N-CA 125.83 1.652 . . . . 0.0 115.072 -177.484 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -61.63 18.26 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.167 0 C-N-CA 130.648 3.579 . . . . 0.0 116.022 -169.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -81.09 174.98 11.06 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 127.903 2.481 . . . . 0.0 114.43 -171.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.5 97.72 5.14 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.131 2.572 . . . . 0.0 107.13 170.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.4 p -145.02 119.03 2.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.76 0 N-CA-C 113.991 1.108 . . . . 0.0 113.991 -148.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 4.2 mt -59.44 142.38 52.52 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.001 1.72 . . . . 0.0 112.432 172.459 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 59.2 mt -136.8 148.0 26.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.61 0 C-N-CA 127.571 2.348 . . . . 0.0 108.377 177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.6 mt-10 -99.19 139.5 34.75 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.354 1.062 . . . . 0.0 111.724 161.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.0 mp -122.3 165.78 15.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 127.42 2.288 . . . . 0.0 109.55 166.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.5 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 7.9 tt0 -95.57 116.93 66.66 Favored Pre-proline 0 CA--C 1.548 0.9 0 C-N-CA 124.642 1.177 . . . . 0.0 109.425 170.793 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 44.9 Cg_endo -98.35 107.14 0.07 OUTLIER 'Trans proline' 0 CA--C 1.55 1.293 1 C-N-CA 125.856 4.371 . . . . 0.0 112.349 -179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_exo -45.76 150.89 1.44 Allowed 'Trans proline' 0 C--N 1.354 0.821 0 C-N-CA 124.046 3.164 . . . . 0.0 115.167 174.19 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -81.71 162.16 23.09 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 123.686 0.795 . . . . 0.0 112.632 -177.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.11 -88.02 0.88 Allowed Glycine 0 CA--C 1.527 0.801 0 N-CA-C 109.236 -1.546 . . . . 0.0 109.236 -162.875 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -116.65 148.08 41.33 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.995 1.318 . . . . 0.0 110.412 175.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -139.58 106.83 5.5 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.497 1.119 . . . . 0.0 109.376 -178.067 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -110.12 129.16 55.74 Favored 'General case' 0 N--CA 1.464 0.227 0 O-C-N 121.438 -0.789 . . . . 0.0 110.34 179.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.0 mm -116.16 111.7 36.48 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 C-N-CA 126.378 1.871 . . . . 0.0 107.917 -168.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 26.0 t -119.08 135.42 59.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.461 0 C-N-CA 123.852 0.861 . . . . 0.0 110.118 -160.732 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -136.22 100.15 2.27 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.316 0 C-N-CA 126.04 1.736 . . . . 0.0 108.525 -168.058 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 132.97 -175.61 19.97 Favored Glycine 0 CA--C 1.527 0.801 0 CA-C-O 122.242 0.912 . . . . 0.0 114.959 173.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 4.6 ptm85 -138.85 141.09 38.64 Favored 'General case' 0 N--CA 1.468 0.449 0 C-N-CA 126.374 1.87 . . . . 0.0 109.789 -169.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 16.28 -87.68 0.0 OUTLIER Glycine 0 CA--C 1.534 1.269 0 C-N-CA 128.213 2.816 . . . . 0.0 116.255 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.1 pm0 -70.06 -20.39 63.23 Favored 'General case' 0 CA--C 1.542 0.649 0 N-CA-C 116.496 2.036 . . . . 0.0 116.496 -176.673 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -139.51 96.7 3.13 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 125.424 1.49 . . . . 0.0 110.382 -175.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -144.74 159.06 43.46 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 114.167 1.173 . . . . 0.0 114.167 178.318 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -134.48 164.07 35.16 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 127.852 2.461 . . . . 0.0 108.519 166.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.0 p30 -148.91 160.75 42.98 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 123.836 0.854 . . . . 0.0 109.74 166.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.0 t-80 -136.16 167.45 21.25 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.303 1.041 . . . . 0.0 109.93 166.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 4.8 p80 -120.86 161.47 21.47 Favored 'General case' 0 C--O 1.235 0.336 0 C-N-CA 124.93 1.292 . . . . 0.0 112.426 -170.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -151.33 157.65 42.77 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 128.927 2.891 . . . . 0.0 109.734 165.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -145.06 148.14 33.35 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 124.234 1.014 . . . . 0.0 109.017 172.533 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.7 pttm -153.05 116.83 4.76 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 123.754 0.821 . . . . 0.0 112.088 178.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 94.7 p 119.68 -0.22 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 131.146 3.778 . . . . 0.0 114.38 159.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.19 43.45 0.72 Allowed Glycine 0 CA--C 1.529 0.951 0 C-N-CA 124.751 1.167 . . . . 0.0 111.687 -176.224 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 14.3 t -88.32 -154.77 0.29 Allowed 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 126.497 1.919 . . . . 0.0 112.313 -173.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 97.5 p -46.95 -31.38 3.13 Favored 'General case' 0 N--CA 1.471 0.617 0 C-N-CA 128.374 2.669 . . . . 0.0 116.577 -167.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.3 mm -112.77 11.23 8.3 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 C-N-CA 125.299 1.44 . . . . 0.0 111.767 179.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 80.83 34.43 27.55 Favored Glycine 0 CA--C 1.533 1.211 0 O-C-N 120.46 -1.4 . . . . 0.0 113.604 -178.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.9 tptp . . . . . 0 C--O 1.249 1.041 0 C-N-CA 125.969 1.708 . . . . 0.0 112.499 -168.837 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 24.9 pt . . . . . 0 N--CA 1.48 1.06 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -147.77 173.54 12.7 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 112.523 0.564 . . . . 0.0 112.523 -177.211 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -138.29 -173.57 3.57 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 127.297 2.239 . . . . 0.0 110.454 175.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 46.4 m-85 -115.07 -53.41 2.63 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.446 -0.784 . . . . 0.0 110.955 175.435 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.5 pm0 -45.28 -53.03 8.92 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 127.969 2.508 . . . . 0.0 114.179 -177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 20.7 tp -59.73 -29.1 67.9 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 123.801 0.84 . . . . 0.0 113.057 -173.664 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 63.1 mttp -75.21 -14.78 60.56 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 124.93 1.292 . . . . 0.0 113.518 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -17.65 129.59 0.01 OUTLIER Glycine 0 CA--C 1.533 1.213 1 C-N-CA 130.986 4.136 . . . . 0.0 117.484 -175.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.9 m -62.82 68.96 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.626 0 C-N-CA 129.882 3.273 . . . . 0.0 113.569 -177.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.5 p -65.39 -22.3 66.77 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.783 2.033 . . . . 0.0 114.092 173.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -150.02 175.45 11.69 Favored 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 127.59 2.356 . . . . 0.0 109.521 177.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.79 143.25 38.0 Favored Glycine 0 CA--C 1.537 1.444 0 O-C-N 121.664 -0.647 . . . . 0.0 111.787 167.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.4 p -74.36 97.3 1.04 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.79 0 N-CA-C 114.072 1.138 . . . . 0.0 114.072 -167.561 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -160.01 173.33 16.02 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 124.949 1.3 . . . . 0.0 111.812 169.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 90.3 p -151.14 -22.49 0.21 Allowed 'General case' 0 N--CA 1.47 0.566 0 C-N-CA 124.794 1.237 . . . . 0.0 114.321 166.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 5.2 ttpm? 56.58 -62.41 0.02 OUTLIER 'General case' 0 N--CA 1.472 0.636 0 C-N-CA 129.974 3.31 . . . . 0.0 115.696 179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -131.89 74.9 1.61 Allowed 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.07 1.348 . . . . 0.0 111.471 -159.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 13.9 m-85 -109.43 160.5 16.14 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.122 1.369 . . . . 0.0 109.709 160.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.9 tttm -134.14 143.59 48.03 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.285 1.834 . . . . 0.0 108.106 163.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.6 m-85 -68.03 140.65 56.33 Favored 'General case' 0 CA--C 1.539 0.532 0 O-C-N 121.762 -0.586 . . . . 0.0 111.075 168.101 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -109.62 -57.05 2.23 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.61 1.164 . . . . 0.0 109.028 174.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -127.9 107.27 0.85 Allowed Glycine 0 C--N 1.336 0.561 0 C-N-CA 125.766 1.651 . . . . 0.0 110.466 -171.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 51.6 m -42.67 137.23 2.44 Favored Pre-proline 0 N--CA 1.47 0.559 0 C-N-CA 126.338 1.855 . . . . 0.0 111.21 170.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -57.89 152.15 52.28 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.299 2.0 . . . . 0.0 113.76 -175.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.61 121.86 13.91 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.228 1.411 . . . . 0.0 110.262 175.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -67.05 123.51 20.45 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 121.997 0.903 . . . . 0.0 110.804 179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 65.6 p -63.38 -16.7 61.27 Favored 'General case' 0 N--CA 1.466 0.335 0 C-N-CA 127.897 2.479 . . . . 0.0 114.352 179.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.93 -13.49 43.41 Favored Glycine 0 CA--C 1.535 1.288 0 CA-C-N 119.03 0.832 . . . . 0.0 113.174 -167.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 35.9 m80 -80.01 8.44 7.05 Favored 'General case' 0 CA--C 1.542 0.65 0 CA-C-N 118.698 1.249 . . . . 0.0 112.063 165.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 85.08 6.74 84.42 Favored Glycine 0 CA--C 1.53 0.978 0 CA-C-O 118.532 -1.149 . . . . 0.0 113.949 -179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.0 p -125.91 146.6 49.77 Favored 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 127.143 2.177 . . . . 0.0 110.091 -176.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.69 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.0 m -91.92 138.18 20.4 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.655 0 C-N-CA 124.105 0.962 . . . . 0.0 111.003 173.129 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.424 ' HB ' HD21 ' A' ' 81' ' ' LEU . 2.5 m -85.81 133.45 29.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.42 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 155.879 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.62 126.15 16.81 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 127.57 2.348 . . . . 0.0 109.043 -167.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -113.12 134.29 54.62 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-N 119.574 1.079 . . . . 0.0 113.471 -176.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.9 mp -128.29 174.27 9.44 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.814 1.645 . . . . 0.0 111.109 174.626 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.8 pt20 -135.67 139.44 43.72 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.431 1.092 . . . . 0.0 110.394 164.637 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 53.3 t80 -89.05 102.99 15.63 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 123.319 0.648 . . . . 0.0 110.039 178.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.9 p -80.39 -9.11 59.75 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 125.183 1.393 . . . . 0.0 113.535 -177.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -73.27 166.04 54.67 Favored Glycine 0 CA--C 1.533 1.173 0 CA-C-N 119.043 0.838 . . . . 0.0 113.394 173.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 26.4 m -118.95 11.76 12.62 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.862 1.665 . . . . 0.0 110.531 175.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -157.71 -178.6 7.45 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 127.913 2.485 . . . . 0.0 110.208 -156.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 81.98 58.98 2.38 Favored Glycine 0 CA--C 1.538 1.518 0 N-CA-C 117.255 1.662 . . . . 0.0 117.255 164.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -51.94 109.01 0.28 Allowed 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 122.936 2.424 . . . . 0.0 111.072 155.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -162.56 155.64 19.88 Favored 'General case' 0 CA--C 1.545 0.781 0 N-CA-C 113.872 1.064 . . . . 0.0 113.872 -164.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.0 tppt? -81.16 91.15 6.11 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.543 1.537 . . . . 0.0 109.482 178.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.2 p -58.35 116.19 14.07 Favored Pre-proline 0 N--CA 1.474 0.767 0 C-N-CA 123.938 0.895 . . . . 0.0 111.942 -178.763 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -78.37 82.22 2.52 Favored 'Trans proline' 0 CA--C 1.54 0.781 0 C-N-CA 123.21 2.607 . . . . 0.0 111.269 176.895 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.2 tt -105.96 145.0 14.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.645 0 C-N-CA 123.782 0.833 . . . . 0.0 109.766 167.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 48.1 t -154.03 170.33 21.38 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 125.152 1.381 . . . . 0.0 113.048 -171.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 38.8 t -144.31 117.16 8.77 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.445 2.298 . . . . 0.0 110.637 -175.539 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.512 HG11 ' HA ' ' A' ' 57' ' ' ASP . 13.9 m -140.72 169.31 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 C-N-CA 124.678 1.191 . . . . 0.0 112.945 -178.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.93 -3.51 21.68 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.58 1.326 . . . . 0.0 114.58 -173.192 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 71.8 m -154.78 30.84 0.41 Allowed 'General case' 0 N--CA 1.476 0.842 0 O-C-N 120.01 -1.681 . . . . 0.0 112.528 178.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 60.8 7.98 1.65 Allowed 'General case' 0 N--CA 1.479 0.982 0 C-N-CA 126.462 1.905 . . . . 0.0 114.286 -175.108 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 11.8 p-10 -69.52 46.48 0.07 Allowed 'General case' 0 CA--C 1.547 0.832 0 C-N-CA 129.875 3.27 . . . . 0.0 113.474 178.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.512 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.0 t0 -62.84 -7.42 5.05 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 115.962 1.838 . . . . 0.0 115.962 -163.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 73.8 mt -58.31 -23.54 56.8 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 125.252 1.421 . . . . 0.0 112.96 162.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 58.0 m -132.71 95.64 19.54 Favored Pre-proline 0 N--CA 1.468 0.467 0 C-N-CA 125.652 1.581 . . . . 0.0 109.407 -173.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -67.34 123.31 10.7 Favored 'Trans proline' 0 CA--C 1.537 0.657 0 C-N-CA 123.108 2.538 . . . . 0.0 110.916 -175.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.8 t -105.17 -22.35 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.984 0 C-N-CA 124.365 1.066 . . . . 0.0 111.181 -176.691 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -111.48 -170.23 18.86 Favored Glycine 0 CA--C 1.532 1.119 0 C-N-CA 126.938 2.208 . . . . 0.0 111.797 165.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.418 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.6 ptp85 -138.16 172.82 12.34 Favored 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 124.918 1.287 . . . . 0.0 112.59 -178.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -93.84 126.79 39.24 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 126.134 1.774 . . . . 0.0 106.809 167.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 75.6 t -98.63 -41.66 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.724 0 CA-C-O 118.681 -0.676 . . . . 0.0 111.62 -168.173 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -63.07 -50.29 71.14 Favored 'General case' 0 N--CA 1.474 0.754 0 CA-C-N 119.127 0.876 . . . . 0.0 113.319 -175.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 12.4 p -164.29 166.66 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 C-N-CA 124.335 1.054 . . . . 0.0 111.428 -165.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -55.06 123.5 48.07 Favored Pre-proline 0 CA--C 1.542 0.672 0 C-N-CA 123.872 0.869 . . . . 0.0 109.164 161.46 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -74.26 95.86 0.94 Allowed 'Trans proline' 0 CA--C 1.538 0.679 0 C-N-CA 122.081 1.854 . . . . 0.0 111.131 -174.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 12.6 p90 -146.46 142.84 28.52 Favored 'General case' 0 N--CA 1.469 0.484 0 O-C-N 121.398 -0.814 . . . . 0.0 112.612 167.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 12.2 t -79.59 95.86 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 126.858 2.063 . . . . 0.0 106.25 168.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 63.4 p -70.24 -22.1 62.93 Favored 'General case' 0 N--CA 1.469 0.499 0 N-CA-C 114.808 1.411 . . . . 0.0 114.808 -171.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 9.4 m -150.8 157.2 5.79 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.584 0 C-N-CA 125.853 1.661 . . . . 0.0 112.065 -170.178 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.59 -22.61 65.36 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 123.974 0.91 . . . . 0.0 113.275 171.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 15.8 p -78.56 8.11 5.75 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.6 1.96 . . . . 0.0 113.711 175.396 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.07 12.82 0.07 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 125.921 1.689 . . . . 0.0 115.357 179.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -65.38 18.04 0.02 OUTLIER 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 129.793 3.237 . . . . 0.0 115.243 -167.022 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -72.23 163.22 28.3 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.19 1.796 . . . . 0.0 113.389 -175.028 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.3 tmtt? -98.82 111.1 23.58 Favored 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 128.244 2.618 . . . . 0.0 106.045 159.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.72 140.3 30.79 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.534 0 C-N-CA 124.319 1.048 . . . . 0.0 112.62 -157.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.424 HD21 ' HB ' ' A' ' 33' ' ' VAL . 2.8 tm? -105.84 131.64 52.93 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 127.963 2.505 . . . . 0.0 109.536 -174.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 2.7 mp -129.95 155.12 41.27 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 C-N-CA 126.457 1.903 . . . . 0.0 109.522 -173.754 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 19.8 mp0 -109.0 132.25 54.29 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 125.644 1.578 . . . . 0.0 110.62 173.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.1 mp -126.57 160.71 29.85 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 125.857 1.663 . . . . 0.0 110.103 172.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.418 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 32.0 tt0 -101.62 104.58 35.46 Favored Pre-proline 0 CA--C 1.542 0.657 0 C-N-CA 124.167 0.987 . . . . 0.0 109.079 172.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.69 ' HG3' HG13 ' A' ' 32' ' ' VAL . 73.8 Cg_endo -83.38 118.35 2.56 Favored 'Trans proline' 0 CA--C 1.54 0.775 0 C-N-CA 124.274 3.316 . . . . 0.0 109.654 171.468 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -69.4 160.61 49.15 Favored 'Trans proline' 0 CA--C 1.538 0.717 0 C-N-CA 122.215 1.943 . . . . 0.0 111.082 173.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 88.2 m-85 -66.09 159.57 25.8 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 124.545 1.138 . . . . 0.0 112.645 179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 100.55 -148.23 18.24 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.581 1.086 . . . . 0.0 110.566 -169.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -65.04 146.0 55.59 Favored 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.68 -0.894 . . . . 0.0 109.048 152.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 5.0 m -135.37 100.56 4.56 Favored 'General case' 0 N--CA 1.469 0.505 0 C-N-CA 123.729 0.812 . . . . 0.0 109.621 -174.33 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 17.3 m-30 -109.08 132.62 53.94 Favored 'General case' 0 CA--C 1.531 0.234 0 CA-C-O 122.084 0.945 . . . . 0.0 111.025 -170.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.9 mm -114.01 99.33 8.37 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.177 0 C-N-CA 127.866 2.466 . . . . 0.0 107.151 -166.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 33.8 t -101.08 139.44 22.34 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 123.461 0.704 . . . . 0.0 109.483 -168.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 40.8 t -135.62 87.71 0.72 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.393 0 C-N-CA 125.29 1.436 . . . . 0.0 108.369 -175.935 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 166.83 168.52 29.14 Favored Glycine 0 CA--C 1.525 0.712 0 N-CA-C 118.243 2.057 . . . . 0.0 118.243 177.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.56 146.35 37.94 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 125.86 1.664 . . . . 0.0 109.512 168.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.25 -98.5 0.01 OUTLIER Glycine 0 CA--C 1.535 1.287 0 C-N-CA 126.398 1.951 . . . . 0.0 115.378 174.119 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 6.7 pm0 -90.11 -13.55 35.56 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.992 1.717 . . . . 0.0 114.317 -175.822 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.1 pt20 -120.49 90.36 3.31 Favored 'General case' 0 CA--C 1.531 0.219 0 C-N-CA 125.569 1.548 . . . . 0.0 109.291 -173.457 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -141.4 155.06 45.93 Favored 'General case' 0 C--N 1.342 0.264 0 N-CA-C 115.134 1.531 . . . . 0.0 115.134 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.73 166.8 6.81 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 129.178 2.991 . . . . 0.0 108.098 170.7 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -153.29 156.38 38.31 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 121.396 -0.815 . . . . 0.0 110.95 174.32 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -130.31 160.83 32.76 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 127.286 2.235 . . . . 0.0 109.231 173.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -138.38 144.88 40.46 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.839 0.456 . . . . 0.0 111.433 -168.013 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -143.67 169.94 16.78 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 125.935 1.694 . . . . 0.0 111.226 175.934 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 89.4 m-70 -136.29 117.24 14.23 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.077 1.751 . . . . 0.0 108.112 -174.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 80.3 tttt -141.03 87.32 2.09 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 124.225 1.01 . . . . 0.0 112.793 -165.011 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 44.9 m 54.65 63.62 2.09 Favored 'General case' 0 N--CA 1.471 0.609 0 C-N-CA 126.749 2.02 . . . . 0.0 113.521 168.336 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 138.57 12.68 0.78 Allowed Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.438 1.494 . . . . 0.0 114.101 179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.5 t -75.53 158.19 32.89 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.734 1.214 . . . . 0.0 112.961 -177.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 2.1 m -40.34 -33.94 0.29 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 130.326 3.45 . . . . 0.0 114.54 166.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 12.6 tt -85.21 -7.51 10.94 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.821 0 C-N-CA 124.358 1.063 . . . . 0.0 113.795 179.703 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 96.81 10.53 55.17 Favored Glycine 0 CA--C 1.536 1.369 0 CA-C-O 118.844 -0.975 . . . . 0.0 115.464 177.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 C-N-CA 125.104 1.362 . . . . 0.0 112.396 173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 40.5 mt . . . . . 0 N--CA 1.481 1.085 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -144.11 162.34 36.51 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 123.229 0.611 . . . . 0.0 111.676 177.251 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.18 -172.68 2.75 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 127.16 2.184 . . . . 0.0 110.773 172.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 24.5 m-85 -106.72 -57.68 2.03 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 121.518 -0.738 . . . . 0.0 110.702 177.787 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.8 pm0 -53.47 -34.41 57.86 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.579 2.352 . . . . 0.0 114.876 -172.126 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 6.9 tt -62.87 -22.03 66.4 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 119.364 0.984 . . . . 0.0 112.91 178.45 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.0 mptt -82.72 -2.49 54.37 Favored 'General case' 0 CA--C 1.544 0.719 0 C-N-CA 123.708 0.803 . . . . 0.0 112.698 174.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -20.07 113.74 0.01 OUTLIER Glycine 0 CA--C 1.532 1.102 1 C-N-CA 130.818 4.056 . . . . 0.0 116.64 -179.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.401 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 82.0 p -67.52 72.57 0.14 Allowed 'General case' 0 N--CA 1.473 0.689 0 C-N-CA 127.86 2.464 . . . . 0.0 113.897 -174.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.0 p -74.27 -19.89 60.33 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 126.021 1.728 . . . . 0.0 114.172 173.682 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 58.7 m-85 -145.66 170.53 16.29 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 126.981 2.112 . . . . 0.0 109.558 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -71.72 142.82 34.2 Favored Glycine 0 CA--C 1.535 1.305 0 C-N-CA 124.119 0.866 . . . . 0.0 112.588 173.576 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.1 p -67.41 103.54 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 C-N-CA 124.65 1.18 . . . . 0.0 112.607 -175.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -159.8 148.24 17.35 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 127.603 2.361 . . . . 0.0 109.064 -171.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 15.7 p -141.0 -21.9 0.78 Allowed 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 114.958 1.466 . . . . 0.0 114.958 176.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 77.5 tttt 45.36 -77.75 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 129.983 3.313 . . . . 0.0 115.328 174.521 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -119.81 80.41 1.58 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.577 1.551 . . . . 0.0 110.571 -163.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 10.1 m-85 -124.62 155.92 38.32 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.366 1.066 . . . . 0.0 110.684 169.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.5 tttm -143.85 146.81 33.31 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.839 1.656 . . . . 0.0 108.493 166.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 63.1 m-85 -69.43 140.28 54.08 Favored 'General case' 0 CA--C 1.539 0.543 0 O-C-N 121.761 -0.587 . . . . 0.0 111.27 168.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -106.58 -44.04 4.58 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 124.431 1.092 . . . . 0.0 109.812 168.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -141.62 117.01 1.15 Allowed Glycine 0 CA--C 1.527 0.839 0 C-N-CA 124.458 1.027 . . . . 0.0 112.419 -171.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 76.9 m -45.59 146.76 1.68 Allowed Pre-proline 0 N--CA 1.47 0.574 0 C-N-CA 127.934 2.494 . . . . 0.0 112.465 171.827 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 77.9 Cg_exo -49.95 135.79 36.4 Favored 'Trans proline' 0 C--N 1.355 0.89 0 C-N-CA 123.099 2.533 . . . . 0.0 113.467 177.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -127.77 111.54 13.77 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.025 1.73 . . . . 0.0 110.023 -178.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 46.6 t0 -59.31 122.06 12.97 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.33 1.452 . . . . 0.0 111.432 177.244 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 70.1 p -75.46 -11.33 60.01 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.58 -26.79 0.37 Allowed Glycine 0 CA--C 1.538 1.501 0 C-N-CA 124.779 1.18 . . . . 0.0 113.866 -168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.47 -9.74 57.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.518 2.327 . . . . 0.0 112.968 174.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 111.33 14.09 12.26 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 124.817 1.199 . . . . 0.0 114.595 -179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 56.3 p -128.43 171.14 12.34 Favored 'General case' 0 N--CA 1.472 0.647 0 C-N-CA 125.26 1.424 . . . . 0.0 111.567 179.432 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.5 m -128.82 120.21 51.61 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 C-N-CA 125.904 1.682 . . . . 0.0 109.087 171.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -88.59 133.74 30.11 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 174.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -135.08 130.23 35.22 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.346 1.858 . . . . 0.0 108.645 -172.146 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 28.2 tt0 -109.63 128.57 55.32 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 121.326 0.584 . . . . 0.0 112.388 -174.394 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 2.0 mt -121.52 167.97 12.25 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 125.001 1.321 . . . . 0.0 110.501 173.464 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 13.5 pt20 -127.41 142.45 51.42 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 124.658 1.183 . . . . 0.0 109.851 162.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 42.8 t80 -94.1 101.26 13.27 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.48 0.712 . . . . 0.0 109.906 177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 7.3 p -76.3 7.95 3.83 Favored 'General case' 0 N--CA 1.472 0.65 0 C-N-CA 127.101 2.16 . . . . 0.0 115.265 -169.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -130.56 169.76 21.26 Favored Glycine 0 CA--C 1.529 0.941 0 CA-C-N 119.66 1.118 . . . . 0.0 113.859 -177.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.0 p -103.12 -0.45 30.6 Favored 'General case' 0 N--CA 1.476 0.86 0 C-N-CA 126.323 1.849 . . . . 0.0 113.666 -179.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 12.9 p-10 -136.72 173.71 11.41 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 126.246 1.818 . . . . 0.0 112.33 -173.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 98.25 56.81 1.04 Allowed Glycine 0 CA--C 1.539 1.535 0 CA-C-O 117.823 -1.543 . . . . 0.0 116.719 172.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -50.17 99.18 0.04 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 123.29 2.66 . . . . 0.0 111.897 155.152 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 45.2 m -151.47 166.72 30.22 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 124.399 1.08 . . . . 0.0 112.548 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.401 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 3.7 ttmm -92.58 98.98 11.79 Favored 'General case' 0 N--CA 1.467 0.424 0 O-C-N 120.772 -1.205 . . . . 0.0 110.811 170.067 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -65.32 117.31 39.05 Favored Pre-proline 0 CA--C 1.543 0.688 0 C-N-CA 125.01 1.324 . . . . 0.0 111.353 174.665 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -83.53 85.62 1.47 Allowed 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 123.658 2.905 . . . . 0.0 111.565 176.461 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.0 tt -104.89 146.79 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 C-N-CA 123.937 0.895 . . . . 0.0 109.966 167.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.2 t -149.65 167.35 26.66 Favored 'General case' 0 CA--C 1.545 0.764 0 C-N-CA 125.01 1.324 . . . . 0.0 113.524 -167.056 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.4 t -142.66 107.55 4.9 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 127.284 2.233 . . . . 0.0 110.974 -175.306 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.45 HG11 ' HA ' ' A' ' 57' ' ' ASP . 20.9 m -136.15 163.72 33.46 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.059 0 N-CA-C 114.193 1.183 . . . . 0.0 114.193 -173.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.04 -7.46 16.92 Favored 'General case' 0 CA--C 1.54 0.566 0 N-CA-C 114.278 1.214 . . . . 0.0 114.278 -166.631 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 74.6 m -154.04 34.75 0.43 Allowed 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.385 -1.447 . . . . 0.0 111.368 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mt 57.71 12.77 1.73 Allowed 'General case' 0 CA--C 1.546 0.819 0 C-N-CA 126.7 2.0 . . . . 0.0 114.546 -173.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.405 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.9 p-10 -67.01 45.83 0.03 OUTLIER 'General case' 0 CA--C 1.547 0.865 0 C-N-CA 130.141 3.376 . . . . 0.0 114.345 179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.45 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.1 t70 -63.68 -9.2 12.77 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 115.884 1.809 . . . . 0.0 115.884 -165.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.1 pp -58.44 -10.36 2.1 Favored 'General case' 0 CA--C 1.547 0.833 0 C-N-CA 125.399 1.48 . . . . 0.0 114.218 162.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 41.4 m -155.49 118.86 2.41 Favored Pre-proline 0 N--CA 1.472 0.659 0 O-C-N 120.251 -1.531 . . . . 0.0 110.541 172.632 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 84.9 Cg_endo -68.3 141.32 51.34 Favored 'Trans proline' 0 CA--C 1.539 0.745 0 C-N-CA 123.214 2.609 . . . . 0.0 111.116 178.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.405 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.5 t -116.58 -34.27 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 C-N-CA 123.945 0.898 . . . . 0.0 110.967 -177.4 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -92.45 -167.43 39.56 Favored Glycine 0 CA--C 1.532 1.15 0 C-N-CA 124.846 1.212 . . . . 0.0 110.753 156.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.405 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 8.9 ptp85 -135.33 172.04 13.58 Favored 'General case' 0 N--CA 1.471 0.607 0 C-N-CA 124.916 1.286 . . . . 0.0 111.621 179.581 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -84.51 139.72 31.96 Favored 'General case' 0 CA--C 1.537 0.443 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 161.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.9 t -109.38 -49.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.784 0 C-N-CA 123.194 0.597 . . . . 0.0 110.754 -177.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 30.4 m -57.87 -43.58 86.1 Favored 'General case' 0 N--CA 1.475 0.81 0 N-CA-C 113.948 1.092 . . . . 0.0 113.948 -174.067 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.7 p -159.97 161.96 1.38 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-N 118.996 0.816 . . . . 0.0 111.061 -175.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 34.4 t-20 -57.64 117.45 18.95 Favored Pre-proline 0 CA--C 1.541 0.625 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 156.739 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -70.92 93.81 0.63 Allowed 'Trans proline' 0 N--CA 1.455 -0.768 0 C-N-CA 122.387 2.058 . . . . 0.0 111.783 -169.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 44.8 p90 -144.82 135.07 24.17 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 125.114 1.365 . . . . 0.0 111.276 168.162 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 15.1 t -69.11 89.65 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.463 0.212 0 C-N-CA 127.609 2.364 . . . . 0.0 107.151 172.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 3.3 m -63.38 -32.02 73.33 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 114.279 1.214 . . . . 0.0 114.279 -165.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 2.0 m -143.92 156.85 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 C-N-CA 126.983 2.113 . . . . 0.0 110.914 -171.427 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -62.04 -25.46 67.68 Favored 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 123.794 0.838 . . . . 0.0 112.436 169.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.32 4.66 5.48 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 127.057 2.143 . . . . 0.0 114.599 175.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -65.04 12.8 0.04 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.656 1.724 . . . . 0.0 115.656 179.709 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -62.75 13.46 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 130.924 3.69 . . . . 0.0 115.219 -169.318 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.91 173.89 10.62 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.593 1.957 . . . . 0.0 113.667 -171.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.5 tmtt? -117.0 108.84 16.25 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 129.615 3.166 . . . . 0.0 105.77 169.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -146.06 127.86 8.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.62 0 C-N-CA 123.632 0.773 . . . . 0.0 112.967 -154.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 10.2 mt -79.52 135.52 36.65 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.777 2.031 . . . . 0.0 110.911 170.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 8.2 mt -131.96 129.35 60.53 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.414 0 C-N-CA 127.089 2.155 . . . . 0.0 108.395 179.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -81.1 134.26 35.62 Favored 'General case' 0 C--O 1.239 0.504 0 CA-C-O 121.782 0.801 . . . . 0.0 111.667 170.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 10.8 mp -115.06 161.59 18.15 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 126.973 2.109 . . . . 0.0 109.38 162.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.405 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 22.7 tt0 -94.41 125.06 53.49 Favored Pre-proline 0 CA--C 1.544 0.715 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 167.407 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 94.2 Cg_endo -79.25 128.22 7.99 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 124.294 3.329 . . . . 0.0 111.036 174.703 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -69.7 168.68 20.79 Favored 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 121.299 1.333 . . . . 0.0 110.599 160.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -89.34 162.71 15.67 Favored 'General case' 0 CA--C 1.536 0.431 0 O-C-N 121.247 -0.908 . . . . 0.0 112.287 -175.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.08 -83.97 1.6 Allowed Glycine 0 CA--C 1.524 0.629 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 -172.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -117.97 170.01 9.18 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 122.313 1.054 . . . . 0.0 110.8 169.242 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 18.9 m -145.73 84.75 1.68 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 125.319 1.447 . . . . 0.0 108.881 177.598 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 78.9 m-85 -86.36 128.83 34.98 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 124.412 1.085 . . . . 0.0 109.048 174.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 48.2 mm -117.92 94.59 3.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 C-N-CA 125.978 1.711 . . . . 0.0 107.749 -164.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -99.46 145.08 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.435 0 C-N-CA 123.689 0.795 . . . . 0.0 109.915 -166.116 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -138.3 94.39 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.413 0 C-N-CA 125.535 1.534 . . . . 0.0 108.132 -174.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 167.73 167.67 28.74 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 119.262 2.465 . . . . 0.0 119.262 177.281 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -139.39 109.66 6.51 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.064 2.546 . . . . 0.0 109.274 178.586 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 46.43 -102.03 0.04 OUTLIER Glycine 0 CA--C 1.532 1.112 0 C-N-CA 125.792 1.663 . . . . 0.0 114.215 176.934 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.79 -18.97 62.74 Favored 'General case' 0 CA--C 1.539 0.525 0 C-N-CA 125.697 1.599 . . . . 0.0 115.151 -177.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -120.73 94.64 4.42 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.001 0.92 . . . . 0.0 108.913 178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -140.71 158.63 43.69 Favored 'General case' 0 N--CA 1.464 0.253 0 N-CA-C 114.273 1.212 . . . . 0.0 114.273 177.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -146.82 167.88 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.486 0 C-N-CA 128.754 2.822 . . . . 0.0 108.569 170.156 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -150.02 149.16 29.95 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.872 0.869 . . . . 0.0 110.805 174.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -122.27 163.39 19.74 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 126.994 2.117 . . . . 0.0 109.232 171.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.0 m80 -138.37 130.73 28.89 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 121.757 -0.59 . . . . 0.0 110.059 -161.349 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.19 165.7 28.4 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.352 1.061 . . . . 0.0 111.62 174.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -144.06 116.45 8.54 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.956 1.303 . . . . 0.0 109.423 -160.758 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 49.1 tttt -144.68 87.63 1.87 Allowed 'General case' 0 N--CA 1.473 0.684 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 -164.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 76.6 p 59.39 84.6 0.11 Allowed 'General case' 0 N--CA 1.472 0.663 0 C-N-CA 126.364 1.865 . . . . 0.0 113.81 169.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 108.36 23.84 6.46 Favored Glycine 0 CA--C 1.533 1.198 0 C-N-CA 125.759 1.647 . . . . 0.0 112.751 -175.415 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 40.4 t -58.42 162.86 3.42 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 126.021 1.728 . . . . 0.0 114.013 -175.383 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 17.4 m -56.37 -15.12 3.56 Favored 'General case' 0 CA--C 1.543 0.682 0 C-N-CA 124.28 1.032 . . . . 0.0 113.612 163.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 4.3 mp -113.45 3.38 8.17 Favored 'Isoleucine or valine' 0 CA--C 1.555 1.15 0 C-N-CA 126.181 1.792 . . . . 0.0 111.551 172.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 90.97 -11.5 71.93 Favored Glycine 0 CA--C 1.532 1.152 0 O-C-N 119.95 -1.719 . . . . 0.0 116.124 169.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.1 ptmm? . . . . . 0 C--O 1.249 1.04 0 CA-C-N 118.904 1.352 . . . . 0.0 113.094 171.174 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 66.4 mt . . . . . 0 N--CA 1.479 0.981 0 N-CA-C 110.121 -0.326 . . . . 0.0 110.121 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 6.7 t -69.05 -178.96 1.37 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.056 2.142 . . . . 0.0 113.197 178.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -129.38 155.76 45.14 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 128.506 2.722 . . . . 0.0 110.827 -163.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -88.66 -61.73 1.64 Allowed 'General case' 0 N--CA 1.467 0.389 0 O-C-N 121.454 -0.779 . . . . 0.0 111.757 -176.764 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 6.1 pm0 -60.04 -31.91 70.41 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.178 1.391 . . . . 0.0 113.938 -171.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -76.75 -4.97 46.14 Favored 'General case' 0 CA--C 1.544 0.723 0 C-N-CA 124.121 0.968 . . . . 0.0 112.997 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 24.9 mmtm -57.72 -31.44 66.44 Favored 'General case' 0 N--CA 1.473 0.715 0 N-CA-C 114.096 1.147 . . . . 0.0 114.096 -178.612 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.24 81.15 0.57 Allowed Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 -169.293 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -68.4 -6.64 25.67 Favored 'General case' 0 N--CA 1.475 0.777 0 C-N-CA 126.453 1.901 . . . . 0.0 114.81 -174.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.9 t -75.12 0.97 14.4 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 116.145 1.905 . . . . 0.0 116.145 -170.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 71.6 m-85 -141.76 154.08 45.01 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 119.877 1.217 . . . . 0.0 112.039 176.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.53 160.22 45.29 Favored Glycine 0 CA--C 1.536 1.404 0 C-N-CA 124.648 1.118 . . . . 0.0 112.708 170.545 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 8.0 p -77.38 95.11 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 122.641 1.21 . . . . 0.0 114.076 -167.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.8 p -159.62 171.28 19.89 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.95 1.7 . . . . 0.0 111.247 167.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 47.6 t -150.42 -3.22 0.36 Allowed 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 118.288 -0.863 . . . . 0.0 113.097 152.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 36.9 ttpt 53.98 -75.95 0.01 OUTLIER 'General case' 0 C--N 1.348 0.509 0 C-N-CA 128.191 2.597 . . . . 0.0 113.586 -176.312 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -92.33 74.34 5.3 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.18 1.792 . . . . 0.0 112.837 -163.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.1 m-85 -132.67 149.2 52.33 Favored 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.635 0.774 . . . . 0.0 111.124 166.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.1 tttm -138.31 141.25 39.78 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.775 1.63 . . . . 0.0 109.827 170.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -61.7 128.69 37.46 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.057 0.943 . . . . 0.0 110.603 165.348 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 40.4 tp -118.34 -26.23 6.33 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.063 0.945 . . . . 0.0 112.854 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.04 123.93 2.82 Favored Glycine 0 CA--C 1.525 0.701 0 C-N-CA 124.367 0.984 . . . . 0.0 111.037 177.359 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 82.0 p -62.54 144.2 95.86 Favored Pre-proline 0 N--CA 1.467 0.418 0 C-N-CA 125.162 1.385 . . . . 0.0 111.427 -178.9 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 34.7 Cg_exo -54.96 148.33 47.88 Favored 'Trans proline' 0 CA--C 1.539 0.729 0 C-N-CA 122.818 2.345 . . . . 0.0 115.142 179.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -141.38 128.15 20.41 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.723 1.609 . . . . 0.0 110.854 167.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -64.71 132.29 49.23 Favored 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 123.552 0.741 . . . . 0.0 111.048 178.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.6 p -78.77 -9.55 59.48 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 125.586 1.554 . . . . 0.0 113.944 -176.299 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.36 -2.84 9.08 Favored Glycine 0 CA--C 1.538 1.497 0 CA-C-N 119.21 0.913 . . . . 0.0 113.891 -167.825 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -103.39 5.9 37.44 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 125.94 1.696 . . . . 0.0 111.704 179.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 95.41 13.76 50.36 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 124.961 1.267 . . . . 0.0 114.083 -177.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.9 p -129.67 168.33 16.65 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 125.272 1.429 . . . . 0.0 111.565 -177.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -116.78 130.73 71.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 125.915 1.686 . . . . 0.0 108.37 164.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.1 m -83.28 124.77 39.87 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.374 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 160.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.02 154.2 49.33 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 124.645 1.178 . . . . 0.0 110.553 170.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -119.61 134.4 55.24 Favored 'General case' 0 N--CA 1.468 0.425 0 O-C-N 121.202 -0.936 . . . . 0.0 111.675 -169.44 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mp -124.77 163.13 22.77 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.159 0.984 . . . . 0.0 111.02 173.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.4 pt20 -126.55 137.11 53.31 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.796 1.239 . . . . 0.0 110.011 170.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 16.3 t80 -89.13 97.34 11.15 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.038 0.935 . . . . 0.0 110.373 -178.26 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 49.9 p -77.43 43.33 0.38 Allowed 'General case' 0 N--CA 1.473 0.705 0 C-N-CA 126.519 1.928 . . . . 0.0 113.688 -166.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . 178.56 -177.77 48.51 Favored Glycine 0 CA--C 1.531 1.06 0 O-C-N 121.071 -1.018 . . . . 0.0 114.869 -173.251 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 35.3 p -116.41 0.76 12.87 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 125.485 1.514 . . . . 0.0 114.295 -167.691 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.0 p-10 -145.96 173.8 11.84 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.421 1.489 . . . . 0.0 112.546 -169.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 108.53 48.24 0.87 Allowed Glycine 0 CA--C 1.546 2.01 0 N-CA-C 118.632 2.213 . . . . 0.0 118.632 166.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_exo -48.04 107.0 0.12 Allowed 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 123.574 2.849 . . . . 0.0 113.03 164.18 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 1.8 t -165.86 165.17 18.46 Favored 'General case' 0 CA--C 1.553 1.094 0 C-N-CA 123.348 0.659 . . . . 0.0 112.523 -164.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.95 91.35 6.57 Favored 'General case' 0 N--CA 1.48 1.039 0 O-C-N 120.365 -1.459 . . . . 0.0 111.49 179.407 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -52.75 114.34 5.64 Favored Pre-proline 0 N--CA 1.474 0.727 0 C-N-CA 125.908 1.683 . . . . 0.0 113.562 -173.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -77.82 84.58 1.96 Allowed 'Trans proline' 0 N--CA 1.454 -0.822 0 C-N-CA 123.114 2.543 . . . . 0.0 111.213 -178.413 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.5 tt -125.04 144.91 33.41 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 124.962 1.305 . . . . 0.0 109.531 169.378 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -146.74 162.11 39.22 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 124.811 1.245 . . . . 0.0 112.883 -172.215 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 22.9 t -142.0 110.88 6.23 Favored 'General case' 0 N--CA 1.466 0.371 0 C-N-CA 126.749 2.02 . . . . 0.0 110.164 176.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.421 HG11 ' HA ' ' A' ' 57' ' ' ASP . 18.4 m -140.01 170.46 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.864 0 C-N-CA 124.315 1.046 . . . . 0.0 111.95 -178.644 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -105.17 -4.63 21.55 Favored 'General case' 0 N--CA 1.472 0.675 0 N-CA-C 114.296 1.221 . . . . 0.0 114.296 -170.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.7 m -152.17 30.84 0.55 Allowed 'General case' 0 N--CA 1.47 0.564 0 O-C-N 120.142 -1.599 . . . . 0.0 111.906 178.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 55.84 25.4 8.46 Favored 'General case' 0 CA--C 1.551 0.996 0 C-N-CA 125.41 1.484 . . . . 0.0 112.394 -173.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.437 HD21 ' CG2' ' A' ' 61' ' ' VAL . 12.5 p-10 -91.61 50.99 1.79 Allowed 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 128.122 2.569 . . . . 0.0 112.201 -173.404 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.421 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.5 m-20 -56.29 -11.11 1.06 Allowed 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 116.324 1.972 . . . . 0.0 116.324 -172.483 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.94 -9.92 11.68 Favored 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 124.909 1.283 . . . . 0.0 114.359 164.428 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.4 m -149.06 95.62 3.84 Favored Pre-proline 0 CA--C 1.541 0.616 0 O-C-N 120.159 -1.588 . . . . 0.0 110.17 177.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_exo -53.53 86.98 0.03 OUTLIER 'Trans proline' 0 CA--C 1.541 0.864 1 C-N-CA 125.639 4.226 . . . . 0.0 115.883 177.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.437 ' CG2' HD21 ' A' ' 56' ' ' ASN . 2.1 t -67.66 -33.96 65.07 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.699 0 C-N-CA 124.03 0.932 . . . . 0.0 111.893 176.582 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -101.07 -161.56 27.52 Favored Glycine 0 CA--C 1.535 1.334 0 C-N-CA 126.427 1.965 . . . . 0.0 112.045 170.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.53 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.3 OUTLIER -146.96 177.69 8.94 Favored 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.09 1.756 . . . . 0.0 112.509 169.849 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -103.37 117.98 35.71 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 127.613 2.365 . . . . 0.0 107.604 171.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 84.7 t -90.51 -58.46 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 111.109 -168.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 86.0 m -59.01 -44.33 91.67 Favored 'General case' 0 N--CA 1.478 0.942 0 CA-C-N 118.593 0.633 . . . . 0.0 112.525 -173.338 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -145.44 139.3 21.8 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.252 0 N-CA-C 107.489 -1.301 . . . . 0.0 107.489 171.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -68.71 160.36 77.57 Favored Pre-proline 0 CA--C 1.557 1.221 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 159.302 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -75.6 77.41 3.33 Favored 'Trans proline' 0 CA--C 1.543 0.931 0 C-N-CA 123.062 2.508 . . . . 0.0 115.303 -156.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 19.3 p90 -145.71 127.34 15.18 Favored 'General case' 0 N--CA 1.47 0.528 0 O-C-N 120.495 -1.378 . . . . 0.0 114.592 154.763 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 34.7 t -80.31 100.74 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.305 0 C-N-CA 125.764 1.626 . . . . 0.0 106.889 166.511 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 12.3 t -77.86 -6.86 55.6 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 115.13 1.53 . . . . 0.0 115.13 -175.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.74 149.52 13.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.6 0 CA-C-N 119.504 1.047 . . . . 0.0 111.956 -170.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -63.95 -21.9 66.69 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 124.719 1.208 . . . . 0.0 113.061 170.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -70.12 0.32 6.38 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 128.183 2.593 . . . . 0.0 114.47 -178.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.34 10.0 0.14 Allowed 'General case' 0 CA--C 1.549 0.904 0 N-CA-C 115.551 1.686 . . . . 0.0 115.551 -177.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -61.09 13.23 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 131.475 3.91 . . . . 0.0 116.06 -166.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -79.18 168.53 19.47 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.375 1.87 . . . . 0.0 114.184 -169.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -103.52 109.09 20.63 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.304 2.642 . . . . 0.0 105.946 158.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.1 p -137.05 125.3 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.419 0 C-N-CA 124.017 0.927 . . . . 0.0 112.412 -159.39 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.2 mt -73.31 133.01 43.75 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.189 0.996 . . . . 0.0 109.447 166.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.5 mt -128.58 143.33 41.41 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.363 0 C-N-CA 126.131 1.772 . . . . 0.0 107.976 -178.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -98.4 137.21 37.44 Favored 'General case' 0 C--O 1.238 0.46 0 CA-C-O 121.76 0.791 . . . . 0.0 111.571 167.7 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.8 mp -121.83 164.31 17.7 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.01 2.124 . . . . 0.0 108.899 166.92 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.53 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 26.0 tt0 -100.39 107.18 46.79 Favored Pre-proline 0 CA--C 1.546 0.814 0 C-N-CA 124.922 1.289 . . . . 0.0 108.392 173.904 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -85.8 108.31 0.98 Allowed 'Trans proline' 0 CA--C 1.542 0.894 1 C-N-CA 126.581 4.854 . . . . 0.0 111.236 -176.093 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 78.2 Cg_endo -64.15 161.0 35.62 Favored 'Trans proline' 0 CA--C 1.539 0.74 0 C-N-CA 121.988 1.792 . . . . 0.0 110.77 175.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 26.7 m-85 -94.56 166.69 11.91 Favored 'General case' 0 CA--C 1.538 0.507 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 -162.021 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.8 -78.97 1.0 Allowed Glycine 0 CA--C 1.527 0.813 0 N-CA-C 109.747 -1.341 . . . . 0.0 109.747 -163.507 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -122.86 150.7 42.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.303 1.041 . . . . 0.0 110.184 172.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 1.1 m -136.86 97.9 3.64 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.693 1.197 . . . . 0.0 109.157 -177.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 86.8 m-85 -95.43 123.53 39.01 Favored 'General case' 0 C--O 1.235 0.328 0 C-N-CA 124.608 1.163 . . . . 0.0 109.933 178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 38.9 mm -115.98 98.43 6.8 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 126.982 2.113 . . . . 0.0 107.153 -166.435 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 24.0 t -105.22 139.8 25.18 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.65 0 C-N-CA 123.387 0.675 . . . . 0.0 109.91 -165.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 69.6 t -135.89 103.33 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 C-N-CA 125.766 1.626 . . . . 0.0 108.698 -175.508 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.438 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 145.68 172.36 15.99 Favored Glycine 0 C--N 1.335 0.506 0 N-CA-C 116.785 1.474 . . . . 0.0 116.785 172.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.5 ptm85 -132.75 143.63 49.73 Favored 'General case' 0 C--O 1.224 -0.257 0 C-N-CA 126.166 1.787 . . . . 0.0 109.875 -173.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 17.06 -91.1 0.01 OUTLIER Glycine 0 CA--C 1.535 1.333 0 C-N-CA 127.741 2.591 . . . . 0.0 116.354 -178.443 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -74.72 -15.3 60.78 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 127.203 2.201 . . . . 0.0 116.72 -176.305 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 11.1 pt20 -137.88 100.38 4.16 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 125.134 1.374 . . . . 0.0 110.747 -175.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.438 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.2 OUTLIER -142.65 160.73 39.73 Favored 'General case' 0 C--N 1.345 0.401 0 N-CA-C 115.033 1.494 . . . . 0.0 115.033 -178.497 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.97 165.96 11.79 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.6 0 C-N-CA 128.814 2.846 . . . . 0.0 108.3 175.753 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.0 p30 -149.64 167.6 25.93 Favored 'General case' 0 CA--C 1.534 0.351 0 O-C-N 120.973 -1.079 . . . . 0.0 110.613 166.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 33.4 t-80 -131.73 158.97 39.77 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.041 1.337 . . . . 0.0 109.052 163.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -112.59 160.17 18.12 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 125.239 1.416 . . . . 0.0 110.867 179.229 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.11 155.83 36.12 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 126.131 1.773 . . . . 0.0 109.212 168.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 12.5 m-70 -144.66 143.41 30.73 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 124.097 0.959 . . . . 0.0 108.753 -176.664 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 42.2 mttt -134.96 158.49 44.18 Favored 'General case' 0 N--CA 1.465 0.277 0 C-N-CA 125.487 1.515 . . . . 0.0 110.247 -179.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 68.9 p 67.96 -1.65 1.67 Allowed 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 116.376 1.991 . . . . 0.0 116.376 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 98.3 42.07 3.08 Favored Glycine 0 CA--C 1.532 1.125 0 CA-C-N 119.395 0.998 . . . . 0.0 112.35 -174.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 8.4 t -84.83 -144.59 0.09 Allowed 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 125.973 1.709 . . . . 0.0 111.934 -174.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 98.3 p -46.7 -46.36 20.08 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 126.59 1.956 . . . . 0.0 115.549 -166.601 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 45.2 mm -91.02 8.26 4.03 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.97 0 C-N-CA 125.539 1.536 . . . . 0.0 112.133 179.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.75 25.52 60.3 Favored Glycine 0 CA--C 1.533 1.197 0 O-C-N 120.248 -1.533 . . . . 0.0 112.848 -175.719 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 10.4 tptp . . . . . 0 C--O 1.247 0.944 0 C-N-CA 126.941 2.096 . . . . 0.0 111.881 -166.771 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 45.5 mt . . . . . 0 N--CA 1.479 1.019 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 26.7 t -147.07 150.31 34.79 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 124.093 0.957 . . . . 0.0 110.766 -168.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -134.39 173.88 11.14 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 127.859 2.464 . . . . 0.0 110.858 -177.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 61.5 t80 -91.93 -59.61 2.07 Favored 'General case' 0 CA--C 1.536 0.406 0 O-C-N 121.408 -0.807 . . . . 0.0 112.664 -175.55 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.1 pm0 -58.17 -36.78 73.55 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.787 1.235 . . . . 0.0 113.632 -168.197 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 25.9 tp -64.05 -15.56 59.77 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.538 1.135 . . . . 0.0 113.318 178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 36.7 mmtm -85.54 -11.11 54.91 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 118.291 -0.861 . . . . 0.0 113.293 177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 18.37 84.98 0.01 OUTLIER Glycine 0 CA--C 1.538 1.487 0 C-N-CA 130.139 3.733 . . . . 0.0 118.453 172.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 74.9 p -72.5 71.74 0.96 Allowed 'General case' 0 N--CA 1.475 0.79 0 O-C-N 121.102 -1.234 . . . . 0.0 111.839 172.088 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 31.8 p -78.36 -20.07 52.08 Favored 'General case' 0 N--CA 1.475 0.782 0 C-N-CA 125.118 1.367 . . . . 0.0 114.551 -178.329 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 5.4 t80 -156.25 -178.82 7.6 Favored 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.113 0.965 . . . . 0.0 111.592 -176.224 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -57.33 130.96 51.77 Favored Glycine 0 CA--C 1.534 1.277 0 C-N-CA 124.484 1.04 . . . . 0.0 112.663 173.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 12.4 p -68.82 102.44 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.469 0.487 0 C-N-CA 124.662 1.185 . . . . 0.0 111.93 -177.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -161.79 155.9 22.05 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 126.418 1.887 . . . . 0.0 110.008 -168.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 74.4 p -160.38 -41.35 0.05 OUTLIER 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 124.543 1.137 . . . . 0.0 111.223 173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.9 ttmt 65.65 -65.46 0.17 Allowed 'General case' 0 N--CA 1.469 0.484 0 C-N-CA 128.385 2.674 . . . . 0.0 113.333 174.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -114.74 79.0 1.21 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.445 1.098 . . . . 0.0 111.434 -161.086 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 16.9 m-85 -126.5 160.09 31.55 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.449 1.5 . . . . 0.0 110.09 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.4 tttm -142.23 147.68 36.91 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.85 1.66 . . . . 0.0 108.997 163.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -61.82 127.89 33.6 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.126 0.57 . . . . 0.0 110.99 167.485 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -99.55 -48.4 4.77 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 124.189 0.996 . . . . 0.0 108.988 168.524 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.97 105.69 0.68 Allowed Glycine 0 CA--C 1.525 0.704 0 C-N-CA 126.491 1.996 . . . . 0.0 109.748 174.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.2 p -57.96 156.31 20.01 Favored Pre-proline 0 CA--C 1.542 0.667 0 C-N-CA 123.627 0.771 . . . . 0.0 111.478 173.027 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 27.3 Cg_endo -63.76 141.87 80.62 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 121.951 1.767 . . . . 0.0 113.166 -165.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.46 119.8 14.78 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.367 1.467 . . . . 0.0 111.449 178.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . 0.407 ' N ' HG12 ' A' ' 32' ' ' VAL . 9.5 t0 -65.32 118.99 10.12 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 122.28 1.038 . . . . 0.0 110.56 179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 44.9 p -68.9 -22.86 64.15 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 127.712 2.405 . . . . 0.0 114.309 -178.16 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.44 -2.99 56.0 Favored Glycine 0 CA--C 1.539 1.583 0 CA-C-O 118.495 -1.169 . . . . 0.0 114.301 -160.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.9 m170 -69.53 -12.42 61.63 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 120.013 1.906 . . . . 0.0 111.296 162.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 105.16 -3.69 40.87 Favored Glycine 0 CA--C 1.535 1.341 0 C-N-CA 126.667 2.08 . . . . 0.0 113.155 -167.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 62.0 p -129.73 152.86 48.77 Favored 'General case' 0 N--CA 1.469 0.517 0 C-N-CA 126.795 2.038 . . . . 0.0 111.599 -166.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.634 HG13 ' HG3' ' A' ' 86' ' ' PRO . 1.2 m -93.64 126.06 46.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 C-N-CA 124.409 1.084 . . . . 0.0 110.327 172.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.2 m -78.43 136.66 23.52 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 N-CA-C 109.642 -0.503 . . . . 0.0 109.642 161.136 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.7 tt -141.81 131.48 24.11 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.084 2.154 . . . . 0.0 108.138 -175.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.5 tt0 -118.94 131.9 56.05 Favored 'General case' 0 C--O 1.236 0.356 0 CA-C-N 118.825 0.739 . . . . 0.0 112.04 176.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.4 mp -119.54 162.21 19.29 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.345 0.658 . . . . 0.0 110.703 170.387 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -115.51 129.55 56.58 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 124.849 1.259 . . . . 0.0 109.015 165.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 29.4 t80 -80.89 100.47 8.89 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.07 0.948 . . . . 0.0 109.392 175.028 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.4 p -78.39 -4.44 48.26 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 125.539 1.536 . . . . 0.0 114.624 -169.158 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -112.92 169.24 12.88 Favored Glycine 0 CA--C 1.527 0.829 0 CA-C-N 119.311 0.96 . . . . 0.0 114.697 -173.873 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.2 p -106.83 0.86 24.32 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 126.447 1.899 . . . . 0.0 113.244 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -138.49 -175.05 3.99 Favored 'General case' 0 CA--C 1.542 0.671 0 C-N-CA 126.115 1.766 . . . . 0.0 111.316 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 100.51 45.61 1.95 Allowed Glycine 0 CA--C 1.542 1.735 0 CA-C-O 116.892 -2.06 . . . . 0.0 117.523 174.61 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_exo -54.73 102.03 0.08 OUTLIER 'Trans proline' 0 CA--C 1.544 0.984 0 CA-C-N 122.057 2.928 . . . . 0.0 111.042 161.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 25.5 m -156.92 171.17 20.92 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.374 1.07 . . . . 0.0 112.624 -164.067 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -94.08 99.98 12.17 Favored 'General case' 0 N--CA 1.469 0.485 0 O-C-N 120.63 -1.294 . . . . 0.0 109.954 173.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -60.39 126.38 84.32 Favored Pre-proline 0 N--CA 1.477 0.9 0 C-N-CA 123.459 0.704 . . . . 0.0 112.603 -177.649 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -83.37 101.63 0.98 Allowed 'Trans proline' 0 CA--C 1.543 0.94 0 C-N-CA 123.711 2.941 . . . . 0.0 111.884 167.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.0 tt -133.47 146.55 31.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.56 0 C-N-CA 124.144 0.978 . . . . 0.0 109.855 165.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 41.6 t -148.76 160.67 42.97 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 113.592 0.96 . . . . 0.0 113.592 -163.096 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 33.0 t -138.19 116.7 12.07 Favored 'General case' 0 N--CA 1.47 0.555 0 C-N-CA 127.073 2.149 . . . . 0.0 110.218 175.105 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.487 HG11 ' HA ' ' A' ' 57' ' ' ASP . 15.6 m -134.62 164.57 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.556 1.142 . . . . 0.0 112.24 179.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -96.16 -10.18 28.82 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 -172.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 75.3 m -154.79 34.34 0.4 Allowed 'General case' 0 N--CA 1.476 0.843 0 O-C-N 120.085 -1.634 . . . . 0.0 112.625 -177.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.78 11.4 1.83 Allowed 'General case' 0 CA--C 1.548 0.889 0 C-N-CA 126.477 1.911 . . . . 0.0 113.958 -174.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.469 HD21 ' CG2' ' A' ' 61' ' ' VAL . 9.2 p-10 -69.83 51.32 0.11 Allowed 'General case' 0 CA--C 1.548 0.886 0 C-N-CA 129.032 2.933 . . . . 0.0 113.026 176.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' HA ' HG11 ' A' ' 52' ' ' VAL . 15.9 t0 -59.14 -16.38 19.58 Favored 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 125.839 1.655 . . . . 0.0 115.349 -165.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.4 pp -58.24 -8.86 1.23 Allowed 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 125.487 1.515 . . . . 0.0 114.876 169.202 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.4 m -155.13 104.57 2.25 Favored Pre-proline 0 N--CA 1.474 0.736 0 O-C-N 120.203 -1.561 . . . . 0.0 111.063 166.555 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 96.6 Cg_exo -45.42 115.69 1.06 Allowed 'Trans proline' 0 C--N 1.353 0.79 0 C-N-CA 125.164 3.909 . . . . 0.0 113.882 171.396 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.469 ' CG2' HD21 ' A' ' 56' ' ' ASN . 3.2 t -97.58 -22.32 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.187 0 C-N-CA 125.931 1.692 . . . . 0.0 111.501 179.825 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.96 -171.11 26.3 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.868 1.699 . . . . 0.0 111.041 163.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.93 176.78 7.95 Favored 'General case' 0 N--CA 1.467 0.422 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 176.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 4.6 mp -107.11 106.82 17.5 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 127.726 2.411 . . . . 0.0 106.374 175.762 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 64.3 t -78.41 -45.58 26.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 C-N-CA 123.734 0.813 . . . . 0.0 110.69 -166.529 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 53.1 m -69.78 -41.4 75.18 Favored 'General case' 0 N--CA 1.472 0.646 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -173.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.6 p -156.11 149.96 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-N 119.833 1.197 . . . . 0.0 113.54 -170.714 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 15.6 t30 -61.74 119.73 50.34 Favored Pre-proline 0 CA--C 1.549 0.917 0 C-N-CA 125.361 1.464 . . . . 0.0 109.762 162.569 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -71.34 90.22 0.68 Allowed 'Trans proline' 0 CA--C 1.544 1.024 0 C-N-CA 123.109 2.539 . . . . 0.0 113.69 -169.201 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 28.8 t80 -147.56 126.27 12.6 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 126.501 1.921 . . . . 0.0 111.515 177.787 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 23.5 t -89.3 88.84 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.621 0 C-N-CA 126.729 2.012 . . . . 0.0 108.263 175.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 21.4 t -70.6 -8.94 55.4 Favored 'General case' 0 CA--C 1.54 0.561 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -170.129 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -155.69 155.35 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 119.906 1.23 . . . . 0.0 112.287 -166.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -70.66 -19.71 62.77 Favored 'General case' 0 CA--C 1.544 0.722 0 C-N-CA 124.125 0.97 . . . . 0.0 112.698 167.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 31.0 p -77.54 9.79 3.08 Favored 'General case' 0 N--CA 1.472 0.664 0 C-N-CA 126.086 1.754 . . . . 0.0 113.133 175.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.63 10.23 0.2 Allowed 'General case' 0 CA--C 1.546 0.791 0 C-N-CA 126.302 1.841 . . . . 0.0 115.235 -178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -66.03 22.85 0.02 OUTLIER 'General case' 0 CA--C 1.554 1.097 0 C-N-CA 130.27 3.428 . . . . 0.0 115.139 -165.087 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.2 165.73 20.22 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.797 2.039 . . . . 0.0 114.183 -170.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.51 109.06 21.16 Favored 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 128.315 2.646 . . . . 0.0 106.269 160.993 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -132.33 121.85 46.78 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 C-N-CA 125.149 1.38 . . . . 0.0 111.964 -156.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -94.57 128.05 40.92 Favored 'General case' 0 CA--C 1.538 0.51 0 C-N-CA 128.056 2.542 . . . . 0.0 109.942 -178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 71.5 mt -132.69 129.53 58.58 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 127.228 2.211 . . . . 0.0 108.34 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 33.1 mt-10 -84.04 138.53 33.03 Favored 'General case' 0 CA--C 1.543 0.687 0 O-C-N 121.468 -0.77 . . . . 0.0 111.022 161.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 5.5 mp -120.94 157.59 29.55 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 127.285 2.234 . . . . 0.0 109.039 166.968 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.5 tt0 -97.73 109.68 51.96 Favored Pre-proline 0 CA--C 1.544 0.729 0 C-N-CA 124.193 0.997 . . . . 0.0 109.24 172.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.634 ' HG3' HG13 ' A' ' 32' ' ' VAL . 54.9 Cg_endo -93.03 116.64 0.32 Allowed 'Trans proline' 0 CA--C 1.548 1.209 0 C-N-CA 125.263 3.975 . . . . 0.0 110.287 170.88 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 79.9 Cg_exo -44.6 158.16 0.16 Allowed 'Trans proline' 0 CA--C 1.542 0.9 0 C-N-CA 124.163 3.242 . . . . 0.0 115.552 170.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 54.9 m-85 -75.52 161.15 29.42 Favored 'General case' 0 CA--C 1.533 0.31 0 O-C-N 121.16 -0.963 . . . . 0.0 112.502 175.715 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.65 -79.04 1.8 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 110.51 -1.036 . . . . 0.0 110.51 -170.026 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -136.52 158.44 44.43 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 124.492 1.117 . . . . 0.0 110.446 -174.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 20.5 m -158.87 156.84 30.33 Favored 'General case' 0 CA--C 1.521 -0.168 0 O-C-N 120.929 -1.107 . . . . 0.0 112.264 174.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -145.71 136.74 24.64 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 124.484 1.113 . . . . 0.0 109.089 178.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 37.5 mm -120.52 114.6 44.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 C-N-CA 126.301 1.841 . . . . 0.0 107.158 -168.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.4 t -113.72 141.31 30.14 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 C-N-CA 123.418 0.687 . . . . 0.0 109.849 -170.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -135.82 101.92 3.07 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.365 0 C-N-CA 127.171 2.188 . . . . 0.0 108.341 -173.009 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 137.43 177.49 15.15 Favored Glycine 0 N--CA 1.47 0.908 0 N-CA-C 116.655 1.422 . . . . 0.0 116.655 174.429 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -132.5 122.2 24.51 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.697 1.999 . . . . 0.0 110.632 -169.696 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.26 -99.84 0.01 OUTLIER Glycine 0 CA--C 1.532 1.107 0 C-N-CA 126.48 1.99 . . . . 0.0 114.807 175.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 4.0 pm0 -68.46 -14.28 62.89 Favored 'General case' 0 CA--C 1.542 0.658 0 C-N-CA 126.365 1.866 . . . . 0.0 115.758 -178.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -136.14 98.67 3.92 Favored 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 124.44 1.096 . . . . 0.0 111.197 -177.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -145.57 167.25 23.5 Favored 'General case' 0 N--CA 1.468 0.459 0 N-CA-C 115.157 1.54 . . . . 0.0 115.157 176.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.09 164.69 20.18 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 C-N-CA 128.648 2.779 . . . . 0.0 108.639 166.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.2 p30 -150.99 164.57 36.09 Favored 'General case' 0 CA--C 1.538 0.511 0 C-N-CA 123.464 0.706 . . . . 0.0 111.33 171.875 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 59.4 t-80 -143.57 136.57 27.66 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 125.296 1.438 . . . . 0.0 110.439 176.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -81.35 162.57 23.36 Favored 'General case' 0 CA--C 1.542 0.644 0 C-N-CA 124.629 1.172 . . . . 0.0 113.071 177.445 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -146.74 150.63 35.73 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 126.684 1.993 . . . . 0.0 111.007 161.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 67.7 m-70 -139.9 113.99 8.96 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.524 1.13 . . . . 0.0 108.156 -170.1 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 18.0 ptmt -149.95 81.68 1.38 Allowed 'General case' 0 N--CA 1.471 0.603 0 N-CA-C 113.621 0.971 . . . . 0.0 113.621 -165.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 38.5 t 69.16 70.8 0.26 Allowed 'General case' 0 N--CA 1.472 0.672 0 C-N-CA 126.756 2.023 . . . . 0.0 113.876 165.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 125.61 21.1 2.03 Favored Glycine 0 CA--C 1.536 1.368 0 C-N-CA 126.739 2.114 . . . . 0.0 113.17 -176.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 34.9 t -65.03 151.94 44.7 Favored 'General case' 0 CA--C 1.531 0.233 0 C-N-CA 126.501 1.92 . . . . 0.0 113.591 -173.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 29.7 t -61.59 -8.48 4.47 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 164.148 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 30.0 mm -104.22 -4.38 9.58 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.906 0 C-N-CA 127.019 2.128 . . . . 0.0 111.308 174.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 97.02 4.67 58.63 Favored Glycine 0 CA--C 1.535 1.294 0 O-C-N 120.628 -1.295 . . . . 0.0 116.207 171.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 116.987 -1.482 . . . . 0.0 112.962 173.907 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 3.6 mp . . . . . 0 N--CA 1.475 0.802 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -138.21 160.47 39.35 Favored 'General case' 0 N--CA 1.47 0.547 0 CA-C-N 119.159 0.89 . . . . 0.0 112.432 -179.07 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.73 145.32 50.64 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.131 2.173 . . . . 0.0 109.664 172.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 72.4 m-85 -73.28 -54.43 8.4 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 120.17 -1.581 . . . . 0.0 112.426 -172.148 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 5.8 pm0 -58.55 -29.8 66.63 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.902 1.681 . . . . 0.0 113.791 -170.872 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 42.9 tp -61.91 -28.73 69.73 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-N 119.176 0.898 . . . . 0.0 112.841 178.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.72 -19.42 62.05 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-O 117.425 -1.274 . . . . 0.0 113.388 174.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 9.46 105.65 0.0 OUTLIER Glycine 0 CA--C 1.536 1.398 0 C-N-CA 130.584 3.945 . . . . 0.0 117.559 176.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 45.1 p -68.82 73.53 0.26 Allowed 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.801 2.04 . . . . 0.0 113.602 179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 23.8 p -71.93 -18.64 62.0 Favored 'General case' 0 N--CA 1.471 0.623 0 C-N-CA 126.717 2.007 . . . . 0.0 114.676 168.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -156.16 176.31 12.84 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.382 1.473 . . . . 0.0 110.511 176.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -63.48 148.54 50.5 Favored Glycine 0 CA--C 1.536 1.402 0 C-N-CA 123.443 0.544 . . . . 0.0 112.496 168.469 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 6.2 p -80.08 97.32 2.89 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.617 0 C-N-CA 124.66 1.184 . . . . 0.0 112.544 -178.421 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 2.5 p -154.76 168.81 25.62 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.876 1.671 . . . . 0.0 111.193 166.365 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . 0.463 ' HB3' ' HA ' ' A' ' 47' ' ' VAL . 94.1 p -144.02 -30.43 0.48 Allowed 'General case' 0 N--CA 1.469 0.519 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 173.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.3 ttpt 59.2 -84.44 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 127.311 2.244 . . . . 0.0 112.536 177.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.36 83.19 3.24 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 124.128 0.971 . . . . 0.0 112.069 -167.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.0 m-85 -131.29 165.25 23.82 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 125.486 1.514 . . . . 0.0 111.587 169.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 27.3 tttm -151.05 155.11 38.33 Favored 'General case' 0 CA--C 1.547 0.85 0 C-N-CA 126.993 2.117 . . . . 0.0 109.627 166.512 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 61.0 m-85 -66.95 140.26 57.74 Favored 'General case' 0 N--CA 1.475 0.78 0 O-C-N 121.275 -0.89 . . . . 0.0 111.742 168.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -118.61 -38.57 3.11 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 124.112 0.965 . . . . 0.0 111.968 176.226 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -143.23 103.97 0.33 Allowed Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.211 1.386 . . . . 0.0 110.279 -175.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 2.7 m -47.74 138.09 9.65 Favored Pre-proline 0 CA--C 1.542 0.656 0 C-N-CA 127.125 2.17 . . . . 0.0 112.221 -177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -54.84 130.83 42.67 Favored 'Trans proline' 0 C--N 1.352 0.748 0 C-N-CA 123.015 2.477 . . . . 0.0 112.768 -179.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.05 119.95 28.98 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.167 1.387 . . . . 0.0 110.158 176.059 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.2 t70 -65.25 129.72 40.74 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.84 0.829 . . . . 0.0 111.032 179.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 72.3 p -78.18 -8.69 58.61 Favored 'General case' 0 C--N 1.331 -0.235 0 C-N-CA 127.077 2.151 . . . . 0.0 113.586 -173.793 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 73.63 -5.35 23.35 Favored Glycine 0 CA--C 1.535 1.326 0 CA-C-N 119.336 0.971 . . . . 0.0 113.945 -168.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 45.8 m80 -96.12 3.17 53.48 Favored 'General case' 0 CA--C 1.542 0.666 0 CA-C-N 118.812 1.306 . . . . 0.0 112.062 179.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 99.33 4.33 56.31 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.829 1.204 . . . . 0.0 113.941 -173.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 70.3 p -123.72 165.12 17.8 Favored 'General case' 0 N--CA 1.469 0.477 0 C-N-CA 125.255 1.422 . . . . 0.0 111.941 -174.974 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.429 HG13 ' HG3' ' A' ' 86' ' ' PRO . 2.4 m -110.15 140.66 28.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 C-N-CA 125.025 1.33 . . . . 0.0 109.543 162.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -91.06 125.33 43.82 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 123.8 0.84 . . . . 0.0 109.014 161.11 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -136.31 120.99 18.41 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 126.531 1.932 . . . . 0.0 109.208 -167.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -106.73 132.6 52.52 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 121.189 -0.944 . . . . 0.0 112.631 179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.5 mp -122.07 162.71 20.72 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.433 1.093 . . . . 0.0 110.462 170.048 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -117.66 134.27 55.07 Favored 'General case' 0 C--O 1.235 0.299 0 C-N-CA 124.157 0.983 . . . . 0.0 109.98 166.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.7 t80 -84.8 108.03 17.27 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.873 0.869 . . . . 0.0 109.668 172.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 22.9 p -82.92 -4.03 57.7 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -169.218 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -115.82 172.5 14.25 Favored Glycine 0 CA--C 1.532 1.137 0 CA-C-N 119.504 1.047 . . . . 0.0 114.718 -176.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 27.6 p -109.18 6.08 24.44 Favored 'General case' 0 N--CA 1.478 0.952 0 C-N-CA 126.209 1.804 . . . . 0.0 113.75 177.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.5 p-10 -138.71 176.14 8.95 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.757 1.623 . . . . 0.0 111.143 176.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 107.75 51.43 0.75 Allowed Glycine 0 CA--C 1.538 1.526 0 CA-C-O 117.288 -1.84 . . . . 0.0 117.168 167.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -54.21 111.12 0.62 Allowed 'Trans proline' 0 CA--C 1.542 0.878 0 CA-C-N 121.399 2.599 . . . . 0.0 110.646 162.845 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -167.83 165.95 13.77 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 124.175 0.99 . . . . 0.0 111.76 -168.071 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 24.2 mtpp -89.43 104.34 16.9 Favored 'General case' 0 N--CA 1.478 0.937 0 O-C-N 119.839 -1.788 . . . . 0.0 113.206 178.548 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.463 ' HA ' ' HB3' ' A' ' 15' ' ' SER . 1.2 p -58.03 117.78 22.05 Favored Pre-proline 0 CA--C 1.537 0.449 0 C-N-CA 124.577 1.151 . . . . 0.0 112.352 -177.121 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -79.35 82.61 2.46 Favored 'Trans proline' 0 N--CA 1.45 -1.039 0 C-N-CA 123.411 2.741 . . . . 0.0 109.827 179.051 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 19.3 tt -118.08 142.46 32.5 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.235 0 C-N-CA 123.833 0.853 . . . . 0.0 109.457 169.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.9 t -151.38 159.73 44.11 Favored 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 123.632 0.773 . . . . 0.0 113.046 -167.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.8 t -132.54 113.55 13.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 128.003 2.521 . . . . 0.0 108.955 176.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.562 HG11 ' HA ' ' A' ' 57' ' ' ASP . 35.5 m -133.75 170.24 20.23 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 C-N-CA 124.464 1.106 . . . . 0.0 111.688 178.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.08 -11.44 20.52 Favored 'General case' 0 CA--C 1.541 0.604 0 N-CA-C 114.478 1.288 . . . . 0.0 114.478 -171.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 64.1 m -152.03 33.2 0.53 Allowed 'General case' 0 N--CA 1.475 0.777 0 O-C-N 120.106 -1.621 . . . . 0.0 112.311 -176.882 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 59.93 10.15 2.04 Favored 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 126.455 1.902 . . . . 0.0 113.45 -173.129 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 17.6 p-10 -72.06 55.6 0.31 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 129.303 3.041 . . . . 0.0 112.589 178.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.562 ' HA ' HG11 ' A' ' 52' ' ' VAL . 4.8 t0 -63.07 -11.91 22.97 Favored 'General case' 0 CA--C 1.541 0.6 0 N-CA-C 115.624 1.713 . . . . 0.0 115.624 -165.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -62.55 -1.28 0.77 Allowed 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 126.471 1.909 . . . . 0.0 114.919 168.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 76.3 m -153.85 119.33 2.78 Favored Pre-proline 0 N--CA 1.473 0.692 0 O-C-N 119.916 -1.74 . . . . 0.0 110.651 168.199 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo -66.4 112.12 2.26 Favored 'Trans proline' 0 C--N 1.351 0.669 0 C-N-CA 123.508 2.805 . . . . 0.0 110.899 179.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 3.7 t -90.38 -27.15 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 C-N-CA 123.336 0.654 . . . . 0.0 110.825 -179.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.89 -161.98 18.98 Favored Glycine 0 CA--C 1.534 1.248 0 C-N-CA 127.383 2.421 . . . . 0.0 111.853 169.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.07 169.58 17.54 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 113.85 1.056 . . . . 0.0 113.85 177.613 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -97.61 96.58 8.39 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.502 1.921 . . . . 0.0 106.132 170.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 61.8 t -65.55 -49.95 74.9 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.593 0 C-N-CA 124.636 1.175 . . . . 0.0 111.678 -161.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 12.0 t -88.41 -17.37 30.63 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.77 1.767 . . . . 0.0 115.77 -165.52 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 6.6 p -159.99 150.14 6.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.691 0 CA-C-N 120.253 1.388 . . . . 0.0 111.631 -177.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 -57.48 134.49 81.95 Favored Pre-proline 0 CA--C 1.546 0.798 0 C-N-CA 123.673 0.789 . . . . 0.0 109.377 166.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -69.98 86.47 0.61 Allowed 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.137 2.558 . . . . 0.0 111.658 -176.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 22.1 t80 -152.91 112.96 3.96 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.602 1.561 . . . . 0.0 112.035 -167.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 11.4 t -72.85 92.91 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.414 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 164.253 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 35.1 p -73.41 -14.04 61.19 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 115.063 1.505 . . . . 0.0 115.063 -172.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -155.75 158.96 3.1 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.668 0 C-N-CA 124.13 0.972 . . . . 0.0 112.064 -173.487 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.66 -23.62 65.35 Favored 'General case' 0 CA--C 1.544 0.744 0 C-N-CA 124.18 0.992 . . . . 0.0 113.153 168.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 55.4 p -81.26 5.17 17.94 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.772 1.629 . . . . 0.0 113.812 176.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.31 22.37 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.99 0 C-N-CA 125.648 1.579 . . . . 0.0 114.882 178.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -66.09 21.12 0.02 OUTLIER 'General case' 0 CA--C 1.551 0.982 0 C-N-CA 130.875 3.67 . . . . 0.0 114.443 -169.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.64 157.15 20.41 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 125.983 1.713 . . . . 0.0 113.275 -164.577 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.34 105.94 17.04 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 127.429 2.291 . . . . 0.0 106.677 153.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.3 p -133.41 135.64 55.83 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.606 0 C-N-CA 124.503 1.121 . . . . 0.0 111.985 -165.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -102.81 118.56 37.1 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.209 2.603 . . . . 0.0 108.921 -172.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 58.8 mt -117.36 136.72 53.61 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 C-N-CA 126.452 1.901 . . . . 0.0 108.418 -174.608 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -88.68 137.95 31.86 Favored 'General case' 0 CA--C 1.535 0.4 0 O-C-N 122.017 -0.427 . . . . 0.0 111.821 163.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -122.48 160.36 25.71 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 126.351 1.86 . . . . 0.0 109.656 167.298 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -104.59 105.78 51.73 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.822 1.249 . . . . 0.0 108.857 170.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.429 ' HG3' HG13 ' A' ' 32' ' ' VAL . 55.6 Cg_endo -84.82 121.03 2.41 Favored 'Trans proline' 0 CA--C 1.542 0.899 0 C-N-CA 123.276 2.65 . . . . 0.0 109.437 160.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -62.31 166.5 12.87 Favored 'Trans proline' 0 CA--C 1.544 1.008 0 C-N-CA 121.88 1.72 . . . . 0.0 111.993 171.191 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -76.88 164.3 25.94 Favored 'General case' 0 CA--C 1.535 0.399 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 -172.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.8 -91.92 1.77 Allowed Glycine 0 C--N 1.337 0.592 0 N-CA-C 109.574 -1.41 . . . . 0.0 109.574 -168.953 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 54.6 m-20 -131.08 165.11 23.96 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.457 1.103 . . . . 0.0 110.764 177.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.0 m -156.92 163.27 39.34 Favored 'General case' 0 C--N 1.333 -0.128 0 O-C-N 121.069 -1.019 . . . . 0.0 111.784 170.357 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 75.4 m-85 -133.43 129.1 36.83 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 126.9 2.08 . . . . 0.0 108.214 176.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 41.5 mm -110.21 109.3 27.94 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 C-N-CA 126.17 1.788 . . . . 0.0 106.768 -175.509 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 21.2 t -110.96 138.53 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.379 0 C-N-CA 123.667 0.787 . . . . 0.0 109.167 -167.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 98.8 t -133.14 89.38 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 C-N-CA 126.85 2.06 . . . . 0.0 106.725 -172.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.462 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 161.02 157.44 8.75 Favored Glycine 0 C--N 1.336 0.529 0 N-CA-C 117.314 1.686 . . . . 0.0 117.314 -176.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.6 ptm85 -123.23 122.77 39.21 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 125.913 1.685 . . . . 0.0 109.395 179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 32.42 -94.83 0.01 OUTLIER Glycine 0 CA--C 1.533 1.167 0 C-N-CA 127.304 2.383 . . . . 0.0 115.385 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -69.53 -18.73 63.69 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.699 2.0 . . . . 0.0 116.161 -176.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -130.11 101.07 5.65 Favored 'General case' 0 N--CA 1.467 0.409 0 C-N-CA 124.189 0.996 . . . . 0.0 109.74 -179.15 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.462 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -141.12 155.92 46.04 Favored 'General case' 0 C--N 1.343 0.288 0 N-CA-C 114.611 1.337 . . . . 0.0 114.611 -179.646 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.23 160.26 35.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.57 0 C-N-CA 127.98 2.512 . . . . 0.0 107.758 169.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.5 p30 -152.95 156.42 38.86 Favored 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.139 -0.976 . . . . 0.0 111.719 179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -138.55 165.5 26.72 Favored 'General case' 0 CA--C 1.544 0.74 0 C-N-CA 127.682 2.393 . . . . 0.0 109.019 174.42 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 13.2 p80 -133.27 155.97 48.41 Favored 'General case' 0 N--CA 1.47 0.54 0 O-C-N 121.327 -0.858 . . . . 0.0 113.101 -172.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -141.75 151.93 43.34 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 125.494 1.518 . . . . 0.0 112.788 -175.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -146.58 108.4 4.35 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.565 1.546 . . . . 0.0 108.567 -163.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 17.2 ptmt -149.51 102.42 3.18 Favored 'General case' 0 N--CA 1.472 0.658 0 N-CA-C 115.057 1.502 . . . . 0.0 115.057 -162.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 46.9 t 61.9 62.17 1.28 Allowed 'General case' 0 N--CA 1.471 0.605 0 C-N-CA 126.417 1.887 . . . . 0.0 113.832 163.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.32 18.01 3.49 Favored Glycine 0 CA--C 1.533 1.194 0 C-N-CA 126.515 2.007 . . . . 0.0 112.835 -174.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.5 t -62.1 152.04 33.93 Favored 'General case' 0 C--O 1.232 0.14 0 C-N-CA 125.8 1.64 . . . . 0.0 112.293 179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 13.2 m -50.59 -24.79 3.51 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 126.845 2.058 . . . . 0.0 113.291 165.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 17.6 mm -84.12 -10.62 11.69 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.882 0 C-N-CA 124.956 1.303 . . . . 0.0 112.138 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.76 22.7 30.2 Favored Glycine 0 CA--C 1.535 1.301 0 O-C-N 121.003 -1.061 . . . . 0.0 114.396 -177.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 ptmm? . . . . . 0 C--O 1.246 0.92 0 C-N-CA 125.025 1.33 . . . . 0.0 113.435 178.709 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 53.7 mt . . . . . 0 N--CA 1.476 0.826 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 15.0 t -146.97 171.86 14.6 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 124.555 1.142 . . . . 0.0 111.625 -165.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.496 ' CD ' ' H ' ' A' ' 3' ' ' GLU . 20.9 mp0 -65.1 104.69 0.93 Allowed 'General case' 0 CA--C 1.536 0.431 1 C-N-CA 132.836 4.454 . . . . 0.0 111.179 -165.577 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 55.7 t80 -55.65 -57.35 12.32 Favored 'General case' 0 CA--C 1.538 0.515 0 N-CA-C 113.798 1.036 . . . . 0.0 113.798 -168.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 8.4 pm0 -72.22 -20.87 61.49 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.295 1.038 . . . . 0.0 113.727 -173.445 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 12.2 tp -80.65 -3.5 50.78 Favored 'General case' 0 CA--C 1.544 0.743 0 C-N-CA 123.943 0.897 . . . . 0.0 113.101 -171.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -67.0 22.27 0.02 OUTLIER 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 129.016 2.926 . . . . 0.0 115.267 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 42.75 69.0 0.67 Allowed Glycine 0 N--CA 1.472 1.061 0 C-N-CA 126.932 2.206 . . . . 0.0 114.293 177.227 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 56.7 p -41.19 -59.62 1.46 Allowed 'General case' 0 N--CA 1.473 0.724 0 C-N-CA 126.654 1.982 . . . . 0.0 113.91 -167.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 8.6 t -59.15 -3.93 0.45 Allowed 'General case' 0 N--CA 1.475 0.796 0 N-CA-C 117.801 2.519 . . . . 0.0 117.801 -168.502 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 63.1 m-85 -119.82 141.82 49.17 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-N 119.934 1.243 . . . . 0.0 111.358 178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -78.02 171.86 55.16 Favored Glycine 0 CA--C 1.535 1.314 0 C-N-CA 124.095 0.855 . . . . 0.0 113.386 175.303 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 10.2 p -79.7 96.76 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 124.483 1.113 . . . . 0.0 113.094 -175.109 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.1 p -161.78 -177.17 5.68 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 125.606 1.562 . . . . 0.0 112.402 174.665 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 30.8 m -170.85 -29.35 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.886 0 C-N-CA 126.324 1.85 . . . . 0.0 111.796 162.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.4 ttpt 64.67 -69.71 0.09 Allowed 'General case' 0 N--CA 1.472 0.666 0 C-N-CA 127.374 2.27 . . . . 0.0 113.349 175.608 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -88.16 73.36 8.98 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.074 0.95 . . . . 0.0 112.857 -166.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -129.69 158.5 39.2 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.294 1.038 . . . . 0.0 111.79 170.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 37.2 tttm -143.52 140.94 30.52 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 126.887 2.075 . . . . 0.0 108.906 166.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -70.39 147.69 49.25 Favored 'General case' 0 CA--C 1.546 0.801 0 C-N-CA 123.382 0.673 . . . . 0.0 111.521 171.337 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -133.76 -52.82 0.87 Allowed 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 123.397 0.679 . . . . 0.0 112.24 175.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -110.24 109.45 2.66 Favored Glycine 0 C--N 1.337 0.606 0 C-N-CA 124.478 1.037 . . . . 0.0 111.279 -176.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 48.5 p -52.8 142.29 34.21 Favored Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 125.222 1.409 . . . . 0.0 111.469 174.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -57.48 146.07 85.45 Favored 'Trans proline' 0 N--CA 1.459 -0.542 0 C-N-CA 122.916 2.411 . . . . 0.0 114.049 -178.615 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.52 130.03 25.68 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 125.764 1.626 . . . . 0.0 109.55 169.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.1 t70 -69.01 135.61 51.15 Favored 'General case' 0 CA--C 1.539 0.552 0 CA-C-N 118.543 0.61 . . . . 0.0 110.57 175.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 51.6 p -68.19 -5.75 19.78 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 126.81 2.044 . . . . 0.0 113.998 179.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -10.66 7.28 Favored Glycine 0 CA--C 1.533 1.216 0 C-N-CA 124.62 1.105 . . . . 0.0 112.699 -169.012 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 28.5 m80 -95.01 -3.63 48.02 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 126.512 1.925 . . . . 0.0 110.875 173.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.01 -4.14 45.21 Favored Glycine 0 CA--C 1.533 1.17 0 C-N-CA 125.57 1.557 . . . . 0.0 114.83 173.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.8 p -96.31 156.71 16.22 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 125.337 1.455 . . . . 0.0 110.409 173.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.7 OUTLIER -106.73 122.26 60.47 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 C-N-CA 124.105 0.962 . . . . 0.0 110.377 170.138 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.2 126.36 39.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 123.642 0.777 . . . . 0.0 109.338 162.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -142.59 155.73 45.01 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.294 1.438 . . . . 0.0 111.055 173.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 23.6 tt0 -125.91 134.78 51.46 Favored 'General case' 0 N--CA 1.472 0.661 0 O-C-N 121.255 -0.903 . . . . 0.0 112.688 -175.396 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 3.2 mp -121.13 168.2 11.82 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 124.851 1.261 . . . . 0.0 109.89 165.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.3 pt20 -126.55 143.38 51.23 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.557 1.143 . . . . 0.0 110.014 169.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 12.9 t80 -96.42 98.23 10.08 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.732 1.213 . . . . 0.0 109.777 -172.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 18.0 p -78.31 9.34 3.93 Favored 'General case' 0 N--CA 1.474 0.728 0 C-N-CA 126.97 2.108 . . . . 0.0 115.788 -162.43 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -147.91 173.41 27.97 Favored Glycine 0 CA--C 1.526 0.758 0 CA-C-N 119.424 1.011 . . . . 0.0 113.821 -173.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 25.5 p -95.64 -1.37 50.32 Favored 'General case' 0 N--CA 1.473 0.683 0 C-N-CA 126.305 1.842 . . . . 0.0 114.019 -173.737 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -136.41 173.29 11.87 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.715 1.606 . . . . 0.0 112.69 -168.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 112.78 43.55 0.87 Allowed Glycine 0 CA--C 1.543 1.802 0 CA-C-O 116.574 -2.237 . . . . 0.0 118.688 166.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -48.84 105.54 0.09 OUTLIER 'Trans proline' 0 CA--C 1.543 0.939 0 CA-C-N 122.308 3.054 . . . . 0.0 112.314 161.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -163.13 162.82 25.81 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 113.86 1.059 . . . . 0.0 113.86 -166.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 13.3 ttmm -82.05 94.47 7.2 Favored 'General case' 0 N--CA 1.474 0.768 0 C-N-CA 124.942 1.297 . . . . 0.0 110.172 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 3.9 p -59.25 115.05 10.75 Favored Pre-proline 0 N--CA 1.475 0.824 0 C-N-CA 125.829 1.652 . . . . 0.0 113.741 -169.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_endo -80.79 83.23 2.26 Favored 'Trans proline' 0 CA--C 1.54 0.801 0 C-N-CA 123.047 2.498 . . . . 0.0 112.147 -179.179 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 20.6 tt -127.31 140.27 49.58 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.582 0 C-N-CA 124.112 0.965 . . . . 0.0 109.903 165.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 46.6 t -140.8 166.86 23.61 Favored 'General case' 0 N--CA 1.468 0.474 0 C-N-CA 124.097 0.959 . . . . 0.0 113.408 -167.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 34.2 t -138.71 104.86 5.21 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.666 2.386 . . . . 0.0 110.439 -172.301 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.502 HG11 ' HA ' ' A' ' 57' ' ' ASP . 16.3 m -132.09 169.1 22.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.781 0 C-N-CA 124.03 0.932 . . . . 0.0 112.478 178.359 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -111.28 0.52 16.73 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.566 1.146 . . . . 0.0 113.742 -173.102 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 70.2 m -151.93 27.88 0.61 Allowed 'General case' 0 N--CA 1.474 0.768 0 O-C-N 120.245 -1.535 . . . . 0.0 112.846 174.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.62 10.4 1.41 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.445 1.898 . . . . 0.0 113.732 -173.695 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 15.9 p-10 -72.14 52.61 0.25 Allowed 'General case' 0 CA--C 1.545 0.752 0 C-N-CA 129.094 2.958 . . . . 0.0 112.487 176.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.502 ' HA ' HG11 ' A' ' 52' ' ' VAL . 10.3 t0 -64.41 -7.35 9.5 Favored 'General case' 0 CA--C 1.54 0.591 0 N-CA-C 115.923 1.823 . . . . 0.0 115.923 -165.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.6 pp -60.51 -5.83 1.36 Allowed 'General case' 0 CA--C 1.546 0.807 0 C-N-CA 125.56 1.544 . . . . 0.0 114.591 166.047 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 91.0 m -154.58 114.78 2.44 Favored Pre-proline 0 N--CA 1.474 0.746 0 O-C-N 120.108 -1.62 . . . . 0.0 110.556 168.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -67.96 111.16 2.35 Favored 'Trans proline' 0 C--N 1.352 0.753 0 C-N-CA 123.683 2.922 . . . . 0.0 111.751 -176.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.5 t -75.77 -39.58 38.75 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 124.443 1.097 . . . . 0.0 110.517 179.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -102.75 -161.94 25.89 Favored Glycine 0 CA--C 1.539 1.55 0 C-N-CA 125.982 1.754 . . . . 0.0 113.589 176.627 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 6.3 ptp85 -130.96 176.74 7.98 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 124.178 0.991 . . . . 0.0 113.27 178.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 5.6 mp -99.41 139.59 34.83 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.786 2.034 . . . . 0.0 108.36 166.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 94.8 t -109.09 -55.16 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.803 0 C-N-CA 123.104 0.562 . . . . 0.0 111.239 -171.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.4 m -55.67 -54.21 47.01 Favored 'General case' 0 N--CA 1.476 0.842 0 N-CA-C 113.173 0.805 . . . . 0.0 113.173 -174.181 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 16.9 t -145.06 148.81 17.42 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.552 0 N-CA-C 106.787 -1.56 . . . . 0.0 106.787 167.65 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.75 159.26 79.81 Favored Pre-proline 0 CA--C 1.556 1.195 0 O-C-N 121.899 -0.501 . . . . 0.0 110.525 168.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -77.1 69.81 6.92 Favored 'Trans proline' 0 CA--C 1.543 0.928 0 C-N-CA 122.713 2.276 . . . . 0.0 115.391 -157.331 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 23.8 p90 -143.62 120.24 11.11 Favored 'General case' 0 N--CA 1.469 0.476 0 O-C-N 120.392 -1.442 . . . . 0.0 113.282 162.724 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 79.1 t -81.45 95.8 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.169 0 N-CA-C 106.956 -1.498 . . . . 0.0 106.956 168.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 14.8 t -76.2 -3.88 38.73 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 115.436 1.643 . . . . 0.0 115.436 -174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -145.05 143.89 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.67 0 C-N-CA 125.892 1.677 . . . . 0.0 111.932 -167.462 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -67.39 -20.93 65.61 Favored 'General case' 0 CA--C 1.543 0.676 0 C-N-CA 124.343 1.057 . . . . 0.0 112.73 169.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.56 4.68 1.72 Allowed 'General case' 0 N--CA 1.472 0.67 0 C-N-CA 128.545 2.738 . . . . 0.0 114.406 179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.65 8.15 0.4 Allowed 'General case' 0 CA--C 1.549 0.919 0 C-N-CA 126.224 1.81 . . . . 0.0 115.605 -175.933 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.43 19.01 0.01 OUTLIER 'General case' 0 CA--C 1.555 1.142 0 C-N-CA 130.853 3.661 . . . . 0.0 116.131 -161.882 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -87.31 173.79 8.96 Favored 'General case' 0 CA--C 1.544 0.733 0 C-N-CA 126.375 1.87 . . . . 0.0 114.434 -169.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 2.8 ttpp -105.39 101.77 11.29 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 129.092 2.957 . . . . 0.0 107.079 166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.2 p -136.46 114.33 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 N-CA-C 114.515 1.302 . . . . 0.0 114.515 -156.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -66.45 129.24 39.19 Favored 'General case' 0 CA--C 1.544 0.736 0 C-N-CA 128.191 2.596 . . . . 0.0 110.562 166.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 9.6 mt -128.0 148.52 32.57 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.517 0 C-N-CA 129.025 2.93 . . . . 0.0 108.825 -174.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -104.34 136.72 43.4 Favored 'General case' 0 C--O 1.238 0.484 0 C-N-CA 125.066 1.346 . . . . 0.0 112.323 165.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.5 mp -121.31 162.84 19.58 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.643 1.977 . . . . 0.0 110.098 163.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.4 tt0 -120.93 107.33 38.03 Favored Pre-proline 0 N--CA 1.468 0.464 0 C-N-CA 125.078 1.351 . . . . 0.0 109.202 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 34.8 Cg_endo -107.02 140.6 0.07 OUTLIER 'Trans proline' 0 CA--C 1.548 1.195 0 C-N-CA 124.197 3.264 . . . . 0.0 110.823 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -51.53 162.11 1.66 Allowed 'Trans proline' 0 CA--C 1.539 0.749 0 C-N-CA 123.851 3.034 . . . . 0.0 114.651 170.648 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 7.6 m-85 -68.09 166.03 16.86 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 124.025 0.93 . . . . 0.0 113.41 176.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.94 -91.35 1.68 Allowed Glycine 0 C--N 1.339 0.736 0 N-CA-C 110.239 -1.145 . . . . 0.0 110.239 -173.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -119.58 159.78 23.71 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.263 1.025 . . . . 0.0 111.064 -179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 49.5 m -157.6 129.73 7.15 Favored 'General case' 0 C--O 1.227 -0.125 0 O-C-N 120.807 -1.183 . . . . 0.0 110.174 -173.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 87.0 m-85 -135.62 122.59 21.33 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.572 0.749 . . . . 0.0 109.263 -178.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 44.1 mm -109.86 113.68 44.88 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 C-N-CA 126.251 1.82 . . . . 0.0 107.732 -173.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 39.6 t -109.02 140.62 26.98 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.483 0 C-N-CA 123.897 0.879 . . . . 0.0 109.245 -176.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 73.2 t -132.95 101.91 4.71 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.42 0 C-N-CA 127.393 2.277 . . . . 0.0 107.999 -173.033 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 149.3 171.53 18.03 Favored Glycine 0 CA--C 1.525 0.702 0 N-CA-C 117.946 1.939 . . . . 0.0 117.946 172.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.12 128.84 30.86 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 126.505 1.922 . . . . 0.0 110.362 -175.051 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 35.55 -98.3 0.01 OUTLIER Glycine 0 CA--C 1.534 1.244 0 C-N-CA 126.89 2.186 . . . . 0.0 115.268 178.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -66.79 -16.39 64.23 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 127.097 2.159 . . . . 0.0 115.993 -178.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.6 pt20 -136.33 105.76 6.09 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 124.281 1.032 . . . . 0.0 111.088 -172.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -142.41 162.98 34.07 Favored 'General case' 0 N--CA 1.468 0.429 0 N-CA-C 115.202 1.556 . . . . 0.0 115.202 173.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -145.03 163.94 12.78 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.534 0 C-N-CA 130.136 3.374 . . . . 0.0 107.308 174.159 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -156.62 163.35 39.43 Favored 'General case' 0 CA--C 1.537 0.465 0 O-C-N 120.983 -1.073 . . . . 0.0 110.994 173.26 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.1 t-80 -142.33 149.39 39.39 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.991 1.317 . . . . 0.0 110.044 173.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.0 p80 -102.75 160.97 14.12 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.864 1.266 . . . . 0.0 111.632 178.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -152.54 158.66 42.84 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 127.014 2.126 . . . . 0.0 110.237 166.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 10.5 m-70 -145.0 142.32 29.69 Favored 'General case' 0 C--O 1.237 0.426 0 N-CA-C 107.177 -1.416 . . . . 0.0 107.177 178.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 29.8 pttt -150.0 105.08 3.35 Favored 'General case' 0 C--O 1.236 0.391 0 C-N-CA 124.407 1.083 . . . . 0.0 112.354 -173.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 78.5 p 128.01 -5.07 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 131.676 3.99 . . . . 0.0 114.619 159.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 122.15 33.82 0.87 Allowed Glycine 0 CA--C 1.531 1.044 0 C-N-CA 124.643 1.116 . . . . 0.0 112.159 -172.975 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.4 t -88.36 -141.0 0.12 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 125.338 1.455 . . . . 0.0 112.241 -166.548 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 88.1 p -52.59 -36.44 56.15 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 120.717 1.599 . . . . 0.0 115.136 -169.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 43.9 mm -93.13 -2.72 10.74 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.942 0 C-N-CA 126.333 1.853 . . . . 0.0 112.515 177.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 78.68 28.8 54.24 Favored Glycine 0 CA--C 1.534 1.235 0 O-C-N 120.518 -1.364 . . . . 0.0 112.521 -169.596 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.3 tptp . . . . . 0 C--O 1.252 1.191 0 C-N-CA 127.174 2.19 . . . . 0.0 111.82 -169.399 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 61.4 mt . . . . . 0 N--CA 1.481 1.09 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.64 152.26 45.26 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 118.61 0.641 . . . . 0.0 111.123 167.562 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -117.42 116.55 27.39 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 126.072 1.749 . . . . 0.0 109.498 172.906 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 53.9 m-85 -64.99 -42.3 94.64 Favored 'General case' 0 CA--C 1.537 0.475 0 O-C-N 121.63 -0.669 . . . . 0.0 111.677 -176.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 17.6 pm0 -59.98 -29.47 68.47 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.875 1.67 . . . . 0.0 114.741 -172.705 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -88.31 -5.11 58.53 Favored 'General case' 0 N--CA 1.469 0.481 0 CA-C-N 119.111 0.868 . . . . 0.0 113.194 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 23.6 mmtm -69.1 -6.31 27.58 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-O 116.808 -1.567 . . . . 0.0 114.073 -175.776 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 48.08 73.52 0.33 Allowed Glycine 0 CA--C 1.536 1.353 0 C-N-CA 126.169 1.843 . . . . 0.0 115.477 168.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 63.9 p -77.18 64.19 2.56 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 124.236 1.015 . . . . 0.0 111.18 175.351 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 12.7 p -73.94 -27.42 61.01 Favored 'General case' 0 N--CA 1.471 0.59 0 C-N-CA 126.614 1.966 . . . . 0.0 113.8 -179.196 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -143.14 172.19 13.06 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 126.68 1.992 . . . . 0.0 110.462 -178.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -66.43 148.8 51.03 Favored Glycine 0 CA--C 1.535 1.297 0 C-N-CA 123.109 0.385 . . . . 0.0 112.33 170.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.3 p -69.52 105.28 1.14 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.208 1.003 . . . . 0.0 112.041 -176.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -156.58 162.46 39.89 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 127.314 2.246 . . . . 0.0 109.202 -178.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 55.6 p -156.87 -43.24 0.07 Allowed 'General case' 0 N--CA 1.469 0.494 0 C-N-CA 124.309 1.043 . . . . 0.0 111.664 171.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.8 ttmt 60.06 -69.81 0.03 OUTLIER 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 128.366 2.666 . . . . 0.0 112.989 -176.461 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -103.24 74.7 1.3 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.153 0.981 . . . . 0.0 112.742 -160.999 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 63.9 m-85 -128.48 161.28 29.9 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 123.375 0.67 . . . . 0.0 111.142 161.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 29.4 tttm -145.77 149.88 35.19 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 126.442 1.897 . . . . 0.0 108.714 164.571 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 70.4 m-85 -61.13 125.61 24.35 Favored 'General case' 0 CA--C 1.541 0.61 0 C-N-CA 123.338 0.655 . . . . 0.0 111.042 166.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -95.24 -45.17 7.28 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.094 0.957 . . . . 0.0 109.043 167.116 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -138.65 119.34 1.74 Allowed Glycine 0 CA--C 1.53 0.982 0 C-N-CA 126.126 1.822 . . . . 0.0 110.835 -179.891 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.4 p -57.93 155.43 23.7 Favored Pre-proline 0 N--CA 1.472 0.665 0 C-N-CA 125.424 1.49 . . . . 0.0 112.932 -179.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -61.17 133.49 47.14 Favored 'Trans proline' 0 CA--C 1.539 0.742 0 C-N-CA 122.808 2.338 . . . . 0.0 112.026 -178.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.59 127.59 22.26 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 125.823 1.649 . . . . 0.0 110.75 -178.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.5 t70 -66.36 133.35 50.31 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-O 121.323 0.583 . . . . 0.0 112.378 -173.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 47.5 p -79.12 -22.84 44.57 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 127.035 2.134 . . . . 0.0 114.563 -178.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.4 -8.28 61.96 Favored Glycine 0 CA--C 1.54 1.607 0 CA-C-O 118.574 -1.126 . . . . 0.0 114.368 -160.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.8 m170 -72.09 -9.9 59.04 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-N 120.121 1.96 . . . . 0.0 111.596 165.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.01 -0.25 62.3 Favored Glycine 0 CA--C 1.536 1.403 0 C-N-CA 125.334 1.445 . . . . 0.0 113.19 -163.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 63.7 p -112.33 164.0 13.74 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.96 2.104 . . . . 0.0 111.068 -170.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 2.4 m -106.77 125.62 62.72 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.659 0 C-N-CA 124.209 1.004 . . . . 0.0 110.382 168.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.6 m -76.87 131.67 34.39 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.502 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 159.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.5 tt -141.6 123.48 15.32 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 127.155 2.182 . . . . 0.0 107.378 -171.213 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -104.83 131.35 52.41 Favored 'General case' 0 N--CA 1.466 0.329 0 CA-C-N 118.999 0.818 . . . . 0.0 111.888 177.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.6 mp -120.24 165.23 15.11 Favored 'General case' 0 CA--C 1.532 0.28 0 CA-C-O 121.929 0.871 . . . . 0.0 110.134 169.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -121.59 138.87 54.14 Favored 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 124.109 0.963 . . . . 0.0 109.475 167.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.4 t80 -86.15 101.14 12.73 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.986 1.314 . . . . 0.0 109.48 179.133 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 17.0 p -83.17 12.92 4.58 Favored 'General case' 0 N--CA 1.474 0.732 0 N-CA-C 115.283 1.586 . . . . 0.0 115.283 -162.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -149.72 178.34 27.29 Favored Glycine 0 CA--C 1.528 0.866 0 CA-C-N 119.237 0.926 . . . . 0.0 114.623 -173.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 43.3 p -109.21 2.91 21.26 Favored 'General case' 0 N--CA 1.475 0.779 0 C-N-CA 126.541 1.937 . . . . 0.0 113.272 -174.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -137.26 -176.63 4.45 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 126.669 1.988 . . . . 0.0 110.76 176.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 113.93 29.08 2.94 Favored Glycine 0 CA--C 1.544 1.854 0 CA-C-O 115.745 -2.697 . . . . 0.0 118.975 177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -48.69 96.16 0.03 OUTLIER 'Trans proline' 0 C--N 1.359 1.124 0 CA-C-N 123.416 3.608 . . . . 0.0 112.981 162.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 30.5 m -160.43 169.69 22.54 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.014 1.326 . . . . 0.0 112.324 -165.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.3 tmtm? -96.78 92.76 6.32 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 124.54 1.136 . . . . 0.0 110.526 -178.503 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.3 p -62.54 115.92 19.83 Favored Pre-proline 0 N--CA 1.48 1.034 0 C-N-CA 125.176 1.39 . . . . 0.0 114.627 -167.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -73.84 93.25 0.87 Allowed 'Trans proline' 0 CA--C 1.541 0.831 0 C-N-CA 122.526 2.15 . . . . 0.0 111.848 170.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.43 HG23 HD21 ' A' ' 64' ' ' LEU . 19.7 tt -128.12 136.08 61.11 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.44 0 C-N-CA 124.22 1.008 . . . . 0.0 108.608 161.393 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 40.8 t -148.81 165.33 31.79 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 123.826 0.85 . . . . 0.0 113.126 -161.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.1 t -140.64 115.33 9.55 Favored 'General case' 0 N--CA 1.468 0.428 0 C-N-CA 126.97 2.108 . . . . 0.0 110.633 -177.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 31.3 m -137.65 175.45 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.745 0 C-N-CA 124.787 1.235 . . . . 0.0 112.262 -179.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -100.47 -18.17 16.81 Favored 'General case' 0 CA--C 1.541 0.628 0 N-CA-C 114.468 1.285 . . . . 0.0 114.468 -171.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.7 m -149.9 32.34 0.69 Allowed 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.114 -1.616 . . . . 0.0 111.636 -177.148 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER 61.94 11.72 4.38 Favored 'General case' 0 CA--C 1.549 0.939 0 C-N-CA 126.391 1.876 . . . . 0.0 113.454 -174.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -67.19 50.79 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.894 0 C-N-CA 130.204 3.401 . . . . 0.0 113.815 175.363 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.0 t0 -58.78 -12.03 3.87 Favored 'General case' 0 CA--C 1.544 0.717 0 N-CA-C 115.563 1.69 . . . . 0.0 115.563 -167.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 3.6 pp -55.36 -12.01 0.95 Allowed 'General case' 0 CA--C 1.548 0.878 0 C-N-CA 127.248 2.219 . . . . 0.0 115.422 167.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 90.3 m -155.67 107.65 2.17 Favored Pre-proline 0 N--CA 1.473 0.69 0 O-C-N 120.352 -1.467 . . . . 0.0 109.791 171.723 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_exo -47.45 110.47 0.31 Allowed 'Trans proline' 0 CA--C 1.538 0.721 0 C-N-CA 124.748 3.632 . . . . 0.0 113.01 170.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.7 t -88.77 -30.38 5.34 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 C-N-CA 124.401 1.08 . . . . 0.0 109.959 177.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -107.29 -173.03 22.41 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.941 2.21 . . . . 0.0 111.305 165.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 10.8 ptp85 -131.68 170.54 14.65 Favored 'General case' 0 N--CA 1.472 0.671 0 C-N-CA 124.438 1.095 . . . . 0.0 112.151 -177.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.43 HD21 HG23 ' A' ' 49' ' ' ILE . 4.4 mp -87.41 133.48 33.72 Favored 'General case' 0 CA--C 1.535 0.397 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 160.968 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.0 t -96.67 -54.43 7.06 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.27 0.628 . . . . 0.0 109.967 -174.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 31.3 m -63.34 -48.33 78.45 Favored 'General case' 0 N--CA 1.475 0.815 0 N-CA-C 113.449 0.907 . . . . 0.0 113.449 -173.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.8 p -151.61 150.26 13.3 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.391 0 C-N-CA 124.385 1.074 . . . . 0.0 108.909 -179.453 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 6.6 m-80 -82.68 156.39 67.97 Favored Pre-proline 0 CA--C 1.552 1.041 0 CA-C-N 118.208 0.458 . . . . 0.0 110.709 173.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -73.13 86.67 1.1 Allowed 'Trans proline' 0 CA--C 1.546 1.124 0 C-N-CA 122.486 2.124 . . . . 0.0 115.731 -155.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -148.57 118.87 7.3 Favored 'General case' 0 N--CA 1.473 0.69 0 O-C-N 120.363 -1.461 . . . . 0.0 114.202 179.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 42.1 t -88.61 87.24 2.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 124.717 1.207 . . . . 0.0 107.759 167.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 19.8 t -72.2 -11.05 60.56 Favored 'General case' 0 CA--C 1.539 0.532 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -176.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -154.54 156.3 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 CA-C-N 120.014 1.279 . . . . 0.0 112.071 -174.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -69.81 -15.6 63.14 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.399 1.48 . . . . 0.0 114.202 173.734 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 44.8 p -76.56 1.72 15.95 Favored 'General case' 0 N--CA 1.475 0.801 0 C-N-CA 126.129 1.772 . . . . 0.0 113.762 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.03 13.27 0.05 OUTLIER 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.632 1.973 . . . . 0.0 115.606 -179.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -64.3 20.65 0.01 OUTLIER 'General case' 0 CA--C 1.554 1.129 0 C-N-CA 129.949 3.3 . . . . 0.0 115.901 -165.173 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -80.18 168.17 19.43 Favored 'General case' 0 CA--C 1.544 0.726 0 C-N-CA 127.096 2.158 . . . . 0.0 114.518 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 1.2 tmtm? -106.3 107.03 17.83 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 129.266 3.026 . . . . 0.0 105.47 160.752 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.4 p -145.27 137.96 21.19 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.673 0 CA-C-O 122.483 1.135 . . . . 0.0 113.634 -158.452 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -101.2 128.21 47.41 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 129.161 2.984 . . . . 0.0 109.779 -169.289 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 67.1 mt -128.76 138.73 53.8 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 C-N-CA 126.868 2.067 . . . . 0.0 109.149 -172.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -89.53 136.67 32.9 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 118.556 0.616 . . . . 0.0 111.803 163.521 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 3.6 mp -120.9 159.17 26.09 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 127.104 2.162 . . . . 0.0 109.775 166.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -103.32 105.25 45.61 Favored Pre-proline 0 CA--C 1.54 0.585 0 C-N-CA 125.229 1.411 . . . . 0.0 109.565 173.604 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -80.01 129.87 8.14 Favored 'Trans proline' 0 CA--C 1.544 0.982 0 C-N-CA 123.604 2.869 . . . . 0.0 110.288 164.804 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -66.44 171.95 9.8 Favored 'Trans proline' 0 CA--C 1.545 1.059 0 C-N-CA 122.304 2.003 . . . . 0.0 112.165 171.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 32.4 m-85 -82.41 166.01 19.77 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 113.742 1.015 . . . . 0.0 113.742 -173.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 77.23 -82.45 1.14 Allowed Glycine 0 C--N 1.34 0.805 0 C-N-CA 124.669 1.128 . . . . 0.0 111.072 -173.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -140.6 145.69 37.01 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.582 1.153 . . . . 0.0 110.12 -178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 92.7 p -150.57 151.13 32.14 Favored 'General case' 0 C--O 1.234 0.254 0 CA-C-O 121.48 0.657 . . . . 0.0 112.525 -175.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -137.36 139.99 41.14 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.928 1.291 . . . . 0.0 110.059 178.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 46.4 mm -119.7 107.68 21.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 C-N-CA 126.284 1.833 . . . . 0.0 107.044 -168.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 19.1 t -103.8 135.71 40.18 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.524 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -172.085 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 97.1 t -129.92 92.85 1.83 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.325 0 C-N-CA 126.905 2.082 . . . . 0.0 107.282 -172.681 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 142.3 170.8 12.82 Favored Glycine 0 CA--C 1.523 0.585 0 N-CA-C 115.782 1.073 . . . . 0.0 115.782 178.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -119.48 123.0 42.95 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 126.077 1.751 . . . . 0.0 109.138 -176.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 31.82 -92.32 0.01 OUTLIER Glycine 0 CA--C 1.534 1.258 0 C-N-CA 127.194 2.331 . . . . 0.0 115.472 176.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.8 pm0 -73.11 -16.77 61.45 Favored 'General case' 0 CA--C 1.543 0.7 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 -176.419 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.2 97.95 4.42 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 124.406 1.082 . . . . 0.0 109.952 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -148.11 163.62 36.36 Favored 'General case' 0 C--N 1.342 0.255 0 N-CA-C 115.407 1.632 . . . . 0.0 115.407 -177.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -136.58 163.77 32.53 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.51 0 C-N-CA 129.841 3.256 . . . . 0.0 107.573 168.655 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -151.48 162.81 40.31 Favored 'General case' 0 CA--C 1.537 0.445 0 O-C-N 121.131 -0.981 . . . . 0.0 111.596 172.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 6.4 t-80 -138.62 173.57 11.45 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.43 1.892 . . . . 0.0 110.409 176.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -124.71 157.94 34.43 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.392 1.877 . . . . 0.0 111.167 -178.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -155.08 154.85 33.04 Favored 'General case' 0 N--CA 1.469 0.508 0 C-N-CA 125.583 1.553 . . . . 0.0 111.89 161.453 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 48.3 m-70 -132.62 140.58 48.28 Favored 'General case' 0 N--CA 1.468 0.469 0 C-N-CA 124.375 1.07 . . . . 0.0 110.885 -166.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 23.3 mttt -136.3 93.87 2.95 Favored 'General case' 0 N--CA 1.47 0.548 0 N-CA-C 112.746 0.647 . . . . 0.0 112.746 179.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 31.6 t 70.79 30.11 3.0 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.779 1.632 . . . . 0.0 114.477 161.518 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 172.1 8.94 0.02 OUTLIER Glycine 0 CA--C 1.532 1.101 0 N-CA-C 117.531 1.773 . . . . 0.0 117.531 178.442 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.3 t -75.25 160.94 29.79 Favored 'General case' 0 CA--C 1.534 0.348 0 CA-C-N 119.959 1.88 . . . . 0.0 112.728 -179.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 23.1 t -62.89 -11.54 19.06 Favored 'General case' 0 N--CA 1.469 0.524 0 C-N-CA 125.063 1.345 . . . . 0.0 114.569 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 26.6 mm -82.59 -16.02 11.71 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.799 0 C-N-CA 124.863 1.265 . . . . 0.0 111.452 172.769 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 112.91 4.94 24.1 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.347 -1.252 . . . . 0.0 115.751 173.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.087 0 CA-C-N 119.391 1.596 . . . . 0.0 114.17 -177.04 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 4.9 mp . . . . . 0 N--CA 1.479 1.024 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 23.0 t -146.11 145.24 30.45 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 123.336 0.654 . . . . 0.0 111.853 -163.386 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -129.89 178.05 6.81 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 128.538 2.735 . . . . 0.0 110.398 177.198 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 32.5 m-85 -100.21 -54.47 2.87 Favored 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.999 0.904 . . . . 0.0 111.166 -174.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 1.4 pm0 -55.89 -34.94 66.0 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 127.98 2.512 . . . . 0.0 113.786 -175.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 4.7 tt -66.56 -43.5 84.87 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 118.472 0.578 . . . . 0.0 110.794 176.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.418 ' HE2' ' CB ' ' A' ' 60' ' ' PRO . 33.0 mmtm -63.41 -45.55 90.49 Favored 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 124.037 0.935 . . . . 0.0 110.393 176.097 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 36.86 104.05 0.01 OUTLIER Glycine 0 C--N 1.344 0.975 0 C-N-CA 129.67 3.51 . . . . 0.0 116.676 159.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 75.2 p -62.8 72.51 0.02 OUTLIER 'General case' 0 N--CA 1.477 0.88 0 C-N-CA 127.346 2.258 . . . . 0.0 112.781 175.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.7 p -80.98 -19.54 43.8 Favored 'General case' 0 N--CA 1.467 0.384 0 C-N-CA 127.879 2.472 . . . . 0.0 114.31 -178.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 22.2 t80 -160.66 175.48 12.61 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.353 1.461 . . . . 0.0 110.257 176.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -69.95 133.41 24.71 Favored Glycine 0 CA--C 1.538 1.481 0 C-N-CA 125.268 1.413 . . . . 0.0 113.681 177.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 14.7 p -71.3 102.31 1.06 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.678 0 C-N-CA 125.556 1.542 . . . . 0.0 114.08 -171.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -151.59 156.36 40.31 Favored 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 127.585 2.354 . . . . 0.0 108.783 178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -147.96 -31.87 0.28 Allowed 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 33.6 ttpt 49.27 -73.01 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.57 0 C-N-CA 130.507 3.523 . . . . 0.0 116.214 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -129.32 68.23 1.42 Allowed 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 123.96 0.904 . . . . 0.0 112.067 -155.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.6 m-85 -114.17 156.07 24.92 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 124.932 1.293 . . . . 0.0 110.331 166.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 28.3 tttm -142.29 145.42 33.98 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.498 1.519 . . . . 0.0 109.139 165.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.4 m-85 -61.76 137.55 58.26 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-O 121.509 0.671 . . . . 0.0 111.31 168.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -113.97 -46.12 3.03 Favored 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.422 1.489 . . . . 0.0 109.708 175.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 128.93 4.93 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 125.095 1.331 . . . . 0.0 111.535 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 32.9 p -58.11 146.26 70.14 Favored Pre-proline 0 N--CA 1.471 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 112.256 179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -59.54 124.75 16.13 Favored 'Trans proline' 0 C--N 1.35 0.624 0 C-N-CA 123.126 2.551 . . . . 0.0 111.55 173.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -126.16 128.55 47.46 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 124.727 1.211 . . . . 0.0 110.46 175.514 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.0 t70 -68.68 129.84 41.1 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.612 0.72 . . . . 0.0 111.021 -175.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 81.0 p -71.98 -4.59 29.41 Favored 'General case' 0 N--CA 1.467 0.397 0 C-N-CA 127.406 2.282 . . . . 0.0 113.845 -177.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.06 -8.72 11.12 Favored Glycine 0 CA--C 1.532 1.155 0 CA-C-N 118.945 0.793 . . . . 0.0 113.174 -168.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 10.8 m80 -89.2 -0.74 57.7 Favored 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.195 1.398 . . . . 0.0 110.758 170.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.71 0.79 74.86 Favored Glycine 0 CA--C 1.531 1.067 0 C-N-CA 125.464 1.507 . . . . 0.0 113.896 -177.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 67.3 p -99.91 161.82 13.37 Favored 'General case' 0 N--CA 1.468 0.466 0 C-N-CA 126.883 2.073 . . . . 0.0 110.205 174.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 11.2 m -113.4 128.88 70.0 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.832 0 CA-C-N 119.457 1.026 . . . . 0.0 110.919 169.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -77.62 119.04 25.53 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.273 1.029 . . . . 0.0 108.937 162.503 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 4.9 tt -132.72 129.27 38.49 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.78 2.432 . . . . 0.0 108.429 -172.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.0 tt0 -119.39 132.96 55.93 Favored 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 119.108 0.867 . . . . 0.0 113.06 -172.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.8 mp -123.47 167.63 13.62 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.294 1.038 . . . . 0.0 111.481 174.151 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 9.8 pt20 -122.58 136.5 54.9 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.207 1.403 . . . . 0.0 109.49 163.958 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 35.3 t80 -90.86 102.97 15.73 Favored 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 123.716 0.806 . . . . 0.0 109.355 173.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 33.5 p -78.61 -7.14 57.3 Favored 'General case' 0 N--CA 1.469 0.521 0 C-N-CA 125.592 1.557 . . . . 0.0 114.017 -173.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -98.03 160.36 20.8 Favored Glycine 0 CA--C 1.528 0.888 0 CA-C-O 122.272 0.929 . . . . 0.0 113.878 -177.692 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.8 p -82.02 -10.92 59.07 Favored 'General case' 0 N--CA 1.47 0.529 0 C-N-CA 127.528 2.331 . . . . 0.0 114.849 177.588 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -164.39 172.93 12.79 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 124.72 1.208 . . . . 0.0 110.748 -153.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.86 61.08 0.62 Allowed Glycine 0 CA--C 1.536 1.39 0 C-N-CA 125.465 1.507 . . . . 0.0 114.715 177.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 13.3 Cg_exo -56.22 105.04 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 122.399 2.066 . . . . 0.0 109.765 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 52.6 m -154.4 162.78 40.97 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.212 1.405 . . . . 0.0 112.09 -166.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 41.7 tttp -87.14 97.39 10.73 Favored 'General case' 0 N--CA 1.47 0.569 0 O-C-N 120.187 -1.571 . . . . 0.0 111.394 169.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.4 p -54.89 115.08 8.08 Favored Pre-proline 0 N--CA 1.474 0.751 0 C-N-CA 124.878 1.271 . . . . 0.0 110.825 169.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -82.86 90.31 1.05 Allowed 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.933 3.089 . . . . 0.0 110.678 174.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.9 tt -115.3 142.91 26.46 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 C-N-CA 124.053 0.941 . . . . 0.0 109.378 169.468 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 36.5 t -150.7 166.64 29.77 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 125.059 1.343 . . . . 0.0 112.844 -170.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.0 t -138.18 121.4 16.93 Favored 'General case' 0 C--O 1.236 0.353 0 C-N-CA 126.948 2.099 . . . . 0.0 110.713 -178.902 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.445 HG11 ' HA ' ' A' ' 57' ' ' ASP . 34.5 m -134.38 179.69 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 C-N-CA 125.487 1.515 . . . . 0.0 112.263 -176.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -107.63 -17.62 14.05 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 125.142 1.377 . . . . 0.0 113.725 -175.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 66.8 m -157.55 43.32 0.33 Allowed 'General case' 0 N--CA 1.474 0.734 0 O-C-N 120.184 -1.573 . . . . 0.0 111.731 -177.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 58.33 8.8 0.88 Allowed 'General case' 0 CA--C 1.553 1.074 0 C-N-CA 126.811 2.045 . . . . 0.0 114.56 -174.448 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.514 HD21 ' CG2' ' A' ' 61' ' ' VAL . 3.8 p-10 -70.58 46.05 0.09 Allowed 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 129.821 3.248 . . . . 0.0 114.952 -174.862 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.445 ' HA ' HG11 ' A' ' 52' ' ' VAL . 8.9 t0 -64.34 -1.77 1.86 Allowed 'General case' 0 N--CA 1.474 0.755 0 N-CA-C 116.206 1.928 . . . . 0.0 116.206 -168.291 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -60.83 -10.36 5.45 Favored 'General case' 0 CA--C 1.546 0.803 0 N-CA-C 113.918 1.081 . . . . 0.0 113.918 159.409 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.1 m -155.96 98.37 2.23 Favored Pre-proline 0 N--CA 1.469 0.513 0 O-C-N 120.381 -1.45 . . . . 0.0 109.8 173.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.418 ' CB ' ' HE2' ' A' ' 7' ' ' LYS . 80.5 Cg_exo -48.38 119.91 4.56 Favored 'Trans proline' 0 CA--C 1.537 0.642 0 C-N-CA 124.678 3.585 . . . . 0.0 113.452 170.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.514 ' CG2' HD21 ' A' ' 56' ' ' ASN . 8.0 t -99.88 -23.77 4.34 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.178 0 C-N-CA 125.538 1.535 . . . . 0.0 111.813 -176.311 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -109.62 -159.71 18.36 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 126.409 1.956 . . . . 0.0 111.29 168.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -140.21 175.48 9.55 Favored 'General case' 0 N--CA 1.467 0.412 0 N-CA-C 113.419 0.896 . . . . 0.0 113.419 174.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.499 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.4 OUTLIER -86.01 149.67 25.01 Favored 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 125.523 1.529 . . . . 0.0 107.187 159.759 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 85.7 t -118.73 -41.88 2.41 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.772 0 CA-C-N 118.735 0.698 . . . . 0.0 111.14 -174.369 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -61.04 -45.81 93.26 Favored 'General case' 0 N--CA 1.474 0.73 0 N-CA-C 113.474 0.916 . . . . 0.0 113.474 179.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 8.3 p -162.75 165.08 0.7 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 119.136 0.88 . . . . 0.0 111.567 -173.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -59.31 123.74 71.62 Favored Pre-proline 0 CA--C 1.54 0.567 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 157.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.54 100.1 1.12 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 121.772 1.648 . . . . 0.0 111.422 -171.569 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -149.07 149.87 31.81 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 124.442 1.097 . . . . 0.0 111.396 159.647 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.5 t -84.62 88.36 2.47 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.386 0 C-N-CA 127.524 2.33 . . . . 0.0 107.055 175.728 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 78.6 p -71.47 -2.86 18.16 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 115.935 1.828 . . . . 0.0 115.935 -168.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.02 158.0 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.743 0 C-N-CA 124.5 1.12 . . . . 0.0 112.13 -175.855 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -71.25 -27.58 63.56 Favored 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 123.538 0.735 . . . . 0.0 112.369 165.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 45.1 p -74.87 4.86 5.75 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 126.249 1.82 . . . . 0.0 113.671 174.398 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -66.66 19.85 0.02 OUTLIER 'General case' 0 CA--C 1.549 0.932 0 C-N-CA 126.29 1.836 . . . . 0.0 115.083 177.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -69.65 27.26 0.03 OUTLIER 'General case' 0 CA--C 1.551 1.015 0 C-N-CA 129.169 2.987 . . . . 0.0 113.681 -172.645 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -82.34 169.08 16.89 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.416 1.886 . . . . 0.0 113.967 -166.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -112.4 108.73 17.99 Favored 'General case' 0 N--CA 1.463 0.192 0 C-N-CA 127.837 2.455 . . . . 0.0 106.092 163.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 7.6 p -141.38 123.38 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 121.775 0.798 . . . . 0.0 112.953 -157.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 mt -74.82 134.99 41.65 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.626 1.571 . . . . 0.0 110.604 169.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.4 mt -132.7 136.53 55.71 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 C-N-CA 126.506 1.922 . . . . 0.0 107.949 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.3 mt-10 -93.87 138.13 32.36 Favored 'General case' 0 C--O 1.237 0.432 0 O-C-N 121.775 -0.578 . . . . 0.0 111.911 167.659 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.4 mp -123.06 163.13 21.07 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 127.131 2.173 . . . . 0.0 110.056 167.165 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.2 tt0 -104.52 100.97 25.07 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 124.543 1.137 . . . . 0.0 109.236 168.072 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 15.7 Cg_endo -74.44 129.13 12.56 Favored 'Trans proline' 0 N--CA 1.455 -0.748 0 C-N-CA 122.802 2.335 . . . . 0.0 109.977 161.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -59.94 172.29 2.4 Favored 'Trans proline' 0 CA--C 1.542 0.88 0 C-N-CA 122.572 2.181 . . . . 0.0 112.504 165.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 31.3 m-85 -99.54 166.09 11.31 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.151 0.981 . . . . 0.0 112.426 -172.265 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.27 -91.67 1.45 Allowed Glycine 0 CA--C 1.525 0.715 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 -164.074 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 52.4 m-20 -119.67 154.0 34.72 Favored 'General case' 0 N--CA 1.464 0.232 0 C-N-CA 124.577 1.151 . . . . 0.0 110.331 168.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 38.5 t -144.95 158.42 43.81 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 115.489 -0.778 . . . . 0.0 111.143 166.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 56.7 m-85 -130.19 145.76 51.76 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 123.969 0.908 . . . . 0.0 108.823 165.098 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 31.1 mm -117.02 113.94 44.33 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 C-N-CA 126.479 1.912 . . . . 0.0 106.219 -176.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 40.9 t -112.18 135.11 52.55 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 N-CA-C 109.139 -0.689 . . . . 0.0 109.139 -166.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 59.4 t -134.24 95.76 1.79 Allowed 'Isoleucine or valine' 0 N--CA 1.467 0.418 0 C-N-CA 125.08 1.352 . . . . 0.0 108.061 -173.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 157.99 171.69 24.23 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 117.945 1.938 . . . . 0.0 117.945 175.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -136.4 114.21 11.2 Favored 'General case' 0 N--CA 1.466 0.364 0 C-N-CA 127.644 2.378 . . . . 0.0 108.938 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 39.83 -98.02 0.01 OUTLIER Glycine 0 CA--C 1.533 1.204 0 C-N-CA 126.166 1.841 . . . . 0.0 114.848 176.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 3.5 pm0 -68.74 -15.08 63.41 Favored 'General case' 0 CA--C 1.541 0.606 0 N-CA-C 115.554 1.687 . . . . 0.0 115.554 -176.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -129.65 99.34 5.12 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 124.718 1.207 . . . . 0.0 109.708 -179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 4.3 pt20 -148.62 159.28 44.25 Favored 'General case' 0 N--CA 1.468 0.428 0 N-CA-C 115.7 1.741 . . . . 0.0 115.7 178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.99 165.64 19.38 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 C-N-CA 129.913 3.285 . . . . 0.0 108.431 172.802 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 4.9 p30 -144.72 170.7 15.6 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.712 -0.617 . . . . 0.0 110.871 161.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 32.8 t-80 -132.79 161.73 33.34 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.909 1.684 . . . . 0.0 108.583 162.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 8.9 p80 -110.8 159.59 17.51 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.273 1.429 . . . . 0.0 110.522 176.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -148.02 152.99 38.37 Favored 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 125.062 1.345 . . . . 0.0 111.119 169.018 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 77.5 m-70 -143.75 115.45 8.19 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.936 1.294 . . . . 0.0 108.41 -170.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 47.4 pttt -152.38 109.88 3.59 Favored 'General case' 0 N--CA 1.473 0.702 0 N-CA-C 114.881 1.438 . . . . 0.0 114.881 -175.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 34.8 t 66.01 37.13 5.45 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 127.321 2.248 . . . . 0.0 114.522 166.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.48 20.46 0.04 OUTLIER Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.025 0.821 . . . . 0.0 114.538 177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.418 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 39.9 t -64.54 154.46 36.01 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 124.985 1.314 . . . . 0.0 113.213 -174.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 6.8 m -54.21 -23.24 13.84 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.432 1.893 . . . . 0.0 112.655 162.337 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 11.4 mm -93.35 -1.32 10.54 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.964 0 C-N-CA 126.425 1.89 . . . . 0.0 111.337 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 91.03 10.24 62.84 Favored Glycine 0 CA--C 1.533 1.166 0 O-C-N 120.75 -1.219 . . . . 0.0 115.727 171.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.418 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.0 ptmm? . . . . . 0 C--O 1.251 1.175 0 C-N-CA 125.086 1.355 . . . . 0.0 114.585 -178.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 25.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 110.078 -0.341 . . . . 0.0 110.078 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.33 168.84 23.53 Favored 'General case' 0 N--CA 1.465 0.291 0 N-CA-C 112.901 0.704 . . . . 0.0 112.901 -173.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -136.22 -175.55 4.03 Favored 'General case' 0 CA--C 1.545 0.773 0 C-N-CA 128.171 2.589 . . . . 0.0 110.472 177.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 77.8 m-85 -99.49 -59.01 1.8 Allowed 'General case' 0 N--CA 1.471 0.593 0 O-C-N 121.067 -1.021 . . . . 0.0 110.434 174.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 3.0 pm0 -51.43 -33.57 31.16 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 128.613 2.765 . . . . 0.0 114.935 -169.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 17.3 tp -61.98 -19.79 63.17 Favored 'General case' 0 CA--C 1.544 0.735 0 CA-C-N 119.004 0.82 . . . . 0.0 112.838 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mptt -87.03 -1.4 57.85 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 124.969 1.308 . . . . 0.0 113.139 175.608 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -4.36 98.98 0.01 OUTLIER Glycine 0 CA--C 1.537 1.45 0 C-N-CA 130.524 3.916 . . . . 0.0 117.507 177.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.551 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 1.0 OUTLIER -64.81 60.29 0.02 OUTLIER 'General case' 0 CA--C 1.55 0.949 0 C-N-CA 130.426 3.49 . . . . 0.0 115.92 -169.096 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.2 m -60.22 -27.62 67.34 Favored 'General case' 0 N--CA 1.483 1.219 0 N-CA-C 115.791 1.774 . . . . 0.0 115.791 -173.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 20.6 m-85 -140.1 -179.06 5.75 Favored 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 126.361 1.864 . . . . 0.0 109.923 179.042 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -61.58 138.63 46.89 Favored Glycine 0 CA--C 1.534 1.279 0 O-C-N 121.655 -0.653 . . . . 0.0 111.71 169.228 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.95 95.55 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.723 0 CA-C-O 122.121 0.962 . . . . 0.0 112.663 -174.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -153.83 172.18 17.77 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.754 2.022 . . . . 0.0 110.585 170.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 77.6 p -142.93 -25.45 0.61 Allowed 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 124.862 1.265 . . . . 0.0 113.934 174.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.4 ttpt 47.28 -78.15 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 130.25 3.42 . . . . 0.0 114.934 -177.075 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -104.21 72.5 1.08 Allowed 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.728 1.211 . . . . 0.0 111.906 -165.011 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 53.8 m-85 -123.32 153.25 40.52 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 123.774 0.83 . . . . 0.0 110.638 167.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 33.0 tttm -139.73 147.46 40.92 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 125.782 1.633 . . . . 0.0 108.205 167.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -67.23 133.22 49.31 Favored 'General case' 0 CA--C 1.538 0.489 0 O-C-N 121.475 -0.765 . . . . 0.0 110.856 169.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -97.4 -50.43 4.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.433 1.093 . . . . 0.0 109.204 172.346 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.26 120.74 1.94 Allowed Glycine 0 CA--C 1.529 0.959 0 C-N-CA 124.499 1.047 . . . . 0.0 112.558 -172.846 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 74.2 m -49.59 147.35 6.1 Favored Pre-proline 0 N--CA 1.471 0.62 0 C-N-CA 127.915 2.486 . . . . 0.0 112.346 174.257 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -56.48 148.4 63.21 Favored 'Trans proline' 0 CA--C 1.542 0.925 0 C-N-CA 122.565 2.177 . . . . 0.0 114.12 -178.202 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -142.0 142.64 32.94 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 126.141 1.776 . . . . 0.0 110.254 175.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 5.7 t70 -75.52 138.83 41.8 Favored 'General case' 0 N--CA 1.47 0.545 0 O-C-N 121.625 -0.672 . . . . 0.0 112.248 -177.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 46.5 p -83.31 -21.87 33.1 Favored 'General case' 0 N--CA 1.47 0.536 0 N-CA-C 114.952 1.464 . . . . 0.0 114.952 178.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 76.82 -7.38 34.69 Favored Glycine 0 CA--C 1.54 1.655 0 CA-C-O 118.488 -1.173 . . . . 0.0 114.421 -159.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -72.08 -14.47 61.86 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 120.115 1.958 . . . . 0.0 111.166 163.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 102.93 -7.34 52.69 Favored Glycine 0 CA--C 1.535 1.33 0 C-N-CA 125.859 1.695 . . . . 0.0 113.012 -165.037 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 69.9 p -102.12 164.95 11.42 Favored 'General case' 0 N--CA 1.468 0.454 0 C-N-CA 126.623 1.969 . . . . 0.0 112.331 -170.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -108.75 119.21 57.9 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.432 0 C-N-CA 124.659 1.184 . . . . 0.0 110.592 171.542 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -80.19 128.34 38.7 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.532 0 C-N-CA 124.765 1.226 . . . . 0.0 110.199 163.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -141.5 136.01 30.78 Favored 'General case' 0 N--CA 1.47 0.545 0 C-N-CA 127.284 2.234 . . . . 0.0 109.514 -169.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -116.67 131.65 56.89 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 113.952 1.093 . . . . 0.0 113.952 -173.555 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -118.56 163.0 17.45 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.071 1.349 . . . . 0.0 111.06 171.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -122.95 142.82 50.4 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.551 1.54 . . . . 0.0 110.128 168.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 44.6 t80 -95.97 97.95 10.02 Favored 'General case' 0 N--CA 1.466 0.352 0 C-N-CA 123.992 0.917 . . . . 0.0 110.923 -179.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.7 p -82.57 35.21 0.45 Allowed 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 125.928 1.691 . . . . 0.0 113.269 -169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -155.87 175.11 33.76 Favored Glycine 0 CA--C 1.531 1.041 0 O-C-N 121.675 -0.64 . . . . 0.0 114.293 -176.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 23.4 p -121.3 3.49 10.32 Favored 'General case' 0 N--CA 1.475 0.809 0 C-N-CA 127.042 2.137 . . . . 0.0 113.228 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -132.04 166.06 22.58 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 127.249 2.22 . . . . 0.0 110.875 179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 105.65 51.71 0.84 Allowed Glycine 0 CA--C 1.542 1.722 0 N-CA-C 118.192 2.037 . . . . 0.0 118.192 167.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -56.15 108.55 0.34 Allowed 'Trans proline' 0 C--N 1.355 0.887 0 CA-C-N 121.774 2.787 . . . . 0.0 110.722 160.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.476 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 0.1 OUTLIER -155.7 168.78 26.07 Favored 'General case' 0 CA--C 1.544 0.729 0 C-N-CA 124.431 1.092 . . . . 0.0 111.38 -166.115 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.551 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 11.3 tppt? -92.9 91.69 7.53 Favored 'General case' 0 N--CA 1.475 0.81 0 O-C-N 120.377 -1.452 . . . . 0.0 109.632 179.113 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.1 p -61.66 114.42 11.08 Favored Pre-proline 0 N--CA 1.476 0.833 0 C-N-CA 124.521 1.129 . . . . 0.0 112.36 -174.021 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -76.28 88.79 1.31 Allowed 'Trans proline' 0 CA--C 1.543 0.944 0 C-N-CA 123.229 2.619 . . . . 0.0 111.466 176.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 17.4 tt -112.53 145.77 18.14 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 C-N-CA 124.015 0.926 . . . . 0.0 110.079 167.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 15.7 t -151.27 172.29 16.1 Favored 'General case' 0 CA--C 1.542 0.667 0 N-CA-C 114.372 1.249 . . . . 0.0 114.372 -171.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 32.2 t -143.63 106.27 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 128.143 2.577 . . . . 0.0 109.705 -179.64 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.494 HG11 ' HA ' ' A' ' 57' ' ' ASP . 14.6 m -136.2 151.43 28.74 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 N-CA-C 113.08 0.77 . . . . 0.0 113.08 -179.231 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -73.5 -32.26 64.16 Favored 'General case' 0 CA--C 1.54 0.595 0 N-CA-C 114.256 1.206 . . . . 0.0 114.256 -172.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -135.72 27.37 3.33 Favored 'General case' 0 N--CA 1.474 0.748 0 C-N-CA 124.277 1.031 . . . . 0.0 112.357 -166.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.4 mt 63.76 3.25 1.52 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 126.232 1.813 . . . . 0.0 113.881 -171.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -67.69 50.5 0.05 Allowed 'General case' 0 CA--C 1.548 0.888 0 C-N-CA 129.117 2.967 . . . . 0.0 114.3 179.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.494 ' HA ' HG11 ' A' ' 52' ' ' VAL . 11.7 t0 -61.49 -13.7 23.12 Favored 'General case' 0 CA--C 1.545 0.768 0 N-CA-C 115.013 1.486 . . . . 0.0 115.013 -170.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.3 pp -58.74 -6.21 0.71 Allowed 'General case' 0 CA--C 1.547 0.848 0 C-N-CA 126.679 1.992 . . . . 0.0 114.665 162.337 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.1 m -153.54 103.67 2.54 Favored Pre-proline 0 CA--C 1.538 0.485 0 O-C-N 120.045 -1.66 . . . . 0.0 109.042 173.99 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -69.95 123.67 10.26 Favored 'Trans proline' 0 CA--C 1.539 0.764 0 C-N-CA 123.37 2.713 . . . . 0.0 111.046 -174.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 t -106.33 -36.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.947 0 C-N-CA 124.193 0.997 . . . . 0.0 111.702 -172.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -98.97 -166.74 30.41 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 125.381 1.467 . . . . 0.0 110.58 161.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.404 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.1 ptp85 -142.03 174.4 10.63 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 123.891 0.876 . . . . 0.0 112.167 178.34 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.486 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.7 OUTLIER -83.47 140.07 32.55 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 125.093 1.357 . . . . 0.0 107.405 163.187 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 54.2 t -104.62 -49.33 9.45 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.822 0 CA-C-N 118.623 0.647 . . . . 0.0 109.669 178.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.9 m -60.01 -49.77 76.38 Favored 'General case' 0 N--CA 1.472 0.661 0 N-CA-C 114.547 1.314 . . . . 0.0 114.547 -172.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.9 p -158.15 159.6 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.866 0 CA-C-N 119.896 1.226 . . . . 0.0 113.031 -170.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 36.4 t-20 -59.41 114.45 9.4 Favored Pre-proline 0 CA--C 1.547 0.842 0 C-N-CA 124.392 1.077 . . . . 0.0 108.491 158.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -75.1 88.06 1.28 Allowed 'Trans proline' 0 N--CA 1.455 -0.785 0 C-N-CA 123.106 2.537 . . . . 0.0 111.938 -167.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -136.18 139.59 42.96 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.744 -1.222 . . . . 0.0 111.94 166.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.476 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 2.6 t -74.24 88.87 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.163 0 C-N-CA 125.557 1.543 . . . . 0.0 106.874 173.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 22.7 t -72.72 -2.81 21.73 Favored 'General case' 0 CA--C 1.54 0.579 0 N-CA-C 114.883 1.438 . . . . 0.0 114.883 -174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -156.95 143.35 9.86 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.529 0 C-N-CA 125.146 1.378 . . . . 0.0 110.813 -172.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -66.36 -27.07 67.6 Favored 'General case' 0 CA--C 1.546 0.82 0 CA-C-O 121.883 0.849 . . . . 0.0 111.539 164.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.46 6.63 0.58 Allowed 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 129.167 2.987 . . . . 0.0 114.192 168.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.49 17.18 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.829 0 C-N-CA 125.888 1.675 . . . . 0.0 115.385 177.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -60.05 15.91 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 C-N-CA 131.143 3.777 . . . . 0.0 115.562 -170.081 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -69.92 170.73 10.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 128.214 2.606 . . . . 0.0 114.3 -173.605 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.9 99.74 6.81 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 129.836 3.254 . . . . 0.0 104.486 164.357 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.6 p -131.32 127.33 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.59 0 C-N-CA 124.946 1.298 . . . . 0.0 112.082 -154.339 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -103.76 121.85 43.86 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.865 2.866 . . . . 0.0 108.898 -169.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.7 mt -125.8 130.69 72.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 126.721 2.008 . . . . 0.0 109.267 -166.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -79.78 133.01 36.28 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 123.539 0.736 . . . . 0.0 111.462 164.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.8 mp -119.6 157.09 29.12 Favored 'General case' 0 CA--C 1.54 0.573 0 C-N-CA 127.147 2.179 . . . . 0.0 109.854 164.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.404 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 38.5 tt0 -89.45 111.88 48.25 Favored Pre-proline 0 CA--C 1.541 0.606 0 C-N-CA 124.558 1.143 . . . . 0.0 108.472 168.08 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -78.23 125.75 7.31 Favored 'Trans proline' 0 CA--C 1.542 0.904 0 C-N-CA 123.336 2.691 . . . . 0.0 109.653 171.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -66.67 164.78 27.78 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 121.245 1.297 . . . . 0.0 110.909 168.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 24.1 m-85 -71.96 155.47 40.32 Favored 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 122.042 0.925 . . . . 0.0 112.751 -179.197 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 81.92 -87.05 1.41 Allowed Glycine 0 CA--C 1.523 0.567 0 C-N-CA 125.4 1.476 . . . . 0.0 109.87 -175.88 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 19.7 m-20 -118.95 156.36 29.7 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 124.245 1.018 . . . . 0.0 110.214 173.79 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 99.5 p -146.11 95.99 2.71 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 124.166 0.986 . . . . 0.0 108.932 178.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 14.4 m-30 -96.42 134.76 39.18 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.313 1.045 . . . . 0.0 109.294 178.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 43.5 mm -115.67 90.82 1.61 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 126.328 1.851 . . . . 0.0 107.343 -159.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 10.1 t -89.45 139.06 18.05 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.295 0 C-N-CA 123.673 0.789 . . . . 0.0 109.378 -172.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 76.6 t -133.52 91.04 1.16 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.329 0 C-N-CA 126.707 2.003 . . . . 0.0 106.45 179.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 164.85 165.39 22.05 Favored Glycine 0 C--N 1.337 0.605 0 N-CA-C 119.167 2.427 . . . . 0.0 119.167 -179.048 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -142.83 147.54 35.59 Favored 'General case' 0 N--CA 1.469 0.495 0 C-N-CA 125.354 1.462 . . . . 0.0 109.972 167.729 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 40.64 -99.59 0.01 OUTLIER Glycine 0 CA--C 1.534 1.267 0 C-N-CA 126.498 1.999 . . . . 0.0 115.092 174.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 10.2 pm0 -85.43 -26.7 26.22 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.772 1.629 . . . . 0.0 113.98 -178.504 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -107.8 81.85 1.57 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 125.284 1.434 . . . . 0.0 108.517 -173.177 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.501 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.0 OUTLIER -138.82 148.12 43.37 Favored 'General case' 0 C--N 1.343 0.3 0 N-CA-C 115.822 1.786 . . . . 0.0 115.822 -177.858 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -142.9 161.29 18.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 C-N-CA 128.593 2.757 . . . . 0.0 108.125 177.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -150.42 147.59 27.74 Favored 'General case' 0 CA--C 1.533 0.326 0 O-C-N 121.47 -0.769 . . . . 0.0 110.967 173.028 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -118.07 162.79 17.62 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.832 2.053 . . . . 0.0 109.434 172.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 86.1 m-70 -132.03 129.57 40.22 Favored 'General case' 0 N--CA 1.461 0.123 0 C-N-CA 122.993 0.517 . . . . 0.0 110.92 -172.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -137.84 166.58 23.66 Favored 'General case' 0 C--O 1.236 0.393 0 C-N-CA 124.145 0.978 . . . . 0.0 111.139 171.0 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 50.0 m-70 -141.34 123.64 15.7 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.848 1.659 . . . . 0.0 108.104 -161.066 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -148.21 99.61 3.07 Favored 'General case' 0 N--CA 1.469 0.504 0 N-CA-C 114.503 1.297 . . . . 0.0 114.503 -169.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 50.3 m 61.69 54.27 3.01 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.409 1.883 . . . . 0.0 113.189 169.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 132.13 30.2 0.53 Allowed Glycine 0 CA--C 1.53 0.991 0 C-N-CA 124.239 0.923 . . . . 0.0 114.303 170.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.4 t -55.39 168.16 0.4 Allowed 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 126.919 2.088 . . . . 0.0 115.59 -175.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 15.7 m -49.75 -20.9 0.93 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 125.044 1.338 . . . . 0.0 113.452 156.625 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 7.4 tp -119.56 24.58 4.59 Favored 'Isoleucine or valine' 0 CA--C 1.553 1.071 0 C-N-CA 126.571 1.948 . . . . 0.0 111.876 171.171 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 73.4 -26.21 0.87 Allowed Glycine 0 CA--C 1.537 1.433 0 C-N-CA 127.285 2.374 . . . . 0.0 116.586 171.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 13.6 tptp . . . . . 0 C--O 1.251 1.133 0 C-N-CA 128.663 2.785 . . . . 0.0 114.223 173.017 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.479 1.016 0 N-CA-C 108.254 -1.017 . . . . 0.0 108.254 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -139.01 169.03 18.53 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.518 0.727 . . . . 0.0 110.955 172.425 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -131.46 171.62 13.17 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 127.124 2.169 . . . . 0.0 109.854 173.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -104.74 -63.99 1.16 Allowed 'General case' 0 N--CA 1.469 0.505 0 O-C-N 121.128 -0.982 . . . . 0.0 111.554 -171.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.3 pm0 -52.66 -31.29 36.29 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.867 2.067 . . . . 0.0 114.427 -173.784 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 38.3 tp -58.09 -29.07 65.16 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 124.581 1.153 . . . . 0.0 113.044 178.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.6 mptt -79.11 -2.73 42.02 Favored 'General case' 0 CA--C 1.543 0.699 0 N-CA-C 113.238 0.829 . . . . 0.0 113.238 178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -44.06 143.47 2.27 Favored Glycine 0 CA--C 1.536 1.38 0 C-N-CA 126.778 2.133 . . . . 0.0 115.683 -174.25 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 53.2 p -70.51 74.44 0.55 Allowed 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 126.748 2.019 . . . . 0.0 113.586 -170.51 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 65.4 p -60.41 -21.24 61.99 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 125.197 1.399 . . . . 0.0 112.412 159.105 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -153.01 179.87 8.3 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 127.432 2.293 . . . . 0.0 108.305 161.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -67.67 157.72 51.84 Favored Glycine 0 CA--C 1.539 1.544 0 O-C-N 122.074 -0.391 . . . . 0.0 112.638 166.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 5.7 p -77.74 103.35 4.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 124.831 1.252 . . . . 0.0 111.614 179.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -158.86 163.66 36.43 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 125.541 1.537 . . . . 0.0 110.767 -179.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.6 p -165.43 -48.13 0.03 OUTLIER 'General case' 0 N--CA 1.472 0.659 0 C-N-CA 123.857 0.863 . . . . 0.0 111.786 173.482 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 28.9 ttpt 65.2 -63.51 0.19 Allowed 'General case' 0 N--CA 1.471 0.596 0 C-N-CA 127.916 2.486 . . . . 0.0 113.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -97.69 78.59 2.63 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 124.202 1.001 . . . . 0.0 112.461 -166.839 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -129.86 156.73 43.9 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.258 1.023 . . . . 0.0 111.664 171.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 35.2 tttm -146.23 150.04 35.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.229 1.812 . . . . 0.0 108.948 164.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 54.7 m-85 -70.02 149.55 47.57 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.882 0.849 . . . . 0.0 112.933 171.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -124.37 -33.97 2.97 Favored 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.312 1.445 . . . . 0.0 111.272 171.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -139.88 104.27 0.41 Allowed Glycine 0 CA--C 1.526 0.762 0 C-N-CA 125.148 1.356 . . . . 0.0 111.239 -179.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 35.3 m -46.53 140.08 5.87 Favored Pre-proline 0 N--CA 1.472 0.638 0 C-N-CA 127.042 2.137 . . . . 0.0 110.518 167.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -61.21 143.43 98.43 Favored 'Trans proline' 0 C--N 1.352 0.723 0 C-N-CA 121.95 1.767 . . . . 0.0 112.805 -170.327 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -137.85 122.51 18.63 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.556 1.143 . . . . 0.0 111.223 175.846 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 9.2 t70 -66.27 131.26 45.71 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 121.615 0.721 . . . . 0.0 111.588 -178.028 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.7 p -79.26 -10.01 59.71 Favored 'General case' 0 N--CA 1.467 0.396 0 C-N-CA 126.503 1.921 . . . . 0.0 113.837 -175.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.29 -6.65 4.08 Favored Glycine 0 CA--C 1.536 1.395 0 C-N-CA 124.203 0.906 . . . . 0.0 114.048 -167.317 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 39.7 m80 -94.53 3.09 55.57 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.526 1.531 . . . . 0.0 111.685 178.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.73 5.7 41.52 Favored Glycine 0 CA--C 1.532 1.097 0 C-N-CA 125.465 1.507 . . . . 0.0 114.279 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 81.9 p -128.0 166.49 18.26 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.519 1.528 . . . . 0.0 111.784 -171.595 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . 0.675 HG13 ' HG3' ' A' ' 86' ' ' PRO . 0.2 OUTLIER -114.95 132.06 65.31 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.728 0 C-N-CA 125.516 1.526 . . . . 0.0 108.958 162.937 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.5 m -80.05 131.65 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.426 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 162.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -141.31 124.33 16.31 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 128.727 2.811 . . . . 0.0 108.211 -169.161 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -118.58 136.28 53.95 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 119.309 0.959 . . . . 0.0 112.922 -176.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 6.9 mt -128.48 164.92 21.72 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.337 1.855 . . . . 0.0 110.562 -179.899 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -127.79 139.9 52.38 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.621 1.168 . . . . 0.0 110.195 163.414 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 28.2 t80 -90.87 101.49 14.25 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 124.729 1.212 . . . . 0.0 109.792 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 25.3 p -80.5 7.63 9.47 Favored 'General case' 0 N--CA 1.472 0.651 0 C-N-CA 125.915 1.686 . . . . 0.0 115.162 -163.726 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -146.39 -179.94 22.92 Favored Glycine 0 CA--C 1.528 0.856 0 CA-C-N 119.297 0.953 . . . . 0.0 114.34 -172.068 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 46.1 p -113.59 6.79 17.13 Favored 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 126.168 1.787 . . . . 0.0 113.913 -165.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 6.7 p-10 -141.52 178.8 7.2 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.872 1.669 . . . . 0.0 111.735 -175.151 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 95.31 44.78 3.16 Favored Glycine 0 CA--C 1.542 1.727 0 CA-C-O 116.83 -2.094 . . . . 0.0 117.963 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_exo -55.13 102.85 0.09 OUTLIER 'Trans proline' 0 C--N 1.357 0.994 0 CA-C-N 122.278 3.039 . . . . 0.0 111.709 164.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 46.7 m -159.57 171.27 19.94 Favored 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 125.263 1.425 . . . . 0.0 111.99 -166.464 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 8.0 mtpp -82.76 110.2 17.58 Favored 'General case' 0 N--CA 1.47 0.548 0 O-C-N 120.67 -1.269 . . . . 0.0 110.519 165.069 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.7 p -61.85 121.45 65.11 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 123.551 0.74 . . . . 0.0 110.776 176.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -71.06 97.17 0.73 Allowed 'Trans proline' 0 CA--C 1.539 0.728 0 C-N-CA 122.327 2.018 . . . . 0.0 110.887 169.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 13.1 tt -134.11 138.77 49.6 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 C-N-CA 124.938 1.295 . . . . 0.0 108.926 169.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 22.9 t -153.32 169.95 21.83 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.912 0.885 . . . . 0.0 113.384 -169.581 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 47.3 t -140.73 117.66 11.12 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 127.536 2.335 . . . . 0.0 110.01 -179.439 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.476 HG11 ' HA ' ' A' ' 57' ' ' ASP . 2.0 m -134.97 170.38 19.62 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 C-N-CA 125.269 1.428 . . . . 0.0 111.473 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -91.4 -23.93 19.9 Favored 'General case' 0 CA--C 1.539 0.553 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -175.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 69.6 m -155.29 51.34 0.58 Allowed 'General case' 0 N--CA 1.473 0.676 0 O-C-N 120.587 -1.321 . . . . 0.0 111.298 -179.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER 56.08 11.8 0.82 Allowed 'General case' 0 CA--C 1.551 0.999 0 C-N-CA 126.806 2.043 . . . . 0.0 114.682 -177.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . 0.434 HD21 HG23 ' A' ' 61' ' ' VAL . 3.3 p-10 -70.17 42.38 0.06 Allowed 'General case' 0 CA--C 1.55 0.968 0 C-N-CA 128.962 2.905 . . . . 0.0 114.453 -178.006 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.476 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.3 t0 -65.47 -3.59 4.6 Favored 'General case' 0 CA--C 1.542 0.667 0 C-N-CA 126.178 1.791 . . . . 0.0 115.585 -166.987 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 2.8 pp -60.39 -14.82 20.93 Favored 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 124.71 1.204 . . . . 0.0 113.283 159.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 52.8 m -152.78 104.61 2.68 Favored Pre-proline 0 N--CA 1.47 0.546 0 O-C-N 120.446 -1.409 . . . . 0.0 109.958 167.073 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 81.3 Cg_exo -47.13 141.01 13.46 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 124.779 3.653 . . . . 0.0 114.285 172.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.434 HG23 HD21 ' A' ' 56' ' ' ASN . 14.2 t -119.33 -27.6 2.17 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 C-N-CA 124.44 1.096 . . . . 0.0 111.014 179.551 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -110.98 -174.15 20.05 Favored Glycine 0 CA--C 1.531 1.074 0 C-N-CA 126.762 2.125 . . . . 0.0 111.0 164.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.462 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 10.8 ptp85 -136.85 175.73 9.35 Favored 'General case' 0 N--CA 1.469 0.522 0 C-N-CA 124.352 1.061 . . . . 0.0 112.43 -175.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -87.26 143.44 27.27 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.817 1.647 . . . . 0.0 107.811 164.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 98.6 t -119.5 -46.34 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.761 0 CA-C-O 118.676 -0.678 . . . . 0.0 111.895 -173.366 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.3 m -62.5 -42.84 99.77 Favored 'General case' 0 N--CA 1.478 0.967 0 CA-C-N 119.374 0.988 . . . . 0.0 113.621 -179.396 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.9 p -158.66 163.66 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.632 0 C-N-CA 123.553 0.741 . . . . 0.0 111.099 -174.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -64.72 137.85 97.27 Favored Pre-proline 0 CA--C 1.547 0.841 0 C-N-CA 123.269 0.627 . . . . 0.0 109.759 166.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 67.2 Cg_endo -70.88 82.47 0.98 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 123.047 2.498 . . . . 0.0 112.781 -175.076 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 11.7 t80 -145.04 110.35 5.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 125.595 1.558 . . . . 0.0 112.093 -172.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 16.0 t -74.66 87.27 0.6 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.535 0 C-N-CA 125.974 1.709 . . . . 0.0 108.014 167.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 16.2 m -69.27 -19.56 63.92 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 115.727 1.751 . . . . 0.0 115.727 -170.046 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 3.6 m -150.51 155.07 7.89 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.741 0 C-N-CA 124.682 1.193 . . . . 0.0 112.026 -170.4 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -68.05 -19.57 64.9 Favored 'General case' 0 CA--C 1.544 0.721 0 C-N-CA 123.981 0.912 . . . . 0.0 112.946 172.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.3 p -80.81 7.88 9.45 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.993 1.717 . . . . 0.0 113.416 174.401 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -67.04 16.96 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.944 0 C-N-CA 125.931 1.693 . . . . 0.0 115.164 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -67.19 23.22 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.042 0 C-N-CA 129.919 3.288 . . . . 0.0 114.644 -168.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -83.81 171.71 12.87 Favored 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 126.634 1.974 . . . . 0.0 113.783 -168.088 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 10.5 tmtt? -112.83 111.31 21.99 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 128.472 2.709 . . . . 0.0 106.198 167.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 6.3 p -139.99 122.65 16.8 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.549 0 C-N-CA 123.782 0.833 . . . . 0.0 112.437 -156.148 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -81.75 135.29 35.49 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 126.07 1.748 . . . . 0.0 109.907 174.038 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 93.4 mt -136.24 139.33 45.74 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.095 1.758 . . . . 0.0 108.716 -175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 32.4 mt-10 -91.88 137.27 32.5 Favored 'General case' 0 C--O 1.238 0.464 0 O-C-N 121.371 -0.83 . . . . 0.0 111.661 164.905 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.9 mp -120.03 165.68 14.38 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.286 2.235 . . . . 0.0 109.545 166.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.462 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 29.9 tt0 -104.88 109.25 62.88 Favored Pre-proline 0 CA--C 1.546 0.794 0 C-N-CA 125.164 1.386 . . . . 0.0 109.502 174.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.675 ' HG3' HG13 ' A' ' 32' ' ' VAL . 60.3 Cg_endo -93.18 118.82 0.36 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.231 3.954 . . . . 0.0 111.138 176.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 84.4 Cg_exo -45.96 152.81 1.05 Allowed 'Trans proline' 0 CA--C 1.538 0.714 0 C-N-CA 123.999 3.133 . . . . 0.0 114.942 170.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 58.3 m-85 -84.34 152.53 24.04 Favored 'General case' 0 CA--C 1.536 0.438 0 O-C-N 121.436 -0.79 . . . . 0.0 110.564 175.097 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 92.87 -93.71 1.8 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.816 -1.314 . . . . 0.0 109.816 -161.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 46.9 m-20 -125.95 168.18 14.26 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.976 1.31 . . . . 0.0 111.315 176.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 57.9 m -154.06 155.1 34.84 Favored 'General case' 0 C--N 1.333 -0.132 0 O-C-N 120.945 -1.097 . . . . 0.0 112.126 171.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 37.2 m-85 -132.03 115.59 16.0 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 127.973 2.509 . . . . 0.0 107.953 171.43 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 47.4 mm -93.52 106.01 17.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.242 0 C-N-CA 127.69 2.396 . . . . 0.0 106.797 177.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 57.8 t -108.7 137.28 41.33 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 124.311 1.045 . . . . 0.0 109.613 -166.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 57.8 t -136.6 110.67 9.56 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.431 0 C-N-CA 125.163 1.385 . . . . 0.0 109.113 -176.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . 0.407 ' HA3' ' HA ' ' A' ' 101' ' ' GLN . . . 130.07 173.21 13.33 Favored Glycine 0 CA--C 1.528 0.906 0 N-CA-C 115.602 1.001 . . . . 0.0 115.602 173.302 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 2.2 ptm85 -126.7 123.5 37.66 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.976 1.71 . . . . 0.0 110.592 -171.664 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.51 -96.97 0.01 OUTLIER Glycine 0 CA--C 1.533 1.218 0 C-N-CA 126.932 2.206 . . . . 0.0 115.163 175.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 5.6 pm0 -65.62 -16.88 64.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 126.273 1.829 . . . . 0.0 115.541 -179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 16.4 pt20 -135.76 91.47 2.71 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 125.114 1.366 . . . . 0.0 110.461 -176.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . 0.407 ' HA ' ' HA3' ' A' ' 96' ' ' GLY . 0.1 OUTLIER -139.54 162.06 35.99 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.737 1.384 . . . . 0.0 114.737 176.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.07 162.82 21.95 Favored 'Isoleucine or valine' 0 C--O 1.236 0.387 0 C-N-CA 128.631 2.773 . . . . 0.0 107.989 171.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 6.2 p30 -150.25 154.64 38.28 Favored 'General case' 0 CA--C 1.534 0.34 0 O-C-N 121.635 -0.666 . . . . 0.0 110.951 173.033 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 37.5 m170 -125.01 169.3 12.25 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 126.452 1.901 . . . . 0.0 108.185 164.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 11.3 p80 -140.0 163.18 33.38 Favored 'General case' 0 N--CA 1.462 0.131 0 O-C-N 121.389 -0.819 . . . . 0.0 112.412 -176.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -143.31 158.54 43.55 Favored 'General case' 0 N--CA 1.456 -0.127 0 C-N-CA 125.476 1.51 . . . . 0.0 111.748 -178.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 81.9 m-70 -145.26 110.44 5.22 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 126.005 1.722 . . . . 0.0 107.089 -167.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 16.4 ptmt -153.99 105.28 2.72 Favored 'General case' 0 N--CA 1.472 0.671 0 N-CA-C 114.94 1.459 . . . . 0.0 114.94 -163.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 42.4 t 64.78 39.81 5.97 Favored 'General case' 0 N--CA 1.47 0.559 0 C-N-CA 126.783 2.033 . . . . 0.0 113.966 168.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 148.33 22.42 0.08 OUTLIER Glycine 0 CA--C 1.531 1.032 0 C-N-CA 124.584 1.088 . . . . 0.0 114.178 177.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 35.6 t -65.05 155.89 33.23 Favored 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 124.928 1.291 . . . . 0.0 113.861 -172.848 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 12.8 m -53.17 -20.57 4.05 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.912 2.085 . . . . 0.0 113.721 161.864 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 3.8 tp -101.05 2.37 10.61 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 124.919 1.287 . . . . 0.0 113.022 173.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 94.31 5.08 62.26 Favored Glycine 0 CA--C 1.534 1.23 0 N-CA-C 116.143 1.217 . . . . 0.0 116.143 169.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.0 ptmm? . . . . . 0 C--O 1.251 1.162 0 CA-C-N 118.985 1.393 . . . . 0.0 114.327 -179.353 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 80.8 mt . . . . . 0 N--CA 1.48 1.031 0 CA-C-O 117.694 -1.146 . . . . 0.0 108.587 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -116.97 153.3 32.88 Favored 'General case' 0 N--CA 1.473 0.716 0 C-N-CA 124.21 1.004 . . . . 0.0 112.969 177.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -112.47 90.6 3.39 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 127.237 2.215 . . . . 0.0 109.09 175.15 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -64.88 -44.01 91.05 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 125.998 1.719 . . . . 0.0 114.149 -163.18 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -61.95 -26.41 68.18 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 123.493 0.717 . . . . 0.0 112.626 178.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 21.7 tp -93.89 -1.53 54.64 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.907 1.283 . . . . 0.0 112.361 179.063 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 11.9 mmtm -62.15 -8.73 5.98 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 119.8 1.182 . . . . 0.0 114.169 174.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 76.71 52.01 6.14 Favored Glycine 0 CA--C 1.526 0.754 0 CA-C-N 119.652 1.115 . . . . 0.0 112.936 171.652 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 3.6 m -75.47 37.39 0.13 Allowed 'General case' 0 N--CA 1.477 0.905 0 C-N-CA 126.06 1.744 . . . . 0.0 111.557 174.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.6 t -78.18 -6.14 53.9 Favored 'General case' 0 N--CA 1.472 0.645 0 C-N-CA 124.7 1.2 . . . . 0.0 114.109 -174.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -153.86 172.82 16.77 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.102 0.961 . . . . 0.0 111.141 179.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -59.2 143.86 45.64 Favored Glycine 0 CA--C 1.534 1.265 0 C-N-CA 123.689 0.662 . . . . 0.0 112.092 171.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.273 4.0 p -80.76 93.16 2.06 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 CA-C-O 122.984 1.373 . . . . 0.0 112.58 -175.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 1.7 p -148.82 164.81 33.36 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.701 2.0 . . . . 0.0 110.847 167.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 73.4 p -140.24 -15.43 0.98 Allowed 'General case' 0 N--CA 1.471 0.615 0 C-N-CA 124.834 1.253 . . . . 0.0 113.651 168.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 23.6 ttmt 50.12 -64.18 0.0 OUTLIER 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 129.686 3.194 . . . . 0.0 114.956 -167.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -117.45 83.15 1.94 Allowed 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 124.548 1.139 . . . . 0.0 112.424 -160.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -130.77 162.22 29.99 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.745 1.218 . . . . 0.0 110.674 166.041 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.3 tttm -155.19 152.69 29.68 Favored 'General case' 0 CA--C 1.545 0.77 0 C-N-CA 126.412 1.885 . . . . 0.0 109.84 166.409 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 30.7 m-85 -62.9 132.19 51.28 Favored 'General case' 0 CA--C 1.546 0.795 0 O-C-N 121.483 -0.761 . . . . 0.0 111.693 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -116.52 -35.52 4.23 Favored 'General case' 0 N--CA 1.474 0.738 0 C-N-CA 124.159 0.983 . . . . 0.0 110.809 174.118 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.86 103.2 0.42 Allowed Glycine 0 CA--C 1.525 0.685 0 C-N-CA 126.016 1.77 . . . . 0.0 110.036 177.313 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 10.9 p -59.51 151.85 58.6 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 123.941 0.896 . . . . 0.0 112.293 -179.425 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -64.08 141.76 77.99 Favored 'Trans proline' 0 CA--C 1.539 0.754 0 C-N-CA 122.13 1.887 . . . . 0.0 113.498 -168.256 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -139.77 135.51 33.15 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.292 1.437 . . . . 0.0 110.722 174.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -69.09 141.59 54.69 Favored 'General case' 0 CA--C 1.541 0.599 0 N-CA-C 112.636 0.606 . . . . 0.0 112.636 -176.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 69.0 p -79.71 -13.38 59.5 Favored 'General case' 0 N--CA 1.469 0.492 0 C-N-CA 125.845 1.658 . . . . 0.0 114.559 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.22 -8.26 47.29 Favored Glycine 0 CA--C 1.537 1.462 0 CA-C-O 119.205 -0.775 . . . . 0.0 113.366 -166.175 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 66.8 m80 -98.21 1.78 47.69 Favored 'General case' 0 CA--C 1.539 0.521 0 C-N-CA 125.1 1.36 . . . . 0.0 112.284 173.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 104.56 -8.79 47.93 Favored Glycine 0 CA--C 1.531 1.092 0 C-N-CA 124.98 1.276 . . . . 0.0 113.89 177.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 43.4 p -102.11 166.51 10.57 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 126.939 2.096 . . . . 0.0 111.988 -178.929 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -114.78 123.74 70.75 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.773 0 C-N-CA 125.455 1.502 . . . . 0.0 110.833 173.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 m -77.74 129.51 37.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.558 0 C-N-CA 123.882 0.873 . . . . 0.0 109.781 164.449 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -146.37 121.14 9.89 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.35 2.26 . . . . 0.0 109.241 -164.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 22.1 tt0 -108.91 133.91 52.28 Favored 'General case' 0 C--O 1.238 0.474 0 O-C-N 120.76 -1.212 . . . . 0.0 113.029 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.1 mt -121.18 159.54 25.66 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.557 0.743 . . . . 0.0 110.25 168.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.1 pt20 -111.26 144.78 39.9 Favored 'General case' 0 C--O 1.234 0.245 0 C-N-CA 124.918 1.287 . . . . 0.0 109.49 167.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -93.36 102.8 15.06 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.177 1.391 . . . . 0.0 109.404 174.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 3.3 p -77.82 16.34 0.71 Allowed 'General case' 0 N--CA 1.475 0.807 0 N-CA-C 115.917 1.821 . . . . 0.0 115.917 -164.698 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -163.98 179.52 38.86 Favored Glycine 0 CA--C 1.531 1.056 0 CA-C-N 120.187 1.358 . . . . 0.0 115.587 -174.27 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 68.1 p -94.53 -15.27 24.28 Favored 'General case' 0 N--CA 1.471 0.614 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.728 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 3.7 p-10 -131.93 177.49 7.5 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.725 1.21 . . . . 0.0 112.61 -175.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 119.32 38.42 0.73 Allowed Glycine 0 CA--C 1.544 1.891 0 CA-C-O 116.307 -2.385 . . . . 0.0 118.706 171.158 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -55.07 107.84 0.26 Allowed 'Trans proline' 0 C--N 1.359 1.08 0 CA-C-N 122.715 3.258 . . . . 0.0 111.474 166.394 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 4.6 t -169.1 173.72 6.67 Favored 'General case' 0 CA--C 1.547 0.859 0 C-N-CA 125.383 1.473 . . . . 0.0 110.394 -165.948 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . . . . . . . . . 6.1 tmtm? -88.72 96.7 10.77 Favored 'General case' 0 N--CA 1.474 0.76 0 O-C-N 119.715 -1.866 . . . . 0.0 111.404 -177.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.4 p -56.75 123.93 60.85 Favored Pre-proline 0 N--CA 1.476 0.853 0 C-N-CA 123.774 0.83 . . . . 0.0 112.853 -178.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 67.1 Cg_endo -86.12 99.37 0.59 Allowed 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.641 2.894 . . . . 0.0 112.31 173.646 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.5 tt -131.07 145.7 35.05 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.537 0 C-N-CA 124.282 1.033 . . . . 0.0 109.255 164.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . 0.408 ' OG ' ' OD1' ' A' ' 57' ' ' ASP . 41.1 t -151.18 166.49 30.69 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.854 1.262 . . . . 0.0 112.789 -169.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 41.7 t -145.99 108.83 4.54 Favored 'General case' 0 C--O 1.237 0.429 0 C-N-CA 127.379 2.272 . . . . 0.0 110.338 -177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . . . . . . . . . 31.5 m -142.42 171.15 10.8 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 C-N-CA 123.839 0.855 . . . . 0.0 112.665 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -104.63 -6.52 20.39 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 -175.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 20.1 m -143.9 20.03 1.8 Allowed 'General case' 0 N--CA 1.473 0.714 0 O-C-N 120.422 -1.424 . . . . 0.0 112.687 -176.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER 61.15 20.48 10.99 Favored 'General case' 0 CA--C 1.55 0.976 0 C-N-CA 126.263 1.825 . . . . 0.0 111.966 -173.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 9.0 p-10 -82.15 48.31 1.24 Allowed 'General case' 0 CA--C 1.544 0.75 0 C-N-CA 129.896 3.278 . . . . 0.0 113.203 179.382 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.408 ' OD1' ' OG ' ' A' ' 50' ' ' SER . 29.9 m-20 -58.14 -17.19 16.76 Favored 'General case' 0 N--CA 1.479 1.004 0 N-CA-C 115.437 1.643 . . . . 0.0 115.437 -173.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -59.07 -7.66 1.2 Allowed 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 126.376 1.87 . . . . 0.0 114.753 163.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 85.1 m -150.05 87.19 5.07 Favored Pre-proline 0 CA--C 1.54 0.575 0 O-C-N 119.925 -1.734 . . . . 0.0 109.655 169.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 88.9 Cg_exo -52.11 115.24 2.04 Favored 'Trans proline' 0 C--N 1.352 0.75 0 C-N-CA 125.129 3.886 . . . . 0.0 114.279 179.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.4 t -92.39 -36.6 7.85 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.575 0 C-N-CA 125.248 1.419 . . . . 0.0 110.67 -178.067 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -94.91 -162.99 34.91 Favored Glycine 0 CA--C 1.536 1.354 0 C-N-CA 126.624 2.059 . . . . 0.0 111.98 170.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . . . . . . . . . 9.3 ptp85 -144.47 167.19 23.08 Favored 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 124.889 1.276 . . . . 0.0 112.261 174.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.514 ' H ' HD22 ' A' ' 64' ' ' LEU . 0.1 OUTLIER -90.78 106.77 18.74 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 125.883 1.673 . . . . 0.0 106.552 167.157 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 95.3 t -74.89 -54.34 14.53 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.808 0 C-N-CA 123.762 0.825 . . . . 0.0 110.164 -171.375 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.7 m -60.64 -49.26 78.23 Favored 'General case' 0 N--CA 1.471 0.612 0 C-N-CA 123.833 0.853 . . . . 0.0 113.002 -173.364 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 7.3 p -155.68 141.28 10.39 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.372 0 C-N-CA 123.028 0.531 . . . . 0.0 110.536 -175.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 45.8 m-80 -75.29 134.32 73.84 Favored Pre-proline 0 CA--C 1.545 0.765 0 C-N-CA 122.22 0.208 . . . . 0.0 110.5 174.133 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -84.38 92.21 0.78 Allowed 'Trans proline' 0 CA--C 1.543 0.955 0 C-N-CA 122.052 1.835 . . . . 0.0 114.309 -153.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 17.8 t80 -140.79 128.73 21.9 Favored 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 125.234 1.413 . . . . 0.0 110.547 169.545 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.411 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -82.92 87.86 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 C-N-CA 125.16 1.384 . . . . 0.0 108.214 178.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 20.2 t -73.26 -5.24 38.2 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 115.684 1.735 . . . . 0.0 115.684 -173.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -156.78 157.02 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.66 0 C-N-CA 124.698 1.199 . . . . 0.0 110.841 -173.426 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -74.36 -19.38 60.47 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 112.973 0.731 . . . . 0.0 112.973 172.749 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 64.8 p -74.17 5.98 3.93 Favored 'General case' 0 N--CA 1.473 0.702 0 C-N-CA 126.421 1.889 . . . . 0.0 113.841 178.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -69.14 12.22 0.17 Allowed 'General case' 0 CA--C 1.547 0.837 0 C-N-CA 125.844 1.658 . . . . 0.0 114.815 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.27 24.5 0.02 OUTLIER 'General case' 0 CA--C 1.553 1.062 0 C-N-CA 130.146 3.378 . . . . 0.0 114.921 -170.583 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -88.7 173.07 8.8 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 126.919 2.087 . . . . 0.0 113.758 -169.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.98 111.48 22.26 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 128.257 2.623 . . . . 0.0 105.306 164.656 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.7 p -140.71 128.12 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-O 121.919 0.866 . . . . 0.0 112.439 -158.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -92.44 125.85 37.26 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 128.052 2.541 . . . . 0.0 109.79 -175.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 96.9 mt -124.57 136.54 60.31 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.371 0 C-N-CA 127.589 2.355 . . . . 0.0 108.15 -173.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 30.0 mt-10 -86.64 134.49 33.61 Favored 'General case' 0 C--O 1.237 0.409 0 O-C-N 121.582 -0.699 . . . . 0.0 110.899 159.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 4.7 mp -115.72 157.34 24.43 Favored 'General case' 0 CA--C 1.534 0.356 0 C-N-CA 125.771 1.628 . . . . 0.0 109.761 164.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -99.65 106.85 42.64 Favored Pre-proline 0 CA--C 1.537 0.475 0 N-CA-C 107.496 -1.298 . . . . 0.0 107.496 169.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 84.6 Cg_endo -80.54 136.2 10.87 Favored 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 123.439 2.76 . . . . 0.0 109.829 170.945 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -61.56 161.72 23.44 Favored 'Trans proline' 0 CA--C 1.542 0.916 0 C-N-CA 121.467 1.445 . . . . 0.0 111.357 167.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 23.7 m-85 -88.23 166.75 14.12 Favored 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 123.35 0.66 . . . . 0.0 112.726 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 79.44 -89.44 1.22 Allowed Glycine 0 C--N 1.339 0.735 0 N-CA-C 109.536 -1.425 . . . . 0.0 109.536 -167.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -127.24 147.26 50.22 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 124.562 1.145 . . . . 0.0 110.304 177.241 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 86.2 p -146.41 141.76 27.49 Favored 'General case' 0 C--O 1.234 0.244 0 CA-C-O 121.737 0.78 . . . . 0.0 112.088 -176.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -130.74 121.34 25.27 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 126.385 1.874 . . . . 0.0 108.266 -178.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 29.0 mm -105.9 108.51 25.22 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 126.002 1.721 . . . . 0.0 107.278 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 32.6 t -113.14 139.25 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 124.289 1.036 . . . . 0.0 109.52 -164.411 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 48.0 t -136.92 97.45 1.51 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 C-N-CA 125.709 1.604 . . . . 0.0 107.899 -169.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 148.58 172.73 18.73 Favored Glycine 0 N--CA 1.467 0.71 0 N-CA-C 118.045 1.978 . . . . 0.0 118.045 176.49 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -131.81 114.82 15.17 Favored 'General case' 0 N--CA 1.464 0.245 0 C-N-CA 126.728 2.011 . . . . 0.0 110.211 -173.294 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 43.37 -103.5 0.04 OUTLIER Glycine 0 CA--C 1.532 1.117 0 C-N-CA 126.202 1.858 . . . . 0.0 114.086 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -70.67 -18.42 62.84 Favored 'General case' 0 CA--C 1.537 0.478 0 C-N-CA 127.138 2.175 . . . . 0.0 115.545 -177.713 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -123.14 93.95 4.11 Favored 'General case' 0 N--CA 1.467 0.412 0 CA-C-N 119.339 0.972 . . . . 0.0 109.844 -179.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -146.72 160.2 42.53 Favored 'General case' 0 C--N 1.343 0.323 0 N-CA-C 114.999 1.481 . . . . 0.0 114.999 -176.822 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.76 159.68 43.03 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.492 0 C-N-CA 129.135 2.974 . . . . 0.0 108.139 168.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 5.5 p30 -146.05 153.95 41.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 123.804 0.842 . . . . 0.0 110.081 165.711 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -137.91 166.91 22.87 Favored 'General case' 0 CA--C 1.534 0.328 0 C-N-CA 125.671 1.588 . . . . 0.0 109.493 173.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 6.3 p80 -124.33 157.89 33.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 123.886 0.874 . . . . 0.0 112.399 -174.228 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.51 151.38 28.84 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.051 1.74 . . . . 0.0 110.738 169.336 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 90.7 m-70 -127.29 136.86 52.55 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 124.808 1.243 . . . . 0.0 109.312 -169.437 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 21.8 mmmt -140.53 91.69 2.45 Favored 'General case' 0 N--CA 1.471 0.608 0 N-CA-C 113.452 0.908 . . . . 0.0 113.452 -153.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 20.0 t 76.35 17.32 2.0 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 127.223 2.209 . . . . 0.0 114.187 163.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.79 25.55 0.05 OUTLIER Glycine 0 CA--C 1.528 0.896 0 CA-C-O 118.644 -1.087 . . . . 0.0 115.727 -174.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 36.6 t -63.53 156.41 26.51 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-N 119.351 1.575 . . . . 0.0 110.849 167.188 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 77.6 p -62.34 -16.78 56.4 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 113.102 0.779 . . . . 0.0 113.102 166.671 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 21.0 mm -67.23 -10.55 12.29 Favored 'Isoleucine or valine' 0 CA--C 1.55 0.955 0 C-N-CA 125.634 1.574 . . . . 0.0 111.903 167.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 92.37 17.1 47.47 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 125.219 1.39 . . . . 0.0 113.993 174.141 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 11.6 tptp . . . . . 0 C--O 1.254 1.323 0 C-N-CA 125.367 1.467 . . . . 0.0 112.833 -161.558 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 29.7 pt . . . . . 0 N--CA 1.482 1.136 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -149.1 164.57 34.28 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 112.207 0.447 . . . . 0.0 112.207 -174.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.62 -174.53 3.49 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.884 2.074 . . . . 0.0 111.45 177.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -104.42 -57.08 2.08 Favored 'General case' 0 N--CA 1.468 0.444 0 O-C-N 121.602 -0.686 . . . . 0.0 110.815 175.129 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 7.2 pm0 -49.09 -52.47 25.63 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 127.842 2.457 . . . . 0.0 114.425 -171.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 46.7 tp -59.34 -31.42 69.16 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 118.917 0.781 . . . . 0.0 112.797 -173.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -76.3 -12.38 60.06 Favored 'General case' 0 N--CA 1.471 0.587 0 C-N-CA 125.064 1.345 . . . . 0.0 113.812 178.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -19.7 126.55 0.01 OUTLIER Glycine 0 CA--C 1.531 1.047 1 C-N-CA 130.773 4.035 . . . . 0.0 116.59 -174.634 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.476 ' HA ' ' HE3' ' A' ' 46' ' ' LYS . 79.3 p -73.96 74.58 1.68 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 126.216 1.806 . . . . 0.0 113.151 -173.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 17.5 p -59.89 -45.91 91.01 Favored 'General case' 0 N--CA 1.472 0.674 0 C-N-CA 125.882 1.673 . . . . 0.0 112.857 171.028 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 23.3 m-30 -123.74 174.4 7.51 Favored 'General case' 0 CA--C 1.547 0.834 0 C-N-CA 126.353 1.861 . . . . 0.0 110.712 174.389 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -79.17 148.94 31.89 Favored Glycine 0 CA--C 1.536 1.344 0 C-N-CA 124.379 0.99 . . . . 0.0 113.085 177.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . . 11.2 p -68.76 105.11 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.732 0 CA-C-O 122.621 1.2 . . . . 0.0 113.336 -170.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -162.92 151.83 14.75 Favored 'General case' 0 CA--C 1.54 0.572 0 C-N-CA 126.928 2.091 . . . . 0.0 109.281 -174.153 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 65.8 p -143.94 -33.62 0.41 Allowed 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 118.108 -0.949 . . . . 0.0 113.493 176.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 70.3 tttt 60.42 -69.27 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 128.596 2.759 . . . . 0.0 114.739 170.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -132.56 72.74 1.5 Allowed 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 125.492 1.517 . . . . 0.0 110.346 -161.05 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.6 m-85 -115.94 160.86 19.66 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.694 1.198 . . . . 0.0 110.049 165.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 31.0 tttm -141.97 144.22 33.6 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.652 1.581 . . . . 0.0 108.377 164.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 -67.72 147.63 52.38 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 121.835 0.826 . . . . 0.0 111.947 170.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -123.64 -46.83 1.99 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.924 1.29 . . . . 0.0 110.388 177.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -133.14 110.54 0.91 Allowed Glycine 0 C--N 1.338 0.642 0 C-N-CA 125.12 1.343 . . . . 0.0 111.239 -175.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 6.6 t -57.92 146.6 67.24 Favored Pre-proline 0 CA--C 1.541 0.62 0 CA-C-O 118.326 -0.845 . . . . 0.0 110.448 167.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_exo -61.2 155.22 52.52 Favored 'Trans proline' 0 C--N 1.351 0.71 0 N-CA-C 115.49 1.304 . . . . 0.0 115.49 -165.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -138.25 142.61 39.89 Favored 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 125.556 1.542 . . . . 0.0 110.282 168.045 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -70.43 132.65 45.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 122.769 0.428 . . . . 0.0 111.134 178.993 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 39.7 p -77.82 -24.25 48.79 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 114.563 1.319 . . . . 0.0 114.563 -175.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 82.19 -8.23 61.45 Favored Glycine 0 CA--C 1.537 1.464 0 CA-C-O 118.68 -1.066 . . . . 0.0 113.976 -160.128 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -75.25 -11.67 60.12 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-N 119.656 1.728 . . . . 0.0 111.342 163.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 98.14 -13.85 62.97 Favored Glycine 0 CA--C 1.537 1.415 0 C-N-CA 126.819 2.152 . . . . 0.0 113.105 -168.363 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 71.0 p -84.29 170.17 13.94 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 127.759 2.424 . . . . 0.0 112.036 177.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 1.9 m -114.24 124.41 70.86 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.449 0 C-N-CA 124.581 1.153 . . . . 0.0 110.317 167.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -79.24 128.06 38.74 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.505 0 C-N-CA 123.793 0.837 . . . . 0.0 109.357 164.07 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -138.53 159.27 42.5 Favored 'General case' 0 N--CA 1.468 0.446 0 C-N-CA 124.533 1.133 . . . . 0.0 111.908 167.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . . . . . . . . . 26.5 tt0 -132.17 135.25 46.22 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 112.572 0.582 . . . . 0.0 112.572 -165.404 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 4.3 mp -128.26 168.04 16.04 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.819 1.247 . . . . 0.0 110.489 171.261 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 10.9 pt20 -123.7 148.17 46.79 Favored 'General case' 0 C--O 1.234 0.257 0 C-N-CA 124.844 1.257 . . . . 0.0 110.267 167.01 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 33.4 t80 -97.51 108.91 21.74 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.137 0.975 . . . . 0.0 109.787 176.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 24.7 p -87.45 0.51 55.41 Favored 'General case' 0 N--CA 1.469 0.496 0 C-N-CA 126.119 1.768 . . . . 0.0 113.775 -171.493 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -109.51 173.16 16.73 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.712 1.149 . . . . 0.0 113.69 178.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.9 m -118.3 11.8 13.22 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 125.995 1.718 . . . . 0.0 111.56 -177.798 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -149.25 -175.3 4.93 Favored 'General case' 0 CA--C 1.542 0.643 0 C-N-CA 127.32 2.248 . . . . 0.0 111.154 -168.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 82.44 56.95 2.7 Favored Glycine 0 CA--C 1.538 1.527 0 CA-C-O 117.805 -1.553 . . . . 0.0 116.907 171.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -49.45 95.74 0.03 OUTLIER 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.548 2.832 . . . . 0.0 112.281 155.586 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -146.3 169.07 19.55 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.851 1.26 . . . . 0.0 112.752 -169.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.476 ' HE3' ' HA ' ' A' ' 9' ' ' THR . 2.5 ttmm -95.78 101.38 13.06 Favored 'General case' 0 N--CA 1.469 0.502 0 O-C-N 120.828 -1.17 . . . . 0.0 110.523 171.32 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 2.7 p -63.78 115.45 18.88 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 124.726 1.21 . . . . 0.0 111.321 176.73 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -78.3 88.45 1.44 Allowed 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.932 2.422 . . . . 0.0 111.221 174.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 14.0 tt -106.77 144.9 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.612 0 C-N-CA 124.23 1.012 . . . . 0.0 109.412 165.39 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 32.8 t -145.85 167.87 22.18 Favored 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 125.011 1.324 . . . . 0.0 113.283 -172.854 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 26.8 t -139.81 110.96 6.96 Favored 'General case' 0 N--CA 1.47 0.527 0 C-N-CA 127.563 2.345 . . . . 0.0 109.811 -179.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.429 HG11 ' HA ' ' A' ' 57' ' ' ASP . 28.4 m -137.3 161.43 34.76 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.899 0 N-CA-C 113.619 0.97 . . . . 0.0 113.619 -176.805 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -97.19 -8.57 29.67 Favored 'General case' 0 CA--C 1.54 0.596 0 N-CA-C 114.306 1.224 . . . . 0.0 114.306 -170.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 72.4 m -155.68 36.65 0.36 Allowed 'General case' 0 N--CA 1.473 0.723 0 O-C-N 120.164 -1.585 . . . . 0.0 112.321 179.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 58.96 8.41 0.98 Allowed 'General case' 0 CA--C 1.551 0.985 0 C-N-CA 126.324 1.85 . . . . 0.0 114.541 -175.309 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 3.2 p-10 -67.96 40.78 0.03 OUTLIER 'General case' 0 CA--C 1.55 0.96 0 C-N-CA 131.104 3.762 . . . . 0.0 114.839 -176.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.429 ' HA ' HG11 ' A' ' 52' ' ' VAL . 7.8 t0 -63.61 0.49 0.75 Allowed 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 117.252 2.316 . . . . 0.0 117.252 -160.306 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 1.8 pp -66.75 -18.67 65.49 Favored 'General case' 0 CA--C 1.546 0.802 0 O-C-N 121.13 -0.981 . . . . 0.0 112.966 160.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.1 m -128.33 101.48 21.77 Favored Pre-proline 0 N--CA 1.471 0.608 0 C-N-CA 126.102 1.761 . . . . 0.0 109.865 179.325 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 62.4 Cg_endo -66.53 117.83 5.04 Favored 'Trans proline' 0 CA--C 1.539 0.752 0 C-N-CA 123.004 2.47 . . . . 0.0 110.325 175.449 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.2 t -96.83 -30.98 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 C-N-CA 123.89 0.876 . . . . 0.0 111.144 -174.163 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -104.4 -164.63 24.55 Favored Glycine 0 CA--C 1.532 1.121 0 C-N-CA 126.335 1.922 . . . . 0.0 111.537 166.298 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.458 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 9.4 ptp85 -139.48 169.62 17.41 Favored 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 125.673 1.589 . . . . 0.0 111.803 179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -92.76 114.79 27.45 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.201 1.8 . . . . 0.0 106.809 170.421 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 76.3 t -86.9 -51.92 12.37 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.664 0 CA-C-O 119.209 -0.424 . . . . 0.0 111.282 -167.748 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 96.4 m -60.73 -44.31 96.82 Favored 'General case' 0 N--CA 1.474 0.745 0 N-CA-C 113.563 0.949 . . . . 0.0 113.563 -171.569 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 14.2 p -159.83 159.0 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.511 0 C-N-CA 123.476 0.71 . . . . 0.0 111.03 -169.153 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -55.77 127.19 67.15 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.667 0.787 . . . . 0.0 109.091 163.789 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -75.06 89.56 1.16 Allowed 'Trans proline' 0 CA--C 1.538 0.708 0 C-N-CA 121.978 1.785 . . . . 0.0 110.916 -175.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 6.4 p90 -144.05 142.78 30.85 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-O 121.792 0.806 . . . . 0.0 112.737 168.331 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . . . . . . . . . 19.8 t -76.49 86.71 0.79 Allowed 'Isoleucine or valine' 0 N--CA 1.464 0.242 0 C-N-CA 127.46 2.304 . . . . 0.0 106.864 171.014 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 37.0 p -59.97 -28.68 67.87 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 115.394 1.628 . . . . 0.0 115.394 -167.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -150.86 161.17 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.607 0 C-N-CA 125.529 1.531 . . . . 0.0 112.146 -173.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -60.78 -28.01 68.43 Favored 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 124.119 0.968 . . . . 0.0 112.702 166.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.62 5.45 4.83 Favored 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 127.384 2.274 . . . . 0.0 114.665 172.33 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -64.41 14.76 0.02 OUTLIER 'General case' 0 CA--C 1.552 1.03 0 N-CA-C 115.901 1.815 . . . . 0.0 115.901 178.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -64.1 16.97 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.694 3.598 . . . . 0.0 115.425 -167.831 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -75.53 169.66 17.66 Favored 'General case' 0 CA--C 1.54 0.588 0 C-N-CA 126.279 1.832 . . . . 0.0 113.768 -172.299 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -108.71 111.14 22.75 Favored 'General case' 0 N--CA 1.466 0.357 0 C-N-CA 128.711 2.805 . . . . 0.0 105.473 159.756 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 3.2 p -136.71 126.65 39.25 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 124.034 0.934 . . . . 0.0 112.342 -159.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -90.97 130.97 36.84 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 127.286 2.234 . . . . 0.0 109.644 179.701 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 13.8 mt -133.97 142.77 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.764 0 C-N-CA 125.106 1.363 . . . . 0.0 109.889 -176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 42.4 mt-10 -88.81 135.1 33.7 Favored 'General case' 0 CA--C 1.537 0.473 0 C-N-CA 124.302 1.041 . . . . 0.0 111.772 168.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 7.1 mp -118.0 157.75 26.21 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.576 1.95 . . . . 0.0 109.844 165.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.458 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 35.6 tt0 -90.95 113.45 58.16 Favored Pre-proline 0 CA--C 1.541 0.634 0 C-N-CA 123.838 0.855 . . . . 0.0 109.041 171.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . . . . . . . . . 97.9 Cg_endo -79.28 122.91 5.34 Favored 'Trans proline' 0 CA--C 1.543 0.946 0 C-N-CA 123.804 3.003 . . . . 0.0 109.92 175.008 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -67.56 164.29 31.58 Favored 'Trans proline' 0 CA--C 1.542 0.892 0 C-N-CA 121.706 1.604 . . . . 0.0 111.846 171.17 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 76.6 m-85 -80.98 145.0 31.41 Favored 'General case' 0 CA--C 1.538 0.509 0 O-C-N 121.29 -0.881 . . . . 0.0 111.783 -178.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 104.09 -94.34 1.06 Allowed Glycine 0 CA--C 1.529 0.925 0 C-N-CA 126.695 2.093 . . . . 0.0 110.268 -173.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -112.77 174.8 5.72 Favored 'General case' 0 CA--C 1.541 0.617 0 C-N-CA 124.7 1.2 . . . . 0.0 110.267 167.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 22.6 m -153.15 96.32 2.05 Favored 'General case' 0 N--CA 1.463 0.187 0 O-C-N 120.606 -1.309 . . . . 0.0 110.917 179.291 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -96.63 127.27 42.46 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 125.446 1.498 . . . . 0.0 109.523 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 36.3 mm -110.28 96.97 5.13 Favored 'Isoleucine or valine' 0 C--O 1.232 0.167 0 C-N-CA 125.263 1.425 . . . . 0.0 107.612 -168.825 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 36.1 t -96.98 140.81 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 C-N-CA 124.182 0.993 . . . . 0.0 109.695 -171.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 86.0 t -135.66 99.31 2.23 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.396 0 C-N-CA 126.348 1.859 . . . . 0.0 107.834 -178.659 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 162.08 169.14 25.01 Favored Glycine 0 CA--C 1.527 0.805 0 N-CA-C 118.332 2.093 . . . . 0.0 118.332 176.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 1.9 ptm180 -137.59 123.9 20.61 Favored 'General case' 0 N--CA 1.469 0.498 0 C-N-CA 127.835 2.454 . . . . 0.0 108.975 178.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . 37.39 -98.54 0.01 OUTLIER Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.407 1.956 . . . . 0.0 114.92 177.165 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 2.9 pm0 -71.37 -17.07 62.44 Favored 'General case' 0 CA--C 1.541 0.602 0 N-CA-C 115.919 1.822 . . . . 0.0 115.919 -177.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -125.58 99.54 6.05 Favored 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 124.632 1.173 . . . . 0.0 109.58 -178.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -141.39 156.28 45.82 Favored 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 114.482 1.29 . . . . 0.0 114.482 175.864 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -141.92 164.79 18.38 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 128.46 2.704 . . . . 0.0 108.182 168.927 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 8.3 p30 -149.83 160.78 43.29 Favored 'General case' 0 CA--C 1.535 0.367 0 O-C-N 121.697 -0.627 . . . . 0.0 111.023 167.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -130.23 171.68 12.63 Favored 'General case' 0 CA--C 1.539 0.534 0 C-N-CA 126.532 1.933 . . . . 0.0 109.899 170.398 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -129.1 144.16 51.11 Favored 'General case' 0 N--CA 1.466 0.368 0 C-N-CA 124.221 1.008 . . . . 0.0 111.56 -166.659 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -149.39 164.07 35.98 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 126.258 1.823 . . . . 0.0 110.783 169.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 80.9 m-70 -146.17 114.46 6.67 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.547 1.539 . . . . 0.0 108.512 -162.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -152.54 96.3 2.12 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 113.999 1.111 . . . . 0.0 113.999 -163.018 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 27.7 p 56.6 82.16 0.12 Allowed 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 128.609 2.763 . . . . 0.0 114.026 173.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 115.9 21.42 4.97 Favored Glycine 0 CA--C 1.534 1.245 0 C-N-CA 126.496 1.998 . . . . 0.0 112.961 -178.465 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 41.8 t -70.77 156.95 38.88 Favored 'General case' 0 CA--C 1.535 0.376 0 N-CA-C 115.211 1.56 . . . . 0.0 115.211 -166.95 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 16.6 m -54.6 -19.05 5.24 Favored 'General case' 0 N--CA 1.469 0.5 0 C-N-CA 125.852 1.661 . . . . 0.0 114.081 164.563 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 8.8 tt -112.98 16.25 8.13 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.807 0 C-N-CA 124.721 1.208 . . . . 0.0 112.735 173.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 88.77 4.4 75.81 Favored Glycine 0 CA--C 1.532 1.132 0 N-CA-C 116.111 1.204 . . . . 0.0 116.111 164.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 3.1 ptmm? . . . . . 0 C--O 1.252 1.186 0 C-N-CA 125.331 1.452 . . . . 0.0 113.56 179.146 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ILE . . . . . . . . . . . . . 36.7 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 10.5 t -146.61 146.95 30.6 Favored 'General case' 0 N--CA 1.461 0.102 0 CA-C-O 121.171 0.51 . . . . 0.0 111.897 -168.007 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.62 173.02 9.79 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 128.061 2.544 . . . . 0.0 109.924 173.175 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' PHE . . . . . . . . . . . . . 16.0 m-85 -98.7 -49.39 4.61 Favored 'General case' 0 N--CA 1.47 0.56 0 O-C-N 121.258 -0.901 . . . . 0.0 111.336 -175.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLN . . . . . . . . . . . . . 14.7 pm0 -61.33 -33.46 73.65 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.452 1.901 . . . . 0.0 114.12 -172.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . . . . . . . . . 2.8 tm? -62.11 -38.16 87.84 Favored 'General case' 0 N--CA 1.469 0.49 0 C-N-CA 123.533 0.733 . . . . 0.0 110.963 173.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.412 ' HE2' ' HB2' ' A' ' 60' ' ' PRO . 32.0 mmtm -69.86 -40.23 75.89 Favored 'General case' 0 N--CA 1.465 0.313 0 CA-C-O 118.101 -0.952 . . . . 0.0 110.917 -179.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 11.62 109.73 0.0 OUTLIER Glycine 0 CA--C 1.534 1.278 0 C-N-CA 130.657 3.98 . . . . 0.0 117.072 170.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.412 ' HA ' ' HE2' ' A' ' 46' ' ' LYS . 80.9 p -67.49 71.34 0.12 Allowed 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 126.925 2.09 . . . . 0.0 112.557 177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -64.14 -19.71 65.48 Favored 'General case' 0 N--CA 1.466 0.329 0 C-N-CA 129.414 3.086 . . . . 0.0 114.78 177.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 8.6 t80 -158.62 -172.97 4.05 Favored 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 124.845 1.258 . . . . 0.0 110.686 173.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -58.59 118.35 13.48 Favored Glycine 0 CA--C 1.534 1.247 0 C-N-CA 124.718 1.151 . . . . 0.0 112.738 175.384 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' VAL . . . . . . . . . . . . 0.27 13.3 p -67.41 99.63 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 C-N-CA 124.66 1.184 . . . . 0.0 112.979 -177.432 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -155.74 160.04 39.98 Favored 'General case' 0 CA--C 1.541 0.599 0 C-N-CA 127.737 2.415 . . . . 0.0 109.467 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' SER . . . . . . . . . . . . . 10.8 p -136.8 -35.57 0.71 Allowed 'General case' 0 N--CA 1.474 0.755 0 C-N-CA 124.672 1.189 . . . . 0.0 112.815 173.36 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 34.3 tttm 54.86 -79.42 0.01 OUTLIER 'General case' 0 C--N 1.341 0.237 0 C-N-CA 127.822 2.449 . . . . 0.0 114.634 178.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ALA . . . . . . . . . . . . . . . -106.53 84.12 1.97 Allowed 'General case' 0 CA--C 1.535 0.38 0 CA-C-N 118.531 0.605 . . . . 0.0 111.958 -162.558 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.62 163.98 26.9 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 123.782 0.833 . . . . 0.0 112.268 169.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LYS . . . . . . . . . . . . . 32.4 tttm -149.93 145.82 26.71 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 127.428 2.291 . . . . 0.0 108.275 160.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' PHE . . . . . . . . . . . . . 24.8 m-85 -65.46 140.27 58.59 Favored 'General case' 0 N--CA 1.472 0.629 0 O-C-N 121.558 -0.714 . . . . 0.0 111.449 169.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -116.34 -52.08 2.59 Favored 'General case' 0 N--CA 1.468 0.434 0 C-N-CA 124.408 1.083 . . . . 0.0 109.903 175.25 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -123.65 112.81 1.94 Allowed Glycine 0 CA--C 1.525 0.673 0 C-N-CA 125.557 1.551 . . . . 0.0 110.37 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 69.1 p -52.23 141.8 30.23 Favored Pre-proline 0 N--CA 1.469 0.482 0 C-N-CA 125.088 1.355 . . . . 0.0 111.092 176.509 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -57.22 145.82 84.97 Favored 'Trans proline' 0 CA--C 1.536 0.61 0 C-N-CA 122.759 2.306 . . . . 0.0 112.764 -176.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ALA . . . . . . . . . . . . . . . -136.33 119.51 16.63 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.349 1.46 . . . . 0.0 110.706 179.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASP . . . . . . . . . . . . . 10.6 t0 -65.0 125.22 24.23 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 121.356 0.598 . . . . 0.0 110.648 178.219 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' THR . . . . . . . . . . . . . 75.0 p -70.26 -8.22 48.49 Favored 'General case' 0 N--CA 1.468 0.427 0 C-N-CA 127.145 2.178 . . . . 0.0 114.0 -178.253 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 69.85 -8.49 3.4 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.64 1.114 . . . . 0.0 113.569 -168.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.5 m80 -94.62 5.62 51.3 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 126.447 1.899 . . . . 0.0 111.276 176.463 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 93.14 18.72 38.55 Favored Glycine 0 CA--C 1.53 1.008 0 C-N-CA 124.698 1.142 . . . . 0.0 113.97 179.238 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' THR . . . . . . . . . . . . . 77.4 p -130.32 161.8 30.45 Favored 'General case' 0 N--CA 1.472 0.627 0 C-N-CA 125.117 1.367 . . . . 0.0 111.144 179.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -112.7 121.71 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 C-N-CA 125.657 1.583 . . . . 0.0 108.701 167.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 4.6 m -80.32 130.4 36.02 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.63 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 162.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' LEU . . . . . 0.416 HD23 ' N ' ' A' ' 35' ' ' GLU . 4.7 tt -141.9 131.89 24.55 Favored 'General case' 0 N--CA 1.469 0.504 0 C-N-CA 126.195 1.798 . . . . 0.0 109.704 -169.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLU . . . . . 0.416 ' N ' HD23 ' A' ' 34' ' ' LEU . 19.0 tt0 -115.91 130.84 57.0 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 119.114 0.87 . . . . 0.0 113.243 -177.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LEU . . . . . . . . . . . . . 1.7 mp -123.05 167.31 13.8 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.36 1.064 . . . . 0.0 111.164 170.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -119.21 142.84 47.66 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 125.371 1.468 . . . . 0.0 109.836 166.349 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' TYR . . . . . . . . . . . . . 24.5 t80 -95.1 98.27 10.54 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 124.303 1.041 . . . . 0.0 110.691 -177.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 20.5 p -76.06 22.25 0.16 Allowed 'General case' 0 N--CA 1.476 0.852 0 C-N-CA 127.459 2.303 . . . . 0.0 115.846 -163.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLY . . . . . . . . . . . . . . . -161.39 176.02 37.95 Favored Glycine 0 N--CA 1.467 0.742 0 O-C-N 120.905 -1.122 . . . . 0.0 114.601 -174.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 28.5 p -99.2 -4.69 31.47 Favored 'General case' 0 N--CA 1.472 0.633 0 C-N-CA 126.501 1.921 . . . . 0.0 113.64 -174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -138.23 176.77 8.41 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 125.718 1.607 . . . . 0.0 112.732 -167.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' GLY . . . . . . . . . . . . . . . 96.78 48.2 2.16 Favored Glycine 0 CA--C 1.539 1.58 0 CA-C-O 117.244 -1.864 . . . . 0.0 116.944 175.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_exo -59.97 99.11 0.13 Allowed 'Trans proline' 0 C--N 1.356 0.959 0 CA-C-N 121.761 2.781 . . . . 0.0 110.068 162.598 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.437 ' H ' ' HB ' ' A' ' 71' ' ' VAL . 56.2 m -145.39 163.72 33.73 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.504 1.522 . . . . 0.0 111.725 -167.173 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' LYS . . . . . 0.412 ' HE2' ' HA ' ' A' ' 9' ' ' THR . 4.3 tmtm? -80.08 90.0 5.41 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.181 -0.949 . . . . 0.0 109.167 172.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 1.9 p -55.11 114.51 7.23 Favored Pre-proline 0 N--CA 1.481 1.106 0 C-N-CA 124.852 1.261 . . . . 0.0 112.516 -175.326 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -72.53 99.46 1.05 Allowed 'Trans proline' 0 CA--C 1.54 0.792 0 C-N-CA 122.345 2.03 . . . . 0.0 110.761 168.214 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . . . . . . . . . 15.7 tt -126.51 145.67 33.66 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.427 0 C-N-CA 125.081 1.352 . . . . 0.0 108.446 163.573 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' SER . . . . . . . . . . . . . 29.3 t -147.02 164.11 34.06 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 124.573 1.149 . . . . 0.0 112.806 -170.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 43.9 t -137.76 115.39 11.3 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 127.556 2.342 . . . . 0.0 109.218 176.35 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 57' ' ' ASP . 11.1 m -130.58 169.96 20.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.736 0 C-N-CA 124.808 1.243 . . . . 0.0 111.593 176.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ALA . . . . . . . . . . . . . . . -108.58 -0.03 20.51 Favored 'General case' 0 CA--C 1.542 0.665 0 N-CA-C 113.782 1.03 . . . . 0.0 113.782 -176.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 73.8 m -154.31 28.87 0.45 Allowed 'General case' 0 N--CA 1.474 0.73 0 O-C-N 120.198 -1.564 . . . . 0.0 112.709 -178.66 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER 56.99 6.44 0.32 Allowed 'General case' 0 N--CA 1.478 0.945 0 C-N-CA 127.223 2.209 . . . . 0.0 115.203 -174.006 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -71.36 56.74 0.24 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 129.912 3.285 . . . . 0.0 112.436 176.721 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.514 ' HA ' HG11 ' A' ' 52' ' ' VAL . 6.8 t70 -64.82 -4.72 4.69 Favored 'General case' 0 CA--C 1.543 0.68 0 N-CA-C 116.534 2.05 . . . . 0.0 116.534 -165.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.45 -16.0 20.93 Favored 'General case' 0 CA--C 1.542 0.672 0 C-N-CA 125.417 1.487 . . . . 0.0 114.515 175.683 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 53.0 m -157.11 116.11 2.0 Allowed Pre-proline 0 N--CA 1.47 0.574 0 O-C-N 120.678 -1.264 . . . . 0.0 109.16 165.789 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.412 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 85.0 Cg_exo -48.23 127.82 16.02 Favored 'Trans proline' 0 CA--C 1.539 0.758 0 C-N-CA 124.229 3.286 . . . . 0.0 113.665 176.979 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 32.9 t -91.37 -26.65 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 126.054 1.742 . . . . 0.0 110.911 174.927 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . -99.56 -164.82 29.42 Favored Glycine 0 CA--C 1.531 1.062 0 C-N-CA 126.484 1.992 . . . . 0.0 111.116 163.034 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ARG . . . . . 0.402 ' H ' ' HB3' ' A' ' 85' ' ' GLU . 0.1 OUTLIER -135.78 177.95 7.43 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 123.403 0.681 . . . . 0.0 112.62 173.598 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -94.49 142.49 27.37 Favored 'General case' 0 CA--C 1.537 0.47 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 163.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' VAL . . . . . . . . . . . . . 70.0 t -106.8 -45.88 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.823 0 CA-C-N 118.548 0.613 . . . . 0.0 110.108 -174.137 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 18.2 m -61.86 -43.81 98.09 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 114.781 1.401 . . . . 0.0 114.781 -175.776 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' VAL . . . . . . . . . . . . . 9.4 p -158.65 157.18 3.45 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 119.823 1.192 . . . . 0.0 112.375 -168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 -62.09 128.6 91.08 Favored Pre-proline 0 N--CA 1.472 0.634 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 159.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -62.29 89.02 0.11 Allowed 'Trans proline' 0 CA--C 1.545 1.03 0 C-N-CA 122.367 2.045 . . . . 0.0 113.707 -172.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' PHE . . . . . . . . . . . . . 50.0 t80 -155.59 114.08 3.46 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.227 1.811 . . . . 0.0 111.815 -174.324 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' VAL . . . . . 0.437 ' HB ' ' H ' ' A' ' 45' ' ' CYS . 20.7 t -76.74 93.49 1.12 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 C-N-CA 126.836 2.054 . . . . 0.0 108.2 171.822 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' SER . . . . . . . . . . . . . 23.1 t -69.63 -7.26 37.3 Favored 'General case' 0 CA--C 1.54 0.588 0 N-CA-C 116.244 1.942 . . . . 0.0 116.244 -171.191 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -158.16 154.06 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.75 0 CA-C-N 119.874 1.216 . . . . 0.0 111.989 -170.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -65.83 -23.91 66.78 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 124.249 1.02 . . . . 0.0 112.322 167.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -69.16 0.05 5.29 Favored 'General case' 0 N--CA 1.47 0.571 0 C-N-CA 129.187 2.995 . . . . 0.0 114.07 178.723 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ALA . . . . . . . . . . . . . . . -68.24 11.82 0.15 Allowed 'General case' 0 CA--C 1.548 0.88 0 C-N-CA 125.849 1.66 . . . . 0.0 115.429 -176.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -64.35 17.34 0.02 OUTLIER 'General case' 0 N--CA 1.479 1.024 0 C-N-CA 130.304 3.442 . . . . 0.0 115.597 -167.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ALA . . . . . . . . . . . . . . . -85.2 176.78 8.15 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 126.893 2.077 . . . . 0.0 114.126 -168.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.29 114.51 27.75 Favored 'General case' 0 N--CA 1.466 0.372 0 C-N-CA 128.836 2.854 . . . . 0.0 106.171 164.209 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 2.6 p -145.62 132.03 14.31 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.715 0 CA-C-O 121.561 0.696 . . . . 0.0 112.749 -158.497 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 6.5 mt -83.86 137.97 33.42 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 127.263 2.225 . . . . 0.0 111.109 172.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 68.6 mt -134.84 144.05 35.78 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 C-N-CA 127.005 2.122 . . . . 0.0 108.69 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 26.4 mt-10 -98.91 135.75 39.89 Favored 'General case' 0 C--O 1.239 0.533 0 C-N-CA 124.281 1.032 . . . . 0.0 112.476 169.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 6.4 mp -122.36 166.56 14.5 Favored 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 127.77 2.428 . . . . 0.0 110.442 170.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.402 ' HB3' ' H ' ' A' ' 63' ' ' ARG . 5.3 tt0 -102.37 110.67 63.32 Favored Pre-proline 0 CA--C 1.546 0.822 0 C-N-CA 124.073 0.949 . . . . 0.0 110.009 171.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PRO . . . . . 0.404 ' HA ' ' HD2' ' A' ' 87' ' ' PRO . 92.0 Cg_endo -84.88 108.59 1.2 Allowed 'Trans proline' 0 CA--C 1.549 1.226 1 C-N-CA 125.729 4.286 . . . . 0.0 111.084 172.571 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.404 ' HD2' ' HA ' ' A' ' 86' ' ' PRO . 58.2 Cg_endo -60.34 161.56 19.79 Favored 'Trans proline' 0 CA--C 1.542 0.915 0 C-N-CA 122.664 2.243 . . . . 0.0 112.53 172.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -86.38 165.31 16.46 Favored 'General case' 0 CA--C 1.534 0.342 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 -168.168 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 76.92 -80.26 1.23 Allowed Glycine 0 C--N 1.338 0.691 0 N-CA-C 109.135 -1.586 . . . . 0.0 109.135 -165.067 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -127.01 156.66 41.27 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 124.801 1.24 . . . . 0.0 111.139 177.555 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' SER . . . . . . . . . . . . . 3.0 m -143.02 142.17 31.51 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.523 1.129 . . . . 0.0 110.161 172.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 91.6 m-85 -137.92 128.63 26.81 Favored 'General case' 0 C--N 1.326 -0.45 0 C-N-CA 124.644 1.178 . . . . 0.0 108.096 175.144 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' ILE . . . . . . . . . . . . . 35.8 mm -119.22 98.64 6.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.265 1.426 . . . . 0.0 107.255 -162.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' VAL . . . . . . . . . . . . . 37.8 t -99.92 136.49 30.97 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.306 0 C-N-CA 123.939 0.896 . . . . 0.0 109.114 -167.153 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' VAL . . . . . . . . . . . . . 61.6 t -128.6 103.98 10.67 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.218 0 C-N-CA 125.67 1.588 . . . . 0.0 107.524 -176.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' GLY . . . . . . . . . . . . . . . 133.97 177.59 15.04 Favored Glycine 0 CA--C 1.523 0.543 0 CA-C-O 122.299 0.944 . . . . 0.0 114.763 179.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' ARG . . . . . . . . . . . . . 7.8 ptm180 -127.47 154.51 45.0 Favored 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 127.195 2.198 . . . . 0.0 108.471 179.216 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' GLY . . . . . . . . . . . . . . . -12.2 -72.74 0.01 OUTLIER Glycine 0 CA--C 1.537 1.428 0 C-N-CA 127.68 2.562 . . . . 0.0 117.164 -173.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -78.11 -13.72 59.76 Favored 'General case' 0 CA--C 1.545 0.787 0 N-CA-C 116.191 1.923 . . . . 0.0 116.191 -175.853 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.9 88.04 2.29 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.623 1.569 . . . . 0.0 109.971 177.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLN . . . . . . . . . . . . . 19.9 pt20 -143.25 157.7 44.26 Favored 'General case' 0 C--N 1.343 0.289 0 N-CA-C 115.879 1.807 . . . . 0.0 115.879 179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -139.29 161.4 28.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.645 0 C-N-CA 129.382 3.073 . . . . 0.0 107.839 177.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.69 150.82 36.15 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 121.05 -1.031 . . . . 0.0 112.513 175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 16.0 t-80 -120.87 170.25 9.66 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.766 1.226 . . . . 0.0 110.832 166.333 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' HIS . . . . . . . . . . . . . 7.3 p80 -125.8 159.74 31.63 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.616 1.967 . . . . 0.0 111.31 -177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -154.0 153.01 31.2 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 128.198 2.599 . . . . 0.0 110.599 169.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' HIS . . . . . . . . . . . . . 70.5 m-70 -143.58 117.3 9.27 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.952 0.901 . . . . 0.0 108.765 -167.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LYS . . . . . . . . . . . . . 19.5 ptmt -150.57 93.04 1.92 Allowed 'General case' 0 N--CA 1.47 0.557 0 N-CA-C 114.434 1.272 . . . . 0.0 114.434 -165.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' SER . . . . . . . . . . . . . 90.1 p 65.8 58.0 0.8 Allowed 'General case' 0 N--CA 1.477 0.884 0 C-N-CA 126.081 1.753 . . . . 0.0 114.077 165.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 128.65 25.3 1.04 Allowed Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.882 1.706 . . . . 0.0 113.439 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 115' ' ' LYS . 30.1 t -61.01 158.0 14.39 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 126.239 1.816 . . . . 0.0 113.475 -177.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' SER . . . . . . . . . . . . . 1.8 m -55.52 -22.81 23.02 Favored 'General case' 0 N--CA 1.469 0.525 0 C-N-CA 124.322 1.049 . . . . 0.0 112.454 163.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' ILE . . . . . . . . . . . . . 13.0 mm -91.33 -3.78 10.66 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.988 0 C-N-CA 126.809 2.044 . . . . 0.0 111.523 177.122 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 85.64 13.54 69.87 Favored Glycine 0 CA--C 1.534 1.277 0 O-C-N 120.635 -1.291 . . . . 0.0 115.469 175.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.4 ' H ' ' HB3' ' A' ' 111' ' ' SER . 2.6 ptmm? . . . . . 0 C--O 1.249 1.029 0 C-N-CA 126.022 1.729 . . . . 0.0 113.206 178.769 . . . . . . . . 1 1 . 1 stop_ save_